data_2k3g_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2k3g _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo . . . . . 0 N--CA 1.503 2.075 0 N-CA-C 111.304 -0.306 . . . . 0.55000000000000004 111.304 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -152.89 49.32 0.73 Allowed 'General case' 0 N--CA 1.498 1.948 0 CA-C-O 121.174 0.511 . . . . 0.79000000000000004 110.699 -178.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 23.2 tp -158.82 101.53 1.64 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.811 -0.555 . . . . 1.04 110.601 -176.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -99.97 118.18 35.83 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 110.167 -0.308 . . . . 1.9199999999999999 110.167 176.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 68.0 m -121.71 140.53 52.2 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 122.025 -0.422 . . . . 0.47999999999999998 110.935 -178.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -78.52 150.54 32.87 Favored 'General case' 0 N--CA 1.501 2.094 0 C-N-CA 120.751 -0.38 . . . . 0.98999999999999999 110.032 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 27.0 p -119.01 140.68 49.62 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 122.044 -0.41 . . . . 0.29999999999999999 110.547 -177.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 30.9 t -123.0 143.14 50.13 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 122.072 -0.392 . . . . 2.0600000000000001 110.155 178.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.63 -69.9 1.43 Allowed Glycine 0 N--CA 1.495 2.606 0 N-CA-C 109.668 -1.373 . . . . 1.0 109.668 177.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -115.51 123.83 49.52 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 122.074 -0.662 . . . . 3.29 110.544 -176.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -138.11 147.7 57.12 Favored Pre-proline 0 N--CA 1.497 1.879 0 N-CA-C 109.386 -0.598 . . . . 0.51000000000000001 109.386 175.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -63.8 151.62 84.32 Favored 'Trans proline' 0 N--CA 1.492 1.432 0 O-C-N 123.203 1.107 . . . . 0.46999999999999997 110.864 -174.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -59.15 -21.86 60.02 Favored 'General case' 0 N--CA 1.507 2.379 0 O-C-N 121.985 -0.447 . . . . 2.0299999999999998 111.521 177.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -96.7 14.15 25.97 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.776 -0.577 . . . . 1.1399999999999999 111.864 -177.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -83.31 162.1 21.22 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.607 -0.683 . . . . 1.0700000000000001 110.466 -173.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 77.5 mt -125.51 142.39 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 N-CA-C 108.873 -0.788 . . . . 1.27 108.873 -178.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 38.44 41.58 0.46 Allowed 'General case' 0 N--CA 1.514 2.735 0 N-CA-C 113.271 0.841 . . . . 1.8700000000000001 113.271 -177.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 54.97 41.01 32.24 Favored 'General case' 0 N--CA 1.508 2.459 0 O-C-N 121.802 -0.561 . . . . 2.1000000000000001 111.489 -179.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 41.6 p -137.68 160.31 39.57 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.877 -0.514 . . . . 1.01 110.373 173.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.3 p -135.75 162.15 33.57 Favored 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 120.957 0.408 . . . . 0.23000000000000001 110.465 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 78.9 mt -129.29 125.91 62.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 108.774 -0.825 . . . . 1.1000000000000001 108.774 -169.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.5 t -140.12 159.21 42.68 Favored 'General case' 0 N--CA 1.5 2.049 0 C-N-CA 120.537 -0.465 . . . . 1.03 111.288 -177.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 38.1 p-10 -106.59 28.22 8.06 Favored 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 120.856 -0.338 . . . . 1.3600000000000001 110.505 164.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -117.35 -113.86 2.69 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 109.057 -1.617 . . . . 0.23000000000000001 109.057 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 7.8 m-70 -136.75 157.57 46.44 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 108.996 -0.742 . . . . 2.1400000000000001 108.996 175.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 96.4 m -99.11 139.43 34.77 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 109.31 -0.626 . . . . 0.25 109.31 176.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -129.35 158.14 39.96 Favored 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 120.604 -0.438 . . . . 0.28000000000000003 110.726 -170.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -151.05 143.39 24.19 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.293 -0.632 . . . . 0.97999999999999998 109.293 177.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 18.0 tt -142.44 149.18 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 C-N-CA 120.686 -0.405 . . . . 1.0900000000000001 110.477 -170.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 16.0 tt -138.76 145.2 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 109.502 -0.555 . . . . 1.0700000000000001 109.502 178.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -150.1 141.08 22.91 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 109.93 -0.396 . . . . 1.1599999999999999 109.93 -170.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.9 tm-20 -101.68 116.29 32.42 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 109.975 -0.379 . . . . 0.35999999999999999 109.975 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -86.73 175.21 8.36 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 122.067 -0.396 . . . . 0.77000000000000002 110.583 -175.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -60.49 -17.29 44.3 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 121.995 -0.441 . . . . 1.5900000000000001 112.184 -172.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -92.49 -11.64 34.1 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.601 -0.687 . . . . 2.1400000000000001 111.83 177.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.82 21.0 37.88 Favored Glycine 0 N--CA 1.497 2.765 0 N-CA-C 111.109 -0.796 . . . . 0.40999999999999998 111.109 176.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -97.42 142.42 29.3 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 118.417 1.108 . . . . 1.28 109.8 169.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.1 p -94.88 129.58 41.84 Favored 'General case' 0 N--CA 1.497 1.908 0 C-N-CA 120.797 -0.361 . . . . 1.0600000000000001 110.356 177.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 17.7 p -97.91 113.04 24.76 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 122.128 -0.357 . . . . 1.01 110.327 177.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -96.77 121.98 39.22 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 110.157 -0.312 . . . . 1.78 110.157 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -143.77 148.52 35.73 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 122.098 -0.376 . . . . 1.0900000000000001 110.486 178.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 96.8 p -143.59 164.15 31.2 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 109.735 -0.469 . . . . 0.44 109.735 176.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -172.51 -179.05 43.07 Favored Glycine 0 N--CA 1.496 2.688 0 N-CA-C 110.215 -1.154 . . . . 0.32000000000000001 110.215 -177.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 6.2 m -100.21 133.83 44.03 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 122.203 -0.587 . . . . 0.57999999999999996 110.282 -178.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 27.5 ttm -99.5 126.96 45.54 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 122.003 -0.436 . . . . 1.1200000000000001 110.114 176.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 22.2 pttm . . . . . 0 N--CA 1.503 2.222 0 O-C-N 122.07 -0.394 . . . . 2.1899999999999999 110.485 177.734 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 26.7 ptt-85 . . . . . 0 N--CA 1.498 1.944 0 CA-C-O 120.815 0.341 . . . . 2.9399999999999999 110.685 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 11.7 m -128.48 149.1 50.73 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 109.676 -0.49 . . . . 1.1299999999999999 109.676 172.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.6 tt -143.17 155.96 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 122.04 -0.412 . . . . 1.0900000000000001 110.098 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -147.48 155.88 42.32 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 120.978 -0.289 . . . . 1.6299999999999999 110.342 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 26.6 p -142.47 157.42 44.78 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 110.113 -0.329 . . . . 1.3700000000000001 110.113 176.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 24.4 p -157.55 138.13 12.99 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 122.014 -0.429 . . . . 0.40999999999999998 110.825 -168.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 70.3 mtp180 -112.01 44.57 1.38 Allowed 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 121.213 0.53 . . . . 2.9900000000000002 110.554 -177.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.3 p -140.44 153.22 46.21 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.863 -0.523 . . . . 1.02 110.276 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 34.7 p-10 -64.51 139.77 58.8 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.817 -0.552 . . . . 1.75 111.233 -170.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 17.0 mt 53.15 25.8 4.51 Favored 'General case' 0 N--CA 1.507 2.381 0 O-C-N 121.936 -0.477 . . . . 1.23 112.282 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 28.1 p -67.95 -25.3 65.38 Favored 'General case' 0 N--CA 1.503 2.217 0 C-N-CA 119.869 -0.732 . . . . 0.34999999999999998 111.067 172.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -81.05 -33.28 33.6 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.888 -0.508 . . . . 1.8200000000000001 110.484 179.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 47.0 tt0 -63.35 -41.42 98.84 Favored 'General case' 0 N--CA 1.506 2.328 0 O-C-N 121.968 -0.458 . . . . 1.8300000000000001 110.797 -176.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -102.32 16.21 26.89 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 122.1 -0.375 . . . . 1.1200000000000001 111.9 -174.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 12.4 tp -126.16 108.94 11.8 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.601 -0.687 . . . . 1.0800000000000001 110.397 -176.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -98.3 120.93 58.43 Favored Pre-proline 0 N--CA 1.496 1.864 0 CA-C-O 118.811 -0.614 . . . . 2.27 110.032 173.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -67.91 136.39 38.17 Favored 'Trans proline' 0 N--CA 1.492 1.424 0 O-C-N 123.18 1.095 . . . . 0.71999999999999997 110.333 176.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 35.0 p -139.25 150.11 45.11 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 122.078 -0.389 . . . . 1.3700000000000001 110.204 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 34.8 mt . . . . . 0 N--CA 1.502 2.135 0 C-N-CA 120.692 -0.403 . . . . 1.27 109.961 178.891 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo . . . . . 0 N--CA 1.498 1.746 0 N-CA-C 111.058 -0.401 . . . . 0.0 111.058 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -157.55 52.86 0.47 Allowed 'General case' 0 N--CA 1.5 2.065 0 CA-C-O 121.358 0.599 . . . . 0.0 110.254 165.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 19.5 tp -158.57 113.98 2.62 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.766 -0.584 . . . . 0.0 109.993 -178.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 51.3 tttt -99.82 131.04 46.05 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 110.116 -0.328 . . . . 0.0 110.116 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 74.8 m -115.58 140.27 49.32 Favored 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 -177.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -85.3 145.07 27.7 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 122.155 -0.341 . . . . 0.0 110.098 176.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 27.8 p -117.64 137.51 52.59 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.983 -0.448 . . . . 0.0 110.562 -178.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 28.8 t -123.04 117.58 25.78 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 122.109 -0.37 . . . . 0.0 110.156 178.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 83.88 -61.74 4.69 Favored Glycine 0 N--CA 1.496 2.655 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -104.47 111.99 24.87 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 122.092 -0.652 . . . . 0.0 110.408 -177.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -138.08 137.38 20.97 Favored Pre-proline 0 N--CA 1.497 1.886 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 177.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -61.36 152.05 75.29 Favored 'Trans proline' 0 N--CA 1.497 1.683 0 O-C-N 123.118 1.062 . . . . 0.0 111.058 -173.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -60.33 -28.17 67.94 Favored 'General case' 0 N--CA 1.507 2.399 0 O-C-N 121.951 -0.468 . . . . 0.0 111.374 -173.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -92.16 14.31 16.5 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.941 -0.474 . . . . 0.0 111.77 -178.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.56 160.82 29.72 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.658 -0.651 . . . . 0.0 110.239 -173.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 70.6 mt -124.24 135.89 62.23 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -178.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 19.5 p30 37.52 43.61 0.44 Allowed 'General case' 0 N--CA 1.513 2.722 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -175.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 55.56 43.82 27.72 Favored 'General case' 0 N--CA 1.508 2.465 0 O-C-N 121.772 -0.58 . . . . 0.0 111.427 -179.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 51.4 p -141.19 161.33 38.14 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.738 -0.602 . . . . 0.0 110.346 171.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.1 p -141.39 164.69 29.54 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-O 120.847 0.356 . . . . 0.0 110.574 178.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 78.2 mt -109.6 132.44 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 -175.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.5 t -139.77 151.43 45.78 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 122.011 -0.431 . . . . 0.0 111.03 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 41.4 p-10 -108.21 30.38 6.45 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 122.097 -0.377 . . . . 0.0 110.636 167.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -124.71 -94.2 1.02 Allowed Glycine 0 N--CA 1.497 2.703 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 176.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 32.1 m80 -146.05 171.72 14.47 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 122.125 -0.632 . . . . 0.0 109.453 177.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 72.8 m -92.41 139.14 30.89 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 163.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -130.5 148.96 52.37 Favored 'General case' 0 N--CA 1.499 2.002 0 C-N-CA 120.404 -0.519 . . . . 0.0 110.54 -176.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -151.68 141.97 22.4 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 177.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 17.9 tt -142.24 149.19 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 CA-C-O 120.908 0.385 . . . . 0.0 110.248 -173.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 16.5 tt -139.15 145.4 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 -146.26 141.06 26.98 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 -167.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.2 tm-20 -101.57 115.78 31.29 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 122.165 -0.334 . . . . 0.0 110.139 -176.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -86.95 175.18 8.28 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 122.194 -0.316 . . . . 0.0 110.599 -175.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -60.59 -17.13 44.6 Favored 'General case' 0 N--CA 1.506 2.354 0 O-C-N 121.975 -0.453 . . . . 0.0 112.14 -172.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -92.48 -11.91 33.41 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.602 -0.686 . . . . 0.0 111.728 177.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.35 21.09 36.01 Favored Glycine 0 N--CA 1.497 2.715 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 176.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -97.28 141.07 30.84 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 118.379 1.089 . . . . 0.0 109.811 170.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.9 p -94.91 126.75 40.45 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 122.155 -0.341 . . . . 0.0 110.322 177.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 17.9 p -98.02 112.96 24.71 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 122.128 -0.358 . . . . 0.0 110.298 176.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.4 mp -99.61 131.09 45.84 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 122.195 -0.316 . . . . 0.0 110.489 -179.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -149.34 145.89 27.25 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 122.168 -0.332 . . . . 0.0 110.249 175.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 83.8 p -143.7 166.94 23.47 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 178.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -178.64 -163.63 30.22 Favored Glycine 0 N--CA 1.496 2.687 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 -178.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 2.0 m -96.72 132.4 42.45 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 122.144 -0.621 . . . . 0.0 110.321 -176.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 45.2 ttm -101.58 124.87 47.94 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 122.13 -0.356 . . . . 0.0 110.277 179.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 25.3 pttt . . . . . 0 N--CA 1.503 2.21 0 O-C-N 122.032 -0.417 . . . . 0.0 110.516 177.097 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 3.1 ptt180 . . . . . 0 N--CA 1.494 1.743 0 CA-C-O 120.901 0.381 . . . . 0.0 110.477 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 17.5 m -126.69 146.43 50.21 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 169.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.3 tt -143.17 155.98 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.993 -0.442 . . . . 0.0 110.29 -174.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -146.82 146.88 30.38 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 120.756 0.312 . . . . 0.0 110.239 179.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 26.4 p -143.11 146.38 33.71 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 177.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 18.2 p -157.55 131.97 8.42 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 122.002 -0.436 . . . . 0.0 110.805 -170.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 20.7 ttm-85 -104.97 48.67 0.83 Allowed 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 121.371 0.605 . . . . 0.0 110.645 -176.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.0 p -137.95 150.94 47.47 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.819 -0.551 . . . . 0.0 109.884 175.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 17.6 p-10 -62.55 132.35 52.15 Favored 'General case' 0 N--CA 1.505 2.286 0 CA-C-O 121.355 0.598 . . . . 0.0 111.674 -163.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 79.1 mt 51.86 27.6 4.39 Favored 'General case' 0 N--CA 1.507 2.409 0 O-C-N 122.061 -0.4 . . . . 0.0 111.937 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 26.1 p -62.7 -23.15 66.99 Favored 'General case' 0 N--CA 1.507 2.403 0 O-C-N 121.847 -0.533 . . . . 0.0 111.6 174.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -75.4 -29.9 59.95 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.855 -0.528 . . . . 0.0 111.01 178.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -62.36 -39.84 94.46 Favored 'General case' 0 N--CA 1.507 2.377 0 O-C-N 121.738 -0.602 . . . . 0.0 110.753 -169.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -100.22 16.2 25.04 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 122.105 -0.372 . . . . 0.0 111.678 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 16.3 tp -111.82 108.98 18.57 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.557 -0.715 . . . . 0.0 110.327 -175.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -97.9 120.87 59.2 Favored Pre-proline 0 N--CA 1.496 1.869 0 CA-C-O 118.858 -0.591 . . . . 0.0 110.14 174.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -69.46 141.05 45.36 Favored 'Trans proline' 0 N--CA 1.491 1.342 0 O-C-N 123.202 1.107 . . . . 0.0 110.182 174.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 34.0 p -139.22 135.81 34.34 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 122.118 -0.364 . . . . 0.0 110.218 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 17.3 mt . . . . . 0 N--CA 1.501 2.107 0 CA-C-O 119.306 -0.378 . . . . 0.0 110.068 178.645 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_exo . . . . . 0 N--CA 1.497 1.711 0 N-CA-C 110.998 -0.424 . . . . 0.0 110.998 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -158.17 53.37 0.45 Allowed 'General case' 0 N--CA 1.5 2.028 0 CA-C-O 121.358 0.599 . . . . 0.0 110.159 165.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 21.9 tp -158.05 114.36 2.81 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.696 -0.627 . . . . 0.0 110.032 -179.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 23.4 ttpt -99.71 130.5 45.93 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 122.137 -0.352 . . . . 0.0 110.194 179.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 78.2 m -115.28 140.32 49.21 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -177.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -84.29 142.91 29.89 Favored 'General case' 0 N--CA 1.502 2.141 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 177.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 28.1 p -115.31 137.29 52.2 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 122.127 -0.358 . . . . 0.0 110.642 -176.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 49.5 m -122.95 139.03 54.49 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 122.069 -0.394 . . . . 0.0 110.051 176.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 75.52 -67.17 2.27 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.721 -1.351 . . . . 0.0 109.721 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -114.08 124.12 51.34 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 122.11 -0.641 . . . . 0.0 110.486 -176.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -137.99 136.87 20.16 Favored Pre-proline 0 N--CA 1.497 1.901 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 175.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.44 151.93 71.29 Favored 'Trans proline' 0 N--CA 1.498 1.745 0 O-C-N 123.083 1.044 . . . . 0.0 111.111 -172.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -60.35 -28.55 68.26 Favored 'General case' 0 N--CA 1.507 2.391 0 O-C-N 121.935 -0.478 . . . . 0.0 111.356 -172.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -91.89 14.37 15.82 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.969 -0.457 . . . . 0.0 111.824 -177.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.65 162.04 27.33 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.622 -0.674 . . . . 0.0 110.27 -173.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 71.7 mt -124.59 136.69 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 -178.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 19.8 p30 37.76 43.07 0.45 Allowed 'General case' 0 N--CA 1.514 2.739 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -176.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 55.39 43.6 28.56 Favored 'General case' 0 N--CA 1.508 2.468 0 O-C-N 121.815 -0.553 . . . . 0.0 111.407 -178.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 59.5 p -139.55 160.56 39.58 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.768 -0.582 . . . . 0.0 110.261 171.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.1 p -139.28 163.99 31.01 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 120.787 0.327 . . . . 0.0 110.613 178.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 77.5 mt -108.73 132.17 57.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -175.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.4 t -140.29 151.63 45.24 Favored 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 120.95 0.405 . . . . 0.0 110.976 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 26.7 p30 -108.72 30.35 6.58 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 122.096 -0.377 . . . . 0.0 110.603 167.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -122.83 -93.93 1.16 Allowed Glycine 0 N--CA 1.496 2.653 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 176.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 74.6 m-70 -149.59 172.11 15.56 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 122.052 -0.675 . . . . 0.0 109.463 176.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 75.0 m -92.41 139.06 30.97 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 166.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -130.81 150.7 51.86 Favored 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 120.401 -0.52 . . . . 0.0 110.539 -176.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -152.08 142.51 22.58 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 177.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 18.0 tt -143.67 149.17 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.354 -173.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 16.1 tt -137.63 145.23 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -148.12 146.65 28.88 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 -167.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.8 tm-20 -101.59 117.77 35.58 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 122.146 -0.346 . . . . 0.0 110.237 -175.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 51.4 p30 -87.28 175.36 8.06 Favored 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 120.909 -0.316 . . . . 0.0 110.628 -175.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -60.34 -18.07 47.46 Favored 'General case' 0 N--CA 1.508 2.453 0 O-C-N 121.988 -0.445 . . . . 0.0 111.915 -173.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 16.1 mm-40 -93.21 -9.48 39.08 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.713 -0.617 . . . . 0.0 111.89 178.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 88.69 21.0 45.17 Favored Glycine 0 N--CA 1.498 2.826 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 177.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -96.9 143.63 27.6 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 118.413 1.107 . . . . 0.0 109.793 169.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.3 p -94.88 125.93 39.87 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.281 177.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 17.9 p -98.04 113.0 24.74 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 122.154 -0.341 . . . . 0.0 110.272 177.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.4 mp -97.8 128.54 44.51 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 122.181 -0.324 . . . . 0.0 110.407 -178.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -145.34 145.78 31.34 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 122.183 -0.323 . . . . 0.0 110.348 176.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 97.1 p -143.6 166.96 23.39 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 178.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 179.95 -164.0 31.53 Favored Glycine 0 N--CA 1.496 2.681 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 -178.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 1.8 m -96.71 132.52 42.31 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 122.248 -0.56 . . . . 0.0 110.356 -175.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 47.4 ttm -102.56 122.0 43.51 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 122.038 -0.414 . . . . 0.0 110.159 177.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 27.7 pttt . . . . . 0 N--CA 1.503 2.195 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.407 177.184 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 28.5 ptt180 . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 120.872 0.367 . . . . 0.0 110.584 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 17.0 m -125.78 149.0 48.93 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 171.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.3 tt -143.15 154.24 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.156 -176.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -146.85 150.81 36.0 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 120.858 0.361 . . . . 0.0 110.407 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 26.9 p -142.95 149.99 39.11 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 122.06 -0.4 . . . . 0.0 110.091 176.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 19.2 p -157.58 133.43 9.3 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.971 -0.456 . . . . 0.0 110.821 -172.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 61.7 ttp85 -106.35 52.51 0.72 Allowed 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 121.353 0.597 . . . . 0.0 110.536 -176.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.1 p -144.08 151.07 39.12 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.788 -0.57 . . . . 0.0 109.947 175.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 18.2 p-10 -62.39 132.11 51.48 Favored 'General case' 0 N--CA 1.503 2.213 0 CA-C-O 121.418 0.627 . . . . 0.0 111.726 -163.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 79.4 mt 51.75 28.06 4.61 Favored 'General case' 0 N--CA 1.506 2.334 0 O-C-N 121.936 -0.477 . . . . 0.0 111.955 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 25.7 p -62.56 -24.16 67.38 Favored 'General case' 0 N--CA 1.507 2.404 0 O-C-N 121.904 -0.498 . . . . 0.0 111.506 174.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -73.0 -30.33 63.71 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.877 -0.514 . . . . 0.0 110.944 178.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -62.84 -39.29 93.9 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.616 -0.678 . . . . 0.0 110.752 -168.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -100.2 16.24 24.88 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 122.103 -0.373 . . . . 0.0 111.696 -179.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 16.9 tp -112.73 110.35 20.43 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.649 -0.657 . . . . 0.0 110.314 -175.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -96.68 120.83 61.22 Favored Pre-proline 0 N--CA 1.496 1.837 0 CA-C-O 118.922 -0.561 . . . . 0.0 110.096 174.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -72.13 138.16 30.2 Favored 'Trans proline' 0 N--CA 1.492 1.415 0 O-C-N 123.293 1.154 . . . . 0.0 110.307 173.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 35.5 p -139.18 150.0 45.07 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 122.096 -0.377 . . . . 0.0 110.203 178.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 12.9 mt . . . . . 0 N--CA 1.501 2.088 0 CA-C-O 119.215 -0.421 . . . . 0.0 109.984 179.741 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo . . . . . 0 N--CA 1.498 1.791 0 N-CA-C 111.145 -0.367 . . . . 0.0 111.145 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -158.28 53.58 0.44 Allowed 'General case' 0 N--CA 1.5 2.034 0 CA-C-O 121.378 0.609 . . . . 0.0 110.235 164.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 22.7 tp -158.42 114.0 2.66 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.731 -0.606 . . . . 0.0 109.971 -179.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 53.1 tttt -99.74 132.27 45.19 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 122.164 -0.335 . . . . 0.0 110.205 -179.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 80.2 m -117.73 140.23 49.96 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 122.047 -0.408 . . . . 0.0 109.901 -177.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 62.9 t80 -84.35 142.83 29.89 Favored 'General case' 0 N--CA 1.501 2.077 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 175.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 28.1 p -114.84 138.36 50.87 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 122.05 -0.406 . . . . 0.0 110.714 -177.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 99.9 p -123.01 141.19 52.23 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 176.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.37 -68.36 1.46 Allowed Glycine 0 N--CA 1.495 2.629 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 83.6 t60 -113.17 124.78 53.34 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 122.08 -0.659 . . . . 0.0 110.663 -176.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -138.05 136.63 19.82 Favored Pre-proline 0 N--CA 1.497 1.92 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 175.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -60.28 152.17 68.56 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 O-C-N 123.107 1.056 . . . . 0.0 111.114 -171.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -60.15 -28.35 67.84 Favored 'General case' 0 N--CA 1.506 2.355 0 O-C-N 121.938 -0.476 . . . . 0.0 111.436 -172.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -92.02 14.23 16.45 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.857 -0.527 . . . . 0.0 111.754 -177.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.19 162.07 25.99 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.582 -0.699 . . . . 0.0 110.382 -172.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 75.2 mt -125.62 138.51 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 -178.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 38.7 43.29 0.69 Allowed 'General case' 0 N--CA 1.512 2.655 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -178.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 30.7 m120 55.05 42.27 31.07 Favored 'General case' 0 N--CA 1.509 2.488 0 O-C-N 121.759 -0.588 . . . . 0.0 111.453 -178.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 68.3 p -141.22 160.41 40.17 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.767 -0.583 . . . . 0.0 110.343 173.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.1 p -140.91 165.03 28.64 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 120.902 0.382 . . . . 0.0 110.641 179.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 78.0 mt -109.85 132.05 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 -175.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.7 t -138.93 150.87 46.4 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.978 -0.451 . . . . 0.0 110.999 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 50.4 p30 -108.16 31.12 5.79 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 122.114 -0.366 . . . . 0.0 110.593 167.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -124.96 -93.39 0.97 Allowed Glycine 0 N--CA 1.497 2.707 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 176.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 45.0 m-70 -149.69 172.21 15.44 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 122.106 -0.644 . . . . 0.0 109.366 176.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 71.9 m -92.1 139.03 31.04 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 166.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 15.5 p90 -129.16 151.93 49.29 Favored 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 120.372 -0.531 . . . . 0.0 110.643 -176.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -151.18 142.68 23.51 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 176.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 18.3 tt -142.05 149.05 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 CA-C-O 120.864 0.364 . . . . 0.0 110.277 -172.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 15.3 tt -140.8 145.25 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 177.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -150.15 144.34 25.62 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 -170.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.5 tm-20 -101.62 117.88 35.8 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 110.11 -0.329 . . . . 0.0 110.11 -178.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 52.3 p30 -86.69 175.19 8.39 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 122.179 -0.326 . . . . 0.0 110.609 -175.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -60.19 -17.43 41.12 Favored 'General case' 0 N--CA 1.507 2.392 0 O-C-N 121.931 -0.48 . . . . 0.0 112.127 -173.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -92.79 -11.12 34.58 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.601 -0.687 . . . . 0.0 111.868 178.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.55 20.97 35.81 Favored Glycine 0 N--CA 1.498 2.781 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 177.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -96.94 139.91 32.27 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-N 118.324 1.062 . . . . 0.0 109.841 171.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.2 p -94.85 125.25 39.39 Favored 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 120.824 -0.351 . . . . 0.0 110.205 176.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 17.7 p -97.94 112.91 24.66 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 122.167 -0.333 . . . . 0.0 110.305 177.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.4 mp -99.01 127.65 44.97 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 122.13 -0.356 . . . . 0.0 110.311 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -146.97 146.08 29.97 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 122.084 -0.385 . . . . 0.0 110.36 177.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 90.4 p -143.77 166.71 24.13 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 177.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 178.09 -163.69 32.02 Favored Glycine 0 N--CA 1.499 2.841 0 N-CA-C 110.256 -1.138 . . . . 0.0 110.256 -179.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 2.9 m -96.62 132.4 42.29 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 122.179 -0.601 . . . . 0.0 110.359 -175.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 44.4 ttm -99.46 121.94 41.85 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 122.034 -0.416 . . . . 0.0 110.042 178.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 26.0 pttt . . . . . 0 N--CA 1.503 2.193 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.562 -179.45 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 10.1 ptm180 . . . . . 0 N--CA 1.498 1.961 0 CA-C-O 120.871 0.367 . . . . 0.0 110.592 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 17.0 m -134.0 149.35 51.2 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 177.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.4 tt -142.6 150.95 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 122.023 -0.423 . . . . 0.0 109.873 178.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 48.5 mm-40 -144.64 151.65 39.3 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 120.862 0.363 . . . . 0.0 110.655 -176.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 26.3 p -143.04 150.98 40.3 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 177.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 19.5 p -157.56 134.43 10.04 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 122.016 -0.427 . . . . 0.0 110.852 -175.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 29.4 ttp180 -106.98 47.38 0.88 Allowed 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 121.208 0.528 . . . . 0.0 110.608 -173.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.0 p -142.16 151.39 42.18 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.88 -0.513 . . . . 0.0 109.888 178.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 15.8 p30 -62.78 132.44 52.24 Favored 'General case' 0 N--CA 1.505 2.285 0 CA-C-O 121.466 0.651 . . . . 0.0 111.628 -163.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 78.9 mt 52.14 27.78 4.89 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 122.03 -0.419 . . . . 0.0 111.922 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 25.8 p -62.71 -24.84 67.87 Favored 'General case' 0 N--CA 1.508 2.444 0 O-C-N 121.9 -0.5 . . . . 0.0 111.489 174.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -72.57 -29.59 63.68 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 121.918 -0.489 . . . . 0.0 111.076 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -62.23 -39.71 93.74 Favored 'General case' 0 N--CA 1.505 2.324 0 O-C-N 121.674 -0.641 . . . . 0.0 110.821 -168.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -101.34 16.22 26.28 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 122.066 -0.396 . . . . 0.0 111.763 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 12.9 tp -115.26 108.89 17.16 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.673 -0.642 . . . . 0.0 110.338 -175.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -100.62 120.78 55.03 Favored Pre-proline 0 N--CA 1.496 1.84 0 CA-C-O 118.913 -0.565 . . . . 0.0 110.183 173.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -67.94 140.06 49.14 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 O-C-N 123.153 1.081 . . . . 0.0 110.256 173.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 49.3 p -139.19 149.65 44.65 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 122.118 -0.364 . . . . 0.0 110.087 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 18.9 mt . . . . . 0 N--CA 1.501 2.098 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.056 179.634 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo . . . . . 0 N--CA 1.502 2.0 0 N-CA-C 111.277 -0.317 . . . . 0.0 111.277 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -150.17 47.52 0.91 Allowed 'General case' 0 N--CA 1.499 1.989 0 CA-C-O 121.14 0.495 . . . . 0.0 110.647 -178.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 20.3 tp -160.69 114.38 2.08 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.796 -0.565 . . . . 0.0 110.378 -174.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 30.1 ttpt -99.85 129.91 45.99 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 175.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 75.4 m -112.4 140.36 47.2 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -82.63 141.43 32.52 Favored 'General case' 0 N--CA 1.5 2.031 0 C-N-CA 120.764 -0.374 . . . . 0.0 109.992 175.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 27.8 p -115.38 137.12 52.38 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 122.021 -0.424 . . . . 0.0 110.649 -175.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 48.3 m -123.02 140.49 52.98 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 122.109 -0.37 . . . . 0.0 110.03 177.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 75.52 -67.24 2.26 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 83.8 t60 -115.92 124.33 50.34 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 122.061 -0.67 . . . . 0.0 110.543 -176.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -138.08 135.72 18.87 Favored Pre-proline 0 N--CA 1.497 1.907 0 N-CA-C 109.19 -0.671 . . . . 0.0 109.19 174.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.77 153.23 64.02 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 O-C-N 123.145 1.076 . . . . 0.0 111.193 -169.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -60.34 -28.33 68.07 Favored 'General case' 0 N--CA 1.506 2.335 0 O-C-N 121.918 -0.489 . . . . 0.0 111.43 -173.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -92.3 14.25 16.92 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.934 -0.479 . . . . 0.0 111.714 -178.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.92 161.99 27.95 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.731 -0.606 . . . . 0.0 110.225 -172.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 69.5 mt -124.92 136.97 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -176.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 18.0 p30 37.78 42.91 0.44 Allowed 'General case' 0 N--CA 1.514 2.731 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -175.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 24.0 t30 56.17 42.26 28.4 Favored 'General case' 0 N--CA 1.508 2.469 0 O-C-N 121.795 -0.566 . . . . 0.0 111.439 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 60.7 p -140.4 164.45 30.08 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.73 -0.606 . . . . 0.0 110.36 172.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.1 p -139.07 163.31 32.74 Favored 'General case' 0 N--CA 1.499 2.024 0 CA-C-O 120.889 0.376 . . . . 0.0 110.638 178.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 77.5 mt -110.36 134.35 52.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -175.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.1 t -144.0 153.97 42.79 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.996 -0.44 . . . . 0.0 111.106 179.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 39.5 p-10 -107.72 29.73 6.96 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 122.128 -0.357 . . . . 0.0 110.652 167.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -122.17 -100.98 1.63 Allowed Glycine 0 N--CA 1.497 2.702 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 176.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 25.6 m-70 -141.13 171.26 14.31 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 122.091 -0.652 . . . . 0.0 109.562 176.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 70.4 m -91.67 139.09 31.02 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 164.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -129.18 148.27 51.1 Favored 'General case' 0 N--CA 1.498 1.939 0 C-N-CA 120.374 -0.531 . . . . 0.0 110.423 -179.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -151.55 140.33 20.88 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 176.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 18.2 tt -143.86 149.3 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 CA-C-O 120.969 0.414 . . . . 0.0 110.611 -170.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 14.7 tt -135.02 145.19 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 175.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -148.27 146.38 28.59 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -169.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.7 tm-20 -101.79 117.95 35.93 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 120.793 0.33 . . . . 0.0 110.202 -175.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 26.9 p-10 -87.98 175.36 7.81 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 122.118 -0.364 . . . . 0.0 110.468 -176.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -60.34 -17.21 41.61 Favored 'General case' 0 N--CA 1.507 2.414 0 O-C-N 121.937 -0.477 . . . . 0.0 112.122 -172.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -92.41 -11.49 34.71 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.608 -0.682 . . . . 0.0 111.842 178.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.13 21.2 36.32 Favored Glycine 0 N--CA 1.497 2.743 0 N-CA-C 111.099 -0.801 . . . . 0.0 111.099 176.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -97.79 144.59 27.23 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-N 118.309 1.055 . . . . 0.0 109.872 170.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.9 p -94.92 128.42 41.69 Favored 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.24 176.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 20.1 p -97.82 116.05 29.27 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 122.138 -0.351 . . . . 0.0 110.474 178.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.3 mt -97.41 126.62 42.77 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 122.101 -0.374 . . . . 0.0 110.456 -179.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -150.52 146.16 26.42 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 122.065 -0.397 . . . . 0.0 110.474 175.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 93.7 p -143.7 167.06 23.17 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 175.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -179.23 -167.23 36.36 Favored Glycine 0 N--CA 1.497 2.748 0 N-CA-C 110.244 -1.142 . . . . 0.0 110.244 -178.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 2.2 m -96.6 132.72 41.93 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 122.221 -0.576 . . . . 0.0 110.147 -175.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 43.2 ttm -97.47 121.83 39.82 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 122.026 -0.421 . . . . 0.0 109.982 177.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 26.7 pttt . . . . . 0 N--CA 1.502 2.14 0 O-C-N 122.028 -0.42 . . . . 0.0 110.609 -176.915 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 43.8 ptt85 . . . . . 0 N--CA 1.495 1.786 0 CA-C-O 120.877 0.37 . . . . 0.0 110.41 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 18.4 m -125.81 148.14 49.21 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 172.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.5 tt -143.2 156.08 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 122.048 -0.408 . . . . 0.0 110.186 -177.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -141.85 147.88 37.91 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 120.879 0.371 . . . . 0.0 110.411 178.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 25.3 p -143.09 136.35 28.2 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 -177.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 22.5 p -157.44 128.82 6.82 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.888 -0.507 . . . . 0.0 111.016 -171.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 52.9 ttt180 -103.73 48.76 0.84 Allowed 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 121.319 0.581 . . . . 0.0 110.481 -178.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 23.9 p -135.66 150.5 49.62 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.919 -0.488 . . . . 0.0 109.739 175.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -62.91 132.13 51.06 Favored 'General case' 0 N--CA 1.504 2.248 0 CA-C-O 121.358 0.599 . . . . 0.0 111.643 -162.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 82.7 mt 51.72 28.0 4.53 Favored 'General case' 0 N--CA 1.507 2.409 0 O-C-N 122.032 -0.418 . . . . 0.0 111.936 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 26.2 p -62.66 -23.01 66.88 Favored 'General case' 0 N--CA 1.507 2.391 0 O-C-N 121.908 -0.495 . . . . 0.0 111.591 174.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -77.39 -29.18 53.06 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.824 -0.547 . . . . 0.0 111.126 177.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -62.04 -40.26 95.13 Favored 'General case' 0 N--CA 1.506 2.357 0 O-C-N 121.69 -0.631 . . . . 0.0 110.879 -168.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -100.04 16.26 24.57 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 122.088 -0.383 . . . . 0.0 111.631 178.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 11.9 tp -115.88 108.9 16.88 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.504 -0.748 . . . . 0.0 110.25 -175.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -98.27 120.79 58.81 Favored Pre-proline 0 N--CA 1.497 1.888 0 CA-C-O 118.96 -0.543 . . . . 0.0 110.102 174.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.7 134.06 19.61 Favored 'Trans proline' 0 N--CA 1.49 1.273 0 O-C-N 123.227 1.119 . . . . 0.0 110.24 172.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 35.1 p -139.31 149.39 44.17 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 122.097 -0.377 . . . . 0.0 110.217 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 15.9 mt . . . . . 0 N--CA 1.501 2.12 0 O-C-N 121.987 -0.445 . . . . 0.0 109.985 177.85 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo . . . . . 0 N--CA 1.497 1.681 0 N-CA-C 110.929 -0.45 . . . . 0.0 110.929 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -156.07 50.99 0.53 Allowed 'General case' 0 N--CA 1.501 2.096 0 CA-C-O 121.305 0.574 . . . . 0.0 110.326 164.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 21.1 tp -158.56 114.57 2.69 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.792 -0.567 . . . . 0.0 110.287 -177.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 29.7 ttmt -99.88 131.72 45.67 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 122.16 -0.338 . . . . 0.0 110.16 177.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 79.7 m -114.74 140.17 49.1 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 -179.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 68.6 t80 -87.49 143.38 27.25 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 122.093 -0.379 . . . . 0.0 110.097 176.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 27.5 p -117.49 137.0 52.84 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 122.089 -0.382 . . . . 0.0 110.58 -175.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 29.3 t -123.01 119.68 31.07 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 122.124 -0.36 . . . . 0.0 110.158 178.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 83.69 -61.96 4.67 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -106.54 112.84 26.01 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 122.109 -0.642 . . . . 0.0 110.519 -177.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -138.04 136.52 19.73 Favored Pre-proline 0 N--CA 1.495 1.803 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 176.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.78 152.78 67.32 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 O-C-N 123.118 1.062 . . . . 0.0 111.186 -171.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -60.55 -28.65 68.6 Favored 'General case' 0 N--CA 1.507 2.419 0 O-C-N 121.932 -0.48 . . . . 0.0 111.34 -172.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -92.21 14.37 16.41 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 122.009 -0.432 . . . . 0.0 111.752 -178.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.4 160.66 30.01 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.671 -0.643 . . . . 0.0 110.361 -172.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 58.7 mt -126.02 140.46 48.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 -178.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 38.74 42.79 0.65 Allowed 'General case' 0 N--CA 1.512 2.655 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -176.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 55.48 41.33 30.98 Favored 'General case' 0 N--CA 1.508 2.453 0 O-C-N 121.789 -0.569 . . . . 0.0 111.401 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 40.1 p -144.09 163.95 32.06 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.804 -0.56 . . . . 0.0 110.647 174.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.3 p -140.63 164.97 28.74 Favored 'General case' 0 N--CA 1.499 1.975 0 CA-C-O 120.882 0.372 . . . . 0.0 110.564 178.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 76.7 mt -112.82 133.62 58.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -175.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.0 t -141.22 153.0 45.04 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 122.054 -0.404 . . . . 0.0 111.083 -178.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -109.77 31.27 5.96 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 122.172 -0.33 . . . . 0.0 110.469 167.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -123.41 -94.11 1.12 Allowed Glycine 0 N--CA 1.497 2.725 0 N-CA-C 109.131 -1.588 . . . . 0.0 109.131 175.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 39.2 m80 -149.81 172.06 15.74 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 122.054 -0.674 . . . . 0.0 109.512 176.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 77.3 m -93.21 139.31 30.75 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 167.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 15.1 p90 -130.46 153.75 48.46 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.833 -0.542 . . . . 0.0 110.599 -176.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -151.52 142.23 22.78 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 177.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 17.8 tt -142.51 149.24 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 CA-C-O 120.888 0.375 . . . . 0.0 110.338 -173.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 16.1 tt -139.87 145.39 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 63.8 mt-10 -146.21 142.82 28.78 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.985 -0.447 . . . . 0.0 109.845 -168.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.3 tm-20 -101.61 116.45 32.78 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 120.793 0.33 . . . . 0.0 110.179 -176.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -87.28 175.19 8.14 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 122.17 -0.331 . . . . 0.0 110.583 -175.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -60.65 -17.11 45.27 Favored 'General case' 0 N--CA 1.506 2.374 0 O-C-N 121.993 -0.442 . . . . 0.0 112.159 -172.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -92.48 -12.01 33.14 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.666 -0.646 . . . . 0.0 111.829 177.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.14 21.01 36.85 Favored Glycine 0 N--CA 1.498 2.785 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 176.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -97.59 142.41 29.44 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 118.395 1.098 . . . . 0.0 109.799 169.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.5 p -94.94 127.25 40.85 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 120.779 -0.369 . . . . 0.0 110.277 178.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.1 p -97.94 112.9 24.66 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 120.906 -0.318 . . . . 0.0 110.348 176.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.4 mp -98.38 129.79 45.03 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 120.774 0.321 . . . . 0.0 110.452 -178.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -149.58 146.27 27.24 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 122.038 -0.413 . . . . 0.0 110.194 175.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 98.8 p -143.64 167.1 23.06 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 178.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -177.36 -163.99 30.23 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 -177.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 2.1 m -97.21 132.56 42.85 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 122.131 -0.629 . . . . 0.0 110.378 -175.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 55.1 ttm -100.3 124.41 45.73 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 122.068 -0.395 . . . . 0.0 110.231 179.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.3 ptpp? . . . . . 0 N--CA 1.504 2.227 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.348 176.442 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 30.4 ptt180 . . . . . 0 N--CA 1.495 1.777 0 CA-C-O 120.902 0.382 . . . . 0.0 110.381 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 14.0 m -123.93 149.02 46.38 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 171.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.2 tt -143.1 153.34 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 122.089 -0.382 . . . . 0.0 110.189 -175.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -148.85 150.91 33.81 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-O 120.804 0.335 . . . . 0.0 110.543 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 26.3 p -143.14 155.31 44.54 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 175.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 19.7 p -157.47 136.71 11.86 Favored 'General case' 0 N--CA 1.503 2.205 0 CA-C-O 121.013 0.435 . . . . 0.0 110.738 -172.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 38.7 ttt180 -108.54 50.45 0.78 Allowed 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.413 0.625 . . . . 0.0 110.653 -171.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.0 p -147.4 151.76 37.02 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.69 -0.631 . . . . 0.0 109.888 178.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 17.6 p-10 -62.07 132.71 53.75 Favored 'General case' 0 N--CA 1.505 2.317 0 CA-C-O 121.44 0.638 . . . . 0.0 111.656 -164.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 74.7 mt 52.57 27.14 4.83 Favored 'General case' 0 N--CA 1.506 2.374 0 O-C-N 121.971 -0.455 . . . . 0.0 111.962 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 26.0 p -63.05 -23.39 67.43 Favored 'General case' 0 N--CA 1.508 2.435 0 C-N-CA 120.402 -0.519 . . . . 0.0 111.605 174.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -70.97 -26.51 63.19 Favored 'General case' 0 N--CA 1.505 2.293 0 O-C-N 121.799 -0.563 . . . . 0.0 111.025 177.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 49.0 tp60 -61.15 -43.32 99.07 Favored 'General case' 0 N--CA 1.508 2.442 0 O-C-N 121.647 -0.658 . . . . 0.0 110.617 -174.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -100.46 16.26 25.17 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 122.157 -0.339 . . . . 0.0 111.851 -176.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 16.4 tp -115.48 108.91 17.08 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.53 -0.731 . . . . 0.0 110.336 -176.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -98.6 120.7 58.49 Favored Pre-proline 0 N--CA 1.496 1.832 0 CA-C-O 118.936 -0.554 . . . . 0.0 110.16 174.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -70.54 134.42 26.29 Favored 'Trans proline' 0 N--CA 1.491 1.336 0 O-C-N 123.133 1.07 . . . . 0.0 110.262 175.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 34.9 p -139.24 150.03 45.02 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 122.137 -0.352 . . . . 0.0 110.2 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 14.9 mt . . . . . 0 N--CA 1.502 2.141 0 CA-C-O 119.208 -0.425 . . . . 0.0 109.955 179.137 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo . . . . . 0 N--CA 1.501 1.961 0 N-CA-C 111.189 -0.35 . . . . 0.0 111.189 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -157.0 48.57 0.44 Allowed 'General case' 0 N--CA 1.499 1.993 0 CA-C-O 121.046 0.451 . . . . 0.0 110.706 173.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 17.5 tp -161.32 114.44 1.92 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.783 -0.573 . . . . 0.0 110.42 -174.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 32.8 tttt -99.92 131.48 45.86 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 177.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 86.0 m -116.76 140.35 49.52 Favored 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -179.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -83.17 142.74 30.98 Favored 'General case' 0 N--CA 1.501 2.097 0 C-N-CA 120.73 -0.388 . . . . 0.0 109.992 175.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 28.1 p -114.66 136.92 52.52 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.849 -0.532 . . . . 0.0 110.561 -178.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.6 m -123.01 138.73 54.61 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 122.099 -0.376 . . . . 0.0 110.116 176.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 75.54 -67.07 2.28 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -113.54 124.54 52.61 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 122.11 -0.641 . . . . 0.0 110.465 -177.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -138.16 136.36 19.4 Favored Pre-proline 0 N--CA 1.496 1.844 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 174.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.36 152.42 67.24 Favored 'Trans proline' 0 N--CA 1.498 1.749 0 O-C-N 123.053 1.028 . . . . 0.0 111.185 -171.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -60.34 -28.11 67.9 Favored 'General case' 0 N--CA 1.507 2.378 0 O-C-N 121.944 -0.472 . . . . 0.0 111.391 -172.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -91.96 14.39 15.87 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.958 -0.464 . . . . 0.0 111.75 -178.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.92 162.07 25.18 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.652 -0.655 . . . . 0.0 110.246 -173.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 76.4 mt -125.53 140.11 49.33 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -177.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 38.72 42.47 0.61 Allowed 'General case' 0 N--CA 1.512 2.629 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -178.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 55.04 42.73 30.69 Favored 'General case' 0 N--CA 1.508 2.461 0 O-C-N 121.768 -0.582 . . . . 0.0 111.432 -178.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 39.9 p -142.75 161.59 37.69 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.785 -0.572 . . . . 0.0 110.622 173.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.5 p -139.53 165.12 28.09 Favored 'General case' 0 N--CA 1.498 1.973 0 CA-C-O 120.97 0.414 . . . . 0.0 110.486 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 75.9 mt -117.01 131.92 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 -173.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.9 t -143.65 155.66 44.31 Favored 'General case' 0 N--CA 1.502 2.143 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.168 -178.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -108.63 30.65 6.29 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 122.081 -0.387 . . . . 0.0 110.524 167.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -118.87 -103.44 2.1 Favored Glycine 0 N--CA 1.497 2.708 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 174.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 23.9 m-70 -139.55 171.93 13.54 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 122.169 -0.606 . . . . 0.0 109.655 176.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 83.2 m -93.92 139.21 31.18 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 165.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -129.59 150.04 51.09 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.591 -177.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -150.32 143.77 25.1 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 175.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 18.3 tt -144.18 149.17 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 122.091 -0.381 . . . . 0.0 110.099 -171.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.409 ' CG1' ' HB ' ' A' ' 71' ' ' THR . 15.6 tt -138.13 118.74 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 CA-C-O 120.877 0.37 . . . . 0.0 110.209 179.052 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 69.2 mt-10 -105.16 145.65 30.29 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 122.107 -0.371 . . . . 0.0 110.505 -178.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.1 tm-20 -101.96 116.49 32.8 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 122.016 -0.427 . . . . 0.0 110.166 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -85.34 175.19 9.04 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 122.008 -0.433 . . . . 0.0 110.56 -175.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -60.75 -17.71 50.43 Favored 'General case' 0 N--CA 1.507 2.41 0 O-C-N 122.019 -0.426 . . . . 0.0 111.989 -173.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -92.87 -10.7 35.72 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.693 -0.629 . . . . 0.0 111.823 178.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 89.65 18.22 52.38 Favored Glycine 0 N--CA 1.498 2.809 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 177.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 69.5 mt-10 -93.98 149.72 20.98 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 118.521 1.161 . . . . 0.0 111.311 168.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.409 ' HB ' ' CG1' ' A' ' 63' ' ' ILE . 4.5 p -94.96 134.97 37.04 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 122.038 -0.414 . . . . 0.0 110.467 177.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.2 p -102.15 110.5 22.48 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 169.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.4 mp -97.27 132.86 42.6 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 122.177 -0.327 . . . . 0.0 110.587 -175.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -148.07 145.32 28.39 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 122.154 -0.341 . . . . 0.0 110.399 175.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 99.2 p -143.74 166.97 23.4 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 176.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 178.58 -164.44 32.96 Favored Glycine 0 N--CA 1.497 2.742 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 2.6 m -96.41 132.74 41.64 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 122.15 -0.618 . . . . 0.0 110.298 -175.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 55.4 ttm -101.21 122.0 42.85 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 122.068 -0.395 . . . . 0.0 110.117 176.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 26.8 pttt . . . . . 0 N--CA 1.503 2.222 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.339 177.164 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 48.6 ptt85 . . . . . 0 N--CA 1.493 1.721 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 15.5 m -112.55 149.15 33.12 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 171.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.8 tt -143.25 154.89 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.017 -177.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 66.8 mt-10 -142.99 149.95 38.99 Favored 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.63 -178.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 92.5 m -141.97 138.8 32.18 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 -177.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 20.4 p -157.63 131.41 8.0 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.906 -0.496 . . . . 0.0 110.914 -175.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 51.1 ttt180 -104.61 48.05 0.85 Allowed 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.287 0.565 . . . . 0.0 110.65 -176.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 23.9 p -136.65 151.47 49.34 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.904 -0.497 . . . . 0.0 109.861 175.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 17.6 p-10 -61.88 132.07 51.84 Favored 'General case' 0 N--CA 1.505 2.3 0 CA-C-O 121.429 0.633 . . . . 0.0 111.735 -163.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 75.4 mt 51.98 26.83 3.95 Favored 'General case' 0 N--CA 1.508 2.474 0 O-C-N 122.098 -0.376 . . . . 0.0 111.923 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 26.3 p -63.16 -21.91 66.52 Favored 'General case' 0 N--CA 1.507 2.384 0 C-N-CA 120.439 -0.504 . . . . 0.0 111.6 176.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -90.91 -22.99 20.63 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.737 -0.602 . . . . 0.0 111.282 177.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -61.01 -38.23 85.33 Favored 'General case' 0 N--CA 1.508 2.46 0 O-C-N 121.604 -0.685 . . . . 0.0 110.791 -175.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -100.69 16.32 25.32 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 122.094 -0.379 . . . . 0.0 111.674 177.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 15.7 tp -112.93 112.31 23.69 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.544 -0.723 . . . . 0.0 110.294 -174.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -96.27 120.86 61.8 Favored Pre-proline 0 N--CA 1.498 1.944 0 CA-C-O 118.894 -0.574 . . . . 0.0 109.912 172.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -71.0 143.71 45.55 Favored 'Trans proline' 0 N--CA 1.491 1.338 0 O-C-N 123.129 1.068 . . . . 0.0 110.225 177.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 35.3 p -139.11 150.05 45.24 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 122.1 -0.375 . . . . 0.0 110.204 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 16.4 mt . . . . . 0 N--CA 1.501 2.124 0 C-N-CA 120.689 -0.405 . . . . 0.0 110.114 -179.754 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo . . . . . 0 N--CA 1.499 1.799 0 N-CA-C 111.16 -0.362 . . . . 0.0 111.16 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -156.67 53.07 0.52 Allowed 'General case' 0 N--CA 1.5 2.06 0 CA-C-O 121.325 0.583 . . . . 0.0 110.3 164.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 20.5 tp -157.61 114.38 2.94 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.804 -0.56 . . . . 0.0 109.967 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 13.0 tttp -99.86 129.08 45.91 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 84.9 m -116.42 140.2 49.61 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -178.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -81.34 146.19 30.47 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 122.033 -0.417 . . . . 0.0 109.891 177.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 27.9 p -115.8 157.77 23.88 Favored 'General case' 0 N--CA 1.502 2.129 0 CA-C-O 120.997 0.427 . . . . 0.0 110.985 -173.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 96.7 p -65.65 162.99 17.23 Favored 'General case' 0 N--CA 1.503 2.196 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 167.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -51.35 -18.14 3.26 Favored Glycine 0 N--CA 1.507 3.397 0 N-CA-C 111.946 -0.462 . . . . 0.0 111.946 -173.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -84.4 111.8 19.77 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.8 -0.824 . . . . 0.0 109.621 163.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -138.32 136.08 18.91 Favored Pre-proline 0 N--CA 1.497 1.901 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -175.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -56.65 153.52 35.6 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 O-C-N 122.978 0.988 . . . . 0.0 111.599 -165.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -60.67 -31.24 70.49 Favored 'General case' 0 N--CA 1.506 2.353 0 O-C-N 121.953 -0.467 . . . . 0.0 111.357 -167.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -91.4 14.17 15.44 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 122.023 -0.423 . . . . 0.0 111.877 -177.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -86.01 162.14 18.63 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.654 -0.654 . . . . 0.0 110.542 -174.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 76.2 mt -122.02 140.53 45.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 -176.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 39.31 42.75 0.84 Allowed 'General case' 0 N--CA 1.513 2.69 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 55.05 41.73 31.53 Favored 'General case' 0 N--CA 1.508 2.438 0 O-C-N 121.844 -0.535 . . . . 0.0 111.455 -179.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 66.8 p -138.84 150.1 45.64 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.776 -0.577 . . . . 0.0 110.279 173.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.8 p -120.65 160.28 23.59 Favored 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 120.963 0.411 . . . . 0.0 110.598 178.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 77.5 mt -108.95 133.23 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -176.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.6 t -140.79 153.9 46.03 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.98 -0.45 . . . . 0.0 111.271 -178.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 26.7 p30 -108.06 30.11 6.68 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 122.178 -0.326 . . . . 0.0 110.528 166.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -122.58 -96.79 1.34 Allowed Glycine 0 N--CA 1.496 2.656 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 177.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 15.9 m80 -148.98 172.07 15.33 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 122.097 -0.649 . . . . 0.0 109.428 178.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 82.3 m -95.84 139.19 32.42 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 168.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 16.5 p90 -132.08 150.83 52.05 Favored 'General case' 0 N--CA 1.499 1.994 0 C-N-CA 120.352 -0.539 . . . . 0.0 110.705 -178.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -152.55 144.66 23.83 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 175.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 18.3 tt -143.36 149.2 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 C-N-CA 120.741 -0.383 . . . . 0.0 110.492 -171.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 13.4 tt -136.1 145.09 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 176.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -150.04 145.86 26.64 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -170.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.3 tm-20 -101.62 117.35 34.71 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 122.128 -0.357 . . . . 0.0 110.098 -178.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -87.21 175.31 8.11 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 122.111 -0.368 . . . . 0.0 110.607 -175.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -60.67 -17.61 48.67 Favored 'General case' 0 N--CA 1.507 2.393 0 O-C-N 121.973 -0.454 . . . . 0.0 112.016 -172.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -92.77 -10.81 35.63 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.547 -0.721 . . . . 0.0 111.863 178.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.27 19.71 44.84 Favored Glycine 0 N--CA 1.498 2.769 0 N-CA-C 111.159 -0.776 . . . . 0.0 111.159 176.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -97.22 145.28 26.21 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 118.472 1.136 . . . . 0.0 109.915 169.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.2 p -94.87 129.62 41.79 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 122.127 -0.358 . . . . 0.0 110.24 178.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 19.3 p -97.9 115.6 28.44 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 122.156 -0.34 . . . . 0.0 110.346 178.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 18.4 mt -97.23 124.97 41.47 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 122.136 -0.352 . . . . 0.0 110.291 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -143.32 143.74 31.81 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 120.842 0.353 . . . . 0.0 110.534 175.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 89.4 p -143.73 166.99 23.33 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 176.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 176.48 -164.32 33.99 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 179.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 2.0 m -98.87 132.49 44.17 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 122.251 -0.558 . . . . 0.0 110.424 -174.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 50.0 ttm -102.52 133.66 47.13 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 122.116 -0.365 . . . . 0.0 110.185 176.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 22.5 pttm . . . . . 0 N--CA 1.503 2.213 0 O-C-N 122.054 -0.404 . . . . 0.0 110.543 178.106 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 46.3 ptt85 . . . . . 0 N--CA 1.496 1.847 0 CA-C-O 120.845 0.355 . . . . 0.0 110.735 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 19.9 m -134.03 149.23 51.17 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 178.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.3 tt -143.07 156.06 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 122.061 -0.399 . . . . 0.0 110.047 -179.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -142.88 146.58 34.22 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 120.825 0.345 . . . . 0.0 110.54 -178.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 26.0 p -143.12 137.67 29.29 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -178.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 20.5 p -157.57 133.74 9.53 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.96 -0.463 . . . . 0.0 110.989 -171.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 62.1 ttt180 -106.65 52.66 0.71 Allowed 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 121.426 0.631 . . . . 0.0 110.451 -176.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.0 p -142.26 151.64 42.27 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.766 -0.583 . . . . 0.0 109.753 174.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -61.28 131.79 51.5 Favored 'General case' 0 N--CA 1.506 2.337 0 CA-C-O 121.427 0.632 . . . . 0.0 111.771 -163.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 74.1 mt 52.08 26.8 4.04 Favored 'General case' 0 N--CA 1.507 2.404 0 O-C-N 122.064 -0.398 . . . . 0.0 111.964 179.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 26.3 p -63.06 -22.06 66.6 Favored 'General case' 0 N--CA 1.506 2.358 0 O-C-N 121.888 -0.507 . . . . 0.0 111.58 176.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -90.07 -22.94 21.58 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.79 -0.569 . . . . 0.0 111.277 176.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -61.14 -38.84 87.82 Favored 'General case' 0 N--CA 1.508 2.438 0 O-C-N 121.595 -0.69 . . . . 0.0 110.768 -175.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -100.06 16.3 24.48 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 122.16 -0.337 . . . . 0.0 111.606 177.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 15.4 tp -112.65 111.81 22.88 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.595 -0.69 . . . . 0.0 110.31 -175.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -96.54 120.8 61.49 Favored Pre-proline 0 N--CA 1.498 1.974 0 CA-C-O 118.904 -0.57 . . . . 0.0 109.922 173.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -71.26 139.03 34.35 Favored 'Trans proline' 0 N--CA 1.49 1.311 0 O-C-N 123.182 1.096 . . . . 0.0 110.164 175.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 50.4 p -139.16 150.06 45.17 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 122.094 -0.379 . . . . 0.0 110.125 178.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 17.4 mt . . . . . 0 N--CA 1.502 2.136 0 CA-C-O 118.975 -0.536 . . . . 0.0 110.012 178.934 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo . . . . . 0 N--CA 1.503 2.049 0 N-CA-C 111.187 -0.351 . . . . 0.0 111.187 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -158.55 49.66 0.37 Allowed 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 121.097 0.475 . . . . 0.0 110.898 172.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 20.2 tp -161.53 114.09 1.84 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.696 -0.627 . . . . 0.0 110.276 -175.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 58.0 tttt -99.76 130.39 45.96 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 122.167 -0.333 . . . . 0.0 110.151 177.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 77.4 m -113.86 140.31 48.45 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -179.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -84.75 140.76 31.02 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 175.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 28.2 p -114.16 138.09 50.89 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 122.024 -0.422 . . . . 0.0 110.676 -176.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.4 m -122.94 139.44 54.05 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 122.036 -0.415 . . . . 0.0 109.947 176.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.16 -68.27 1.4 Allowed Glycine 0 N--CA 1.496 2.659 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 63.9 m170 -110.8 123.06 49.35 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 122.163 -0.61 . . . . 0.0 110.602 -176.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -138.08 136.25 19.4 Favored Pre-proline 0 N--CA 1.497 1.881 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 174.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -60.32 152.47 66.68 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 O-C-N 123.062 1.033 . . . . 0.0 111.221 -170.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -60.34 -28.15 67.94 Favored 'General case' 0 N--CA 1.507 2.379 0 O-C-N 121.961 -0.462 . . . . 0.0 111.43 -172.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -92.07 14.25 16.48 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.955 -0.466 . . . . 0.0 111.782 -178.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.89 162.01 26.33 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.631 -0.668 . . . . 0.0 110.308 -172.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 76.7 mt -125.97 139.77 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -177.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 38.6 43.29 0.66 Allowed 'General case' 0 N--CA 1.512 2.64 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -177.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 55.44 42.29 30.12 Favored 'General case' 0 N--CA 1.507 2.418 0 O-C-N 121.811 -0.555 . . . . 0.0 111.467 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 39.2 p -144.38 162.72 35.77 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.76 -0.588 . . . . 0.0 110.658 173.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.3 p -139.77 164.95 28.59 Favored 'General case' 0 N--CA 1.499 1.992 0 CA-C-O 120.787 0.327 . . . . 0.0 110.613 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 77.2 mt -113.74 133.05 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -174.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.1 t -142.5 154.09 44.2 Favored 'General case' 0 N--CA 1.502 2.143 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.059 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 40.1 p-10 -108.37 30.29 6.57 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 122.109 -0.369 . . . . 0.0 110.608 167.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -122.31 -97.78 1.43 Allowed Glycine 0 N--CA 1.497 2.717 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 176.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 31.1 m80 -143.8 170.66 15.46 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 122.136 -0.626 . . . . 0.0 109.473 177.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 71.4 m -91.85 139.14 30.95 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 164.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 15.9 p90 -130.0 148.17 51.83 Favored 'General case' 0 N--CA 1.497 1.9 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.518 -177.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -151.46 141.75 22.37 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 178.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 18.0 tt -144.17 149.2 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 122.065 -0.397 . . . . 0.0 110.559 -171.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 16.4 tt -134.26 145.21 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 176.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -147.94 146.18 28.89 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -167.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.4 tm-20 -101.49 116.83 33.66 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 120.864 0.364 . . . . 0.0 110.179 -176.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -87.36 175.24 8.09 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 122.03 -0.419 . . . . 0.0 110.594 -175.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -60.49 -17.51 45.74 Favored 'General case' 0 N--CA 1.506 2.359 0 O-C-N 121.904 -0.498 . . . . 0.0 112.12 -172.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -92.89 -11.35 33.7 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.613 -0.679 . . . . 0.0 111.811 178.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.56 20.13 42.09 Favored Glycine 0 N--CA 1.497 2.751 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 177.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -97.32 145.27 26.28 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 118.49 1.145 . . . . 0.0 109.786 169.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.8 p -94.89 128.8 41.93 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 122.117 -0.364 . . . . 0.0 110.183 178.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 21.4 p -97.98 118.99 35.82 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 122.165 -0.334 . . . . 0.0 110.276 178.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 23.0 mt -97.61 127.13 43.33 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 122.14 -0.35 . . . . 0.0 110.408 179.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -147.98 144.88 28.29 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 122.039 -0.413 . . . . 0.0 110.481 174.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 78.8 p -143.69 167.01 23.28 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 176.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -178.3 -166.5 34.71 Favored Glycine 0 N--CA 1.497 2.709 0 N-CA-C 110.15 -1.18 . . . . 0.0 110.15 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 2.2 m -96.99 132.85 42.38 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 122.172 -0.605 . . . . 0.0 110.415 -176.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 56.0 ttm -100.66 122.93 44.15 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 122.097 -0.377 . . . . 0.0 110.15 178.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.1 pttm . . . . . 0 N--CA 1.504 2.264 0 O-C-N 122.01 -0.431 . . . . 0.0 110.59 -179.736 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 28.2 ptt-85 . . . . . 0 N--CA 1.494 1.768 0 CA-C-O 120.805 0.336 . . . . 0.0 110.388 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 15.1 m -124.41 147.91 47.95 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 171.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.5 tt -143.18 155.99 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 122.0 -0.437 . . . . 0.0 110.284 -174.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -144.81 149.84 36.14 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 120.723 0.297 . . . . 0.0 110.388 178.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 26.7 p -143.06 142.06 31.45 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 21.8 p -157.55 129.29 6.97 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 122.011 -0.431 . . . . 0.0 110.802 -171.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 53.0 ttp180 -104.02 48.45 0.85 Allowed 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.329 0.585 . . . . 0.0 110.504 -177.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.1 p -135.5 150.72 49.86 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.905 -0.497 . . . . 0.0 109.798 175.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 17.6 p-10 -62.5 131.93 50.79 Favored 'General case' 0 N--CA 1.504 2.269 0 CA-C-O 121.388 0.613 . . . . 0.0 111.734 -162.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 79.6 mt 51.76 27.84 4.46 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 122.003 -0.436 . . . . 0.0 111.936 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 26.0 p -62.69 -23.26 67.05 Favored 'General case' 0 N--CA 1.506 2.337 0 O-C-N 121.874 -0.516 . . . . 0.0 111.564 174.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -75.5 -29.66 59.58 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.907 -0.495 . . . . 0.0 111.079 177.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -62.16 -39.39 92.49 Favored 'General case' 0 N--CA 1.507 2.399 0 O-C-N 121.764 -0.585 . . . . 0.0 110.826 -169.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -100.3 16.16 25.28 Favored 'General case' 0 N--CA 1.498 1.938 0 C-N-CA 120.936 -0.306 . . . . 0.0 111.688 179.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 12.2 tp -117.99 108.93 15.86 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.511 -0.743 . . . . 0.0 110.296 -176.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -98.7 120.87 57.94 Favored Pre-proline 0 N--CA 1.497 1.896 0 CA-C-O 118.86 -0.59 . . . . 0.0 110.078 174.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -71.15 133.89 23.96 Favored 'Trans proline' 0 N--CA 1.491 1.341 0 O-C-N 123.247 1.13 . . . . 0.0 110.15 172.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 35.0 p -139.16 147.14 41.46 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 122.102 -0.374 . . . . 0.0 110.371 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 27.0 mt . . . . . 0 N--CA 1.502 2.162 0 CA-C-O 119.277 -0.392 . . . . 0.0 110.01 176.607 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo . . . . . 0 N--CA 1.498 1.785 0 N-CA-C 111.208 -0.343 . . . . 0.0 111.208 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -158.32 53.37 0.44 Allowed 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 121.332 0.586 . . . . 0.0 110.264 164.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 19.1 tp -158.41 114.72 2.75 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.803 -0.561 . . . . 0.0 110.032 -179.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -99.74 131.6 45.62 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 122.112 -0.367 . . . . 0.0 110.256 178.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 73.3 m -117.87 140.38 49.8 Favored 'General case' 0 N--CA 1.502 2.155 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 -178.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -82.4 146.2 29.46 Favored 'General case' 0 N--CA 1.501 2.079 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.125 178.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 27.9 p -116.05 136.99 52.52 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 122.021 -0.424 . . . . 0.0 110.54 -178.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 29.1 t -122.29 135.04 54.67 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 122.039 -0.413 . . . . 0.0 110.064 177.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.83 -66.52 2.77 Favored Glycine 0 N--CA 1.496 2.698 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -112.42 124.0 51.52 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 122.077 -0.66 . . . . 0.0 110.57 -177.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -138.03 136.98 20.21 Favored Pre-proline 0 N--CA 1.496 1.875 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 175.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -60.59 151.78 73.26 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 O-C-N 123.171 1.09 . . . . 0.0 111.105 -172.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -60.25 -28.1 67.77 Favored 'General case' 0 N--CA 1.508 2.431 0 O-C-N 121.995 -0.441 . . . . 0.0 111.383 -172.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -92.21 14.29 16.63 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.935 -0.478 . . . . 0.0 111.782 -177.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.4 161.98 26.76 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.708 -0.62 . . . . 0.0 110.232 -172.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 71.4 mt -124.76 137.02 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -177.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 19.9 p30 37.81 43.16 0.47 Allowed 'General case' 0 N--CA 1.514 2.773 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -176.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 30.8 m120 55.32 43.08 29.59 Favored 'General case' 0 N--CA 1.509 2.493 0 O-C-N 121.882 -0.511 . . . . 0.0 111.43 -178.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 71.5 p -139.13 160.87 38.77 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.814 -0.554 . . . . 0.0 110.283 171.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.1 p -137.57 161.27 36.88 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-O 120.973 0.416 . . . . 0.0 110.452 178.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 77.7 mt -107.52 131.63 57.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -175.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.4 t -140.07 151.65 45.55 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 122.04 -0.413 . . . . 0.0 110.972 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 49.9 p30 -107.81 30.57 6.21 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 122.127 -0.358 . . . . 0.0 110.585 167.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -122.86 -95.77 1.25 Allowed Glycine 0 N--CA 1.497 2.733 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 176.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 38.1 m-70 -149.59 172.03 15.68 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 122.108 -0.643 . . . . 0.0 109.556 176.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 82.7 m -94.51 139.2 31.46 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 168.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 19.5 p90 -129.06 151.28 49.92 Favored 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.476 -178.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -151.21 143.39 24.05 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 175.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 18.2 tt -144.02 149.33 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 122.109 -0.369 . . . . 0.0 110.276 -172.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 16.5 tt -136.46 145.25 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 178.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -147.99 145.88 28.71 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 122.013 -0.429 . . . . 0.0 109.914 -168.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.5 tm-20 -101.61 117.18 34.38 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 120.751 0.31 . . . . 0.0 110.185 -176.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 26.6 p-10 -87.6 175.35 7.95 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 122.123 -0.36 . . . . 0.0 110.563 -176.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -60.47 -17.24 43.6 Favored 'General case' 0 N--CA 1.506 2.368 0 O-C-N 122.007 -0.433 . . . . 0.0 112.082 -172.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -91.89 -11.57 35.99 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.551 -0.718 . . . . 0.0 111.819 178.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.84 20.95 37.98 Favored Glycine 0 N--CA 1.498 2.774 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 176.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -97.58 143.87 27.84 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 118.324 1.062 . . . . 0.0 109.898 170.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.8 p -94.84 124.32 38.82 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.234 176.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.7 p -97.92 113.72 25.62 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 122.093 -0.38 . . . . 0.0 110.336 178.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.4 mp -97.51 128.35 44.2 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 122.147 -0.346 . . . . 0.0 110.26 -178.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -144.37 147.84 33.93 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 122.099 -0.375 . . . . 0.0 110.349 176.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 87.3 p -143.69 166.18 25.58 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 178.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -179.22 -167.11 36.17 Favored Glycine 0 N--CA 1.496 2.69 0 N-CA-C 110.354 -1.098 . . . . 0.0 110.354 -178.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 2.9 m -96.55 132.25 42.34 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 122.187 -0.596 . . . . 0.0 110.25 -175.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 51.1 ttm -98.53 121.88 41.02 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.946 -0.471 . . . . 0.0 110.087 176.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 26.6 pttt . . . . . 0 N--CA 1.503 2.19 0 O-C-N 122.043 -0.411 . . . . 0.0 110.508 -178.271 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 30.7 ptt180 . . . . . 0 N--CA 1.494 1.736 0 CA-C-O 120.903 0.382 . . . . 0.0 110.557 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 16.6 m -128.69 149.12 50.81 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 172.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.6 tt -143.02 156.0 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 122.023 -0.423 . . . . 0.0 110.165 -176.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -143.8 151.63 40.19 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 120.947 0.403 . . . . 0.0 110.581 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 89.6 m -141.98 141.31 32.89 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 19.9 p -157.56 137.9 12.78 Favored 'General case' 0 N--CA 1.504 2.243 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.137 -174.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 27.8 ttt180 -109.38 45.82 1.04 Allowed 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 121.275 0.56 . . . . 0.0 110.637 -172.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.0 p -141.92 152.08 43.22 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.869 -0.519 . . . . 0.0 109.97 178.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 17.6 p-10 -61.78 132.68 53.92 Favored 'General case' 0 N--CA 1.505 2.281 0 CA-C-O 121.373 0.606 . . . . 0.0 111.793 -164.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 74.4 mt 52.24 26.76 4.18 Favored 'General case' 0 N--CA 1.507 2.416 0 O-C-N 122.048 -0.408 . . . . 0.0 111.966 179.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 25.9 p -63.15 -22.2 66.7 Favored 'General case' 0 N--CA 1.507 2.419 0 O-C-N 121.858 -0.526 . . . . 0.0 111.572 175.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -91.1 -22.95 20.46 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.723 -0.611 . . . . 0.0 111.304 177.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -60.97 -37.9 84.08 Favored 'General case' 0 N--CA 1.509 2.504 0 O-C-N 121.595 -0.691 . . . . 0.0 110.721 -176.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -100.16 16.22 24.9 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 122.126 -0.359 . . . . 0.0 111.59 177.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 17.4 tp -113.73 112.83 24.1 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.579 -0.701 . . . . 0.0 110.345 -175.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 37.8 tt0 -96.48 120.72 61.72 Favored Pre-proline 0 N--CA 1.496 1.872 0 CA-C-O 118.853 -0.594 . . . . 0.0 110.028 173.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -71.11 139.33 35.37 Favored 'Trans proline' 0 N--CA 1.49 1.303 0 O-C-N 123.197 1.104 . . . . 0.0 110.326 175.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 35.0 p -139.17 149.96 45.05 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 122.113 -0.367 . . . . 0.0 110.206 178.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 17.4 mt . . . . . 0 N--CA 1.502 2.157 0 CA-C-O 118.896 -0.573 . . . . 0.0 110.037 179.318 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo . . . . . 0 N--CA 1.497 1.68 0 N-CA-C 110.978 -0.431 . . . . 0.0 110.978 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -157.84 50.94 0.43 Allowed 'General case' 0 N--CA 1.498 1.967 0 CA-C-O 121.423 0.63 . . . . 0.0 110.407 164.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 20.5 tp -158.72 114.88 2.68 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.733 -0.604 . . . . 0.0 110.29 -177.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -99.77 132.14 45.3 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 120.95 -0.3 . . . . 0.0 110.233 176.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 76.4 m -117.52 140.33 49.75 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -179.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -81.86 142.13 32.79 Favored 'General case' 0 N--CA 1.502 2.143 0 C-N-CA 120.535 -0.466 . . . . 0.0 109.961 176.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 28.2 p -113.38 136.98 52.17 Favored 'General case' 0 N--CA 1.501 2.111 0 C-N-CA 120.779 -0.368 . . . . 0.0 110.589 -177.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.8 m -122.61 142.94 50.11 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 122.095 -0.378 . . . . 0.0 110.021 177.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.44 -68.13 1.5 Allowed Glycine 0 N--CA 1.494 2.547 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -115.27 126.47 54.54 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 122.003 -0.704 . . . . 0.0 110.613 -176.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -137.96 136.25 19.56 Favored Pre-proline 0 N--CA 1.496 1.852 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 174.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -60.7 152.65 67.76 Favored 'Trans proline' 0 N--CA 1.497 1.702 0 O-C-N 123.072 1.038 . . . . 0.0 111.194 -170.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -60.25 -28.03 67.7 Favored 'General case' 0 N--CA 1.508 2.44 0 O-C-N 122.021 -0.424 . . . . 0.0 111.34 -173.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -92.1 14.39 16.16 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.9 -0.5 . . . . 0.0 111.78 -178.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.92 162.04 26.29 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.581 -0.699 . . . . 0.0 110.259 -173.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 70.7 mt -124.11 136.45 60.33 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -176.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 19.8 p30 37.8 43.15 0.46 Allowed 'General case' 0 N--CA 1.512 2.658 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 -176.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 55.5 43.34 28.67 Favored 'General case' 0 N--CA 1.509 2.476 0 O-C-N 121.83 -0.544 . . . . 0.0 111.429 -178.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 56.1 p -139.53 161.98 36.17 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.801 -0.562 . . . . 0.0 110.273 171.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.4 p -137.29 160.43 39.07 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-O 120.737 0.304 . . . . 0.0 110.608 178.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 76.5 mt -110.09 132.97 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -174.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.0 t -143.5 155.19 44.27 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.952 -0.468 . . . . 0.0 111.022 -179.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 48.9 p30 -108.09 29.31 7.43 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 122.036 -0.415 . . . . 0.0 110.705 167.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -119.59 -102.63 1.99 Allowed Glycine 0 N--CA 1.497 2.741 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 176.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 24.6 m-70 -140.89 169.75 17.03 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 122.007 -0.702 . . . . 0.0 109.709 177.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 78.0 m -93.13 139.24 30.79 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 166.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -129.38 149.58 51.1 Favored 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.486 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -152.12 138.4 18.42 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 176.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 18.2 tt -136.36 149.05 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 CA-C-O 120.961 0.41 . . . . 0.0 110.459 -168.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 16.3 tt -132.36 145.11 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 177.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -149.79 143.43 25.37 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 -169.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.6 tm-20 -101.64 117.68 35.38 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 122.169 -0.332 . . . . 0.0 110.119 -177.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 51.7 p30 -87.05 175.34 8.16 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 122.132 -0.355 . . . . 0.0 110.676 -175.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -60.44 -17.55 45.35 Favored 'General case' 0 N--CA 1.507 2.413 0 O-C-N 121.941 -0.474 . . . . 0.0 112.069 -173.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -93.18 -10.71 34.81 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.589 -0.695 . . . . 0.0 111.9 178.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 89.99 21.16 40.1 Favored Glycine 0 N--CA 1.498 2.785 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 178.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -96.98 143.79 27.51 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-N 118.312 1.056 . . . . 0.0 109.77 170.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 15.8 p -94.81 126.54 40.2 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 122.069 -0.395 . . . . 0.0 110.2 177.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 20.7 p -97.91 117.56 32.51 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 122.13 -0.357 . . . . 0.0 110.298 179.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 83.7 mt -97.7 128.18 44.19 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 122.136 -0.353 . . . . 0.0 110.295 -179.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -146.98 144.7 29.38 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 122.079 -0.388 . . . . 0.0 110.523 175.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 97.0 p -143.72 167.02 23.26 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 177.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -178.26 -169.14 38.69 Favored Glycine 0 N--CA 1.496 2.659 0 N-CA-C 110.224 -1.15 . . . . 0.0 110.224 -179.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 2.9 m -96.17 132.77 41.24 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 122.175 -0.603 . . . . 0.0 110.181 -176.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 54.9 ttm -98.92 122.01 41.62 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 122.052 -0.405 . . . . 0.0 110.071 175.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 17.5 pttm . . . . . 0 N--CA 1.503 2.191 0 O-C-N 122.024 -0.423 . . . . 0.0 110.48 -179.028 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 46.4 ptt85 . . . . . 0 N--CA 1.495 1.81 0 CA-C-O 120.824 0.345 . . . . 0.0 110.594 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 18.1 m -128.75 148.78 50.87 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 172.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.4 tt -143.18 127.38 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.997 -0.439 . . . . 0.0 110.167 -176.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -105.81 149.23 26.68 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 122.234 -0.291 . . . . 0.0 110.455 177.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 26.7 p -143.02 134.63 26.46 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 177.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 20.4 p -157.57 131.38 8.04 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.926 -0.484 . . . . 0.0 110.81 -170.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 21.6 ttp-105 -104.86 48.48 0.84 Allowed 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 121.385 0.612 . . . . 0.0 110.604 -176.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.0 p -135.12 151.36 50.63 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.895 -0.503 . . . . 0.0 109.785 174.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 15.7 p30 -61.77 132.24 52.51 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 121.724 -0.61 . . . . 0.0 111.793 -163.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 75.3 mt 52.0 26.55 3.8 Favored 'General case' 0 N--CA 1.507 2.376 0 O-C-N 122.089 -0.382 . . . . 0.0 111.991 179.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 26.3 p -63.11 -21.99 66.56 Favored 'General case' 0 N--CA 1.506 2.363 0 O-C-N 121.849 -0.532 . . . . 0.0 111.583 176.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -93.04 -22.93 18.85 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.684 -0.635 . . . . 0.0 111.323 178.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -60.66 -38.6 85.42 Favored 'General case' 0 N--CA 1.508 2.436 0 O-C-N 121.577 -0.702 . . . . 0.0 110.768 -177.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -100.74 16.23 25.67 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 122.078 -0.389 . . . . 0.0 111.685 179.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 16.8 tp -111.87 117.34 32.52 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.586 -0.697 . . . . 0.0 110.394 -174.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 3.3 tp-100 -96.45 120.71 61.79 Favored Pre-proline 0 N--CA 1.496 1.868 0 CA-C-O 118.862 -0.589 . . . . 0.0 109.965 171.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -69.93 145.22 55.51 Favored 'Trans proline' 0 N--CA 1.491 1.347 0 O-C-N 123.235 1.124 . . . . 0.0 110.291 175.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 34.5 p -139.22 147.05 41.25 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 122.175 -0.328 . . . . 0.0 110.156 179.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 14.9 mt . . . . . 0 N--CA 1.502 2.166 0 CA-C-O 119.305 -0.379 . . . . 0.0 110.152 178.987 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo . . . . . 0 N--CA 1.502 2.011 0 N-CA-C 111.224 -0.337 . . . . 0.0 111.224 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -151.73 47.99 0.8 Allowed 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 121.188 0.518 . . . . 0.0 110.743 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 18.9 tp -161.0 115.01 2.05 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.771 -0.581 . . . . 0.0 110.449 -174.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 48.6 tttt -99.81 132.5 45.12 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 122.146 -0.347 . . . . 0.0 110.223 177.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 86.4 m -118.97 140.43 50.01 Favored 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 -178.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -83.07 144.49 29.86 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 122.027 -0.421 . . . . 0.0 110.015 176.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 28.1 p -115.67 137.07 52.44 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.952 -0.467 . . . . 0.0 110.588 -178.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 98.6 p -123.02 141.57 51.82 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 109.894 -0.409 . . . . 0.0 109.894 175.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.18 -68.16 1.41 Allowed Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -112.15 123.59 50.59 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.997 -0.708 . . . . 0.0 110.498 -176.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -138.07 136.99 20.14 Favored Pre-proline 0 N--CA 1.496 1.87 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 174.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -61.11 152.52 70.99 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 O-C-N 123.087 1.046 . . . . 0.0 111.077 -172.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -60.44 -28.21 68.11 Favored 'General case' 0 N--CA 1.508 2.462 0 O-C-N 121.88 -0.512 . . . . 0.0 111.415 -172.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -91.97 14.26 16.27 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.953 -0.467 . . . . 0.0 111.735 -177.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.86 161.97 27.22 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.533 -0.73 . . . . 0.0 110.243 -173.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 70.7 mt -124.36 136.38 60.69 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -177.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 19.8 p30 37.78 43.36 0.48 Allowed 'General case' 0 N--CA 1.515 2.776 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -176.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 30.8 m120 55.39 44.0 27.88 Favored 'General case' 0 N--CA 1.507 2.386 0 O-C-N 121.785 -0.572 . . . . 0.0 111.466 -178.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 58.2 p -140.76 161.75 37.05 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.725 -0.609 . . . . 0.0 110.306 171.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.4 p -139.66 165.07 28.26 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-O 120.752 0.311 . . . . 0.0 110.691 179.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 76.4 mt -111.91 132.53 60.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 -175.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.1 t -140.44 153.05 46.14 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 122.027 -0.421 . . . . 0.0 111.059 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 48.5 p30 -108.61 29.96 6.92 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 122.037 -0.415 . . . . 0.0 110.672 167.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -122.89 -96.05 1.26 Allowed Glycine 0 N--CA 1.497 2.73 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 176.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 49.7 m-70 -144.5 171.03 14.93 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 122.136 -0.626 . . . . 0.0 109.761 176.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 73.7 m -92.96 139.09 30.89 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 164.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -129.52 150.34 50.9 Favored 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 120.291 -0.564 . . . . 0.0 110.613 -178.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -151.26 143.98 24.39 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 175.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 18.1 tt -143.29 149.26 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.397 -171.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 13.5 tt -134.28 145.32 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 177.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -148.58 145.15 27.69 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 -169.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.3 tm-20 -101.53 116.94 33.9 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 122.146 -0.346 . . . . 0.0 110.134 -176.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -87.4 175.33 8.04 Favored 'General case' 0 N--CA 1.501 2.101 0 CA-C-O 120.796 0.332 . . . . 0.0 110.584 -175.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -60.44 -17.86 47.35 Favored 'General case' 0 N--CA 1.506 2.372 0 O-C-N 121.895 -0.503 . . . . 0.0 112.0 -172.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -92.85 -10.37 36.96 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.599 -0.688 . . . . 0.0 111.861 178.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 89.47 20.21 45.73 Favored Glycine 0 N--CA 1.498 2.791 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 176.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -97.38 145.74 25.86 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-N 118.466 1.133 . . . . 0.0 109.793 169.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 13.6 p -94.92 129.16 42.06 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 122.106 -0.371 . . . . 0.0 110.26 178.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 20.9 p -97.86 118.16 33.81 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 122.057 -0.402 . . . . 0.0 110.353 178.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 23.2 mt -97.53 126.87 43.07 Favored 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 120.966 -0.294 . . . . 0.0 110.307 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -145.18 143.41 30.3 Favored 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.646 174.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 98.9 p -143.85 167.06 23.2 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 176.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 178.91 -165.66 34.8 Favored Glycine 0 N--CA 1.496 2.663 0 N-CA-C 110.379 -1.088 . . . . 0.0 110.379 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 2.6 m -96.27 132.4 41.78 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 122.178 -0.601 . . . . 0.0 110.227 -176.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 55.8 ttm -98.49 121.82 40.91 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 122.069 -0.394 . . . . 0.0 110.156 177.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 22.5 pttt . . . . . 0 N--CA 1.503 2.199 0 C-N-CA 120.699 -0.401 . . . . 0.0 110.537 -178.9 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 33.4 ptt-85 . . . . . 0 N--CA 1.496 1.833 0 CA-C-O 120.984 0.421 . . . . 0.0 110.575 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 17.0 m -126.81 149.06 49.88 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 171.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.5 tt -143.14 155.92 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.963 -0.461 . . . . 0.0 110.308 -175.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 57.1 mm-40 -141.46 147.75 38.39 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 120.866 0.365 . . . . 0.0 110.412 179.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 26.8 p -143.1 136.84 28.69 Favored 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 179.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 18.9 p -157.5 132.53 8.8 Favored 'General case' 0 N--CA 1.504 2.244 0 O-C-N 121.97 -0.456 . . . . 0.0 110.973 -171.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 22.4 ttm180 -105.14 48.68 0.83 Allowed 'General case' 0 N--CA 1.498 1.974 0 CA-C-O 121.382 0.61 . . . . 0.0 110.559 -177.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 23.8 p -136.02 151.16 49.59 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.714 -0.616 . . . . 0.0 109.799 174.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -61.73 131.98 51.68 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.69 -0.631 . . . . 0.0 111.821 -163.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 72.9 mt 52.28 26.4 4.0 Favored 'General case' 0 N--CA 1.506 2.36 0 O-C-N 122.047 -0.408 . . . . 0.0 111.948 179.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 26.4 p -62.86 -22.06 66.42 Favored 'General case' 0 N--CA 1.507 2.422 0 O-C-N 121.859 -0.526 . . . . 0.0 111.615 176.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -92.21 -22.86 19.57 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.83 -0.544 . . . . 0.0 111.331 177.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -60.76 -38.1 84.09 Favored 'General case' 0 N--CA 1.507 2.395 0 O-C-N 121.635 -0.666 . . . . 0.0 110.775 -177.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -100.24 16.26 24.88 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 122.179 -0.325 . . . . 0.0 111.701 178.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 14.0 tp -116.9 111.53 19.78 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.492 -0.755 . . . . 0.0 110.289 -175.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 21.9 tp60 -96.49 120.7 61.74 Favored Pre-proline 0 N--CA 1.497 1.893 0 CA-C-O 118.756 -0.64 . . . . 0.0 109.982 172.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.69 133.89 21.12 Favored 'Trans proline' 0 N--CA 1.49 1.296 0 O-C-N 123.237 1.125 . . . . 0.0 110.395 176.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 34.9 p -139.22 147.84 42.3 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 122.004 -0.435 . . . . 0.0 110.048 177.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 13.5 mt . . . . . 0 N--CA 1.502 2.128 0 CA-C-O 119.01 -0.519 . . . . 0.0 109.929 179.56 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo . . . . . 0 N--CA 1.502 1.996 0 N-CA-C 111.237 -0.332 . . . . 0.0 111.237 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -155.38 47.29 0.51 Allowed 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.931 -0.481 . . . . 0.0 110.752 172.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 25.1 tp -159.33 102.77 1.59 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.767 -0.583 . . . . 0.0 110.396 -173.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 41.0 tttp -99.91 119.07 37.64 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 110.288 -0.264 . . . . 0.0 110.288 177.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 69.2 m -121.73 140.63 52.09 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 122.078 -0.389 . . . . 0.0 110.945 -178.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -79.7 155.44 28.01 Favored 'General case' 0 N--CA 1.501 2.087 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.07 -178.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 27.2 p -119.3 141.14 49.25 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.996 -0.44 . . . . 0.0 110.529 -179.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 49.7 m -122.98 138.93 54.55 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 122.086 -0.383 . . . . 0.0 110.169 177.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.52 -68.38 1.51 Allowed Glycine 0 N--CA 1.496 2.661 0 N-CA-C 109.669 -1.373 . . . . 0.0 109.669 178.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 83.2 t60 -112.97 125.79 54.78 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 122.073 -0.663 . . . . 0.0 110.537 -176.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -138.03 137.68 21.73 Favored Pre-proline 0 N--CA 1.496 1.839 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 176.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -61.11 150.89 82.18 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 O-C-N 123.049 1.026 . . . . 0.0 111.072 -174.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -59.77 -27.18 66.32 Favored 'General case' 0 N--CA 1.507 2.41 0 O-C-N 121.938 -0.477 . . . . 0.0 111.463 -173.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -92.17 14.23 16.74 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.871 -0.518 . . . . 0.0 111.746 -177.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.63 162.03 25.53 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.655 -0.653 . . . . 0.0 110.333 -173.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 76.2 mt -125.75 140.52 48.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -178.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 38.8 42.08 0.59 Allowed 'General case' 0 N--CA 1.513 2.696 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -178.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 30.7 m120 54.96 41.8 31.59 Favored 'General case' 0 N--CA 1.509 2.511 0 O-C-N 121.955 -0.465 . . . . 0.0 111.437 -178.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 43.1 p -140.54 161.77 36.95 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.825 -0.547 . . . . 0.0 110.332 173.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.4 p -138.38 163.32 32.18 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 120.967 0.413 . . . . 0.0 110.542 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 79.1 mt -129.33 125.32 61.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -168.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.2 t -143.6 158.25 43.81 Favored 'General case' 0 N--CA 1.501 2.12 0 C-N-CA 120.578 -0.449 . . . . 0.0 111.337 -177.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 10.6 p-10 -109.58 29.23 7.77 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 122.168 -0.333 . . . . 0.0 110.473 165.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -112.44 -103.66 2.67 Favored Glycine 0 N--CA 1.496 2.662 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 178.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 22.9 m80 -147.22 158.88 44.11 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 170.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 87.5 m -96.71 139.35 32.9 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 176.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -129.01 158.36 39.11 Favored 'General case' 0 N--CA 1.497 1.915 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.694 -171.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -150.98 143.86 24.55 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 176.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 18.2 tt -142.21 149.15 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.444 -170.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 15.4 tt -137.88 145.11 29.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 178.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -150.04 140.85 22.74 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 -170.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.1 tm-20 -101.67 116.54 32.98 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -86.78 175.23 8.33 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 122.068 -0.395 . . . . 0.0 110.582 -175.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -60.65 -17.49 47.74 Favored 'General case' 0 N--CA 1.507 2.423 0 O-C-N 122.076 -0.39 . . . . 0.0 112.002 -172.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -92.49 -10.82 36.42 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.628 -0.67 . . . . 0.0 111.855 178.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.14 20.91 40.5 Favored Glycine 0 N--CA 1.497 2.757 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 176.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -97.49 142.8 28.88 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 118.378 1.089 . . . . 0.0 109.784 169.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.3 p -94.91 128.83 41.99 Favored 'General case' 0 N--CA 1.498 1.961 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.273 177.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.1 p -98.05 114.33 26.46 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 120.851 0.358 . . . . 0.0 110.232 177.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 82.4 mt -96.66 123.98 40.51 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 122.169 -0.332 . . . . 0.0 110.235 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -145.23 147.88 32.9 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 122.087 -0.383 . . . . 0.0 110.465 178.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 92.5 p -143.57 164.99 28.83 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 176.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -173.98 -178.96 44.3 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 -177.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 6.6 m -100.08 133.46 44.43 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 122.203 -0.587 . . . . 0.0 110.309 -178.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 35.2 ttm -99.85 123.13 43.78 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 122.038 -0.414 . . . . 0.0 110.167 176.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 24.5 pttt . . . . . 0 N--CA 1.504 2.27 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.381 177.039 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 62.1 ttp85 . . . . . 0 N--CA 1.495 1.818 0 CA-C-O 120.901 0.382 . . . . 0.0 110.147 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 12.2 m -134.26 149.09 50.92 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 172.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.6 tt -143.06 155.99 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 177.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -145.95 156.64 43.65 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 120.873 0.368 . . . . 0.0 110.474 -178.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 97.0 m -141.81 154.12 44.98 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 178.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 25.4 p -157.6 133.34 9.22 Favored 'General case' 0 N--CA 1.502 2.146 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.842 -170.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 48.9 ttt85 -109.46 45.91 1.04 Allowed 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.299 0.571 . . . . 0.0 110.516 -179.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 44.2 p -138.1 151.97 48.31 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.805 -0.559 . . . . 0.0 110.055 176.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 21.3 p30 -64.12 140.46 58.87 Favored 'General case' 0 N--CA 1.505 2.292 0 CA-C-O 121.315 0.579 . . . . 0.0 111.198 -169.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 20.3 mt 53.07 25.85 4.44 Favored 'General case' 0 N--CA 1.507 2.39 0 O-C-N 121.814 -0.554 . . . . 0.0 112.289 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 27.9 p -67.84 -25.18 65.42 Favored 'General case' 0 N--CA 1.505 2.275 0 C-N-CA 119.968 -0.693 . . . . 0.0 111.164 172.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -81.09 -33.79 33.09 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.723 -0.611 . . . . 0.0 110.463 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -63.06 -40.73 98.57 Favored 'General case' 0 N--CA 1.506 2.358 0 O-C-N 122.002 -0.436 . . . . 0.0 110.89 -177.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -102.4 16.26 26.79 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 122.067 -0.395 . . . . 0.0 111.978 -174.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 13.5 tp -125.84 109.05 12.06 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.535 -0.728 . . . . 0.0 110.37 -176.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -98.33 120.78 58.74 Favored Pre-proline 0 N--CA 1.497 1.889 0 CA-C-O 118.799 -0.619 . . . . 0.0 110.132 173.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -68.84 147.13 68.06 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 O-C-N 123.234 1.123 . . . . 0.0 110.205 175.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 35.3 p -139.17 149.98 45.07 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 122.133 -0.355 . . . . 0.0 110.169 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 64.1 mt . . . . . 0 N--CA 1.502 2.145 0 CA-C-O 119.187 -0.435 . . . . 0.0 110.138 179.723 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_exo . . . . . 0 N--CA 1.498 1.757 0 N-CA-C 110.942 -0.445 . . . . 0.0 110.942 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -156.12 51.33 0.53 Allowed 'General case' 0 N--CA 1.498 1.971 0 CA-C-O 121.364 0.602 . . . . 0.0 110.372 164.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 20.8 tp -158.26 114.81 2.81 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.615 -0.678 . . . . 0.0 110.29 -178.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 55.5 tttt -99.79 130.09 45.96 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 178.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 80.1 m -114.62 140.21 49.0 Favored 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -84.5 142.79 29.79 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 176.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 28.1 p -113.88 137.67 51.35 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 122.052 -0.405 . . . . 0.0 110.595 -177.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 28.0 t -122.95 133.05 54.4 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 122.089 -0.382 . . . . 0.0 110.109 178.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.75 -66.26 2.77 Favored Glycine 0 N--CA 1.495 2.586 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 63.9 m170 -110.79 123.34 49.88 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 122.069 -0.665 . . . . 0.0 110.554 -177.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -138.1 136.01 19.14 Favored Pre-proline 0 N--CA 1.496 1.858 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 175.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -60.54 152.69 66.46 Favored 'Trans proline' 0 N--CA 1.496 1.662 0 O-C-N 123.024 1.013 . . . . 0.0 111.201 -170.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -60.36 -28.15 67.95 Favored 'General case' 0 N--CA 1.507 2.377 0 O-C-N 122.04 -0.412 . . . . 0.0 111.365 -172.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -92.32 14.35 16.68 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.985 -0.447 . . . . 0.0 111.763 -178.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.45 162.07 27.47 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.554 -0.716 . . . . 0.0 110.217 -172.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 68.7 mt -126.06 137.59 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -176.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 17.2 p30 37.82 43.31 0.48 Allowed 'General case' 0 N--CA 1.512 2.675 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -175.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 24.9 t30 56.1 42.66 28.08 Favored 'General case' 0 N--CA 1.508 2.457 0 O-C-N 121.805 -0.559 . . . . 0.0 111.451 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 44.3 p -142.02 165.24 27.99 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.765 -0.584 . . . . 0.0 110.555 171.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.6 p -137.8 163.7 30.74 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 122.166 -0.333 . . . . 0.0 110.567 176.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 77.0 mt -112.55 132.57 60.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -175.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.1 t -139.62 152.78 47.06 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.95 -0.469 . . . . 0.0 111.104 -178.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -108.92 31.25 5.82 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 122.116 -0.365 . . . . 0.0 110.432 167.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -124.79 -95.85 1.09 Allowed Glycine 0 N--CA 1.496 2.648 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 176.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 23.3 m80 -146.86 171.91 14.48 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 122.076 -0.661 . . . . 0.0 109.507 177.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 74.8 m -93.78 139.25 31.07 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 166.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -130.41 148.65 52.25 Favored 'General case' 0 N--CA 1.499 2.006 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.49 -178.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -151.9 143.5 23.55 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 177.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 18.3 tt -145.15 149.27 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 122.063 -0.398 . . . . 0.0 110.479 -171.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 15.4 tt -135.75 145.32 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 176.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -148.2 148.49 30.58 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 -169.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.4 tm-20 -101.6 117.51 35.06 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 -175.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -87.38 175.28 8.06 Favored 'General case' 0 N--CA 1.501 2.093 0 CA-C-O 120.796 0.331 . . . . 0.0 110.582 -175.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -60.84 -17.57 50.74 Favored 'General case' 0 N--CA 1.506 2.347 0 O-C-N 121.988 -0.445 . . . . 0.0 111.954 -172.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -92.63 -10.86 35.86 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.678 -0.639 . . . . 0.0 111.801 178.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.54 19.33 45.26 Favored Glycine 0 N--CA 1.497 2.766 0 O-C-N 121.469 -0.769 . . . . 0.0 111.194 177.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -97.2 145.37 26.12 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-N 118.483 1.141 . . . . 0.0 109.818 169.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.9 p -94.72 128.54 41.48 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 122.079 -0.388 . . . . 0.0 110.342 178.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 19.8 p -97.96 116.25 29.79 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 122.134 -0.354 . . . . 0.0 110.354 178.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 14.7 mt -97.42 126.58 42.76 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 122.152 -0.342 . . . . 0.0 110.423 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -145.75 144.82 30.56 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 120.811 -0.355 . . . . 0.0 110.434 175.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 80.1 p -143.72 165.55 27.35 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 176.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -178.02 -166.87 35.17 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 110.226 -1.15 . . . . 0.0 110.226 -178.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 2.7 m -97.32 132.68 42.82 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 122.212 -0.581 . . . . 0.0 110.309 -175.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 47.3 ttm -99.1 123.33 43.32 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 122.028 -0.42 . . . . 0.0 110.197 178.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 23.5 pttm . . . . . 0 N--CA 1.504 2.241 0 O-C-N 122.049 -0.407 . . . . 0.0 110.642 -178.881 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 16.9 ptt-85 . . . . . 0 N--CA 1.495 1.776 0 CA-C-O 120.841 0.353 . . . . 0.0 110.332 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 15.2 m -128.56 149.14 50.75 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 173.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.5 tt -143.09 155.77 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 122.064 -0.397 . . . . 0.0 109.976 -179.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -143.02 149.76 38.69 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 120.932 0.396 . . . . 0.0 110.506 -178.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 25.6 p -143.06 137.78 29.46 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -178.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 22.6 p -157.39 131.7 8.4 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.895 -0.503 . . . . 0.0 110.979 -172.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 30.4 ttp180 -105.83 44.81 1.01 Allowed 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 121.285 0.564 . . . . 0.0 110.532 -176.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.0 p -135.19 150.89 50.21 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.929 -0.482 . . . . 0.0 109.931 177.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 17.6 p-10 -62.82 131.81 50.08 Favored 'General case' 0 N--CA 1.504 2.228 0 CA-C-O 121.436 0.636 . . . . 0.0 111.635 -163.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 81.2 mt 51.76 28.13 4.69 Favored 'General case' 0 N--CA 1.506 2.355 0 O-C-N 121.927 -0.483 . . . . 0.0 111.934 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 25.8 p -62.46 -23.85 67.12 Favored 'General case' 0 N--CA 1.506 2.36 0 O-C-N 121.823 -0.548 . . . . 0.0 111.53 173.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -75.31 -30.0 60.22 Favored 'General case' 0 N--CA 1.504 2.241 0 O-C-N 121.811 -0.556 . . . . 0.0 111.046 177.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -62.3 -39.63 93.63 Favored 'General case' 0 N--CA 1.506 2.339 0 O-C-N 121.673 -0.642 . . . . 0.0 110.81 -168.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -100.17 16.11 25.27 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 122.176 -0.328 . . . . 0.0 111.693 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 12.5 tp -116.36 108.95 16.71 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.597 -0.69 . . . . 0.0 110.347 -175.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -99.45 120.72 57.1 Favored Pre-proline 0 N--CA 1.497 1.903 0 CA-C-O 118.955 -0.545 . . . . 0.0 110.125 173.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -68.79 137.41 38.31 Favored 'Trans proline' 0 N--CA 1.49 1.277 0 O-C-N 123.158 1.083 . . . . 0.0 110.157 172.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 34.7 p -139.29 146.8 40.8 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.119 178.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 21.0 mt . . . . . 0 N--CA 1.503 2.205 0 C-N-CA 120.685 -0.406 . . . . 0.0 109.94 179.233 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo . . . . . 0 N--CA 1.499 1.807 0 N-CA-C 111.19 -0.35 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -161.76 54.21 0.25 Allowed 'General case' 0 N--CA 1.5 2.034 0 CA-C-O 121.359 0.6 . . . . 0.0 110.281 165.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 21.6 tp -157.63 115.47 3.08 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.748 -0.595 . . . . 0.0 109.919 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.3 tptt -99.67 131.1 45.88 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 122.18 -0.325 . . . . 0.0 110.162 -178.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 72.6 m -121.12 140.59 51.78 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -176.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -83.71 144.15 29.56 Favored 'General case' 0 N--CA 1.5 2.033 0 C-N-CA 120.601 -0.44 . . . . 0.0 109.9 176.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 27.1 p -118.57 136.96 53.56 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 122.056 -0.403 . . . . 0.0 110.568 -177.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.4 m -123.0 141.19 52.24 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 122.059 -0.4 . . . . 0.0 110.088 177.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 75.89 -67.14 2.39 Favored Glycine 0 N--CA 1.496 2.636 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -116.68 123.68 47.86 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 122.132 -0.628 . . . . 0.0 110.579 -176.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -138.08 136.75 19.91 Favored Pre-proline 0 N--CA 1.497 1.891 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 174.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -61.31 151.77 76.98 Favored 'Trans proline' 0 N--CA 1.496 1.633 0 O-C-N 123.114 1.06 . . . . 0.0 111.094 -172.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -59.21 -25.72 64.23 Favored 'General case' 0 N--CA 1.507 2.394 0 O-C-N 122.032 -0.418 . . . . 0.0 111.625 -173.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -91.57 14.27 15.47 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.944 -0.473 . . . . 0.0 111.899 -176.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -82.67 161.53 22.12 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.565 -0.71 . . . . 0.0 110.242 -175.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 76.4 mt -125.74 139.38 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -178.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 38.42 42.26 0.52 Allowed 'General case' 0 N--CA 1.513 2.708 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -177.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 55.16 42.37 30.71 Favored 'General case' 0 N--CA 1.509 2.494 0 O-C-N 121.921 -0.487 . . . . 0.0 111.487 -178.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 27.4 p -140.43 157.49 45.44 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.878 -0.514 . . . . 0.0 110.402 172.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.8 p -145.82 165.82 27.75 Favored 'General case' 0 N--CA 1.499 1.988 0 CA-C-O 121.0 0.429 . . . . 0.0 110.718 -172.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 78.0 mt -123.58 120.32 59.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -166.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.9 t -135.8 153.26 51.57 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-O 121.0 0.428 . . . . 0.0 110.965 -174.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 44.3 p-10 -102.57 30.15 4.83 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 122.121 -0.362 . . . . 0.0 110.659 170.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -122.45 -108.33 1.97 Allowed Glycine 0 N--CA 1.496 2.658 0 N-CA-C 109.08 -1.608 . . . . 0.0 109.08 172.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -141.18 172.14 13.09 Favored 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -176.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 67.0 m -97.68 139.27 33.82 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 170.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -135.47 155.79 49.96 Favored 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 120.053 -0.659 . . . . 0.0 110.952 -176.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -151.06 150.66 30.98 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 18.4 tt -143.15 149.14 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 CA-C-O 120.904 0.383 . . . . 0.0 110.364 -172.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 16.0 tt -138.01 145.2 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 177.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -150.21 141.18 22.92 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 122.109 -0.369 . . . . 0.0 110.04 -170.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.0 tm-20 -101.69 116.52 32.93 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -86.67 175.25 8.37 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 122.212 -0.305 . . . . 0.0 110.59 -175.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -60.74 -17.5 48.97 Favored 'General case' 0 N--CA 1.506 2.35 0 O-C-N 122.032 -0.417 . . . . 0.0 111.998 -172.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -92.56 -10.8 36.3 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.668 -0.645 . . . . 0.0 111.819 178.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.1 20.95 40.49 Favored Glycine 0 N--CA 1.496 2.641 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 176.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -97.59 142.01 29.93 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-N 118.368 1.084 . . . . 0.0 109.893 169.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 10.9 p -94.84 129.62 41.74 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 122.168 -0.333 . . . . 0.0 110.36 178.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 17.9 p -97.85 112.94 24.66 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 122.147 -0.346 . . . . 0.0 110.324 177.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -97.36 122.31 40.25 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 122.124 -0.36 . . . . 0.0 110.254 179.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -144.99 155.66 43.51 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 122.004 -0.435 . . . . 0.0 110.541 178.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 91.0 p -143.51 162.89 34.66 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 176.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -158.81 -177.76 32.19 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 110.289 -1.124 . . . . 0.0 110.289 -173.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 1.7 m -113.09 115.71 28.74 Favored 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 -169.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 49.8 ttm -95.88 121.93 38.14 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.878 -0.514 . . . . 0.0 110.474 -170.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 22.1 pttt . . . . . 0 N--CA 1.503 2.209 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.412 175.695 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 30.1 ptt180 . . . . . 0 N--CA 1.496 1.862 0 CA-C-O 120.808 0.337 . . . . 0.0 110.7 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 24.3 m -133.95 149.39 51.25 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 177.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.6 tt -141.75 156.06 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 122.017 -0.427 . . . . 0.0 109.94 -178.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 51.6 mm-40 -143.86 151.43 39.87 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 122.146 -0.346 . . . . 0.0 110.615 -176.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 99.0 m -142.89 149.37 38.41 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 176.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 15.4 p -157.51 141.31 15.86 Favored 'General case' 0 N--CA 1.502 2.155 0 CA-C-O 121.07 0.462 . . . . 0.0 110.951 -173.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 68.8 mtp180 -110.55 49.51 0.85 Allowed 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.377 0.608 . . . . 0.0 110.693 -169.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.1 p -148.66 152.26 36.38 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.793 -0.567 . . . . 0.0 109.966 178.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -60.96 132.02 52.52 Favored 'General case' 0 N--CA 1.507 2.376 0 O-C-N 121.646 -0.659 . . . . 0.0 111.81 -163.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 69.1 mt 52.49 26.03 3.97 Favored 'General case' 0 N--CA 1.507 2.387 0 O-C-N 122.085 -0.385 . . . . 0.0 111.925 179.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 26.1 p -62.71 -21.97 66.18 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 121.853 -0.529 . . . . 0.0 111.762 177.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -90.09 -22.9 21.57 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.748 -0.595 . . . . 0.0 111.275 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -60.45 -38.9 85.62 Favored 'General case' 0 N--CA 1.509 2.488 0 O-C-N 121.58 -0.7 . . . . 0.0 110.775 -175.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -101.37 16.25 26.2 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 122.104 -0.373 . . . . 0.0 111.73 179.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 15.5 tp -110.53 113.54 26.25 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.567 -0.708 . . . . 0.0 110.38 -174.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 -96.83 120.76 61.1 Favored Pre-proline 0 N--CA 1.497 1.911 0 CA-C-O 118.803 -0.617 . . . . 0.0 109.989 172.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -68.34 133.89 29.58 Favored 'Trans proline' 0 N--CA 1.491 1.364 0 O-C-N 123.273 1.144 . . . . 0.0 110.408 176.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 32.7 p -98.84 125.32 44.19 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 122.098 -0.376 . . . . 0.0 110.428 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 15.7 mt . . . . . 0 N--CA 1.501 2.102 0 CA-C-O 119.282 -0.39 . . . . 0.0 110.097 176.663 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo . . . . . 0 N--CA 1.503 2.047 0 N-CA-C 111.268 -0.32 . . . . 0.0 111.268 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -153.38 49.84 0.7 Allowed 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.882 -0.511 . . . . 0.0 110.677 178.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 19.7 tp -159.94 114.97 2.34 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.821 -0.549 . . . . 0.0 110.112 -176.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 50.9 tttt -99.86 130.87 46.09 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 122.151 -0.343 . . . . 0.0 110.158 178.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 85.8 m -117.01 140.39 49.54 Favored 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 -178.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -83.83 145.91 28.4 Favored 'General case' 0 N--CA 1.501 2.082 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.16 178.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 27.8 p -118.26 137.03 53.32 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 122.086 -0.384 . . . . 0.0 110.457 178.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 29.3 t -123.03 120.22 32.68 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 122.025 -0.422 . . . . 0.0 110.145 177.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 82.35 -62.77 4.53 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -103.89 112.05 24.85 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 122.03 -0.688 . . . . 0.0 110.486 -177.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -138.09 137.51 21.23 Favored Pre-proline 0 N--CA 1.497 1.915 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 176.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -60.97 151.85 75.13 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 O-C-N 123.114 1.06 . . . . 0.0 111.101 -174.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -60.35 -28.1 67.91 Favored 'General case' 0 N--CA 1.507 2.414 0 O-C-N 121.896 -0.503 . . . . 0.0 111.439 -172.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -92.28 14.36 16.59 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.921 -0.487 . . . . 0.0 111.749 -177.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.16 161.99 26.95 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.706 -0.621 . . . . 0.0 110.293 -173.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 76.1 mt -125.92 139.85 50.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 -177.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 38.88 42.75 0.68 Allowed 'General case' 0 N--CA 1.513 2.686 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -178.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 30.7 m120 54.96 43.0 30.59 Favored 'General case' 0 N--CA 1.508 2.452 0 O-C-N 121.838 -0.538 . . . . 0.0 111.496 -178.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 40.3 p -144.01 161.99 37.34 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.881 -0.512 . . . . 0.0 110.535 173.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.5 p -139.75 165.0 28.45 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 120.837 0.351 . . . . 0.0 110.666 179.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 77.4 mt -112.07 131.86 62.33 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -175.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.0 t -140.37 152.86 46.11 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 122.041 -0.412 . . . . 0.0 111.065 -178.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 40.1 p-10 -109.28 29.38 7.59 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 122.109 -0.369 . . . . 0.0 110.711 167.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -122.03 -92.79 1.18 Allowed Glycine 0 N--CA 1.496 2.65 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 177.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -149.86 172.04 15.8 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 122.099 -0.647 . . . . 0.0 109.574 176.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 75.9 m -94.01 139.17 31.27 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 166.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -129.11 153.22 47.87 Favored 'General case' 0 N--CA 1.499 1.997 0 C-N-CA 120.338 -0.545 . . . . 0.0 110.635 -178.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -151.24 143.39 24.03 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 176.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 18.1 tt -143.12 149.26 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.277 -172.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 14.9 tt -138.35 145.32 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 -179.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -148.71 145.76 27.81 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 -169.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.6 tm-20 -101.62 118.22 36.5 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 122.142 -0.349 . . . . 0.0 110.089 -176.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 52.1 p30 -87.17 175.29 8.14 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 122.21 -0.306 . . . . 0.0 110.601 -175.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -60.39 -17.93 47.11 Favored 'General case' 0 N--CA 1.508 2.43 0 O-C-N 122.025 -0.422 . . . . 0.0 111.988 -173.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -92.74 -10.47 36.94 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.689 -0.632 . . . . 0.0 111.921 178.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.08 21.03 40.21 Favored Glycine 0 N--CA 1.498 2.776 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 177.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -97.29 142.8 28.74 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 118.41 1.105 . . . . 0.0 109.823 170.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.1 p -94.83 125.67 39.65 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.249 177.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.2 p -97.89 112.95 24.68 Favored 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 120.877 -0.329 . . . . 0.0 110.296 177.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.4 mp -97.51 127.2 43.28 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 122.157 -0.339 . . . . 0.0 110.313 -178.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -142.79 145.36 33.17 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 122.021 -0.424 . . . . 0.0 110.329 177.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 88.1 p -143.53 166.53 24.55 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 177.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -179.72 -165.77 34.26 Favored Glycine 0 N--CA 1.497 2.736 0 N-CA-C 110.239 -1.145 . . . . 0.0 110.239 -178.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 3.7 m -96.66 132.11 42.64 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 122.226 -0.573 . . . . 0.0 110.343 -175.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 53.5 ttm -98.62 121.82 41.04 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.1 176.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.3 ptpp? . . . . . 0 N--CA 1.504 2.233 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.398 -178.614 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 46.5 ptt85 . . . . . 0 N--CA 1.496 1.825 0 CA-C-O 120.771 0.32 . . . . 0.0 110.509 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 17.1 m -129.47 149.09 51.4 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 174.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.5 tt -143.09 155.91 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.993 -0.442 . . . . 0.0 110.135 -177.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -146.53 152.1 38.42 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 120.834 0.35 . . . . 0.0 110.632 -178.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 26.9 p -143.01 148.3 36.54 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 177.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 14.9 p -157.56 137.51 12.44 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.919 -0.488 . . . . 0.0 111.171 -173.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 44.9 ttt85 -107.91 53.01 0.7 Allowed 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 121.356 0.598 . . . . 0.0 110.604 -173.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.0 p -148.38 151.99 36.24 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.765 -0.584 . . . . 0.0 109.92 175.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 16.5 p30 -61.76 133.46 55.55 Favored 'General case' 0 N--CA 1.505 2.295 0 CA-C-O 121.444 0.64 . . . . 0.0 111.74 -164.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 72.8 mt 52.08 26.5 3.85 Favored 'General case' 0 N--CA 1.506 2.363 0 O-C-N 121.949 -0.469 . . . . 0.0 111.962 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 25.9 p -63.22 -21.92 66.54 Favored 'General case' 0 N--CA 1.506 2.338 0 O-C-N 121.889 -0.507 . . . . 0.0 111.7 176.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -92.29 -22.89 19.49 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.761 -0.587 . . . . 0.0 111.275 178.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -60.52 -37.17 80.29 Favored 'General case' 0 N--CA 1.506 2.338 0 O-C-N 121.433 -0.792 . . . . 0.0 110.762 -177.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -100.6 16.16 25.72 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 122.085 -0.384 . . . . 0.0 111.616 177.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 17.6 tp -112.19 113.48 25.76 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.675 -0.641 . . . . 0.0 110.346 -174.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -96.72 120.65 61.5 Favored Pre-proline 0 N--CA 1.496 1.863 0 CA-C-O 118.827 -0.606 . . . . 0.0 110.073 173.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -70.19 148.07 61.52 Favored 'Trans proline' 0 N--CA 1.49 1.293 0 O-C-N 123.122 1.064 . . . . 0.0 110.283 175.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 34.9 p -139.19 149.95 45.0 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 122.028 -0.42 . . . . 0.0 110.123 178.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 15.9 mt . . . . . 0 N--CA 1.503 2.177 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.112 -179.961 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_exo . . . . . 0 N--CA 1.498 1.791 0 N-CA-C 111.012 -0.418 . . . . 0.0 111.012 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -158.29 52.34 0.43 Allowed 'General case' 0 N--CA 1.501 2.107 0 CA-C-O 121.32 0.581 . . . . 0.0 110.515 164.175 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 21.4 tp -158.22 114.65 2.8 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.656 -0.652 . . . . 0.0 110.23 -179.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -99.77 131.63 45.63 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 122.11 -0.369 . . . . 0.0 110.225 177.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 79.3 m -115.31 140.22 49.3 Favored 'General case' 0 N--CA 1.501 2.077 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 -178.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -84.59 141.34 30.75 Favored 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 176.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 28.1 p -115.01 137.01 52.5 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 122.008 -0.433 . . . . 0.0 110.608 -177.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 49.4 m -122.99 135.58 54.53 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 175.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 75.49 -67.05 2.27 Favored Glycine 0 N--CA 1.495 2.606 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 83.7 t60 -109.2 119.55 39.85 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.99 -0.712 . . . . 0.0 110.576 -176.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -137.99 136.71 19.99 Favored Pre-proline 0 N--CA 1.496 1.868 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 174.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -60.12 151.88 69.65 Favored 'Trans proline' 0 N--CA 1.497 1.714 0 O-C-N 123.04 1.021 . . . . 0.0 111.225 -171.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -60.32 -28.14 67.89 Favored 'General case' 0 N--CA 1.507 2.394 0 O-C-N 121.966 -0.459 . . . . 0.0 111.401 -172.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -92.21 14.34 16.5 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.923 -0.486 . . . . 0.0 111.786 -178.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.46 162.06 26.64 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.606 -0.684 . . . . 0.0 110.348 -172.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 77.4 mt -126.08 140.5 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -177.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 38.68 42.69 0.62 Allowed 'General case' 0 N--CA 1.514 2.743 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -178.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 55.03 42.55 30.87 Favored 'General case' 0 N--CA 1.506 2.372 0 O-C-N 121.841 -0.537 . . . . 0.0 111.47 -179.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 41.5 p -142.96 161.16 38.87 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.89 -0.507 . . . . 0.0 110.465 173.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.3 p -138.46 162.52 34.27 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 120.874 0.369 . . . . 0.0 110.622 177.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 77.5 mt -108.73 132.58 56.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -176.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.9 t -138.74 151.95 47.55 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.989 -0.445 . . . . 0.0 110.936 -179.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.4 p-10 -108.8 29.76 7.15 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 122.143 -0.348 . . . . 0.0 110.64 167.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -125.19 -93.29 0.95 Allowed Glycine 0 N--CA 1.496 2.659 0 N-CA-C 109.286 -1.525 . . . . 0.0 109.286 177.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 42.8 m-70 -148.4 172.06 15.04 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 122.074 -0.662 . . . . 0.0 109.521 177.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 71.9 m -93.32 139.21 30.91 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 165.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 15.6 p90 -129.98 151.38 50.6 Favored 'General case' 0 N--CA 1.499 2.024 0 C-N-CA 120.365 -0.534 . . . . 0.0 110.595 -177.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -151.02 143.68 24.39 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -179.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 18.1 tt -143.82 149.22 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 CA-C-O 120.905 0.383 . . . . 0.0 110.413 -173.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 16.6 tt -133.85 145.23 33.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -146.92 145.17 29.71 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -167.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.7 tm-20 -101.58 118.17 36.4 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -176.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 50.8 p30 -87.45 175.31 8.02 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 122.077 -0.39 . . . . 0.0 110.605 -175.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -60.42 -17.91 47.41 Favored 'General case' 0 N--CA 1.508 2.443 0 O-C-N 122.033 -0.417 . . . . 0.0 111.957 -173.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 84.1 mm-40 -93.27 -9.84 37.62 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.662 -0.649 . . . . 0.0 111.926 178.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 89.4 20.96 42.79 Favored Glycine 0 N--CA 1.499 2.877 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 177.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -97.16 144.39 27.04 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-N 118.427 1.113 . . . . 0.0 109.791 169.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.8 p -94.84 126.31 40.09 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.988 -0.445 . . . . 0.0 110.276 177.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 24.5 p -97.92 122.68 41.33 Favored 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 120.921 -0.312 . . . . 0.0 110.284 178.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 75.2 mt -97.09 127.84 43.45 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 122.119 -0.363 . . . . 0.0 110.289 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -143.0 144.24 32.22 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 122.025 -0.422 . . . . 0.0 110.369 175.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 40.5 p -143.78 167.01 23.31 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 178.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -177.84 -167.25 35.65 Favored Glycine 0 N--CA 1.496 2.691 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 2.0 m -97.4 132.84 42.74 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 122.211 -0.582 . . . . 0.0 110.271 -176.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 54.7 ttm -100.91 129.62 46.8 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 122.039 -0.413 . . . . 0.0 110.279 179.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.6 pttm . . . . . 0 N--CA 1.503 2.223 0 O-C-N 122.08 -0.388 . . . . 0.0 110.58 177.385 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 44.6 ptt85 . . . . . 0 N--CA 1.494 1.766 0 CA-C-O 120.954 0.406 . . . . 0.0 110.711 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 13.6 m -124.95 149.12 47.98 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 169.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.2 tt -143.09 154.57 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 C-N-CA 120.537 -0.465 . . . . 0.0 110.326 -172.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -147.26 154.68 41.28 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 120.811 0.339 . . . . 0.0 110.573 -178.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 26.6 p -143.05 151.9 41.3 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 177.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 20.3 p -157.6 134.49 10.03 Favored 'General case' 0 N--CA 1.502 2.152 0 CA-C-O 120.976 0.417 . . . . 0.0 110.77 -174.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 40.8 ttp85 -107.37 49.38 0.81 Allowed 'General case' 0 N--CA 1.497 1.907 0 CA-C-O 121.384 0.611 . . . . 0.0 110.661 -173.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.2 p -143.41 151.5 40.45 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.759 -0.588 . . . . 0.0 109.863 177.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 15.8 p30 -62.24 132.57 53.15 Favored 'General case' 0 N--CA 1.506 2.359 0 CA-C-O 121.406 0.622 . . . . 0.0 111.684 -164.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 76.5 mt 52.24 27.31 4.6 Favored 'General case' 0 N--CA 1.506 2.357 0 O-C-N 121.976 -0.453 . . . . 0.0 111.961 179.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 25.7 p -62.75 -23.32 67.14 Favored 'General case' 0 N--CA 1.507 2.42 0 O-C-N 121.852 -0.53 . . . . 0.0 111.624 174.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -73.73 -29.86 62.49 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.735 -0.603 . . . . 0.0 111.043 178.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -62.11 -39.55 92.91 Favored 'General case' 0 N--CA 1.505 2.318 0 O-C-N 121.653 -0.655 . . . . 0.0 110.855 -169.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -100.83 16.17 26.0 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 122.073 -0.392 . . . . 0.0 111.75 -178.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 15.9 tp -114.19 108.98 17.68 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.635 -0.665 . . . . 0.0 110.367 -175.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -98.15 120.82 58.94 Favored Pre-proline 0 N--CA 1.497 1.876 0 CA-C-O 118.943 -0.551 . . . . 0.0 110.102 174.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -70.99 143.37 44.73 Favored 'Trans proline' 0 N--CA 1.49 1.313 0 O-C-N 123.142 1.075 . . . . 0.0 110.343 174.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 35.1 p -139.16 150.01 45.12 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 122.154 -0.341 . . . . 0.0 110.095 178.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 15.0 mt . . . . . 0 N--CA 1.502 2.172 0 O-C-N 122.02 -0.425 . . . . 0.0 110.066 -179.568 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo . . . . . 0 N--CA 1.504 2.14 0 N-CA-C 111.369 -0.281 . . . . 0.0 111.369 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -156.32 48.19 0.47 Allowed 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 121.067 0.46 . . . . 0.0 110.872 176.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 18.5 tp -161.35 116.06 2.04 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.805 -0.56 . . . . 0.0 110.388 -173.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -99.81 133.66 43.85 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 122.214 -0.304 . . . . 0.0 110.21 176.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 64.3 m -120.82 140.34 51.87 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 -179.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -82.37 148.21 28.39 Favored 'General case' 0 N--CA 1.501 2.085 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.061 177.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 27.9 p -117.06 137.02 52.54 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.982 -0.448 . . . . 0.0 110.565 -179.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.0 m -123.02 139.25 54.27 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 176.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 75.06 -67.27 2.11 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -114.34 127.51 55.89 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 122.086 -0.655 . . . . 0.0 110.565 -177.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -138.04 136.93 20.14 Favored Pre-proline 0 N--CA 1.497 1.897 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 174.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -60.74 151.91 73.34 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 O-C-N 123.044 1.023 . . . . 0.0 111.142 -172.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -60.26 -28.09 67.76 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 121.966 -0.459 . . . . 0.0 111.476 -172.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -92.13 14.29 16.47 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 122.019 -0.426 . . . . 0.0 111.817 -177.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.93 162.07 26.25 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.602 -0.686 . . . . 0.0 110.33 -172.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 75.0 mt -125.29 138.14 55.34 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -178.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 38.84 43.0 0.69 Allowed 'General case' 0 N--CA 1.512 2.65 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -178.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 55.09 41.85 31.34 Favored 'General case' 0 N--CA 1.507 2.418 0 O-C-N 121.817 -0.552 . . . . 0.0 111.484 -178.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 70.9 p -140.25 161.02 38.67 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.857 -0.527 . . . . 0.0 110.314 173.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.3 p -140.65 165.12 28.34 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 120.874 0.369 . . . . 0.0 110.606 -179.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 77.2 mt -114.36 132.45 63.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -174.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.1 t -145.27 155.81 43.45 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 122.024 -0.423 . . . . 0.0 111.112 -179.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 41.4 p-10 -111.53 28.42 8.76 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 122.072 -0.393 . . . . 0.0 110.944 167.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -113.32 -95.39 2.16 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 109.105 -1.598 . . . . 0.0 109.105 173.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 76.0 m-70 -149.45 172.05 15.59 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 122.106 -0.643 . . . . 0.0 109.546 175.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 79.4 m -93.09 139.12 30.89 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 167.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 19.4 p90 -128.72 151.19 49.82 Favored 'General case' 0 N--CA 1.499 2.019 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.745 -178.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -151.25 141.83 22.63 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 173.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 18.1 tt -141.84 149.11 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 CA-C-O 120.979 0.419 . . . . 0.0 110.488 -170.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 15.9 tt -136.07 145.07 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 177.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -150.15 139.23 21.11 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 122.118 -0.364 . . . . 0.0 110.084 -169.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.2 tm-20 -101.8 116.18 32.15 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 51.2 p30 -85.74 175.25 8.81 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 122.097 -0.377 . . . . 0.0 110.494 -175.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -60.13 -17.48 40.68 Favored 'General case' 0 N--CA 1.507 2.415 0 O-C-N 121.976 -0.452 . . . . 0.0 112.006 -174.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -92.13 -11.07 36.65 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.607 -0.683 . . . . 0.0 111.9 178.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.18 21.09 36.51 Favored Glycine 0 N--CA 1.497 2.731 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 177.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -96.28 139.06 32.96 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-N 118.373 1.086 . . . . 0.0 109.799 171.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.8 p -94.87 124.53 38.96 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 122.141 -0.349 . . . . 0.0 110.335 176.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.2 p -97.99 114.49 26.64 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 122.138 -0.351 . . . . 0.0 110.366 178.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 24.8 mt -97.4 126.6 42.74 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 122.173 -0.329 . . . . 0.0 110.275 178.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -146.7 144.77 29.68 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 122.021 -0.424 . . . . 0.0 110.627 176.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 86.4 p -143.81 167.03 23.26 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 175.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 174.2 -164.24 35.35 Favored Glycine 0 N--CA 1.497 2.734 0 N-CA-C 110.33 -1.108 . . . . 0.0 110.33 179.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 4.5 m -95.95 133.14 40.5 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 122.316 -0.52 . . . . 0.0 110.302 -175.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 49.1 ttm -99.51 121.66 41.48 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 174.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 33.4 pttt . . . . . 0 N--CA 1.503 2.202 0 O-C-N 122.032 -0.417 . . . . 0.0 110.518 -178.805 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 48.8 ttp180 . . . . . 0 N--CA 1.497 1.886 0 CA-C-O 120.976 0.417 . . . . 0.0 110.386 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 14.4 m -134.24 149.01 50.94 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 170.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.2 tt -143.24 156.14 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.982 -0.448 . . . . 0.0 110.022 -179.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -143.7 146.45 33.2 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 120.959 0.409 . . . . 0.0 110.39 -179.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 25.3 p -143.09 141.41 31.24 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 -179.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 17.9 p -157.59 135.54 10.82 Favored 'General case' 0 N--CA 1.502 2.152 0 C-N-CA 120.514 -0.475 . . . . 0.0 111.044 -171.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 58.5 ttt180 -107.4 51.42 0.74 Allowed 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.364 0.602 . . . . 0.0 110.569 -175.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 23.6 p -143.23 151.67 40.85 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.778 -0.576 . . . . 0.0 109.861 175.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 15.9 p30 -61.72 132.3 52.75 Favored 'General case' 0 N--CA 1.506 2.355 0 CA-C-O 121.42 0.628 . . . . 0.0 111.772 -163.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 73.9 mt 52.19 26.93 4.23 Favored 'General case' 0 N--CA 1.507 2.403 0 O-C-N 122.036 -0.415 . . . . 0.0 111.891 179.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 26.1 p -63.0 -23.35 67.41 Favored 'General case' 0 N--CA 1.508 2.442 0 O-C-N 121.935 -0.478 . . . . 0.0 111.567 175.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -92.27 -22.81 19.55 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.77 -0.581 . . . . 0.0 111.273 178.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -60.67 -37.85 82.94 Favored 'General case' 0 N--CA 1.508 2.447 0 O-C-N 121.615 -0.678 . . . . 0.0 110.745 -177.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -100.03 16.15 24.93 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 122.135 -0.353 . . . . 0.0 111.709 178.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 14.8 tp -116.22 111.41 20.14 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.661 -0.649 . . . . 0.0 110.362 -174.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 3.1 tp-100 -96.39 120.73 61.84 Favored Pre-proline 0 N--CA 1.496 1.863 0 CA-C-O 118.848 -0.596 . . . . 0.0 110.04 172.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -70.69 141.84 42.42 Favored 'Trans proline' 0 N--CA 1.491 1.372 0 O-C-N 123.213 1.112 . . . . 0.0 110.168 175.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 48.4 p -139.22 150.02 45.04 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 122.135 -0.353 . . . . 0.0 110.138 179.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 15.0 mt . . . . . 0 N--CA 1.502 2.164 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.016 179.09 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo . . . . . 0 N--CA 1.502 2.013 0 N-CA-C 111.137 -0.37 . . . . 0.0 111.137 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -149.95 46.67 0.93 Allowed 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.159 0.504 . . . . 0.0 110.792 -179.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 15.5 tp -161.15 112.14 1.76 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.882 -0.511 . . . . 0.0 110.272 -173.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 29.2 ttpt -99.74 134.95 41.88 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 122.171 -0.331 . . . . 0.0 110.257 178.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 80.2 m -120.97 140.35 52.0 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 -176.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -82.77 143.16 31.05 Favored 'General case' 0 N--CA 1.501 2.091 0 C-N-CA 120.631 -0.428 . . . . 0.0 109.97 178.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 28.1 p -115.68 136.99 52.52 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 122.0 -0.438 . . . . 0.0 110.576 -178.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.2 m -122.88 138.75 54.57 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 176.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 75.47 -67.35 2.23 Favored Glycine 0 N--CA 1.495 2.626 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 179.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -113.14 122.74 48.44 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 122.035 -0.685 . . . . 0.0 110.522 -176.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -138.08 136.53 19.68 Favored Pre-proline 0 N--CA 1.496 1.826 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 174.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -60.55 152.13 70.53 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 O-C-N 123.075 1.039 . . . . 0.0 111.151 -171.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -60.26 -27.83 67.56 Favored 'General case' 0 N--CA 1.507 2.415 0 O-C-N 121.996 -0.44 . . . . 0.0 111.356 -173.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -92.12 14.26 16.56 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.843 -0.536 . . . . 0.0 111.737 -178.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.8 162.05 26.37 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.62 -0.675 . . . . 0.0 110.334 -173.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 70.9 mt -124.41 136.71 59.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -176.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 19.7 p30 37.95 43.12 0.5 Allowed 'General case' 0 N--CA 1.513 2.704 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -176.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 30.8 m120 55.36 43.41 28.93 Favored 'General case' 0 N--CA 1.508 2.428 0 O-C-N 121.824 -0.547 . . . . 0.0 111.462 -178.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 60.7 p -139.63 161.22 38.05 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.796 -0.565 . . . . 0.0 110.305 171.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.5 p -137.49 162.91 32.43 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 120.766 0.317 . . . . 0.0 110.565 178.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 77.5 mt -111.63 131.79 62.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -175.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.7 t -141.34 153.7 45.27 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.955 -0.465 . . . . 0.0 110.99 -177.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 26.8 p30 -107.57 28.66 7.93 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 122.055 -0.403 . . . . 0.0 110.771 167.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -119.15 -96.58 1.7 Allowed Glycine 0 N--CA 1.497 2.717 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 175.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 74.7 m80 -150.75 170.79 18.37 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 122.125 -0.633 . . . . 0.0 110.14 178.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 72.8 m -94.42 139.36 31.21 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 170.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -131.78 153.41 50.14 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.492 -178.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -152.91 136.01 15.62 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 174.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 18.1 tt -133.57 149.05 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 122.06 -0.4 . . . . 0.0 110.42 -168.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 13.5 tt -136.62 145.04 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -150.25 142.78 24.45 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 -172.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.4 tm-20 -101.63 117.81 35.65 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 -178.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 51.7 p30 -86.84 175.28 8.28 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-O 120.753 0.311 . . . . 0.0 110.551 -175.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -60.31 -17.64 44.2 Favored 'General case' 0 N--CA 1.507 2.414 0 O-C-N 121.915 -0.491 . . . . 0.0 112.1 -173.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -92.87 -11.0 34.64 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.616 -0.677 . . . . 0.0 111.88 178.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.18 21.06 36.59 Favored Glycine 0 N--CA 1.498 2.827 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 177.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -96.82 140.54 31.24 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 118.411 1.106 . . . . 0.0 109.866 170.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 10.9 p -94.86 125.67 39.68 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.304 176.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 17.9 p -97.97 112.92 24.68 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 122.124 -0.36 . . . . 0.0 110.289 177.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.4 mp -98.77 126.67 44.47 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 122.12 -0.363 . . . . 0.0 110.379 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -146.52 145.63 30.23 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 122.098 -0.376 . . . . 0.0 110.402 176.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 98.1 p -143.64 166.91 23.55 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 178.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 177.59 -164.7 33.96 Favored Glycine 0 N--CA 1.497 2.721 0 N-CA-C 110.301 -1.119 . . . . 0.0 110.301 -178.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 2.1 m -95.86 131.68 41.93 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 122.187 -0.596 . . . . 0.0 110.244 -174.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 53.8 ttm -98.75 122.7 42.32 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 122.011 -0.431 . . . . 0.0 110.162 175.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 22.2 pttt . . . . . 0 N--CA 1.503 2.202 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.552 175.858 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 30.1 ptt180 . . . . . 0 N--CA 1.498 1.956 0 CA-C-O 120.856 0.36 . . . . 0.0 110.648 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 18.9 m -133.79 149.13 51.41 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 177.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 17.9 tt -143.27 119.73 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 122.017 -0.427 . . . . 0.0 110.078 -178.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -105.91 149.87 26.17 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 120.824 0.345 . . . . 0.0 110.595 -179.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 90.9 m -143.15 163.16 33.65 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 175.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 12.1 p -157.21 150.99 24.4 Favored 'General case' 0 N--CA 1.501 2.106 0 C-N-CA 120.071 -0.652 . . . . 0.0 111.267 176.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 59.3 ttt180 -99.68 44.49 1.02 Allowed 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.259 0.552 . . . . 0.0 109.826 166.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 34.2 p -144.73 142.7 30.24 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 121.37 0.605 . . . . 0.0 110.6 -175.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 17.8 p-10 -70.98 138.87 50.33 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-O 121.449 0.642 . . . . 0.0 111.544 -162.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 29.5 mt 51.38 27.92 4.03 Favored 'General case' 0 N--CA 1.505 2.302 0 CA-C-N 116.361 -0.381 . . . . 0.0 112.006 174.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 18.3 p -60.11 -32.72 71.25 Favored 'General case' 0 N--CA 1.51 2.541 0 C-N-CA 119.969 -0.693 . . . . 0.0 111.162 174.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -81.77 -22.95 36.9 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 122.1 -0.375 . . . . 0.0 111.45 -168.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -61.52 -39.32 90.6 Favored 'General case' 0 N--CA 1.508 2.435 0 O-C-N 121.658 -0.651 . . . . 0.0 110.717 -174.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -99.75 16.29 24.08 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 122.072 -0.392 . . . . 0.0 111.628 176.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 18.5 tp -108.73 116.73 32.54 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.613 -0.679 . . . . 0.0 110.224 -174.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -95.84 120.63 62.84 Favored Pre-proline 0 N--CA 1.497 1.885 0 CA-C-O 118.766 -0.635 . . . . 0.0 109.955 172.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -70.68 142.26 43.43 Favored 'Trans proline' 0 N--CA 1.491 1.368 0 O-C-N 123.329 1.173 . . . . 0.0 110.289 174.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 49.0 p -139.22 150.09 45.12 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 178.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 44.0 mt . . . . . 0 N--CA 1.501 2.111 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.079 179.458 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo . . . . . 0 N--CA 1.497 1.732 0 N-CA-C 111.14 -0.369 . . . . 0.0 111.14 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -158.1 52.24 0.44 Allowed 'General case' 0 N--CA 1.501 2.092 0 CA-C-O 121.434 0.635 . . . . 0.0 110.283 164.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 20.7 tp -158.56 115.22 2.77 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.65 -0.656 . . . . 0.0 110.185 -177.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 49.8 tttt -99.82 133.59 43.96 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 122.162 -0.336 . . . . 0.0 110.236 179.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 77.6 m -121.01 140.44 51.92 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 -178.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -82.23 142.95 31.71 Favored 'General case' 0 N--CA 1.502 2.125 0 C-N-CA 120.581 -0.448 . . . . 0.0 109.958 176.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 27.8 p -115.82 136.99 52.52 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 122.016 -0.428 . . . . 0.0 110.561 -177.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 28.2 t -123.07 134.73 54.24 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 178.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.35 -66.33 2.95 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -111.54 118.42 35.67 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 122.098 -0.648 . . . . 0.0 110.548 -176.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -138.01 135.95 19.2 Favored Pre-proline 0 N--CA 1.495 1.809 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 174.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -61.75 153.84 64.82 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 O-C-N 123.237 1.125 . . . . 0.0 111.105 -170.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -60.2 -27.67 67.36 Favored 'General case' 0 N--CA 1.508 2.465 0 O-C-N 122.01 -0.431 . . . . 0.0 111.44 -173.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -92.22 14.27 16.73 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.964 -0.46 . . . . 0.0 111.737 -177.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.03 162.07 27.0 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.687 -0.633 . . . . 0.0 110.182 -174.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 70.3 mt -124.1 136.14 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -175.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 19.4 p30 37.62 43.36 0.44 Allowed 'General case' 0 N--CA 1.515 2.788 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 -176.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 30.6 t30 56.29 43.07 27.04 Favored 'General case' 0 N--CA 1.507 2.379 0 O-C-N 121.706 -0.621 . . . . 0.0 111.413 -179.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 51.0 p -140.69 163.97 31.45 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.78 -0.575 . . . . 0.0 110.363 171.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.7 p -139.05 164.97 28.37 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 120.955 0.407 . . . . 0.0 110.549 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 77.5 mt -112.62 133.03 59.71 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -175.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.8 t -140.67 152.62 45.51 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 122.022 -0.424 . . . . 0.0 111.163 -178.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -108.78 30.04 6.88 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 122.022 -0.424 . . . . 0.0 110.659 167.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -122.35 -94.81 1.25 Allowed Glycine 0 N--CA 1.496 2.657 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 176.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 27.5 m80 -147.73 171.95 14.86 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 122.042 -0.681 . . . . 0.0 109.429 176.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 78.6 m -93.85 139.0 31.4 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 166.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -129.81 152.27 49.48 Favored 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 120.306 -0.558 . . . . 0.0 110.7 -177.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -150.89 145.4 25.62 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 176.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 18.1 tt -142.07 149.25 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 CA-C-O 120.998 0.428 . . . . 0.0 110.357 -172.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 16.7 tt -136.54 145.19 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 178.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -149.48 138.44 21.19 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 -170.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.3 tm-20 -101.69 116.52 32.91 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 -179.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 24.1 p-10 -86.95 175.34 8.2 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 122.12 -0.363 . . . . 0.0 110.608 -176.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -60.37 -17.27 42.4 Favored 'General case' 0 N--CA 1.508 2.433 0 O-C-N 121.946 -0.471 . . . . 0.0 112.008 -173.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -91.88 -11.41 36.45 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.647 -0.658 . . . . 0.0 111.787 178.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.02 21.03 37.13 Favored Glycine 0 N--CA 1.497 2.754 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 176.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -96.66 141.13 30.28 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 118.263 1.031 . . . . 0.0 109.838 171.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.5 p -94.86 126.63 40.32 Favored 'General case' 0 N--CA 1.499 2.009 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.196 176.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.5 p -98.01 114.51 26.68 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 122.134 -0.354 . . . . 0.0 110.267 177.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 70.7 mt -97.09 127.81 43.42 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 122.149 -0.345 . . . . 0.0 110.297 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -144.68 144.98 31.51 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 122.089 -0.382 . . . . 0.0 110.572 176.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 99.8 p -143.67 166.48 24.74 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 176.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 179.47 -166.27 35.51 Favored Glycine 0 N--CA 1.497 2.731 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 2.2 m -97.24 133.0 42.44 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 122.319 -0.518 . . . . 0.0 110.263 -175.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 47.1 ttm -105.05 121.68 44.3 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 122.135 -0.353 . . . . 0.0 110.146 173.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 12.1 pttt . . . . . 0 N--CA 1.501 2.085 0 C-N-CA 120.514 -0.474 . . . . 0.0 110.262 174.865 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 27.7 ptt180 . . . . . 0 N--CA 1.497 1.892 0 CA-C-O 120.891 0.377 . . . . 0.0 110.803 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 19.1 m -133.66 149.43 51.56 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.3 tt -143.03 155.96 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.964 -0.46 . . . . 0.0 110.21 -177.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 52.1 mm-40 -143.65 152.01 40.82 Favored 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 120.901 -0.32 . . . . 0.0 110.613 -176.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 26.7 p -143.12 144.47 32.24 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 178.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 20.1 p -157.7 133.85 9.48 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.991 -0.443 . . . . 0.0 110.792 -175.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 31.6 ttp180 -106.25 47.21 0.89 Allowed 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.26 0.552 . . . . 0.0 110.659 -173.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.1 p -139.36 152.14 46.92 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.95 -0.469 . . . . 0.0 109.829 176.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 17.5 p-10 -61.35 131.94 51.93 Favored 'General case' 0 N--CA 1.506 2.344 0 CA-C-O 121.373 0.606 . . . . 0.0 111.904 -163.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 72.4 mt 52.22 26.38 3.93 Favored 'General case' 0 N--CA 1.506 2.348 0 O-C-N 122.078 -0.389 . . . . 0.0 112.007 179.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 26.2 p -62.9 -22.22 66.58 Favored 'General case' 0 N--CA 1.507 2.384 0 O-C-N 121.843 -0.536 . . . . 0.0 111.806 176.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -91.71 -22.81 20.02 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.785 -0.572 . . . . 0.0 111.37 179.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -60.29 -37.43 80.47 Favored 'General case' 0 N--CA 1.509 2.491 0 O-C-N 121.682 -0.637 . . . . 0.0 110.717 -175.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -101.41 16.19 26.43 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 122.116 -0.365 . . . . 0.0 111.649 177.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 15.0 tp -111.67 110.24 20.53 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.532 -0.73 . . . . 0.0 110.384 -174.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -97.08 120.76 60.74 Favored Pre-proline 0 N--CA 1.495 1.823 0 CA-C-O 118.94 -0.553 . . . . 0.0 110.063 173.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.4 149.32 50.28 Favored 'Trans proline' 0 N--CA 1.489 1.239 0 O-C-N 123.092 1.048 . . . . 0.0 110.274 175.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 34.1 p -139.13 137.82 36.45 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 122.144 -0.348 . . . . 0.0 110.238 178.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 41.9 mt . . . . . 0 N--CA 1.502 2.156 0 C-N-CA 120.669 -0.413 . . . . 0.0 110.151 179.788 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo . . . . . 0 N--CA 1.497 1.699 0 N-CA-C 111.193 -0.349 . . . . 0.0 111.193 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -157.82 52.53 0.45 Allowed 'General case' 0 N--CA 1.501 2.098 0 CA-C-O 121.363 0.601 . . . . 0.0 110.26 165.082 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 21.1 tp -158.35 114.89 2.79 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.77 -0.581 . . . . 0.0 110.111 -177.858 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 27.9 ttmt -99.74 131.77 45.51 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 122.11 -0.368 . . . . 0.0 110.314 178.989 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 70.0 m -118.25 140.33 49.96 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -178.852 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -82.62 145.83 29.47 Favored 'General case' 0 N--CA 1.501 2.092 0 C-N-CA 120.624 -0.43 . . . . 0.0 109.984 176.255 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 28.0 p -115.15 137.07 52.43 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 122.007 -0.433 . . . . 0.0 110.599 -177.864 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 99.2 p -123.01 144.0 49.56 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 176.598 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.36 -68.22 1.46 Allowed Glycine 0 N--CA 1.495 2.587 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 -179.789 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -116.84 129.59 56.18 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.939 -0.742 . . . . 0.0 110.518 -177.042 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -138.07 136.86 20.02 Favored Pre-proline 0 N--CA 1.496 1.838 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 174.689 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -60.21 151.53 72.7 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 O-C-N 123.078 1.041 . . . . 0.0 111.231 -172.191 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -60.1 -28.21 67.66 Favored 'General case' 0 N--CA 1.507 2.407 0 O-C-N 121.98 -0.45 . . . . 0.0 111.478 -172.595 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -92.11 14.28 16.47 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.981 -0.449 . . . . 0.0 111.794 -177.937 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.85 161.61 26.64 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.674 -0.641 . . . . 0.0 110.277 -173.117 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 75.7 mt -126.08 141.1 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -177.991 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 38.9 41.87 0.58 Allowed 'General case' 0 N--CA 1.512 2.663 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -177.206 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 30.7 m120 54.89 41.55 31.81 Favored 'General case' 0 N--CA 1.508 2.464 0 O-C-N 121.845 -0.535 . . . . 0.0 111.461 -178.955 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 43.7 p -141.65 162.6 35.08 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.82 -0.55 . . . . 0.0 110.376 174.323 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.3 p -139.31 163.49 32.34 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 120.967 0.413 . . . . 0.0 110.555 -179.384 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 77.9 mt -109.43 131.95 58.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -176.189 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.9 t -139.16 152.83 47.73 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.935 -0.478 . . . . 0.0 110.893 179.804 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 26.8 p30 -110.04 31.56 5.78 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 122.046 -0.409 . . . . 0.0 110.575 166.91 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -123.29 -94.71 1.16 Allowed Glycine 0 N--CA 1.497 2.718 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 175.642 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 31.9 m-70 -146.35 172.05 14.07 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 122.056 -0.673 . . . . 0.0 109.513 176.668 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 81.0 m -94.36 139.22 31.38 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 165.161 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 21.3 p90 -127.92 146.44 50.64 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 120.35 -0.54 . . . . 0.0 110.431 -179.199 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -147.61 140.2 24.68 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 174.431 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 18.3 tt -143.09 149.28 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.31 -171.644 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 15.6 tt -137.96 145.26 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 178.09 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -150.2 146.91 27.13 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 122.041 -0.412 . . . . 0.0 110.023 -168.044 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.3 tm-20 -101.69 116.94 33.84 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 122.124 -0.36 . . . . 0.0 110.117 -177.059 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -87.2 175.3 8.12 Favored 'General case' 0 N--CA 1.502 2.148 0 CA-C-O 120.868 0.366 . . . . 0.0 110.536 -175.621 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -60.56 -17.35 45.59 Favored 'General case' 0 N--CA 1.506 2.365 0 O-C-N 121.914 -0.491 . . . . 0.0 112.17 -172.646 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -92.77 -11.6 33.4 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.643 -0.66 . . . . 0.0 111.803 178.172 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.9 20.12 40.87 Favored Glycine 0 N--CA 1.499 2.862 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 177.083 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -97.37 143.88 27.68 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 118.399 1.099 . . . . 0.0 109.806 169.821 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.8 p -94.87 124.99 39.23 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.255 178.014 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 17.8 p -97.94 112.96 24.7 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 120.923 -0.311 . . . . 0.0 110.289 178.223 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.3 mp -98.24 128.53 44.74 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 122.144 -0.347 . . . . 0.0 110.273 -179.91 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -145.87 145.94 30.92 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.347 177.275 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 86.8 p -143.68 165.85 26.5 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 177.015 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 178.4 -164.53 33.22 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 -179.902 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 3.9 m -97.07 132.51 42.8 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 122.185 -0.597 . . . . 0.0 110.384 -175.53 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 49.1 ttm -99.56 121.88 41.82 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.993 -0.442 . . . . 0.0 110.231 176.662 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.3 ptpp? . . . . . 0 N--CA 1.503 2.219 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.214 178.135 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 27.7 ptt180 . . . . . 0 N--CA 1.494 1.772 0 CA-C-O 120.843 0.354 . . . . 0.0 110.401 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 18.1 m -131.03 149.04 52.8 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 174.841 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.5 tt -143.13 154.97 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.991 -0.443 . . . . 0.0 110.051 -178.586 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -143.92 125.9 15.36 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 120.842 0.353 . . . . 0.0 110.699 -179.572 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 92.8 m -104.9 147.55 27.64 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 168.63 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 22.9 p -157.76 135.19 10.37 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.858 -0.526 . . . . 0.0 111.031 176.22 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 9.4 ttm180 -108.2 47.04 0.92 Allowed 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 121.29 0.567 . . . . 0.0 110.788 -173.315 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.3 p -141.87 151.93 43.16 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.771 -0.581 . . . . 0.0 110.033 177.713 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 17.5 p-10 -61.69 132.43 53.21 Favored 'General case' 0 N--CA 1.505 2.287 0 CA-C-O 121.339 0.59 . . . . 0.0 111.821 -164.243 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 75.7 mt 52.0 27.13 4.18 Favored 'General case' 0 N--CA 1.506 2.365 0 O-C-N 122.051 -0.406 . . . . 0.0 111.995 179.547 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 25.3 p -62.62 -22.8 66.68 Favored 'General case' 0 N--CA 1.507 2.42 0 O-C-N 121.847 -0.533 . . . . 0.0 111.585 175.419 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -92.82 -22.82 19.09 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.682 -0.636 . . . . 0.0 111.224 178.071 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -61.63 -38.62 88.35 Favored 'General case' 0 N--CA 1.507 2.381 0 O-C-N 121.57 -0.706 . . . . 0.0 110.671 -177.034 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -100.1 16.19 24.89 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 122.113 -0.367 . . . . 0.0 111.596 178.772 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 18.0 tp -112.68 114.31 26.84 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.625 -0.672 . . . . 0.0 110.361 -175.458 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -96.31 120.83 61.78 Favored Pre-proline 0 N--CA 1.496 1.87 0 CA-C-O 118.927 -0.558 . . . . 0.0 109.944 173.022 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -68.81 144.93 60.97 Favored 'Trans proline' 0 N--CA 1.491 1.353 0 O-C-N 123.17 1.089 . . . . 0.0 110.253 175.33 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 47.6 p -139.18 134.15 32.38 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 122.074 -0.391 . . . . 0.0 110.121 179.624 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 17.2 mt . . . . . 0 N--CA 1.5 2.035 0 CA-C-O 119.287 -0.387 . . . . 0.0 110.173 179.664 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.314 0 N-CA-C 109.554 -1.419 . . . . 7.4500000000000002 109.554 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -58.4 117.7 4.46 Favored 'Trans proline' 0 N--CA 1.501 1.945 0 O-C-N 123.339 1.178 . . . . 6.9400000000000004 111.372 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -155.34 79.8 1.04 Allowed 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 109.551 -0.537 . . . . 5.7400000000000002 109.551 -176.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -78.66 88.09 4.57 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.888 -0.507 . . . . 3.1699999999999999 109.881 177.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 21.7 m -101.92 97.51 7.86 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 122.017 -0.427 . . . . 2.7000000000000002 110.191 179.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 72.6 mt -142.41 118.85 6.97 Favored Pre-proline 0 N--CA 1.497 1.9 0 N-CA-C 109.445 -0.576 . . . . 1.6000000000000001 109.445 178.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -58.89 146.61 92.81 Favored 'Trans proline' 0 N--CA 1.503 2.075 0 C-N-CA 120.893 1.062 . . . . 0.55000000000000004 111.304 -178.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -152.89 49.32 0.73 Allowed 'General case' 0 N--CA 1.498 1.948 0 CA-C-O 121.174 0.511 . . . . 0.79000000000000004 110.699 -178.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 23.2 tp -158.82 101.53 1.64 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.811 -0.555 . . . . 1.04 110.601 -176.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -99.97 118.18 35.83 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 110.167 -0.308 . . . . 1.9199999999999999 110.167 176.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 68.0 m -121.71 140.53 52.2 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 122.025 -0.422 . . . . 0.47999999999999998 110.935 -178.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -78.52 150.54 32.87 Favored 'General case' 0 N--CA 1.501 2.094 0 C-N-CA 120.751 -0.38 . . . . 0.98999999999999999 110.032 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 27.0 p -119.01 140.68 49.62 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 122.044 -0.41 . . . . 0.29999999999999999 110.547 -177.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 30.9 t -123.0 143.14 50.13 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 122.072 -0.392 . . . . 2.0600000000000001 110.155 178.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.63 -69.9 1.43 Allowed Glycine 0 N--CA 1.495 2.606 0 N-CA-C 109.668 -1.373 . . . . 1.0 109.668 177.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -115.51 123.83 49.52 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 122.074 -0.662 . . . . 3.29 110.544 -176.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -138.11 147.7 57.12 Favored Pre-proline 0 N--CA 1.497 1.879 0 N-CA-C 109.386 -0.598 . . . . 0.51000000000000001 109.386 175.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -63.8 151.62 84.32 Favored 'Trans proline' 0 N--CA 1.492 1.432 0 O-C-N 123.203 1.107 . . . . 0.46999999999999997 110.864 -174.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -59.15 -21.86 60.02 Favored 'General case' 0 N--CA 1.507 2.379 0 O-C-N 121.985 -0.447 . . . . 2.0299999999999998 111.521 177.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -96.7 14.15 25.97 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.776 -0.577 . . . . 1.1399999999999999 111.864 -177.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -83.31 162.1 21.22 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.607 -0.683 . . . . 1.0700000000000001 110.466 -173.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 77.5 mt -125.51 142.39 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 N-CA-C 108.873 -0.788 . . . . 1.27 108.873 -178.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 38.44 41.58 0.46 Allowed 'General case' 0 N--CA 1.514 2.735 0 N-CA-C 113.271 0.841 . . . . 1.8700000000000001 113.271 -177.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 54.97 41.01 32.24 Favored 'General case' 0 N--CA 1.508 2.459 0 O-C-N 121.802 -0.561 . . . . 2.1000000000000001 111.489 -179.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 41.6 p -137.68 160.31 39.57 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.877 -0.514 . . . . 1.01 110.373 173.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.3 p -135.75 162.15 33.57 Favored 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 120.957 0.408 . . . . 0.23000000000000001 110.465 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 78.9 mt -129.29 125.91 62.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 108.774 -0.825 . . . . 1.1000000000000001 108.774 -169.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.5 t -140.12 159.21 42.68 Favored 'General case' 0 N--CA 1.5 2.049 0 C-N-CA 120.537 -0.465 . . . . 1.03 111.288 -177.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 38.1 p-10 -106.59 28.22 8.06 Favored 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 120.856 -0.338 . . . . 1.3600000000000001 110.505 164.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -117.35 -113.86 2.69 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 109.057 -1.617 . . . . 0.23000000000000001 109.057 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 7.8 m-70 -136.75 157.57 46.44 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 108.996 -0.742 . . . . 2.1400000000000001 108.996 175.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 96.4 m -99.11 139.43 34.77 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 109.31 -0.626 . . . . 0.25 109.31 176.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -129.35 158.14 39.96 Favored 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 120.604 -0.438 . . . . 0.28000000000000003 110.726 -170.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -151.05 143.39 24.19 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.293 -0.632 . . . . 0.97999999999999998 109.293 177.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 18.0 tt -142.44 149.18 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 C-N-CA 120.686 -0.405 . . . . 1.0900000000000001 110.477 -170.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 16.0 tt -138.76 145.2 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 109.502 -0.555 . . . . 1.0700000000000001 109.502 178.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -150.1 141.08 22.91 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 109.93 -0.396 . . . . 1.1599999999999999 109.93 -170.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.9 tm-20 -101.68 116.29 32.42 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 109.975 -0.379 . . . . 0.35999999999999999 109.975 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -86.73 175.21 8.36 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 122.067 -0.396 . . . . 0.77000000000000002 110.583 -175.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -60.49 -17.29 44.3 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 121.995 -0.441 . . . . 1.5900000000000001 112.184 -172.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -92.49 -11.64 34.1 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.601 -0.687 . . . . 2.1400000000000001 111.83 177.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.82 21.0 37.88 Favored Glycine 0 N--CA 1.497 2.765 0 N-CA-C 111.109 -0.796 . . . . 0.40999999999999998 111.109 176.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -97.42 142.42 29.3 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 118.417 1.108 . . . . 1.28 109.8 169.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.1 p -94.88 129.58 41.84 Favored 'General case' 0 N--CA 1.497 1.908 0 C-N-CA 120.797 -0.361 . . . . 1.0600000000000001 110.356 177.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 17.7 p -97.91 113.04 24.76 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 122.128 -0.357 . . . . 1.01 110.327 177.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -96.77 121.98 39.22 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 110.157 -0.312 . . . . 1.78 110.157 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -143.77 148.52 35.73 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 122.098 -0.376 . . . . 1.0900000000000001 110.486 178.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 96.8 p -143.59 164.15 31.2 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 109.735 -0.469 . . . . 0.44 109.735 176.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -172.51 -179.05 43.07 Favored Glycine 0 N--CA 1.496 2.688 0 N-CA-C 110.215 -1.154 . . . . 0.32000000000000001 110.215 -177.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 6.2 m -100.21 133.83 44.03 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 122.203 -0.587 . . . . 0.57999999999999996 110.282 -178.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 27.5 ttm -99.5 126.96 45.54 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 122.003 -0.436 . . . . 1.1200000000000001 110.114 176.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 22.2 pttm -65.69 172.0 3.79 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 122.07 -0.394 . . . . 2.1899999999999999 110.485 177.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 56.7 t80 -65.02 146.61 54.79 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 122.095 -0.378 . . . . 4.79 110.472 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -133.17 -47.22 0.84 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 122.137 -0.352 . . . . 2.0 110.326 -177.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 146.85 -35.41 1.29 Allowed Glycine 0 N--CA 1.496 2.64 0 N-CA-C 109.714 -1.354 . . . . 1.6799999999999999 109.714 -178.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 46.4 m -72.76 123.34 23.13 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 122.084 -0.656 . . . . 3.3100000000000001 110.113 -179.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -76.36 -37.53 57.11 Favored 'General case' 0 N--CA 1.501 2.118 0 C-N-CA 120.752 -0.379 . . . . 2.9900000000000002 110.398 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -155.62 68.1 0.65 Allowed 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 121.265 0.555 . . . . 7.1399999999999997 109.968 -179.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -155.37 106.87 2.6 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.868 -0.52 . . . . 4.5 109.837 -177.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 87.3 m -105.28 88.95 2.98 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.045 0.45 . . . . 1.8300000000000001 109.869 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -82.75 175.09 10.39 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.994 -0.441 . . . . 4.8099999999999996 110.767 -173.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -132.72 150.31 52.17 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 109.983 -0.377 . . . . 2.73 109.983 171.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.1 m -75.23 139.38 72.16 Favored Pre-proline 0 N--CA 1.502 2.137 0 CA-C-O 119.246 -0.407 . . . . 3.29 109.92 -178.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -81.11 60.52 7.86 Favored 'Trans proline' 0 N--CA 1.494 1.539 0 O-C-N 123.277 1.146 . . . . 4.3499999999999996 111.393 -172.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 16.9 pttp -155.67 33.9 0.36 Allowed 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.554 -0.716 . . . . 5.4199999999999999 110.338 172.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -83.74 122.82 29.16 Favored 'General case' 0 N--CA 1.499 2.012 0 C-N-CA 120.933 -0.307 . . . . 2.6099999999999999 110.498 -176.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -119.81 53.64 1.05 Allowed 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.265 0.555 . . . . 6.6699999999999999 110.281 176.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 20.4 tp -155.18 154.12 31.79 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.738 -0.601 . . . . 2.3700000000000001 110.29 -178.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 71.6 mtp85 -93.32 122.55 35.84 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 109.985 -0.376 . . . . 3.6099999999999999 109.985 175.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 26.7 ptt-85 -161.51 165.38 28.7 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 122.063 -0.398 . . . . 2.9399999999999999 110.685 -173.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 11.7 m -128.48 149.1 50.73 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 109.676 -0.49 . . . . 1.1299999999999999 109.676 172.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.6 tt -143.17 155.96 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 122.04 -0.412 . . . . 1.0900000000000001 110.098 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -147.48 155.88 42.32 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 120.978 -0.289 . . . . 1.6299999999999999 110.342 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 26.6 p -142.47 157.42 44.78 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 110.113 -0.329 . . . . 1.3700000000000001 110.113 176.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 24.4 p -157.55 138.13 12.99 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 122.014 -0.429 . . . . 0.40999999999999998 110.825 -168.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 70.3 mtp180 -112.01 44.57 1.38 Allowed 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 121.213 0.53 . . . . 2.9900000000000002 110.554 -177.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.3 p -140.44 153.22 46.21 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.863 -0.523 . . . . 1.02 110.276 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 34.7 p-10 -64.51 139.77 58.8 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.817 -0.552 . . . . 1.75 111.233 -170.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 17.0 mt 53.15 25.8 4.51 Favored 'General case' 0 N--CA 1.507 2.381 0 O-C-N 121.936 -0.477 . . . . 1.23 112.282 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 28.1 p -67.95 -25.3 65.38 Favored 'General case' 0 N--CA 1.503 2.217 0 C-N-CA 119.869 -0.732 . . . . 0.34999999999999998 111.067 172.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -81.05 -33.28 33.6 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.888 -0.508 . . . . 1.8200000000000001 110.484 179.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 47.0 tt0 -63.35 -41.42 98.84 Favored 'General case' 0 N--CA 1.506 2.328 0 O-C-N 121.968 -0.458 . . . . 1.8300000000000001 110.797 -176.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -102.32 16.21 26.89 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 122.1 -0.375 . . . . 1.1200000000000001 111.9 -174.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 12.4 tp -126.16 108.94 11.8 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.601 -0.687 . . . . 1.0800000000000001 110.397 -176.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -98.3 120.93 58.43 Favored Pre-proline 0 N--CA 1.496 1.864 0 CA-C-O 118.811 -0.614 . . . . 2.27 110.032 173.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -67.91 136.39 38.17 Favored 'Trans proline' 0 N--CA 1.492 1.424 0 O-C-N 123.18 1.095 . . . . 0.71999999999999997 110.333 176.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 35.0 p -139.25 150.11 45.11 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 122.078 -0.389 . . . . 1.3700000000000001 110.204 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 34.8 mt -70.3 152.83 95.51 Favored Pre-proline 0 N--CA 1.502 2.135 0 C-N-CA 120.692 -0.403 . . . . 1.27 109.961 178.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -67.87 148.88 77.52 Favored 'Trans proline' 0 N--CA 1.491 1.336 0 O-C-N 123.49 1.258 . . . . 1.5 110.347 -176.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -69.43 165.56 30.16 Favored 'Trans proline' 0 N--CA 1.491 1.339 0 O-C-N 123.482 1.253 . . . . 1.8700000000000001 110.282 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 43.3 t -79.09 164.85 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 N-CA-C 109.052 -0.721 . . . . 3.3900000000000001 109.052 179.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 79.2 t -147.06 151.7 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 N-CA-C 109.259 -0.645 . . . . 5.0099999999999998 109.259 -178.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 37.3 pt -146.87 137.77 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 CA-C-O 120.997 0.427 . . . . 7.6600000000000001 109.976 173.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -73.98 -56.25 5.41 Favored Glycine 0 N--CA 1.496 2.654 0 N-CA-C 109.596 -1.402 . . . . 7.75 109.596 177.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_exo -58.1 152.28 53.09 Favored 'Trans proline' 0 N--CA 1.501 1.947 0 C-N-CA 121.119 1.212 . . . . 9.7100000000000009 111.503 -178.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -155.18 162.37 40.97 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 122.115 -0.366 . . . . 12.630000000000001 110.267 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -155.81 161.31 40.66 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 122.076 -0.39 . . . . 12.01 110.082 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -84.24 119.59 25.22 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 122.111 -0.368 . . . . 14.42 110.146 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -113.6 -39.97 1.05 Allowed Glycine 0 N--CA 1.497 2.717 0 N-CA-C 109.601 -1.4 . . . . 15.73 109.601 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 62.2 m -155.45 172.76 17.69 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 122.085 -0.656 . . . . 16.77 110.114 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 75.5 mt -89.15 132.94 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 N-CA-C 109.193 -0.669 . . . . 19.23 109.193 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 53.8 ttt180 . . . . . 0 N--CA 1.509 2.487 0 CA-C-O 118.319 -0.848 . . . . 21.059999999999999 111.478 -178.466 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.275 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_exo -58.5 120.59 8.57 Favored 'Trans proline' 0 N--CA 1.501 1.97 0 O-C-N 123.336 1.177 . . . . 0.0 111.351 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -155.49 78.84 1.02 Allowed 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 121.209 0.528 . . . . 0.0 109.581 -176.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -79.04 86.73 4.86 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.929 -0.482 . . . . 0.0 109.982 179.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 20.2 m -152.47 122.77 7.19 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 122.014 -0.429 . . . . 0.0 110.084 177.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 43.0 mt -78.29 150.36 76.99 Favored Pre-proline 0 N--CA 1.501 2.075 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.102 -178.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -64.63 121.5 9.08 Favored 'Trans proline' 0 N--CA 1.498 1.746 0 O-C-N 123.288 1.152 . . . . 0.0 111.058 168.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -157.55 52.86 0.47 Allowed 'General case' 0 N--CA 1.5 2.065 0 CA-C-O 121.358 0.599 . . . . 0.0 110.254 165.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 19.5 tp -158.57 113.98 2.62 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.766 -0.584 . . . . 0.0 109.993 -178.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 51.3 tttt -99.82 131.04 46.05 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 110.116 -0.328 . . . . 0.0 110.116 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 74.8 m -115.58 140.27 49.32 Favored 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 -177.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -85.3 145.07 27.7 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 122.155 -0.341 . . . . 0.0 110.098 176.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 27.8 p -117.64 137.51 52.59 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.983 -0.448 . . . . 0.0 110.562 -178.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 28.8 t -123.04 117.58 25.78 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 122.109 -0.37 . . . . 0.0 110.156 178.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 83.88 -61.74 4.69 Favored Glycine 0 N--CA 1.496 2.655 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -104.47 111.99 24.87 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 122.092 -0.652 . . . . 0.0 110.408 -177.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -138.08 137.38 20.97 Favored Pre-proline 0 N--CA 1.497 1.886 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 177.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -61.36 152.05 75.29 Favored 'Trans proline' 0 N--CA 1.497 1.683 0 O-C-N 123.118 1.062 . . . . 0.0 111.058 -173.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -60.33 -28.17 67.94 Favored 'General case' 0 N--CA 1.507 2.399 0 O-C-N 121.951 -0.468 . . . . 0.0 111.374 -173.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -92.16 14.31 16.5 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.941 -0.474 . . . . 0.0 111.77 -178.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.56 160.82 29.72 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.658 -0.651 . . . . 0.0 110.239 -173.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 70.6 mt -124.24 135.89 62.23 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -178.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 19.5 p30 37.52 43.61 0.44 Allowed 'General case' 0 N--CA 1.513 2.722 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -175.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 55.56 43.82 27.72 Favored 'General case' 0 N--CA 1.508 2.465 0 O-C-N 121.772 -0.58 . . . . 0.0 111.427 -179.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 51.4 p -141.19 161.33 38.14 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.738 -0.602 . . . . 0.0 110.346 171.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.1 p -141.39 164.69 29.54 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-O 120.847 0.356 . . . . 0.0 110.574 178.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 78.2 mt -109.6 132.44 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 -175.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.5 t -139.77 151.43 45.78 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 122.011 -0.431 . . . . 0.0 111.03 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 41.4 p-10 -108.21 30.38 6.45 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 122.097 -0.377 . . . . 0.0 110.636 167.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -124.71 -94.2 1.02 Allowed Glycine 0 N--CA 1.497 2.703 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 176.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 32.1 m80 -146.05 171.72 14.47 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 122.125 -0.632 . . . . 0.0 109.453 177.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 72.8 m -92.41 139.14 30.89 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 163.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -130.5 148.96 52.37 Favored 'General case' 0 N--CA 1.499 2.002 0 C-N-CA 120.404 -0.519 . . . . 0.0 110.54 -176.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -151.68 141.97 22.4 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 177.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 17.9 tt -142.24 149.19 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 CA-C-O 120.908 0.385 . . . . 0.0 110.248 -173.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 16.5 tt -139.15 145.4 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 -146.26 141.06 26.98 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 -167.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.2 tm-20 -101.57 115.78 31.29 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 122.165 -0.334 . . . . 0.0 110.139 -176.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -86.95 175.18 8.28 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 122.194 -0.316 . . . . 0.0 110.599 -175.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -60.59 -17.13 44.6 Favored 'General case' 0 N--CA 1.506 2.354 0 O-C-N 121.975 -0.453 . . . . 0.0 112.14 -172.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -92.48 -11.91 33.41 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.602 -0.686 . . . . 0.0 111.728 177.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.35 21.09 36.01 Favored Glycine 0 N--CA 1.497 2.715 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 176.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -97.28 141.07 30.84 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 118.379 1.089 . . . . 0.0 109.811 170.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.9 p -94.91 126.75 40.45 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 122.155 -0.341 . . . . 0.0 110.322 177.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 17.9 p -98.02 112.96 24.71 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 122.128 -0.358 . . . . 0.0 110.298 176.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.4 mp -99.61 131.09 45.84 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 122.195 -0.316 . . . . 0.0 110.489 -179.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -149.34 145.89 27.25 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 122.168 -0.332 . . . . 0.0 110.249 175.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 83.8 p -143.7 166.94 23.47 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 178.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -178.64 -163.63 30.22 Favored Glycine 0 N--CA 1.496 2.687 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 -178.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 2.0 m -96.72 132.4 42.45 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 122.144 -0.621 . . . . 0.0 110.321 -176.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 45.2 ttm -101.58 124.87 47.94 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 122.13 -0.356 . . . . 0.0 110.277 179.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 25.3 pttt -65.69 168.66 7.36 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 122.032 -0.417 . . . . 0.0 110.516 177.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 56.7 t80 -65.36 146.82 54.41 Favored 'General case' 0 N--CA 1.504 2.267 0 O-C-N 122.062 -0.399 . . . . 0.0 110.483 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -140.97 -48.4 0.41 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 122.115 -0.365 . . . . 0.0 110.397 -178.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 136.8 -34.97 2.15 Favored Glycine 0 N--CA 1.497 2.709 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 -178.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.1 m -72.23 123.97 24.06 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 122.042 -0.681 . . . . 0.0 110.029 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -75.59 -41.35 54.82 Favored 'General case' 0 N--CA 1.502 2.131 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.446 -179.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -155.72 30.0 0.37 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 122.061 -0.399 . . . . 0.0 110.81 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 65.7 mt-30 -78.4 82.12 4.71 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.84 -0.537 . . . . 0.0 109.852 177.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 90.6 m -123.45 33.04 5.46 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.828 -0.545 . . . . 0.0 110.385 -177.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -82.36 160.72 22.76 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.96 -0.462 . . . . 0.0 110.356 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -116.98 120.77 39.44 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 122.13 -0.356 . . . . 0.0 110.357 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 7.0 m -78.69 150.31 75.7 Favored Pre-proline 0 N--CA 1.5 2.069 0 O-C-N 122.086 -0.384 . . . . 0.0 110.17 179.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -82.82 56.25 5.57 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 O-C-N 123.424 1.223 . . . . 0.0 111.006 174.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 16.5 pttp -155.67 50.08 0.54 Allowed 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.63 -0.669 . . . . 0.0 109.693 -178.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -155.66 -169.39 3.1 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.949 -0.469 . . . . 0.0 110.49 -166.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -64.56 -169.23 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.274 0 CA-C-O 120.968 0.413 . . . . 0.0 110.148 -175.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.8 tp -64.21 163.77 12.15 Favored 'General case' 0 N--CA 1.506 2.342 0 O-C-N 122.014 -0.429 . . . . 0.0 109.971 -168.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 72.2 mtp85 -66.44 155.76 36.6 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.788 -0.57 . . . . 0.0 110.172 -163.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 3.1 ptt180 -161.39 165.41 28.95 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 120.901 0.381 . . . . 0.0 110.477 -175.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 17.5 m -126.69 146.43 50.21 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 169.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.3 tt -143.17 155.98 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.993 -0.442 . . . . 0.0 110.29 -174.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -146.82 146.88 30.38 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 120.756 0.312 . . . . 0.0 110.239 179.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 26.4 p -143.11 146.38 33.71 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 177.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 18.2 p -157.55 131.97 8.42 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 122.002 -0.436 . . . . 0.0 110.805 -170.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 20.7 ttm-85 -104.97 48.67 0.83 Allowed 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 121.371 0.605 . . . . 0.0 110.645 -176.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.0 p -137.95 150.94 47.47 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.819 -0.551 . . . . 0.0 109.884 175.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 17.6 p-10 -62.55 132.35 52.15 Favored 'General case' 0 N--CA 1.505 2.286 0 CA-C-O 121.355 0.598 . . . . 0.0 111.674 -163.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 79.1 mt 51.86 27.6 4.39 Favored 'General case' 0 N--CA 1.507 2.409 0 O-C-N 122.061 -0.4 . . . . 0.0 111.937 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 26.1 p -62.7 -23.15 66.99 Favored 'General case' 0 N--CA 1.507 2.403 0 O-C-N 121.847 -0.533 . . . . 0.0 111.6 174.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -75.4 -29.9 59.95 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.855 -0.528 . . . . 0.0 111.01 178.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -62.36 -39.84 94.46 Favored 'General case' 0 N--CA 1.507 2.377 0 O-C-N 121.738 -0.602 . . . . 0.0 110.753 -169.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -100.22 16.2 25.04 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 122.105 -0.372 . . . . 0.0 111.678 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 16.3 tp -111.82 108.98 18.57 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.557 -0.715 . . . . 0.0 110.327 -175.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -97.9 120.87 59.2 Favored Pre-proline 0 N--CA 1.496 1.869 0 CA-C-O 118.858 -0.591 . . . . 0.0 110.14 174.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -69.46 141.05 45.36 Favored 'Trans proline' 0 N--CA 1.491 1.342 0 O-C-N 123.202 1.107 . . . . 0.0 110.182 174.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 34.0 p -139.22 135.81 34.34 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 122.118 -0.364 . . . . 0.0 110.218 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 17.3 mt -71.77 155.07 92.65 Favored Pre-proline 0 N--CA 1.501 2.107 0 CA-C-O 119.306 -0.378 . . . . 0.0 110.068 178.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -62.77 152.61 77.54 Favored 'Trans proline' 0 N--CA 1.495 1.573 0 O-C-N 123.351 1.185 . . . . 0.0 110.792 179.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -67.62 133.09 28.74 Favored 'Trans proline' 0 N--CA 1.491 1.35 0 O-C-N 123.542 1.286 . . . . 0.0 110.478 -176.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 43.7 t -80.42 166.25 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 11.9 p -88.1 145.25 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 122.091 -0.38 . . . . 0.0 110.052 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 75.8 mt -89.49 127.84 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -178.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -112.1 -63.66 0.47 Allowed Glycine 0 N--CA 1.496 2.67 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_exo -58.05 167.12 4.73 Favored 'Trans proline' 0 N--CA 1.501 1.965 0 O-C-N 123.36 1.189 . . . . 0.0 111.446 179.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -83.3 153.45 24.62 Favored 'General case' 0 N--CA 1.5 2.036 0 C-N-CA 120.824 -0.35 . . . . 0.0 110.201 -179.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -71.51 152.22 43.2 Favored 'General case' 0 N--CA 1.502 2.131 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.155 -179.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -81.76 -33.6 30.88 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 122.102 -0.374 . . . . 0.0 110.285 -179.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 80.75 59.29 2.51 Favored Glycine 0 N--CA 1.495 2.62 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 87.7 p -79.66 163.64 24.4 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 122.148 -0.619 . . . . 0.0 110.167 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 76.2 mt -89.77 139.96 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 -179.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 54.6 ttt180 . . . . . 0 N--CA 1.495 1.812 0 CA-C-O 117.98 -1.009 . . . . 0.0 110.196 179.899 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.333 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo -58.45 120.53 8.48 Favored 'Trans proline' 0 N--CA 1.5 1.876 0 C-N-CA 121.106 1.204 . . . . 0.0 111.357 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -155.4 78.81 1.02 Allowed 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -177.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -79.15 87.04 4.91 Favored 'General case' 0 N--CA 1.501 2.098 0 CA-C-O 121.13 0.491 . . . . 0.0 109.948 178.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 22.3 m -135.81 65.09 1.55 Allowed 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.365 0.602 . . . . 0.0 110.071 177.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 21.7 mt -78.68 150.84 76.45 Favored Pre-proline 0 N--CA 1.5 2.061 0 O-C-N 121.736 -0.603 . . . . 0.0 110.091 -179.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_exo -64.68 120.68 8.01 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 O-C-N 123.322 1.17 . . . . 0.0 110.998 167.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -158.17 53.37 0.45 Allowed 'General case' 0 N--CA 1.5 2.028 0 CA-C-O 121.358 0.599 . . . . 0.0 110.159 165.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 21.9 tp -158.05 114.36 2.81 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.696 -0.627 . . . . 0.0 110.032 -179.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 23.4 ttpt -99.71 130.5 45.93 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 122.137 -0.352 . . . . 0.0 110.194 179.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 78.2 m -115.28 140.32 49.21 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -177.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -84.29 142.91 29.89 Favored 'General case' 0 N--CA 1.502 2.141 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 177.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 28.1 p -115.31 137.29 52.2 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 122.127 -0.358 . . . . 0.0 110.642 -176.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 49.5 m -122.95 139.03 54.49 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 122.069 -0.394 . . . . 0.0 110.051 176.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 75.52 -67.17 2.27 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.721 -1.351 . . . . 0.0 109.721 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -114.08 124.12 51.34 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 122.11 -0.641 . . . . 0.0 110.486 -176.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -137.99 136.87 20.16 Favored Pre-proline 0 N--CA 1.497 1.901 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 175.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.44 151.93 71.29 Favored 'Trans proline' 0 N--CA 1.498 1.745 0 O-C-N 123.083 1.044 . . . . 0.0 111.111 -172.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -60.35 -28.55 68.26 Favored 'General case' 0 N--CA 1.507 2.391 0 O-C-N 121.935 -0.478 . . . . 0.0 111.356 -172.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -91.89 14.37 15.82 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.969 -0.457 . . . . 0.0 111.824 -177.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.65 162.04 27.33 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.622 -0.674 . . . . 0.0 110.27 -173.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 71.7 mt -124.59 136.69 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 -178.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 19.8 p30 37.76 43.07 0.45 Allowed 'General case' 0 N--CA 1.514 2.739 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -176.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 55.39 43.6 28.56 Favored 'General case' 0 N--CA 1.508 2.468 0 O-C-N 121.815 -0.553 . . . . 0.0 111.407 -178.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 59.5 p -139.55 160.56 39.58 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.768 -0.582 . . . . 0.0 110.261 171.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.1 p -139.28 163.99 31.01 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 120.787 0.327 . . . . 0.0 110.613 178.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 77.5 mt -108.73 132.17 57.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -175.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.4 t -140.29 151.63 45.24 Favored 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 120.95 0.405 . . . . 0.0 110.976 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 26.7 p30 -108.72 30.35 6.58 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 122.096 -0.377 . . . . 0.0 110.603 167.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -122.83 -93.93 1.16 Allowed Glycine 0 N--CA 1.496 2.653 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 176.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 74.6 m-70 -149.59 172.11 15.56 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 122.052 -0.675 . . . . 0.0 109.463 176.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 75.0 m -92.41 139.06 30.97 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 166.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -130.81 150.7 51.86 Favored 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 120.401 -0.52 . . . . 0.0 110.539 -176.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -152.08 142.51 22.58 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 177.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 18.0 tt -143.67 149.17 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.354 -173.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 16.1 tt -137.63 145.23 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -148.12 146.65 28.88 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 -167.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.8 tm-20 -101.59 117.77 35.58 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 122.146 -0.346 . . . . 0.0 110.237 -175.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 51.4 p30 -87.28 175.36 8.06 Favored 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 120.909 -0.316 . . . . 0.0 110.628 -175.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -60.34 -18.07 47.46 Favored 'General case' 0 N--CA 1.508 2.453 0 O-C-N 121.988 -0.445 . . . . 0.0 111.915 -173.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 16.1 mm-40 -93.21 -9.48 39.08 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.713 -0.617 . . . . 0.0 111.89 178.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 88.69 21.0 45.17 Favored Glycine 0 N--CA 1.498 2.826 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 177.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -96.9 143.63 27.6 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 118.413 1.107 . . . . 0.0 109.793 169.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.3 p -94.88 125.93 39.87 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.281 177.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 17.9 p -98.04 113.0 24.74 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 122.154 -0.341 . . . . 0.0 110.272 177.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.4 mp -97.8 128.54 44.51 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 122.181 -0.324 . . . . 0.0 110.407 -178.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -145.34 145.78 31.34 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 122.183 -0.323 . . . . 0.0 110.348 176.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 97.1 p -143.6 166.96 23.39 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 178.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 179.95 -164.0 31.53 Favored Glycine 0 N--CA 1.496 2.681 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 -178.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 1.8 m -96.71 132.52 42.31 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 122.248 -0.56 . . . . 0.0 110.356 -175.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 47.4 ttm -102.56 122.0 43.51 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 122.038 -0.414 . . . . 0.0 110.159 177.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 27.7 pttt -67.03 162.05 23.01 Favored 'General case' 0 N--CA 1.503 2.195 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.407 177.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -67.06 147.7 52.84 Favored 'General case' 0 N--CA 1.504 2.244 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.215 179.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -155.02 26.44 0.42 Allowed 'General case' 0 N--CA 1.499 2.009 0 O-C-N 122.133 -0.354 . . . . 0.0 111.389 178.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 98.23 -40.06 2.59 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 110.151 -1.18 . . . . 0.0 110.151 176.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 54.1 m -74.57 111.49 9.81 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 122.021 -0.693 . . . . 0.0 110.376 -175.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -80.21 -38.35 31.3 Favored 'General case' 0 N--CA 1.5 2.038 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.049 177.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -155.64 76.69 0.96 Allowed 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.145 0.498 . . . . 0.0 109.869 -178.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -155.33 118.08 4.29 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.99 -0.444 . . . . 0.0 109.891 -177.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 91.2 m -140.19 38.26 1.92 Allowed 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 120.966 0.412 . . . . 0.0 109.899 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 35.7 pttt -76.33 170.72 15.81 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.925 -0.484 . . . . 0.0 110.728 -176.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -148.27 127.52 12.98 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 122.148 -0.345 . . . . 0.0 110.43 177.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.4 m -73.09 162.81 72.71 Favored Pre-proline 0 N--CA 1.501 2.086 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 176.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -83.25 57.81 5.97 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 O-C-N 123.325 1.171 . . . . 0.0 111.621 -173.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 32.2 tptt -155.77 36.38 0.36 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.603 -0.686 . . . . 0.0 109.538 170.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -82.35 -169.84 2.63 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-O 121.09 0.471 . . . . 0.0 110.958 -170.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 2.2 tp60 -65.0 -168.84 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.223 0 O-C-N 122.126 -0.359 . . . . 0.0 110.034 174.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 9.2 tp -64.0 168.62 5.06 Favored 'General case' 0 N--CA 1.508 2.452 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 -173.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 43.0 mtp180 -68.03 134.21 50.29 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.647 -0.658 . . . . 0.0 110.23 -161.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 28.5 ptt180 -161.51 165.34 28.76 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 120.872 0.367 . . . . 0.0 110.584 -167.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 17.0 m -125.78 149.0 48.93 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 171.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.3 tt -143.15 154.24 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.156 -176.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -146.85 150.81 36.0 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 120.858 0.361 . . . . 0.0 110.407 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 26.9 p -142.95 149.99 39.11 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 122.06 -0.4 . . . . 0.0 110.091 176.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 19.2 p -157.58 133.43 9.3 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.971 -0.456 . . . . 0.0 110.821 -172.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 61.7 ttp85 -106.35 52.51 0.72 Allowed 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 121.353 0.597 . . . . 0.0 110.536 -176.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.1 p -144.08 151.07 39.12 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.788 -0.57 . . . . 0.0 109.947 175.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 18.2 p-10 -62.39 132.11 51.48 Favored 'General case' 0 N--CA 1.503 2.213 0 CA-C-O 121.418 0.627 . . . . 0.0 111.726 -163.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 79.4 mt 51.75 28.06 4.61 Favored 'General case' 0 N--CA 1.506 2.334 0 O-C-N 121.936 -0.477 . . . . 0.0 111.955 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 25.7 p -62.56 -24.16 67.38 Favored 'General case' 0 N--CA 1.507 2.404 0 O-C-N 121.904 -0.498 . . . . 0.0 111.506 174.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -73.0 -30.33 63.71 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.877 -0.514 . . . . 0.0 110.944 178.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -62.84 -39.29 93.9 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.616 -0.678 . . . . 0.0 110.752 -168.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -100.2 16.24 24.88 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 122.103 -0.373 . . . . 0.0 111.696 -179.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 16.9 tp -112.73 110.35 20.43 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.649 -0.657 . . . . 0.0 110.314 -175.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -96.68 120.83 61.22 Favored Pre-proline 0 N--CA 1.496 1.837 0 CA-C-O 118.922 -0.561 . . . . 0.0 110.096 174.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -72.13 138.16 30.2 Favored 'Trans proline' 0 N--CA 1.492 1.415 0 O-C-N 123.293 1.154 . . . . 0.0 110.307 173.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 35.5 p -139.18 150.0 45.07 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 122.096 -0.377 . . . . 0.0 110.203 178.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 12.9 mt -71.48 146.88 92.13 Favored Pre-proline 0 N--CA 1.501 2.088 0 CA-C-O 119.215 -0.421 . . . . 0.0 109.984 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -70.55 149.72 62.31 Favored 'Trans proline' 0 N--CA 1.491 1.338 0 O-C-N 123.477 1.251 . . . . 0.0 110.252 -178.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -68.86 142.54 52.35 Favored 'Trans proline' 0 N--CA 1.491 1.362 0 O-C-N 123.493 1.259 . . . . 0.0 110.276 177.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 47.9 t -150.34 165.26 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.168 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 14.6 p -88.63 135.14 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 122.026 -0.421 . . . . 0.0 110.378 -179.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 7.1 tp -152.68 119.36 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 122.071 -0.393 . . . . 0.0 109.962 178.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 68.75 -156.2 53.4 Favored Glycine 0 N--CA 1.496 2.68 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -178.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_exo -58.62 139.97 92.92 Favored 'Trans proline' 0 N--CA 1.501 1.956 0 O-C-N 123.364 1.192 . . . . 0.0 111.232 176.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -84.34 144.42 28.85 Favored 'General case' 0 N--CA 1.499 2.009 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.371 -179.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -155.84 112.72 3.19 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 177.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -155.37 152.11 28.71 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 122.069 -0.394 . . . . 0.0 110.157 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -102.33 34.9 5.35 Favored Glycine 0 N--CA 1.496 2.695 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 70.5 m -155.39 155.61 33.91 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 122.09 -0.653 . . . . 0.0 110.123 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 75.4 mt -90.2 131.47 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 67.2 ttp85 . . . . . 0 N--CA 1.499 2.001 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.201 -179.978 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.242 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_exo -58.55 120.04 7.67 Favored 'Trans proline' 0 N--CA 1.501 1.929 0 O-C-N 123.367 1.193 . . . . 0.0 111.313 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -90.47 47.2 1.41 Allowed 'General case' 0 N--CA 1.501 2.093 0 CA-C-O 121.056 0.455 . . . . 0.0 110.898 179.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -79.65 61.42 3.63 Favored 'General case' 0 N--CA 1.504 2.259 0 CA-C-O 121.277 0.561 . . . . 0.0 110.503 -178.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 18.3 m -108.9 51.67 0.74 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.702 -0.624 . . . . 0.0 109.994 -178.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 27.2 mt -76.8 151.02 82.12 Favored Pre-proline 0 N--CA 1.5 2.04 0 O-C-N 121.831 -0.543 . . . . 0.0 110.101 -178.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -64.36 121.32 8.89 Favored 'Trans proline' 0 N--CA 1.498 1.791 0 O-C-N 123.368 1.194 . . . . 0.0 111.145 169.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -158.28 53.58 0.44 Allowed 'General case' 0 N--CA 1.5 2.034 0 CA-C-O 121.378 0.609 . . . . 0.0 110.235 164.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 22.7 tp -158.42 114.0 2.66 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.731 -0.606 . . . . 0.0 109.971 -179.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 53.1 tttt -99.74 132.27 45.19 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 122.164 -0.335 . . . . 0.0 110.205 -179.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 80.2 m -117.73 140.23 49.96 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 122.047 -0.408 . . . . 0.0 109.901 -177.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 62.9 t80 -84.35 142.83 29.89 Favored 'General case' 0 N--CA 1.501 2.077 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 175.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 28.1 p -114.84 138.36 50.87 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 122.05 -0.406 . . . . 0.0 110.714 -177.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 99.9 p -123.01 141.19 52.23 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 176.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.37 -68.36 1.46 Allowed Glycine 0 N--CA 1.495 2.629 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 83.6 t60 -113.17 124.78 53.34 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 122.08 -0.659 . . . . 0.0 110.663 -176.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -138.05 136.63 19.82 Favored Pre-proline 0 N--CA 1.497 1.92 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 175.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -60.28 152.17 68.56 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 O-C-N 123.107 1.056 . . . . 0.0 111.114 -171.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -60.15 -28.35 67.84 Favored 'General case' 0 N--CA 1.506 2.355 0 O-C-N 121.938 -0.476 . . . . 0.0 111.436 -172.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -92.02 14.23 16.45 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.857 -0.527 . . . . 0.0 111.754 -177.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.19 162.07 25.99 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.582 -0.699 . . . . 0.0 110.382 -172.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 75.2 mt -125.62 138.51 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 -178.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 38.7 43.29 0.69 Allowed 'General case' 0 N--CA 1.512 2.655 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -178.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 30.7 m120 55.05 42.27 31.07 Favored 'General case' 0 N--CA 1.509 2.488 0 O-C-N 121.759 -0.588 . . . . 0.0 111.453 -178.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 68.3 p -141.22 160.41 40.17 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.767 -0.583 . . . . 0.0 110.343 173.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.1 p -140.91 165.03 28.64 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 120.902 0.382 . . . . 0.0 110.641 179.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 78.0 mt -109.85 132.05 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 -175.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.7 t -138.93 150.87 46.4 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.978 -0.451 . . . . 0.0 110.999 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 50.4 p30 -108.16 31.12 5.79 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 122.114 -0.366 . . . . 0.0 110.593 167.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -124.96 -93.39 0.97 Allowed Glycine 0 N--CA 1.497 2.707 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 176.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 45.0 m-70 -149.69 172.21 15.44 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 122.106 -0.644 . . . . 0.0 109.366 176.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 71.9 m -92.1 139.03 31.04 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 166.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 15.5 p90 -129.16 151.93 49.29 Favored 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 120.372 -0.531 . . . . 0.0 110.643 -176.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -151.18 142.68 23.51 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 176.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 18.3 tt -142.05 149.05 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 CA-C-O 120.864 0.364 . . . . 0.0 110.277 -172.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 15.3 tt -140.8 145.25 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 177.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -150.15 144.34 25.62 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 -170.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.5 tm-20 -101.62 117.88 35.8 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 110.11 -0.329 . . . . 0.0 110.11 -178.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 52.3 p30 -86.69 175.19 8.39 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 122.179 -0.326 . . . . 0.0 110.609 -175.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -60.19 -17.43 41.12 Favored 'General case' 0 N--CA 1.507 2.392 0 O-C-N 121.931 -0.48 . . . . 0.0 112.127 -173.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -92.79 -11.12 34.58 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.601 -0.687 . . . . 0.0 111.868 178.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.55 20.97 35.81 Favored Glycine 0 N--CA 1.498 2.781 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 177.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -96.94 139.91 32.27 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-N 118.324 1.062 . . . . 0.0 109.841 171.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.2 p -94.85 125.25 39.39 Favored 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 120.824 -0.351 . . . . 0.0 110.205 176.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 17.7 p -97.94 112.91 24.66 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 122.167 -0.333 . . . . 0.0 110.305 177.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.4 mp -99.01 127.65 44.97 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 122.13 -0.356 . . . . 0.0 110.311 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -146.97 146.08 29.97 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 122.084 -0.385 . . . . 0.0 110.36 177.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 90.4 p -143.77 166.71 24.13 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 177.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 178.09 -163.69 32.02 Favored Glycine 0 N--CA 1.499 2.841 0 N-CA-C 110.256 -1.138 . . . . 0.0 110.256 -179.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 2.9 m -96.62 132.4 42.29 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 122.179 -0.601 . . . . 0.0 110.359 -175.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 44.4 ttm -99.46 121.94 41.85 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 122.034 -0.416 . . . . 0.0 110.042 178.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 26.0 pttt -66.08 166.12 12.25 Favored 'General case' 0 N--CA 1.503 2.193 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.562 -179.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 54.1 p90 -64.96 125.29 24.43 Favored 'General case' 0 N--CA 1.504 2.251 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.572 -179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -110.9 -34.48 6.22 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 122.146 -0.346 . . . . 0.0 110.255 178.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 102.16 -39.8 2.64 Favored Glycine 0 N--CA 1.497 2.731 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 -179.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.2 m -75.29 117.22 16.86 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 122.154 -0.615 . . . . 0.0 110.209 178.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -78.9 -33.4 45.65 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 122.056 -0.402 . . . . 0.0 110.537 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -82.19 4.11 24.67 Favored 'General case' 0 N--CA 1.502 2.135 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -175.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -75.94 65.7 2.05 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.379 -0.826 . . . . 0.0 110.14 -178.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 38.4 t -155.19 62.85 0.63 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.705 -0.622 . . . . 0.0 109.881 179.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -155.43 161.99 40.86 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.728 -0.607 . . . . 0.0 110.222 -177.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -99.89 121.59 41.55 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 178.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.8 m -76.38 143.93 73.54 Favored Pre-proline 0 N--CA 1.498 1.95 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.069 -173.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -77.81 62.58 7.9 Favored 'Trans proline' 0 N--CA 1.494 1.531 0 O-C-N 123.34 1.179 . . . . 0.0 110.508 176.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 60.3 tttt -155.41 43.86 0.46 Allowed 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.325 0.583 . . . . 0.0 109.873 -178.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -155.65 147.55 23.29 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -107.72 67.16 0.68 Allowed 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 121.346 0.594 . . . . 0.0 110.103 -179.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 17.1 tp -155.0 149.86 26.71 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.839 -0.538 . . . . 0.0 110.171 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 93.6 mtt-85 -98.24 124.09 42.66 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 122.065 -0.397 . . . . 0.0 110.114 179.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 10.1 ptm180 -161.48 165.11 29.18 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 122.087 -0.383 . . . . 0.0 110.592 -178.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 17.0 m -134.0 149.35 51.2 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 177.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.4 tt -142.6 150.95 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 122.023 -0.423 . . . . 0.0 109.873 178.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 48.5 mm-40 -144.64 151.65 39.3 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 120.862 0.363 . . . . 0.0 110.655 -176.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 26.3 p -143.04 150.98 40.3 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 177.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 19.5 p -157.56 134.43 10.04 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 122.016 -0.427 . . . . 0.0 110.852 -175.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 29.4 ttp180 -106.98 47.38 0.88 Allowed 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 121.208 0.528 . . . . 0.0 110.608 -173.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.0 p -142.16 151.39 42.18 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.88 -0.513 . . . . 0.0 109.888 178.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 15.8 p30 -62.78 132.44 52.24 Favored 'General case' 0 N--CA 1.505 2.285 0 CA-C-O 121.466 0.651 . . . . 0.0 111.628 -163.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 78.9 mt 52.14 27.78 4.89 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 122.03 -0.419 . . . . 0.0 111.922 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 25.8 p -62.71 -24.84 67.87 Favored 'General case' 0 N--CA 1.508 2.444 0 O-C-N 121.9 -0.5 . . . . 0.0 111.489 174.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -72.57 -29.59 63.68 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 121.918 -0.489 . . . . 0.0 111.076 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -62.23 -39.71 93.74 Favored 'General case' 0 N--CA 1.505 2.324 0 O-C-N 121.674 -0.641 . . . . 0.0 110.821 -168.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -101.34 16.22 26.28 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 122.066 -0.396 . . . . 0.0 111.763 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 12.9 tp -115.26 108.89 17.16 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.673 -0.642 . . . . 0.0 110.338 -175.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -100.62 120.78 55.03 Favored Pre-proline 0 N--CA 1.496 1.84 0 CA-C-O 118.913 -0.565 . . . . 0.0 110.183 173.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -67.94 140.06 49.14 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 O-C-N 123.153 1.081 . . . . 0.0 110.256 173.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 49.3 p -139.19 149.65 44.65 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 122.118 -0.364 . . . . 0.0 110.087 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 18.9 mt -71.29 155.03 93.45 Favored Pre-proline 0 N--CA 1.501 2.098 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.056 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -68.07 146.56 71.1 Favored 'Trans proline' 0 N--CA 1.491 1.35 0 O-C-N 123.476 1.25 . . . . 0.0 110.3 -178.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -70.44 151.97 65.5 Favored 'Trans proline' 0 N--CA 1.491 1.361 0 O-C-N 123.477 1.251 . . . . 0.0 110.328 -178.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 43.7 t -79.37 165.61 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 177.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 59.5 t -87.85 129.07 39.75 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -178.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 16.7 tt -153.71 122.16 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 177.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -67.63 -85.45 0.1 OUTLIER Glycine 0 N--CA 1.497 2.704 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 -178.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -59.46 151.33 69.53 Favored 'Trans proline' 0 N--CA 1.503 2.073 0 C-N-CA 121.012 1.142 . . . . 0.0 111.11 178.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -155.16 149.43 26.01 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 122.141 -0.349 . . . . 0.0 110.318 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -155.42 96.91 1.84 Allowed 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -178.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -155.38 -55.94 0.09 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 122.131 -0.356 . . . . 0.0 110.22 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -82.28 169.56 49.75 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -178.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 86.9 p -155.46 163.69 39.69 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 122.059 -0.671 . . . . 0.0 110.106 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 50.8 mm -90.27 132.01 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 54.6 ttt180 . . . . . 0 N--CA 1.498 1.925 0 CA-C-O 118.026 -0.988 . . . . 0.0 110.194 179.954 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.219 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_exo -58.59 123.73 14.22 Favored 'Trans proline' 0 N--CA 1.499 1.843 0 C-N-CA 121.109 1.206 . . . . 0.0 111.356 179.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -90.16 47.13 1.41 Allowed 'General case' 0 N--CA 1.503 2.178 0 CA-C-O 121.096 0.474 . . . . 0.0 110.781 179.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -77.38 83.04 3.83 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.729 -0.607 . . . . 0.0 109.89 -176.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 21.6 m -124.72 108.34 11.9 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.978 -0.452 . . . . 0.0 110.241 178.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 73.5 mt -142.48 118.65 6.88 Favored Pre-proline 0 N--CA 1.496 1.87 0 CA-C-O 118.777 -0.63 . . . . 0.0 109.325 178.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -59.52 143.46 99.68 Favored 'Trans proline' 0 N--CA 1.502 2.0 0 C-N-CA 120.835 1.023 . . . . 0.0 111.277 -177.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -150.17 47.52 0.91 Allowed 'General case' 0 N--CA 1.499 1.989 0 CA-C-O 121.14 0.495 . . . . 0.0 110.647 -178.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 20.3 tp -160.69 114.38 2.08 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.796 -0.565 . . . . 0.0 110.378 -174.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 30.1 ttpt -99.85 129.91 45.99 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 175.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 75.4 m -112.4 140.36 47.2 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -82.63 141.43 32.52 Favored 'General case' 0 N--CA 1.5 2.031 0 C-N-CA 120.764 -0.374 . . . . 0.0 109.992 175.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 27.8 p -115.38 137.12 52.38 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 122.021 -0.424 . . . . 0.0 110.649 -175.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 48.3 m -123.02 140.49 52.98 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 122.109 -0.37 . . . . 0.0 110.03 177.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 75.52 -67.24 2.26 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 83.8 t60 -115.92 124.33 50.34 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 122.061 -0.67 . . . . 0.0 110.543 -176.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -138.08 135.72 18.87 Favored Pre-proline 0 N--CA 1.497 1.907 0 N-CA-C 109.19 -0.671 . . . . 0.0 109.19 174.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.77 153.23 64.02 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 O-C-N 123.145 1.076 . . . . 0.0 111.193 -169.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -60.34 -28.33 68.07 Favored 'General case' 0 N--CA 1.506 2.335 0 O-C-N 121.918 -0.489 . . . . 0.0 111.43 -173.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -92.3 14.25 16.92 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.934 -0.479 . . . . 0.0 111.714 -178.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.92 161.99 27.95 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.731 -0.606 . . . . 0.0 110.225 -172.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 69.5 mt -124.92 136.97 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -176.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 18.0 p30 37.78 42.91 0.44 Allowed 'General case' 0 N--CA 1.514 2.731 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -175.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 24.0 t30 56.17 42.26 28.4 Favored 'General case' 0 N--CA 1.508 2.469 0 O-C-N 121.795 -0.566 . . . . 0.0 111.439 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 60.7 p -140.4 164.45 30.08 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.73 -0.606 . . . . 0.0 110.36 172.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.1 p -139.07 163.31 32.74 Favored 'General case' 0 N--CA 1.499 2.024 0 CA-C-O 120.889 0.376 . . . . 0.0 110.638 178.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 77.5 mt -110.36 134.35 52.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -175.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.1 t -144.0 153.97 42.79 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.996 -0.44 . . . . 0.0 111.106 179.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 39.5 p-10 -107.72 29.73 6.96 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 122.128 -0.357 . . . . 0.0 110.652 167.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -122.17 -100.98 1.63 Allowed Glycine 0 N--CA 1.497 2.702 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 176.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 25.6 m-70 -141.13 171.26 14.31 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 122.091 -0.652 . . . . 0.0 109.562 176.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 70.4 m -91.67 139.09 31.02 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 164.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -129.18 148.27 51.1 Favored 'General case' 0 N--CA 1.498 1.939 0 C-N-CA 120.374 -0.531 . . . . 0.0 110.423 -179.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -151.55 140.33 20.88 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 176.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 18.2 tt -143.86 149.3 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 CA-C-O 120.969 0.414 . . . . 0.0 110.611 -170.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 14.7 tt -135.02 145.19 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 175.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -148.27 146.38 28.59 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -169.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.7 tm-20 -101.79 117.95 35.93 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 120.793 0.33 . . . . 0.0 110.202 -175.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 26.9 p-10 -87.98 175.36 7.81 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 122.118 -0.364 . . . . 0.0 110.468 -176.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -60.34 -17.21 41.61 Favored 'General case' 0 N--CA 1.507 2.414 0 O-C-N 121.937 -0.477 . . . . 0.0 112.122 -172.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -92.41 -11.49 34.71 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.608 -0.682 . . . . 0.0 111.842 178.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.13 21.2 36.32 Favored Glycine 0 N--CA 1.497 2.743 0 N-CA-C 111.099 -0.801 . . . . 0.0 111.099 176.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -97.79 144.59 27.23 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-N 118.309 1.055 . . . . 0.0 109.872 170.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.9 p -94.92 128.42 41.69 Favored 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.24 176.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 20.1 p -97.82 116.05 29.27 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 122.138 -0.351 . . . . 0.0 110.474 178.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.3 mt -97.41 126.62 42.77 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 122.101 -0.374 . . . . 0.0 110.456 -179.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -150.52 146.16 26.42 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 122.065 -0.397 . . . . 0.0 110.474 175.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 93.7 p -143.7 167.06 23.17 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 175.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -179.23 -167.23 36.36 Favored Glycine 0 N--CA 1.497 2.748 0 N-CA-C 110.244 -1.142 . . . . 0.0 110.244 -178.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 2.2 m -96.6 132.72 41.93 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 122.221 -0.576 . . . . 0.0 110.147 -175.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 43.2 ttm -97.47 121.83 39.82 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 122.026 -0.421 . . . . 0.0 109.982 177.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 26.7 pttt -67.5 165.96 15.71 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 122.028 -0.42 . . . . 0.0 110.609 -176.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 58.1 t80 -66.44 148.11 52.34 Favored 'General case' 0 N--CA 1.503 2.182 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.267 176.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -140.03 -47.89 0.45 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 122.158 -0.339 . . . . 0.0 110.492 -178.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 150.08 -33.99 1.02 Allowed Glycine 0 N--CA 1.494 2.535 0 N-CA-C 109.729 -1.349 . . . . 0.0 109.729 -177.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.1 m -71.9 123.54 22.92 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 122.026 -0.69 . . . . 0.0 109.892 178.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -75.76 -41.46 53.09 Favored 'General case' 0 N--CA 1.501 2.122 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.373 -178.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -155.78 31.19 0.36 Allowed 'General case' 0 N--CA 1.498 1.931 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.665 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -77.31 82.68 3.77 Favored 'General case' 0 N--CA 1.501 2.083 0 CA-C-O 121.231 0.539 . . . . 0.0 109.885 178.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 14.8 t -117.76 32.12 6.33 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.917 -0.489 . . . . 0.0 110.374 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -83.73 -170.98 3.34 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.996 -0.44 . . . . 0.0 110.453 -178.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -107.24 121.05 43.76 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 122.14 -0.35 . . . . 0.0 110.211 178.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.4 m -81.78 172.33 9.91 Favored Pre-proline 0 N--CA 1.498 1.957 0 O-C-N 122.07 -0.394 . . . . 0.0 110.124 -177.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -85.61 51.38 2.88 Favored 'Trans proline' 0 N--CA 1.494 1.516 0 O-C-N 123.398 1.21 . . . . 0.0 111.396 174.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 43.4 tptt -155.81 45.07 0.45 Allowed 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.86 -173.09 1.14 Allowed 'General case' 0 N--CA 1.5 2.071 0 CA-C-O 121.109 0.48 . . . . 0.0 110.798 -162.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 2.2 tp60 -133.86 -168.95 2.21 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -167.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 9.1 tp -64.3 166.77 7.6 Favored 'General case' 0 N--CA 1.508 2.445 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -178.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 -68.21 123.59 21.13 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 121.799 -0.563 . . . . 0.0 110.146 -165.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 43.8 ptt85 -161.46 165.37 28.83 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 120.877 0.37 . . . . 0.0 110.41 -170.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 18.4 m -125.81 148.14 49.21 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 172.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.5 tt -143.2 156.08 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 122.048 -0.408 . . . . 0.0 110.186 -177.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -141.85 147.88 37.91 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 120.879 0.371 . . . . 0.0 110.411 178.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 25.3 p -143.09 136.35 28.2 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 -177.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 22.5 p -157.44 128.82 6.82 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.888 -0.507 . . . . 0.0 111.016 -171.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 52.9 ttt180 -103.73 48.76 0.84 Allowed 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 121.319 0.581 . . . . 0.0 110.481 -178.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 23.9 p -135.66 150.5 49.62 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.919 -0.488 . . . . 0.0 109.739 175.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -62.91 132.13 51.06 Favored 'General case' 0 N--CA 1.504 2.248 0 CA-C-O 121.358 0.599 . . . . 0.0 111.643 -162.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 82.7 mt 51.72 28.0 4.53 Favored 'General case' 0 N--CA 1.507 2.409 0 O-C-N 122.032 -0.418 . . . . 0.0 111.936 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 26.2 p -62.66 -23.01 66.88 Favored 'General case' 0 N--CA 1.507 2.391 0 O-C-N 121.908 -0.495 . . . . 0.0 111.591 174.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -77.39 -29.18 53.06 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.824 -0.547 . . . . 0.0 111.126 177.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -62.04 -40.26 95.13 Favored 'General case' 0 N--CA 1.506 2.357 0 O-C-N 121.69 -0.631 . . . . 0.0 110.879 -168.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -100.04 16.26 24.57 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 122.088 -0.383 . . . . 0.0 111.631 178.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 11.9 tp -115.88 108.9 16.88 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.504 -0.748 . . . . 0.0 110.25 -175.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -98.27 120.79 58.81 Favored Pre-proline 0 N--CA 1.497 1.888 0 CA-C-O 118.96 -0.543 . . . . 0.0 110.102 174.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.7 134.06 19.61 Favored 'Trans proline' 0 N--CA 1.49 1.273 0 O-C-N 123.227 1.119 . . . . 0.0 110.24 172.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 35.1 p -139.31 149.39 44.17 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 122.097 -0.377 . . . . 0.0 110.217 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 15.9 mt -72.16 155.09 92.02 Favored Pre-proline 0 N--CA 1.501 2.12 0 O-C-N 121.987 -0.445 . . . . 0.0 109.985 177.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -63.48 147.51 93.18 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 O-C-N 123.504 1.265 . . . . 0.0 110.704 178.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -68.72 134.14 29.45 Favored 'Trans proline' 0 N--CA 1.49 1.302 0 O-C-N 123.633 1.333 . . . . 0.0 110.328 -177.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 43.4 t -80.39 165.71 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 178.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 35.8 m -88.13 145.14 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 O-C-N 122.037 -0.414 . . . . 0.0 110.341 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 23.1 pt -91.44 51.67 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 CA-C-O 121.149 0.499 . . . . 0.0 110.314 179.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 68.95 164.26 3.46 Favored Glycine 0 N--CA 1.496 2.676 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 -178.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_exo -58.66 133.08 51.86 Favored 'Trans proline' 0 N--CA 1.503 2.038 0 C-N-CA 121.091 1.194 . . . . 0.0 111.317 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -84.29 137.62 33.36 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 122.109 -0.37 . . . . 0.0 110.343 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -155.86 150.26 25.82 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 178.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -81.11 156.32 25.83 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 139.48 51.21 0.05 OUTLIER Glycine 0 N--CA 1.495 2.574 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 87.6 p -80.3 161.08 25.27 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 122.201 -0.588 . . . . 0.0 110.243 179.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 50.7 mm -90.19 137.77 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 63.6 ttt180 . . . . . 0 N--CA 1.499 1.994 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.211 179.895 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.269 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_exo -58.42 123.38 13.48 Favored 'Trans proline' 0 N--CA 1.502 2.006 0 C-N-CA 121.059 1.173 . . . . 0.0 111.436 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 69.5 mt-10 -90.36 46.85 1.37 Allowed 'General case' 0 N--CA 1.501 2.124 0 CA-C-O 121.167 0.508 . . . . 0.0 110.813 178.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -77.95 69.78 4.22 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.738 -0.601 . . . . 0.0 110.3 -176.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 18.3 m -147.81 119.42 7.99 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.851 -0.531 . . . . 0.0 110.047 176.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 20.4 mt -81.02 149.68 67.12 Favored Pre-proline 0 N--CA 1.501 2.097 0 O-C-N 122.106 -0.372 . . . . 0.0 110.311 -175.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -65.51 127.75 18.75 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 O-C-N 123.266 1.14 . . . . 0.0 110.929 166.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -156.07 50.99 0.53 Allowed 'General case' 0 N--CA 1.501 2.096 0 CA-C-O 121.305 0.574 . . . . 0.0 110.326 164.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 21.1 tp -158.56 114.57 2.69 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.792 -0.567 . . . . 0.0 110.287 -177.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 29.7 ttmt -99.88 131.72 45.67 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 122.16 -0.338 . . . . 0.0 110.16 177.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 79.7 m -114.74 140.17 49.1 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 -179.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 68.6 t80 -87.49 143.38 27.25 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 122.093 -0.379 . . . . 0.0 110.097 176.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 27.5 p -117.49 137.0 52.84 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 122.089 -0.382 . . . . 0.0 110.58 -175.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 29.3 t -123.01 119.68 31.07 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 122.124 -0.36 . . . . 0.0 110.158 178.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 83.69 -61.96 4.67 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -106.54 112.84 26.01 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 122.109 -0.642 . . . . 0.0 110.519 -177.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -138.04 136.52 19.73 Favored Pre-proline 0 N--CA 1.495 1.803 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 176.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.78 152.78 67.32 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 O-C-N 123.118 1.062 . . . . 0.0 111.186 -171.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -60.55 -28.65 68.6 Favored 'General case' 0 N--CA 1.507 2.419 0 O-C-N 121.932 -0.48 . . . . 0.0 111.34 -172.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -92.21 14.37 16.41 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 122.009 -0.432 . . . . 0.0 111.752 -178.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.4 160.66 30.01 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.671 -0.643 . . . . 0.0 110.361 -172.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 58.7 mt -126.02 140.46 48.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 -178.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 38.74 42.79 0.65 Allowed 'General case' 0 N--CA 1.512 2.655 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -176.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 55.48 41.33 30.98 Favored 'General case' 0 N--CA 1.508 2.453 0 O-C-N 121.789 -0.569 . . . . 0.0 111.401 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 40.1 p -144.09 163.95 32.06 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.804 -0.56 . . . . 0.0 110.647 174.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.3 p -140.63 164.97 28.74 Favored 'General case' 0 N--CA 1.499 1.975 0 CA-C-O 120.882 0.372 . . . . 0.0 110.564 178.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 76.7 mt -112.82 133.62 58.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -175.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.0 t -141.22 153.0 45.04 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 122.054 -0.404 . . . . 0.0 111.083 -178.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -109.77 31.27 5.96 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 122.172 -0.33 . . . . 0.0 110.469 167.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -123.41 -94.11 1.12 Allowed Glycine 0 N--CA 1.497 2.725 0 N-CA-C 109.131 -1.588 . . . . 0.0 109.131 175.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 39.2 m80 -149.81 172.06 15.74 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 122.054 -0.674 . . . . 0.0 109.512 176.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 77.3 m -93.21 139.31 30.75 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 167.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 15.1 p90 -130.46 153.75 48.46 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.833 -0.542 . . . . 0.0 110.599 -176.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -151.52 142.23 22.78 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 177.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 17.8 tt -142.51 149.24 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 CA-C-O 120.888 0.375 . . . . 0.0 110.338 -173.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 16.1 tt -139.87 145.39 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 63.8 mt-10 -146.21 142.82 28.78 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.985 -0.447 . . . . 0.0 109.845 -168.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.3 tm-20 -101.61 116.45 32.78 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 120.793 0.33 . . . . 0.0 110.179 -176.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -87.28 175.19 8.14 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 122.17 -0.331 . . . . 0.0 110.583 -175.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -60.65 -17.11 45.27 Favored 'General case' 0 N--CA 1.506 2.374 0 O-C-N 121.993 -0.442 . . . . 0.0 112.159 -172.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -92.48 -12.01 33.14 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.666 -0.646 . . . . 0.0 111.829 177.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.14 21.01 36.85 Favored Glycine 0 N--CA 1.498 2.785 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 176.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -97.59 142.41 29.44 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 118.395 1.098 . . . . 0.0 109.799 169.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.5 p -94.94 127.25 40.85 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 120.779 -0.369 . . . . 0.0 110.277 178.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.1 p -97.94 112.9 24.66 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 120.906 -0.318 . . . . 0.0 110.348 176.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.4 mp -98.38 129.79 45.03 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 120.774 0.321 . . . . 0.0 110.452 -178.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -149.58 146.27 27.24 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 122.038 -0.413 . . . . 0.0 110.194 175.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 98.8 p -143.64 167.1 23.06 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 178.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -177.36 -163.99 30.23 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 -177.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 2.1 m -97.21 132.56 42.85 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 122.131 -0.629 . . . . 0.0 110.378 -175.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 55.1 ttm -100.3 124.41 45.73 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 122.068 -0.395 . . . . 0.0 110.231 179.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.3 ptpp? -66.94 172.14 4.73 Favored 'General case' 0 N--CA 1.504 2.227 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.348 176.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -64.82 136.39 56.83 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 122.038 -0.414 . . . . 0.0 110.559 -176.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -131.25 -47.02 1.0 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 122.107 -0.371 . . . . 0.0 110.394 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 138.43 -35.06 2.05 Favored Glycine 0 N--CA 1.496 2.637 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 74.6 m -72.31 115.59 11.74 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.983 -0.716 . . . . 0.0 110.219 -178.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -79.03 -36.06 41.68 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 122.115 -0.365 . . . . 0.0 110.381 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -155.5 75.21 0.92 Allowed 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.274 0.559 . . . . 0.0 110.182 176.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 63.4 mt-30 -155.3 103.63 2.36 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.928 -0.483 . . . . 0.0 109.731 -178.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 97.7 m -140.54 36.53 1.84 Allowed 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 120.914 0.388 . . . . 0.0 110.206 -176.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 55.7 mttm -79.82 173.83 12.2 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.965 -0.46 . . . . 0.0 110.213 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -135.79 136.73 40.94 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 122.156 -0.34 . . . . 0.0 110.557 -179.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.4 m -77.74 156.13 80.46 Favored Pre-proline 0 N--CA 1.5 2.036 0 O-C-N 122.155 -0.34 . . . . 0.0 110.208 178.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -83.85 53.08 3.95 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 O-C-N 123.53 1.279 . . . . 0.0 111.132 173.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 71.2 mttt -155.46 55.27 0.62 Allowed 'General case' 0 N--CA 1.498 1.925 0 CA-C-O 121.558 0.694 . . . . 0.0 109.141 -175.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -155.7 -169.48 3.12 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 120.954 0.407 . . . . 0.0 110.523 -166.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 2.3 tp60 -64.56 -169.16 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.326 0 CA-C-O 120.99 0.424 . . . . 0.0 110.231 -176.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.7 tp -64.12 163.65 12.15 Favored 'General case' 0 N--CA 1.507 2.376 0 O-C-N 121.903 -0.498 . . . . 0.0 109.949 -166.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 79.3 mtp180 -68.29 146.35 53.39 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.775 -0.578 . . . . 0.0 110.485 -163.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 30.4 ptt180 -161.49 165.23 28.98 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-O 120.902 0.382 . . . . 0.0 110.381 -175.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 14.0 m -123.93 149.02 46.38 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 171.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.2 tt -143.1 153.34 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 122.089 -0.382 . . . . 0.0 110.189 -175.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -148.85 150.91 33.81 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-O 120.804 0.335 . . . . 0.0 110.543 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 26.3 p -143.14 155.31 44.54 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 175.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 19.7 p -157.47 136.71 11.86 Favored 'General case' 0 N--CA 1.503 2.205 0 CA-C-O 121.013 0.435 . . . . 0.0 110.738 -172.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 38.7 ttt180 -108.54 50.45 0.78 Allowed 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.413 0.625 . . . . 0.0 110.653 -171.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.0 p -147.4 151.76 37.02 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.69 -0.631 . . . . 0.0 109.888 178.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 17.6 p-10 -62.07 132.71 53.75 Favored 'General case' 0 N--CA 1.505 2.317 0 CA-C-O 121.44 0.638 . . . . 0.0 111.656 -164.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 74.7 mt 52.57 27.14 4.83 Favored 'General case' 0 N--CA 1.506 2.374 0 O-C-N 121.971 -0.455 . . . . 0.0 111.962 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 26.0 p -63.05 -23.39 67.43 Favored 'General case' 0 N--CA 1.508 2.435 0 C-N-CA 120.402 -0.519 . . . . 0.0 111.605 174.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -70.97 -26.51 63.19 Favored 'General case' 0 N--CA 1.505 2.293 0 O-C-N 121.799 -0.563 . . . . 0.0 111.025 177.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 49.0 tp60 -61.15 -43.32 99.07 Favored 'General case' 0 N--CA 1.508 2.442 0 O-C-N 121.647 -0.658 . . . . 0.0 110.617 -174.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -100.46 16.26 25.17 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 122.157 -0.339 . . . . 0.0 111.851 -176.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 16.4 tp -115.48 108.91 17.08 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.53 -0.731 . . . . 0.0 110.336 -176.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -98.6 120.7 58.49 Favored Pre-proline 0 N--CA 1.496 1.832 0 CA-C-O 118.936 -0.554 . . . . 0.0 110.16 174.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -70.54 134.42 26.29 Favored 'Trans proline' 0 N--CA 1.491 1.336 0 O-C-N 123.133 1.07 . . . . 0.0 110.262 175.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 34.9 p -139.24 150.03 45.02 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 122.137 -0.352 . . . . 0.0 110.2 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 14.9 mt -70.45 155.07 93.98 Favored Pre-proline 0 N--CA 1.502 2.141 0 CA-C-O 119.208 -0.425 . . . . 0.0 109.955 179.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -62.52 154.97 61.08 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 O-C-N 123.393 1.207 . . . . 0.0 110.844 -176.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -63.83 160.25 37.93 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 O-C-N 123.339 1.178 . . . . 0.0 110.802 179.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 48.2 t -150.16 165.16 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 58.9 t -89.54 130.14 39.34 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 -178.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 75.7 mt -90.66 116.57 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 177.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -104.19 167.55 16.0 Favored Glycine 0 N--CA 1.496 2.661 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -58.17 141.6 96.65 Favored 'Trans proline' 0 N--CA 1.502 2.004 0 C-N-CA 121.05 1.167 . . . . 0.0 111.426 179.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -84.25 140.04 31.94 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 122.085 -0.384 . . . . 0.0 110.257 -179.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -73.1 152.04 41.37 Favored 'General case' 0 N--CA 1.501 2.115 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.054 178.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -82.28 61.13 5.35 Favored 'General case' 0 N--CA 1.501 2.115 0 CA-C-O 121.332 0.587 . . . . 0.0 110.317 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -93.06 -170.75 39.93 Favored Glycine 0 N--CA 1.496 2.657 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 88.5 p -79.99 166.2 21.82 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 122.098 -0.648 . . . . 0.0 110.063 179.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 50.9 mm -89.55 138.1 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -179.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 22.4 ttm180 . . . . . 0 N--CA 1.498 1.96 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.151 -179.741 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.289 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_exo -58.34 120.61 8.61 Favored 'Trans proline' 0 N--CA 1.501 1.97 0 O-C-N 123.35 1.184 . . . . 0.0 111.39 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -155.4 79.03 1.03 Allowed 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.204 0.526 . . . . 0.0 109.612 -177.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -79.3 86.47 5.05 Favored 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 121.131 0.491 . . . . 0.0 109.939 178.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 18.9 m -152.1 125.88 9.01 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.997 -0.439 . . . . 0.0 110.13 178.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 67.6 mt -80.71 118.78 73.95 Favored Pre-proline 0 N--CA 1.5 2.051 0 CA-C-O 118.769 -0.634 . . . . 0.0 109.819 -178.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -61.78 141.0 88.82 Favored 'Trans proline' 0 N--CA 1.501 1.961 0 O-C-N 123.218 1.115 . . . . 0.0 111.189 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -157.0 48.57 0.44 Allowed 'General case' 0 N--CA 1.499 1.993 0 CA-C-O 121.046 0.451 . . . . 0.0 110.706 173.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 17.5 tp -161.32 114.44 1.92 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.783 -0.573 . . . . 0.0 110.42 -174.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 32.8 tttt -99.92 131.48 45.86 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 177.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 86.0 m -116.76 140.35 49.52 Favored 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -179.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -83.17 142.74 30.98 Favored 'General case' 0 N--CA 1.501 2.097 0 C-N-CA 120.73 -0.388 . . . . 0.0 109.992 175.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 28.1 p -114.66 136.92 52.52 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.849 -0.532 . . . . 0.0 110.561 -178.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.6 m -123.01 138.73 54.61 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 122.099 -0.376 . . . . 0.0 110.116 176.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 75.54 -67.07 2.28 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -113.54 124.54 52.61 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 122.11 -0.641 . . . . 0.0 110.465 -177.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -138.16 136.36 19.4 Favored Pre-proline 0 N--CA 1.496 1.844 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 174.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.36 152.42 67.24 Favored 'Trans proline' 0 N--CA 1.498 1.749 0 O-C-N 123.053 1.028 . . . . 0.0 111.185 -171.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -60.34 -28.11 67.9 Favored 'General case' 0 N--CA 1.507 2.378 0 O-C-N 121.944 -0.472 . . . . 0.0 111.391 -172.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -91.96 14.39 15.87 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.958 -0.464 . . . . 0.0 111.75 -178.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.92 162.07 25.18 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.652 -0.655 . . . . 0.0 110.246 -173.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 76.4 mt -125.53 140.11 49.33 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -177.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 38.72 42.47 0.61 Allowed 'General case' 0 N--CA 1.512 2.629 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -178.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 55.04 42.73 30.69 Favored 'General case' 0 N--CA 1.508 2.461 0 O-C-N 121.768 -0.582 . . . . 0.0 111.432 -178.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 39.9 p -142.75 161.59 37.69 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.785 -0.572 . . . . 0.0 110.622 173.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.5 p -139.53 165.12 28.09 Favored 'General case' 0 N--CA 1.498 1.973 0 CA-C-O 120.97 0.414 . . . . 0.0 110.486 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 75.9 mt -117.01 131.92 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 -173.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.9 t -143.65 155.66 44.31 Favored 'General case' 0 N--CA 1.502 2.143 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.168 -178.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -108.63 30.65 6.29 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 122.081 -0.387 . . . . 0.0 110.524 167.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -118.87 -103.44 2.1 Favored Glycine 0 N--CA 1.497 2.708 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 174.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 23.9 m-70 -139.55 171.93 13.54 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 122.169 -0.606 . . . . 0.0 109.655 176.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 83.2 m -93.92 139.21 31.18 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 165.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -129.59 150.04 51.09 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.591 -177.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -150.32 143.77 25.1 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 175.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 18.3 tt -144.18 149.17 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 122.091 -0.381 . . . . 0.0 110.099 -171.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.409 ' CG1' ' HB ' ' A' ' 71' ' ' THR . 15.6 tt -138.13 118.74 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 CA-C-O 120.877 0.37 . . . . 0.0 110.209 179.052 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 69.2 mt-10 -105.16 145.65 30.29 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 122.107 -0.371 . . . . 0.0 110.505 -178.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.1 tm-20 -101.96 116.49 32.8 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 122.016 -0.427 . . . . 0.0 110.166 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -85.34 175.19 9.04 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 122.008 -0.433 . . . . 0.0 110.56 -175.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -60.75 -17.71 50.43 Favored 'General case' 0 N--CA 1.507 2.41 0 O-C-N 122.019 -0.426 . . . . 0.0 111.989 -173.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -92.87 -10.7 35.72 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.693 -0.629 . . . . 0.0 111.823 178.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 89.65 18.22 52.38 Favored Glycine 0 N--CA 1.498 2.809 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 177.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 69.5 mt-10 -93.98 149.72 20.98 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 118.521 1.161 . . . . 0.0 111.311 168.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.409 ' HB ' ' CG1' ' A' ' 63' ' ' ILE . 4.5 p -94.96 134.97 37.04 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 122.038 -0.414 . . . . 0.0 110.467 177.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.2 p -102.15 110.5 22.48 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 169.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.4 mp -97.27 132.86 42.6 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 122.177 -0.327 . . . . 0.0 110.587 -175.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -148.07 145.32 28.39 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 122.154 -0.341 . . . . 0.0 110.399 175.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 99.2 p -143.74 166.97 23.4 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 176.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 178.58 -164.44 32.96 Favored Glycine 0 N--CA 1.497 2.742 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 2.6 m -96.41 132.74 41.64 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 122.15 -0.618 . . . . 0.0 110.298 -175.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 55.4 ttm -101.21 122.0 42.85 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 122.068 -0.395 . . . . 0.0 110.117 176.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 26.8 pttt -66.36 165.89 13.29 Favored 'General case' 0 N--CA 1.503 2.222 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.339 177.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -65.74 147.04 54.03 Favored 'General case' 0 N--CA 1.505 2.289 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.4 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -142.18 -48.83 0.36 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 122.112 -0.368 . . . . 0.0 110.347 -178.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 142.38 -33.91 1.86 Allowed Glycine 0 N--CA 1.497 2.704 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -176.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.9 m -71.42 124.3 24.29 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 122.126 -0.632 . . . . 0.0 109.975 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -77.37 -40.17 44.81 Favored 'General case' 0 N--CA 1.5 2.072 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.29 -178.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -155.55 33.59 0.36 Allowed 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.503 -176.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 91.9 mm-40 -75.48 65.31 1.71 Allowed 'General case' 0 N--CA 1.502 2.156 0 CA-C-O 121.391 0.615 . . . . 0.0 109.852 178.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 4.0 t -111.8 30.19 7.21 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.809 -0.557 . . . . 0.0 110.672 -177.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 6.3 mmmm -84.86 -178.81 6.94 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.986 -0.446 . . . . 0.0 110.411 -178.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -146.05 112.85 6.02 Favored 'General case' 0 N--CA 1.499 2.009 0 CA-C-O 120.946 0.403 . . . . 0.0 110.555 177.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.2 m -80.32 152.07 72.99 Favored Pre-proline 0 N--CA 1.502 2.146 0 O-C-N 122.006 -0.434 . . . . 0.0 110.26 179.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -83.33 55.5 5.07 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 O-C-N 123.427 1.225 . . . . 0.0 111.101 173.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 37.7 tttp -155.7 47.82 0.5 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.622 -0.674 . . . . 0.0 109.206 -178.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -155.68 -169.2 3.03 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.96 -0.463 . . . . 0.0 110.401 -162.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 2.8 tp60 -64.15 -168.93 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.25 0 CA-C-O 120.899 0.381 . . . . 0.0 110.243 -176.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 9.7 tt -64.09 155.7 30.58 Favored 'General case' 0 N--CA 1.506 2.331 0 O-C-N 121.872 -0.517 . . . . 0.0 110.322 -162.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 43.0 mtp180 -68.67 138.63 55.12 Favored 'General case' 0 N--CA 1.5 2.062 0 CA-C-O 120.893 0.377 . . . . 0.0 110.332 -166.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 48.6 ptt85 -161.54 165.16 28.94 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 -178.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 15.5 m -112.55 149.15 33.12 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 171.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.8 tt -143.25 154.89 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.017 -177.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 66.8 mt-10 -142.99 149.95 38.99 Favored 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.63 -178.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 92.5 m -141.97 138.8 32.18 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 -177.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 20.4 p -157.63 131.41 8.0 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.906 -0.496 . . . . 0.0 110.914 -175.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 51.1 ttt180 -104.61 48.05 0.85 Allowed 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.287 0.565 . . . . 0.0 110.65 -176.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 23.9 p -136.65 151.47 49.34 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.904 -0.497 . . . . 0.0 109.861 175.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 17.6 p-10 -61.88 132.07 51.84 Favored 'General case' 0 N--CA 1.505 2.3 0 CA-C-O 121.429 0.633 . . . . 0.0 111.735 -163.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 75.4 mt 51.98 26.83 3.95 Favored 'General case' 0 N--CA 1.508 2.474 0 O-C-N 122.098 -0.376 . . . . 0.0 111.923 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 26.3 p -63.16 -21.91 66.52 Favored 'General case' 0 N--CA 1.507 2.384 0 C-N-CA 120.439 -0.504 . . . . 0.0 111.6 176.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -90.91 -22.99 20.63 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.737 -0.602 . . . . 0.0 111.282 177.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -61.01 -38.23 85.33 Favored 'General case' 0 N--CA 1.508 2.46 0 O-C-N 121.604 -0.685 . . . . 0.0 110.791 -175.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -100.69 16.32 25.32 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 122.094 -0.379 . . . . 0.0 111.674 177.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 15.7 tp -112.93 112.31 23.69 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.544 -0.723 . . . . 0.0 110.294 -174.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -96.27 120.86 61.8 Favored Pre-proline 0 N--CA 1.498 1.944 0 CA-C-O 118.894 -0.574 . . . . 0.0 109.912 172.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -71.0 143.71 45.55 Favored 'Trans proline' 0 N--CA 1.491 1.338 0 O-C-N 123.129 1.068 . . . . 0.0 110.225 177.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 35.3 p -139.11 150.05 45.24 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 122.1 -0.375 . . . . 0.0 110.204 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 16.4 mt -71.94 150.14 92.67 Favored Pre-proline 0 N--CA 1.501 2.124 0 C-N-CA 120.689 -0.405 . . . . 0.0 110.114 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -69.11 152.61 72.64 Favored 'Trans proline' 0 N--CA 1.491 1.35 0 O-C-N 123.55 1.29 . . . . 0.0 110.198 178.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -68.13 136.94 39.2 Favored 'Trans proline' 0 N--CA 1.49 1.313 0 O-C-N 123.502 1.264 . . . . 0.0 110.353 179.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 60.9 t -77.46 -38.65 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.19 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 58.1 t -89.78 135.2 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 76.2 mt -89.94 113.63 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 127.53 -171.52 18.94 Favored Glycine 0 N--CA 1.497 2.734 0 N-CA-C 109.439 -1.465 . . . . 0.0 109.439 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_exo -58.14 152.3 53.22 Favored 'Trans proline' 0 N--CA 1.501 1.961 0 C-N-CA 121.113 1.209 . . . . 0.0 111.429 178.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -155.29 164.3 38.96 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 122.177 -0.327 . . . . 0.0 110.217 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -155.88 130.79 9.22 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 109.981 -0.378 . . . . 0.0 109.981 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -155.18 34.08 0.38 Allowed 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 120.946 -0.301 . . . . 0.0 110.274 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -68.1 -35.78 84.28 Favored Glycine 0 N--CA 1.496 2.673 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 28.7 t -81.12 134.53 35.66 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 122.136 -0.626 . . . . 0.0 110.194 -179.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 76.3 mt -90.78 134.62 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 39.4 ttm180 . . . . . 0 N--CA 1.5 2.052 0 CA-C-O 118.117 -0.944 . . . . 0.0 110.111 179.519 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.288 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_exo -58.37 123.18 13.04 Favored 'Trans proline' 0 N--CA 1.501 1.971 0 O-C-N 123.367 1.193 . . . . 0.0 111.343 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -90.12 47.62 1.47 Allowed 'General case' 0 N--CA 1.5 2.035 0 CA-C-O 121.125 0.488 . . . . 0.0 110.796 179.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -77.5 82.06 3.95 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.749 -0.594 . . . . 0.0 109.865 -177.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 21.3 m -147.22 123.77 11.08 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.88 -0.512 . . . . 0.0 110.074 179.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 17.5 mt -76.53 150.95 82.68 Favored Pre-proline 0 N--CA 1.5 2.04 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.079 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -63.79 122.98 11.23 Favored 'Trans proline' 0 N--CA 1.499 1.799 0 O-C-N 123.269 1.142 . . . . 0.0 111.16 170.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -156.67 53.07 0.52 Allowed 'General case' 0 N--CA 1.5 2.06 0 CA-C-O 121.325 0.583 . . . . 0.0 110.3 164.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 20.5 tp -157.61 114.38 2.94 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.804 -0.56 . . . . 0.0 109.967 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 13.0 tttp -99.86 129.08 45.91 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 84.9 m -116.42 140.2 49.61 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -178.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -81.34 146.19 30.47 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 122.033 -0.417 . . . . 0.0 109.891 177.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 27.9 p -115.8 157.77 23.88 Favored 'General case' 0 N--CA 1.502 2.129 0 CA-C-O 120.997 0.427 . . . . 0.0 110.985 -173.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 96.7 p -65.65 162.99 17.23 Favored 'General case' 0 N--CA 1.503 2.196 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 167.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -51.35 -18.14 3.26 Favored Glycine 0 N--CA 1.507 3.397 0 N-CA-C 111.946 -0.462 . . . . 0.0 111.946 -173.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -84.4 111.8 19.77 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.8 -0.824 . . . . 0.0 109.621 163.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -138.32 136.08 18.91 Favored Pre-proline 0 N--CA 1.497 1.901 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -175.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -56.65 153.52 35.6 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 O-C-N 122.978 0.988 . . . . 0.0 111.599 -165.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -60.67 -31.24 70.49 Favored 'General case' 0 N--CA 1.506 2.353 0 O-C-N 121.953 -0.467 . . . . 0.0 111.357 -167.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -91.4 14.17 15.44 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 122.023 -0.423 . . . . 0.0 111.877 -177.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -86.01 162.14 18.63 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.654 -0.654 . . . . 0.0 110.542 -174.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 76.2 mt -122.02 140.53 45.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 -176.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 39.31 42.75 0.84 Allowed 'General case' 0 N--CA 1.513 2.69 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 55.05 41.73 31.53 Favored 'General case' 0 N--CA 1.508 2.438 0 O-C-N 121.844 -0.535 . . . . 0.0 111.455 -179.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 66.8 p -138.84 150.1 45.64 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.776 -0.577 . . . . 0.0 110.279 173.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.8 p -120.65 160.28 23.59 Favored 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 120.963 0.411 . . . . 0.0 110.598 178.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 77.5 mt -108.95 133.23 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -176.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.6 t -140.79 153.9 46.03 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.98 -0.45 . . . . 0.0 111.271 -178.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 26.7 p30 -108.06 30.11 6.68 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 122.178 -0.326 . . . . 0.0 110.528 166.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -122.58 -96.79 1.34 Allowed Glycine 0 N--CA 1.496 2.656 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 177.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 15.9 m80 -148.98 172.07 15.33 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 122.097 -0.649 . . . . 0.0 109.428 178.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 82.3 m -95.84 139.19 32.42 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 168.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 16.5 p90 -132.08 150.83 52.05 Favored 'General case' 0 N--CA 1.499 1.994 0 C-N-CA 120.352 -0.539 . . . . 0.0 110.705 -178.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -152.55 144.66 23.83 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 175.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 18.3 tt -143.36 149.2 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 C-N-CA 120.741 -0.383 . . . . 0.0 110.492 -171.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 13.4 tt -136.1 145.09 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 176.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -150.04 145.86 26.64 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -170.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.3 tm-20 -101.62 117.35 34.71 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 122.128 -0.357 . . . . 0.0 110.098 -178.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -87.21 175.31 8.11 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 122.111 -0.368 . . . . 0.0 110.607 -175.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -60.67 -17.61 48.67 Favored 'General case' 0 N--CA 1.507 2.393 0 O-C-N 121.973 -0.454 . . . . 0.0 112.016 -172.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -92.77 -10.81 35.63 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.547 -0.721 . . . . 0.0 111.863 178.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.27 19.71 44.84 Favored Glycine 0 N--CA 1.498 2.769 0 N-CA-C 111.159 -0.776 . . . . 0.0 111.159 176.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -97.22 145.28 26.21 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 118.472 1.136 . . . . 0.0 109.915 169.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.2 p -94.87 129.62 41.79 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 122.127 -0.358 . . . . 0.0 110.24 178.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 19.3 p -97.9 115.6 28.44 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 122.156 -0.34 . . . . 0.0 110.346 178.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 18.4 mt -97.23 124.97 41.47 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 122.136 -0.352 . . . . 0.0 110.291 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -143.32 143.74 31.81 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 120.842 0.353 . . . . 0.0 110.534 175.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 89.4 p -143.73 166.99 23.33 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 176.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 176.48 -164.32 33.99 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 179.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 2.0 m -98.87 132.49 44.17 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 122.251 -0.558 . . . . 0.0 110.424 -174.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 50.0 ttm -102.52 133.66 47.13 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 122.116 -0.365 . . . . 0.0 110.185 176.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 22.5 pttm -65.98 172.05 4.01 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 122.054 -0.404 . . . . 0.0 110.543 178.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -64.93 147.12 53.99 Favored 'General case' 0 N--CA 1.504 2.274 0 O-C-N 122.063 -0.398 . . . . 0.0 110.397 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 74.8 mt-10 -137.21 -48.69 0.6 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 122.032 -0.417 . . . . 0.0 110.586 -175.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 147.81 140.81 3.42 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -177.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 27.5 t -78.23 0.26 25.87 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 122.085 -0.656 . . . . 0.0 112.525 -178.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -77.59 -32.17 53.49 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.524 -0.735 . . . . 0.0 110.366 178.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -155.65 77.29 0.97 Allowed 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.329 0.585 . . . . 0.0 109.78 176.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -78.94 60.2 2.82 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.833 -0.542 . . . . 0.0 110.857 -176.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 1.3 t -155.55 119.9 4.64 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.569 -0.707 . . . . 0.0 109.966 178.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 25.5 mmtt -79.6 117.62 20.69 Favored 'General case' 0 N--CA 1.502 2.146 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.316 179.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -149.67 110.82 4.39 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 122.143 -0.348 . . . . 0.0 110.108 176.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 21.3 m -81.48 114.7 51.64 Favored Pre-proline 0 N--CA 1.502 2.133 0 CA-C-O 118.978 -0.534 . . . . 0.0 110.034 -177.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -75.37 61.78 6.02 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 O-C-N 123.083 1.044 . . . . 0.0 110.809 173.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 47.8 tttm -155.76 43.11 0.42 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.692 -0.63 . . . . 0.0 109.449 -178.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -155.63 121.91 5.17 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 122.047 -0.408 . . . . 0.0 110.041 -170.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 44.9 tt0 -111.45 52.94 0.73 Allowed 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.309 0.576 . . . . 0.0 110.093 -179.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 4.4 tt -120.19 143.33 48.3 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.905 -0.497 . . . . 0.0 109.983 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 55.2 ttt85 -68.95 114.8 7.57 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 122.031 -0.418 . . . . 0.0 109.878 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 46.3 ptt85 -161.43 165.14 29.24 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 122.078 -0.389 . . . . 0.0 110.735 -176.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 19.9 m -134.03 149.23 51.17 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 178.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.3 tt -143.07 156.06 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 122.061 -0.399 . . . . 0.0 110.047 -179.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -142.88 146.58 34.22 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 120.825 0.345 . . . . 0.0 110.54 -178.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 26.0 p -143.12 137.67 29.29 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -178.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 20.5 p -157.57 133.74 9.53 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.96 -0.463 . . . . 0.0 110.989 -171.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 62.1 ttt180 -106.65 52.66 0.71 Allowed 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 121.426 0.631 . . . . 0.0 110.451 -176.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.0 p -142.26 151.64 42.27 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.766 -0.583 . . . . 0.0 109.753 174.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -61.28 131.79 51.5 Favored 'General case' 0 N--CA 1.506 2.337 0 CA-C-O 121.427 0.632 . . . . 0.0 111.771 -163.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 74.1 mt 52.08 26.8 4.04 Favored 'General case' 0 N--CA 1.507 2.404 0 O-C-N 122.064 -0.398 . . . . 0.0 111.964 179.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 26.3 p -63.06 -22.06 66.6 Favored 'General case' 0 N--CA 1.506 2.358 0 O-C-N 121.888 -0.507 . . . . 0.0 111.58 176.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -90.07 -22.94 21.58 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.79 -0.569 . . . . 0.0 111.277 176.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -61.14 -38.84 87.82 Favored 'General case' 0 N--CA 1.508 2.438 0 O-C-N 121.595 -0.69 . . . . 0.0 110.768 -175.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -100.06 16.3 24.48 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 122.16 -0.337 . . . . 0.0 111.606 177.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 15.4 tp -112.65 111.81 22.88 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.595 -0.69 . . . . 0.0 110.31 -175.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -96.54 120.8 61.49 Favored Pre-proline 0 N--CA 1.498 1.974 0 CA-C-O 118.904 -0.57 . . . . 0.0 109.922 173.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -71.26 139.03 34.35 Favored 'Trans proline' 0 N--CA 1.49 1.311 0 O-C-N 123.182 1.096 . . . . 0.0 110.164 175.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 50.4 p -139.16 150.06 45.17 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 122.094 -0.379 . . . . 0.0 110.125 178.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 17.4 mt -73.21 111.64 12.5 Favored Pre-proline 0 N--CA 1.502 2.136 0 CA-C-O 118.975 -0.536 . . . . 0.0 110.012 178.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -68.06 150.57 77.6 Favored 'Trans proline' 0 N--CA 1.491 1.336 0 O-C-N 123.132 1.07 . . . . 0.0 110.265 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -63.61 146.39 92.51 Favored 'Trans proline' 0 N--CA 1.494 1.532 0 O-C-N 123.414 1.218 . . . . 0.0 110.787 176.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 48.0 t -150.4 165.17 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 60.4 t -90.64 131.86 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -178.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 17.3 tt -153.18 118.59 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 122.109 -0.369 . . . . 0.0 110.078 178.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 68.36 170.11 5.68 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_exo -58.76 132.39 47.61 Favored 'Trans proline' 0 N--CA 1.501 1.966 0 C-N-CA 121.103 1.202 . . . . 0.0 111.307 178.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -85.89 127.5 34.61 Favored 'General case' 0 N--CA 1.5 2.04 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.284 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -70.04 131.23 44.03 Favored 'General case' 0 N--CA 1.501 2.113 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.188 178.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -82.42 165.5 20.2 Favored 'General case' 0 N--CA 1.501 2.089 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.526 -179.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 72.11 35.43 60.9 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 28.9 t -82.22 133.31 35.25 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.982 -0.717 . . . . 0.0 110.19 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 76.2 mt -90.86 130.65 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 23.1 ttm180 . . . . . 0 N--CA 1.496 1.853 0 CA-C-O 117.917 -1.04 . . . . 0.0 110.283 179.737 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.282 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -58.22 123.26 13.24 Favored 'Trans proline' 0 N--CA 1.501 1.939 0 C-N-CA 121.12 1.213 . . . . 0.0 111.383 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -90.08 47.33 1.44 Allowed 'General case' 0 N--CA 1.501 2.124 0 CA-C-O 121.13 0.49 . . . . 0.0 110.709 179.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -77.12 83.8 3.61 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.677 -0.639 . . . . 0.0 109.896 -176.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 22.1 m -124.35 107.72 11.44 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 122.025 -0.422 . . . . 0.0 110.126 178.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 76.6 mt -142.43 148.94 49.34 Favored Pre-proline 0 N--CA 1.497 1.881 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -61.24 142.15 95.43 Favored 'Trans proline' 0 N--CA 1.503 2.049 0 O-C-N 123.269 1.142 . . . . 0.0 111.187 175.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -158.55 49.66 0.37 Allowed 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 121.097 0.475 . . . . 0.0 110.898 172.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 20.2 tp -161.53 114.09 1.84 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.696 -0.627 . . . . 0.0 110.276 -175.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 58.0 tttt -99.76 130.39 45.96 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 122.167 -0.333 . . . . 0.0 110.151 177.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 77.4 m -113.86 140.31 48.45 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -179.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -84.75 140.76 31.02 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 175.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 28.2 p -114.16 138.09 50.89 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 122.024 -0.422 . . . . 0.0 110.676 -176.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.4 m -122.94 139.44 54.05 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 122.036 -0.415 . . . . 0.0 109.947 176.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.16 -68.27 1.4 Allowed Glycine 0 N--CA 1.496 2.659 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 63.9 m170 -110.8 123.06 49.35 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 122.163 -0.61 . . . . 0.0 110.602 -176.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -138.08 136.25 19.4 Favored Pre-proline 0 N--CA 1.497 1.881 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 174.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -60.32 152.47 66.68 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 O-C-N 123.062 1.033 . . . . 0.0 111.221 -170.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -60.34 -28.15 67.94 Favored 'General case' 0 N--CA 1.507 2.379 0 O-C-N 121.961 -0.462 . . . . 0.0 111.43 -172.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -92.07 14.25 16.48 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.955 -0.466 . . . . 0.0 111.782 -178.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.89 162.01 26.33 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.631 -0.668 . . . . 0.0 110.308 -172.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 76.7 mt -125.97 139.77 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -177.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 38.6 43.29 0.66 Allowed 'General case' 0 N--CA 1.512 2.64 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -177.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 55.44 42.29 30.12 Favored 'General case' 0 N--CA 1.507 2.418 0 O-C-N 121.811 -0.555 . . . . 0.0 111.467 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 39.2 p -144.38 162.72 35.77 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.76 -0.588 . . . . 0.0 110.658 173.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.3 p -139.77 164.95 28.59 Favored 'General case' 0 N--CA 1.499 1.992 0 CA-C-O 120.787 0.327 . . . . 0.0 110.613 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 77.2 mt -113.74 133.05 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -174.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.1 t -142.5 154.09 44.2 Favored 'General case' 0 N--CA 1.502 2.143 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.059 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 40.1 p-10 -108.37 30.29 6.57 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 122.109 -0.369 . . . . 0.0 110.608 167.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -122.31 -97.78 1.43 Allowed Glycine 0 N--CA 1.497 2.717 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 176.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 31.1 m80 -143.8 170.66 15.46 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 122.136 -0.626 . . . . 0.0 109.473 177.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 71.4 m -91.85 139.14 30.95 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 164.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 15.9 p90 -130.0 148.17 51.83 Favored 'General case' 0 N--CA 1.497 1.9 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.518 -177.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -151.46 141.75 22.37 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 178.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 18.0 tt -144.17 149.2 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 122.065 -0.397 . . . . 0.0 110.559 -171.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 16.4 tt -134.26 145.21 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 176.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -147.94 146.18 28.89 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -167.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.4 tm-20 -101.49 116.83 33.66 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 120.864 0.364 . . . . 0.0 110.179 -176.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -87.36 175.24 8.09 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 122.03 -0.419 . . . . 0.0 110.594 -175.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -60.49 -17.51 45.74 Favored 'General case' 0 N--CA 1.506 2.359 0 O-C-N 121.904 -0.498 . . . . 0.0 112.12 -172.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -92.89 -11.35 33.7 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.613 -0.679 . . . . 0.0 111.811 178.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.56 20.13 42.09 Favored Glycine 0 N--CA 1.497 2.751 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 177.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -97.32 145.27 26.28 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 118.49 1.145 . . . . 0.0 109.786 169.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.8 p -94.89 128.8 41.93 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 122.117 -0.364 . . . . 0.0 110.183 178.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 21.4 p -97.98 118.99 35.82 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 122.165 -0.334 . . . . 0.0 110.276 178.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 23.0 mt -97.61 127.13 43.33 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 122.14 -0.35 . . . . 0.0 110.408 179.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -147.98 144.88 28.29 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 122.039 -0.413 . . . . 0.0 110.481 174.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 78.8 p -143.69 167.01 23.28 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 176.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -178.3 -166.5 34.71 Favored Glycine 0 N--CA 1.497 2.709 0 N-CA-C 110.15 -1.18 . . . . 0.0 110.15 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 2.2 m -96.99 132.85 42.38 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 122.172 -0.605 . . . . 0.0 110.415 -176.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 56.0 ttm -100.66 122.93 44.15 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 122.097 -0.377 . . . . 0.0 110.15 178.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.1 pttm -65.88 167.97 8.74 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 122.01 -0.431 . . . . 0.0 110.59 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -65.74 147.6 53.12 Favored 'General case' 0 N--CA 1.504 2.244 0 O-C-N 122.045 -0.409 . . . . 0.0 110.515 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 68.5 mt-10 -142.09 -48.37 0.36 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 122.126 -0.359 . . . . 0.0 110.455 -178.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 142.7 -34.18 1.81 Allowed Glycine 0 N--CA 1.496 2.691 0 N-CA-C 109.816 -1.313 . . . . 0.0 109.816 -178.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 11.5 p -71.75 125.2 26.53 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 122.125 -0.632 . . . . 0.0 110.076 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -75.83 -45.0 38.18 Favored 'General case' 0 N--CA 1.501 2.089 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.121 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -155.67 30.24 0.37 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 122.065 -0.397 . . . . 0.0 110.632 177.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -79.07 83.43 5.16 Favored 'General case' 0 N--CA 1.501 2.084 0 CA-C-O 121.125 0.488 . . . . 0.0 109.974 179.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 90.2 m -111.48 32.04 5.68 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.883 -0.51 . . . . 0.0 110.347 178.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -83.4 175.53 9.77 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 122.023 -0.423 . . . . 0.0 110.325 -179.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -155.01 142.79 19.92 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 122.119 -0.363 . . . . 0.0 110.399 176.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 7.4 m -77.5 163.04 66.39 Favored Pre-proline 0 N--CA 1.501 2.082 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 177.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -84.28 56.01 4.78 Favored 'Trans proline' 0 N--CA 1.495 1.568 0 O-C-N 123.391 1.206 . . . . 0.0 111.717 -174.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 71.8 tttt -155.81 36.72 0.36 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.64 -0.662 . . . . 0.0 109.503 171.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -83.46 -169.91 2.79 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-O 121.137 0.494 . . . . 0.0 111.212 -166.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -65.03 -168.83 0.04 OUTLIER 'General case' 0 N--CA 1.504 2.244 0 CA-C-O 120.902 0.382 . . . . 0.0 110.045 173.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 9.2 tp -63.99 164.69 10.05 Favored 'General case' 0 N--CA 1.509 2.475 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 -173.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 73.9 mtt85 -68.18 137.07 54.56 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.824 -0.547 . . . . 0.0 110.425 -161.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 28.2 ptt-85 -161.41 165.31 29.04 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 120.805 0.336 . . . . 0.0 110.388 -174.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 15.1 m -124.41 147.91 47.95 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 171.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.5 tt -143.18 155.99 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 122.0 -0.437 . . . . 0.0 110.284 -174.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -144.81 149.84 36.14 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 120.723 0.297 . . . . 0.0 110.388 178.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 26.7 p -143.06 142.06 31.45 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 21.8 p -157.55 129.29 6.97 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 122.011 -0.431 . . . . 0.0 110.802 -171.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 53.0 ttp180 -104.02 48.45 0.85 Allowed 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.329 0.585 . . . . 0.0 110.504 -177.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.1 p -135.5 150.72 49.86 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.905 -0.497 . . . . 0.0 109.798 175.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 17.6 p-10 -62.5 131.93 50.79 Favored 'General case' 0 N--CA 1.504 2.269 0 CA-C-O 121.388 0.613 . . . . 0.0 111.734 -162.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 79.6 mt 51.76 27.84 4.46 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 122.003 -0.436 . . . . 0.0 111.936 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 26.0 p -62.69 -23.26 67.05 Favored 'General case' 0 N--CA 1.506 2.337 0 O-C-N 121.874 -0.516 . . . . 0.0 111.564 174.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -75.5 -29.66 59.58 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.907 -0.495 . . . . 0.0 111.079 177.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -62.16 -39.39 92.49 Favored 'General case' 0 N--CA 1.507 2.399 0 O-C-N 121.764 -0.585 . . . . 0.0 110.826 -169.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -100.3 16.16 25.28 Favored 'General case' 0 N--CA 1.498 1.938 0 C-N-CA 120.936 -0.306 . . . . 0.0 111.688 179.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 12.2 tp -117.99 108.93 15.86 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.511 -0.743 . . . . 0.0 110.296 -176.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -98.7 120.87 57.94 Favored Pre-proline 0 N--CA 1.497 1.896 0 CA-C-O 118.86 -0.59 . . . . 0.0 110.078 174.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -71.15 133.89 23.96 Favored 'Trans proline' 0 N--CA 1.491 1.341 0 O-C-N 123.247 1.13 . . . . 0.0 110.15 172.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 35.0 p -139.16 147.14 41.46 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 122.102 -0.374 . . . . 0.0 110.371 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 27.0 mt -72.23 155.11 91.88 Favored Pre-proline 0 N--CA 1.502 2.162 0 CA-C-O 119.277 -0.392 . . . . 0.0 110.01 176.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -62.26 146.8 95.8 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 O-C-N 123.313 1.165 . . . . 0.0 110.778 -178.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -68.37 143.11 56.85 Favored 'Trans proline' 0 N--CA 1.49 1.313 0 O-C-N 123.432 1.227 . . . . 0.0 110.402 -175.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 48.5 t -150.66 165.55 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 12.3 p -90.04 144.09 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 O-C-N 122.002 -0.436 . . . . 0.0 110.127 -179.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 76.3 mt -91.26 117.26 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 68.19 178.39 14.84 Favored Glycine 0 N--CA 1.497 2.718 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 178.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -58.45 161.38 14.48 Favored 'Trans proline' 0 N--CA 1.501 1.92 0 C-N-CA 121.109 1.206 . . . . 0.0 111.377 178.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -155.24 162.1 40.99 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 122.195 -0.316 . . . . 0.0 110.188 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -155.75 168.85 25.87 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 -178.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -155.23 -46.07 0.08 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 122.095 -0.378 . . . . 0.0 110.18 -179.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 90.79 36.82 6.64 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 30.6 t -155.39 101.85 2.22 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 122.133 -0.628 . . . . 0.0 110.108 179.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 76.3 mt -90.93 139.11 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 58.5 ttm-85 . . . . . 0 N--CA 1.498 1.961 0 CA-C-O 117.973 -1.013 . . . . 0.0 110.186 179.39 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.31 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -58.56 120.57 8.54 Favored 'Trans proline' 0 N--CA 1.501 1.951 0 O-C-N 123.328 1.173 . . . . 0.0 111.309 179.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -90.3 47.1 1.4 Allowed 'General case' 0 N--CA 1.501 2.121 0 CA-C-O 121.164 0.507 . . . . 0.0 110.703 179.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -77.63 82.18 4.05 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.639 -0.663 . . . . 0.0 109.922 -176.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.1 m -106.4 50.37 0.78 Allowed 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.296 0.569 . . . . 0.0 109.991 178.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 23.9 mt -77.65 151.0 79.71 Favored Pre-proline 0 N--CA 1.501 2.117 0 O-C-N 121.838 -0.539 . . . . 0.0 110.052 -178.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -64.13 122.21 10.12 Favored 'Trans proline' 0 N--CA 1.498 1.785 0 O-C-N 123.369 1.194 . . . . 0.0 111.208 169.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -158.32 53.37 0.44 Allowed 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 121.332 0.586 . . . . 0.0 110.264 164.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 19.1 tp -158.41 114.72 2.75 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.803 -0.561 . . . . 0.0 110.032 -179.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -99.74 131.6 45.62 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 122.112 -0.367 . . . . 0.0 110.256 178.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 73.3 m -117.87 140.38 49.8 Favored 'General case' 0 N--CA 1.502 2.155 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 -178.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -82.4 146.2 29.46 Favored 'General case' 0 N--CA 1.501 2.079 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.125 178.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 27.9 p -116.05 136.99 52.52 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 122.021 -0.424 . . . . 0.0 110.54 -178.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 29.1 t -122.29 135.04 54.67 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 122.039 -0.413 . . . . 0.0 110.064 177.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.83 -66.52 2.77 Favored Glycine 0 N--CA 1.496 2.698 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -112.42 124.0 51.52 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 122.077 -0.66 . . . . 0.0 110.57 -177.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -138.03 136.98 20.21 Favored Pre-proline 0 N--CA 1.496 1.875 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 175.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -60.59 151.78 73.26 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 O-C-N 123.171 1.09 . . . . 0.0 111.105 -172.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -60.25 -28.1 67.77 Favored 'General case' 0 N--CA 1.508 2.431 0 O-C-N 121.995 -0.441 . . . . 0.0 111.383 -172.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -92.21 14.29 16.63 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.935 -0.478 . . . . 0.0 111.782 -177.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.4 161.98 26.76 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.708 -0.62 . . . . 0.0 110.232 -172.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 71.4 mt -124.76 137.02 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -177.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 19.9 p30 37.81 43.16 0.47 Allowed 'General case' 0 N--CA 1.514 2.773 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -176.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 30.8 m120 55.32 43.08 29.59 Favored 'General case' 0 N--CA 1.509 2.493 0 O-C-N 121.882 -0.511 . . . . 0.0 111.43 -178.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 71.5 p -139.13 160.87 38.77 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.814 -0.554 . . . . 0.0 110.283 171.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.1 p -137.57 161.27 36.88 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-O 120.973 0.416 . . . . 0.0 110.452 178.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 77.7 mt -107.52 131.63 57.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -175.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.4 t -140.07 151.65 45.55 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 122.04 -0.413 . . . . 0.0 110.972 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 49.9 p30 -107.81 30.57 6.21 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 122.127 -0.358 . . . . 0.0 110.585 167.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -122.86 -95.77 1.25 Allowed Glycine 0 N--CA 1.497 2.733 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 176.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 38.1 m-70 -149.59 172.03 15.68 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 122.108 -0.643 . . . . 0.0 109.556 176.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 82.7 m -94.51 139.2 31.46 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 168.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 19.5 p90 -129.06 151.28 49.92 Favored 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.476 -178.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -151.21 143.39 24.05 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 175.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 18.2 tt -144.02 149.33 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 122.109 -0.369 . . . . 0.0 110.276 -172.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 16.5 tt -136.46 145.25 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 178.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -147.99 145.88 28.71 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 122.013 -0.429 . . . . 0.0 109.914 -168.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.5 tm-20 -101.61 117.18 34.38 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 120.751 0.31 . . . . 0.0 110.185 -176.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 26.6 p-10 -87.6 175.35 7.95 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 122.123 -0.36 . . . . 0.0 110.563 -176.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -60.47 -17.24 43.6 Favored 'General case' 0 N--CA 1.506 2.368 0 O-C-N 122.007 -0.433 . . . . 0.0 112.082 -172.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -91.89 -11.57 35.99 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.551 -0.718 . . . . 0.0 111.819 178.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.84 20.95 37.98 Favored Glycine 0 N--CA 1.498 2.774 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 176.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -97.58 143.87 27.84 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 118.324 1.062 . . . . 0.0 109.898 170.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.8 p -94.84 124.32 38.82 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.234 176.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.7 p -97.92 113.72 25.62 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 122.093 -0.38 . . . . 0.0 110.336 178.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.4 mp -97.51 128.35 44.2 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 122.147 -0.346 . . . . 0.0 110.26 -178.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -144.37 147.84 33.93 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 122.099 -0.375 . . . . 0.0 110.349 176.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 87.3 p -143.69 166.18 25.58 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 178.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -179.22 -167.11 36.17 Favored Glycine 0 N--CA 1.496 2.69 0 N-CA-C 110.354 -1.098 . . . . 0.0 110.354 -178.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 2.9 m -96.55 132.25 42.34 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 122.187 -0.596 . . . . 0.0 110.25 -175.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 51.1 ttm -98.53 121.88 41.02 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.946 -0.471 . . . . 0.0 110.087 176.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 26.6 pttt -66.77 165.28 15.42 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 122.043 -0.411 . . . . 0.0 110.508 -178.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 54.3 p90 -65.02 126.21 27.31 Favored 'General case' 0 N--CA 1.504 2.263 0 O-C-N 122.056 -0.403 . . . . 0.0 110.498 177.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -122.41 -44.16 2.26 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 122.101 -0.374 . . . . 0.0 110.488 -179.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 137.43 -33.54 2.28 Favored Glycine 0 N--CA 1.495 2.626 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 -176.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 86.4 p -71.26 125.11 26.09 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 122.067 -0.667 . . . . 0.0 109.955 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -75.87 -41.42 52.33 Favored 'General case' 0 N--CA 1.501 2.116 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.421 -176.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -155.69 34.52 0.36 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 122.037 -0.415 . . . . 0.0 110.504 -176.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -75.96 83.14 2.85 Favored 'General case' 0 N--CA 1.502 2.136 0 CA-C-O 121.274 0.559 . . . . 0.0 109.985 177.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 4.4 t -123.86 29.57 6.46 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.88 -0.512 . . . . 0.0 110.556 176.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 77.5 mttt -85.57 -175.54 5.69 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.913 -0.492 . . . . 0.0 110.488 -178.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -150.4 115.44 5.34 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 122.174 -0.329 . . . . 0.0 110.325 178.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 5.4 m -76.52 160.35 77.5 Favored Pre-proline 0 N--CA 1.501 2.092 0 O-C-N 122.062 -0.399 . . . . 0.0 109.945 176.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -84.23 55.81 4.74 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 O-C-N 123.394 1.207 . . . . 0.0 111.866 -173.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 22.2 pttm -155.83 32.38 0.35 Allowed 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.558 -0.714 . . . . 0.0 110.055 170.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -84.73 -169.94 2.88 Favored 'General case' 0 N--CA 1.499 2.0 0 CA-C-O 121.078 0.466 . . . . 0.0 111.124 -168.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -64.83 -168.73 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.261 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 170.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 9.0 tp -63.96 165.71 8.49 Favored 'General case' 0 N--CA 1.507 2.397 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 -172.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -68.03 137.81 55.35 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.509 -0.744 . . . . 0.0 110.47 -157.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 30.7 ptt180 -161.45 165.32 28.92 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 120.903 0.382 . . . . 0.0 110.557 -170.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 16.6 m -128.69 149.12 50.81 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 172.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.6 tt -143.02 156.0 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 122.023 -0.423 . . . . 0.0 110.165 -176.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -143.8 151.63 40.19 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 120.947 0.403 . . . . 0.0 110.581 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 89.6 m -141.98 141.31 32.89 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 19.9 p -157.56 137.9 12.78 Favored 'General case' 0 N--CA 1.504 2.243 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.137 -174.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 27.8 ttt180 -109.38 45.82 1.04 Allowed 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 121.275 0.56 . . . . 0.0 110.637 -172.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.0 p -141.92 152.08 43.22 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.869 -0.519 . . . . 0.0 109.97 178.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 17.6 p-10 -61.78 132.68 53.92 Favored 'General case' 0 N--CA 1.505 2.281 0 CA-C-O 121.373 0.606 . . . . 0.0 111.793 -164.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 74.4 mt 52.24 26.76 4.18 Favored 'General case' 0 N--CA 1.507 2.416 0 O-C-N 122.048 -0.408 . . . . 0.0 111.966 179.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 25.9 p -63.15 -22.2 66.7 Favored 'General case' 0 N--CA 1.507 2.419 0 O-C-N 121.858 -0.526 . . . . 0.0 111.572 175.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -91.1 -22.95 20.46 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.723 -0.611 . . . . 0.0 111.304 177.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -60.97 -37.9 84.08 Favored 'General case' 0 N--CA 1.509 2.504 0 O-C-N 121.595 -0.691 . . . . 0.0 110.721 -176.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -100.16 16.22 24.9 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 122.126 -0.359 . . . . 0.0 111.59 177.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 17.4 tp -113.73 112.83 24.1 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.579 -0.701 . . . . 0.0 110.345 -175.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 37.8 tt0 -96.48 120.72 61.72 Favored Pre-proline 0 N--CA 1.496 1.872 0 CA-C-O 118.853 -0.594 . . . . 0.0 110.028 173.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -71.11 139.33 35.37 Favored 'Trans proline' 0 N--CA 1.49 1.303 0 O-C-N 123.197 1.104 . . . . 0.0 110.326 175.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 35.0 p -139.17 149.96 45.05 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 122.113 -0.367 . . . . 0.0 110.206 178.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 17.4 mt -72.68 111.16 10.12 Favored Pre-proline 0 N--CA 1.502 2.157 0 CA-C-O 118.896 -0.573 . . . . 0.0 110.037 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -68.44 150.64 75.8 Favored 'Trans proline' 0 N--CA 1.492 1.432 0 O-C-N 123.234 1.123 . . . . 0.0 110.284 -178.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -68.61 155.29 69.42 Favored 'Trans proline' 0 N--CA 1.492 1.389 0 O-C-N 123.517 1.272 . . . . 0.0 110.222 178.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 42.5 t -79.08 165.16 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 58.4 t -89.81 131.48 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 -178.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 76.2 mt -90.43 116.15 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 177.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 72.41 -163.25 54.68 Favored Glycine 0 N--CA 1.495 2.607 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_exo -58.25 148.99 75.86 Favored 'Trans proline' 0 N--CA 1.501 1.928 0 C-N-CA 121.119 1.213 . . . . 0.0 111.447 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -82.73 153.38 25.33 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 122.076 -0.39 . . . . 0.0 110.286 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -155.77 159.07 39.15 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 122.119 -0.363 . . . . 0.0 110.158 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -82.89 -42.56 17.58 Favored 'General case' 0 N--CA 1.5 2.028 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.159 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -150.03 175.61 29.05 Favored Glycine 0 N--CA 1.495 2.621 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 29.3 t -155.41 143.32 19.91 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 122.128 -0.631 . . . . 0.0 110.136 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 76.4 mt -90.21 139.44 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 30.3 ttp180 . . . . . 0 N--CA 1.499 1.98 0 CA-C-O 118.003 -0.999 . . . . 0.0 110.22 -179.616 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.209 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_exo -58.51 120.18 7.9 Favored 'Trans proline' 0 N--CA 1.5 1.908 0 C-N-CA 121.061 1.174 . . . . 0.0 111.403 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -90.42 46.97 1.38 Allowed 'General case' 0 N--CA 1.5 2.068 0 CA-C-O 121.131 0.491 . . . . 0.0 110.847 178.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -77.42 78.41 3.94 Favored 'General case' 0 N--CA 1.503 2.179 0 CA-C-O 121.313 0.578 . . . . 0.0 110.335 -177.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 14.0 m -109.35 98.57 7.96 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.799 -0.563 . . . . 0.0 110.024 178.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 25.3 mt -80.77 150.97 70.44 Favored Pre-proline 0 N--CA 1.502 2.136 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.369 -175.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -65.16 129.68 23.58 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 O-C-N 123.3 1.158 . . . . 0.0 110.978 165.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -157.84 50.94 0.43 Allowed 'General case' 0 N--CA 1.498 1.967 0 CA-C-O 121.423 0.63 . . . . 0.0 110.407 164.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 20.5 tp -158.72 114.88 2.68 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.733 -0.604 . . . . 0.0 110.29 -177.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -99.77 132.14 45.3 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 120.95 -0.3 . . . . 0.0 110.233 176.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 76.4 m -117.52 140.33 49.75 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -179.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -81.86 142.13 32.79 Favored 'General case' 0 N--CA 1.502 2.143 0 C-N-CA 120.535 -0.466 . . . . 0.0 109.961 176.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 28.2 p -113.38 136.98 52.17 Favored 'General case' 0 N--CA 1.501 2.111 0 C-N-CA 120.779 -0.368 . . . . 0.0 110.589 -177.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.8 m -122.61 142.94 50.11 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 122.095 -0.378 . . . . 0.0 110.021 177.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.44 -68.13 1.5 Allowed Glycine 0 N--CA 1.494 2.547 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -115.27 126.47 54.54 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 122.003 -0.704 . . . . 0.0 110.613 -176.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -137.96 136.25 19.56 Favored Pre-proline 0 N--CA 1.496 1.852 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 174.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -60.7 152.65 67.76 Favored 'Trans proline' 0 N--CA 1.497 1.702 0 O-C-N 123.072 1.038 . . . . 0.0 111.194 -170.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -60.25 -28.03 67.7 Favored 'General case' 0 N--CA 1.508 2.44 0 O-C-N 122.021 -0.424 . . . . 0.0 111.34 -173.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -92.1 14.39 16.16 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.9 -0.5 . . . . 0.0 111.78 -178.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.92 162.04 26.29 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.581 -0.699 . . . . 0.0 110.259 -173.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 70.7 mt -124.11 136.45 60.33 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -176.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 19.8 p30 37.8 43.15 0.46 Allowed 'General case' 0 N--CA 1.512 2.658 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 -176.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 55.5 43.34 28.67 Favored 'General case' 0 N--CA 1.509 2.476 0 O-C-N 121.83 -0.544 . . . . 0.0 111.429 -178.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 56.1 p -139.53 161.98 36.17 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.801 -0.562 . . . . 0.0 110.273 171.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.4 p -137.29 160.43 39.07 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-O 120.737 0.304 . . . . 0.0 110.608 178.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 76.5 mt -110.09 132.97 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -174.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.0 t -143.5 155.19 44.27 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.952 -0.468 . . . . 0.0 111.022 -179.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 48.9 p30 -108.09 29.31 7.43 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 122.036 -0.415 . . . . 0.0 110.705 167.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -119.59 -102.63 1.99 Allowed Glycine 0 N--CA 1.497 2.741 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 176.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 24.6 m-70 -140.89 169.75 17.03 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 122.007 -0.702 . . . . 0.0 109.709 177.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 78.0 m -93.13 139.24 30.79 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 166.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -129.38 149.58 51.1 Favored 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.486 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -152.12 138.4 18.42 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 176.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 18.2 tt -136.36 149.05 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 CA-C-O 120.961 0.41 . . . . 0.0 110.459 -168.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 16.3 tt -132.36 145.11 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 177.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -149.79 143.43 25.37 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 -169.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.6 tm-20 -101.64 117.68 35.38 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 122.169 -0.332 . . . . 0.0 110.119 -177.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 51.7 p30 -87.05 175.34 8.16 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 122.132 -0.355 . . . . 0.0 110.676 -175.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -60.44 -17.55 45.35 Favored 'General case' 0 N--CA 1.507 2.413 0 O-C-N 121.941 -0.474 . . . . 0.0 112.069 -173.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -93.18 -10.71 34.81 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.589 -0.695 . . . . 0.0 111.9 178.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 89.99 21.16 40.1 Favored Glycine 0 N--CA 1.498 2.785 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 178.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -96.98 143.79 27.51 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-N 118.312 1.056 . . . . 0.0 109.77 170.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 15.8 p -94.81 126.54 40.2 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 122.069 -0.395 . . . . 0.0 110.2 177.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 20.7 p -97.91 117.56 32.51 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 122.13 -0.357 . . . . 0.0 110.298 179.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 83.7 mt -97.7 128.18 44.19 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 122.136 -0.353 . . . . 0.0 110.295 -179.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -146.98 144.7 29.38 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 122.079 -0.388 . . . . 0.0 110.523 175.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 97.0 p -143.72 167.02 23.26 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 177.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -178.26 -169.14 38.69 Favored Glycine 0 N--CA 1.496 2.659 0 N-CA-C 110.224 -1.15 . . . . 0.0 110.224 -179.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 2.9 m -96.17 132.77 41.24 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 122.175 -0.603 . . . . 0.0 110.181 -176.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 54.9 ttm -98.92 122.01 41.62 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 122.052 -0.405 . . . . 0.0 110.071 175.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 17.5 pttm -66.74 163.84 18.34 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 122.024 -0.423 . . . . 0.0 110.48 -179.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -66.08 146.78 54.27 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 122.031 -0.418 . . . . 0.0 110.418 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -146.08 -48.32 0.21 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 122.173 -0.33 . . . . 0.0 110.242 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 136.82 58.64 0.05 OUTLIER Glycine 0 N--CA 1.495 2.586 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 -178.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.7 m -152.58 115.93 4.71 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 122.198 -0.589 . . . . 0.0 110.396 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -74.35 -39.27 62.9 Favored 'General case' 0 N--CA 1.503 2.188 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.244 177.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -155.63 30.78 0.37 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 122.153 -0.342 . . . . 0.0 110.569 176.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 60.0 mt-30 -78.57 83.98 4.72 Favored 'General case' 0 N--CA 1.502 2.16 0 CA-C-O 121.173 0.511 . . . . 0.0 110.066 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 87.9 m -113.38 36.32 3.62 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.937 -0.477 . . . . 0.0 109.892 177.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -79.3 -172.08 3.01 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.99 -0.444 . . . . 0.0 110.399 -175.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -122.15 139.81 53.31 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 122.043 -0.41 . . . . 0.0 111.863 -178.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.0 m -77.67 175.18 4.82 Favored Pre-proline 0 N--CA 1.499 1.987 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 177.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -88.39 52.44 1.95 Allowed 'Trans proline' 0 N--CA 1.494 1.53 0 N-CA-C 107.857 -1.632 . . . . 0.0 107.857 173.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 51.6 tttm -155.71 42.88 0.42 Allowed 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.59 163.52 27.6 Favored 'General case' 0 N--CA 1.5 2.026 0 CA-C-O 121.146 0.498 . . . . 0.0 110.952 -161.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -98.91 -169.05 1.72 Allowed 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 -177.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.9 tp -64.29 169.62 4.46 Favored 'General case' 0 N--CA 1.506 2.347 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 57.9 mtm180 -68.02 130.69 43.73 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.488 -0.758 . . . . 0.0 110.295 -163.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 46.4 ptt85 -161.46 165.25 29.03 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 120.824 0.345 . . . . 0.0 110.594 -168.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 18.1 m -128.75 148.78 50.87 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 172.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.4 tt -143.18 127.38 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.997 -0.439 . . . . 0.0 110.167 -176.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -105.81 149.23 26.68 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 122.234 -0.291 . . . . 0.0 110.455 177.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 26.7 p -143.02 134.63 26.46 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 177.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 20.4 p -157.57 131.38 8.04 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.926 -0.484 . . . . 0.0 110.81 -170.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 21.6 ttp-105 -104.86 48.48 0.84 Allowed 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 121.385 0.612 . . . . 0.0 110.604 -176.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.0 p -135.12 151.36 50.63 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.895 -0.503 . . . . 0.0 109.785 174.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 15.7 p30 -61.77 132.24 52.51 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 121.724 -0.61 . . . . 0.0 111.793 -163.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 75.3 mt 52.0 26.55 3.8 Favored 'General case' 0 N--CA 1.507 2.376 0 O-C-N 122.089 -0.382 . . . . 0.0 111.991 179.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 26.3 p -63.11 -21.99 66.56 Favored 'General case' 0 N--CA 1.506 2.363 0 O-C-N 121.849 -0.532 . . . . 0.0 111.583 176.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -93.04 -22.93 18.85 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.684 -0.635 . . . . 0.0 111.323 178.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -60.66 -38.6 85.42 Favored 'General case' 0 N--CA 1.508 2.436 0 O-C-N 121.577 -0.702 . . . . 0.0 110.768 -177.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -100.74 16.23 25.67 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 122.078 -0.389 . . . . 0.0 111.685 179.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 16.8 tp -111.87 117.34 32.52 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.586 -0.697 . . . . 0.0 110.394 -174.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 3.3 tp-100 -96.45 120.71 61.79 Favored Pre-proline 0 N--CA 1.496 1.868 0 CA-C-O 118.862 -0.589 . . . . 0.0 109.965 171.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -69.93 145.22 55.51 Favored 'Trans proline' 0 N--CA 1.491 1.347 0 O-C-N 123.235 1.124 . . . . 0.0 110.291 175.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 34.5 p -139.22 147.05 41.25 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 122.175 -0.328 . . . . 0.0 110.156 179.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 14.9 mt -72.1 154.97 92.2 Favored Pre-proline 0 N--CA 1.502 2.166 0 CA-C-O 119.305 -0.379 . . . . 0.0 110.152 178.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -67.94 148.85 77.08 Favored 'Trans proline' 0 N--CA 1.491 1.326 0 O-C-N 123.47 1.247 . . . . 0.0 110.292 179.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -68.25 140.42 48.84 Favored 'Trans proline' 0 N--CA 1.492 1.394 0 O-C-N 123.452 1.238 . . . . 0.0 110.425 -178.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 43.5 t -80.14 165.86 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.182 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 58.2 t -88.82 125.64 41.94 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -179.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 76.3 mt -91.53 117.88 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 178.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 101.99 79.94 1.44 Allowed Glycine 0 N--CA 1.495 2.587 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 177.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_exo -58.68 -177.47 0.11 Allowed 'Trans proline' 0 N--CA 1.502 1.978 0 O-C-N 123.352 1.185 . . . . 0.0 111.361 176.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -155.23 94.88 1.66 Allowed 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 120.836 0.35 . . . . 0.0 110.254 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -73.21 154.06 40.41 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 122.065 -0.397 . . . . 0.0 110.099 178.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -81.63 -34.15 31.01 Favored 'General case' 0 N--CA 1.5 2.044 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.174 179.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 87.13 166.13 42.17 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 109.594 -1.403 . . . . 0.0 109.594 178.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 60.2 m -80.85 157.82 25.56 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 122.125 -0.632 . . . . 0.0 110.228 179.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 76.2 mt -89.88 134.66 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 55.5 ttt85 . . . . . 0 N--CA 1.498 1.93 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.152 -179.924 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.351 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_exo -58.39 119.87 7.4 Favored 'Trans proline' 0 N--CA 1.501 1.958 0 O-C-N 123.357 1.188 . . . . 0.0 111.365 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -90.31 47.01 1.39 Allowed 'General case' 0 N--CA 1.501 2.107 0 CA-C-O 121.082 0.468 . . . . 0.0 110.722 179.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -78.12 81.17 4.51 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.708 -0.62 . . . . 0.0 109.866 -177.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 21.6 m -135.52 114.37 12.02 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.856 -0.527 . . . . 0.0 110.188 178.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 73.4 mt -142.48 118.7 6.89 Favored Pre-proline 0 N--CA 1.496 1.862 0 CA-C-O 118.817 -0.611 . . . . 0.0 109.414 178.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -60.45 145.29 98.99 Favored 'Trans proline' 0 N--CA 1.502 2.011 0 C-N-CA 120.823 1.015 . . . . 0.0 111.224 -178.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -151.73 47.99 0.8 Allowed 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 121.188 0.518 . . . . 0.0 110.743 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 18.9 tp -161.0 115.01 2.05 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.771 -0.581 . . . . 0.0 110.449 -174.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 48.6 tttt -99.81 132.5 45.12 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 122.146 -0.347 . . . . 0.0 110.223 177.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 86.4 m -118.97 140.43 50.01 Favored 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 -178.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -83.07 144.49 29.86 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 122.027 -0.421 . . . . 0.0 110.015 176.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 28.1 p -115.67 137.07 52.44 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.952 -0.467 . . . . 0.0 110.588 -178.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 98.6 p -123.02 141.57 51.82 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 109.894 -0.409 . . . . 0.0 109.894 175.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.18 -68.16 1.41 Allowed Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -112.15 123.59 50.59 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.997 -0.708 . . . . 0.0 110.498 -176.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -138.07 136.99 20.14 Favored Pre-proline 0 N--CA 1.496 1.87 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 174.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -61.11 152.52 70.99 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 O-C-N 123.087 1.046 . . . . 0.0 111.077 -172.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -60.44 -28.21 68.11 Favored 'General case' 0 N--CA 1.508 2.462 0 O-C-N 121.88 -0.512 . . . . 0.0 111.415 -172.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -91.97 14.26 16.27 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.953 -0.467 . . . . 0.0 111.735 -177.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.86 161.97 27.22 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.533 -0.73 . . . . 0.0 110.243 -173.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 70.7 mt -124.36 136.38 60.69 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -177.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 19.8 p30 37.78 43.36 0.48 Allowed 'General case' 0 N--CA 1.515 2.776 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -176.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 30.8 m120 55.39 44.0 27.88 Favored 'General case' 0 N--CA 1.507 2.386 0 O-C-N 121.785 -0.572 . . . . 0.0 111.466 -178.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 58.2 p -140.76 161.75 37.05 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.725 -0.609 . . . . 0.0 110.306 171.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.4 p -139.66 165.07 28.26 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-O 120.752 0.311 . . . . 0.0 110.691 179.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 76.4 mt -111.91 132.53 60.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 -175.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.1 t -140.44 153.05 46.14 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 122.027 -0.421 . . . . 0.0 111.059 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 48.5 p30 -108.61 29.96 6.92 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 122.037 -0.415 . . . . 0.0 110.672 167.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -122.89 -96.05 1.26 Allowed Glycine 0 N--CA 1.497 2.73 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 176.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 49.7 m-70 -144.5 171.03 14.93 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 122.136 -0.626 . . . . 0.0 109.761 176.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 73.7 m -92.96 139.09 30.89 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 164.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -129.52 150.34 50.9 Favored 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 120.291 -0.564 . . . . 0.0 110.613 -178.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -151.26 143.98 24.39 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 175.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 18.1 tt -143.29 149.26 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.397 -171.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 13.5 tt -134.28 145.32 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 177.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -148.58 145.15 27.69 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 -169.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.3 tm-20 -101.53 116.94 33.9 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 122.146 -0.346 . . . . 0.0 110.134 -176.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -87.4 175.33 8.04 Favored 'General case' 0 N--CA 1.501 2.101 0 CA-C-O 120.796 0.332 . . . . 0.0 110.584 -175.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -60.44 -17.86 47.35 Favored 'General case' 0 N--CA 1.506 2.372 0 O-C-N 121.895 -0.503 . . . . 0.0 112.0 -172.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -92.85 -10.37 36.96 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.599 -0.688 . . . . 0.0 111.861 178.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 89.47 20.21 45.73 Favored Glycine 0 N--CA 1.498 2.791 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 176.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -97.38 145.74 25.86 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-N 118.466 1.133 . . . . 0.0 109.793 169.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 13.6 p -94.92 129.16 42.06 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 122.106 -0.371 . . . . 0.0 110.26 178.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 20.9 p -97.86 118.16 33.81 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 122.057 -0.402 . . . . 0.0 110.353 178.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 23.2 mt -97.53 126.87 43.07 Favored 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 120.966 -0.294 . . . . 0.0 110.307 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -145.18 143.41 30.3 Favored 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.646 174.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 98.9 p -143.85 167.06 23.2 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 176.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 178.91 -165.66 34.8 Favored Glycine 0 N--CA 1.496 2.663 0 N-CA-C 110.379 -1.088 . . . . 0.0 110.379 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 2.6 m -96.27 132.4 41.78 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 122.178 -0.601 . . . . 0.0 110.227 -176.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 55.8 ttm -98.49 121.82 40.91 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 122.069 -0.394 . . . . 0.0 110.156 177.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 22.5 pttt -66.99 165.05 16.39 Favored 'General case' 0 N--CA 1.503 2.199 0 C-N-CA 120.699 -0.401 . . . . 0.0 110.537 -178.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -66.44 148.54 51.73 Favored 'General case' 0 N--CA 1.503 2.22 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.244 177.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -139.62 -48.58 0.47 Allowed 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.404 -178.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 147.31 -33.82 1.32 Allowed Glycine 0 N--CA 1.497 2.726 0 N-CA-C 109.846 -1.301 . . . . 0.0 109.846 -176.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.9 m -71.1 125.49 27.04 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 122.028 -0.689 . . . . 0.0 109.907 178.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -74.04 -41.27 62.05 Favored 'General case' 0 N--CA 1.502 2.133 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.294 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -155.6 28.55 0.38 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 122.138 -0.351 . . . . 0.0 110.826 178.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -79.67 85.39 5.39 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.837 -0.539 . . . . 0.0 110.153 -179.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 90.8 m -100.88 34.61 2.42 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.88 -0.512 . . . . 0.0 109.979 175.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 79.2 mttt -80.06 -171.69 3.06 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 122.089 -0.382 . . . . 0.0 110.366 -176.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -116.08 135.74 53.66 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 122.129 -0.357 . . . . 0.0 111.421 -177.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.0 m -78.59 174.88 5.33 Favored Pre-proline 0 N--CA 1.498 1.934 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 178.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -88.18 52.49 2.05 Favored 'Trans proline' 0 N--CA 1.495 1.616 0 N-CA-C 108.324 -1.452 . . . . 0.0 108.324 173.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 11.8 ptmt -155.74 43.06 0.42 Allowed 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 177.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.98 -171.41 0.71 Allowed 'General case' 0 N--CA 1.5 2.057 0 CA-C-O 121.069 0.461 . . . . 0.0 110.988 -162.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -136.49 -169.1 2.38 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -169.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.6 tp -64.47 166.52 8.27 Favored 'General case' 0 N--CA 1.51 2.525 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 -178.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 42.2 ttt180 -68.18 135.7 52.48 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.654 -0.654 . . . . 0.0 110.428 -164.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 33.4 ptt-85 -161.51 165.42 28.63 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 120.984 0.421 . . . . 0.0 110.575 -170.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 17.0 m -126.81 149.06 49.88 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 171.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.5 tt -143.14 155.92 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.963 -0.461 . . . . 0.0 110.308 -175.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 57.1 mm-40 -141.46 147.75 38.39 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 120.866 0.365 . . . . 0.0 110.412 179.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 26.8 p -143.1 136.84 28.69 Favored 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 179.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 18.9 p -157.5 132.53 8.8 Favored 'General case' 0 N--CA 1.504 2.244 0 O-C-N 121.97 -0.456 . . . . 0.0 110.973 -171.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 22.4 ttm180 -105.14 48.68 0.83 Allowed 'General case' 0 N--CA 1.498 1.974 0 CA-C-O 121.382 0.61 . . . . 0.0 110.559 -177.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 23.8 p -136.02 151.16 49.59 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.714 -0.616 . . . . 0.0 109.799 174.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -61.73 131.98 51.68 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.69 -0.631 . . . . 0.0 111.821 -163.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 72.9 mt 52.28 26.4 4.0 Favored 'General case' 0 N--CA 1.506 2.36 0 O-C-N 122.047 -0.408 . . . . 0.0 111.948 179.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 26.4 p -62.86 -22.06 66.42 Favored 'General case' 0 N--CA 1.507 2.422 0 O-C-N 121.859 -0.526 . . . . 0.0 111.615 176.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -92.21 -22.86 19.57 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.83 -0.544 . . . . 0.0 111.331 177.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -60.76 -38.1 84.09 Favored 'General case' 0 N--CA 1.507 2.395 0 O-C-N 121.635 -0.666 . . . . 0.0 110.775 -177.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -100.24 16.26 24.88 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 122.179 -0.325 . . . . 0.0 111.701 178.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 14.0 tp -116.9 111.53 19.78 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.492 -0.755 . . . . 0.0 110.289 -175.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 21.9 tp60 -96.49 120.7 61.74 Favored Pre-proline 0 N--CA 1.497 1.893 0 CA-C-O 118.756 -0.64 . . . . 0.0 109.982 172.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.69 133.89 21.12 Favored 'Trans proline' 0 N--CA 1.49 1.296 0 O-C-N 123.237 1.125 . . . . 0.0 110.395 176.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 34.9 p -139.22 147.84 42.3 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 122.004 -0.435 . . . . 0.0 110.048 177.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 13.5 mt -72.46 138.16 80.89 Favored Pre-proline 0 N--CA 1.502 2.128 0 CA-C-O 119.01 -0.519 . . . . 0.0 109.929 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -75.82 146.67 30.07 Favored 'Trans proline' 0 N--CA 1.489 1.255 0 O-C-N 123.285 1.15 . . . . 0.0 110.247 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -71.28 132.35 20.75 Favored 'Trans proline' 0 N--CA 1.49 1.32 0 O-C-N 123.379 1.2 . . . . 0.0 110.134 175.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 42.5 t -80.75 165.19 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 13.2 p -90.18 114.17 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 CA-C-O 120.984 0.421 . . . . 0.0 110.314 -179.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 10.0 tt -155.15 47.18 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 121.996 -0.44 . . . . 0.0 110.063 176.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 66.66 65.23 2.9 Favored Glycine 0 N--CA 1.497 2.725 0 N-CA-C 109.846 -1.301 . . . . 0.0 109.846 -178.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_exo -57.87 150.85 60.63 Favored 'Trans proline' 0 N--CA 1.502 2.017 0 C-N-CA 121.125 1.217 . . . . 0.0 111.504 -177.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -155.24 160.19 40.64 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 122.178 -0.327 . . . . 0.0 110.248 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -155.33 45.5 0.49 Allowed 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 121.281 0.562 . . . . 0.0 109.54 -176.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -85.2 113.79 21.82 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.937 -0.477 . . . . 0.0 110.174 -178.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 77.31 -159.19 48.49 Favored Glycine 0 N--CA 1.495 2.625 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 32.8 t -155.45 145.33 21.46 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 122.147 -0.619 . . . . 0.0 110.064 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 76.8 mt -90.19 134.08 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 32.7 ttp180 . . . . . 0 N--CA 1.495 1.82 0 CA-C-O 117.993 -1.004 . . . . 0.0 110.286 179.755 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.331 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_exo -58.22 120.38 8.23 Favored 'Trans proline' 0 N--CA 1.502 1.978 0 O-C-N 123.361 1.19 . . . . 0.0 111.395 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -90.27 47.15 1.41 Allowed 'General case' 0 N--CA 1.501 2.108 0 CA-C-O 121.117 0.485 . . . . 0.0 110.85 179.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -78.09 80.83 4.51 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.746 -0.596 . . . . 0.0 109.853 -177.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 22.5 m -140.64 118.71 11.92 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.968 -0.458 . . . . 0.0 110.152 179.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 28.2 mt -79.31 145.06 63.39 Favored Pre-proline 0 N--CA 1.501 2.09 0 CA-C-O 119.053 -0.498 . . . . 0.0 109.872 179.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -61.17 138.55 78.47 Favored 'Trans proline' 0 N--CA 1.502 1.996 0 O-C-N 123.176 1.093 . . . . 0.0 111.237 176.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -155.38 47.29 0.51 Allowed 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.931 -0.481 . . . . 0.0 110.752 172.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 25.1 tp -159.33 102.77 1.59 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.767 -0.583 . . . . 0.0 110.396 -173.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 41.0 tttp -99.91 119.07 37.64 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 110.288 -0.264 . . . . 0.0 110.288 177.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 69.2 m -121.73 140.63 52.09 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 122.078 -0.389 . . . . 0.0 110.945 -178.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -79.7 155.44 28.01 Favored 'General case' 0 N--CA 1.501 2.087 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.07 -178.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 27.2 p -119.3 141.14 49.25 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.996 -0.44 . . . . 0.0 110.529 -179.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 49.7 m -122.98 138.93 54.55 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 122.086 -0.383 . . . . 0.0 110.169 177.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.52 -68.38 1.51 Allowed Glycine 0 N--CA 1.496 2.661 0 N-CA-C 109.669 -1.373 . . . . 0.0 109.669 178.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 83.2 t60 -112.97 125.79 54.78 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 122.073 -0.663 . . . . 0.0 110.537 -176.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -138.03 137.68 21.73 Favored Pre-proline 0 N--CA 1.496 1.839 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 176.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -61.11 150.89 82.18 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 O-C-N 123.049 1.026 . . . . 0.0 111.072 -174.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -59.77 -27.18 66.32 Favored 'General case' 0 N--CA 1.507 2.41 0 O-C-N 121.938 -0.477 . . . . 0.0 111.463 -173.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -92.17 14.23 16.74 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.871 -0.518 . . . . 0.0 111.746 -177.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.63 162.03 25.53 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.655 -0.653 . . . . 0.0 110.333 -173.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 76.2 mt -125.75 140.52 48.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -178.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 38.8 42.08 0.59 Allowed 'General case' 0 N--CA 1.513 2.696 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -178.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 30.7 m120 54.96 41.8 31.59 Favored 'General case' 0 N--CA 1.509 2.511 0 O-C-N 121.955 -0.465 . . . . 0.0 111.437 -178.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 43.1 p -140.54 161.77 36.95 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.825 -0.547 . . . . 0.0 110.332 173.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.4 p -138.38 163.32 32.18 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 120.967 0.413 . . . . 0.0 110.542 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 79.1 mt -129.33 125.32 61.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -168.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.2 t -143.6 158.25 43.81 Favored 'General case' 0 N--CA 1.501 2.12 0 C-N-CA 120.578 -0.449 . . . . 0.0 111.337 -177.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 10.6 p-10 -109.58 29.23 7.77 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 122.168 -0.333 . . . . 0.0 110.473 165.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -112.44 -103.66 2.67 Favored Glycine 0 N--CA 1.496 2.662 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 178.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 22.9 m80 -147.22 158.88 44.11 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 170.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 87.5 m -96.71 139.35 32.9 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 176.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -129.01 158.36 39.11 Favored 'General case' 0 N--CA 1.497 1.915 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.694 -171.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -150.98 143.86 24.55 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 176.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 18.2 tt -142.21 149.15 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.444 -170.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 15.4 tt -137.88 145.11 29.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 178.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -150.04 140.85 22.74 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 -170.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.1 tm-20 -101.67 116.54 32.98 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -86.78 175.23 8.33 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 122.068 -0.395 . . . . 0.0 110.582 -175.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -60.65 -17.49 47.74 Favored 'General case' 0 N--CA 1.507 2.423 0 O-C-N 122.076 -0.39 . . . . 0.0 112.002 -172.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -92.49 -10.82 36.42 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.628 -0.67 . . . . 0.0 111.855 178.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.14 20.91 40.5 Favored Glycine 0 N--CA 1.497 2.757 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 176.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -97.49 142.8 28.88 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 118.378 1.089 . . . . 0.0 109.784 169.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.3 p -94.91 128.83 41.99 Favored 'General case' 0 N--CA 1.498 1.961 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.273 177.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.1 p -98.05 114.33 26.46 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 120.851 0.358 . . . . 0.0 110.232 177.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 82.4 mt -96.66 123.98 40.51 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 122.169 -0.332 . . . . 0.0 110.235 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -145.23 147.88 32.9 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 122.087 -0.383 . . . . 0.0 110.465 178.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 92.5 p -143.57 164.99 28.83 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 176.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -173.98 -178.96 44.3 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 -177.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 6.6 m -100.08 133.46 44.43 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 122.203 -0.587 . . . . 0.0 110.309 -178.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 35.2 ttm -99.85 123.13 43.78 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 122.038 -0.414 . . . . 0.0 110.167 176.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 24.5 pttt -65.49 170.86 4.49 Favored 'General case' 0 N--CA 1.504 2.27 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.381 177.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -65.46 144.51 56.99 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.957 -0.464 . . . . 0.0 110.424 -179.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -148.15 -48.23 0.16 Allowed 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.293 -178.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 147.42 -35.42 1.23 Allowed Glycine 0 N--CA 1.495 2.626 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -178.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 64.4 m -72.98 123.62 23.84 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 122.028 -0.69 . . . . 0.0 110.006 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -78.24 -46.16 21.07 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 122.043 -0.41 . . . . 0.0 110.199 -179.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -155.67 33.62 0.36 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.999 -0.438 . . . . 0.0 110.41 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -76.09 65.38 2.09 Favored 'General case' 0 N--CA 1.501 2.105 0 CA-C-O 121.402 0.62 . . . . 0.0 110.013 179.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 95.6 m -111.81 33.77 4.59 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.748 -0.595 . . . . 0.0 110.232 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 63.3 mttm -80.83 170.23 16.55 Favored 'General case' 0 N--CA 1.501 2.11 0 C-N-CA 120.706 -0.397 . . . . 0.0 110.296 -178.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -109.52 132.89 53.72 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.6 t -78.33 142.69 63.34 Favored Pre-proline 0 N--CA 1.498 1.974 0 C-N-CA 120.604 -0.438 . . . . 0.0 110.123 -175.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -78.23 61.59 7.83 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 O-C-N 123.25 1.132 . . . . 0.0 110.479 173.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 25.8 ttmt -155.45 46.15 0.49 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.774 -0.579 . . . . 0.0 109.901 -177.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -155.69 144.07 20.16 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -109.99 60.48 0.6 Allowed 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.406 0.622 . . . . 0.0 110.178 -176.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 20.5 tp -154.96 153.85 31.68 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.723 -0.61 . . . . 0.0 110.03 178.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 3.8 mmp_? -87.06 126.99 35.11 Favored 'General case' 0 N--CA 1.5 2.038 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.01 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 62.1 ttp85 -161.39 145.76 13.25 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 122.056 -0.403 . . . . 0.0 110.147 -177.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 12.2 m -134.26 149.09 50.92 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 172.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.6 tt -143.06 155.99 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 177.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -145.95 156.64 43.65 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 120.873 0.368 . . . . 0.0 110.474 -178.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 97.0 m -141.81 154.12 44.98 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 178.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 25.4 p -157.6 133.34 9.22 Favored 'General case' 0 N--CA 1.502 2.146 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.842 -170.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 48.9 ttt85 -109.46 45.91 1.04 Allowed 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.299 0.571 . . . . 0.0 110.516 -179.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 44.2 p -138.1 151.97 48.31 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.805 -0.559 . . . . 0.0 110.055 176.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 21.3 p30 -64.12 140.46 58.87 Favored 'General case' 0 N--CA 1.505 2.292 0 CA-C-O 121.315 0.579 . . . . 0.0 111.198 -169.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 20.3 mt 53.07 25.85 4.44 Favored 'General case' 0 N--CA 1.507 2.39 0 O-C-N 121.814 -0.554 . . . . 0.0 112.289 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 27.9 p -67.84 -25.18 65.42 Favored 'General case' 0 N--CA 1.505 2.275 0 C-N-CA 119.968 -0.693 . . . . 0.0 111.164 172.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -81.09 -33.79 33.09 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.723 -0.611 . . . . 0.0 110.463 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -63.06 -40.73 98.57 Favored 'General case' 0 N--CA 1.506 2.358 0 O-C-N 122.002 -0.436 . . . . 0.0 110.89 -177.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -102.4 16.26 26.79 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 122.067 -0.395 . . . . 0.0 111.978 -174.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 13.5 tp -125.84 109.05 12.06 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.535 -0.728 . . . . 0.0 110.37 -176.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -98.33 120.78 58.74 Favored Pre-proline 0 N--CA 1.497 1.889 0 CA-C-O 118.799 -0.619 . . . . 0.0 110.132 173.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -68.84 147.13 68.06 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 O-C-N 123.234 1.123 . . . . 0.0 110.205 175.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 35.3 p -139.17 149.98 45.07 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 122.133 -0.355 . . . . 0.0 110.169 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 64.1 mt -71.76 155.02 92.7 Favored Pre-proline 0 N--CA 1.502 2.145 0 CA-C-O 119.187 -0.435 . . . . 0.0 110.138 179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -64.82 156.69 60.46 Favored 'Trans proline' 0 N--CA 1.492 1.424 0 O-C-N 123.36 1.189 . . . . 0.0 110.596 178.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -68.25 147.12 71.71 Favored 'Trans proline' 0 N--CA 1.492 1.439 0 O-C-N 123.555 1.292 . . . . 0.0 110.227 178.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 61.0 t -76.92 -37.63 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 60.4 t -89.72 138.33 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 179.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 4.5 tp -153.26 68.71 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 CA-C-O 121.169 0.509 . . . . 0.0 110.156 -179.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -169.11 -100.89 0.14 Allowed Glycine 0 N--CA 1.496 2.64 0 N-CA-C 103.557 -3.817 . . . . 0.0 103.557 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -39.59 146.73 0.2 Allowed 'Trans proline' 0 N--CA 1.502 2.0 0 O-C-N 123.369 1.194 . . . . 0.0 114.885 177.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -84.45 136.39 33.86 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 122.13 -0.356 . . . . 0.0 110.457 179.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -155.79 164.31 38.71 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 122.096 -0.378 . . . . 0.0 110.073 178.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -155.19 155.96 34.83 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 122.154 -0.342 . . . . 0.0 110.109 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 85.93 170.25 46.81 Favored Glycine 0 N--CA 1.495 2.603 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 87.9 p -81.09 159.7 24.66 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 122.17 -0.606 . . . . 0.0 110.232 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 76.1 mt -90.26 132.26 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 63.6 ttt180 . . . . . 0 N--CA 1.498 1.939 0 CA-C-O 118.066 -0.969 . . . . 0.0 110.198 179.954 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.304 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_exo -58.35 120.5 8.43 Favored 'Trans proline' 0 N--CA 1.502 1.975 0 O-C-N 123.3 1.158 . . . . 0.0 111.409 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -155.48 78.78 1.02 Allowed 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 -176.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -79.15 86.55 4.95 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.822 -0.549 . . . . 0.0 110.006 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 18.8 m -146.04 120.04 9.4 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.932 -0.48 . . . . 0.0 109.949 177.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 22.0 mt -80.17 148.45 67.44 Favored Pre-proline 0 N--CA 1.5 2.071 0 O-C-N 122.098 -0.376 . . . . 0.0 110.217 -175.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_exo -65.48 127.88 19.04 Favored 'Trans proline' 0 N--CA 1.498 1.757 0 O-C-N 123.279 1.147 . . . . 0.0 110.942 166.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -156.12 51.33 0.53 Allowed 'General case' 0 N--CA 1.498 1.971 0 CA-C-O 121.364 0.602 . . . . 0.0 110.372 164.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 20.8 tp -158.26 114.81 2.81 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.615 -0.678 . . . . 0.0 110.29 -178.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 55.5 tttt -99.79 130.09 45.96 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 178.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 80.1 m -114.62 140.21 49.0 Favored 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -84.5 142.79 29.79 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 176.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 28.1 p -113.88 137.67 51.35 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 122.052 -0.405 . . . . 0.0 110.595 -177.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 28.0 t -122.95 133.05 54.4 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 122.089 -0.382 . . . . 0.0 110.109 178.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.75 -66.26 2.77 Favored Glycine 0 N--CA 1.495 2.586 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 63.9 m170 -110.79 123.34 49.88 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 122.069 -0.665 . . . . 0.0 110.554 -177.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -138.1 136.01 19.14 Favored Pre-proline 0 N--CA 1.496 1.858 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 175.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -60.54 152.69 66.46 Favored 'Trans proline' 0 N--CA 1.496 1.662 0 O-C-N 123.024 1.013 . . . . 0.0 111.201 -170.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -60.36 -28.15 67.95 Favored 'General case' 0 N--CA 1.507 2.377 0 O-C-N 122.04 -0.412 . . . . 0.0 111.365 -172.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -92.32 14.35 16.68 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.985 -0.447 . . . . 0.0 111.763 -178.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.45 162.07 27.47 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.554 -0.716 . . . . 0.0 110.217 -172.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 68.7 mt -126.06 137.59 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -176.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 17.2 p30 37.82 43.31 0.48 Allowed 'General case' 0 N--CA 1.512 2.675 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -175.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 24.9 t30 56.1 42.66 28.08 Favored 'General case' 0 N--CA 1.508 2.457 0 O-C-N 121.805 -0.559 . . . . 0.0 111.451 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 44.3 p -142.02 165.24 27.99 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.765 -0.584 . . . . 0.0 110.555 171.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.6 p -137.8 163.7 30.74 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 122.166 -0.333 . . . . 0.0 110.567 176.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 77.0 mt -112.55 132.57 60.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -175.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.1 t -139.62 152.78 47.06 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.95 -0.469 . . . . 0.0 111.104 -178.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -108.92 31.25 5.82 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 122.116 -0.365 . . . . 0.0 110.432 167.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -124.79 -95.85 1.09 Allowed Glycine 0 N--CA 1.496 2.648 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 176.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 23.3 m80 -146.86 171.91 14.48 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 122.076 -0.661 . . . . 0.0 109.507 177.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 74.8 m -93.78 139.25 31.07 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 166.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -130.41 148.65 52.25 Favored 'General case' 0 N--CA 1.499 2.006 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.49 -178.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -151.9 143.5 23.55 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 177.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 18.3 tt -145.15 149.27 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 122.063 -0.398 . . . . 0.0 110.479 -171.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 15.4 tt -135.75 145.32 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 176.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -148.2 148.49 30.58 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 -169.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.4 tm-20 -101.6 117.51 35.06 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 -175.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -87.38 175.28 8.06 Favored 'General case' 0 N--CA 1.501 2.093 0 CA-C-O 120.796 0.331 . . . . 0.0 110.582 -175.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -60.84 -17.57 50.74 Favored 'General case' 0 N--CA 1.506 2.347 0 O-C-N 121.988 -0.445 . . . . 0.0 111.954 -172.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -92.63 -10.86 35.86 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.678 -0.639 . . . . 0.0 111.801 178.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.54 19.33 45.26 Favored Glycine 0 N--CA 1.497 2.766 0 O-C-N 121.469 -0.769 . . . . 0.0 111.194 177.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -97.2 145.37 26.12 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-N 118.483 1.141 . . . . 0.0 109.818 169.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.9 p -94.72 128.54 41.48 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 122.079 -0.388 . . . . 0.0 110.342 178.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 19.8 p -97.96 116.25 29.79 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 122.134 -0.354 . . . . 0.0 110.354 178.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 14.7 mt -97.42 126.58 42.76 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 122.152 -0.342 . . . . 0.0 110.423 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -145.75 144.82 30.56 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 120.811 -0.355 . . . . 0.0 110.434 175.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 80.1 p -143.72 165.55 27.35 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 176.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -178.02 -166.87 35.17 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 110.226 -1.15 . . . . 0.0 110.226 -178.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 2.7 m -97.32 132.68 42.82 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 122.212 -0.581 . . . . 0.0 110.309 -175.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 47.3 ttm -99.1 123.33 43.32 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 122.028 -0.42 . . . . 0.0 110.197 178.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 23.5 pttm -65.22 172.02 3.37 Favored 'General case' 0 N--CA 1.504 2.241 0 O-C-N 122.049 -0.407 . . . . 0.0 110.642 -178.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -65.49 148.35 51.88 Favored 'General case' 0 N--CA 1.505 2.321 0 O-C-N 122.006 -0.434 . . . . 0.0 110.542 -178.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 69.3 mt-10 -132.7 -45.97 0.88 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 122.143 -0.348 . . . . 0.0 110.268 178.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 108.52 34.31 2.7 Favored Glycine 0 N--CA 1.497 2.735 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 28.2 p -155.79 109.54 2.79 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 122.072 -0.664 . . . . 0.0 109.915 177.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -79.32 -43.58 23.29 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 122.12 -0.363 . . . . 0.0 110.376 -178.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -78.8 -12.16 60.02 Favored 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -174.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -75.32 85.12 2.48 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.729 -0.607 . . . . 0.0 110.278 -172.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 13.4 t -151.21 27.72 0.67 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 122.069 -0.395 . . . . 0.0 110.657 173.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 73.6 mttt -87.61 -169.83 2.76 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.948 -0.47 . . . . 0.0 110.549 -178.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -102.58 120.55 40.73 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 122.053 -0.404 . . . . 0.0 110.218 176.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.0 m -81.66 172.07 10.57 Favored Pre-proline 0 N--CA 1.497 1.89 0 O-C-N 122.057 -0.402 . . . . 0.0 110.3 -173.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -84.95 52.9 3.53 Favored 'Trans proline' 0 N--CA 1.494 1.518 0 O-C-N 123.412 1.217 . . . . 0.0 111.406 173.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 8.8 ptpt -155.74 44.23 0.44 Allowed 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 178.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.46 -171.04 0.57 Allowed 'General case' 0 N--CA 1.5 2.068 0 CA-C-O 121.133 0.492 . . . . 0.0 110.831 -161.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -147.23 -168.96 3.19 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -164.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.9 tp -64.2 164.5 10.85 Favored 'General case' 0 N--CA 1.507 2.393 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 -179.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 79.7 mtm180 -68.19 126.8 30.68 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.725 -0.609 . . . . 0.0 110.33 -162.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 16.9 ptt-85 -161.49 165.35 28.8 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 120.841 0.353 . . . . 0.0 110.332 -174.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 15.2 m -128.56 149.14 50.75 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 173.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.5 tt -143.09 155.77 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 122.064 -0.397 . . . . 0.0 109.976 -179.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -143.02 149.76 38.69 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 120.932 0.396 . . . . 0.0 110.506 -178.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 25.6 p -143.06 137.78 29.46 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -178.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 22.6 p -157.39 131.7 8.4 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.895 -0.503 . . . . 0.0 110.979 -172.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 30.4 ttp180 -105.83 44.81 1.01 Allowed 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 121.285 0.564 . . . . 0.0 110.532 -176.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.0 p -135.19 150.89 50.21 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.929 -0.482 . . . . 0.0 109.931 177.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 17.6 p-10 -62.82 131.81 50.08 Favored 'General case' 0 N--CA 1.504 2.228 0 CA-C-O 121.436 0.636 . . . . 0.0 111.635 -163.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 81.2 mt 51.76 28.13 4.69 Favored 'General case' 0 N--CA 1.506 2.355 0 O-C-N 121.927 -0.483 . . . . 0.0 111.934 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 25.8 p -62.46 -23.85 67.12 Favored 'General case' 0 N--CA 1.506 2.36 0 O-C-N 121.823 -0.548 . . . . 0.0 111.53 173.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -75.31 -30.0 60.22 Favored 'General case' 0 N--CA 1.504 2.241 0 O-C-N 121.811 -0.556 . . . . 0.0 111.046 177.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -62.3 -39.63 93.63 Favored 'General case' 0 N--CA 1.506 2.339 0 O-C-N 121.673 -0.642 . . . . 0.0 110.81 -168.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -100.17 16.11 25.27 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 122.176 -0.328 . . . . 0.0 111.693 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 12.5 tp -116.36 108.95 16.71 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.597 -0.69 . . . . 0.0 110.347 -175.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -99.45 120.72 57.1 Favored Pre-proline 0 N--CA 1.497 1.903 0 CA-C-O 118.955 -0.545 . . . . 0.0 110.125 173.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -68.79 137.41 38.31 Favored 'Trans proline' 0 N--CA 1.49 1.277 0 O-C-N 123.158 1.083 . . . . 0.0 110.157 172.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 34.7 p -139.29 146.8 40.8 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.119 178.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 21.0 mt -71.26 149.58 94.21 Favored Pre-proline 0 N--CA 1.503 2.205 0 C-N-CA 120.685 -0.406 . . . . 0.0 109.94 179.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -68.1 146.51 70.73 Favored 'Trans proline' 0 N--CA 1.491 1.326 0 O-C-N 123.435 1.229 . . . . 0.0 110.273 -178.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -69.11 145.34 60.56 Favored 'Trans proline' 0 N--CA 1.49 1.294 0 O-C-N 123.468 1.246 . . . . 0.0 110.301 -179.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 43.7 t -79.68 165.31 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.214 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 178.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 12.0 p -152.07 137.32 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.999 -0.438 . . . . 0.0 110.18 -178.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 4.5 tp -154.81 68.35 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 CA-C-O 121.186 0.517 . . . . 0.0 110.014 178.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 80.98 -171.06 53.54 Favored Glycine 0 N--CA 1.496 2.666 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -178.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_exo -58.32 144.71 95.7 Favored 'Trans proline' 0 N--CA 1.502 1.985 0 C-N-CA 121.064 1.176 . . . . 0.0 111.37 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -84.92 145.99 27.49 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 122.071 -0.393 . . . . 0.0 110.231 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -155.74 49.88 0.53 Allowed 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.238 0.542 . . . . 0.0 109.913 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -155.25 33.67 0.38 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.806 -0.559 . . . . 0.0 110.275 -179.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 83.83 170.03 45.99 Favored Glycine 0 N--CA 1.496 2.663 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 31.0 t -82.06 140.82 33.67 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 122.171 -0.606 . . . . 0.0 110.197 179.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 50.9 mm -90.65 136.71 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 179.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 . . . . . 0 N--CA 1.497 1.886 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.229 179.839 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.366 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_exo -58.35 117.17 3.84 Favored 'Trans proline' 0 N--CA 1.502 1.989 0 O-C-N 123.355 1.187 . . . . 0.0 111.398 179.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -155.44 78.16 1.0 Allowed 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.204 0.526 . . . . 0.0 109.738 -176.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -78.11 73.87 4.67 Favored 'General case' 0 N--CA 1.502 2.144 0 CA-C-O 121.355 0.598 . . . . 0.0 110.353 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 19.8 m -147.68 121.93 9.59 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.818 -0.551 . . . . 0.0 110.102 179.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 22.8 mt -77.6 151.09 79.93 Favored Pre-proline 0 N--CA 1.502 2.141 0 O-C-N 122.118 -0.364 . . . . 0.0 110.24 -177.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo -63.64 122.99 11.29 Favored 'Trans proline' 0 N--CA 1.499 1.807 0 O-C-N 123.304 1.16 . . . . 0.0 111.19 167.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -161.76 54.21 0.25 Allowed 'General case' 0 N--CA 1.5 2.034 0 CA-C-O 121.359 0.6 . . . . 0.0 110.281 165.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 21.6 tp -157.63 115.47 3.08 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.748 -0.595 . . . . 0.0 109.919 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.3 tptt -99.67 131.1 45.88 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 122.18 -0.325 . . . . 0.0 110.162 -178.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 72.6 m -121.12 140.59 51.78 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -176.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -83.71 144.15 29.56 Favored 'General case' 0 N--CA 1.5 2.033 0 C-N-CA 120.601 -0.44 . . . . 0.0 109.9 176.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 27.1 p -118.57 136.96 53.56 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 122.056 -0.403 . . . . 0.0 110.568 -177.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.4 m -123.0 141.19 52.24 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 122.059 -0.4 . . . . 0.0 110.088 177.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 75.89 -67.14 2.39 Favored Glycine 0 N--CA 1.496 2.636 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -116.68 123.68 47.86 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 122.132 -0.628 . . . . 0.0 110.579 -176.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -138.08 136.75 19.91 Favored Pre-proline 0 N--CA 1.497 1.891 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 174.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -61.31 151.77 76.98 Favored 'Trans proline' 0 N--CA 1.496 1.633 0 O-C-N 123.114 1.06 . . . . 0.0 111.094 -172.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -59.21 -25.72 64.23 Favored 'General case' 0 N--CA 1.507 2.394 0 O-C-N 122.032 -0.418 . . . . 0.0 111.625 -173.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -91.57 14.27 15.47 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.944 -0.473 . . . . 0.0 111.899 -176.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -82.67 161.53 22.12 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.565 -0.71 . . . . 0.0 110.242 -175.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 76.4 mt -125.74 139.38 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -178.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 38.42 42.26 0.52 Allowed 'General case' 0 N--CA 1.513 2.708 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -177.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 55.16 42.37 30.71 Favored 'General case' 0 N--CA 1.509 2.494 0 O-C-N 121.921 -0.487 . . . . 0.0 111.487 -178.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 27.4 p -140.43 157.49 45.44 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.878 -0.514 . . . . 0.0 110.402 172.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.8 p -145.82 165.82 27.75 Favored 'General case' 0 N--CA 1.499 1.988 0 CA-C-O 121.0 0.429 . . . . 0.0 110.718 -172.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 78.0 mt -123.58 120.32 59.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -166.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.9 t -135.8 153.26 51.57 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-O 121.0 0.428 . . . . 0.0 110.965 -174.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 44.3 p-10 -102.57 30.15 4.83 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 122.121 -0.362 . . . . 0.0 110.659 170.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -122.45 -108.33 1.97 Allowed Glycine 0 N--CA 1.496 2.658 0 N-CA-C 109.08 -1.608 . . . . 0.0 109.08 172.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -141.18 172.14 13.09 Favored 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -176.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 67.0 m -97.68 139.27 33.82 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 170.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -135.47 155.79 49.96 Favored 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 120.053 -0.659 . . . . 0.0 110.952 -176.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -151.06 150.66 30.98 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 18.4 tt -143.15 149.14 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 CA-C-O 120.904 0.383 . . . . 0.0 110.364 -172.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 16.0 tt -138.01 145.2 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 177.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -150.21 141.18 22.92 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 122.109 -0.369 . . . . 0.0 110.04 -170.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.0 tm-20 -101.69 116.52 32.93 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -86.67 175.25 8.37 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 122.212 -0.305 . . . . 0.0 110.59 -175.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -60.74 -17.5 48.97 Favored 'General case' 0 N--CA 1.506 2.35 0 O-C-N 122.032 -0.417 . . . . 0.0 111.998 -172.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -92.56 -10.8 36.3 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.668 -0.645 . . . . 0.0 111.819 178.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.1 20.95 40.49 Favored Glycine 0 N--CA 1.496 2.641 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 176.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -97.59 142.01 29.93 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-N 118.368 1.084 . . . . 0.0 109.893 169.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 10.9 p -94.84 129.62 41.74 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 122.168 -0.333 . . . . 0.0 110.36 178.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 17.9 p -97.85 112.94 24.66 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 122.147 -0.346 . . . . 0.0 110.324 177.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -97.36 122.31 40.25 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 122.124 -0.36 . . . . 0.0 110.254 179.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -144.99 155.66 43.51 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 122.004 -0.435 . . . . 0.0 110.541 178.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 91.0 p -143.51 162.89 34.66 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 176.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -158.81 -177.76 32.19 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 110.289 -1.124 . . . . 0.0 110.289 -173.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 1.7 m -113.09 115.71 28.74 Favored 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 -169.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 49.8 ttm -95.88 121.93 38.14 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.878 -0.514 . . . . 0.0 110.474 -170.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 22.1 pttt -66.08 171.49 4.55 Favored 'General case' 0 N--CA 1.503 2.209 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.412 175.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -65.7 145.74 55.64 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 122.025 -0.422 . . . . 0.0 110.427 178.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 67.2 mt-10 -143.21 -48.45 0.31 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 122.18 -0.325 . . . . 0.0 110.361 -177.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 143.07 -35.27 1.7 Allowed Glycine 0 N--CA 1.494 2.561 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -178.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 36.6 m -72.99 113.99 10.64 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 122.125 -0.633 . . . . 0.0 110.094 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -76.92 -34.64 57.68 Favored 'General case' 0 N--CA 1.501 2.121 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.114 178.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -155.39 76.03 0.95 Allowed 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.195 0.521 . . . . 0.0 109.868 179.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -155.38 94.37 1.59 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.941 -0.474 . . . . 0.0 109.971 -179.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 14.0 m -125.42 47.6 2.17 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.213 0.53 . . . . 0.0 109.809 177.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 74.6 mttt -78.59 -173.98 3.64 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.917 -0.49 . . . . 0.0 110.435 -174.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -119.21 141.86 48.52 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 176.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.3 m -74.91 145.68 81.62 Favored Pre-proline 0 N--CA 1.5 2.03 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.034 -177.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -77.92 63.16 8.09 Favored 'Trans proline' 0 N--CA 1.493 1.485 0 O-C-N 123.354 1.187 . . . . 0.0 110.578 177.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 37.0 tttp -155.41 42.54 0.44 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.73 -0.606 . . . . 0.0 109.798 179.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -155.73 145.33 21.11 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 109.929 -0.396 . . . . 0.0 109.929 178.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 44.5 tt0 -109.93 75.89 0.96 Allowed 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 121.334 0.587 . . . . 0.0 110.176 -179.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 17.9 tp -155.1 149.63 26.3 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.851 -0.531 . . . . 0.0 110.105 177.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 18.5 mmt180 -98.68 124.69 43.66 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 122.067 -0.395 . . . . 0.0 110.0 178.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 30.1 ptt180 -161.55 165.06 29.07 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 122.064 -0.398 . . . . 0.0 110.7 -178.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 24.3 m -133.95 149.39 51.25 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 177.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.6 tt -141.75 156.06 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 122.017 -0.427 . . . . 0.0 109.94 -178.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 51.6 mm-40 -143.86 151.43 39.87 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 122.146 -0.346 . . . . 0.0 110.615 -176.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 99.0 m -142.89 149.37 38.41 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 176.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 15.4 p -157.51 141.31 15.86 Favored 'General case' 0 N--CA 1.502 2.155 0 CA-C-O 121.07 0.462 . . . . 0.0 110.951 -173.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 68.8 mtp180 -110.55 49.51 0.85 Allowed 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.377 0.608 . . . . 0.0 110.693 -169.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.1 p -148.66 152.26 36.38 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.793 -0.567 . . . . 0.0 109.966 178.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -60.96 132.02 52.52 Favored 'General case' 0 N--CA 1.507 2.376 0 O-C-N 121.646 -0.659 . . . . 0.0 111.81 -163.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 69.1 mt 52.49 26.03 3.97 Favored 'General case' 0 N--CA 1.507 2.387 0 O-C-N 122.085 -0.385 . . . . 0.0 111.925 179.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 26.1 p -62.71 -21.97 66.18 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 121.853 -0.529 . . . . 0.0 111.762 177.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -90.09 -22.9 21.57 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.748 -0.595 . . . . 0.0 111.275 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -60.45 -38.9 85.62 Favored 'General case' 0 N--CA 1.509 2.488 0 O-C-N 121.58 -0.7 . . . . 0.0 110.775 -175.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -101.37 16.25 26.2 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 122.104 -0.373 . . . . 0.0 111.73 179.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 15.5 tp -110.53 113.54 26.25 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.567 -0.708 . . . . 0.0 110.38 -174.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 -96.83 120.76 61.1 Favored Pre-proline 0 N--CA 1.497 1.911 0 CA-C-O 118.803 -0.617 . . . . 0.0 109.989 172.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -68.34 133.89 29.58 Favored 'Trans proline' 0 N--CA 1.491 1.364 0 O-C-N 123.273 1.144 . . . . 0.0 110.408 176.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 32.7 p -98.84 125.32 44.19 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 122.098 -0.376 . . . . 0.0 110.428 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 15.7 mt -72.79 155.1 91.01 Favored Pre-proline 0 N--CA 1.501 2.102 0 CA-C-O 119.282 -0.39 . . . . 0.0 110.097 176.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -68.2 159.08 54.71 Favored 'Trans proline' 0 N--CA 1.491 1.365 0 O-C-N 123.455 1.239 . . . . 0.0 110.302 -178.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -64.01 147.68 91.7 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 O-C-N 123.384 1.202 . . . . 0.0 110.728 179.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 43.4 t -79.53 165.29 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.162 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 11.8 p -152.19 146.6 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 122.071 -0.393 . . . . 0.0 110.105 -178.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 7.1 tp -151.62 131.18 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 122.131 -0.355 . . . . 0.0 110.123 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 111.05 168.59 18.97 Favored Glycine 0 N--CA 1.496 2.687 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 178.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_exo -58.2 142.23 97.11 Favored 'Trans proline' 0 N--CA 1.501 1.97 0 C-N-CA 121.078 1.185 . . . . 0.0 111.431 -179.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -85.77 130.24 34.61 Favored 'General case' 0 N--CA 1.501 2.096 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.303 -179.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -155.74 47.73 0.5 Allowed 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 121.108 0.48 . . . . 0.0 109.787 178.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -155.28 173.14 17.05 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.981 -0.449 . . . . 0.0 110.314 -178.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 101.38 -35.57 4.81 Favored Glycine 0 N--CA 1.496 2.681 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 87.2 p -80.15 157.94 26.47 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 122.082 -0.658 . . . . 0.0 110.237 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 76.1 mt -90.37 136.77 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 63.9 ttt180 . . . . . 0 N--CA 1.499 2.016 0 CA-C-O 118.081 -0.961 . . . . 0.0 110.12 179.76 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.376 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_exo -58.5 120.16 7.86 Favored 'Trans proline' 0 N--CA 1.501 1.913 0 O-C-N 123.411 1.216 . . . . 0.0 111.379 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -90.13 47.25 1.43 Allowed 'General case' 0 N--CA 1.502 2.165 0 CA-C-O 121.163 0.506 . . . . 0.0 110.685 179.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -76.8 84.67 3.4 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.631 -0.668 . . . . 0.0 109.79 -176.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 22.0 m -128.88 110.51 12.18 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.982 -0.449 . . . . 0.0 110.08 177.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 74.1 mt -142.47 118.9 6.94 Favored Pre-proline 0 N--CA 1.498 1.93 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -179.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -59.82 144.98 99.36 Favored 'Trans proline' 0 N--CA 1.503 2.047 0 O-C-N 123.016 1.009 . . . . 0.0 111.268 -177.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -153.38 49.84 0.7 Allowed 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.882 -0.511 . . . . 0.0 110.677 178.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 19.7 tp -159.94 114.97 2.34 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.821 -0.549 . . . . 0.0 110.112 -176.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 50.9 tttt -99.86 130.87 46.09 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 122.151 -0.343 . . . . 0.0 110.158 178.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 85.8 m -117.01 140.39 49.54 Favored 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 -178.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -83.83 145.91 28.4 Favored 'General case' 0 N--CA 1.501 2.082 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.16 178.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 27.8 p -118.26 137.03 53.32 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 122.086 -0.384 . . . . 0.0 110.457 178.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 29.3 t -123.03 120.22 32.68 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 122.025 -0.422 . . . . 0.0 110.145 177.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 82.35 -62.77 4.53 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -103.89 112.05 24.85 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 122.03 -0.688 . . . . 0.0 110.486 -177.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -138.09 137.51 21.23 Favored Pre-proline 0 N--CA 1.497 1.915 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 176.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -60.97 151.85 75.13 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 O-C-N 123.114 1.06 . . . . 0.0 111.101 -174.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -60.35 -28.1 67.91 Favored 'General case' 0 N--CA 1.507 2.414 0 O-C-N 121.896 -0.503 . . . . 0.0 111.439 -172.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -92.28 14.36 16.59 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.921 -0.487 . . . . 0.0 111.749 -177.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.16 161.99 26.95 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.706 -0.621 . . . . 0.0 110.293 -173.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 76.1 mt -125.92 139.85 50.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 -177.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 38.88 42.75 0.68 Allowed 'General case' 0 N--CA 1.513 2.686 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -178.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 30.7 m120 54.96 43.0 30.59 Favored 'General case' 0 N--CA 1.508 2.452 0 O-C-N 121.838 -0.538 . . . . 0.0 111.496 -178.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 40.3 p -144.01 161.99 37.34 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.881 -0.512 . . . . 0.0 110.535 173.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.5 p -139.75 165.0 28.45 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 120.837 0.351 . . . . 0.0 110.666 179.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 77.4 mt -112.07 131.86 62.33 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -175.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.0 t -140.37 152.86 46.11 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 122.041 -0.412 . . . . 0.0 111.065 -178.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 40.1 p-10 -109.28 29.38 7.59 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 122.109 -0.369 . . . . 0.0 110.711 167.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -122.03 -92.79 1.18 Allowed Glycine 0 N--CA 1.496 2.65 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 177.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -149.86 172.04 15.8 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 122.099 -0.647 . . . . 0.0 109.574 176.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 75.9 m -94.01 139.17 31.27 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 166.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -129.11 153.22 47.87 Favored 'General case' 0 N--CA 1.499 1.997 0 C-N-CA 120.338 -0.545 . . . . 0.0 110.635 -178.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -151.24 143.39 24.03 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 176.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 18.1 tt -143.12 149.26 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.277 -172.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 14.9 tt -138.35 145.32 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 -179.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -148.71 145.76 27.81 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 -169.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.6 tm-20 -101.62 118.22 36.5 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 122.142 -0.349 . . . . 0.0 110.089 -176.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 52.1 p30 -87.17 175.29 8.14 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 122.21 -0.306 . . . . 0.0 110.601 -175.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -60.39 -17.93 47.11 Favored 'General case' 0 N--CA 1.508 2.43 0 O-C-N 122.025 -0.422 . . . . 0.0 111.988 -173.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -92.74 -10.47 36.94 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.689 -0.632 . . . . 0.0 111.921 178.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.08 21.03 40.21 Favored Glycine 0 N--CA 1.498 2.776 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 177.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -97.29 142.8 28.74 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 118.41 1.105 . . . . 0.0 109.823 170.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.1 p -94.83 125.67 39.65 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.249 177.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.2 p -97.89 112.95 24.68 Favored 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 120.877 -0.329 . . . . 0.0 110.296 177.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.4 mp -97.51 127.2 43.28 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 122.157 -0.339 . . . . 0.0 110.313 -178.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -142.79 145.36 33.17 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 122.021 -0.424 . . . . 0.0 110.329 177.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 88.1 p -143.53 166.53 24.55 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 177.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -179.72 -165.77 34.26 Favored Glycine 0 N--CA 1.497 2.736 0 N-CA-C 110.239 -1.145 . . . . 0.0 110.239 -178.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 3.7 m -96.66 132.11 42.64 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 122.226 -0.573 . . . . 0.0 110.343 -175.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 53.5 ttm -98.62 121.82 41.04 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.1 176.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.3 ptpp? -68.09 155.32 39.82 Favored 'General case' 0 N--CA 1.504 2.233 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.398 -178.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 55.9 t80 -66.51 146.53 54.42 Favored 'General case' 0 N--CA 1.504 2.231 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.275 178.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -151.44 -34.8 0.14 Allowed 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -179.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 137.73 50.44 0.06 OUTLIER Glycine 0 N--CA 1.495 2.568 0 N-CA-C 111.555 -0.618 . . . . 0.0 111.555 -178.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.4 m -155.5 113.21 3.35 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 122.219 -0.577 . . . . 0.0 109.842 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -74.44 -40.31 62.02 Favored 'General case' 0 N--CA 1.503 2.182 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.292 -179.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -155.68 31.49 0.36 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 122.168 -0.333 . . . . 0.0 110.373 177.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -77.48 83.99 3.89 Favored 'General case' 0 N--CA 1.501 2.112 0 CA-C-O 121.12 0.486 . . . . 0.0 110.059 -178.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 93.2 m -117.49 42.2 2.64 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.264 0.554 . . . . 0.0 109.753 176.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -78.71 -169.89 1.91 Allowed 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.92 -0.487 . . . . 0.0 110.426 -175.002 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -97.16 -170.02 1.96 Allowed 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 169.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.1 m -155.63 176.7 2.4 Favored Pre-proline 0 N--CA 1.493 1.697 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 -178.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -82.38 56.56 5.8 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 O-C-N 123.38 1.2 . . . . 0.0 111.149 167.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 46.9 pttt -155.76 49.39 0.52 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.666 -0.647 . . . . 0.0 109.397 177.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.65 177.41 1.6 Allowed 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.999 -0.438 . . . . 0.0 110.564 -168.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -154.99 -169.48 3.2 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 -167.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.2 tp -64.54 162.31 15.67 Favored 'General case' 0 N--CA 1.507 2.418 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 177.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 79.4 mtp180 -68.33 129.27 39.42 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.807 -0.558 . . . . 0.0 110.346 -166.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 46.5 ptt85 -161.48 165.3 28.88 Favored 'General case' 0 N--CA 1.496 1.825 0 CA-C-O 120.771 0.32 . . . . 0.0 110.509 -175.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 17.1 m -129.47 149.09 51.4 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 174.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.5 tt -143.09 155.91 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.993 -0.442 . . . . 0.0 110.135 -177.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -146.53 152.1 38.42 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 120.834 0.35 . . . . 0.0 110.632 -178.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 26.9 p -143.01 148.3 36.54 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 177.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 14.9 p -157.56 137.51 12.44 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.919 -0.488 . . . . 0.0 111.171 -173.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 44.9 ttt85 -107.91 53.01 0.7 Allowed 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 121.356 0.598 . . . . 0.0 110.604 -173.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.0 p -148.38 151.99 36.24 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.765 -0.584 . . . . 0.0 109.92 175.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 16.5 p30 -61.76 133.46 55.55 Favored 'General case' 0 N--CA 1.505 2.295 0 CA-C-O 121.444 0.64 . . . . 0.0 111.74 -164.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 72.8 mt 52.08 26.5 3.85 Favored 'General case' 0 N--CA 1.506 2.363 0 O-C-N 121.949 -0.469 . . . . 0.0 111.962 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 25.9 p -63.22 -21.92 66.54 Favored 'General case' 0 N--CA 1.506 2.338 0 O-C-N 121.889 -0.507 . . . . 0.0 111.7 176.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -92.29 -22.89 19.49 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.761 -0.587 . . . . 0.0 111.275 178.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -60.52 -37.17 80.29 Favored 'General case' 0 N--CA 1.506 2.338 0 O-C-N 121.433 -0.792 . . . . 0.0 110.762 -177.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -100.6 16.16 25.72 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 122.085 -0.384 . . . . 0.0 111.616 177.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 17.6 tp -112.19 113.48 25.76 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.675 -0.641 . . . . 0.0 110.346 -174.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -96.72 120.65 61.5 Favored Pre-proline 0 N--CA 1.496 1.863 0 CA-C-O 118.827 -0.606 . . . . 0.0 110.073 173.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -70.19 148.07 61.52 Favored 'Trans proline' 0 N--CA 1.49 1.293 0 O-C-N 123.122 1.064 . . . . 0.0 110.283 175.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 34.9 p -139.19 149.95 45.0 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 122.028 -0.42 . . . . 0.0 110.123 178.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 15.9 mt -71.9 149.89 92.68 Favored Pre-proline 0 N--CA 1.503 2.177 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.112 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -69.9 160.26 50.29 Favored 'Trans proline' 0 N--CA 1.489 1.214 0 O-C-N 123.472 1.248 . . . . 0.0 110.237 178.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -67.91 149.94 77.99 Favored 'Trans proline' 0 N--CA 1.491 1.355 0 O-C-N 123.512 1.27 . . . . 0.0 110.306 178.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 42.6 t -79.27 165.1 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 -179.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 12.0 p -89.96 145.54 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 122.024 -0.422 . . . . 0.0 110.232 -178.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 17.7 tt -152.08 124.39 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 122.062 -0.399 . . . . 0.0 110.05 179.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 68.55 66.09 2.42 Favored Glycine 0 N--CA 1.496 2.64 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_exo -58.47 135.16 65.89 Favored 'Trans proline' 0 N--CA 1.502 2.009 0 O-C-N 123.433 1.228 . . . . 0.0 111.373 -179.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -86.02 131.49 34.26 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 122.022 -0.424 . . . . 0.0 110.146 178.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 31.8 p90 -71.86 140.85 49.51 Favored 'General case' 0 N--CA 1.501 2.104 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.152 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -155.3 98.11 1.96 Allowed 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -140.69 35.43 1.87 Allowed Glycine 0 N--CA 1.497 2.71 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 27.9 t -155.46 100.49 2.12 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 122.163 -0.61 . . . . 0.0 110.098 179.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 76.3 mt -90.9 129.41 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 10.0 tpp180 . . . . . 0 N--CA 1.499 2.023 0 CA-C-O 118.022 -0.989 . . . . 0.0 110.21 179.527 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.247 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_exo -58.62 123.2 13.03 Favored 'Trans proline' 0 N--CA 1.501 1.944 0 C-N-CA 121.082 1.188 . . . . 0.0 111.3 179.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -90.33 47.32 1.43 Allowed 'General case' 0 N--CA 1.5 2.07 0 CA-C-O 121.102 0.477 . . . . 0.0 110.884 179.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -78.19 80.18 4.62 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.703 -0.623 . . . . 0.0 109.807 -178.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.8 m -107.36 51.06 0.75 Allowed 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.281 0.562 . . . . 0.0 110.113 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 19.7 mt -79.13 119.87 78.67 Favored Pre-proline 0 N--CA 1.501 2.085 0 O-C-N 121.884 -0.51 . . . . 0.0 110.111 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_exo -65.59 131.27 27.26 Favored 'Trans proline' 0 N--CA 1.498 1.791 0 O-C-N 123.12 1.063 . . . . 0.0 111.012 168.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -158.29 52.34 0.43 Allowed 'General case' 0 N--CA 1.501 2.107 0 CA-C-O 121.32 0.581 . . . . 0.0 110.515 164.175 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 21.4 tp -158.22 114.65 2.8 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.656 -0.652 . . . . 0.0 110.23 -179.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -99.77 131.63 45.63 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 122.11 -0.369 . . . . 0.0 110.225 177.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 79.3 m -115.31 140.22 49.3 Favored 'General case' 0 N--CA 1.501 2.077 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 -178.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -84.59 141.34 30.75 Favored 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 176.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 28.1 p -115.01 137.01 52.5 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 122.008 -0.433 . . . . 0.0 110.608 -177.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 49.4 m -122.99 135.58 54.53 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 175.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 75.49 -67.05 2.27 Favored Glycine 0 N--CA 1.495 2.606 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 83.7 t60 -109.2 119.55 39.85 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.99 -0.712 . . . . 0.0 110.576 -176.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -137.99 136.71 19.99 Favored Pre-proline 0 N--CA 1.496 1.868 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 174.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -60.12 151.88 69.65 Favored 'Trans proline' 0 N--CA 1.497 1.714 0 O-C-N 123.04 1.021 . . . . 0.0 111.225 -171.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -60.32 -28.14 67.89 Favored 'General case' 0 N--CA 1.507 2.394 0 O-C-N 121.966 -0.459 . . . . 0.0 111.401 -172.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -92.21 14.34 16.5 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.923 -0.486 . . . . 0.0 111.786 -178.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.46 162.06 26.64 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.606 -0.684 . . . . 0.0 110.348 -172.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 77.4 mt -126.08 140.5 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -177.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 38.68 42.69 0.62 Allowed 'General case' 0 N--CA 1.514 2.743 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -178.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 55.03 42.55 30.87 Favored 'General case' 0 N--CA 1.506 2.372 0 O-C-N 121.841 -0.537 . . . . 0.0 111.47 -179.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 41.5 p -142.96 161.16 38.87 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.89 -0.507 . . . . 0.0 110.465 173.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.3 p -138.46 162.52 34.27 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 120.874 0.369 . . . . 0.0 110.622 177.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 77.5 mt -108.73 132.58 56.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -176.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.9 t -138.74 151.95 47.55 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.989 -0.445 . . . . 0.0 110.936 -179.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.4 p-10 -108.8 29.76 7.15 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 122.143 -0.348 . . . . 0.0 110.64 167.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -125.19 -93.29 0.95 Allowed Glycine 0 N--CA 1.496 2.659 0 N-CA-C 109.286 -1.525 . . . . 0.0 109.286 177.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 42.8 m-70 -148.4 172.06 15.04 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 122.074 -0.662 . . . . 0.0 109.521 177.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 71.9 m -93.32 139.21 30.91 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 165.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 15.6 p90 -129.98 151.38 50.6 Favored 'General case' 0 N--CA 1.499 2.024 0 C-N-CA 120.365 -0.534 . . . . 0.0 110.595 -177.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -151.02 143.68 24.39 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -179.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 18.1 tt -143.82 149.22 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 CA-C-O 120.905 0.383 . . . . 0.0 110.413 -173.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 16.6 tt -133.85 145.23 33.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -146.92 145.17 29.71 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -167.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.7 tm-20 -101.58 118.17 36.4 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -176.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 50.8 p30 -87.45 175.31 8.02 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 122.077 -0.39 . . . . 0.0 110.605 -175.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -60.42 -17.91 47.41 Favored 'General case' 0 N--CA 1.508 2.443 0 O-C-N 122.033 -0.417 . . . . 0.0 111.957 -173.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 84.1 mm-40 -93.27 -9.84 37.62 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.662 -0.649 . . . . 0.0 111.926 178.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 89.4 20.96 42.79 Favored Glycine 0 N--CA 1.499 2.877 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 177.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -97.16 144.39 27.04 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-N 118.427 1.113 . . . . 0.0 109.791 169.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.8 p -94.84 126.31 40.09 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.988 -0.445 . . . . 0.0 110.276 177.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 24.5 p -97.92 122.68 41.33 Favored 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 120.921 -0.312 . . . . 0.0 110.284 178.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 75.2 mt -97.09 127.84 43.45 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 122.119 -0.363 . . . . 0.0 110.289 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -143.0 144.24 32.22 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 122.025 -0.422 . . . . 0.0 110.369 175.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 40.5 p -143.78 167.01 23.31 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 178.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -177.84 -167.25 35.65 Favored Glycine 0 N--CA 1.496 2.691 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 2.0 m -97.4 132.84 42.74 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 122.211 -0.582 . . . . 0.0 110.271 -176.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 54.7 ttm -100.91 129.62 46.8 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 122.039 -0.413 . . . . 0.0 110.279 179.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.6 pttm -64.96 172.04 3.15 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 122.08 -0.388 . . . . 0.0 110.58 177.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -64.93 139.91 58.81 Favored 'General case' 0 N--CA 1.505 2.28 0 C-N-CA 120.781 -0.367 . . . . 0.0 110.597 -177.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 67.5 mt-10 -131.8 -46.26 0.95 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 122.125 -0.359 . . . . 0.0 110.281 179.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 99.75 37.01 4.07 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 85.6 p -155.71 110.83 2.96 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 122.142 -0.622 . . . . 0.0 109.961 177.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -80.17 -48.03 13.78 Favored 'General case' 0 N--CA 1.501 2.092 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.41 -177.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -79.67 -21.3 44.92 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 122.078 -0.388 . . . . 0.0 111.7 -174.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 90.9 mm-40 -73.63 84.76 1.58 Allowed 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 121.207 0.527 . . . . 0.0 110.249 -172.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 95.0 m -139.17 33.31 2.12 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.964 -0.46 . . . . 0.0 110.089 174.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 47.2 mttp -81.23 169.4 17.38 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 122.049 -0.407 . . . . 0.0 110.352 -176.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -109.13 114.71 28.66 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 122.144 -0.347 . . . . 0.0 110.309 179.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.9 m -78.12 149.17 76.03 Favored Pre-proline 0 N--CA 1.5 2.047 0 O-C-N 122.121 -0.362 . . . . 0.0 110.078 179.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -82.23 56.49 5.81 Favored 'Trans proline' 0 N--CA 1.495 1.561 0 O-C-N 123.358 1.189 . . . . 0.0 110.855 174.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 30.8 pttt -155.69 49.0 0.52 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.661 -0.65 . . . . 0.0 109.782 -177.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -155.56 -169.51 3.14 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.93 -0.481 . . . . 0.0 110.492 -168.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -64.71 -169.26 0.04 OUTLIER 'General case' 0 N--CA 1.504 2.248 0 CA-C-O 120.959 0.409 . . . . 0.0 110.413 -174.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 9.4 tp -64.45 173.61 2.03 Favored 'General case' 0 N--CA 1.507 2.377 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 -170.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -68.23 148.94 50.13 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.504 -0.748 . . . . 0.0 110.318 -163.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 44.6 ptt85 -161.48 165.25 28.96 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 120.954 0.406 . . . . 0.0 110.711 -171.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 13.6 m -124.95 149.12 47.98 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 169.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.2 tt -143.09 154.57 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 C-N-CA 120.537 -0.465 . . . . 0.0 110.326 -172.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -147.26 154.68 41.28 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 120.811 0.339 . . . . 0.0 110.573 -178.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 26.6 p -143.05 151.9 41.3 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 177.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 20.3 p -157.6 134.49 10.03 Favored 'General case' 0 N--CA 1.502 2.152 0 CA-C-O 120.976 0.417 . . . . 0.0 110.77 -174.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 40.8 ttp85 -107.37 49.38 0.81 Allowed 'General case' 0 N--CA 1.497 1.907 0 CA-C-O 121.384 0.611 . . . . 0.0 110.661 -173.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.2 p -143.41 151.5 40.45 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.759 -0.588 . . . . 0.0 109.863 177.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 15.8 p30 -62.24 132.57 53.15 Favored 'General case' 0 N--CA 1.506 2.359 0 CA-C-O 121.406 0.622 . . . . 0.0 111.684 -164.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 76.5 mt 52.24 27.31 4.6 Favored 'General case' 0 N--CA 1.506 2.357 0 O-C-N 121.976 -0.453 . . . . 0.0 111.961 179.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 25.7 p -62.75 -23.32 67.14 Favored 'General case' 0 N--CA 1.507 2.42 0 O-C-N 121.852 -0.53 . . . . 0.0 111.624 174.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -73.73 -29.86 62.49 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.735 -0.603 . . . . 0.0 111.043 178.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -62.11 -39.55 92.91 Favored 'General case' 0 N--CA 1.505 2.318 0 O-C-N 121.653 -0.655 . . . . 0.0 110.855 -169.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -100.83 16.17 26.0 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 122.073 -0.392 . . . . 0.0 111.75 -178.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 15.9 tp -114.19 108.98 17.68 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.635 -0.665 . . . . 0.0 110.367 -175.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -98.15 120.82 58.94 Favored Pre-proline 0 N--CA 1.497 1.876 0 CA-C-O 118.943 -0.551 . . . . 0.0 110.102 174.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -70.99 143.37 44.73 Favored 'Trans proline' 0 N--CA 1.49 1.313 0 O-C-N 123.142 1.075 . . . . 0.0 110.343 174.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 35.1 p -139.16 150.01 45.12 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 122.154 -0.341 . . . . 0.0 110.095 178.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 15.0 mt -70.54 153.28 95.1 Favored Pre-proline 0 N--CA 1.502 2.172 0 O-C-N 122.02 -0.425 . . . . 0.0 110.066 -179.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -68.06 155.23 70.36 Favored 'Trans proline' 0 N--CA 1.492 1.405 0 O-C-N 123.599 1.315 . . . . 0.0 110.307 -178.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -64.21 169.77 10.25 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 O-C-N 123.373 1.196 . . . . 0.0 110.671 178.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 43.5 t -78.36 164.97 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 76.6 t -146.28 131.27 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -177.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 7.8 tp -89.75 124.15 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 122.121 -0.362 . . . . 0.0 110.119 173.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -65.07 -56.41 16.22 Favored Glycine 0 N--CA 1.499 2.852 0 N-CA-C 109.974 -1.25 . . . . 0.0 109.974 179.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_exo -58.87 152.89 54.35 Favored 'Trans proline' 0 N--CA 1.501 1.944 0 C-N-CA 121.042 1.161 . . . . 0.0 111.204 173.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -155.16 160.29 40.8 Favored 'General case' 0 N--CA 1.498 1.932 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.533 -178.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -155.82 175.3 14.11 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 178.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -80.08 109.12 14.23 Favored 'General case' 0 N--CA 1.502 2.126 0 CA-C-O 121.056 0.455 . . . . 0.0 110.354 -179.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -150.1 60.85 0.42 Allowed Glycine 0 N--CA 1.495 2.567 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 52.3 m -79.96 137.48 36.86 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 122.098 -0.648 . . . . 0.0 110.311 -178.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 76.3 mt -91.06 135.89 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 38.5 tpt85 . . . . . 0 N--CA 1.496 1.862 0 CA-C-O 118.003 -0.999 . . . . 0.0 110.258 179.748 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.373 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -58.5 123.25 13.16 Favored 'Trans proline' 0 N--CA 1.501 1.918 0 C-N-CA 121.099 1.199 . . . . 0.0 111.362 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -90.16 47.53 1.46 Allowed 'General case' 0 N--CA 1.502 2.134 0 CA-C-O 121.134 0.492 . . . . 0.0 110.652 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -76.76 84.38 3.37 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.653 -0.654 . . . . 0.0 109.783 -177.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 22.2 m -133.74 114.89 13.93 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.998 -0.439 . . . . 0.0 110.13 179.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 75.1 mt -142.42 145.85 36.6 Favored Pre-proline 0 N--CA 1.497 1.879 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 178.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -59.23 142.5 99.26 Favored 'Trans proline' 0 N--CA 1.504 2.14 0 O-C-N 123.273 1.144 . . . . 0.0 111.369 -179.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -156.32 48.19 0.47 Allowed 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 121.067 0.46 . . . . 0.0 110.872 176.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 18.5 tp -161.35 116.06 2.04 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.805 -0.56 . . . . 0.0 110.388 -173.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -99.81 133.66 43.85 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 122.214 -0.304 . . . . 0.0 110.21 176.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 64.3 m -120.82 140.34 51.87 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 -179.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -82.37 148.21 28.39 Favored 'General case' 0 N--CA 1.501 2.085 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.061 177.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 27.9 p -117.06 137.02 52.54 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.982 -0.448 . . . . 0.0 110.565 -179.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.0 m -123.02 139.25 54.27 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 176.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 75.06 -67.27 2.11 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -114.34 127.51 55.89 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 122.086 -0.655 . . . . 0.0 110.565 -177.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -138.04 136.93 20.14 Favored Pre-proline 0 N--CA 1.497 1.897 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 174.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -60.74 151.91 73.34 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 O-C-N 123.044 1.023 . . . . 0.0 111.142 -172.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -60.26 -28.09 67.76 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 121.966 -0.459 . . . . 0.0 111.476 -172.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -92.13 14.29 16.47 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 122.019 -0.426 . . . . 0.0 111.817 -177.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.93 162.07 26.25 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.602 -0.686 . . . . 0.0 110.33 -172.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 75.0 mt -125.29 138.14 55.34 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -178.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 38.84 43.0 0.69 Allowed 'General case' 0 N--CA 1.512 2.65 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -178.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 55.09 41.85 31.34 Favored 'General case' 0 N--CA 1.507 2.418 0 O-C-N 121.817 -0.552 . . . . 0.0 111.484 -178.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 70.9 p -140.25 161.02 38.67 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.857 -0.527 . . . . 0.0 110.314 173.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.3 p -140.65 165.12 28.34 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 120.874 0.369 . . . . 0.0 110.606 -179.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 77.2 mt -114.36 132.45 63.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -174.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.1 t -145.27 155.81 43.45 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 122.024 -0.423 . . . . 0.0 111.112 -179.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 41.4 p-10 -111.53 28.42 8.76 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 122.072 -0.393 . . . . 0.0 110.944 167.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -113.32 -95.39 2.16 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 109.105 -1.598 . . . . 0.0 109.105 173.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 76.0 m-70 -149.45 172.05 15.59 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 122.106 -0.643 . . . . 0.0 109.546 175.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 79.4 m -93.09 139.12 30.89 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 167.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 19.4 p90 -128.72 151.19 49.82 Favored 'General case' 0 N--CA 1.499 2.019 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.745 -178.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -151.25 141.83 22.63 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 173.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 18.1 tt -141.84 149.11 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 CA-C-O 120.979 0.419 . . . . 0.0 110.488 -170.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 15.9 tt -136.07 145.07 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 177.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -150.15 139.23 21.11 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 122.118 -0.364 . . . . 0.0 110.084 -169.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.2 tm-20 -101.8 116.18 32.15 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 51.2 p30 -85.74 175.25 8.81 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 122.097 -0.377 . . . . 0.0 110.494 -175.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -60.13 -17.48 40.68 Favored 'General case' 0 N--CA 1.507 2.415 0 O-C-N 121.976 -0.452 . . . . 0.0 112.006 -174.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -92.13 -11.07 36.65 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.607 -0.683 . . . . 0.0 111.9 178.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.18 21.09 36.51 Favored Glycine 0 N--CA 1.497 2.731 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 177.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -96.28 139.06 32.96 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-N 118.373 1.086 . . . . 0.0 109.799 171.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.8 p -94.87 124.53 38.96 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 122.141 -0.349 . . . . 0.0 110.335 176.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.2 p -97.99 114.49 26.64 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 122.138 -0.351 . . . . 0.0 110.366 178.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 24.8 mt -97.4 126.6 42.74 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 122.173 -0.329 . . . . 0.0 110.275 178.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -146.7 144.77 29.68 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 122.021 -0.424 . . . . 0.0 110.627 176.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 86.4 p -143.81 167.03 23.26 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 175.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 174.2 -164.24 35.35 Favored Glycine 0 N--CA 1.497 2.734 0 N-CA-C 110.33 -1.108 . . . . 0.0 110.33 179.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 4.5 m -95.95 133.14 40.5 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 122.316 -0.52 . . . . 0.0 110.302 -175.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 49.1 ttm -99.51 121.66 41.48 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 174.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 33.4 pttt -69.85 163.36 26.05 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 122.032 -0.417 . . . . 0.0 110.518 -178.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -65.95 126.36 28.3 Favored 'General case' 0 N--CA 1.502 2.173 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.329 176.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -127.29 26.52 6.01 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 122.032 -0.418 . . . . 0.0 111.176 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 98.78 -37.42 3.5 Favored Glycine 0 N--CA 1.496 2.663 0 N-CA-C 110.086 -1.206 . . . . 0.0 110.086 178.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 15.7 m -73.14 126.31 29.73 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 122.1 -0.647 . . . . 0.0 110.245 -175.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -76.6 -42.95 40.64 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 174.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -155.78 30.85 0.36 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 122.116 -0.365 . . . . 0.0 110.435 175.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -78.33 84.11 4.53 Favored 'General case' 0 N--CA 1.5 2.072 0 CA-C-O 121.22 0.533 . . . . 0.0 110.059 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 31.7 t -109.13 45.41 1.05 Allowed 'General case' 0 N--CA 1.497 1.89 0 CA-C-O 121.169 0.509 . . . . 0.0 109.985 179.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -80.3 166.31 21.47 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.851 -0.53 . . . . 0.0 110.376 -178.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -120.91 142.94 49.24 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 175.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 8.4 p -75.48 141.36 73.02 Favored Pre-proline 0 N--CA 1.501 2.125 0 C-N-CA 120.577 -0.449 . . . . 0.0 109.94 -178.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -83.78 56.78 5.31 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 O-C-N 123.176 1.093 . . . . 0.0 111.452 -179.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 63.6 tttt -155.74 35.76 0.36 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.645 -0.66 . . . . 0.0 110.196 174.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -82.71 117.82 22.91 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 122.097 -0.377 . . . . 0.0 110.252 179.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 43.1 tt0 -110.45 49.84 0.83 Allowed 'General case' 0 N--CA 1.498 1.97 0 CA-C-O 121.284 0.564 . . . . 0.0 110.428 -178.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 21.4 tp -155.29 154.55 32.28 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.829 -0.544 . . . . 0.0 109.984 179.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 75.6 mtt85 -77.55 116.0 17.77 Favored 'General case' 0 N--CA 1.501 2.084 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 174.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 48.8 ttp180 -161.33 146.97 14.04 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 120.976 0.417 . . . . 0.0 110.386 -172.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 14.4 m -134.24 149.01 50.94 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 170.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.2 tt -143.24 156.14 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.982 -0.448 . . . . 0.0 110.022 -179.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -143.7 146.45 33.2 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 120.959 0.409 . . . . 0.0 110.39 -179.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 25.3 p -143.09 141.41 31.24 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 -179.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 17.9 p -157.59 135.54 10.82 Favored 'General case' 0 N--CA 1.502 2.152 0 C-N-CA 120.514 -0.475 . . . . 0.0 111.044 -171.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 58.5 ttt180 -107.4 51.42 0.74 Allowed 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.364 0.602 . . . . 0.0 110.569 -175.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 23.6 p -143.23 151.67 40.85 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.778 -0.576 . . . . 0.0 109.861 175.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 15.9 p30 -61.72 132.3 52.75 Favored 'General case' 0 N--CA 1.506 2.355 0 CA-C-O 121.42 0.628 . . . . 0.0 111.772 -163.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 73.9 mt 52.19 26.93 4.23 Favored 'General case' 0 N--CA 1.507 2.403 0 O-C-N 122.036 -0.415 . . . . 0.0 111.891 179.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 26.1 p -63.0 -23.35 67.41 Favored 'General case' 0 N--CA 1.508 2.442 0 O-C-N 121.935 -0.478 . . . . 0.0 111.567 175.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -92.27 -22.81 19.55 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.77 -0.581 . . . . 0.0 111.273 178.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -60.67 -37.85 82.94 Favored 'General case' 0 N--CA 1.508 2.447 0 O-C-N 121.615 -0.678 . . . . 0.0 110.745 -177.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -100.03 16.15 24.93 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 122.135 -0.353 . . . . 0.0 111.709 178.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 14.8 tp -116.22 111.41 20.14 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.661 -0.649 . . . . 0.0 110.362 -174.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 3.1 tp-100 -96.39 120.73 61.84 Favored Pre-proline 0 N--CA 1.496 1.863 0 CA-C-O 118.848 -0.596 . . . . 0.0 110.04 172.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -70.69 141.84 42.42 Favored 'Trans proline' 0 N--CA 1.491 1.372 0 O-C-N 123.213 1.112 . . . . 0.0 110.168 175.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 48.4 p -139.22 150.02 45.04 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 122.135 -0.353 . . . . 0.0 110.138 179.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 15.0 mt -71.22 155.15 93.4 Favored Pre-proline 0 N--CA 1.502 2.164 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.016 179.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -62.36 150.39 87.37 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 O-C-N 123.356 1.187 . . . . 0.0 110.809 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -67.41 135.34 36.22 Favored 'Trans proline' 0 N--CA 1.492 1.415 0 O-C-N 123.537 1.283 . . . . 0.0 110.506 -176.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 48.9 t -150.66 165.77 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 60.3 t -89.58 120.55 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -179.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 33.7 pt -149.37 47.82 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 CA-C-O 121.195 0.521 . . . . 0.0 109.883 179.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 89.72 87.14 1.3 Allowed Glycine 0 N--CA 1.497 2.7 0 N-CA-C 109.416 -1.473 . . . . 0.0 109.416 -177.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_exo -58.05 147.08 84.76 Favored 'Trans proline' 0 N--CA 1.501 1.939 0 C-N-CA 121.112 1.208 . . . . 0.0 111.414 -178.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -84.84 136.3 33.72 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 122.048 -0.408 . . . . 0.0 110.099 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -72.04 143.83 48.98 Favored 'General case' 0 N--CA 1.501 2.094 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.156 -179.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -155.29 96.87 1.85 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 122.118 -0.364 . . . . 0.0 110.12 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 84.81 -174.19 49.65 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 49.8 m -80.76 153.0 28.03 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 122.149 -0.618 . . . . 0.0 110.181 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 75.7 mt -90.29 134.76 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 54.0 ttt180 . . . . . 0 N--CA 1.496 1.829 0 CA-C-O 118.05 -0.976 . . . . 0.0 110.217 179.91 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.32 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_exo -58.39 120.01 7.63 Favored 'Trans proline' 0 N--CA 1.499 1.828 0 C-N-CA 121.094 1.196 . . . . 0.0 111.461 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -90.35 46.94 1.38 Allowed 'General case' 0 N--CA 1.501 2.083 0 CA-C-O 121.084 0.469 . . . . 0.0 110.94 179.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -80.12 61.24 3.9 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.734 -0.604 . . . . 0.0 110.511 -177.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 21.9 m -132.91 112.46 11.9 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.851 -0.53 . . . . 0.0 110.167 -179.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 72.8 mt -142.56 118.78 6.85 Favored Pre-proline 0 N--CA 1.497 1.916 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -60.44 143.28 99.46 Favored 'Trans proline' 0 N--CA 1.502 2.013 0 O-C-N 123.072 1.038 . . . . 0.0 111.137 -179.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -149.95 46.67 0.93 Allowed 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.159 0.504 . . . . 0.0 110.792 -179.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 15.5 tp -161.15 112.14 1.76 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.882 -0.511 . . . . 0.0 110.272 -173.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 29.2 ttpt -99.74 134.95 41.88 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 122.171 -0.331 . . . . 0.0 110.257 178.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 80.2 m -120.97 140.35 52.0 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 -176.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -82.77 143.16 31.05 Favored 'General case' 0 N--CA 1.501 2.091 0 C-N-CA 120.631 -0.428 . . . . 0.0 109.97 178.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 28.1 p -115.68 136.99 52.52 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 122.0 -0.438 . . . . 0.0 110.576 -178.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.2 m -122.88 138.75 54.57 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 176.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 75.47 -67.35 2.23 Favored Glycine 0 N--CA 1.495 2.626 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 179.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -113.14 122.74 48.44 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 122.035 -0.685 . . . . 0.0 110.522 -176.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -138.08 136.53 19.68 Favored Pre-proline 0 N--CA 1.496 1.826 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 174.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -60.55 152.13 70.53 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 O-C-N 123.075 1.039 . . . . 0.0 111.151 -171.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -60.26 -27.83 67.56 Favored 'General case' 0 N--CA 1.507 2.415 0 O-C-N 121.996 -0.44 . . . . 0.0 111.356 -173.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -92.12 14.26 16.56 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.843 -0.536 . . . . 0.0 111.737 -178.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.8 162.05 26.37 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.62 -0.675 . . . . 0.0 110.334 -173.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 70.9 mt -124.41 136.71 59.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -176.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 19.7 p30 37.95 43.12 0.5 Allowed 'General case' 0 N--CA 1.513 2.704 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -176.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 30.8 m120 55.36 43.41 28.93 Favored 'General case' 0 N--CA 1.508 2.428 0 O-C-N 121.824 -0.547 . . . . 0.0 111.462 -178.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 60.7 p -139.63 161.22 38.05 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.796 -0.565 . . . . 0.0 110.305 171.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.5 p -137.49 162.91 32.43 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 120.766 0.317 . . . . 0.0 110.565 178.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 77.5 mt -111.63 131.79 62.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -175.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.7 t -141.34 153.7 45.27 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.955 -0.465 . . . . 0.0 110.99 -177.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 26.8 p30 -107.57 28.66 7.93 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 122.055 -0.403 . . . . 0.0 110.771 167.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -119.15 -96.58 1.7 Allowed Glycine 0 N--CA 1.497 2.717 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 175.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 74.7 m80 -150.75 170.79 18.37 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 122.125 -0.633 . . . . 0.0 110.14 178.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 72.8 m -94.42 139.36 31.21 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 170.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -131.78 153.41 50.14 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.492 -178.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -152.91 136.01 15.62 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 174.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 18.1 tt -133.57 149.05 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 122.06 -0.4 . . . . 0.0 110.42 -168.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 13.5 tt -136.62 145.04 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -150.25 142.78 24.45 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 -172.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.4 tm-20 -101.63 117.81 35.65 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 -178.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 51.7 p30 -86.84 175.28 8.28 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-O 120.753 0.311 . . . . 0.0 110.551 -175.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -60.31 -17.64 44.2 Favored 'General case' 0 N--CA 1.507 2.414 0 O-C-N 121.915 -0.491 . . . . 0.0 112.1 -173.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -92.87 -11.0 34.64 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.616 -0.677 . . . . 0.0 111.88 178.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.18 21.06 36.59 Favored Glycine 0 N--CA 1.498 2.827 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 177.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -96.82 140.54 31.24 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 118.411 1.106 . . . . 0.0 109.866 170.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 10.9 p -94.86 125.67 39.68 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.304 176.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 17.9 p -97.97 112.92 24.68 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 122.124 -0.36 . . . . 0.0 110.289 177.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.4 mp -98.77 126.67 44.47 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 122.12 -0.363 . . . . 0.0 110.379 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -146.52 145.63 30.23 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 122.098 -0.376 . . . . 0.0 110.402 176.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 98.1 p -143.64 166.91 23.55 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 178.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 177.59 -164.7 33.96 Favored Glycine 0 N--CA 1.497 2.721 0 N-CA-C 110.301 -1.119 . . . . 0.0 110.301 -178.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 2.1 m -95.86 131.68 41.93 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 122.187 -0.596 . . . . 0.0 110.244 -174.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 53.8 ttm -98.75 122.7 42.32 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 122.011 -0.431 . . . . 0.0 110.162 175.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 22.2 pttt -65.61 170.34 5.21 Favored 'General case' 0 N--CA 1.503 2.202 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.552 175.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 54.1 p90 -64.89 126.16 27.12 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 122.055 -0.403 . . . . 0.0 110.576 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -120.7 -46.52 2.35 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 122.171 -0.331 . . . . 0.0 110.352 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 149.65 -35.48 1.02 Allowed Glycine 0 N--CA 1.495 2.619 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 -179.155 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 87.3 p -72.93 122.88 22.39 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 122.039 -0.683 . . . . 0.0 110.157 -178.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -78.34 -34.64 48.37 Favored 'General case' 0 N--CA 1.501 2.114 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.389 -178.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -155.69 50.85 0.55 Allowed 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.161 0.505 . . . . 0.0 110.058 -179.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 60.6 mt-30 -155.5 120.43 4.8 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.89 -0.506 . . . . 0.0 110.218 -176.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 4.6 m -110.75 94.02 4.79 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 173.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -79.96 164.93 23.11 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.938 -0.476 . . . . 0.0 110.589 -174.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -119.44 143.97 47.21 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 174.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.4 m -74.5 141.11 76.11 Favored Pre-proline 0 N--CA 1.5 2.058 0 C-N-CA 120.604 -0.439 . . . . 0.0 109.959 -176.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -77.63 63.5 7.98 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 O-C-N 123.317 1.167 . . . . 0.0 110.613 179.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 15.4 ttmm -155.5 41.1 0.41 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.703 -0.623 . . . . 0.0 109.884 178.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -155.84 140.29 16.79 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 179.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -121.44 91.11 3.45 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 122.031 -0.418 . . . . 0.0 110.126 178.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 20.6 tp -155.07 154.18 32.04 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.994 -0.441 . . . . 0.0 110.099 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 73.4 mtt85 -91.39 118.63 30.7 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 110.062 -0.348 . . . . 0.0 110.062 177.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 30.1 ptt180 -161.36 165.22 29.31 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 122.064 -0.398 . . . . 0.0 110.648 -176.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 18.9 m -133.79 149.13 51.41 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 177.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 17.9 tt -143.27 119.73 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 122.017 -0.427 . . . . 0.0 110.078 -178.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -105.91 149.87 26.17 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 120.824 0.345 . . . . 0.0 110.595 -179.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 90.9 m -143.15 163.16 33.65 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 175.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 12.1 p -157.21 150.99 24.4 Favored 'General case' 0 N--CA 1.501 2.106 0 C-N-CA 120.071 -0.652 . . . . 0.0 111.267 176.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 59.3 ttt180 -99.68 44.49 1.02 Allowed 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.259 0.552 . . . . 0.0 109.826 166.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 34.2 p -144.73 142.7 30.24 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 121.37 0.605 . . . . 0.0 110.6 -175.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 17.8 p-10 -70.98 138.87 50.33 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-O 121.449 0.642 . . . . 0.0 111.544 -162.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 29.5 mt 51.38 27.92 4.03 Favored 'General case' 0 N--CA 1.505 2.302 0 CA-C-N 116.361 -0.381 . . . . 0.0 112.006 174.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 18.3 p -60.11 -32.72 71.25 Favored 'General case' 0 N--CA 1.51 2.541 0 C-N-CA 119.969 -0.693 . . . . 0.0 111.162 174.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -81.77 -22.95 36.9 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 122.1 -0.375 . . . . 0.0 111.45 -168.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -61.52 -39.32 90.6 Favored 'General case' 0 N--CA 1.508 2.435 0 O-C-N 121.658 -0.651 . . . . 0.0 110.717 -174.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -99.75 16.29 24.08 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 122.072 -0.392 . . . . 0.0 111.628 176.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 18.5 tp -108.73 116.73 32.54 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.613 -0.679 . . . . 0.0 110.224 -174.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -95.84 120.63 62.84 Favored Pre-proline 0 N--CA 1.497 1.885 0 CA-C-O 118.766 -0.635 . . . . 0.0 109.955 172.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -70.68 142.26 43.43 Favored 'Trans proline' 0 N--CA 1.491 1.368 0 O-C-N 123.329 1.173 . . . . 0.0 110.289 174.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 49.0 p -139.22 150.09 45.12 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 178.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 44.0 mt -71.22 150.83 94.5 Favored Pre-proline 0 N--CA 1.501 2.111 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.079 179.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -67.94 149.9 77.82 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 O-C-N 123.487 1.256 . . . . 0.0 110.338 -178.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -68.39 152.33 75.44 Favored 'Trans proline' 0 N--CA 1.491 1.368 0 O-C-N 123.482 1.253 . . . . 0.0 110.267 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 43.1 t -79.4 165.37 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 14.6 p -87.12 138.43 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 122.031 -0.418 . . . . 0.0 110.429 -178.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 17.9 tt -152.08 128.13 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 122.143 -0.348 . . . . 0.0 110.154 179.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -97.1 157.47 21.05 Favored Glycine 0 N--CA 1.496 2.638 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_exo -58.7 99.69 0.11 Allowed 'Trans proline' 0 N--CA 1.5 1.908 0 C-N-CA 121.057 1.172 . . . . 0.0 111.444 178.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -155.12 153.49 30.9 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 122.146 -0.346 . . . . 0.0 110.118 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -155.9 125.14 6.19 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -82.69 -39.59 21.79 Favored 'General case' 0 N--CA 1.5 2.032 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.146 -178.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 74.8 37.72 44.13 Favored Glycine 0 N--CA 1.495 2.607 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 87.4 p -80.21 159.31 25.99 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 122.099 -0.648 . . . . 0.0 110.211 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 50.6 mm -90.37 136.8 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 39.2 ttm180 . . . . . 0 N--CA 1.496 1.853 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.234 -179.891 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.25 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_exo -58.32 117.6 4.34 Favored 'Trans proline' 0 N--CA 1.502 1.985 0 O-C-N 123.319 1.168 . . . . 0.0 111.403 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -155.41 79.12 1.03 Allowed 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 -177.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -78.65 87.93 4.57 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.925 -0.485 . . . . 0.0 110.007 179.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.8 m -137.87 117.06 12.62 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.974 -0.454 . . . . 0.0 110.048 177.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 20.4 mt -78.43 151.04 77.44 Favored Pre-proline 0 N--CA 1.502 2.142 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.097 -177.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -64.47 126.26 16.58 Favored 'Trans proline' 0 N--CA 1.497 1.732 0 O-C-N 123.342 1.18 . . . . 0.0 111.14 168.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -158.1 52.24 0.44 Allowed 'General case' 0 N--CA 1.501 2.092 0 CA-C-O 121.434 0.635 . . . . 0.0 110.283 164.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 20.7 tp -158.56 115.22 2.77 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.65 -0.656 . . . . 0.0 110.185 -177.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 49.8 tttt -99.82 133.59 43.96 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 122.162 -0.336 . . . . 0.0 110.236 179.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 77.6 m -121.01 140.44 51.92 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 -178.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -82.23 142.95 31.71 Favored 'General case' 0 N--CA 1.502 2.125 0 C-N-CA 120.581 -0.448 . . . . 0.0 109.958 176.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 27.8 p -115.82 136.99 52.52 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 122.016 -0.428 . . . . 0.0 110.561 -177.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 28.2 t -123.07 134.73 54.24 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 178.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.35 -66.33 2.95 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -111.54 118.42 35.67 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 122.098 -0.648 . . . . 0.0 110.548 -176.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -138.01 135.95 19.2 Favored Pre-proline 0 N--CA 1.495 1.809 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 174.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -61.75 153.84 64.82 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 O-C-N 123.237 1.125 . . . . 0.0 111.105 -170.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -60.2 -27.67 67.36 Favored 'General case' 0 N--CA 1.508 2.465 0 O-C-N 122.01 -0.431 . . . . 0.0 111.44 -173.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -92.22 14.27 16.73 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.964 -0.46 . . . . 0.0 111.737 -177.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.03 162.07 27.0 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.687 -0.633 . . . . 0.0 110.182 -174.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 70.3 mt -124.1 136.14 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -175.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 19.4 p30 37.62 43.36 0.44 Allowed 'General case' 0 N--CA 1.515 2.788 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 -176.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 30.6 t30 56.29 43.07 27.04 Favored 'General case' 0 N--CA 1.507 2.379 0 O-C-N 121.706 -0.621 . . . . 0.0 111.413 -179.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 51.0 p -140.69 163.97 31.45 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.78 -0.575 . . . . 0.0 110.363 171.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.7 p -139.05 164.97 28.37 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 120.955 0.407 . . . . 0.0 110.549 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 77.5 mt -112.62 133.03 59.71 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -175.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.8 t -140.67 152.62 45.51 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 122.022 -0.424 . . . . 0.0 111.163 -178.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -108.78 30.04 6.88 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 122.022 -0.424 . . . . 0.0 110.659 167.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -122.35 -94.81 1.25 Allowed Glycine 0 N--CA 1.496 2.657 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 176.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 27.5 m80 -147.73 171.95 14.86 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 122.042 -0.681 . . . . 0.0 109.429 176.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 78.6 m -93.85 139.0 31.4 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 166.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -129.81 152.27 49.48 Favored 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 120.306 -0.558 . . . . 0.0 110.7 -177.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -150.89 145.4 25.62 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 176.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 18.1 tt -142.07 149.25 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 CA-C-O 120.998 0.428 . . . . 0.0 110.357 -172.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 16.7 tt -136.54 145.19 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 178.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -149.48 138.44 21.19 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 -170.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.3 tm-20 -101.69 116.52 32.91 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 -179.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 24.1 p-10 -86.95 175.34 8.2 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 122.12 -0.363 . . . . 0.0 110.608 -176.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -60.37 -17.27 42.4 Favored 'General case' 0 N--CA 1.508 2.433 0 O-C-N 121.946 -0.471 . . . . 0.0 112.008 -173.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -91.88 -11.41 36.45 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.647 -0.658 . . . . 0.0 111.787 178.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.02 21.03 37.13 Favored Glycine 0 N--CA 1.497 2.754 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 176.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -96.66 141.13 30.28 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 118.263 1.031 . . . . 0.0 109.838 171.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.5 p -94.86 126.63 40.32 Favored 'General case' 0 N--CA 1.499 2.009 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.196 176.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.5 p -98.01 114.51 26.68 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 122.134 -0.354 . . . . 0.0 110.267 177.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 70.7 mt -97.09 127.81 43.42 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 122.149 -0.345 . . . . 0.0 110.297 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -144.68 144.98 31.51 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 122.089 -0.382 . . . . 0.0 110.572 176.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 99.8 p -143.67 166.48 24.74 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 176.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 179.47 -166.27 35.51 Favored Glycine 0 N--CA 1.497 2.731 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 2.2 m -97.24 133.0 42.44 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 122.319 -0.518 . . . . 0.0 110.263 -175.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 47.1 ttm -105.05 121.68 44.3 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 122.135 -0.353 . . . . 0.0 110.146 173.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 12.1 pttt -68.58 156.4 38.14 Favored 'General case' 0 N--CA 1.501 2.085 0 C-N-CA 120.514 -0.474 . . . . 0.0 110.262 174.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 35.2 t80 -68.58 139.71 55.56 Favored 'General case' 0 N--CA 1.501 2.078 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.24 -178.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -154.1 -65.8 0.14 Allowed 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 177.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -145.24 101.79 0.25 Allowed Glycine 0 N--CA 1.496 2.681 0 N-CA-C 108.013 -2.035 . . . . 0.0 108.013 178.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 16.1 m -82.49 -7.2 59.64 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.965 -0.727 . . . . 0.0 110.312 -179.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -81.56 -30.69 32.96 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.561 -0.712 . . . . 0.0 110.95 -174.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -155.55 79.52 1.02 Allowed 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 121.337 0.589 . . . . 0.0 110.305 -179.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -155.28 48.75 0.54 Allowed 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.329 0.585 . . . . 0.0 109.707 178.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 34.0 t -155.09 50.7 0.59 Allowed 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 121.223 0.535 . . . . 0.0 110.097 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.9 mmtp -154.98 -170.41 3.49 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -174.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -129.67 143.29 50.75 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 122.127 -0.358 . . . . 0.0 110.235 178.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.7 t -78.49 144.07 65.0 Favored Pre-proline 0 N--CA 1.499 1.982 0 CA-C-O 119.208 -0.425 . . . . 0.0 110.006 179.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -78.69 61.12 7.91 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 O-C-N 123.24 1.126 . . . . 0.0 110.598 175.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 50.4 tttm -155.5 44.94 0.47 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.795 -0.566 . . . . 0.0 109.928 -178.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -155.56 139.35 16.17 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.971 -0.456 . . . . 0.0 110.019 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -99.51 61.79 1.19 Allowed 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.363 0.601 . . . . 0.0 110.081 -177.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 19.6 tp -144.87 149.21 34.96 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.703 -0.623 . . . . 0.0 110.261 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 -104.89 123.47 47.79 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 122.086 -0.384 . . . . 0.0 110.104 179.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 27.7 ptt180 -161.57 165.15 28.89 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 122.007 -0.433 . . . . 0.0 110.803 -179.121 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 19.1 m -133.66 149.43 51.56 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.3 tt -143.03 155.96 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.964 -0.46 . . . . 0.0 110.21 -177.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 52.1 mm-40 -143.65 152.01 40.82 Favored 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 120.901 -0.32 . . . . 0.0 110.613 -176.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 26.7 p -143.12 144.47 32.24 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 178.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 20.1 p -157.7 133.85 9.48 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.991 -0.443 . . . . 0.0 110.792 -175.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 31.6 ttp180 -106.25 47.21 0.89 Allowed 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.26 0.552 . . . . 0.0 110.659 -173.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.1 p -139.36 152.14 46.92 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.95 -0.469 . . . . 0.0 109.829 176.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 17.5 p-10 -61.35 131.94 51.93 Favored 'General case' 0 N--CA 1.506 2.344 0 CA-C-O 121.373 0.606 . . . . 0.0 111.904 -163.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 72.4 mt 52.22 26.38 3.93 Favored 'General case' 0 N--CA 1.506 2.348 0 O-C-N 122.078 -0.389 . . . . 0.0 112.007 179.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 26.2 p -62.9 -22.22 66.58 Favored 'General case' 0 N--CA 1.507 2.384 0 O-C-N 121.843 -0.536 . . . . 0.0 111.806 176.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -91.71 -22.81 20.02 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.785 -0.572 . . . . 0.0 111.37 179.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -60.29 -37.43 80.47 Favored 'General case' 0 N--CA 1.509 2.491 0 O-C-N 121.682 -0.637 . . . . 0.0 110.717 -175.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -101.41 16.19 26.43 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 122.116 -0.365 . . . . 0.0 111.649 177.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 15.0 tp -111.67 110.24 20.53 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.532 -0.73 . . . . 0.0 110.384 -174.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -97.08 120.76 60.74 Favored Pre-proline 0 N--CA 1.495 1.823 0 CA-C-O 118.94 -0.553 . . . . 0.0 110.063 173.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.4 149.32 50.28 Favored 'Trans proline' 0 N--CA 1.489 1.239 0 O-C-N 123.092 1.048 . . . . 0.0 110.274 175.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 34.1 p -139.13 137.82 36.45 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 122.144 -0.348 . . . . 0.0 110.238 178.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 41.9 mt -72.53 149.7 91.07 Favored Pre-proline 0 N--CA 1.502 2.156 0 C-N-CA 120.669 -0.413 . . . . 0.0 110.151 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -70.34 156.93 60.76 Favored 'Trans proline' 0 N--CA 1.49 1.32 0 O-C-N 123.491 1.258 . . . . 0.0 110.245 179.037 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -64.17 155.09 67.09 Favored 'Trans proline' 0 N--CA 1.494 1.549 0 O-C-N 123.348 1.183 . . . . 0.0 110.675 177.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 48.0 t -150.1 165.52 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 -179.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 11.7 p -152.64 146.89 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 122.05 -0.406 . . . . 0.0 110.04 -179.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 17.8 tt -154.27 73.19 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 -179.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 118.1 -72.06 0.3 Allowed Glycine 0 N--CA 1.496 2.657 0 CA-C-O 119.457 -0.635 . . . . 0.0 112.671 178.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -63.88 148.21 91.88 Favored 'Trans proline' 0 N--CA 1.501 1.939 0 C-N-CA 121.086 1.191 . . . . 0.0 110.06 -179.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -84.2 150.41 25.5 Favored 'General case' 0 N--CA 1.499 2.018 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.261 179.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -73.29 65.32 0.85 Allowed 'General case' 0 N--CA 1.502 2.159 0 CA-C-O 121.295 0.569 . . . . 0.0 110.058 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -85.04 -35.42 21.9 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.737 -0.602 . . . . 0.0 110.726 -177.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -130.79 64.01 0.62 Allowed Glycine 0 N--CA 1.497 2.748 0 C-N-CA 121.087 -0.578 . . . . 0.0 112.958 -173.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 57.8 m -152.47 153.93 34.51 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 122.002 -0.705 . . . . 0.0 110.462 179.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 70.6 mt -87.23 134.13 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 O-C-N 122.039 -0.413 . . . . 0.0 111.102 -178.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 71.1 ttt-85 . . . . . 0 N--CA 1.498 1.94 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.243 179.902 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.29 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo -58.47 120.62 8.61 Favored 'Trans proline' 0 N--CA 1.502 1.977 0 C-N-CA 121.063 1.175 . . . . 0.0 111.34 179.12 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -90.45 47.04 1.39 Allowed 'General case' 0 N--CA 1.501 2.109 0 CA-C-O 121.156 0.503 . . . . 0.0 110.906 179.278 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -78.25 72.38 4.78 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.696 -0.628 . . . . 0.0 110.298 -178.2 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 20.0 m -145.34 120.73 10.3 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.841 -0.537 . . . . 0.0 110.096 179.666 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 21.6 mt -77.45 150.93 80.24 Favored Pre-proline 0 N--CA 1.501 2.091 0 CA-C-O 119.366 -0.35 . . . . 0.0 110.148 -178.934 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -63.99 122.95 11.15 Favored 'Trans proline' 0 N--CA 1.497 1.699 0 O-C-N 123.298 1.157 . . . . 0.0 111.193 168.961 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -157.82 52.53 0.45 Allowed 'General case' 0 N--CA 1.501 2.098 0 CA-C-O 121.363 0.601 . . . . 0.0 110.26 165.082 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 21.1 tp -158.35 114.89 2.79 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.77 -0.581 . . . . 0.0 110.111 -177.858 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 27.9 ttmt -99.74 131.77 45.51 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 122.11 -0.368 . . . . 0.0 110.314 178.989 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 70.0 m -118.25 140.33 49.96 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -178.852 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -82.62 145.83 29.47 Favored 'General case' 0 N--CA 1.501 2.092 0 C-N-CA 120.624 -0.43 . . . . 0.0 109.984 176.255 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 28.0 p -115.15 137.07 52.43 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 122.007 -0.433 . . . . 0.0 110.599 -177.864 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 99.2 p -123.01 144.0 49.56 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 176.598 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.36 -68.22 1.46 Allowed Glycine 0 N--CA 1.495 2.587 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 -179.789 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -116.84 129.59 56.18 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.939 -0.742 . . . . 0.0 110.518 -177.042 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -138.07 136.86 20.02 Favored Pre-proline 0 N--CA 1.496 1.838 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 174.689 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -60.21 151.53 72.7 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 O-C-N 123.078 1.041 . . . . 0.0 111.231 -172.191 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -60.1 -28.21 67.66 Favored 'General case' 0 N--CA 1.507 2.407 0 O-C-N 121.98 -0.45 . . . . 0.0 111.478 -172.595 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -92.11 14.28 16.47 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.981 -0.449 . . . . 0.0 111.794 -177.937 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.85 161.61 26.64 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.674 -0.641 . . . . 0.0 110.277 -173.117 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 75.7 mt -126.08 141.1 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -177.991 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 38.9 41.87 0.58 Allowed 'General case' 0 N--CA 1.512 2.663 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -177.206 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 30.7 m120 54.89 41.55 31.81 Favored 'General case' 0 N--CA 1.508 2.464 0 O-C-N 121.845 -0.535 . . . . 0.0 111.461 -178.955 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 43.7 p -141.65 162.6 35.08 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.82 -0.55 . . . . 0.0 110.376 174.323 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.3 p -139.31 163.49 32.34 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 120.967 0.413 . . . . 0.0 110.555 -179.384 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 77.9 mt -109.43 131.95 58.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -176.189 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.9 t -139.16 152.83 47.73 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.935 -0.478 . . . . 0.0 110.893 179.804 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 26.8 p30 -110.04 31.56 5.78 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 122.046 -0.409 . . . . 0.0 110.575 166.91 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -123.29 -94.71 1.16 Allowed Glycine 0 N--CA 1.497 2.718 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 175.642 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 31.9 m-70 -146.35 172.05 14.07 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 122.056 -0.673 . . . . 0.0 109.513 176.668 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 81.0 m -94.36 139.22 31.38 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 165.161 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 21.3 p90 -127.92 146.44 50.64 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 120.35 -0.54 . . . . 0.0 110.431 -179.199 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -147.61 140.2 24.68 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 174.431 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 18.3 tt -143.09 149.28 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.31 -171.644 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 15.6 tt -137.96 145.26 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 178.09 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -150.2 146.91 27.13 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 122.041 -0.412 . . . . 0.0 110.023 -168.044 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.3 tm-20 -101.69 116.94 33.84 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 122.124 -0.36 . . . . 0.0 110.117 -177.059 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -87.2 175.3 8.12 Favored 'General case' 0 N--CA 1.502 2.148 0 CA-C-O 120.868 0.366 . . . . 0.0 110.536 -175.621 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -60.56 -17.35 45.59 Favored 'General case' 0 N--CA 1.506 2.365 0 O-C-N 121.914 -0.491 . . . . 0.0 112.17 -172.646 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -92.77 -11.6 33.4 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.643 -0.66 . . . . 0.0 111.803 178.172 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.9 20.12 40.87 Favored Glycine 0 N--CA 1.499 2.862 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 177.083 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -97.37 143.88 27.68 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 118.399 1.099 . . . . 0.0 109.806 169.821 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.8 p -94.87 124.99 39.23 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.255 178.014 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 17.8 p -97.94 112.96 24.7 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 120.923 -0.311 . . . . 0.0 110.289 178.223 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.3 mp -98.24 128.53 44.74 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 122.144 -0.347 . . . . 0.0 110.273 -179.91 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -145.87 145.94 30.92 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.347 177.275 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 86.8 p -143.68 165.85 26.5 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 177.015 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 178.4 -164.53 33.22 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 -179.902 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 3.9 m -97.07 132.51 42.8 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 122.185 -0.597 . . . . 0.0 110.384 -175.53 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 49.1 ttm -99.56 121.88 41.82 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.993 -0.442 . . . . 0.0 110.231 176.662 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.3 ptpp? -67.9 152.4 45.62 Favored 'General case' 0 N--CA 1.503 2.219 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.214 178.135 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -67.48 140.62 57.07 Favored 'General case' 0 N--CA 1.502 2.127 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.454 -176.981 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -153.76 -60.12 0.13 Allowed 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 178.818 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -147.51 69.06 0.37 Allowed Glycine 0 N--CA 1.494 2.536 0 N-CA-C 114.529 0.572 . . . . 0.0 114.529 174.068 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 54.7 m -66.27 8.52 0.22 Allowed 'General case' 0 N--CA 1.504 2.232 0 N-CA-C 117.98 2.585 . . . . 0.0 117.98 -168.778 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -74.63 -47.81 29.94 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.489 -0.757 . . . . 0.0 110.129 -175.047 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -156.0 26.44 0.37 Allowed 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 120.654 -0.418 . . . . 0.0 111.524 -175.133 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 62.7 mm-40 -83.23 60.47 5.57 Favored 'General case' 0 N--CA 1.504 2.271 0 CA-C-O 121.353 0.597 . . . . 0.0 111.155 -175.969 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 5.2 t -155.34 24.49 0.41 Allowed 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.46 -0.775 . . . . 0.0 110.929 168.974 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 69.7 mttt -86.84 -171.21 3.41 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.743 -0.598 . . . . 0.0 110.545 -176.504 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -110.44 117.62 34.08 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 122.115 -0.366 . . . . 0.0 110.284 177.904 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 7.0 m -80.02 167.65 31.9 Favored Pre-proline 0 N--CA 1.498 1.964 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.946 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -84.85 52.66 3.5 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 O-C-N 123.296 1.156 . . . . 0.0 111.338 175.201 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 54.0 tttm -155.84 45.66 0.46 Allowed 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.625 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.47 160.27 33.02 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.835 -0.541 . . . . 0.0 111.111 -157.956 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -98.96 -168.91 1.69 Allowed 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -177.42 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.8 tp -64.17 168.59 5.3 Favored 'General case' 0 N--CA 1.508 2.444 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -179.955 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 85.2 mtt180 -68.13 128.52 36.83 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.53 -0.732 . . . . 0.0 110.303 -160.696 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 27.7 ptt180 -161.47 165.19 29.07 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 120.843 0.354 . . . . 0.0 110.401 -170.682 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 18.1 m -131.03 149.04 52.8 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 174.841 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.5 tt -143.13 154.97 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.991 -0.443 . . . . 0.0 110.051 -178.586 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -143.92 125.9 15.36 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 120.842 0.353 . . . . 0.0 110.699 -179.572 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 92.8 m -104.9 147.55 27.64 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 168.63 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 22.9 p -157.76 135.19 10.37 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.858 -0.526 . . . . 0.0 111.031 176.22 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 9.4 ttm180 -108.2 47.04 0.92 Allowed 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 121.29 0.567 . . . . 0.0 110.788 -173.315 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.3 p -141.87 151.93 43.16 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.771 -0.581 . . . . 0.0 110.033 177.713 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 17.5 p-10 -61.69 132.43 53.21 Favored 'General case' 0 N--CA 1.505 2.287 0 CA-C-O 121.339 0.59 . . . . 0.0 111.821 -164.243 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 75.7 mt 52.0 27.13 4.18 Favored 'General case' 0 N--CA 1.506 2.365 0 O-C-N 122.051 -0.406 . . . . 0.0 111.995 179.547 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 25.3 p -62.62 -22.8 66.68 Favored 'General case' 0 N--CA 1.507 2.42 0 O-C-N 121.847 -0.533 . . . . 0.0 111.585 175.419 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -92.82 -22.82 19.09 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.682 -0.636 . . . . 0.0 111.224 178.071 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -61.63 -38.62 88.35 Favored 'General case' 0 N--CA 1.507 2.381 0 O-C-N 121.57 -0.706 . . . . 0.0 110.671 -177.034 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -100.1 16.19 24.89 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 122.113 -0.367 . . . . 0.0 111.596 178.772 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 18.0 tp -112.68 114.31 26.84 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.625 -0.672 . . . . 0.0 110.361 -175.458 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -96.31 120.83 61.78 Favored Pre-proline 0 N--CA 1.496 1.87 0 CA-C-O 118.927 -0.558 . . . . 0.0 109.944 173.022 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -68.81 144.93 60.97 Favored 'Trans proline' 0 N--CA 1.491 1.353 0 O-C-N 123.17 1.089 . . . . 0.0 110.253 175.33 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 47.6 p -139.18 134.15 32.38 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 122.074 -0.391 . . . . 0.0 110.121 179.624 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 17.2 mt -72.48 155.01 91.58 Favored Pre-proline 0 N--CA 1.5 2.035 0 CA-C-O 119.287 -0.387 . . . . 0.0 110.173 179.664 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_exo -63.42 163.05 25.0 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 O-C-N 123.453 1.239 . . . . 0.0 110.725 175.905 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -62.53 121.95 10.12 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 O-C-N 123.372 1.196 . . . . 0.0 110.954 -176.852 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 43.4 t -81.66 167.14 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.196 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -178.674 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 11.7 p -87.55 165.28 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 177.566 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 17.7 tt -146.27 138.58 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 -179.139 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 166.64 -59.94 0.23 Allowed Glycine 0 N--CA 1.496 2.675 0 N-CA-C 118.255 2.062 . . . . 0.0 118.255 -179.803 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_exo -87.09 170.29 7.14 Favored 'Trans proline' 0 N--CA 1.502 1.974 0 N-CA-C 104.385 -2.967 . . . . 0.0 104.385 173.523 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -155.21 159.84 40.4 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 122.115 -0.366 . . . . 0.0 110.365 -179.557 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -155.43 154.17 31.49 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 -177.194 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -155.18 33.65 0.38 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 122.141 -0.35 . . . . 0.0 110.313 -178.846 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -139.75 46.27 0.96 Allowed Glycine 0 N--CA 1.496 2.69 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.267 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 50.6 m -80.59 136.15 36.19 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 122.166 -0.608 . . . . 0.0 110.194 179.809 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 50.9 mm -91.53 140.7 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.577 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 71.3 ttt-85 . . . . . 0 N--CA 1.499 1.98 0 CA-C-O 117.979 -1.01 . . . . 0.0 110.136 179.103 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo . . . . . 0 N--CA 1.503 2.075 0 N-CA-C 111.304 -0.306 . . . . 0.40000000000000002 111.304 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -152.89 49.32 0.73 Allowed 'General case' 0 N--CA 1.498 1.948 0 CA-C-O 121.174 0.511 . . . . 0.64000000000000001 110.699 -178.197 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.443 HD23 HG23 ' A' ' 55' ' ' THR . 23.2 tp -158.82 101.53 1.64 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.811 -0.555 . . . . 0.19 110.601 -176.457 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -99.97 118.18 35.83 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 110.167 -0.308 . . . . 1.51 110.167 176.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 68.0 m -121.71 140.53 52.2 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 122.025 -0.422 . . . . 0.47999999999999998 110.935 -178.034 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -78.52 150.54 32.87 Favored 'General case' 0 N--CA 1.501 2.094 0 C-N-CA 120.751 -0.38 . . . . 0.51000000000000001 110.032 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 27.0 p -119.01 140.68 49.62 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 122.044 -0.41 . . . . 0.29999999999999999 110.547 -177.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 30.9 t -123.0 143.14 50.13 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 122.072 -0.392 . . . . 1.6899999999999999 110.155 178.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.63 -69.9 1.43 Allowed Glycine 0 N--CA 1.495 2.606 0 N-CA-C 109.668 -1.373 . . . . 0.77000000000000002 109.668 177.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -115.51 123.83 49.52 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 122.074 -0.662 . . . . 2.8199999999999998 110.544 -176.345 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -138.11 147.7 57.12 Favored Pre-proline 0 N--CA 1.497 1.879 0 N-CA-C 109.386 -0.598 . . . . 0.47999999999999998 109.386 175.356 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -63.8 151.62 84.32 Favored 'Trans proline' 0 N--CA 1.492 1.432 0 O-C-N 123.203 1.107 . . . . 0.41999999999999998 110.864 -174.123 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -59.15 -21.86 60.02 Favored 'General case' 0 N--CA 1.507 2.379 0 O-C-N 121.985 -0.447 . . . . 2.0299999999999998 111.521 177.62 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -96.7 14.15 25.97 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.776 -0.577 . . . . 1.1399999999999999 111.864 -177.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -83.31 162.1 21.22 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.607 -0.683 . . . . 0.34999999999999998 110.466 -173.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 77.5 mt -125.51 142.39 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 N-CA-C 108.873 -0.788 . . . . 0.45000000000000001 108.873 -178.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 38.44 41.58 0.46 Allowed 'General case' 0 N--CA 1.514 2.735 0 N-CA-C 113.271 0.841 . . . . 1.1100000000000001 113.271 -177.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 54.97 41.01 32.24 Favored 'General case' 0 N--CA 1.508 2.459 0 O-C-N 121.802 -0.561 . . . . 1.6499999999999999 111.489 -179.115 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 41.6 p -137.68 160.31 39.57 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.877 -0.514 . . . . 0.22 110.373 173.603 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.3 p -135.75 162.15 33.57 Favored 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 120.957 0.408 . . . . 0.20999999999999999 110.465 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 78.9 mt -129.29 125.91 62.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 108.774 -0.825 . . . . 0.33000000000000002 108.774 -169.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.443 HG23 HD23 ' A' ' 36' ' ' LEU . 9.5 t -140.12 159.21 42.68 Favored 'General case' 0 N--CA 1.5 2.049 0 C-N-CA 120.537 -0.465 . . . . 0.23000000000000001 111.288 -177.605 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 38.1 p-10 -106.59 28.22 8.06 Favored 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 120.856 -0.338 . . . . 0.81999999999999995 110.505 164.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -117.35 -113.86 2.69 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 109.057 -1.617 . . . . 0.23000000000000001 109.057 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 7.8 m-70 -136.75 157.57 46.44 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 108.996 -0.742 . . . . 1.26 108.996 175.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 96.4 m -99.11 139.43 34.77 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 109.31 -0.626 . . . . 0.25 109.31 176.417 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -129.35 158.14 39.96 Favored 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 120.604 -0.438 . . . . 0.23000000000000001 110.726 -170.118 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -151.05 143.39 24.19 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.293 -0.632 . . . . 0.22 109.293 177.11 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.44 HD12 HD12 ' A' ' 99' ' ' ILE . 18.0 tt -142.44 149.18 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 C-N-CA 120.686 -0.405 . . . . 0.29999999999999999 110.477 -170.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.799 HD12 HD11 ' A' ' 73' ' ' LEU . 16.0 tt -138.76 145.2 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 109.502 -0.555 . . . . 0.34000000000000002 109.502 178.438 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -150.1 141.08 22.91 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 109.93 -0.396 . . . . 1.1599999999999999 109.93 -170.082 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.9 tm-20 -101.68 116.29 32.42 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 109.975 -0.379 . . . . 0.35999999999999999 109.975 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -86.73 175.21 8.36 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 122.067 -0.396 . . . . 0.77000000000000002 110.583 -175.227 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -60.49 -17.29 44.3 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 121.995 -0.441 . . . . 1.5900000000000001 112.184 -172.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -92.49 -11.64 34.1 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.601 -0.687 . . . . 2.0 111.83 177.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.82 21.0 37.88 Favored Glycine 0 N--CA 1.497 2.765 0 N-CA-C 111.109 -0.796 . . . . 0.40000000000000002 111.109 176.624 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -97.42 142.42 29.3 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 118.417 1.108 . . . . 1.28 109.8 169.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.1 p -94.88 129.58 41.84 Favored 'General case' 0 N--CA 1.497 1.908 0 C-N-CA 120.797 -0.361 . . . . 0.33000000000000002 110.356 177.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 17.7 p -97.91 113.04 24.76 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 122.128 -0.357 . . . . 0.34000000000000002 110.327 177.318 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.799 HD11 HD12 ' A' ' 63' ' ' ILE . 4.5 mm? -96.77 121.98 39.22 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 110.157 -0.312 . . . . 1.1799999999999999 110.157 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -143.77 148.52 35.73 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 122.098 -0.376 . . . . 0.25 110.486 178.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 96.8 p -143.59 164.15 31.2 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 109.735 -0.469 . . . . 0.17000000000000001 109.735 176.411 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -172.51 -179.05 43.07 Favored Glycine 0 N--CA 1.496 2.688 0 N-CA-C 110.215 -1.154 . . . . 0.23999999999999999 110.215 -177.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 6.2 m -100.21 133.83 44.03 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 122.203 -0.587 . . . . 0.57999999999999996 110.282 -178.389 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 27.5 ttm -99.5 126.96 45.54 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 122.003 -0.436 . . . . 0.39000000000000001 110.114 176.709 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 22.2 pttm . . . . . 0 N--CA 1.503 2.222 0 O-C-N 122.07 -0.394 . . . . 1.6799999999999999 110.485 177.734 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 26.7 ptt-85 . . . . . 0 N--CA 1.498 1.944 0 CA-C-O 120.815 0.341 . . . . 2.21 110.685 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.494 ' OG1' HD23 ' A' ' 115' ' ' LEU . 11.7 m -128.48 149.1 50.73 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 109.676 -0.49 . . . . 0.40000000000000002 109.676 172.384 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.44 HD12 HD12 ' A' ' 62' ' ' ILE . 18.6 tt -143.17 155.96 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 122.04 -0.412 . . . . 0.44 110.098 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -147.48 155.88 42.32 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 120.978 -0.289 . . . . 1.6299999999999999 110.342 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 26.6 p -142.47 157.42 44.78 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 110.113 -0.329 . . . . 1.3700000000000001 110.113 176.375 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 24.4 p -157.55 138.13 12.99 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 122.014 -0.429 . . . . 0.40999999999999998 110.825 -168.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 70.3 mtp180 -112.01 44.57 1.38 Allowed 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 121.213 0.53 . . . . 2.4100000000000001 110.554 -177.347 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.3 p -140.44 153.22 46.21 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.863 -0.523 . . . . 0.27000000000000002 110.276 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 34.7 p-10 -64.51 139.77 58.8 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.817 -0.552 . . . . 1.02 111.233 -170.536 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 17.0 mt 53.15 25.8 4.51 Favored 'General case' 0 N--CA 1.507 2.381 0 O-C-N 121.936 -0.477 . . . . 0.42999999999999999 112.282 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 28.1 p -67.95 -25.3 65.38 Favored 'General case' 0 N--CA 1.503 2.217 0 C-N-CA 119.869 -0.732 . . . . 0.34999999999999998 111.067 172.444 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -81.05 -33.28 33.6 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.888 -0.508 . . . . 1.3700000000000001 110.484 179.357 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 47.0 tt0 -63.35 -41.42 98.84 Favored 'General case' 0 N--CA 1.506 2.328 0 O-C-N 121.968 -0.458 . . . . 1.3300000000000001 110.797 -176.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -102.32 16.21 26.89 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 122.1 -0.375 . . . . 0.64000000000000001 111.9 -174.579 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 12.4 tp -126.16 108.94 11.8 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.601 -0.687 . . . . 0.31 110.397 -176.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -98.3 120.93 58.43 Favored Pre-proline 0 N--CA 1.496 1.864 0 CA-C-O 118.811 -0.614 . . . . 1.8300000000000001 110.032 173.145 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -67.91 136.39 38.17 Favored 'Trans proline' 0 N--CA 1.492 1.424 0 O-C-N 123.18 1.095 . . . . 0.5 110.333 176.447 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 35.0 p -139.25 150.11 45.11 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 122.078 -0.389 . . . . 0.76000000000000001 110.204 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.494 HD23 ' OG1' ' A' ' 98' ' ' THR . 34.8 mt . . . . . 0 N--CA 1.502 2.135 0 C-N-CA 120.692 -0.403 . . . . 0.62 109.961 178.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo . . . . . 0 N--CA 1.498 1.746 0 N-CA-C 111.058 -0.401 . . . . 0.0 111.058 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -157.55 52.86 0.47 Allowed 'General case' 0 N--CA 1.5 2.065 0 CA-C-O 121.358 0.599 . . . . 0.0 110.254 165.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.455 HD23 HG23 ' A' ' 55' ' ' THR . 19.5 tp -158.57 113.98 2.62 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.766 -0.584 . . . . 0.0 109.993 -178.529 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 51.3 tttt -99.82 131.04 46.05 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 110.116 -0.328 . . . . 0.0 110.116 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 74.8 m -115.58 140.27 49.32 Favored 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 -177.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -85.3 145.07 27.7 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 122.155 -0.341 . . . . 0.0 110.098 176.07 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 27.8 p -117.64 137.51 52.59 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.983 -0.448 . . . . 0.0 110.562 -178.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 28.8 t -123.04 117.58 25.78 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 122.109 -0.37 . . . . 0.0 110.156 178.089 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 83.88 -61.74 4.69 Favored Glycine 0 N--CA 1.496 2.655 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -104.47 111.99 24.87 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 122.092 -0.652 . . . . 0.0 110.408 -177.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -138.08 137.38 20.97 Favored Pre-proline 0 N--CA 1.497 1.886 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 177.153 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -61.36 152.05 75.29 Favored 'Trans proline' 0 N--CA 1.497 1.683 0 O-C-N 123.118 1.062 . . . . 0.0 111.058 -173.515 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -60.33 -28.17 67.94 Favored 'General case' 0 N--CA 1.507 2.399 0 O-C-N 121.951 -0.468 . . . . 0.0 111.374 -173.344 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -92.16 14.31 16.5 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.941 -0.474 . . . . 0.0 111.77 -178.202 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.56 160.82 29.72 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.658 -0.651 . . . . 0.0 110.239 -173.158 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 70.6 mt -124.24 135.89 62.23 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -178.632 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 19.5 p30 37.52 43.61 0.44 Allowed 'General case' 0 N--CA 1.513 2.722 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -175.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 55.56 43.82 27.72 Favored 'General case' 0 N--CA 1.508 2.465 0 O-C-N 121.772 -0.58 . . . . 0.0 111.427 -179.115 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 51.4 p -141.19 161.33 38.14 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.738 -0.602 . . . . 0.0 110.346 171.062 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.1 p -141.39 164.69 29.54 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-O 120.847 0.356 . . . . 0.0 110.574 178.243 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 78.2 mt -109.6 132.44 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 -175.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.455 HG23 HD23 ' A' ' 36' ' ' LEU . 8.5 t -139.77 151.43 45.78 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 122.011 -0.431 . . . . 0.0 111.03 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 41.4 p-10 -108.21 30.38 6.45 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 122.097 -0.377 . . . . 0.0 110.636 167.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -124.71 -94.2 1.02 Allowed Glycine 0 N--CA 1.497 2.703 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 176.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 32.1 m80 -146.05 171.72 14.47 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 122.125 -0.632 . . . . 0.0 109.453 177.145 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 72.8 m -92.41 139.14 30.89 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 163.588 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -130.5 148.96 52.37 Favored 'General case' 0 N--CA 1.499 2.002 0 C-N-CA 120.404 -0.519 . . . . 0.0 110.54 -176.595 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -151.68 141.97 22.4 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 177.419 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.419 HD12 HD12 ' A' ' 99' ' ' ILE . 17.9 tt -142.24 149.19 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 CA-C-O 120.908 0.385 . . . . 0.0 110.248 -173.097 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.506 HD12 ' HG ' ' A' ' 73' ' ' LEU . 16.5 tt -139.15 145.4 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 -146.26 141.06 26.98 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 -167.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.2 tm-20 -101.57 115.78 31.29 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 122.165 -0.334 . . . . 0.0 110.139 -176.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -86.95 175.18 8.28 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 122.194 -0.316 . . . . 0.0 110.599 -175.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -60.59 -17.13 44.6 Favored 'General case' 0 N--CA 1.506 2.354 0 O-C-N 121.975 -0.453 . . . . 0.0 112.14 -172.389 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -92.48 -11.91 33.41 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.602 -0.686 . . . . 0.0 111.728 177.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.35 21.09 36.01 Favored Glycine 0 N--CA 1.497 2.715 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 176.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -97.28 141.07 30.84 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 118.379 1.089 . . . . 0.0 109.811 170.231 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.9 p -94.91 126.75 40.45 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 122.155 -0.341 . . . . 0.0 110.322 177.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 17.9 p -98.02 112.96 24.71 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 122.128 -0.358 . . . . 0.0 110.298 176.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.538 ' N ' HD12 ' A' ' 73' ' ' LEU . 6.4 mp -99.61 131.09 45.84 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 122.195 -0.316 . . . . 0.0 110.489 -179.044 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -149.34 145.89 27.25 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 122.168 -0.332 . . . . 0.0 110.249 175.118 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 83.8 p -143.7 166.94 23.47 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 178.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -178.64 -163.63 30.22 Favored Glycine 0 N--CA 1.496 2.687 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 -178.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 2.0 m -96.72 132.4 42.45 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 122.144 -0.621 . . . . 0.0 110.321 -176.102 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 45.2 ttm -101.58 124.87 47.94 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 122.13 -0.356 . . . . 0.0 110.277 179.25 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 25.3 pttt . . . . . 0 N--CA 1.503 2.21 0 O-C-N 122.032 -0.417 . . . . 0.0 110.516 177.097 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 3.1 ptt180 . . . . . 0 N--CA 1.494 1.743 0 CA-C-O 120.901 0.381 . . . . 0.0 110.477 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.404 ' O ' HG22 ' A' ' 63' ' ' ILE . 17.5 m -126.69 146.43 50.21 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 169.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.419 HD12 HD12 ' A' ' 62' ' ' ILE . 18.3 tt -143.17 155.98 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.993 -0.442 . . . . 0.0 110.29 -174.072 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.429 ' HB3' HD21 ' A' ' 111' ' ' LEU . 43.6 mt-10 -146.82 146.88 30.38 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 120.756 0.312 . . . . 0.0 110.239 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 26.4 p -143.11 146.38 33.71 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 177.058 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 18.2 p -157.55 131.97 8.42 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 122.002 -0.436 . . . . 0.0 110.805 -170.376 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 20.7 ttm-85 -104.97 48.67 0.83 Allowed 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 121.371 0.605 . . . . 0.0 110.645 -176.578 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.0 p -137.95 150.94 47.47 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.819 -0.551 . . . . 0.0 109.884 175.47 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 17.6 p-10 -62.55 132.35 52.15 Favored 'General case' 0 N--CA 1.505 2.286 0 CA-C-O 121.355 0.598 . . . . 0.0 111.674 -163.384 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 79.1 mt 51.86 27.6 4.39 Favored 'General case' 0 N--CA 1.507 2.409 0 O-C-N 122.061 -0.4 . . . . 0.0 111.937 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 26.1 p -62.7 -23.15 66.99 Favored 'General case' 0 N--CA 1.507 2.403 0 O-C-N 121.847 -0.533 . . . . 0.0 111.6 174.644 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -75.4 -29.9 59.95 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.855 -0.528 . . . . 0.0 111.01 178.176 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -62.36 -39.84 94.46 Favored 'General case' 0 N--CA 1.507 2.377 0 O-C-N 121.738 -0.602 . . . . 0.0 110.753 -169.373 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -100.22 16.2 25.04 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 122.105 -0.372 . . . . 0.0 111.678 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.429 HD21 ' HB3' ' A' ' 100' ' ' GLU . 16.3 tp -111.82 108.98 18.57 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.557 -0.715 . . . . 0.0 110.327 -175.62 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -97.9 120.87 59.2 Favored Pre-proline 0 N--CA 1.496 1.869 0 CA-C-O 118.858 -0.591 . . . . 0.0 110.14 174.592 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.413 ' HB2' HG21 ' A' ' 63' ' ' ILE . 37.2 Cg_endo -69.46 141.05 45.36 Favored 'Trans proline' 0 N--CA 1.491 1.342 0 O-C-N 123.202 1.107 . . . . 0.0 110.182 174.61 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 34.0 p -139.22 135.81 34.34 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 122.118 -0.364 . . . . 0.0 110.218 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 17.3 mt . . . . . 0 N--CA 1.501 2.107 0 CA-C-O 119.306 -0.378 . . . . 0.0 110.068 178.645 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_exo . . . . . 0 N--CA 1.497 1.711 0 N-CA-C 110.998 -0.424 . . . . 0.0 110.998 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -158.17 53.37 0.45 Allowed 'General case' 0 N--CA 1.5 2.028 0 CA-C-O 121.358 0.599 . . . . 0.0 110.159 165.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.403 HD23 HG23 ' A' ' 55' ' ' THR . 21.9 tp -158.05 114.36 2.81 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.696 -0.627 . . . . 0.0 110.032 -179.06 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.47 ' CE ' HD21 ' A' ' 106' ' ' LEU . 23.4 ttpt -99.71 130.5 45.93 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 122.137 -0.352 . . . . 0.0 110.194 179.19 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 78.2 m -115.28 140.32 49.21 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -177.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -84.29 142.91 29.89 Favored 'General case' 0 N--CA 1.502 2.141 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 177.129 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 28.1 p -115.31 137.29 52.2 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 122.127 -0.358 . . . . 0.0 110.642 -176.681 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 49.5 m -122.95 139.03 54.49 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 122.069 -0.394 . . . . 0.0 110.051 176.281 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 75.52 -67.17 2.27 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.721 -1.351 . . . . 0.0 109.721 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -114.08 124.12 51.34 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 122.11 -0.641 . . . . 0.0 110.486 -176.694 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -137.99 136.87 20.16 Favored Pre-proline 0 N--CA 1.497 1.901 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 175.336 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.44 151.93 71.29 Favored 'Trans proline' 0 N--CA 1.498 1.745 0 O-C-N 123.083 1.044 . . . . 0.0 111.111 -172.276 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -60.35 -28.55 68.26 Favored 'General case' 0 N--CA 1.507 2.391 0 O-C-N 121.935 -0.478 . . . . 0.0 111.356 -172.187 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -91.89 14.37 15.82 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.969 -0.457 . . . . 0.0 111.824 -177.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.65 162.04 27.33 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.622 -0.674 . . . . 0.0 110.27 -173.381 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 71.7 mt -124.59 136.69 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 -178.26 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 19.8 p30 37.76 43.07 0.45 Allowed 'General case' 0 N--CA 1.514 2.739 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -176.435 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 55.39 43.6 28.56 Favored 'General case' 0 N--CA 1.508 2.468 0 O-C-N 121.815 -0.553 . . . . 0.0 111.407 -178.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 59.5 p -139.55 160.56 39.58 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.768 -0.582 . . . . 0.0 110.261 171.188 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.1 p -139.28 163.99 31.01 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 120.787 0.327 . . . . 0.0 110.613 178.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 77.5 mt -108.73 132.17 57.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -175.709 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.403 HG23 HD23 ' A' ' 36' ' ' LEU . 8.4 t -140.29 151.63 45.24 Favored 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 120.95 0.405 . . . . 0.0 110.976 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 26.7 p30 -108.72 30.35 6.58 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 122.096 -0.377 . . . . 0.0 110.603 167.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -122.83 -93.93 1.16 Allowed Glycine 0 N--CA 1.496 2.653 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 176.456 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 74.6 m-70 -149.59 172.11 15.56 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 122.052 -0.675 . . . . 0.0 109.463 176.075 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 75.0 m -92.41 139.06 30.97 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 166.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -130.81 150.7 51.86 Favored 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 120.401 -0.52 . . . . 0.0 110.539 -176.177 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -152.08 142.51 22.58 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 177.613 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.489 HD12 HD12 ' A' ' 99' ' ' ILE . 18.0 tt -143.67 149.17 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.354 -173.444 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.517 HD12 ' HG ' ' A' ' 73' ' ' LEU . 16.1 tt -137.63 145.23 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.193 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -148.12 146.65 28.88 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 -167.431 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.8 tm-20 -101.59 117.77 35.58 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 122.146 -0.346 . . . . 0.0 110.237 -175.637 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 51.4 p30 -87.28 175.36 8.06 Favored 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 120.909 -0.316 . . . . 0.0 110.628 -175.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -60.34 -18.07 47.46 Favored 'General case' 0 N--CA 1.508 2.453 0 O-C-N 121.988 -0.445 . . . . 0.0 111.915 -173.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 16.1 mm-40 -93.21 -9.48 39.08 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.713 -0.617 . . . . 0.0 111.89 178.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 88.69 21.0 45.17 Favored Glycine 0 N--CA 1.498 2.826 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 177.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -96.9 143.63 27.6 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 118.413 1.107 . . . . 0.0 109.793 169.563 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.3 p -94.88 125.93 39.87 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.281 177.606 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 17.9 p -98.04 113.0 24.74 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 122.154 -0.341 . . . . 0.0 110.272 177.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.541 ' N ' HD12 ' A' ' 73' ' ' LEU . 6.4 mp -97.8 128.54 44.51 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 122.181 -0.324 . . . . 0.0 110.407 -178.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -145.34 145.78 31.34 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 122.183 -0.323 . . . . 0.0 110.348 176.455 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 97.1 p -143.6 166.96 23.39 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 178.483 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 179.95 -164.0 31.53 Favored Glycine 0 N--CA 1.496 2.681 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 -178.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 1.8 m -96.71 132.52 42.31 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 122.248 -0.56 . . . . 0.0 110.356 -175.389 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 47.4 ttm -102.56 122.0 43.51 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 122.038 -0.414 . . . . 0.0 110.159 177.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 27.7 pttt . . . . . 0 N--CA 1.503 2.195 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.407 177.184 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 28.5 ptt180 . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 120.872 0.367 . . . . 0.0 110.584 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.418 HG21 ' O ' ' A' ' 114' ' ' THR . 17.0 m -125.78 149.0 48.93 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 171.7 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.489 HD12 HD12 ' A' ' 62' ' ' ILE . 18.3 tt -143.15 154.24 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.156 -176.013 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -146.85 150.81 36.0 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 120.858 0.361 . . . . 0.0 110.407 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 26.9 p -142.95 149.99 39.11 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 122.06 -0.4 . . . . 0.0 110.091 176.509 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 19.2 p -157.58 133.43 9.3 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.971 -0.456 . . . . 0.0 110.821 -172.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 61.7 ttp85 -106.35 52.51 0.72 Allowed 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 121.353 0.597 . . . . 0.0 110.536 -176.426 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.1 p -144.08 151.07 39.12 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.788 -0.57 . . . . 0.0 109.947 175.452 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 18.2 p-10 -62.39 132.11 51.48 Favored 'General case' 0 N--CA 1.503 2.213 0 CA-C-O 121.418 0.627 . . . . 0.0 111.726 -163.298 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.47 HD21 ' CE ' ' A' ' 37' ' ' LYS . 79.4 mt 51.75 28.06 4.61 Favored 'General case' 0 N--CA 1.506 2.334 0 O-C-N 121.936 -0.477 . . . . 0.0 111.955 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 25.7 p -62.56 -24.16 67.38 Favored 'General case' 0 N--CA 1.507 2.404 0 O-C-N 121.904 -0.498 . . . . 0.0 111.506 174.289 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -73.0 -30.33 63.71 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.877 -0.514 . . . . 0.0 110.944 178.485 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -62.84 -39.29 93.9 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.616 -0.678 . . . . 0.0 110.752 -168.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -100.2 16.24 24.88 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 122.103 -0.373 . . . . 0.0 111.696 -179.028 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 16.9 tp -112.73 110.35 20.43 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.649 -0.657 . . . . 0.0 110.314 -175.592 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -96.68 120.83 61.22 Favored Pre-proline 0 N--CA 1.496 1.837 0 CA-C-O 118.922 -0.561 . . . . 0.0 110.096 174.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -72.13 138.16 30.2 Favored 'Trans proline' 0 N--CA 1.492 1.415 0 O-C-N 123.293 1.154 . . . . 0.0 110.307 173.317 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.418 ' O ' HG21 ' A' ' 98' ' ' THR . 35.5 p -139.18 150.0 45.07 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 122.096 -0.377 . . . . 0.0 110.203 178.022 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 12.9 mt . . . . . 0 N--CA 1.501 2.088 0 CA-C-O 119.215 -0.421 . . . . 0.0 109.984 179.741 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo . . . . . 0 N--CA 1.498 1.791 0 N-CA-C 111.145 -0.367 . . . . 0.0 111.145 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -158.28 53.58 0.44 Allowed 'General case' 0 N--CA 1.5 2.034 0 CA-C-O 121.378 0.609 . . . . 0.0 110.235 164.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 22.7 tp -158.42 114.0 2.66 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.731 -0.606 . . . . 0.0 109.971 -179.073 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 53.1 tttt -99.74 132.27 45.19 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 122.164 -0.335 . . . . 0.0 110.205 -179.542 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 80.2 m -117.73 140.23 49.96 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 122.047 -0.408 . . . . 0.0 109.901 -177.42 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 62.9 t80 -84.35 142.83 29.89 Favored 'General case' 0 N--CA 1.501 2.077 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 175.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 28.1 p -114.84 138.36 50.87 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 122.05 -0.406 . . . . 0.0 110.714 -177.009 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 99.9 p -123.01 141.19 52.23 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 176.064 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.37 -68.36 1.46 Allowed Glycine 0 N--CA 1.495 2.629 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 83.6 t60 -113.17 124.78 53.34 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 122.08 -0.659 . . . . 0.0 110.663 -176.578 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -138.05 136.63 19.82 Favored Pre-proline 0 N--CA 1.497 1.92 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 175.27 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -60.28 152.17 68.56 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 O-C-N 123.107 1.056 . . . . 0.0 111.114 -171.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -60.15 -28.35 67.84 Favored 'General case' 0 N--CA 1.506 2.355 0 O-C-N 121.938 -0.476 . . . . 0.0 111.436 -172.606 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -92.02 14.23 16.45 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.857 -0.527 . . . . 0.0 111.754 -177.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.19 162.07 25.99 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.582 -0.699 . . . . 0.0 110.382 -172.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 75.2 mt -125.62 138.51 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 -178.086 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 38.7 43.29 0.69 Allowed 'General case' 0 N--CA 1.512 2.655 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -178.054 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 30.7 m120 55.05 42.27 31.07 Favored 'General case' 0 N--CA 1.509 2.488 0 O-C-N 121.759 -0.588 . . . . 0.0 111.453 -178.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 68.3 p -141.22 160.41 40.17 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.767 -0.583 . . . . 0.0 110.343 173.585 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.1 p -140.91 165.03 28.64 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 120.902 0.382 . . . . 0.0 110.641 179.497 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 78.0 mt -109.85 132.05 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 -175.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.7 t -138.93 150.87 46.4 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.978 -0.451 . . . . 0.0 110.999 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 50.4 p30 -108.16 31.12 5.79 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 122.114 -0.366 . . . . 0.0 110.593 167.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -124.96 -93.39 0.97 Allowed Glycine 0 N--CA 1.497 2.707 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 176.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 45.0 m-70 -149.69 172.21 15.44 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 122.106 -0.644 . . . . 0.0 109.366 176.007 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 71.9 m -92.1 139.03 31.04 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 166.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 15.5 p90 -129.16 151.93 49.29 Favored 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 120.372 -0.531 . . . . 0.0 110.643 -176.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -151.18 142.68 23.51 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 176.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.478 HD11 ' NH2' ' A' ' 97' ' ' ARG . 18.3 tt -142.05 149.05 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 CA-C-O 120.864 0.364 . . . . 0.0 110.277 -172.67 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.53 HD12 ' HG ' ' A' ' 73' ' ' LEU . 15.3 tt -140.8 145.25 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 177.601 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -150.15 144.34 25.62 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 -170.084 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.5 tm-20 -101.62 117.88 35.8 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 110.11 -0.329 . . . . 0.0 110.11 -178.204 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 52.3 p30 -86.69 175.19 8.39 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 122.179 -0.326 . . . . 0.0 110.609 -175.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -60.19 -17.43 41.12 Favored 'General case' 0 N--CA 1.507 2.392 0 O-C-N 121.931 -0.48 . . . . 0.0 112.127 -173.674 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -92.79 -11.12 34.58 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.601 -0.687 . . . . 0.0 111.868 178.457 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.55 20.97 35.81 Favored Glycine 0 N--CA 1.498 2.781 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 177.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -96.94 139.91 32.27 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-N 118.324 1.062 . . . . 0.0 109.841 171.257 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.2 p -94.85 125.25 39.39 Favored 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 120.824 -0.351 . . . . 0.0 110.205 176.578 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 17.7 p -97.94 112.91 24.66 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 122.167 -0.333 . . . . 0.0 110.305 177.437 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.533 ' N ' HD12 ' A' ' 73' ' ' LEU . 6.4 mp -99.01 127.65 44.97 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 122.13 -0.356 . . . . 0.0 110.311 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -146.97 146.08 29.97 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 122.084 -0.385 . . . . 0.0 110.36 177.031 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 90.4 p -143.77 166.71 24.13 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 177.686 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 178.09 -163.69 32.02 Favored Glycine 0 N--CA 1.499 2.841 0 N-CA-C 110.256 -1.138 . . . . 0.0 110.256 -179.043 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 2.9 m -96.62 132.4 42.29 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 122.179 -0.601 . . . . 0.0 110.359 -175.384 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 44.4 ttm -99.46 121.94 41.85 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 122.034 -0.416 . . . . 0.0 110.042 178.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 26.0 pttt . . . . . 0 N--CA 1.503 2.193 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.562 -179.45 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.478 ' NH2' HD11 ' A' ' 62' ' ' ILE . 10.1 ptm180 . . . . . 0 N--CA 1.498 1.961 0 CA-C-O 120.871 0.367 . . . . 0.0 110.592 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 17.0 m -134.0 149.35 51.2 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 177.092 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.4 tt -142.6 150.95 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 122.023 -0.423 . . . . 0.0 109.873 178.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 48.5 mm-40 -144.64 151.65 39.3 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 120.862 0.363 . . . . 0.0 110.655 -176.414 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 26.3 p -143.04 150.98 40.3 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 177.371 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 19.5 p -157.56 134.43 10.04 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 122.016 -0.427 . . . . 0.0 110.852 -175.1 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 29.4 ttp180 -106.98 47.38 0.88 Allowed 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 121.208 0.528 . . . . 0.0 110.608 -173.484 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.0 p -142.16 151.39 42.18 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.88 -0.513 . . . . 0.0 109.888 178.402 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 15.8 p30 -62.78 132.44 52.24 Favored 'General case' 0 N--CA 1.505 2.285 0 CA-C-O 121.466 0.651 . . . . 0.0 111.628 -163.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 78.9 mt 52.14 27.78 4.89 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 122.03 -0.419 . . . . 0.0 111.922 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 25.8 p -62.71 -24.84 67.87 Favored 'General case' 0 N--CA 1.508 2.444 0 O-C-N 121.9 -0.5 . . . . 0.0 111.489 174.09 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -72.57 -29.59 63.68 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 121.918 -0.489 . . . . 0.0 111.076 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -62.23 -39.71 93.74 Favored 'General case' 0 N--CA 1.505 2.324 0 O-C-N 121.674 -0.641 . . . . 0.0 110.821 -168.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -101.34 16.22 26.28 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 122.066 -0.396 . . . . 0.0 111.763 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 12.9 tp -115.26 108.89 17.16 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.673 -0.642 . . . . 0.0 110.338 -175.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -100.62 120.78 55.03 Favored Pre-proline 0 N--CA 1.496 1.84 0 CA-C-O 118.913 -0.565 . . . . 0.0 110.183 173.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -67.94 140.06 49.14 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 O-C-N 123.153 1.081 . . . . 0.0 110.256 173.108 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 49.3 p -139.19 149.65 44.65 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 122.118 -0.364 . . . . 0.0 110.087 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 18.9 mt . . . . . 0 N--CA 1.501 2.098 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.056 179.634 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo . . . . . 0 N--CA 1.502 2.0 0 N-CA-C 111.277 -0.317 . . . . 0.0 111.277 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -150.17 47.52 0.91 Allowed 'General case' 0 N--CA 1.499 1.989 0 CA-C-O 121.14 0.495 . . . . 0.0 110.647 -178.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.458 HD23 HG23 ' A' ' 55' ' ' THR . 20.3 tp -160.69 114.38 2.08 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.796 -0.565 . . . . 0.0 110.378 -174.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.448 ' CE ' HD21 ' A' ' 106' ' ' LEU . 30.1 ttpt -99.85 129.91 45.99 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 175.696 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 75.4 m -112.4 140.36 47.2 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -82.63 141.43 32.52 Favored 'General case' 0 N--CA 1.5 2.031 0 C-N-CA 120.764 -0.374 . . . . 0.0 109.992 175.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 27.8 p -115.38 137.12 52.38 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 122.021 -0.424 . . . . 0.0 110.649 -175.149 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 48.3 m -123.02 140.49 52.98 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 122.109 -0.37 . . . . 0.0 110.03 177.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 75.52 -67.24 2.26 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.307 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 83.8 t60 -115.92 124.33 50.34 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 122.061 -0.67 . . . . 0.0 110.543 -176.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -138.08 135.72 18.87 Favored Pre-proline 0 N--CA 1.497 1.907 0 N-CA-C 109.19 -0.671 . . . . 0.0 109.19 174.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.77 153.23 64.02 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 O-C-N 123.145 1.076 . . . . 0.0 111.193 -169.429 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -60.34 -28.33 68.07 Favored 'General case' 0 N--CA 1.506 2.335 0 O-C-N 121.918 -0.489 . . . . 0.0 111.43 -173.032 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -92.3 14.25 16.92 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.934 -0.479 . . . . 0.0 111.714 -178.212 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.92 161.99 27.95 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.731 -0.606 . . . . 0.0 110.225 -172.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 69.5 mt -124.92 136.97 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -176.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 18.0 p30 37.78 42.91 0.44 Allowed 'General case' 0 N--CA 1.514 2.731 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -175.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 24.0 t30 56.17 42.26 28.4 Favored 'General case' 0 N--CA 1.508 2.469 0 O-C-N 121.795 -0.566 . . . . 0.0 111.439 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 60.7 p -140.4 164.45 30.08 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.73 -0.606 . . . . 0.0 110.36 172.329 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.1 p -139.07 163.31 32.74 Favored 'General case' 0 N--CA 1.499 2.024 0 CA-C-O 120.889 0.376 . . . . 0.0 110.638 178.502 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 77.5 mt -110.36 134.35 52.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -175.18 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.458 HG23 HD23 ' A' ' 36' ' ' LEU . 8.1 t -144.0 153.97 42.79 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.996 -0.44 . . . . 0.0 111.106 179.129 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 39.5 p-10 -107.72 29.73 6.96 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 122.128 -0.357 . . . . 0.0 110.652 167.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -122.17 -100.98 1.63 Allowed Glycine 0 N--CA 1.497 2.702 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 176.558 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 25.6 m-70 -141.13 171.26 14.31 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 122.091 -0.652 . . . . 0.0 109.562 176.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 70.4 m -91.67 139.09 31.02 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 164.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -129.18 148.27 51.1 Favored 'General case' 0 N--CA 1.498 1.939 0 C-N-CA 120.374 -0.531 . . . . 0.0 110.423 -179.297 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -151.55 140.33 20.88 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 176.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.52 HD12 HD12 ' A' ' 99' ' ' ILE . 18.2 tt -143.86 149.3 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 CA-C-O 120.969 0.414 . . . . 0.0 110.611 -170.055 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.65 HD12 HD21 ' A' ' 73' ' ' LEU . 14.7 tt -135.02 145.19 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 175.452 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -148.27 146.38 28.59 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -169.085 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.7 tm-20 -101.79 117.95 35.93 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 120.793 0.33 . . . . 0.0 110.202 -175.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 26.9 p-10 -87.98 175.36 7.81 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 122.118 -0.364 . . . . 0.0 110.468 -176.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -60.34 -17.21 41.61 Favored 'General case' 0 N--CA 1.507 2.414 0 O-C-N 121.937 -0.477 . . . . 0.0 112.122 -172.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -92.41 -11.49 34.71 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.608 -0.682 . . . . 0.0 111.842 178.416 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.13 21.2 36.32 Favored Glycine 0 N--CA 1.497 2.743 0 N-CA-C 111.099 -0.801 . . . . 0.0 111.099 176.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -97.79 144.59 27.23 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-N 118.309 1.055 . . . . 0.0 109.872 170.388 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.9 p -94.92 128.42 41.69 Favored 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.24 176.549 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 20.1 p -97.82 116.05 29.27 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 122.138 -0.351 . . . . 0.0 110.474 178.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.65 HD21 HD12 ' A' ' 63' ' ' ILE . 15.3 mt -97.41 126.62 42.77 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 122.101 -0.374 . . . . 0.0 110.456 -179.476 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -150.52 146.16 26.42 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 122.065 -0.397 . . . . 0.0 110.474 175.17 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 93.7 p -143.7 167.06 23.17 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 175.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -179.23 -167.23 36.36 Favored Glycine 0 N--CA 1.497 2.748 0 N-CA-C 110.244 -1.142 . . . . 0.0 110.244 -178.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 2.2 m -96.6 132.72 41.93 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 122.221 -0.576 . . . . 0.0 110.147 -175.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 43.2 ttm -97.47 121.83 39.82 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 122.026 -0.421 . . . . 0.0 109.982 177.199 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 26.7 pttt . . . . . 0 N--CA 1.502 2.14 0 O-C-N 122.028 -0.42 . . . . 0.0 110.609 -176.915 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 43.8 ptt85 . . . . . 0 N--CA 1.495 1.786 0 CA-C-O 120.877 0.37 . . . . 0.0 110.41 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 18.4 m -125.81 148.14 49.21 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 172.725 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.52 HD12 HD12 ' A' ' 62' ' ' ILE . 18.5 tt -143.2 156.08 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 122.048 -0.408 . . . . 0.0 110.186 -177.118 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.467 ' HB3' HD21 ' A' ' 111' ' ' LEU . 45.3 mt-10 -141.85 147.88 37.91 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 120.879 0.371 . . . . 0.0 110.411 178.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 25.3 p -143.09 136.35 28.2 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 -177.571 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 22.5 p -157.44 128.82 6.82 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.888 -0.507 . . . . 0.0 111.016 -171.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 52.9 ttt180 -103.73 48.76 0.84 Allowed 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 121.319 0.581 . . . . 0.0 110.481 -178.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 23.9 p -135.66 150.5 49.62 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.919 -0.488 . . . . 0.0 109.739 175.356 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -62.91 132.13 51.06 Favored 'General case' 0 N--CA 1.504 2.248 0 CA-C-O 121.358 0.599 . . . . 0.0 111.643 -162.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.448 HD21 ' CE ' ' A' ' 37' ' ' LYS . 82.7 mt 51.72 28.0 4.53 Favored 'General case' 0 N--CA 1.507 2.409 0 O-C-N 122.032 -0.418 . . . . 0.0 111.936 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 26.2 p -62.66 -23.01 66.88 Favored 'General case' 0 N--CA 1.507 2.391 0 O-C-N 121.908 -0.495 . . . . 0.0 111.591 174.01 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -77.39 -29.18 53.06 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.824 -0.547 . . . . 0.0 111.126 177.521 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -62.04 -40.26 95.13 Favored 'General case' 0 N--CA 1.506 2.357 0 O-C-N 121.69 -0.631 . . . . 0.0 110.879 -168.439 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -100.04 16.26 24.57 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 122.088 -0.383 . . . . 0.0 111.631 178.437 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.467 HD21 ' HB3' ' A' ' 100' ' ' GLU . 11.9 tp -115.88 108.9 16.88 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.504 -0.748 . . . . 0.0 110.25 -175.616 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -98.27 120.79 58.81 Favored Pre-proline 0 N--CA 1.497 1.888 0 CA-C-O 118.96 -0.543 . . . . 0.0 110.102 174.294 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.7 134.06 19.61 Favored 'Trans proline' 0 N--CA 1.49 1.273 0 O-C-N 123.227 1.119 . . . . 0.0 110.24 172.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 35.1 p -139.31 149.39 44.17 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 122.097 -0.377 . . . . 0.0 110.217 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 15.9 mt . . . . . 0 N--CA 1.501 2.12 0 O-C-N 121.987 -0.445 . . . . 0.0 109.985 177.85 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo . . . . . 0 N--CA 1.497 1.681 0 N-CA-C 110.929 -0.45 . . . . 0.0 110.929 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -156.07 50.99 0.53 Allowed 'General case' 0 N--CA 1.501 2.096 0 CA-C-O 121.305 0.574 . . . . 0.0 110.326 164.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.445 HD23 HG23 ' A' ' 55' ' ' THR . 21.1 tp -158.56 114.57 2.69 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.792 -0.567 . . . . 0.0 110.287 -177.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 29.7 ttmt -99.88 131.72 45.67 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 122.16 -0.338 . . . . 0.0 110.16 177.422 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 79.7 m -114.74 140.17 49.1 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 -179.395 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.484 ' CD1' ' NE2' ' A' ' 109' ' ' GLN . 68.6 t80 -87.49 143.38 27.25 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 122.093 -0.379 . . . . 0.0 110.097 176.537 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 27.5 p -117.49 137.0 52.84 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 122.089 -0.382 . . . . 0.0 110.58 -175.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 29.3 t -123.01 119.68 31.07 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 122.124 -0.36 . . . . 0.0 110.158 178.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 83.69 -61.96 4.67 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -106.54 112.84 26.01 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 122.109 -0.642 . . . . 0.0 110.519 -177.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -138.04 136.52 19.73 Favored Pre-proline 0 N--CA 1.495 1.803 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 176.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.78 152.78 67.32 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 O-C-N 123.118 1.062 . . . . 0.0 111.186 -171.189 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -60.55 -28.65 68.6 Favored 'General case' 0 N--CA 1.507 2.419 0 O-C-N 121.932 -0.48 . . . . 0.0 111.34 -172.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -92.21 14.37 16.41 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 122.009 -0.432 . . . . 0.0 111.752 -178.345 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.4 160.66 30.01 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.671 -0.643 . . . . 0.0 110.361 -172.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 58.7 mt -126.02 140.46 48.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 -178.388 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 38.74 42.79 0.65 Allowed 'General case' 0 N--CA 1.512 2.655 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -176.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 18.7 t30 55.48 41.33 30.98 Favored 'General case' 0 N--CA 1.508 2.453 0 O-C-N 121.789 -0.569 . . . . 0.0 111.401 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 40.1 p -144.09 163.95 32.06 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.804 -0.56 . . . . 0.0 110.647 174.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.3 p -140.63 164.97 28.74 Favored 'General case' 0 N--CA 1.499 1.975 0 CA-C-O 120.882 0.372 . . . . 0.0 110.564 178.168 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 76.7 mt -112.82 133.62 58.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -175.304 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.445 HG23 HD23 ' A' ' 36' ' ' LEU . 9.0 t -141.22 153.0 45.04 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 122.054 -0.404 . . . . 0.0 111.083 -178.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -109.77 31.27 5.96 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 122.172 -0.33 . . . . 0.0 110.469 167.083 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -123.41 -94.11 1.12 Allowed Glycine 0 N--CA 1.497 2.725 0 N-CA-C 109.131 -1.588 . . . . 0.0 109.131 175.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 39.2 m80 -149.81 172.06 15.74 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 122.054 -0.674 . . . . 0.0 109.512 176.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 77.3 m -93.21 139.31 30.75 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 167.545 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 15.1 p90 -130.46 153.75 48.46 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.833 -0.542 . . . . 0.0 110.599 -176.584 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -151.52 142.23 22.78 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 177.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 17.8 tt -142.51 149.24 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 CA-C-O 120.888 0.375 . . . . 0.0 110.338 -173.32 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.529 HD12 ' HG ' ' A' ' 73' ' ' LEU . 16.1 tt -139.87 145.39 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 63.8 mt-10 -146.21 142.82 28.78 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.985 -0.447 . . . . 0.0 109.845 -168.07 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.3 tm-20 -101.61 116.45 32.78 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 120.793 0.33 . . . . 0.0 110.179 -176.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -87.28 175.19 8.14 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 122.17 -0.331 . . . . 0.0 110.583 -175.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -60.65 -17.11 45.27 Favored 'General case' 0 N--CA 1.506 2.374 0 O-C-N 121.993 -0.442 . . . . 0.0 112.159 -172.364 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -92.48 -12.01 33.14 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.666 -0.646 . . . . 0.0 111.829 177.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.14 21.01 36.85 Favored Glycine 0 N--CA 1.498 2.785 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 176.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -97.59 142.41 29.44 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 118.395 1.098 . . . . 0.0 109.799 169.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.5 p -94.94 127.25 40.85 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 120.779 -0.369 . . . . 0.0 110.277 178.109 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.1 p -97.94 112.9 24.66 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 120.906 -0.318 . . . . 0.0 110.348 176.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.536 ' N ' HD12 ' A' ' 73' ' ' LEU . 6.4 mp -98.38 129.79 45.03 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 120.774 0.321 . . . . 0.0 110.452 -178.557 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -149.58 146.27 27.24 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 122.038 -0.413 . . . . 0.0 110.194 175.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 98.8 p -143.64 167.1 23.06 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 178.664 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -177.36 -163.99 30.23 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 -177.392 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 2.1 m -97.21 132.56 42.85 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 122.131 -0.629 . . . . 0.0 110.378 -175.374 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 55.1 ttm -100.3 124.41 45.73 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 122.068 -0.395 . . . . 0.0 110.231 179.293 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.3 ptpp? . . . . . 0 N--CA 1.504 2.227 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.348 176.442 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 30.4 ptt180 . . . . . 0 N--CA 1.495 1.777 0 CA-C-O 120.902 0.382 . . . . 0.0 110.381 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.467 HG21 ' O ' ' A' ' 114' ' ' THR . 14.0 m -123.93 149.02 46.38 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 171.672 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.2 tt -143.1 153.34 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 122.089 -0.382 . . . . 0.0 110.189 -175.542 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -148.85 150.91 33.81 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-O 120.804 0.335 . . . . 0.0 110.543 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 26.3 p -143.14 155.31 44.54 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 175.453 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 19.7 p -157.47 136.71 11.86 Favored 'General case' 0 N--CA 1.503 2.205 0 CA-C-O 121.013 0.435 . . . . 0.0 110.738 -172.195 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 38.7 ttt180 -108.54 50.45 0.78 Allowed 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.413 0.625 . . . . 0.0 110.653 -171.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.0 p -147.4 151.76 37.02 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.69 -0.631 . . . . 0.0 109.888 178.065 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 17.6 p-10 -62.07 132.71 53.75 Favored 'General case' 0 N--CA 1.505 2.317 0 CA-C-O 121.44 0.638 . . . . 0.0 111.656 -164.468 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 74.7 mt 52.57 27.14 4.83 Favored 'General case' 0 N--CA 1.506 2.374 0 O-C-N 121.971 -0.455 . . . . 0.0 111.962 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 26.0 p -63.05 -23.39 67.43 Favored 'General case' 0 N--CA 1.508 2.435 0 C-N-CA 120.402 -0.519 . . . . 0.0 111.605 174.331 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -70.97 -26.51 63.19 Favored 'General case' 0 N--CA 1.505 2.293 0 O-C-N 121.799 -0.563 . . . . 0.0 111.025 177.183 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLN . . . . . 0.484 ' NE2' ' CD1' ' A' ' 39' ' ' TYR . 7.6 tp-100 -61.15 -43.32 99.07 Favored 'General case' 0 N--CA 1.508 2.442 0 O-C-N 121.647 -0.658 . . . . 0.0 110.617 -174.191 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -100.46 16.26 25.17 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 122.157 -0.339 . . . . 0.0 111.851 -176.332 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 16.4 tp -115.48 108.91 17.08 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.53 -0.731 . . . . 0.0 110.336 -176.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -98.6 120.7 58.49 Favored Pre-proline 0 N--CA 1.496 1.832 0 CA-C-O 118.936 -0.554 . . . . 0.0 110.16 174.481 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -70.54 134.42 26.29 Favored 'Trans proline' 0 N--CA 1.491 1.336 0 O-C-N 123.133 1.07 . . . . 0.0 110.262 175.073 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.467 ' O ' HG21 ' A' ' 98' ' ' THR . 34.9 p -139.24 150.03 45.02 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 122.137 -0.352 . . . . 0.0 110.2 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 14.9 mt . . . . . 0 N--CA 1.502 2.141 0 CA-C-O 119.208 -0.425 . . . . 0.0 109.955 179.137 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo . . . . . 0 N--CA 1.501 1.961 0 N-CA-C 111.189 -0.35 . . . . 0.0 111.189 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -157.0 48.57 0.44 Allowed 'General case' 0 N--CA 1.499 1.993 0 CA-C-O 121.046 0.451 . . . . 0.0 110.706 173.347 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 17.5 tp -161.32 114.44 1.92 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.783 -0.573 . . . . 0.0 110.42 -174.157 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 32.8 tttt -99.92 131.48 45.86 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 177.592 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 86.0 m -116.76 140.35 49.52 Favored 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -179.233 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -83.17 142.74 30.98 Favored 'General case' 0 N--CA 1.501 2.097 0 C-N-CA 120.73 -0.388 . . . . 0.0 109.992 175.773 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 28.1 p -114.66 136.92 52.52 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.849 -0.532 . . . . 0.0 110.561 -178.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.6 m -123.01 138.73 54.61 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 122.099 -0.376 . . . . 0.0 110.116 176.484 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 75.54 -67.07 2.28 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -113.54 124.54 52.61 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 122.11 -0.641 . . . . 0.0 110.465 -177.07 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -138.16 136.36 19.4 Favored Pre-proline 0 N--CA 1.496 1.844 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 174.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.36 152.42 67.24 Favored 'Trans proline' 0 N--CA 1.498 1.749 0 O-C-N 123.053 1.028 . . . . 0.0 111.185 -171.115 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -60.34 -28.11 67.9 Favored 'General case' 0 N--CA 1.507 2.378 0 O-C-N 121.944 -0.472 . . . . 0.0 111.391 -172.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -91.96 14.39 15.87 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.958 -0.464 . . . . 0.0 111.75 -178.085 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.92 162.07 25.18 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.652 -0.655 . . . . 0.0 110.246 -173.297 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 76.4 mt -125.53 140.11 49.33 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -177.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 38.72 42.47 0.61 Allowed 'General case' 0 N--CA 1.512 2.629 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -178.284 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 55.04 42.73 30.69 Favored 'General case' 0 N--CA 1.508 2.461 0 O-C-N 121.768 -0.582 . . . . 0.0 111.432 -178.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 39.9 p -142.75 161.59 37.69 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.785 -0.572 . . . . 0.0 110.622 173.174 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.5 p -139.53 165.12 28.09 Favored 'General case' 0 N--CA 1.498 1.973 0 CA-C-O 120.97 0.414 . . . . 0.0 110.486 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 75.9 mt -117.01 131.92 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 -173.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.9 t -143.65 155.66 44.31 Favored 'General case' 0 N--CA 1.502 2.143 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.168 -178.127 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -108.63 30.65 6.29 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 122.081 -0.387 . . . . 0.0 110.524 167.648 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -118.87 -103.44 2.1 Favored Glycine 0 N--CA 1.497 2.708 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 174.334 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 23.9 m-70 -139.55 171.93 13.54 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 122.169 -0.606 . . . . 0.0 109.655 176.582 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 83.2 m -93.92 139.21 31.18 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 165.593 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -129.59 150.04 51.09 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.591 -177.219 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.44 ' HB2' ' ND2' ' A' ' 108' ' ' ASN . . . -150.32 143.77 25.1 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 175.516 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.515 HD12 HD12 ' A' ' 99' ' ' ILE . 18.3 tt -144.18 149.17 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 122.091 -0.381 . . . . 0.0 110.099 -171.295 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.436 ' O ' HG23 ' A' ' 63' ' ' ILE . 15.6 tt -138.13 118.74 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 CA-C-O 120.877 0.37 . . . . 0.0 110.209 179.052 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 69.2 mt-10 -105.16 145.65 30.29 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 122.107 -0.371 . . . . 0.0 110.505 -178.382 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.1 tm-20 -101.96 116.49 32.8 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 122.016 -0.427 . . . . 0.0 110.166 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -85.34 175.19 9.04 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 122.008 -0.433 . . . . 0.0 110.56 -175.065 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -60.75 -17.71 50.43 Favored 'General case' 0 N--CA 1.507 2.41 0 O-C-N 122.019 -0.426 . . . . 0.0 111.989 -173.061 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -92.87 -10.7 35.72 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.693 -0.629 . . . . 0.0 111.823 178.526 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 89.65 18.22 52.38 Favored Glycine 0 N--CA 1.498 2.809 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 177.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 69.5 mt-10 -93.98 149.72 20.98 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 118.521 1.161 . . . . 0.0 111.311 168.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.403 ' HB ' ' CG1' ' A' ' 63' ' ' ILE . 4.5 p -94.96 134.97 37.04 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 122.038 -0.414 . . . . 0.0 110.467 177.62 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.2 p -102.15 110.5 22.48 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 169.344 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.543 ' N ' HD12 ' A' ' 73' ' ' LEU . 6.4 mp -97.27 132.86 42.6 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 122.177 -0.327 . . . . 0.0 110.587 -175.286 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -148.07 145.32 28.39 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 122.154 -0.341 . . . . 0.0 110.399 175.385 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 99.2 p -143.74 166.97 23.4 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 176.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 178.58 -164.44 32.96 Favored Glycine 0 N--CA 1.497 2.742 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 2.6 m -96.41 132.74 41.64 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 122.15 -0.618 . . . . 0.0 110.298 -175.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 55.4 ttm -101.21 122.0 42.85 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 122.068 -0.395 . . . . 0.0 110.117 176.386 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 26.8 pttt . . . . . 0 N--CA 1.503 2.222 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.339 177.164 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 48.6 ptt85 . . . . . 0 N--CA 1.493 1.721 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.461 HG21 ' O ' ' A' ' 114' ' ' THR . 15.5 m -112.55 149.15 33.12 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 171.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.515 HD12 HD12 ' A' ' 62' ' ' ILE . 18.8 tt -143.25 154.89 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.017 -177.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 66.8 mt-10 -142.99 149.95 38.99 Favored 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.63 -178.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 92.5 m -141.97 138.8 32.18 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 -177.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 20.4 p -157.63 131.41 8.0 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.906 -0.496 . . . . 0.0 110.914 -175.371 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 51.1 ttt180 -104.61 48.05 0.85 Allowed 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.287 0.565 . . . . 0.0 110.65 -176.335 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 23.9 p -136.65 151.47 49.34 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.904 -0.497 . . . . 0.0 109.861 175.518 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 17.6 p-10 -61.88 132.07 51.84 Favored 'General case' 0 N--CA 1.505 2.3 0 CA-C-O 121.429 0.633 . . . . 0.0 111.735 -163.344 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.464 HD22 ' OE1' ' A' ' 109' ' ' GLN . 75.4 mt 51.98 26.83 3.95 Favored 'General case' 0 N--CA 1.508 2.474 0 O-C-N 122.098 -0.376 . . . . 0.0 111.923 179.3 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 26.3 p -63.16 -21.91 66.52 Favored 'General case' 0 N--CA 1.507 2.384 0 C-N-CA 120.439 -0.504 . . . . 0.0 111.6 176.373 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.44 ' ND2' ' HB2' ' A' ' 61' ' ' ALA . 4.6 m120 -90.91 -22.99 20.63 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.737 -0.602 . . . . 0.0 111.282 177.693 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLN . . . . . 0.464 ' OE1' HD22 ' A' ' 106' ' ' LEU . 27.2 tt0 -61.01 -38.23 85.33 Favored 'General case' 0 N--CA 1.508 2.46 0 O-C-N 121.604 -0.685 . . . . 0.0 110.791 -175.49 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -100.69 16.32 25.32 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 122.094 -0.379 . . . . 0.0 111.674 177.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 15.7 tp -112.93 112.31 23.69 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.544 -0.723 . . . . 0.0 110.294 -174.524 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -96.27 120.86 61.8 Favored Pre-proline 0 N--CA 1.498 1.944 0 CA-C-O 118.894 -0.574 . . . . 0.0 109.912 172.187 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -71.0 143.71 45.55 Favored 'Trans proline' 0 N--CA 1.491 1.338 0 O-C-N 123.129 1.068 . . . . 0.0 110.225 177.181 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.461 ' O ' HG21 ' A' ' 98' ' ' THR . 35.3 p -139.11 150.05 45.24 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 122.1 -0.375 . . . . 0.0 110.204 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 16.4 mt . . . . . 0 N--CA 1.501 2.124 0 C-N-CA 120.689 -0.405 . . . . 0.0 110.114 -179.754 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo . . . . . 0 N--CA 1.499 1.799 0 N-CA-C 111.16 -0.362 . . . . 0.0 111.16 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -156.67 53.07 0.52 Allowed 'General case' 0 N--CA 1.5 2.06 0 CA-C-O 121.325 0.583 . . . . 0.0 110.3 164.573 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 20.5 tp -157.61 114.38 2.94 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.804 -0.56 . . . . 0.0 109.967 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 13.0 tttp -99.86 129.08 45.91 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 84.9 m -116.42 140.2 49.61 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -178.004 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -81.34 146.19 30.47 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 122.033 -0.417 . . . . 0.0 109.891 177.172 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 27.9 p -115.8 157.77 23.88 Favored 'General case' 0 N--CA 1.502 2.129 0 CA-C-O 120.997 0.427 . . . . 0.0 110.985 -173.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 96.7 p -65.65 162.99 17.23 Favored 'General case' 0 N--CA 1.503 2.196 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 167.475 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -51.35 -18.14 3.26 Favored Glycine 0 N--CA 1.507 3.397 0 N-CA-C 111.946 -0.462 . . . . 0.0 111.946 -173.107 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -84.4 111.8 19.77 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.8 -0.824 . . . . 0.0 109.621 163.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -138.32 136.08 18.91 Favored Pre-proline 0 N--CA 1.497 1.901 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -175.343 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -56.65 153.52 35.6 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 O-C-N 122.978 0.988 . . . . 0.0 111.599 -165.352 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -60.67 -31.24 70.49 Favored 'General case' 0 N--CA 1.506 2.353 0 O-C-N 121.953 -0.467 . . . . 0.0 111.357 -167.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -91.4 14.17 15.44 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 122.023 -0.423 . . . . 0.0 111.877 -177.192 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -86.01 162.14 18.63 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.654 -0.654 . . . . 0.0 110.542 -174.195 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 76.2 mt -122.02 140.53 45.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 -176.071 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 39.31 42.75 0.84 Allowed 'General case' 0 N--CA 1.513 2.69 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 55.05 41.73 31.53 Favored 'General case' 0 N--CA 1.508 2.438 0 O-C-N 121.844 -0.535 . . . . 0.0 111.455 -179.132 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 66.8 p -138.84 150.1 45.64 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.776 -0.577 . . . . 0.0 110.279 173.413 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.8 p -120.65 160.28 23.59 Favored 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 120.963 0.411 . . . . 0.0 110.598 178.249 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 77.5 mt -108.95 133.23 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -176.405 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.6 t -140.79 153.9 46.03 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.98 -0.45 . . . . 0.0 111.271 -178.34 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 26.7 p30 -108.06 30.11 6.68 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 122.178 -0.326 . . . . 0.0 110.528 166.256 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -122.58 -96.79 1.34 Allowed Glycine 0 N--CA 1.496 2.656 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 177.517 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 47.1 m-70 -148.98 172.07 15.33 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 122.097 -0.649 . . . . 0.0 109.428 178.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 82.3 m -95.84 139.19 32.42 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 168.737 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 16.5 p90 -132.08 150.83 52.05 Favored 'General case' 0 N--CA 1.499 1.994 0 C-N-CA 120.352 -0.539 . . . . 0.0 110.705 -178.33 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -152.55 144.66 23.83 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 175.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.529 HD12 HD12 ' A' ' 99' ' ' ILE . 18.3 tt -143.36 149.2 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 C-N-CA 120.741 -0.383 . . . . 0.0 110.492 -171.498 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.673 HD12 HD21 ' A' ' 73' ' ' LEU . 13.4 tt -136.1 145.09 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 176.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -150.04 145.86 26.64 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -170.714 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.3 tm-20 -101.62 117.35 34.71 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 122.128 -0.357 . . . . 0.0 110.098 -178.059 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -87.21 175.31 8.11 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 122.111 -0.368 . . . . 0.0 110.607 -175.565 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -60.67 -17.61 48.67 Favored 'General case' 0 N--CA 1.507 2.393 0 O-C-N 121.973 -0.454 . . . . 0.0 112.016 -172.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -92.77 -10.81 35.63 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.547 -0.721 . . . . 0.0 111.863 178.263 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.27 19.71 44.84 Favored Glycine 0 N--CA 1.498 2.769 0 N-CA-C 111.159 -0.776 . . . . 0.0 111.159 176.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -97.22 145.28 26.21 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 118.472 1.136 . . . . 0.0 109.915 169.538 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.2 p -94.87 129.62 41.79 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 122.127 -0.358 . . . . 0.0 110.24 178.393 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 19.3 p -97.9 115.6 28.44 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 122.156 -0.34 . . . . 0.0 110.346 178.24 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.673 HD21 HD12 ' A' ' 63' ' ' ILE . 18.4 mt -97.23 124.97 41.47 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 122.136 -0.352 . . . . 0.0 110.291 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -143.32 143.74 31.81 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 120.842 0.353 . . . . 0.0 110.534 175.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 89.4 p -143.73 166.99 23.33 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 176.285 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 176.48 -164.32 33.99 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 179.256 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 2.0 m -98.87 132.49 44.17 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 122.251 -0.558 . . . . 0.0 110.424 -174.178 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 50.0 ttm -102.52 133.66 47.13 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 122.116 -0.365 . . . . 0.0 110.185 176.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 22.5 pttm . . . . . 0 N--CA 1.503 2.213 0 O-C-N 122.054 -0.404 . . . . 0.0 110.543 178.106 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 46.3 ptt85 . . . . . 0 N--CA 1.496 1.847 0 CA-C-O 120.845 0.355 . . . . 0.0 110.735 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 19.9 m -134.03 149.23 51.17 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 178.424 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.529 HD12 HD12 ' A' ' 62' ' ' ILE . 18.3 tt -143.07 156.06 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 122.061 -0.399 . . . . 0.0 110.047 -179.267 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -142.88 146.58 34.22 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 120.825 0.345 . . . . 0.0 110.54 -178.17 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 26.0 p -143.12 137.67 29.29 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -178.441 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 20.5 p -157.57 133.74 9.53 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.96 -0.463 . . . . 0.0 110.989 -171.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 62.1 ttt180 -106.65 52.66 0.71 Allowed 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 121.426 0.631 . . . . 0.0 110.451 -176.519 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.0 p -142.26 151.64 42.27 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.766 -0.583 . . . . 0.0 109.753 174.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -61.28 131.79 51.5 Favored 'General case' 0 N--CA 1.506 2.337 0 CA-C-O 121.427 0.632 . . . . 0.0 111.771 -163.391 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.473 HD22 ' OE1' ' A' ' 109' ' ' GLN . 74.1 mt 52.08 26.8 4.04 Favored 'General case' 0 N--CA 1.507 2.404 0 O-C-N 122.064 -0.398 . . . . 0.0 111.964 179.274 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 26.3 p -63.06 -22.06 66.6 Favored 'General case' 0 N--CA 1.506 2.358 0 O-C-N 121.888 -0.507 . . . . 0.0 111.58 176.065 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -90.07 -22.94 21.58 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.79 -0.569 . . . . 0.0 111.277 176.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLN . . . . . 0.473 ' OE1' HD22 ' A' ' 106' ' ' LEU . 28.5 tt0 -61.14 -38.84 87.82 Favored 'General case' 0 N--CA 1.508 2.438 0 O-C-N 121.595 -0.69 . . . . 0.0 110.768 -175.246 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -100.06 16.3 24.48 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 122.16 -0.337 . . . . 0.0 111.606 177.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 15.4 tp -112.65 111.81 22.88 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.595 -0.69 . . . . 0.0 110.31 -175.028 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -96.54 120.8 61.49 Favored Pre-proline 0 N--CA 1.498 1.974 0 CA-C-O 118.904 -0.57 . . . . 0.0 109.922 173.568 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -71.26 139.03 34.35 Favored 'Trans proline' 0 N--CA 1.49 1.311 0 O-C-N 123.182 1.096 . . . . 0.0 110.164 175.126 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 50.4 p -139.16 150.06 45.17 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 122.094 -0.379 . . . . 0.0 110.125 178.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 17.4 mt . . . . . 0 N--CA 1.502 2.136 0 CA-C-O 118.975 -0.536 . . . . 0.0 110.012 178.934 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo . . . . . 0 N--CA 1.503 2.049 0 N-CA-C 111.187 -0.351 . . . . 0.0 111.187 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -158.55 49.66 0.37 Allowed 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 121.097 0.475 . . . . 0.0 110.898 172.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.426 HD23 HG23 ' A' ' 55' ' ' THR . 20.2 tp -161.53 114.09 1.84 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.696 -0.627 . . . . 0.0 110.276 -175.495 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.4 ' HE2' HG21 ' A' ' 52' ' ' THR . 58.0 tttt -99.76 130.39 45.96 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 122.167 -0.333 . . . . 0.0 110.151 177.406 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 77.4 m -113.86 140.31 48.45 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -179.174 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -84.75 140.76 31.02 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 175.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 28.2 p -114.16 138.09 50.89 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 122.024 -0.422 . . . . 0.0 110.676 -176.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.4 m -122.94 139.44 54.05 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 122.036 -0.415 . . . . 0.0 109.947 176.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.16 -68.27 1.4 Allowed Glycine 0 N--CA 1.496 2.659 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 63.9 m170 -110.8 123.06 49.35 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 122.163 -0.61 . . . . 0.0 110.602 -176.675 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -138.08 136.25 19.4 Favored Pre-proline 0 N--CA 1.497 1.881 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 174.618 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -60.32 152.47 66.68 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 O-C-N 123.062 1.033 . . . . 0.0 111.221 -170.481 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -60.34 -28.15 67.94 Favored 'General case' 0 N--CA 1.507 2.379 0 O-C-N 121.961 -0.462 . . . . 0.0 111.43 -172.616 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -92.07 14.25 16.48 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.955 -0.466 . . . . 0.0 111.782 -178.194 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.89 162.01 26.33 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.631 -0.668 . . . . 0.0 110.308 -172.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 76.7 mt -125.97 139.77 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -177.413 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 38.6 43.29 0.66 Allowed 'General case' 0 N--CA 1.512 2.64 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -177.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 16.2 t30 55.44 42.29 30.12 Favored 'General case' 0 N--CA 1.507 2.418 0 O-C-N 121.811 -0.555 . . . . 0.0 111.467 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.4 HG21 ' HE2' ' A' ' 37' ' ' LYS . 39.2 p -144.38 162.72 35.77 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.76 -0.588 . . . . 0.0 110.658 173.661 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.3 p -139.77 164.95 28.59 Favored 'General case' 0 N--CA 1.499 1.992 0 CA-C-O 120.787 0.327 . . . . 0.0 110.613 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 77.2 mt -113.74 133.05 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -174.34 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.426 HG23 HD23 ' A' ' 36' ' ' LEU . 9.1 t -142.5 154.09 44.2 Favored 'General case' 0 N--CA 1.502 2.143 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.059 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 40.1 p-10 -108.37 30.29 6.57 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 122.109 -0.369 . . . . 0.0 110.608 167.311 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -122.31 -97.78 1.43 Allowed Glycine 0 N--CA 1.497 2.717 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 176.521 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 31.1 m80 -143.8 170.66 15.46 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 122.136 -0.626 . . . . 0.0 109.473 177.195 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 71.4 m -91.85 139.14 30.95 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 164.222 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 15.9 p90 -130.0 148.17 51.83 Favored 'General case' 0 N--CA 1.497 1.9 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.518 -177.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -151.46 141.75 22.37 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 178.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.498 HD12 HD12 ' A' ' 99' ' ' ILE . 18.0 tt -144.17 149.2 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 122.065 -0.397 . . . . 0.0 110.559 -171.603 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.749 HD12 HD21 ' A' ' 73' ' ' LEU . 16.4 tt -134.26 145.21 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 176.679 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -147.94 146.18 28.89 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -167.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.4 tm-20 -101.49 116.83 33.66 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 120.864 0.364 . . . . 0.0 110.179 -176.206 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -87.36 175.24 8.09 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 122.03 -0.419 . . . . 0.0 110.594 -175.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -60.49 -17.51 45.74 Favored 'General case' 0 N--CA 1.506 2.359 0 O-C-N 121.904 -0.498 . . . . 0.0 112.12 -172.622 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -92.89 -11.35 33.7 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.613 -0.679 . . . . 0.0 111.811 178.242 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.56 20.13 42.09 Favored Glycine 0 N--CA 1.497 2.751 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 177.039 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -97.32 145.27 26.28 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 118.49 1.145 . . . . 0.0 109.786 169.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.8 p -94.89 128.8 41.93 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 122.117 -0.364 . . . . 0.0 110.183 178.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 21.4 p -97.98 118.99 35.82 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 122.165 -0.334 . . . . 0.0 110.276 178.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.749 HD21 HD12 ' A' ' 63' ' ' ILE . 23.0 mt -97.61 127.13 43.33 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 122.14 -0.35 . . . . 0.0 110.408 179.179 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -147.98 144.88 28.29 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 122.039 -0.413 . . . . 0.0 110.481 174.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 78.8 p -143.69 167.01 23.28 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 176.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -178.3 -166.5 34.71 Favored Glycine 0 N--CA 1.497 2.709 0 N-CA-C 110.15 -1.18 . . . . 0.0 110.15 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 2.2 m -96.99 132.85 42.38 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 122.172 -0.605 . . . . 0.0 110.415 -176.414 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 56.0 ttm -100.66 122.93 44.15 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 122.097 -0.377 . . . . 0.0 110.15 178.449 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.1 pttm . . . . . 0 N--CA 1.504 2.264 0 O-C-N 122.01 -0.431 . . . . 0.0 110.59 -179.736 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 28.2 ptt-85 . . . . . 0 N--CA 1.494 1.768 0 CA-C-O 120.805 0.336 . . . . 0.0 110.388 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 15.1 m -124.41 147.91 47.95 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 171.524 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.498 HD12 HD12 ' A' ' 62' ' ' ILE . 18.5 tt -143.18 155.99 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 122.0 -0.437 . . . . 0.0 110.284 -174.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.424 ' HB3' HD21 ' A' ' 111' ' ' LEU . 47.7 mt-10 -144.81 149.84 36.14 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 120.723 0.297 . . . . 0.0 110.388 178.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 26.7 p -143.06 142.06 31.45 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 21.8 p -157.55 129.29 6.97 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 122.011 -0.431 . . . . 0.0 110.802 -171.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 53.0 ttp180 -104.02 48.45 0.85 Allowed 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.329 0.585 . . . . 0.0 110.504 -177.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.1 p -135.5 150.72 49.86 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.905 -0.497 . . . . 0.0 109.798 175.122 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 17.6 p-10 -62.5 131.93 50.79 Favored 'General case' 0 N--CA 1.504 2.269 0 CA-C-O 121.388 0.613 . . . . 0.0 111.734 -162.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 79.6 mt 51.76 27.84 4.46 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 122.003 -0.436 . . . . 0.0 111.936 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 26.0 p -62.69 -23.26 67.05 Favored 'General case' 0 N--CA 1.506 2.337 0 O-C-N 121.874 -0.516 . . . . 0.0 111.564 174.504 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -75.5 -29.66 59.58 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.907 -0.495 . . . . 0.0 111.079 177.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -62.16 -39.39 92.49 Favored 'General case' 0 N--CA 1.507 2.399 0 O-C-N 121.764 -0.585 . . . . 0.0 110.826 -169.435 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -100.3 16.16 25.28 Favored 'General case' 0 N--CA 1.498 1.938 0 C-N-CA 120.936 -0.306 . . . . 0.0 111.688 179.064 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.424 HD21 ' HB3' ' A' ' 100' ' ' GLU . 12.2 tp -117.99 108.93 15.86 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.511 -0.743 . . . . 0.0 110.296 -176.18 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -98.7 120.87 57.94 Favored Pre-proline 0 N--CA 1.497 1.896 0 CA-C-O 118.86 -0.59 . . . . 0.0 110.078 174.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -71.15 133.89 23.96 Favored 'Trans proline' 0 N--CA 1.491 1.341 0 O-C-N 123.247 1.13 . . . . 0.0 110.15 172.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 35.0 p -139.16 147.14 41.46 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 122.102 -0.374 . . . . 0.0 110.371 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 27.0 mt . . . . . 0 N--CA 1.502 2.162 0 CA-C-O 119.277 -0.392 . . . . 0.0 110.01 176.607 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo . . . . . 0 N--CA 1.498 1.785 0 N-CA-C 111.208 -0.343 . . . . 0.0 111.208 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -158.32 53.37 0.44 Allowed 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 121.332 0.586 . . . . 0.0 110.264 164.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.404 HD23 HG23 ' A' ' 55' ' ' THR . 19.1 tp -158.41 114.72 2.75 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.803 -0.561 . . . . 0.0 110.032 -179.251 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.44 ' HE3' HD21 ' A' ' 106' ' ' LEU . 35.4 ttpt -99.74 131.6 45.62 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 122.112 -0.367 . . . . 0.0 110.256 178.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 73.3 m -117.87 140.38 49.8 Favored 'General case' 0 N--CA 1.502 2.155 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 -178.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -82.4 146.2 29.46 Favored 'General case' 0 N--CA 1.501 2.079 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.125 178.512 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 27.9 p -116.05 136.99 52.52 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 122.021 -0.424 . . . . 0.0 110.54 -178.287 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 29.1 t -122.29 135.04 54.67 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 122.039 -0.413 . . . . 0.0 110.064 177.531 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.83 -66.52 2.77 Favored Glycine 0 N--CA 1.496 2.698 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -112.42 124.0 51.52 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 122.077 -0.66 . . . . 0.0 110.57 -177.15 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -138.03 136.98 20.21 Favored Pre-proline 0 N--CA 1.496 1.875 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 175.42 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -60.59 151.78 73.26 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 O-C-N 123.171 1.09 . . . . 0.0 111.105 -172.562 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -60.25 -28.1 67.77 Favored 'General case' 0 N--CA 1.508 2.431 0 O-C-N 121.995 -0.441 . . . . 0.0 111.383 -172.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -92.21 14.29 16.63 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.935 -0.478 . . . . 0.0 111.782 -177.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.4 161.98 26.76 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.708 -0.62 . . . . 0.0 110.232 -172.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 71.4 mt -124.76 137.02 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -177.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 19.9 p30 37.81 43.16 0.47 Allowed 'General case' 0 N--CA 1.514 2.773 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -176.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 30.8 m120 55.32 43.08 29.59 Favored 'General case' 0 N--CA 1.509 2.493 0 O-C-N 121.882 -0.511 . . . . 0.0 111.43 -178.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 71.5 p -139.13 160.87 38.77 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.814 -0.554 . . . . 0.0 110.283 171.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.1 p -137.57 161.27 36.88 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-O 120.973 0.416 . . . . 0.0 110.452 178.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 77.7 mt -107.52 131.63 57.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -175.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.404 HG23 HD23 ' A' ' 36' ' ' LEU . 8.4 t -140.07 151.65 45.55 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 122.04 -0.413 . . . . 0.0 110.972 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 49.9 p30 -107.81 30.57 6.21 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 122.127 -0.358 . . . . 0.0 110.585 167.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -122.86 -95.77 1.25 Allowed Glycine 0 N--CA 1.497 2.733 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 176.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 38.1 m-70 -149.59 172.03 15.68 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 122.108 -0.643 . . . . 0.0 109.556 176.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 82.7 m -94.51 139.2 31.46 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 168.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 19.5 p90 -129.06 151.28 49.92 Favored 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.476 -178.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.416 ' HB2' ' ND2' ' A' ' 108' ' ' ASN . . . -151.21 143.39 24.05 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 175.24 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.572 HD12 HD12 ' A' ' 99' ' ' ILE . 18.2 tt -144.02 149.33 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 122.109 -0.369 . . . . 0.0 110.276 -172.274 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.522 HD12 ' HG ' ' A' ' 73' ' ' LEU . 16.5 tt -136.46 145.25 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 178.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -147.99 145.88 28.71 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 122.013 -0.429 . . . . 0.0 109.914 -168.01 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.5 tm-20 -101.61 117.18 34.38 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 120.751 0.31 . . . . 0.0 110.185 -176.423 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 26.6 p-10 -87.6 175.35 7.95 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 122.123 -0.36 . . . . 0.0 110.563 -176.353 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -60.47 -17.24 43.6 Favored 'General case' 0 N--CA 1.506 2.368 0 O-C-N 122.007 -0.433 . . . . 0.0 112.082 -172.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -91.89 -11.57 35.99 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.551 -0.718 . . . . 0.0 111.819 178.128 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.84 20.95 37.98 Favored Glycine 0 N--CA 1.498 2.774 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 176.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -97.58 143.87 27.84 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 118.324 1.062 . . . . 0.0 109.898 170.515 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.8 p -94.84 124.32 38.82 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.234 176.496 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.7 p -97.92 113.72 25.62 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 122.093 -0.38 . . . . 0.0 110.336 178.258 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.542 ' N ' HD12 ' A' ' 73' ' ' LEU . 6.4 mp -97.51 128.35 44.2 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 122.147 -0.346 . . . . 0.0 110.26 -178.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -144.37 147.84 33.93 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 122.099 -0.375 . . . . 0.0 110.349 176.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 87.3 p -143.69 166.18 25.58 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 178.089 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -179.22 -167.11 36.17 Favored Glycine 0 N--CA 1.496 2.69 0 N-CA-C 110.354 -1.098 . . . . 0.0 110.354 -178.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 2.9 m -96.55 132.25 42.34 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 122.187 -0.596 . . . . 0.0 110.25 -175.439 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 51.1 ttm -98.53 121.88 41.02 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.946 -0.471 . . . . 0.0 110.087 176.396 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 26.6 pttt . . . . . 0 N--CA 1.503 2.19 0 O-C-N 122.043 -0.411 . . . . 0.0 110.508 -178.271 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 30.7 ptt180 . . . . . 0 N--CA 1.494 1.736 0 CA-C-O 120.903 0.382 . . . . 0.0 110.557 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 16.6 m -128.69 149.12 50.81 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 172.434 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.572 HD12 HD12 ' A' ' 62' ' ' ILE . 18.6 tt -143.02 156.0 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 122.023 -0.423 . . . . 0.0 110.165 -176.506 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -143.8 151.63 40.19 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 120.947 0.403 . . . . 0.0 110.581 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 89.6 m -141.98 141.31 32.89 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 19.9 p -157.56 137.9 12.78 Favored 'General case' 0 N--CA 1.504 2.243 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.137 -174.164 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 27.8 ttt180 -109.38 45.82 1.04 Allowed 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 121.275 0.56 . . . . 0.0 110.637 -172.056 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.0 p -141.92 152.08 43.22 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.869 -0.519 . . . . 0.0 109.97 178.612 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 17.6 p-10 -61.78 132.68 53.92 Favored 'General case' 0 N--CA 1.505 2.281 0 CA-C-O 121.373 0.606 . . . . 0.0 111.793 -164.375 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.478 HD22 ' OE1' ' A' ' 109' ' ' GLN . 74.4 mt 52.24 26.76 4.18 Favored 'General case' 0 N--CA 1.507 2.416 0 O-C-N 122.048 -0.408 . . . . 0.0 111.966 179.337 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 25.9 p -63.15 -22.2 66.7 Favored 'General case' 0 N--CA 1.507 2.419 0 O-C-N 121.858 -0.526 . . . . 0.0 111.572 175.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.416 ' ND2' ' HB2' ' A' ' 61' ' ' ALA . 4.9 m120 -91.1 -22.95 20.46 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.723 -0.611 . . . . 0.0 111.304 177.498 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLN . . . . . 0.478 ' OE1' HD22 ' A' ' 106' ' ' LEU . 28.3 tt0 -60.97 -37.9 84.08 Favored 'General case' 0 N--CA 1.509 2.504 0 O-C-N 121.595 -0.691 . . . . 0.0 110.721 -176.47 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -100.16 16.22 24.9 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 122.126 -0.359 . . . . 0.0 111.59 177.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 17.4 tp -113.73 112.83 24.1 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.579 -0.701 . . . . 0.0 110.345 -175.168 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 37.8 tt0 -96.48 120.72 61.72 Favored Pre-proline 0 N--CA 1.496 1.872 0 CA-C-O 118.853 -0.594 . . . . 0.0 110.028 173.326 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -71.11 139.33 35.37 Favored 'Trans proline' 0 N--CA 1.49 1.303 0 O-C-N 123.197 1.104 . . . . 0.0 110.326 175.219 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 35.0 p -139.17 149.96 45.05 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 122.113 -0.367 . . . . 0.0 110.206 178.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 17.4 mt . . . . . 0 N--CA 1.502 2.157 0 CA-C-O 118.896 -0.573 . . . . 0.0 110.037 179.318 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo . . . . . 0 N--CA 1.497 1.68 0 N-CA-C 110.978 -0.431 . . . . 0.0 110.978 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -157.84 50.94 0.43 Allowed 'General case' 0 N--CA 1.498 1.967 0 CA-C-O 121.423 0.63 . . . . 0.0 110.407 164.479 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 20.5 tp -158.72 114.88 2.68 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.733 -0.604 . . . . 0.0 110.29 -177.043 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.425 ' HE3' HD21 ' A' ' 106' ' ' LEU . 33.1 ttpt -99.77 132.14 45.3 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 120.95 -0.3 . . . . 0.0 110.233 176.767 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 76.4 m -117.52 140.33 49.75 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -179.46 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -81.86 142.13 32.79 Favored 'General case' 0 N--CA 1.502 2.143 0 C-N-CA 120.535 -0.466 . . . . 0.0 109.961 176.788 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 28.2 p -113.38 136.98 52.17 Favored 'General case' 0 N--CA 1.501 2.111 0 C-N-CA 120.779 -0.368 . . . . 0.0 110.589 -177.318 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.8 m -122.61 142.94 50.11 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 122.095 -0.378 . . . . 0.0 110.021 177.118 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.44 -68.13 1.5 Allowed Glycine 0 N--CA 1.494 2.547 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.535 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -115.27 126.47 54.54 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 122.003 -0.704 . . . . 0.0 110.613 -176.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -137.96 136.25 19.56 Favored Pre-proline 0 N--CA 1.496 1.852 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 174.532 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -60.7 152.65 67.76 Favored 'Trans proline' 0 N--CA 1.497 1.702 0 O-C-N 123.072 1.038 . . . . 0.0 111.194 -170.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -60.25 -28.03 67.7 Favored 'General case' 0 N--CA 1.508 2.44 0 O-C-N 122.021 -0.424 . . . . 0.0 111.34 -173.129 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -92.1 14.39 16.16 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.9 -0.5 . . . . 0.0 111.78 -178.105 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.92 162.04 26.29 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.581 -0.699 . . . . 0.0 110.259 -173.182 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 70.7 mt -124.11 136.45 60.33 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -176.628 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 19.8 p30 37.8 43.15 0.46 Allowed 'General case' 0 N--CA 1.512 2.658 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 -176.505 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 55.5 43.34 28.67 Favored 'General case' 0 N--CA 1.509 2.476 0 O-C-N 121.83 -0.544 . . . . 0.0 111.429 -178.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 56.1 p -139.53 161.98 36.17 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.801 -0.562 . . . . 0.0 110.273 171.076 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.4 p -137.29 160.43 39.07 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-O 120.737 0.304 . . . . 0.0 110.608 178.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 76.5 mt -110.09 132.97 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -174.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.0 t -143.5 155.19 44.27 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.952 -0.468 . . . . 0.0 111.022 -179.395 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 48.9 p30 -108.09 29.31 7.43 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 122.036 -0.415 . . . . 0.0 110.705 167.181 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -119.59 -102.63 1.99 Allowed Glycine 0 N--CA 1.497 2.741 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 176.781 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 24.6 m-70 -140.89 169.75 17.03 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 122.007 -0.702 . . . . 0.0 109.709 177.19 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 78.0 m -93.13 139.24 30.79 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 166.16 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -129.38 149.58 51.1 Favored 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.486 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -152.12 138.4 18.42 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 176.198 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.579 HD12 HD12 ' A' ' 99' ' ' ILE . 18.2 tt -136.36 149.05 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 CA-C-O 120.961 0.41 . . . . 0.0 110.459 -168.552 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.791 HD12 HD21 ' A' ' 73' ' ' LEU . 16.3 tt -132.36 145.11 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 177.609 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -149.79 143.43 25.37 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 -169.67 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.6 tm-20 -101.64 117.68 35.38 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 122.169 -0.332 . . . . 0.0 110.119 -177.049 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 51.7 p30 -87.05 175.34 8.16 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 122.132 -0.355 . . . . 0.0 110.676 -175.755 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -60.44 -17.55 45.35 Favored 'General case' 0 N--CA 1.507 2.413 0 O-C-N 121.941 -0.474 . . . . 0.0 112.069 -173.481 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -93.18 -10.71 34.81 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.589 -0.695 . . . . 0.0 111.9 178.481 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 89.99 21.16 40.1 Favored Glycine 0 N--CA 1.498 2.785 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 178.055 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -96.98 143.79 27.51 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-N 118.312 1.056 . . . . 0.0 109.77 170.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 15.8 p -94.81 126.54 40.2 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 122.069 -0.395 . . . . 0.0 110.2 177.71 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 20.7 p -97.91 117.56 32.51 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 122.13 -0.357 . . . . 0.0 110.298 179.031 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.791 HD21 HD12 ' A' ' 63' ' ' ILE . 83.7 mt -97.7 128.18 44.19 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 122.136 -0.353 . . . . 0.0 110.295 -179.617 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -146.98 144.7 29.38 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 122.079 -0.388 . . . . 0.0 110.523 175.548 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 97.0 p -143.72 167.02 23.26 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 177.48 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -178.26 -169.14 38.69 Favored Glycine 0 N--CA 1.496 2.659 0 N-CA-C 110.224 -1.15 . . . . 0.0 110.224 -179.197 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 2.9 m -96.17 132.77 41.24 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 122.175 -0.603 . . . . 0.0 110.181 -176.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 54.9 ttm -98.92 122.01 41.62 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 122.052 -0.405 . . . . 0.0 110.071 175.233 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 17.5 pttm . . . . . 0 N--CA 1.503 2.191 0 O-C-N 122.024 -0.423 . . . . 0.0 110.48 -179.028 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 46.4 ptt85 . . . . . 0 N--CA 1.495 1.81 0 CA-C-O 120.824 0.345 . . . . 0.0 110.594 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 18.1 m -128.75 148.78 50.87 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 172.605 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.579 HD12 HD12 ' A' ' 62' ' ' ILE . 18.4 tt -143.18 127.38 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.997 -0.439 . . . . 0.0 110.167 -176.263 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -105.81 149.23 26.68 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 122.234 -0.291 . . . . 0.0 110.455 177.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 26.7 p -143.02 134.63 26.46 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 177.575 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 20.4 p -157.57 131.38 8.04 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.926 -0.484 . . . . 0.0 110.81 -170.034 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 21.6 ttp-105 -104.86 48.48 0.84 Allowed 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 121.385 0.612 . . . . 0.0 110.604 -176.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.0 p -135.12 151.36 50.63 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.895 -0.503 . . . . 0.0 109.785 174.117 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 15.7 p30 -61.77 132.24 52.51 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 121.724 -0.61 . . . . 0.0 111.793 -163.257 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.425 HD21 ' HE3' ' A' ' 37' ' ' LYS . 75.3 mt 52.0 26.55 3.8 Favored 'General case' 0 N--CA 1.507 2.376 0 O-C-N 122.089 -0.382 . . . . 0.0 111.991 179.394 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 26.3 p -63.11 -21.99 66.56 Favored 'General case' 0 N--CA 1.506 2.363 0 O-C-N 121.849 -0.532 . . . . 0.0 111.583 176.503 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -93.04 -22.93 18.85 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.684 -0.635 . . . . 0.0 111.323 178.009 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -60.66 -38.6 85.42 Favored 'General case' 0 N--CA 1.508 2.436 0 O-C-N 121.577 -0.702 . . . . 0.0 110.768 -177.137 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -100.74 16.23 25.67 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 122.078 -0.389 . . . . 0.0 111.685 179.207 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 16.8 tp -111.87 117.34 32.52 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.586 -0.697 . . . . 0.0 110.394 -174.324 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 3.3 tp-100 -96.45 120.71 61.79 Favored Pre-proline 0 N--CA 1.496 1.868 0 CA-C-O 118.862 -0.589 . . . . 0.0 109.965 171.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -69.93 145.22 55.51 Favored 'Trans proline' 0 N--CA 1.491 1.347 0 O-C-N 123.235 1.124 . . . . 0.0 110.291 175.49 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 34.5 p -139.22 147.05 41.25 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 122.175 -0.328 . . . . 0.0 110.156 179.148 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 14.9 mt . . . . . 0 N--CA 1.502 2.166 0 CA-C-O 119.305 -0.379 . . . . 0.0 110.152 178.987 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo . . . . . 0 N--CA 1.502 2.011 0 N-CA-C 111.224 -0.337 . . . . 0.0 111.224 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -151.73 47.99 0.8 Allowed 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 121.188 0.518 . . . . 0.0 110.743 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.433 HD23 HG23 ' A' ' 55' ' ' THR . 18.9 tp -161.0 115.01 2.05 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.771 -0.581 . . . . 0.0 110.449 -174.475 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 48.6 tttt -99.81 132.5 45.12 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 122.146 -0.347 . . . . 0.0 110.223 177.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 86.4 m -118.97 140.43 50.01 Favored 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 -178.614 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -83.07 144.49 29.86 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 122.027 -0.421 . . . . 0.0 110.015 176.273 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 28.1 p -115.67 137.07 52.44 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.952 -0.467 . . . . 0.0 110.588 -178.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 98.6 p -123.02 141.57 51.82 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 109.894 -0.409 . . . . 0.0 109.894 175.724 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.18 -68.16 1.41 Allowed Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -112.15 123.59 50.59 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.997 -0.708 . . . . 0.0 110.498 -176.815 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -138.07 136.99 20.14 Favored Pre-proline 0 N--CA 1.496 1.87 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 174.108 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -61.11 152.52 70.99 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 O-C-N 123.087 1.046 . . . . 0.0 111.077 -172.61 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -60.44 -28.21 68.11 Favored 'General case' 0 N--CA 1.508 2.462 0 O-C-N 121.88 -0.512 . . . . 0.0 111.415 -172.495 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -91.97 14.26 16.27 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.953 -0.467 . . . . 0.0 111.735 -177.662 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.86 161.97 27.22 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.533 -0.73 . . . . 0.0 110.243 -173.515 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 70.7 mt -124.36 136.38 60.69 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -177.154 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 19.8 p30 37.78 43.36 0.48 Allowed 'General case' 0 N--CA 1.515 2.776 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -176.547 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 30.8 m120 55.39 44.0 27.88 Favored 'General case' 0 N--CA 1.507 2.386 0 O-C-N 121.785 -0.572 . . . . 0.0 111.466 -178.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 58.2 p -140.76 161.75 37.05 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.725 -0.609 . . . . 0.0 110.306 171.174 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.4 p -139.66 165.07 28.26 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-O 120.752 0.311 . . . . 0.0 110.691 179.235 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 76.4 mt -111.91 132.53 60.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 -175.534 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.433 HG23 HD23 ' A' ' 36' ' ' LEU . 9.1 t -140.44 153.05 46.14 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 122.027 -0.421 . . . . 0.0 111.059 -179.522 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 48.5 p30 -108.61 29.96 6.92 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 122.037 -0.415 . . . . 0.0 110.672 167.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -122.89 -96.05 1.26 Allowed Glycine 0 N--CA 1.497 2.73 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 176.244 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 49.7 m-70 -144.5 171.03 14.93 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 122.136 -0.626 . . . . 0.0 109.761 176.716 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 73.7 m -92.96 139.09 30.89 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 164.354 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -129.52 150.34 50.9 Favored 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 120.291 -0.564 . . . . 0.0 110.613 -178.611 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -151.26 143.98 24.39 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 175.362 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.487 HD12 HD12 ' A' ' 99' ' ' ILE . 18.1 tt -143.29 149.26 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.397 -171.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.668 HD12 HD21 ' A' ' 73' ' ' LEU . 13.5 tt -134.28 145.32 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 177.68 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -148.58 145.15 27.69 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 -169.471 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.3 tm-20 -101.53 116.94 33.9 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 122.146 -0.346 . . . . 0.0 110.134 -176.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -87.4 175.33 8.04 Favored 'General case' 0 N--CA 1.501 2.101 0 CA-C-O 120.796 0.332 . . . . 0.0 110.584 -175.384 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -60.44 -17.86 47.35 Favored 'General case' 0 N--CA 1.506 2.372 0 O-C-N 121.895 -0.503 . . . . 0.0 112.0 -172.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -92.85 -10.37 36.96 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.599 -0.688 . . . . 0.0 111.861 178.299 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 89.47 20.21 45.73 Favored Glycine 0 N--CA 1.498 2.791 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 176.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -97.38 145.74 25.86 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-N 118.466 1.133 . . . . 0.0 109.793 169.386 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 13.6 p -94.92 129.16 42.06 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 122.106 -0.371 . . . . 0.0 110.26 178.49 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 20.9 p -97.86 118.16 33.81 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 122.057 -0.402 . . . . 0.0 110.353 178.476 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.668 HD21 HD12 ' A' ' 63' ' ' ILE . 23.2 mt -97.53 126.87 43.07 Favored 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 120.966 -0.294 . . . . 0.0 110.307 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -145.18 143.41 30.3 Favored 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.646 174.609 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 98.9 p -143.85 167.06 23.2 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 176.204 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 178.91 -165.66 34.8 Favored Glycine 0 N--CA 1.496 2.663 0 N-CA-C 110.379 -1.088 . . . . 0.0 110.379 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 2.6 m -96.27 132.4 41.78 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 122.178 -0.601 . . . . 0.0 110.227 -176.242 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 55.8 ttm -98.49 121.82 40.91 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 122.069 -0.394 . . . . 0.0 110.156 177.176 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 22.5 pttt . . . . . 0 N--CA 1.503 2.199 0 C-N-CA 120.699 -0.401 . . . . 0.0 110.537 -178.9 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 33.4 ptt-85 . . . . . 0 N--CA 1.496 1.833 0 CA-C-O 120.984 0.421 . . . . 0.0 110.575 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 17.0 m -126.81 149.06 49.88 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 171.289 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.487 HD12 HD12 ' A' ' 62' ' ' ILE . 18.5 tt -143.14 155.92 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.963 -0.461 . . . . 0.0 110.308 -175.28 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 57.1 mm-40 -141.46 147.75 38.39 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 120.866 0.365 . . . . 0.0 110.412 179.299 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 26.8 p -143.1 136.84 28.69 Favored 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 179.597 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 18.9 p -157.5 132.53 8.8 Favored 'General case' 0 N--CA 1.504 2.244 0 O-C-N 121.97 -0.456 . . . . 0.0 110.973 -171.026 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 22.4 ttm180 -105.14 48.68 0.83 Allowed 'General case' 0 N--CA 1.498 1.974 0 CA-C-O 121.382 0.61 . . . . 0.0 110.559 -177.043 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 23.8 p -136.02 151.16 49.59 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.714 -0.616 . . . . 0.0 109.799 174.522 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -61.73 131.98 51.68 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.69 -0.631 . . . . 0.0 111.821 -163.296 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 72.9 mt 52.28 26.4 4.0 Favored 'General case' 0 N--CA 1.506 2.36 0 O-C-N 122.047 -0.408 . . . . 0.0 111.948 179.306 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 26.4 p -62.86 -22.06 66.42 Favored 'General case' 0 N--CA 1.507 2.422 0 O-C-N 121.859 -0.526 . . . . 0.0 111.615 176.35 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -92.21 -22.86 19.57 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.83 -0.544 . . . . 0.0 111.331 177.218 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -60.76 -38.1 84.09 Favored 'General case' 0 N--CA 1.507 2.395 0 O-C-N 121.635 -0.666 . . . . 0.0 110.775 -177.362 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -100.24 16.26 24.88 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 122.179 -0.325 . . . . 0.0 111.701 178.191 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 14.0 tp -116.9 111.53 19.78 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.492 -0.755 . . . . 0.0 110.289 -175.025 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 21.9 tp60 -96.49 120.7 61.74 Favored Pre-proline 0 N--CA 1.497 1.893 0 CA-C-O 118.756 -0.64 . . . . 0.0 109.982 172.274 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.69 133.89 21.12 Favored 'Trans proline' 0 N--CA 1.49 1.296 0 O-C-N 123.237 1.125 . . . . 0.0 110.395 176.53 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 34.9 p -139.22 147.84 42.3 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 122.004 -0.435 . . . . 0.0 110.048 177.264 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 13.5 mt . . . . . 0 N--CA 1.502 2.128 0 CA-C-O 119.01 -0.519 . . . . 0.0 109.929 179.56 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo . . . . . 0 N--CA 1.502 1.996 0 N-CA-C 111.237 -0.332 . . . . 0.0 111.237 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -155.38 47.29 0.51 Allowed 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.931 -0.481 . . . . 0.0 110.752 172.804 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 25.1 tp -159.33 102.77 1.59 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.767 -0.583 . . . . 0.0 110.396 -173.026 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 41.0 tttp -99.91 119.07 37.64 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 110.288 -0.264 . . . . 0.0 110.288 177.49 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 69.2 m -121.73 140.63 52.09 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 122.078 -0.389 . . . . 0.0 110.945 -178.485 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -79.7 155.44 28.01 Favored 'General case' 0 N--CA 1.501 2.087 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.07 -178.358 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 27.2 p -119.3 141.14 49.25 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.996 -0.44 . . . . 0.0 110.529 -179.356 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 49.7 m -122.98 138.93 54.55 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 122.086 -0.383 . . . . 0.0 110.169 177.627 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.52 -68.38 1.51 Allowed Glycine 0 N--CA 1.496 2.661 0 N-CA-C 109.669 -1.373 . . . . 0.0 109.669 178.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 83.2 t60 -112.97 125.79 54.78 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 122.073 -0.663 . . . . 0.0 110.537 -176.402 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -138.03 137.68 21.73 Favored Pre-proline 0 N--CA 1.496 1.839 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 176.17 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -61.11 150.89 82.18 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 O-C-N 123.049 1.026 . . . . 0.0 111.072 -174.001 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -59.77 -27.18 66.32 Favored 'General case' 0 N--CA 1.507 2.41 0 O-C-N 121.938 -0.477 . . . . 0.0 111.463 -173.083 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -92.17 14.23 16.74 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.871 -0.518 . . . . 0.0 111.746 -177.665 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.63 162.03 25.53 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.655 -0.653 . . . . 0.0 110.333 -173.561 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 76.2 mt -125.75 140.52 48.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -178.204 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 38.8 42.08 0.59 Allowed 'General case' 0 N--CA 1.513 2.696 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -178.519 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 30.7 m120 54.96 41.8 31.59 Favored 'General case' 0 N--CA 1.509 2.511 0 O-C-N 121.955 -0.465 . . . . 0.0 111.437 -178.784 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 43.1 p -140.54 161.77 36.95 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.825 -0.547 . . . . 0.0 110.332 173.722 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.4 p -138.38 163.32 32.18 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 120.967 0.413 . . . . 0.0 110.542 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 79.1 mt -129.33 125.32 61.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -168.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.2 t -143.6 158.25 43.81 Favored 'General case' 0 N--CA 1.501 2.12 0 C-N-CA 120.578 -0.449 . . . . 0.0 111.337 -177.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 10.6 p-10 -109.58 29.23 7.77 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 122.168 -0.333 . . . . 0.0 110.473 165.211 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -112.44 -103.66 2.67 Favored Glycine 0 N--CA 1.496 2.662 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 178.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 22.9 m80 -147.22 158.88 44.11 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 170.026 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 87.5 m -96.71 139.35 32.9 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 176.476 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -129.01 158.36 39.11 Favored 'General case' 0 N--CA 1.497 1.915 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.694 -171.093 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -150.98 143.86 24.55 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 176.678 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.476 HD12 HD12 ' A' ' 99' ' ' ILE . 18.2 tt -142.21 149.15 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.444 -170.417 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.858 HD12 HD21 ' A' ' 73' ' ' LEU . 15.4 tt -137.88 145.11 29.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 178.327 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -150.04 140.85 22.74 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 -170.117 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.1 tm-20 -101.67 116.54 32.98 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -86.78 175.23 8.33 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 122.068 -0.395 . . . . 0.0 110.582 -175.401 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -60.65 -17.49 47.74 Favored 'General case' 0 N--CA 1.507 2.423 0 O-C-N 122.076 -0.39 . . . . 0.0 112.002 -172.748 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -92.49 -10.82 36.42 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.628 -0.67 . . . . 0.0 111.855 178.035 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.14 20.91 40.5 Favored Glycine 0 N--CA 1.497 2.757 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 176.335 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -97.49 142.8 28.88 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 118.378 1.089 . . . . 0.0 109.784 169.762 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.3 p -94.91 128.83 41.99 Favored 'General case' 0 N--CA 1.498 1.961 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.273 177.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.1 p -98.05 114.33 26.46 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 120.851 0.358 . . . . 0.0 110.232 177.526 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.858 HD21 HD12 ' A' ' 63' ' ' ILE . 82.4 mt -96.66 123.98 40.51 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 122.169 -0.332 . . . . 0.0 110.235 179.646 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -145.23 147.88 32.9 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 122.087 -0.383 . . . . 0.0 110.465 178.368 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 92.5 p -143.57 164.99 28.83 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 176.129 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -173.98 -178.96 44.3 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 -177.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 6.6 m -100.08 133.46 44.43 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 122.203 -0.587 . . . . 0.0 110.309 -178.128 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 35.2 ttm -99.85 123.13 43.78 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 122.038 -0.414 . . . . 0.0 110.167 176.505 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 24.5 pttt . . . . . 0 N--CA 1.504 2.27 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.381 177.039 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 62.1 ttp85 . . . . . 0 N--CA 1.495 1.818 0 CA-C-O 120.901 0.382 . . . . 0.0 110.147 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 12.2 m -134.26 149.09 50.92 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 172.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.476 HD12 HD12 ' A' ' 62' ' ' ILE . 18.6 tt -143.06 155.99 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 177.138 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -145.95 156.64 43.65 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 120.873 0.368 . . . . 0.0 110.474 -178.274 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 97.0 m -141.81 154.12 44.98 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 178.628 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 25.4 p -157.6 133.34 9.22 Favored 'General case' 0 N--CA 1.502 2.146 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.842 -170.465 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 48.9 ttt85 -109.46 45.91 1.04 Allowed 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.299 0.571 . . . . 0.0 110.516 -179.172 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 44.2 p -138.1 151.97 48.31 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.805 -0.559 . . . . 0.0 110.055 176.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 21.3 p30 -64.12 140.46 58.87 Favored 'General case' 0 N--CA 1.505 2.292 0 CA-C-O 121.315 0.579 . . . . 0.0 111.198 -169.445 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 20.3 mt 53.07 25.85 4.44 Favored 'General case' 0 N--CA 1.507 2.39 0 O-C-N 121.814 -0.554 . . . . 0.0 112.289 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 27.9 p -67.84 -25.18 65.42 Favored 'General case' 0 N--CA 1.505 2.275 0 C-N-CA 119.968 -0.693 . . . . 0.0 111.164 172.567 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -81.09 -33.79 33.09 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.723 -0.611 . . . . 0.0 110.463 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' GLN . . . . . 0.475 ' NE2' ' CZ ' ' A' ' 110' ' ' TYR . 12.2 tt0 -63.06 -40.73 98.57 Favored 'General case' 0 N--CA 1.506 2.358 0 O-C-N 122.002 -0.436 . . . . 0.0 110.89 -177.332 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.475 ' CZ ' ' NE2' ' A' ' 109' ' ' GLN . 67.0 m-85 -102.4 16.26 26.79 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 122.067 -0.395 . . . . 0.0 111.978 -174.221 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 13.5 tp -125.84 109.05 12.06 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.535 -0.728 . . . . 0.0 110.37 -176.789 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -98.33 120.78 58.74 Favored Pre-proline 0 N--CA 1.497 1.889 0 CA-C-O 118.799 -0.619 . . . . 0.0 110.132 173.456 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -68.84 147.13 68.06 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 O-C-N 123.234 1.123 . . . . 0.0 110.205 175.576 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 35.3 p -139.17 149.98 45.07 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 122.133 -0.355 . . . . 0.0 110.169 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 64.1 mt . . . . . 0 N--CA 1.502 2.145 0 CA-C-O 119.187 -0.435 . . . . 0.0 110.138 179.723 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_exo . . . . . 0 N--CA 1.498 1.757 0 N-CA-C 110.942 -0.445 . . . . 0.0 110.942 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -156.12 51.33 0.53 Allowed 'General case' 0 N--CA 1.498 1.971 0 CA-C-O 121.364 0.602 . . . . 0.0 110.372 164.565 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.436 HD23 HG23 ' A' ' 55' ' ' THR . 20.8 tp -158.26 114.81 2.81 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.615 -0.678 . . . . 0.0 110.29 -178.547 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 55.5 tttt -99.79 130.09 45.96 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 178.245 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 80.1 m -114.62 140.21 49.0 Favored 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.231 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -84.5 142.79 29.79 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 176.547 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 28.1 p -113.88 137.67 51.35 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 122.052 -0.405 . . . . 0.0 110.595 -177.644 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 28.0 t -122.95 133.05 54.4 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 122.089 -0.382 . . . . 0.0 110.109 178.403 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.75 -66.26 2.77 Favored Glycine 0 N--CA 1.495 2.586 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 63.9 m170 -110.79 123.34 49.88 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 122.069 -0.665 . . . . 0.0 110.554 -177.366 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -138.1 136.01 19.14 Favored Pre-proline 0 N--CA 1.496 1.858 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 175.331 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -60.54 152.69 66.46 Favored 'Trans proline' 0 N--CA 1.496 1.662 0 O-C-N 123.024 1.013 . . . . 0.0 111.201 -170.108 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -60.36 -28.15 67.95 Favored 'General case' 0 N--CA 1.507 2.377 0 O-C-N 122.04 -0.412 . . . . 0.0 111.365 -172.687 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -92.32 14.35 16.68 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.985 -0.447 . . . . 0.0 111.763 -178.329 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.45 162.07 27.47 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.554 -0.716 . . . . 0.0 110.217 -172.024 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.419 HG22 HD22 ' A' ' 50' ' ' ASN . 68.7 mt -126.06 137.59 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -176.897 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.419 HD22 HG22 ' A' ' 49' ' ' ILE . 17.2 p30 37.82 43.31 0.48 Allowed 'General case' 0 N--CA 1.512 2.675 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -175.574 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 24.9 t30 56.1 42.66 28.08 Favored 'General case' 0 N--CA 1.508 2.457 0 O-C-N 121.805 -0.559 . . . . 0.0 111.451 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 44.3 p -142.02 165.24 27.99 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.765 -0.584 . . . . 0.0 110.555 171.7 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.6 p -137.8 163.7 30.74 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 122.166 -0.333 . . . . 0.0 110.567 176.685 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 77.0 mt -112.55 132.57 60.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -175.341 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.436 HG23 HD23 ' A' ' 36' ' ' LEU . 9.1 t -139.62 152.78 47.06 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.95 -0.469 . . . . 0.0 111.104 -178.002 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -108.92 31.25 5.82 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 122.116 -0.365 . . . . 0.0 110.432 167.098 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -124.79 -95.85 1.09 Allowed Glycine 0 N--CA 1.496 2.648 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 176.171 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 23.3 m80 -146.86 171.91 14.48 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 122.076 -0.661 . . . . 0.0 109.507 177.53 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 74.8 m -93.78 139.25 31.07 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 166.485 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -130.41 148.65 52.25 Favored 'General case' 0 N--CA 1.499 2.006 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.49 -178.384 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -151.9 143.5 23.55 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 177.646 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.549 HD12 HD12 ' A' ' 99' ' ' ILE . 18.3 tt -145.15 149.27 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 122.063 -0.398 . . . . 0.0 110.479 -171.628 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.658 HD12 HD21 ' A' ' 73' ' ' LEU . 15.4 tt -135.75 145.32 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 176.319 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -148.2 148.49 30.58 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 -169.683 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.4 tm-20 -101.6 117.51 35.06 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 -175.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -87.38 175.28 8.06 Favored 'General case' 0 N--CA 1.501 2.093 0 CA-C-O 120.796 0.331 . . . . 0.0 110.582 -175.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -60.84 -17.57 50.74 Favored 'General case' 0 N--CA 1.506 2.347 0 O-C-N 121.988 -0.445 . . . . 0.0 111.954 -172.552 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -92.63 -10.86 35.86 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.678 -0.639 . . . . 0.0 111.801 178.238 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.54 19.33 45.26 Favored Glycine 0 N--CA 1.497 2.766 0 O-C-N 121.469 -0.769 . . . . 0.0 111.194 177.003 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -97.2 145.37 26.12 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-N 118.483 1.141 . . . . 0.0 109.818 169.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.9 p -94.72 128.54 41.48 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 122.079 -0.388 . . . . 0.0 110.342 178.116 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 19.8 p -97.96 116.25 29.79 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 122.134 -0.354 . . . . 0.0 110.354 178.248 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.658 HD21 HD12 ' A' ' 63' ' ' ILE . 14.7 mt -97.42 126.58 42.76 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 122.152 -0.342 . . . . 0.0 110.423 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -145.75 144.82 30.56 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 120.811 -0.355 . . . . 0.0 110.434 175.294 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 80.1 p -143.72 165.55 27.35 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 176.818 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -178.02 -166.87 35.17 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 110.226 -1.15 . . . . 0.0 110.226 -178.698 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 2.7 m -97.32 132.68 42.82 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 122.212 -0.581 . . . . 0.0 110.309 -175.687 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 47.3 ttm -99.1 123.33 43.32 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 122.028 -0.42 . . . . 0.0 110.197 178.36 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 23.5 pttm . . . . . 0 N--CA 1.504 2.241 0 O-C-N 122.049 -0.407 . . . . 0.0 110.642 -178.881 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 16.9 ptt-85 . . . . . 0 N--CA 1.495 1.776 0 CA-C-O 120.841 0.353 . . . . 0.0 110.332 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 15.2 m -128.56 149.14 50.75 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 173.768 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.549 HD12 HD12 ' A' ' 62' ' ' ILE . 18.5 tt -143.09 155.77 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 122.064 -0.397 . . . . 0.0 109.976 -179.111 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.454 ' HB3' HD21 ' A' ' 111' ' ' LEU . 45.2 mt-10 -143.02 149.76 38.69 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 120.932 0.396 . . . . 0.0 110.506 -178.729 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 25.6 p -143.06 137.78 29.46 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -178.124 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 22.6 p -157.39 131.7 8.4 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.895 -0.503 . . . . 0.0 110.979 -172.545 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 30.4 ttp180 -105.83 44.81 1.01 Allowed 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 121.285 0.564 . . . . 0.0 110.532 -176.072 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.0 p -135.19 150.89 50.21 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.929 -0.482 . . . . 0.0 109.931 177.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 17.6 p-10 -62.82 131.81 50.08 Favored 'General case' 0 N--CA 1.504 2.228 0 CA-C-O 121.436 0.636 . . . . 0.0 111.635 -163.191 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 81.2 mt 51.76 28.13 4.69 Favored 'General case' 0 N--CA 1.506 2.355 0 O-C-N 121.927 -0.483 . . . . 0.0 111.934 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 25.8 p -62.46 -23.85 67.12 Favored 'General case' 0 N--CA 1.506 2.36 0 O-C-N 121.823 -0.548 . . . . 0.0 111.53 173.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -75.31 -30.0 60.22 Favored 'General case' 0 N--CA 1.504 2.241 0 O-C-N 121.811 -0.556 . . . . 0.0 111.046 177.705 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -62.3 -39.63 93.63 Favored 'General case' 0 N--CA 1.506 2.339 0 O-C-N 121.673 -0.642 . . . . 0.0 110.81 -168.686 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -100.17 16.11 25.27 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 122.176 -0.328 . . . . 0.0 111.693 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.454 HD21 ' HB3' ' A' ' 100' ' ' GLU . 12.5 tp -116.36 108.95 16.71 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.597 -0.69 . . . . 0.0 110.347 -175.256 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -99.45 120.72 57.1 Favored Pre-proline 0 N--CA 1.497 1.903 0 CA-C-O 118.955 -0.545 . . . . 0.0 110.125 173.626 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -68.79 137.41 38.31 Favored 'Trans proline' 0 N--CA 1.49 1.277 0 O-C-N 123.158 1.083 . . . . 0.0 110.157 172.385 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 34.7 p -139.29 146.8 40.8 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.119 178.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 21.0 mt . . . . . 0 N--CA 1.503 2.205 0 C-N-CA 120.685 -0.406 . . . . 0.0 109.94 179.233 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo . . . . . 0 N--CA 1.499 1.807 0 N-CA-C 111.19 -0.35 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -161.76 54.21 0.25 Allowed 'General case' 0 N--CA 1.5 2.034 0 CA-C-O 121.359 0.6 . . . . 0.0 110.281 165.149 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 21.6 tp -157.63 115.47 3.08 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.748 -0.595 . . . . 0.0 109.919 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.3 tptt -99.67 131.1 45.88 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 122.18 -0.325 . . . . 0.0 110.162 -178.349 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 72.6 m -121.12 140.59 51.78 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -176.325 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -83.71 144.15 29.56 Favored 'General case' 0 N--CA 1.5 2.033 0 C-N-CA 120.601 -0.44 . . . . 0.0 109.9 176.136 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 27.1 p -118.57 136.96 53.56 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 122.056 -0.403 . . . . 0.0 110.568 -177.1 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.4 m -123.0 141.19 52.24 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 122.059 -0.4 . . . . 0.0 110.088 177.692 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 75.89 -67.14 2.39 Favored Glycine 0 N--CA 1.496 2.636 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.263 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -116.68 123.68 47.86 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 122.132 -0.628 . . . . 0.0 110.579 -176.739 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -138.08 136.75 19.91 Favored Pre-proline 0 N--CA 1.497 1.891 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 174.607 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -61.31 151.77 76.98 Favored 'Trans proline' 0 N--CA 1.496 1.633 0 O-C-N 123.114 1.06 . . . . 0.0 111.094 -172.008 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -59.21 -25.72 64.23 Favored 'General case' 0 N--CA 1.507 2.394 0 O-C-N 122.032 -0.418 . . . . 0.0 111.625 -173.141 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -91.57 14.27 15.47 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.944 -0.473 . . . . 0.0 111.899 -176.691 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -82.67 161.53 22.12 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.565 -0.71 . . . . 0.0 110.242 -175.695 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 76.4 mt -125.74 139.38 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -178.652 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 38.42 42.26 0.52 Allowed 'General case' 0 N--CA 1.513 2.708 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -177.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 55.16 42.37 30.71 Favored 'General case' 0 N--CA 1.509 2.494 0 O-C-N 121.921 -0.487 . . . . 0.0 111.487 -178.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 27.4 p -140.43 157.49 45.44 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.878 -0.514 . . . . 0.0 110.402 172.612 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.8 p -145.82 165.82 27.75 Favored 'General case' 0 N--CA 1.499 1.988 0 CA-C-O 121.0 0.429 . . . . 0.0 110.718 -172.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 78.0 mt -123.58 120.32 59.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -166.544 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.9 t -135.8 153.26 51.57 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-O 121.0 0.428 . . . . 0.0 110.965 -174.374 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 44.3 p-10 -102.57 30.15 4.83 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 122.121 -0.362 . . . . 0.0 110.659 170.34 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -122.45 -108.33 1.97 Allowed Glycine 0 N--CA 1.496 2.658 0 N-CA-C 109.08 -1.608 . . . . 0.0 109.08 172.671 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -141.18 172.14 13.09 Favored 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -176.655 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 67.0 m -97.68 139.27 33.82 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 170.266 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -135.47 155.79 49.96 Favored 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 120.053 -0.659 . . . . 0.0 110.952 -176.694 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -151.06 150.66 30.98 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.392 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 18.4 tt -143.15 149.14 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 CA-C-O 120.904 0.383 . . . . 0.0 110.364 -172.179 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.823 HD12 HD11 ' A' ' 73' ' ' LEU . 16.0 tt -138.01 145.2 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 177.35 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -150.21 141.18 22.92 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 122.109 -0.369 . . . . 0.0 110.04 -170.597 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.0 tm-20 -101.69 116.52 32.93 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -86.67 175.25 8.37 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 122.212 -0.305 . . . . 0.0 110.59 -175.289 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -60.74 -17.5 48.97 Favored 'General case' 0 N--CA 1.506 2.35 0 O-C-N 122.032 -0.417 . . . . 0.0 111.998 -172.699 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -92.56 -10.8 36.3 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.668 -0.645 . . . . 0.0 111.819 178.047 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.1 20.95 40.49 Favored Glycine 0 N--CA 1.496 2.641 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 176.411 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -97.59 142.01 29.93 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-N 118.368 1.084 . . . . 0.0 109.893 169.621 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 10.9 p -94.84 129.62 41.74 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 122.168 -0.333 . . . . 0.0 110.36 178.153 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 17.9 p -97.85 112.94 24.66 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 122.147 -0.346 . . . . 0.0 110.324 177.153 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.823 HD11 HD12 ' A' ' 63' ' ' ILE . 4.6 mm? -97.36 122.31 40.25 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 122.124 -0.36 . . . . 0.0 110.254 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -144.99 155.66 43.51 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 122.004 -0.435 . . . . 0.0 110.541 178.456 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 91.0 p -143.51 162.89 34.66 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 176.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -158.81 -177.76 32.19 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 110.289 -1.124 . . . . 0.0 110.289 -173.127 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 1.7 m -113.09 115.71 28.74 Favored 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 -169.293 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 49.8 ttm -95.88 121.93 38.14 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.878 -0.514 . . . . 0.0 110.474 -170.302 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 22.1 pttt . . . . . 0 N--CA 1.503 2.209 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.412 175.695 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 30.1 ptt180 . . . . . 0 N--CA 1.496 1.862 0 CA-C-O 120.808 0.337 . . . . 0.0 110.7 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 24.3 m -133.95 149.39 51.25 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 177.511 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.6 tt -141.75 156.06 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 122.017 -0.427 . . . . 0.0 109.94 -178.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 51.6 mm-40 -143.86 151.43 39.87 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 122.146 -0.346 . . . . 0.0 110.615 -176.818 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 99.0 m -142.89 149.37 38.41 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 176.423 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 15.4 p -157.51 141.31 15.86 Favored 'General case' 0 N--CA 1.502 2.155 0 CA-C-O 121.07 0.462 . . . . 0.0 110.951 -173.593 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 68.8 mtp180 -110.55 49.51 0.85 Allowed 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.377 0.608 . . . . 0.0 110.693 -169.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.1 p -148.66 152.26 36.38 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.793 -0.567 . . . . 0.0 109.966 178.561 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -60.96 132.02 52.52 Favored 'General case' 0 N--CA 1.507 2.376 0 O-C-N 121.646 -0.659 . . . . 0.0 111.81 -163.664 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 69.1 mt 52.49 26.03 3.97 Favored 'General case' 0 N--CA 1.507 2.387 0 O-C-N 122.085 -0.385 . . . . 0.0 111.925 179.115 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 26.1 p -62.71 -21.97 66.18 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 121.853 -0.529 . . . . 0.0 111.762 177.489 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -90.09 -22.9 21.57 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.748 -0.595 . . . . 0.0 111.275 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -60.45 -38.9 85.62 Favored 'General case' 0 N--CA 1.509 2.488 0 O-C-N 121.58 -0.7 . . . . 0.0 110.775 -175.377 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -101.37 16.25 26.2 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 122.104 -0.373 . . . . 0.0 111.73 179.158 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 15.5 tp -110.53 113.54 26.25 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.567 -0.708 . . . . 0.0 110.38 -174.026 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 -96.83 120.76 61.1 Favored Pre-proline 0 N--CA 1.497 1.911 0 CA-C-O 118.803 -0.617 . . . . 0.0 109.989 172.021 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -68.34 133.89 29.58 Favored 'Trans proline' 0 N--CA 1.491 1.364 0 O-C-N 123.273 1.144 . . . . 0.0 110.408 176.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 32.7 p -98.84 125.32 44.19 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 122.098 -0.376 . . . . 0.0 110.428 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 15.7 mt . . . . . 0 N--CA 1.501 2.102 0 CA-C-O 119.282 -0.39 . . . . 0.0 110.097 176.663 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo . . . . . 0 N--CA 1.503 2.047 0 N-CA-C 111.268 -0.32 . . . . 0.0 111.268 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -153.38 49.84 0.7 Allowed 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.882 -0.511 . . . . 0.0 110.677 178.89 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.448 HD23 HG23 ' A' ' 55' ' ' THR . 19.7 tp -159.94 114.97 2.34 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.821 -0.549 . . . . 0.0 110.112 -176.328 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 50.9 tttt -99.86 130.87 46.09 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 122.151 -0.343 . . . . 0.0 110.158 178.848 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 85.8 m -117.01 140.39 49.54 Favored 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 -178.611 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -83.83 145.91 28.4 Favored 'General case' 0 N--CA 1.501 2.082 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.16 178.243 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 27.8 p -118.26 137.03 53.32 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 122.086 -0.384 . . . . 0.0 110.457 178.703 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 29.3 t -123.03 120.22 32.68 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 122.025 -0.422 . . . . 0.0 110.145 177.671 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 82.35 -62.77 4.53 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -103.89 112.05 24.85 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 122.03 -0.688 . . . . 0.0 110.486 -177.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -138.09 137.51 21.23 Favored Pre-proline 0 N--CA 1.497 1.915 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 176.472 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -60.97 151.85 75.13 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 O-C-N 123.114 1.06 . . . . 0.0 111.101 -174.019 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -60.35 -28.1 67.91 Favored 'General case' 0 N--CA 1.507 2.414 0 O-C-N 121.896 -0.503 . . . . 0.0 111.439 -172.725 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -92.28 14.36 16.59 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.921 -0.487 . . . . 0.0 111.749 -177.7 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.16 161.99 26.95 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.706 -0.621 . . . . 0.0 110.293 -173.329 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 76.1 mt -125.92 139.85 50.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 -177.385 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 38.88 42.75 0.68 Allowed 'General case' 0 N--CA 1.513 2.686 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -178.313 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 30.7 m120 54.96 43.0 30.59 Favored 'General case' 0 N--CA 1.508 2.452 0 O-C-N 121.838 -0.538 . . . . 0.0 111.496 -178.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 40.3 p -144.01 161.99 37.34 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.881 -0.512 . . . . 0.0 110.535 173.557 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.5 p -139.75 165.0 28.45 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 120.837 0.351 . . . . 0.0 110.666 179.136 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 77.4 mt -112.07 131.86 62.33 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -175.21 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.448 HG23 HD23 ' A' ' 36' ' ' LEU . 9.0 t -140.37 152.86 46.11 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 122.041 -0.412 . . . . 0.0 111.065 -178.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 40.1 p-10 -109.28 29.38 7.59 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 122.109 -0.369 . . . . 0.0 110.711 167.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -122.03 -92.79 1.18 Allowed Glycine 0 N--CA 1.496 2.65 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 177.449 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -149.86 172.04 15.8 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 122.099 -0.647 . . . . 0.0 109.574 176.027 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 75.9 m -94.01 139.17 31.27 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 166.513 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -129.11 153.22 47.87 Favored 'General case' 0 N--CA 1.499 1.997 0 C-N-CA 120.338 -0.545 . . . . 0.0 110.635 -178.223 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -151.24 143.39 24.03 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 176.577 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.534 HD12 HD12 ' A' ' 99' ' ' ILE . 18.1 tt -143.12 149.26 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.277 -172.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.46 HD12 ' HG ' ' A' ' 73' ' ' LEU . 14.9 tt -138.35 145.32 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 -179.4 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -148.71 145.76 27.81 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 -169.52 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.6 tm-20 -101.62 118.22 36.5 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 122.142 -0.349 . . . . 0.0 110.089 -176.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 52.1 p30 -87.17 175.29 8.14 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 122.21 -0.306 . . . . 0.0 110.601 -175.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -60.39 -17.93 47.11 Favored 'General case' 0 N--CA 1.508 2.43 0 O-C-N 122.025 -0.422 . . . . 0.0 111.988 -173.466 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -92.74 -10.47 36.94 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.689 -0.632 . . . . 0.0 111.921 178.579 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.08 21.03 40.21 Favored Glycine 0 N--CA 1.498 2.776 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 177.757 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -97.29 142.8 28.74 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 118.41 1.105 . . . . 0.0 109.823 170.196 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.1 p -94.83 125.67 39.65 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.249 177.225 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.2 p -97.89 112.95 24.68 Favored 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 120.877 -0.329 . . . . 0.0 110.296 177.632 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.544 ' N ' HD12 ' A' ' 73' ' ' LEU . 6.4 mp -97.51 127.2 43.28 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 122.157 -0.339 . . . . 0.0 110.313 -178.87 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -142.79 145.36 33.17 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 122.021 -0.424 . . . . 0.0 110.329 177.139 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 88.1 p -143.53 166.53 24.55 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 177.658 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -179.72 -165.77 34.26 Favored Glycine 0 N--CA 1.497 2.736 0 N-CA-C 110.239 -1.145 . . . . 0.0 110.239 -178.486 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 3.7 m -96.66 132.11 42.64 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 122.226 -0.573 . . . . 0.0 110.343 -175.314 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 53.5 ttm -98.62 121.82 41.04 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.1 176.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.3 ptpp? . . . . . 0 N--CA 1.504 2.233 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.398 -178.614 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 46.5 ptt85 . . . . . 0 N--CA 1.496 1.825 0 CA-C-O 120.771 0.32 . . . . 0.0 110.509 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.41 HG21 ' O ' ' A' ' 114' ' ' THR . 17.1 m -129.47 149.09 51.4 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 174.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.534 HD12 HD12 ' A' ' 62' ' ' ILE . 18.5 tt -143.09 155.91 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.993 -0.442 . . . . 0.0 110.135 -177.373 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -146.53 152.1 38.42 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 120.834 0.35 . . . . 0.0 110.632 -178.773 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 26.9 p -143.01 148.3 36.54 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 177.066 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 14.9 p -157.56 137.51 12.44 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.919 -0.488 . . . . 0.0 111.171 -173.182 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 44.9 ttt85 -107.91 53.01 0.7 Allowed 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 121.356 0.598 . . . . 0.0 110.604 -173.742 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.0 p -148.38 151.99 36.24 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.765 -0.584 . . . . 0.0 109.92 175.618 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 16.5 p30 -61.76 133.46 55.55 Favored 'General case' 0 N--CA 1.505 2.295 0 CA-C-O 121.444 0.64 . . . . 0.0 111.74 -164.314 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 72.8 mt 52.08 26.5 3.85 Favored 'General case' 0 N--CA 1.506 2.363 0 O-C-N 121.949 -0.469 . . . . 0.0 111.962 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 25.9 p -63.22 -21.92 66.54 Favored 'General case' 0 N--CA 1.506 2.338 0 O-C-N 121.889 -0.507 . . . . 0.0 111.7 176.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -92.29 -22.89 19.49 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.761 -0.587 . . . . 0.0 111.275 178.723 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -60.52 -37.17 80.29 Favored 'General case' 0 N--CA 1.506 2.338 0 O-C-N 121.433 -0.792 . . . . 0.0 110.762 -177.607 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -100.6 16.16 25.72 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 122.085 -0.384 . . . . 0.0 111.616 177.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 17.6 tp -112.19 113.48 25.76 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.675 -0.641 . . . . 0.0 110.346 -174.795 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -96.72 120.65 61.5 Favored Pre-proline 0 N--CA 1.496 1.863 0 CA-C-O 118.827 -0.606 . . . . 0.0 110.073 173.337 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -70.19 148.07 61.52 Favored 'Trans proline' 0 N--CA 1.49 1.293 0 O-C-N 123.122 1.064 . . . . 0.0 110.283 175.082 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.41 ' O ' HG21 ' A' ' 98' ' ' THR . 34.9 p -139.19 149.95 45.0 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 122.028 -0.42 . . . . 0.0 110.123 178.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 15.9 mt . . . . . 0 N--CA 1.503 2.177 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.112 -179.961 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_exo . . . . . 0 N--CA 1.498 1.791 0 N-CA-C 111.012 -0.418 . . . . 0.0 111.012 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -158.29 52.34 0.43 Allowed 'General case' 0 N--CA 1.501 2.107 0 CA-C-O 121.32 0.581 . . . . 0.0 110.515 164.175 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.467 HD23 HG23 ' A' ' 55' ' ' THR . 21.4 tp -158.22 114.65 2.8 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.656 -0.652 . . . . 0.0 110.23 -179.275 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.413 ' HE3' HD21 ' A' ' 106' ' ' LEU . 32.8 ttpt -99.77 131.63 45.63 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 122.11 -0.369 . . . . 0.0 110.225 177.546 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 79.3 m -115.31 140.22 49.3 Favored 'General case' 0 N--CA 1.501 2.077 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 -178.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -84.59 141.34 30.75 Favored 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 176.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 28.1 p -115.01 137.01 52.5 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 122.008 -0.433 . . . . 0.0 110.608 -177.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 49.4 m -122.99 135.58 54.53 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 175.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 75.49 -67.05 2.27 Favored Glycine 0 N--CA 1.495 2.606 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 83.7 t60 -109.2 119.55 39.85 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.99 -0.712 . . . . 0.0 110.576 -176.662 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -137.99 136.71 19.99 Favored Pre-proline 0 N--CA 1.496 1.868 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 174.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -60.12 151.88 69.65 Favored 'Trans proline' 0 N--CA 1.497 1.714 0 O-C-N 123.04 1.021 . . . . 0.0 111.225 -171.809 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -60.32 -28.14 67.89 Favored 'General case' 0 N--CA 1.507 2.394 0 O-C-N 121.966 -0.459 . . . . 0.0 111.401 -172.638 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -92.21 14.34 16.5 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.923 -0.486 . . . . 0.0 111.786 -178.051 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.46 162.06 26.64 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.606 -0.684 . . . . 0.0 110.348 -172.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 77.4 mt -126.08 140.5 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -177.744 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 38.68 42.69 0.62 Allowed 'General case' 0 N--CA 1.514 2.743 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -178.148 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 55.03 42.55 30.87 Favored 'General case' 0 N--CA 1.506 2.372 0 O-C-N 121.841 -0.537 . . . . 0.0 111.47 -179.113 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 41.5 p -142.96 161.16 38.87 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.89 -0.507 . . . . 0.0 110.465 173.74 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.3 p -138.46 162.52 34.27 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 120.874 0.369 . . . . 0.0 110.622 177.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 77.5 mt -108.73 132.58 56.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -176.087 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.467 HG23 HD23 ' A' ' 36' ' ' LEU . 7.9 t -138.74 151.95 47.55 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.989 -0.445 . . . . 0.0 110.936 -179.579 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.4 p-10 -108.8 29.76 7.15 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 122.143 -0.348 . . . . 0.0 110.64 167.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -125.19 -93.29 0.95 Allowed Glycine 0 N--CA 1.496 2.659 0 N-CA-C 109.286 -1.525 . . . . 0.0 109.286 177.596 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 41.7 m80 -148.4 172.06 15.04 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 122.074 -0.662 . . . . 0.0 109.521 177.106 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 71.9 m -93.32 139.21 30.91 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 165.698 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 15.6 p90 -129.98 151.38 50.6 Favored 'General case' 0 N--CA 1.499 2.024 0 C-N-CA 120.365 -0.534 . . . . 0.0 110.595 -177.198 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -151.02 143.68 24.39 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -179.505 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.459 HD12 HD12 ' A' ' 99' ' ' ILE . 18.1 tt -143.82 149.22 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 CA-C-O 120.905 0.383 . . . . 0.0 110.413 -173.081 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.806 HD12 HD21 ' A' ' 73' ' ' LEU . 16.6 tt -133.85 145.23 33.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.638 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -146.92 145.17 29.71 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -167.636 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.7 tm-20 -101.58 118.17 36.4 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -176.354 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 50.8 p30 -87.45 175.31 8.02 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 122.077 -0.39 . . . . 0.0 110.605 -175.826 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -60.42 -17.91 47.41 Favored 'General case' 0 N--CA 1.508 2.443 0 O-C-N 122.033 -0.417 . . . . 0.0 111.957 -173.45 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 84.1 mm-40 -93.27 -9.84 37.62 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.662 -0.649 . . . . 0.0 111.926 178.569 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 89.4 20.96 42.79 Favored Glycine 0 N--CA 1.499 2.877 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 177.637 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -97.16 144.39 27.04 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-N 118.427 1.113 . . . . 0.0 109.791 169.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.8 p -94.84 126.31 40.09 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.988 -0.445 . . . . 0.0 110.276 177.728 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 24.5 p -97.92 122.68 41.33 Favored 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 120.921 -0.312 . . . . 0.0 110.284 178.724 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.806 HD21 HD12 ' A' ' 63' ' ' ILE . 75.2 mt -97.09 127.84 43.45 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 122.119 -0.363 . . . . 0.0 110.289 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -143.0 144.24 32.22 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 122.025 -0.422 . . . . 0.0 110.369 175.288 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 40.5 p -143.78 167.01 23.31 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 178.409 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -177.84 -167.25 35.65 Favored Glycine 0 N--CA 1.496 2.691 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 2.0 m -97.4 132.84 42.74 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 122.211 -0.582 . . . . 0.0 110.271 -176.355 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 54.7 ttm -100.91 129.62 46.8 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 122.039 -0.413 . . . . 0.0 110.279 179.098 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.6 pttm . . . . . 0 N--CA 1.503 2.223 0 O-C-N 122.08 -0.388 . . . . 0.0 110.58 177.385 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 44.6 ptt85 . . . . . 0 N--CA 1.494 1.766 0 CA-C-O 120.954 0.406 . . . . 0.0 110.711 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.406 HG21 ' O ' ' A' ' 114' ' ' THR . 13.6 m -124.95 149.12 47.98 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 169.738 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.459 HD12 HD12 ' A' ' 62' ' ' ILE . 18.2 tt -143.09 154.57 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 C-N-CA 120.537 -0.465 . . . . 0.0 110.326 -172.603 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -147.26 154.68 41.28 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 120.811 0.339 . . . . 0.0 110.573 -178.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 26.6 p -143.05 151.9 41.3 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 177.166 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 20.3 p -157.6 134.49 10.03 Favored 'General case' 0 N--CA 1.502 2.152 0 CA-C-O 120.976 0.417 . . . . 0.0 110.77 -174.102 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 40.8 ttp85 -107.37 49.38 0.81 Allowed 'General case' 0 N--CA 1.497 1.907 0 CA-C-O 121.384 0.611 . . . . 0.0 110.661 -173.67 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.2 p -143.41 151.5 40.45 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.759 -0.588 . . . . 0.0 109.863 177.241 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 15.8 p30 -62.24 132.57 53.15 Favored 'General case' 0 N--CA 1.506 2.359 0 CA-C-O 121.406 0.622 . . . . 0.0 111.684 -164.039 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.413 HD21 ' HE3' ' A' ' 37' ' ' LYS . 76.5 mt 52.24 27.31 4.6 Favored 'General case' 0 N--CA 1.506 2.357 0 O-C-N 121.976 -0.453 . . . . 0.0 111.961 179.671 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 25.7 p -62.75 -23.32 67.14 Favored 'General case' 0 N--CA 1.507 2.42 0 O-C-N 121.852 -0.53 . . . . 0.0 111.624 174.548 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -73.73 -29.86 62.49 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.735 -0.603 . . . . 0.0 111.043 178.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -62.11 -39.55 92.91 Favored 'General case' 0 N--CA 1.505 2.318 0 O-C-N 121.653 -0.655 . . . . 0.0 110.855 -169.479 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -100.83 16.17 26.0 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 122.073 -0.392 . . . . 0.0 111.75 -178.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 15.9 tp -114.19 108.98 17.68 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.635 -0.665 . . . . 0.0 110.367 -175.651 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -98.15 120.82 58.94 Favored Pre-proline 0 N--CA 1.497 1.876 0 CA-C-O 118.943 -0.551 . . . . 0.0 110.102 174.752 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -70.99 143.37 44.73 Favored 'Trans proline' 0 N--CA 1.49 1.313 0 O-C-N 123.142 1.075 . . . . 0.0 110.343 174.597 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.406 ' O ' HG21 ' A' ' 98' ' ' THR . 35.1 p -139.16 150.01 45.12 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 122.154 -0.341 . . . . 0.0 110.095 178.493 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 15.0 mt . . . . . 0 N--CA 1.502 2.172 0 O-C-N 122.02 -0.425 . . . . 0.0 110.066 -179.568 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo . . . . . 0 N--CA 1.504 2.14 0 N-CA-C 111.369 -0.281 . . . . 0.0 111.369 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -156.32 48.19 0.47 Allowed 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 121.067 0.46 . . . . 0.0 110.872 176.087 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 18.5 tp -161.35 116.06 2.04 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.805 -0.56 . . . . 0.0 110.388 -173.349 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -99.81 133.66 43.85 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 122.214 -0.304 . . . . 0.0 110.21 176.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 64.3 m -120.82 140.34 51.87 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 -179.476 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -82.37 148.21 28.39 Favored 'General case' 0 N--CA 1.501 2.085 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.061 177.691 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 27.9 p -117.06 137.02 52.54 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.982 -0.448 . . . . 0.0 110.565 -179.147 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.0 m -123.02 139.25 54.27 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 176.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 75.06 -67.27 2.11 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -114.34 127.51 55.89 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 122.086 -0.655 . . . . 0.0 110.565 -177.315 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -138.04 136.93 20.14 Favored Pre-proline 0 N--CA 1.497 1.897 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 174.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -60.74 151.91 73.34 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 O-C-N 123.044 1.023 . . . . 0.0 111.142 -172.506 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -60.26 -28.09 67.76 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 121.966 -0.459 . . . . 0.0 111.476 -172.401 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -92.13 14.29 16.47 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 122.019 -0.426 . . . . 0.0 111.817 -177.809 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.93 162.07 26.25 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.602 -0.686 . . . . 0.0 110.33 -172.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 75.0 mt -125.29 138.14 55.34 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -178.447 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 38.84 43.0 0.69 Allowed 'General case' 0 N--CA 1.512 2.65 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -178.124 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 55.09 41.85 31.34 Favored 'General case' 0 N--CA 1.507 2.418 0 O-C-N 121.817 -0.552 . . . . 0.0 111.484 -178.76 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 70.9 p -140.25 161.02 38.67 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.857 -0.527 . . . . 0.0 110.314 173.631 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.3 p -140.65 165.12 28.34 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 120.874 0.369 . . . . 0.0 110.606 -179.423 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 77.2 mt -114.36 132.45 63.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -174.053 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.1 t -145.27 155.81 43.45 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 122.024 -0.423 . . . . 0.0 111.112 -179.25 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 41.4 p-10 -111.53 28.42 8.76 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 122.072 -0.393 . . . . 0.0 110.944 167.377 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -113.32 -95.39 2.16 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 109.105 -1.598 . . . . 0.0 109.105 173.234 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 76.0 m-70 -149.45 172.05 15.59 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 122.106 -0.643 . . . . 0.0 109.546 175.705 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 79.4 m -93.09 139.12 30.89 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 167.651 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 19.4 p90 -128.72 151.19 49.82 Favored 'General case' 0 N--CA 1.499 2.019 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.745 -178.707 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -151.25 141.83 22.63 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 173.641 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.42 HD12 HD12 ' A' ' 99' ' ' ILE . 18.1 tt -141.84 149.11 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 CA-C-O 120.979 0.419 . . . . 0.0 110.488 -170.153 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.875 HD12 HD21 ' A' ' 73' ' ' LEU . 15.9 tt -136.07 145.07 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 177.397 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -150.15 139.23 21.11 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 122.118 -0.364 . . . . 0.0 110.084 -169.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.2 tm-20 -101.8 116.18 32.15 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 51.2 p30 -85.74 175.25 8.81 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 122.097 -0.377 . . . . 0.0 110.494 -175.568 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -60.13 -17.48 40.68 Favored 'General case' 0 N--CA 1.507 2.415 0 O-C-N 121.976 -0.452 . . . . 0.0 112.006 -174.379 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -92.13 -11.07 36.65 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.607 -0.683 . . . . 0.0 111.9 178.076 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.18 21.09 36.51 Favored Glycine 0 N--CA 1.497 2.731 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 177.475 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -96.28 139.06 32.96 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-N 118.373 1.086 . . . . 0.0 109.799 171.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.8 p -94.87 124.53 38.96 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 122.141 -0.349 . . . . 0.0 110.335 176.831 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.2 p -97.99 114.49 26.64 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 122.138 -0.351 . . . . 0.0 110.366 178.285 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.875 HD21 HD12 ' A' ' 63' ' ' ILE . 24.8 mt -97.4 126.6 42.74 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 122.173 -0.329 . . . . 0.0 110.275 178.011 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -146.7 144.77 29.68 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 122.021 -0.424 . . . . 0.0 110.627 176.325 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 86.4 p -143.81 167.03 23.26 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 175.599 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 174.2 -164.24 35.35 Favored Glycine 0 N--CA 1.497 2.734 0 N-CA-C 110.33 -1.108 . . . . 0.0 110.33 179.387 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 4.5 m -95.95 133.14 40.5 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 122.316 -0.52 . . . . 0.0 110.302 -175.624 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 49.1 ttm -99.51 121.66 41.48 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 174.329 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 33.4 pttt . . . . . 0 N--CA 1.503 2.202 0 O-C-N 122.032 -0.417 . . . . 0.0 110.518 -178.805 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 48.8 ttp180 . . . . . 0 N--CA 1.497 1.886 0 CA-C-O 120.976 0.417 . . . . 0.0 110.386 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 14.4 m -134.24 149.01 50.94 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 170.145 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.42 HD12 HD12 ' A' ' 62' ' ' ILE . 18.2 tt -143.24 156.14 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.982 -0.448 . . . . 0.0 110.022 -179.004 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -143.7 146.45 33.2 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 120.959 0.409 . . . . 0.0 110.39 -179.206 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 25.3 p -143.09 141.41 31.24 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 -179.126 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 17.9 p -157.59 135.54 10.82 Favored 'General case' 0 N--CA 1.502 2.152 0 C-N-CA 120.514 -0.475 . . . . 0.0 111.044 -171.147 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 58.5 ttt180 -107.4 51.42 0.74 Allowed 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.364 0.602 . . . . 0.0 110.569 -175.722 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 23.6 p -143.23 151.67 40.85 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.778 -0.576 . . . . 0.0 109.861 175.322 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 15.9 p30 -61.72 132.3 52.75 Favored 'General case' 0 N--CA 1.506 2.355 0 CA-C-O 121.42 0.628 . . . . 0.0 111.772 -163.692 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.44 HD22 ' OE1' ' A' ' 109' ' ' GLN . 73.9 mt 52.19 26.93 4.23 Favored 'General case' 0 N--CA 1.507 2.403 0 O-C-N 122.036 -0.415 . . . . 0.0 111.891 179.461 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 26.1 p -63.0 -23.35 67.41 Favored 'General case' 0 N--CA 1.508 2.442 0 O-C-N 121.935 -0.478 . . . . 0.0 111.567 175.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -92.27 -22.81 19.55 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.77 -0.581 . . . . 0.0 111.273 178.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' GLN . . . . . 0.44 ' OE1' HD22 ' A' ' 106' ' ' LEU . 29.2 tt0 -60.67 -37.85 82.94 Favored 'General case' 0 N--CA 1.508 2.447 0 O-C-N 121.615 -0.678 . . . . 0.0 110.745 -177.491 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -100.03 16.15 24.93 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 122.135 -0.353 . . . . 0.0 111.709 178.036 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 14.8 tp -116.22 111.41 20.14 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.661 -0.649 . . . . 0.0 110.362 -174.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 3.1 tp-100 -96.39 120.73 61.84 Favored Pre-proline 0 N--CA 1.496 1.863 0 CA-C-O 118.848 -0.596 . . . . 0.0 110.04 172.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -70.69 141.84 42.42 Favored 'Trans proline' 0 N--CA 1.491 1.372 0 O-C-N 123.213 1.112 . . . . 0.0 110.168 175.285 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 48.4 p -139.22 150.02 45.04 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 122.135 -0.353 . . . . 0.0 110.138 179.557 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 15.0 mt . . . . . 0 N--CA 1.502 2.164 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.016 179.09 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo . . . . . 0 N--CA 1.502 2.013 0 N-CA-C 111.137 -0.37 . . . . 0.0 111.137 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -149.95 46.67 0.93 Allowed 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.159 0.504 . . . . 0.0 110.792 -179.175 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.403 HD23 HG23 ' A' ' 55' ' ' THR . 15.5 tp -161.15 112.14 1.76 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.882 -0.511 . . . . 0.0 110.272 -173.696 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 29.2 ttpt -99.74 134.95 41.88 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 122.171 -0.331 . . . . 0.0 110.257 178.545 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 80.2 m -120.97 140.35 52.0 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 -176.728 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -82.77 143.16 31.05 Favored 'General case' 0 N--CA 1.501 2.091 0 C-N-CA 120.631 -0.428 . . . . 0.0 109.97 178.028 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 28.1 p -115.68 136.99 52.52 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 122.0 -0.438 . . . . 0.0 110.576 -178.404 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.2 m -122.88 138.75 54.57 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 176.581 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 75.47 -67.35 2.23 Favored Glycine 0 N--CA 1.495 2.626 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 179.619 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -113.14 122.74 48.44 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 122.035 -0.685 . . . . 0.0 110.522 -176.626 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -138.08 136.53 19.68 Favored Pre-proline 0 N--CA 1.496 1.826 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 174.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -60.55 152.13 70.53 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 O-C-N 123.075 1.039 . . . . 0.0 111.151 -171.409 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -60.26 -27.83 67.56 Favored 'General case' 0 N--CA 1.507 2.415 0 O-C-N 121.996 -0.44 . . . . 0.0 111.356 -173.052 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -92.12 14.26 16.56 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.843 -0.536 . . . . 0.0 111.737 -178.093 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.8 162.05 26.37 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.62 -0.675 . . . . 0.0 110.334 -173.355 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 70.9 mt -124.41 136.71 59.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -176.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 19.7 p30 37.95 43.12 0.5 Allowed 'General case' 0 N--CA 1.513 2.704 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -176.593 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 30.8 m120 55.36 43.41 28.93 Favored 'General case' 0 N--CA 1.508 2.428 0 O-C-N 121.824 -0.547 . . . . 0.0 111.462 -178.835 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 60.7 p -139.63 161.22 38.05 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.796 -0.565 . . . . 0.0 110.305 171.259 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.5 p -137.49 162.91 32.43 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 120.766 0.317 . . . . 0.0 110.565 178.316 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 77.5 mt -111.63 131.79 62.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -175.1 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.403 HG23 HD23 ' A' ' 36' ' ' LEU . 8.7 t -141.34 153.7 45.27 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.955 -0.465 . . . . 0.0 110.99 -177.943 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 26.8 p30 -107.57 28.66 7.93 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 122.055 -0.403 . . . . 0.0 110.771 167.643 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -119.15 -96.58 1.7 Allowed Glycine 0 N--CA 1.497 2.717 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 175.07 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 74.7 m80 -150.75 170.79 18.37 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 122.125 -0.633 . . . . 0.0 110.14 178.483 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 72.8 m -94.42 139.36 31.21 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 170.023 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -131.78 153.41 50.14 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.492 -178.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -152.91 136.01 15.62 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 174.082 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.689 HD12 HD12 ' A' ' 99' ' ' ILE . 18.1 tt -133.57 149.05 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 122.06 -0.4 . . . . 0.0 110.42 -168.414 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 13.5 tt -136.62 145.04 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.076 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -150.25 142.78 24.45 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 -172.096 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.4 tm-20 -101.63 117.81 35.65 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 -178.67 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 51.7 p30 -86.84 175.28 8.28 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-O 120.753 0.311 . . . . 0.0 110.551 -175.604 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -60.31 -17.64 44.2 Favored 'General case' 0 N--CA 1.507 2.414 0 O-C-N 121.915 -0.491 . . . . 0.0 112.1 -173.5 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -92.87 -11.0 34.64 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.616 -0.677 . . . . 0.0 111.88 178.476 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.18 21.06 36.59 Favored Glycine 0 N--CA 1.498 2.827 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 177.723 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -96.82 140.54 31.24 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 118.411 1.106 . . . . 0.0 109.866 170.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 10.9 p -94.86 125.67 39.68 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.304 176.859 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 17.9 p -97.97 112.92 24.68 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 122.124 -0.36 . . . . 0.0 110.289 177.789 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.54 ' N ' HD12 ' A' ' 73' ' ' LEU . 6.4 mp -98.77 126.67 44.47 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 122.12 -0.363 . . . . 0.0 110.379 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -146.52 145.63 30.23 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 122.098 -0.376 . . . . 0.0 110.402 176.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 98.1 p -143.64 166.91 23.55 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 178.355 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 177.59 -164.7 33.96 Favored Glycine 0 N--CA 1.497 2.721 0 N-CA-C 110.301 -1.119 . . . . 0.0 110.301 -178.451 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 2.1 m -95.86 131.68 41.93 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 122.187 -0.596 . . . . 0.0 110.244 -174.651 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 53.8 ttm -98.75 122.7 42.32 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 122.011 -0.431 . . . . 0.0 110.162 175.792 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 22.2 pttt . . . . . 0 N--CA 1.503 2.202 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.552 175.858 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 30.1 ptt180 . . . . . 0 N--CA 1.498 1.956 0 CA-C-O 120.856 0.36 . . . . 0.0 110.648 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 18.9 m -133.79 149.13 51.41 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 177.669 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.689 HD12 HD12 ' A' ' 62' ' ' ILE . 17.9 tt -143.27 119.73 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 122.017 -0.427 . . . . 0.0 110.078 -178.848 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -105.91 149.87 26.17 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 120.824 0.345 . . . . 0.0 110.595 -179.106 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 90.9 m -143.15 163.16 33.65 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 175.32 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 12.1 p -157.21 150.99 24.4 Favored 'General case' 0 N--CA 1.501 2.106 0 C-N-CA 120.071 -0.652 . . . . 0.0 111.267 176.437 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 59.3 ttt180 -99.68 44.49 1.02 Allowed 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.259 0.552 . . . . 0.0 109.826 166.358 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 34.2 p -144.73 142.7 30.24 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 121.37 0.605 . . . . 0.0 110.6 -175.794 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 17.8 p-10 -70.98 138.87 50.33 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-O 121.449 0.642 . . . . 0.0 111.544 -162.239 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 29.5 mt 51.38 27.92 4.03 Favored 'General case' 0 N--CA 1.505 2.302 0 CA-C-N 116.361 -0.381 . . . . 0.0 112.006 174.269 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 18.3 p -60.11 -32.72 71.25 Favored 'General case' 0 N--CA 1.51 2.541 0 C-N-CA 119.969 -0.693 . . . . 0.0 111.162 174.382 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -81.77 -22.95 36.9 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 122.1 -0.375 . . . . 0.0 111.45 -168.472 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -61.52 -39.32 90.6 Favored 'General case' 0 N--CA 1.508 2.435 0 O-C-N 121.658 -0.651 . . . . 0.0 110.717 -174.763 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -99.75 16.29 24.08 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 122.072 -0.392 . . . . 0.0 111.628 176.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 18.5 tp -108.73 116.73 32.54 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.613 -0.679 . . . . 0.0 110.224 -174.739 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -95.84 120.63 62.84 Favored Pre-proline 0 N--CA 1.497 1.885 0 CA-C-O 118.766 -0.635 . . . . 0.0 109.955 172.397 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -70.68 142.26 43.43 Favored 'Trans proline' 0 N--CA 1.491 1.368 0 O-C-N 123.329 1.173 . . . . 0.0 110.289 174.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 49.0 p -139.22 150.09 45.12 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 178.748 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 44.0 mt . . . . . 0 N--CA 1.501 2.111 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.079 179.458 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo . . . . . 0 N--CA 1.497 1.732 0 N-CA-C 111.14 -0.369 . . . . 0.0 111.14 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -158.1 52.24 0.44 Allowed 'General case' 0 N--CA 1.501 2.092 0 CA-C-O 121.434 0.635 . . . . 0.0 110.283 164.021 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.403 HD23 HG23 ' A' ' 55' ' ' THR . 20.7 tp -158.56 115.22 2.77 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.65 -0.656 . . . . 0.0 110.185 -177.644 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 49.8 tttt -99.82 133.59 43.96 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 122.162 -0.336 . . . . 0.0 110.236 179.483 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 77.6 m -121.01 140.44 51.92 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 -178.127 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -82.23 142.95 31.71 Favored 'General case' 0 N--CA 1.502 2.125 0 C-N-CA 120.581 -0.448 . . . . 0.0 109.958 176.466 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 27.8 p -115.82 136.99 52.52 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 122.016 -0.428 . . . . 0.0 110.561 -177.828 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 28.2 t -123.07 134.73 54.24 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 178.201 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.35 -66.33 2.95 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.008 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -111.54 118.42 35.67 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 122.098 -0.648 . . . . 0.0 110.548 -176.863 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -138.01 135.95 19.2 Favored Pre-proline 0 N--CA 1.495 1.809 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 174.831 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -61.75 153.84 64.82 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 O-C-N 123.237 1.125 . . . . 0.0 111.105 -170.512 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -60.2 -27.67 67.36 Favored 'General case' 0 N--CA 1.508 2.465 0 O-C-N 122.01 -0.431 . . . . 0.0 111.44 -173.519 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -92.22 14.27 16.73 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.964 -0.46 . . . . 0.0 111.737 -177.855 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.03 162.07 27.0 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.687 -0.633 . . . . 0.0 110.182 -174.018 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 70.3 mt -124.1 136.14 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -175.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 19.4 p30 37.62 43.36 0.44 Allowed 'General case' 0 N--CA 1.515 2.788 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 -176.092 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 30.6 t30 56.29 43.07 27.04 Favored 'General case' 0 N--CA 1.507 2.379 0 O-C-N 121.706 -0.621 . . . . 0.0 111.413 -179.608 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 51.0 p -140.69 163.97 31.45 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.78 -0.575 . . . . 0.0 110.363 171.462 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.7 p -139.05 164.97 28.37 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 120.955 0.407 . . . . 0.0 110.549 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 77.5 mt -112.62 133.03 59.71 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -175.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.403 HG23 HD23 ' A' ' 36' ' ' LEU . 8.8 t -140.67 152.62 45.51 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 122.022 -0.424 . . . . 0.0 111.163 -178.786 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -108.78 30.04 6.88 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 122.022 -0.424 . . . . 0.0 110.659 167.522 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -122.35 -94.81 1.25 Allowed Glycine 0 N--CA 1.496 2.657 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 176.533 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 27.5 m80 -147.73 171.95 14.86 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 122.042 -0.681 . . . . 0.0 109.429 176.396 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 78.6 m -93.85 139.0 31.4 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 166.144 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -129.81 152.27 49.48 Favored 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 120.306 -0.558 . . . . 0.0 110.7 -177.606 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -150.89 145.4 25.62 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 176.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.487 HD12 HD12 ' A' ' 99' ' ' ILE . 18.1 tt -142.07 149.25 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 CA-C-O 120.998 0.428 . . . . 0.0 110.357 -172.502 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.813 HD12 HD21 ' A' ' 73' ' ' LEU . 16.7 tt -136.54 145.19 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 178.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -149.48 138.44 21.19 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 -170.467 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.3 tm-20 -101.69 116.52 32.91 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 -179.626 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 24.1 p-10 -86.95 175.34 8.2 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 122.12 -0.363 . . . . 0.0 110.608 -176.224 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -60.37 -17.27 42.4 Favored 'General case' 0 N--CA 1.508 2.433 0 O-C-N 121.946 -0.471 . . . . 0.0 112.008 -173.05 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -91.88 -11.41 36.45 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.647 -0.658 . . . . 0.0 111.787 178.148 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.02 21.03 37.13 Favored Glycine 0 N--CA 1.497 2.754 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 176.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -96.66 141.13 30.28 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 118.263 1.031 . . . . 0.0 109.838 171.13 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.5 p -94.86 126.63 40.32 Favored 'General case' 0 N--CA 1.499 2.009 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.196 176.718 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.5 p -98.01 114.51 26.68 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 122.134 -0.354 . . . . 0.0 110.267 177.648 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.813 HD21 HD12 ' A' ' 63' ' ' ILE . 70.7 mt -97.09 127.81 43.42 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 122.149 -0.345 . . . . 0.0 110.297 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -144.68 144.98 31.51 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 122.089 -0.382 . . . . 0.0 110.572 176.206 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 99.8 p -143.67 166.48 24.74 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 176.495 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 179.47 -166.27 35.51 Favored Glycine 0 N--CA 1.497 2.731 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 2.2 m -97.24 133.0 42.44 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 122.319 -0.518 . . . . 0.0 110.263 -175.644 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 47.1 ttm -105.05 121.68 44.3 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 122.135 -0.353 . . . . 0.0 110.146 173.557 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 12.1 pttt . . . . . 0 N--CA 1.501 2.085 0 C-N-CA 120.514 -0.474 . . . . 0.0 110.262 174.865 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 27.7 ptt180 . . . . . 0 N--CA 1.497 1.892 0 CA-C-O 120.891 0.377 . . . . 0.0 110.803 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.421 ' O ' HG22 ' A' ' 63' ' ' ILE . 19.1 m -133.66 149.43 51.56 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.487 HD12 HD12 ' A' ' 62' ' ' ILE . 18.3 tt -143.03 155.96 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.964 -0.46 . . . . 0.0 110.21 -177.299 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 52.1 mm-40 -143.65 152.01 40.82 Favored 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 120.901 -0.32 . . . . 0.0 110.613 -176.422 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 26.7 p -143.12 144.47 32.24 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 178.465 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 20.1 p -157.7 133.85 9.48 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.991 -0.443 . . . . 0.0 110.792 -175.229 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 31.6 ttp180 -106.25 47.21 0.89 Allowed 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.26 0.552 . . . . 0.0 110.659 -173.371 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.1 p -139.36 152.14 46.92 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.95 -0.469 . . . . 0.0 109.829 176.784 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 17.5 p-10 -61.35 131.94 51.93 Favored 'General case' 0 N--CA 1.506 2.344 0 CA-C-O 121.373 0.606 . . . . 0.0 111.904 -163.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 72.4 mt 52.22 26.38 3.93 Favored 'General case' 0 N--CA 1.506 2.348 0 O-C-N 122.078 -0.389 . . . . 0.0 112.007 179.059 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 26.2 p -62.9 -22.22 66.58 Favored 'General case' 0 N--CA 1.507 2.384 0 O-C-N 121.843 -0.536 . . . . 0.0 111.806 176.825 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -91.71 -22.81 20.02 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.785 -0.572 . . . . 0.0 111.37 179.419 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -60.29 -37.43 80.47 Favored 'General case' 0 N--CA 1.509 2.491 0 O-C-N 121.682 -0.637 . . . . 0.0 110.717 -175.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -101.41 16.19 26.43 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 122.116 -0.365 . . . . 0.0 111.649 177.772 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 15.0 tp -111.67 110.24 20.53 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.532 -0.73 . . . . 0.0 110.384 -174.518 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -97.08 120.76 60.74 Favored Pre-proline 0 N--CA 1.495 1.823 0 CA-C-O 118.94 -0.553 . . . . 0.0 110.063 173.496 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.4 149.32 50.28 Favored 'Trans proline' 0 N--CA 1.489 1.239 0 O-C-N 123.092 1.048 . . . . 0.0 110.274 175.62 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 34.1 p -139.13 137.82 36.45 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 122.144 -0.348 . . . . 0.0 110.238 178.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 41.9 mt . . . . . 0 N--CA 1.502 2.156 0 C-N-CA 120.669 -0.413 . . . . 0.0 110.151 179.788 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo . . . . . 0 N--CA 1.497 1.699 0 N-CA-C 111.193 -0.349 . . . . 0.0 111.193 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -157.82 52.53 0.45 Allowed 'General case' 0 N--CA 1.501 2.098 0 CA-C-O 121.363 0.601 . . . . 0.0 110.26 165.082 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.435 HD23 HG23 ' A' ' 55' ' ' THR . 21.1 tp -158.35 114.89 2.79 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.77 -0.581 . . . . 0.0 110.111 -177.858 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 27.9 ttmt -99.74 131.77 45.51 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 122.11 -0.368 . . . . 0.0 110.314 178.989 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 70.0 m -118.25 140.33 49.96 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -178.852 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -82.62 145.83 29.47 Favored 'General case' 0 N--CA 1.501 2.092 0 C-N-CA 120.624 -0.43 . . . . 0.0 109.984 176.255 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 28.0 p -115.15 137.07 52.43 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 122.007 -0.433 . . . . 0.0 110.599 -177.864 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 99.2 p -123.01 144.0 49.56 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 176.598 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.36 -68.22 1.46 Allowed Glycine 0 N--CA 1.495 2.587 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 -179.789 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -116.84 129.59 56.18 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.939 -0.742 . . . . 0.0 110.518 -177.042 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -138.07 136.86 20.02 Favored Pre-proline 0 N--CA 1.496 1.838 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 174.689 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -60.21 151.53 72.7 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 O-C-N 123.078 1.041 . . . . 0.0 111.231 -172.191 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -60.1 -28.21 67.66 Favored 'General case' 0 N--CA 1.507 2.407 0 O-C-N 121.98 -0.45 . . . . 0.0 111.478 -172.595 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -92.11 14.28 16.47 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.981 -0.449 . . . . 0.0 111.794 -177.937 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.85 161.61 26.64 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.674 -0.641 . . . . 0.0 110.277 -173.117 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 75.7 mt -126.08 141.1 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -177.991 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 38.9 41.87 0.58 Allowed 'General case' 0 N--CA 1.512 2.663 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -177.206 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 30.7 m120 54.89 41.55 31.81 Favored 'General case' 0 N--CA 1.508 2.464 0 O-C-N 121.845 -0.535 . . . . 0.0 111.461 -178.955 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 43.7 p -141.65 162.6 35.08 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.82 -0.55 . . . . 0.0 110.376 174.323 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.3 p -139.31 163.49 32.34 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 120.967 0.413 . . . . 0.0 110.555 -179.384 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 77.9 mt -109.43 131.95 58.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -176.189 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.435 HG23 HD23 ' A' ' 36' ' ' LEU . 8.9 t -139.16 152.83 47.73 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.935 -0.478 . . . . 0.0 110.893 179.804 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 26.8 p30 -110.04 31.56 5.78 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 122.046 -0.409 . . . . 0.0 110.575 166.91 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -123.29 -94.71 1.16 Allowed Glycine 0 N--CA 1.497 2.718 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 175.642 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 35.1 m80 -146.35 172.05 14.07 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 122.056 -0.673 . . . . 0.0 109.513 176.668 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 81.0 m -94.36 139.22 31.38 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 165.161 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 21.3 p90 -127.92 146.44 50.64 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 120.35 -0.54 . . . . 0.0 110.431 -179.199 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -147.61 140.2 24.68 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 174.431 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.63 HD12 HD12 ' A' ' 99' ' ' ILE . 18.3 tt -143.09 149.28 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.31 -171.644 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.511 HD12 ' HG ' ' A' ' 73' ' ' LEU . 15.6 tt -137.96 145.26 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 178.09 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -150.2 146.91 27.13 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 122.041 -0.412 . . . . 0.0 110.023 -168.044 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.3 tm-20 -101.69 116.94 33.84 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 122.124 -0.36 . . . . 0.0 110.117 -177.059 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -87.2 175.3 8.12 Favored 'General case' 0 N--CA 1.502 2.148 0 CA-C-O 120.868 0.366 . . . . 0.0 110.536 -175.621 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -60.56 -17.35 45.59 Favored 'General case' 0 N--CA 1.506 2.365 0 O-C-N 121.914 -0.491 . . . . 0.0 112.17 -172.646 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -92.77 -11.6 33.4 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.643 -0.66 . . . . 0.0 111.803 178.172 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.9 20.12 40.87 Favored Glycine 0 N--CA 1.499 2.862 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 177.083 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -97.37 143.88 27.68 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 118.399 1.099 . . . . 0.0 109.806 169.821 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.8 p -94.87 124.99 39.23 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.255 178.014 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 17.8 p -97.94 112.96 24.7 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 120.923 -0.311 . . . . 0.0 110.289 178.223 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.542 ' N ' HD12 ' A' ' 73' ' ' LEU . 6.3 mp -98.24 128.53 44.74 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 122.144 -0.347 . . . . 0.0 110.273 -179.91 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -145.87 145.94 30.92 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.347 177.275 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 86.8 p -143.68 165.85 26.5 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 177.015 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 178.4 -164.53 33.22 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 -179.902 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 3.9 m -97.07 132.51 42.8 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 122.185 -0.597 . . . . 0.0 110.384 -175.53 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 49.1 ttm -99.56 121.88 41.82 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.993 -0.442 . . . . 0.0 110.231 176.662 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.3 ptpp? . . . . . 0 N--CA 1.503 2.219 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.214 178.135 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 27.7 ptt180 . . . . . 0 N--CA 1.494 1.772 0 CA-C-O 120.843 0.354 . . . . 0.0 110.401 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 18.1 m -131.03 149.04 52.8 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 174.841 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.63 HD12 HD12 ' A' ' 62' ' ' ILE . 18.5 tt -143.13 154.97 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.991 -0.443 . . . . 0.0 110.051 -178.586 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -143.92 125.9 15.36 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 120.842 0.353 . . . . 0.0 110.699 -179.572 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 92.8 m -104.9 147.55 27.64 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 168.63 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 22.9 p -157.76 135.19 10.37 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.858 -0.526 . . . . 0.0 111.031 176.22 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 9.4 ttm180 -108.2 47.04 0.92 Allowed 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 121.29 0.567 . . . . 0.0 110.788 -173.315 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.3 p -141.87 151.93 43.16 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.771 -0.581 . . . . 0.0 110.033 177.713 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 17.5 p-10 -61.69 132.43 53.21 Favored 'General case' 0 N--CA 1.505 2.287 0 CA-C-O 121.339 0.59 . . . . 0.0 111.821 -164.243 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.475 HD22 ' OE1' ' A' ' 109' ' ' GLN . 75.7 mt 52.0 27.13 4.18 Favored 'General case' 0 N--CA 1.506 2.365 0 O-C-N 122.051 -0.406 . . . . 0.0 111.995 179.547 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 25.3 p -62.62 -22.8 66.68 Favored 'General case' 0 N--CA 1.507 2.42 0 O-C-N 121.847 -0.533 . . . . 0.0 111.585 175.419 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -92.82 -22.82 19.09 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.682 -0.636 . . . . 0.0 111.224 178.071 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 109' ' ' GLN . . . . . 0.475 ' OE1' HD22 ' A' ' 106' ' ' LEU . 27.7 tt0 -61.63 -38.62 88.35 Favored 'General case' 0 N--CA 1.507 2.381 0 O-C-N 121.57 -0.706 . . . . 0.0 110.671 -177.034 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -100.1 16.19 24.89 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 122.113 -0.367 . . . . 0.0 111.596 178.772 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 18.0 tp -112.68 114.31 26.84 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.625 -0.672 . . . . 0.0 110.361 -175.458 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -96.31 120.83 61.78 Favored Pre-proline 0 N--CA 1.496 1.87 0 CA-C-O 118.927 -0.558 . . . . 0.0 109.944 173.022 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -68.81 144.93 60.97 Favored 'Trans proline' 0 N--CA 1.491 1.353 0 O-C-N 123.17 1.089 . . . . 0.0 110.253 175.33 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 47.6 p -139.18 134.15 32.38 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 122.074 -0.391 . . . . 0.0 110.121 179.624 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 17.2 mt . . . . . 0 N--CA 1.5 2.035 0 CA-C-O 119.287 -0.387 . . . . 0.0 110.173 179.664 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.314 0 N-CA-C 109.554 -1.419 . . . . 7.0800000000000001 109.554 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -58.4 117.7 4.46 Favored 'Trans proline' 0 N--CA 1.501 1.945 0 O-C-N 123.339 1.178 . . . . 6.3700000000000001 111.372 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -155.34 79.8 1.04 Allowed 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 109.551 -0.537 . . . . 5.7400000000000002 109.551 -176.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -78.66 88.09 4.57 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.888 -0.507 . . . . 3.1499999999999999 109.881 177.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 21.7 m -101.92 97.51 7.86 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 122.017 -0.427 . . . . 2.2000000000000002 110.191 179.14 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 72.6 mt -142.41 118.85 6.97 Favored Pre-proline 0 N--CA 1.497 1.9 0 N-CA-C 109.445 -0.576 . . . . 1.1499999999999999 109.445 178.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -58.89 146.61 92.81 Favored 'Trans proline' 0 N--CA 1.503 2.075 0 C-N-CA 120.893 1.062 . . . . 0.40000000000000002 111.304 -178.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -152.89 49.32 0.73 Allowed 'General case' 0 N--CA 1.498 1.948 0 CA-C-O 121.174 0.511 . . . . 0.64000000000000001 110.699 -178.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.443 HD23 HG23 ' A' ' 55' ' ' THR . 23.2 tp -158.82 101.53 1.64 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.811 -0.555 . . . . 0.19 110.601 -176.457 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -99.97 118.18 35.83 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 110.167 -0.308 . . . . 1.51 110.167 176.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 68.0 m -121.71 140.53 52.2 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 122.025 -0.422 . . . . 0.47999999999999998 110.935 -178.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -78.52 150.54 32.87 Favored 'General case' 0 N--CA 1.501 2.094 0 C-N-CA 120.751 -0.38 . . . . 0.51000000000000001 110.032 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 27.0 p -119.01 140.68 49.62 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 122.044 -0.41 . . . . 0.29999999999999999 110.547 -177.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 30.9 t -123.0 143.14 50.13 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 122.072 -0.392 . . . . 1.6899999999999999 110.155 178.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.63 -69.9 1.43 Allowed Glycine 0 N--CA 1.495 2.606 0 N-CA-C 109.668 -1.373 . . . . 0.77000000000000002 109.668 177.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -115.51 123.83 49.52 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 122.074 -0.662 . . . . 2.8199999999999998 110.544 -176.345 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -138.11 147.7 57.12 Favored Pre-proline 0 N--CA 1.497 1.879 0 N-CA-C 109.386 -0.598 . . . . 0.47999999999999998 109.386 175.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -63.8 151.62 84.32 Favored 'Trans proline' 0 N--CA 1.492 1.432 0 O-C-N 123.203 1.107 . . . . 0.41999999999999998 110.864 -174.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -59.15 -21.86 60.02 Favored 'General case' 0 N--CA 1.507 2.379 0 O-C-N 121.985 -0.447 . . . . 2.0299999999999998 111.521 177.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -96.7 14.15 25.97 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.776 -0.577 . . . . 1.1399999999999999 111.864 -177.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -83.31 162.1 21.22 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.607 -0.683 . . . . 0.34999999999999998 110.466 -173.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 77.5 mt -125.51 142.39 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 N-CA-C 108.873 -0.788 . . . . 0.45000000000000001 108.873 -178.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 38.44 41.58 0.46 Allowed 'General case' 0 N--CA 1.514 2.735 0 N-CA-C 113.271 0.841 . . . . 1.1100000000000001 113.271 -177.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 54.97 41.01 32.24 Favored 'General case' 0 N--CA 1.508 2.459 0 O-C-N 121.802 -0.561 . . . . 1.6499999999999999 111.489 -179.115 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 41.6 p -137.68 160.31 39.57 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.877 -0.514 . . . . 0.22 110.373 173.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.3 p -135.75 162.15 33.57 Favored 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 120.957 0.408 . . . . 0.20999999999999999 110.465 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 78.9 mt -129.29 125.91 62.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 108.774 -0.825 . . . . 0.33000000000000002 108.774 -169.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.443 HG23 HD23 ' A' ' 36' ' ' LEU . 9.5 t -140.12 159.21 42.68 Favored 'General case' 0 N--CA 1.5 2.049 0 C-N-CA 120.537 -0.465 . . . . 0.23000000000000001 111.288 -177.605 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 38.1 p-10 -106.59 28.22 8.06 Favored 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 120.856 -0.338 . . . . 0.81999999999999995 110.505 164.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -117.35 -113.86 2.69 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 109.057 -1.617 . . . . 0.23000000000000001 109.057 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 7.8 m-70 -136.75 157.57 46.44 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 108.996 -0.742 . . . . 1.26 108.996 175.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 96.4 m -99.11 139.43 34.77 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 109.31 -0.626 . . . . 0.25 109.31 176.417 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -129.35 158.14 39.96 Favored 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 120.604 -0.438 . . . . 0.23000000000000001 110.726 -170.118 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -151.05 143.39 24.19 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.293 -0.632 . . . . 0.22 109.293 177.11 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.44 HD12 HD12 ' A' ' 99' ' ' ILE . 18.0 tt -142.44 149.18 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 C-N-CA 120.686 -0.405 . . . . 0.29999999999999999 110.477 -170.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.799 HD12 HD11 ' A' ' 73' ' ' LEU . 16.0 tt -138.76 145.2 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 109.502 -0.555 . . . . 0.34000000000000002 109.502 178.438 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -150.1 141.08 22.91 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 109.93 -0.396 . . . . 1.1599999999999999 109.93 -170.082 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.9 tm-20 -101.68 116.29 32.42 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 109.975 -0.379 . . . . 0.35999999999999999 109.975 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -86.73 175.21 8.36 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 122.067 -0.396 . . . . 0.77000000000000002 110.583 -175.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -60.49 -17.29 44.3 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 121.995 -0.441 . . . . 1.5900000000000001 112.184 -172.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -92.49 -11.64 34.1 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.601 -0.687 . . . . 2.0 111.83 177.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.82 21.0 37.88 Favored Glycine 0 N--CA 1.497 2.765 0 N-CA-C 111.109 -0.796 . . . . 0.40000000000000002 111.109 176.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -97.42 142.42 29.3 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 118.417 1.108 . . . . 1.28 109.8 169.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.1 p -94.88 129.58 41.84 Favored 'General case' 0 N--CA 1.497 1.908 0 C-N-CA 120.797 -0.361 . . . . 0.33000000000000002 110.356 177.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 17.7 p -97.91 113.04 24.76 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 122.128 -0.357 . . . . 0.34000000000000002 110.327 177.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.799 HD11 HD12 ' A' ' 63' ' ' ILE . 4.5 mm? -96.77 121.98 39.22 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 110.157 -0.312 . . . . 1.1799999999999999 110.157 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -143.77 148.52 35.73 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 122.098 -0.376 . . . . 0.25 110.486 178.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 96.8 p -143.59 164.15 31.2 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 109.735 -0.469 . . . . 0.17000000000000001 109.735 176.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -172.51 -179.05 43.07 Favored Glycine 0 N--CA 1.496 2.688 0 N-CA-C 110.215 -1.154 . . . . 0.23999999999999999 110.215 -177.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 6.2 m -100.21 133.83 44.03 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 122.203 -0.587 . . . . 0.57999999999999996 110.282 -178.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 27.5 ttm -99.5 126.96 45.54 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 122.003 -0.436 . . . . 0.39000000000000001 110.114 176.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 22.2 pttm -65.69 172.0 3.79 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 122.07 -0.394 . . . . 1.6799999999999999 110.485 177.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 56.7 t80 -65.02 146.61 54.79 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 122.095 -0.378 . . . . 4.4800000000000004 110.472 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -133.17 -47.22 0.84 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 122.137 -0.352 . . . . 2.0 110.326 -177.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 146.85 -35.41 1.29 Allowed Glycine 0 N--CA 1.496 2.64 0 N-CA-C 109.714 -1.354 . . . . 1.6799999999999999 109.714 -178.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 46.4 m -72.76 123.34 23.13 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 122.084 -0.656 . . . . 2.9500000000000002 110.113 -179.102 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -76.36 -37.53 57.11 Favored 'General case' 0 N--CA 1.501 2.118 0 C-N-CA 120.752 -0.379 . . . . 2.9900000000000002 110.398 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -155.62 68.1 0.65 Allowed 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 121.265 0.555 . . . . 6.2000000000000002 109.968 -179.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -155.37 106.87 2.6 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.868 -0.52 . . . . 4.0 109.837 -177.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 87.3 m -105.28 88.95 2.98 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.045 0.45 . . . . 1.6499999999999999 109.869 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -82.75 175.09 10.39 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.994 -0.441 . . . . 4.4800000000000004 110.767 -173.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -132.72 150.31 52.17 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 109.983 -0.377 . . . . 2.73 109.983 171.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.1 m -75.23 139.38 72.16 Favored Pre-proline 0 N--CA 1.502 2.137 0 CA-C-O 119.246 -0.407 . . . . 3.1600000000000001 109.92 -178.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -81.11 60.52 7.86 Favored 'Trans proline' 0 N--CA 1.494 1.539 0 O-C-N 123.277 1.146 . . . . 3.9100000000000001 111.393 -172.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 16.9 pttp -155.67 33.9 0.36 Allowed 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.554 -0.716 . . . . 5.0599999999999996 110.338 172.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.454 ' HB1' ' NH1' ' A' ' 97' ' ' ARG . . . -83.74 122.82 29.16 Favored 'General case' 0 N--CA 1.499 2.012 0 C-N-CA 120.933 -0.307 . . . . 2.23 110.498 -176.569 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -119.81 53.64 1.05 Allowed 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.265 0.555 . . . . 6.1500000000000004 110.281 176.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 20.4 tp -155.18 154.12 31.79 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.738 -0.601 . . . . 1.8600000000000001 110.29 -178.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 71.6 mtp85 -93.32 122.55 35.84 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 109.985 -0.376 . . . . 2.98 109.985 175.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.454 ' NH1' ' HB1' ' A' ' 93' ' ' ALA . 26.7 ptt-85 -161.51 165.38 28.7 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 122.063 -0.398 . . . . 2.21 110.685 -173.219 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.494 ' OG1' HD23 ' A' ' 115' ' ' LEU . 11.7 m -128.48 149.1 50.73 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 109.676 -0.49 . . . . 0.40000000000000002 109.676 172.384 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.44 HD12 HD12 ' A' ' 62' ' ' ILE . 18.6 tt -143.17 155.96 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 122.04 -0.412 . . . . 0.44 110.098 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -147.48 155.88 42.32 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 120.978 -0.289 . . . . 1.6299999999999999 110.342 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 26.6 p -142.47 157.42 44.78 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 110.113 -0.329 . . . . 1.3700000000000001 110.113 176.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 24.4 p -157.55 138.13 12.99 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 122.014 -0.429 . . . . 0.40999999999999998 110.825 -168.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 70.3 mtp180 -112.01 44.57 1.38 Allowed 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 121.213 0.53 . . . . 2.4100000000000001 110.554 -177.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.3 p -140.44 153.22 46.21 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.863 -0.523 . . . . 0.27000000000000002 110.276 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 34.7 p-10 -64.51 139.77 58.8 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.817 -0.552 . . . . 1.02 111.233 -170.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 17.0 mt 53.15 25.8 4.51 Favored 'General case' 0 N--CA 1.507 2.381 0 O-C-N 121.936 -0.477 . . . . 0.42999999999999999 112.282 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 28.1 p -67.95 -25.3 65.38 Favored 'General case' 0 N--CA 1.503 2.217 0 C-N-CA 119.869 -0.732 . . . . 0.34999999999999998 111.067 172.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -81.05 -33.28 33.6 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.888 -0.508 . . . . 1.3700000000000001 110.484 179.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 47.0 tt0 -63.35 -41.42 98.84 Favored 'General case' 0 N--CA 1.506 2.328 0 O-C-N 121.968 -0.458 . . . . 1.3300000000000001 110.797 -176.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -102.32 16.21 26.89 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 122.1 -0.375 . . . . 0.64000000000000001 111.9 -174.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 12.4 tp -126.16 108.94 11.8 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.601 -0.687 . . . . 0.31 110.397 -176.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -98.3 120.93 58.43 Favored Pre-proline 0 N--CA 1.496 1.864 0 CA-C-O 118.811 -0.614 . . . . 1.8300000000000001 110.032 173.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -67.91 136.39 38.17 Favored 'Trans proline' 0 N--CA 1.492 1.424 0 O-C-N 123.18 1.095 . . . . 0.5 110.333 176.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 35.0 p -139.25 150.11 45.11 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 122.078 -0.389 . . . . 0.76000000000000001 110.204 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.494 HD23 ' OG1' ' A' ' 98' ' ' THR . 34.8 mt -70.3 152.83 95.51 Favored Pre-proline 0 N--CA 1.502 2.135 0 C-N-CA 120.692 -0.403 . . . . 0.62 109.961 178.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -67.87 148.88 77.52 Favored 'Trans proline' 0 N--CA 1.491 1.336 0 O-C-N 123.49 1.258 . . . . 1.26 110.347 -176.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -69.43 165.56 30.16 Favored 'Trans proline' 0 N--CA 1.491 1.339 0 O-C-N 123.482 1.253 . . . . 1.8700000000000001 110.282 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.405 HG12 ' N ' ' A' ' 119' ' ' VAL . 43.3 t -79.09 164.85 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 N-CA-C 109.052 -0.721 . . . . 3.0499999999999998 109.052 179.127 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.405 ' N ' HG12 ' A' ' 118' ' ' VAL . 79.2 t -147.06 151.7 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 N-CA-C 109.259 -0.645 . . . . 4.6900000000000004 109.259 -178.05 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 37.3 pt -146.87 137.77 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 CA-C-O 120.997 0.427 . . . . 7.2599999999999998 109.976 173.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -73.98 -56.25 5.41 Favored Glycine 0 N--CA 1.496 2.654 0 N-CA-C 109.596 -1.402 . . . . 7.75 109.596 177.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_exo -58.1 152.28 53.09 Favored 'Trans proline' 0 N--CA 1.501 1.947 0 C-N-CA 121.119 1.212 . . . . 9.0899999999999999 111.503 -178.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -155.18 162.37 40.97 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 122.115 -0.366 . . . . 11.949999999999999 110.267 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -155.81 161.31 40.66 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 122.076 -0.39 . . . . 12.01 110.082 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -84.24 119.59 25.22 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 122.111 -0.368 . . . . 14.42 110.146 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -113.6 -39.97 1.05 Allowed Glycine 0 N--CA 1.497 2.717 0 N-CA-C 109.601 -1.4 . . . . 15.73 109.601 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 62.2 m -155.45 172.76 17.69 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 122.085 -0.656 . . . . 16.629999999999999 110.114 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 75.5 mt -89.15 132.94 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 N-CA-C 109.193 -0.669 . . . . 18.789999999999999 109.193 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 53.8 ttt180 . . . . . 0 N--CA 1.509 2.487 0 CA-C-O 118.319 -0.848 . . . . 20.73 111.478 -178.466 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.275 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_exo -58.5 120.59 8.57 Favored 'Trans proline' 0 N--CA 1.501 1.97 0 O-C-N 123.336 1.177 . . . . 0.0 111.351 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -155.49 78.84 1.02 Allowed 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 121.209 0.528 . . . . 0.0 109.581 -176.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -79.04 86.73 4.86 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.929 -0.482 . . . . 0.0 109.982 179.277 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.533 HG22 ' HB2' ' A' ' 56' ' ' ASN . 20.2 m -152.47 122.77 7.19 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 122.014 -0.429 . . . . 0.0 110.084 177.541 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 43.0 mt -78.29 150.36 76.99 Favored Pre-proline 0 N--CA 1.501 2.075 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.102 -178.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -64.63 121.5 9.08 Favored 'Trans proline' 0 N--CA 1.498 1.746 0 O-C-N 123.288 1.152 . . . . 0.0 111.058 168.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -157.55 52.86 0.47 Allowed 'General case' 0 N--CA 1.5 2.065 0 CA-C-O 121.358 0.599 . . . . 0.0 110.254 165.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.455 HD23 HG23 ' A' ' 55' ' ' THR . 19.5 tp -158.57 113.98 2.62 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.766 -0.584 . . . . 0.0 109.993 -178.529 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 51.3 tttt -99.82 131.04 46.05 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 110.116 -0.328 . . . . 0.0 110.116 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 74.8 m -115.58 140.27 49.32 Favored 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 -177.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -85.3 145.07 27.7 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 122.155 -0.341 . . . . 0.0 110.098 176.07 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 27.8 p -117.64 137.51 52.59 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.983 -0.448 . . . . 0.0 110.562 -178.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 28.8 t -123.04 117.58 25.78 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 122.109 -0.37 . . . . 0.0 110.156 178.089 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 83.88 -61.74 4.69 Favored Glycine 0 N--CA 1.496 2.655 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -104.47 111.99 24.87 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 122.092 -0.652 . . . . 0.0 110.408 -177.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -138.08 137.38 20.97 Favored Pre-proline 0 N--CA 1.497 1.886 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 177.153 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -61.36 152.05 75.29 Favored 'Trans proline' 0 N--CA 1.497 1.683 0 O-C-N 123.118 1.062 . . . . 0.0 111.058 -173.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -60.33 -28.17 67.94 Favored 'General case' 0 N--CA 1.507 2.399 0 O-C-N 121.951 -0.468 . . . . 0.0 111.374 -173.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -92.16 14.31 16.5 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.941 -0.474 . . . . 0.0 111.77 -178.202 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.56 160.82 29.72 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.658 -0.651 . . . . 0.0 110.239 -173.158 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 70.6 mt -124.24 135.89 62.23 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -178.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 19.5 p30 37.52 43.61 0.44 Allowed 'General case' 0 N--CA 1.513 2.722 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -175.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 55.56 43.82 27.72 Favored 'General case' 0 N--CA 1.508 2.465 0 O-C-N 121.772 -0.58 . . . . 0.0 111.427 -179.115 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 51.4 p -141.19 161.33 38.14 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.738 -0.602 . . . . 0.0 110.346 171.062 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.1 p -141.39 164.69 29.54 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-O 120.847 0.356 . . . . 0.0 110.574 178.243 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 78.2 mt -109.6 132.44 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 -175.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.455 HG23 HD23 ' A' ' 36' ' ' LEU . 8.5 t -139.77 151.43 45.78 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 122.011 -0.431 . . . . 0.0 111.03 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.533 ' HB2' HG22 ' A' ' 32' ' ' THR . 41.4 p-10 -108.21 30.38 6.45 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 122.097 -0.377 . . . . 0.0 110.636 167.71 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -124.71 -94.2 1.02 Allowed Glycine 0 N--CA 1.497 2.703 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 176.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 32.1 m80 -146.05 171.72 14.47 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 122.125 -0.632 . . . . 0.0 109.453 177.145 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 72.8 m -92.41 139.14 30.89 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 163.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -130.5 148.96 52.37 Favored 'General case' 0 N--CA 1.499 2.002 0 C-N-CA 120.404 -0.519 . . . . 0.0 110.54 -176.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -151.68 141.97 22.4 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 177.419 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.419 HD12 HD12 ' A' ' 99' ' ' ILE . 17.9 tt -142.24 149.19 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 CA-C-O 120.908 0.385 . . . . 0.0 110.248 -173.097 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.506 HD12 ' HG ' ' A' ' 73' ' ' LEU . 16.5 tt -139.15 145.4 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 -146.26 141.06 26.98 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 -167.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.52 ' O ' HD23 ' A' ' 95' ' ' LEU . 13.2 tm-20 -101.57 115.78 31.29 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 122.165 -0.334 . . . . 0.0 110.139 -176.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -86.95 175.18 8.28 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 122.194 -0.316 . . . . 0.0 110.599 -175.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -60.59 -17.13 44.6 Favored 'General case' 0 N--CA 1.506 2.354 0 O-C-N 121.975 -0.453 . . . . 0.0 112.14 -172.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -92.48 -11.91 33.41 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.602 -0.686 . . . . 0.0 111.728 177.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.35 21.09 36.01 Favored Glycine 0 N--CA 1.497 2.715 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 176.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -97.28 141.07 30.84 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 118.379 1.089 . . . . 0.0 109.811 170.231 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.9 p -94.91 126.75 40.45 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 122.155 -0.341 . . . . 0.0 110.322 177.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 17.9 p -98.02 112.96 24.71 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 122.128 -0.358 . . . . 0.0 110.298 176.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.538 ' N ' HD12 ' A' ' 73' ' ' LEU . 6.4 mp -99.61 131.09 45.84 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 122.195 -0.316 . . . . 0.0 110.489 -179.044 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -149.34 145.89 27.25 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 122.168 -0.332 . . . . 0.0 110.249 175.118 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 83.8 p -143.7 166.94 23.47 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 178.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -178.64 -163.63 30.22 Favored Glycine 0 N--CA 1.496 2.687 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 -178.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 2.0 m -96.72 132.4 42.45 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 122.144 -0.621 . . . . 0.0 110.321 -176.102 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 45.2 ttm -101.58 124.87 47.94 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 122.13 -0.356 . . . . 0.0 110.277 179.25 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 25.3 pttt -65.69 168.66 7.36 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 122.032 -0.417 . . . . 0.0 110.516 177.097 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 56.7 t80 -65.36 146.82 54.41 Favored 'General case' 0 N--CA 1.504 2.267 0 O-C-N 122.062 -0.399 . . . . 0.0 110.483 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -140.97 -48.4 0.41 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 122.115 -0.365 . . . . 0.0 110.397 -178.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 136.8 -34.97 2.15 Favored Glycine 0 N--CA 1.497 2.709 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 -178.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.1 m -72.23 123.97 24.06 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 122.042 -0.681 . . . . 0.0 110.029 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -75.59 -41.35 54.82 Favored 'General case' 0 N--CA 1.502 2.131 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.446 -179.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -155.72 30.0 0.37 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 122.061 -0.399 . . . . 0.0 110.81 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -78.4 82.12 4.71 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.84 -0.537 . . . . 0.0 109.852 177.22 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 90.6 m -123.45 33.04 5.46 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.828 -0.545 . . . . 0.0 110.385 -177.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -82.36 160.72 22.76 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.96 -0.462 . . . . 0.0 110.356 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -116.98 120.77 39.44 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 122.13 -0.356 . . . . 0.0 110.357 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 7.0 m -78.69 150.31 75.7 Favored Pre-proline 0 N--CA 1.5 2.069 0 O-C-N 122.086 -0.384 . . . . 0.0 110.17 179.221 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -82.82 56.25 5.57 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 O-C-N 123.424 1.223 . . . . 0.0 111.006 174.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 16.5 pttp -155.67 50.08 0.54 Allowed 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.63 -0.669 . . . . 0.0 109.693 -178.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.463 ' HB1' HH22 ' A' ' 97' ' ' ARG . . . -155.66 -169.39 3.1 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.949 -0.469 . . . . 0.0 110.49 -166.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -64.56 -169.23 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.274 0 CA-C-O 120.968 0.413 . . . . 0.0 110.148 -175.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.52 HD23 ' O ' ' A' ' 65' ' ' GLU . 8.8 tp -64.21 163.77 12.15 Favored 'General case' 0 N--CA 1.506 2.342 0 O-C-N 122.014 -0.429 . . . . 0.0 109.971 -168.01 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 72.2 mtp85 -66.44 155.76 36.6 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.788 -0.57 . . . . 0.0 110.172 -163.284 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.463 HH22 ' HB1' ' A' ' 93' ' ' ALA . 3.1 ptt180 -161.39 165.41 28.95 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 120.901 0.381 . . . . 0.0 110.477 -175.731 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.404 ' O ' HG22 ' A' ' 63' ' ' ILE . 17.5 m -126.69 146.43 50.21 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 169.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.419 HD12 HD12 ' A' ' 62' ' ' ILE . 18.3 tt -143.17 155.98 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.993 -0.442 . . . . 0.0 110.29 -174.072 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.429 ' HB3' HD21 ' A' ' 111' ' ' LEU . 43.6 mt-10 -146.82 146.88 30.38 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 120.756 0.312 . . . . 0.0 110.239 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 26.4 p -143.11 146.38 33.71 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 177.058 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 18.2 p -157.55 131.97 8.42 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 122.002 -0.436 . . . . 0.0 110.805 -170.376 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 20.7 ttm-85 -104.97 48.67 0.83 Allowed 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 121.371 0.605 . . . . 0.0 110.645 -176.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.0 p -137.95 150.94 47.47 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.819 -0.551 . . . . 0.0 109.884 175.47 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 17.6 p-10 -62.55 132.35 52.15 Favored 'General case' 0 N--CA 1.505 2.286 0 CA-C-O 121.355 0.598 . . . . 0.0 111.674 -163.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 79.1 mt 51.86 27.6 4.39 Favored 'General case' 0 N--CA 1.507 2.409 0 O-C-N 122.061 -0.4 . . . . 0.0 111.937 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 26.1 p -62.7 -23.15 66.99 Favored 'General case' 0 N--CA 1.507 2.403 0 O-C-N 121.847 -0.533 . . . . 0.0 111.6 174.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -75.4 -29.9 59.95 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.855 -0.528 . . . . 0.0 111.01 178.176 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -62.36 -39.84 94.46 Favored 'General case' 0 N--CA 1.507 2.377 0 O-C-N 121.738 -0.602 . . . . 0.0 110.753 -169.373 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -100.22 16.2 25.04 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 122.105 -0.372 . . . . 0.0 111.678 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.429 HD21 ' HB3' ' A' ' 100' ' ' GLU . 16.3 tp -111.82 108.98 18.57 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.557 -0.715 . . . . 0.0 110.327 -175.62 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -97.9 120.87 59.2 Favored Pre-proline 0 N--CA 1.496 1.869 0 CA-C-O 118.858 -0.591 . . . . 0.0 110.14 174.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.413 ' HB2' HG21 ' A' ' 63' ' ' ILE . 37.2 Cg_endo -69.46 141.05 45.36 Favored 'Trans proline' 0 N--CA 1.491 1.342 0 O-C-N 123.202 1.107 . . . . 0.0 110.182 174.61 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 34.0 p -139.22 135.81 34.34 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 122.118 -0.364 . . . . 0.0 110.218 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 17.3 mt -71.77 155.07 92.65 Favored Pre-proline 0 N--CA 1.501 2.107 0 CA-C-O 119.306 -0.378 . . . . 0.0 110.068 178.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -62.77 152.61 77.54 Favored 'Trans proline' 0 N--CA 1.495 1.573 0 O-C-N 123.351 1.185 . . . . 0.0 110.792 179.149 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -67.62 133.09 28.74 Favored 'Trans proline' 0 N--CA 1.491 1.35 0 O-C-N 123.542 1.286 . . . . 0.0 110.478 -176.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.425 HG12 ' N ' ' A' ' 119' ' ' VAL . 43.7 t -80.42 166.25 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.093 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.425 ' N ' HG12 ' A' ' 118' ' ' VAL . 11.9 p -88.1 145.25 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 122.091 -0.38 . . . . 0.0 110.052 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.43 HD13 ' CZ ' ' A' ' 124' ' ' PHE . 75.8 mt -89.49 127.84 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -178.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -112.1 -63.66 0.47 Allowed Glycine 0 N--CA 1.496 2.67 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.252 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_exo -58.05 167.12 4.73 Favored 'Trans proline' 0 N--CA 1.501 1.965 0 O-C-N 123.36 1.189 . . . . 0.0 111.446 179.196 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -83.3 153.45 24.62 Favored 'General case' 0 N--CA 1.5 2.036 0 C-N-CA 120.824 -0.35 . . . . 0.0 110.201 -179.073 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.43 ' CZ ' HD13 ' A' ' 120' ' ' ILE . 97.0 m-85 -71.51 152.22 43.2 Favored 'General case' 0 N--CA 1.502 2.131 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.155 -179.09 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -81.76 -33.6 30.88 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 122.102 -0.374 . . . . 0.0 110.285 -179.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 80.75 59.29 2.51 Favored Glycine 0 N--CA 1.495 2.62 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 87.7 p -79.66 163.64 24.4 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 122.148 -0.619 . . . . 0.0 110.167 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 76.2 mt -89.77 139.96 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 -179.169 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 54.6 ttt180 . . . . . 0 N--CA 1.495 1.812 0 CA-C-O 117.98 -1.009 . . . . 0.0 110.196 179.899 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.333 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo -58.45 120.53 8.48 Favored 'Trans proline' 0 N--CA 1.5 1.876 0 C-N-CA 121.106 1.204 . . . . 0.0 111.357 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -155.4 78.81 1.02 Allowed 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -177.028 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -79.15 87.04 4.91 Favored 'General case' 0 N--CA 1.501 2.098 0 CA-C-O 121.13 0.491 . . . . 0.0 109.948 178.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 22.3 m -135.81 65.09 1.55 Allowed 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.365 0.602 . . . . 0.0 110.071 177.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 21.7 mt -78.68 150.84 76.45 Favored Pre-proline 0 N--CA 1.5 2.061 0 O-C-N 121.736 -0.603 . . . . 0.0 110.091 -179.19 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_exo -64.68 120.68 8.01 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 O-C-N 123.322 1.17 . . . . 0.0 110.998 167.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -158.17 53.37 0.45 Allowed 'General case' 0 N--CA 1.5 2.028 0 CA-C-O 121.358 0.599 . . . . 0.0 110.159 165.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.403 HD23 HG23 ' A' ' 55' ' ' THR . 21.9 tp -158.05 114.36 2.81 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.696 -0.627 . . . . 0.0 110.032 -179.06 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.47 ' CE ' HD21 ' A' ' 106' ' ' LEU . 23.4 ttpt -99.71 130.5 45.93 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 122.137 -0.352 . . . . 0.0 110.194 179.19 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 78.2 m -115.28 140.32 49.21 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -177.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -84.29 142.91 29.89 Favored 'General case' 0 N--CA 1.502 2.141 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 177.129 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 28.1 p -115.31 137.29 52.2 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 122.127 -0.358 . . . . 0.0 110.642 -176.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 49.5 m -122.95 139.03 54.49 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 122.069 -0.394 . . . . 0.0 110.051 176.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 75.52 -67.17 2.27 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.721 -1.351 . . . . 0.0 109.721 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -114.08 124.12 51.34 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 122.11 -0.641 . . . . 0.0 110.486 -176.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -137.99 136.87 20.16 Favored Pre-proline 0 N--CA 1.497 1.901 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 175.336 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.44 151.93 71.29 Favored 'Trans proline' 0 N--CA 1.498 1.745 0 O-C-N 123.083 1.044 . . . . 0.0 111.111 -172.276 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -60.35 -28.55 68.26 Favored 'General case' 0 N--CA 1.507 2.391 0 O-C-N 121.935 -0.478 . . . . 0.0 111.356 -172.187 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -91.89 14.37 15.82 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.969 -0.457 . . . . 0.0 111.824 -177.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.65 162.04 27.33 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.622 -0.674 . . . . 0.0 110.27 -173.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 71.7 mt -124.59 136.69 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 -178.26 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 19.8 p30 37.76 43.07 0.45 Allowed 'General case' 0 N--CA 1.514 2.739 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -176.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 55.39 43.6 28.56 Favored 'General case' 0 N--CA 1.508 2.468 0 O-C-N 121.815 -0.553 . . . . 0.0 111.407 -178.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 59.5 p -139.55 160.56 39.58 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.768 -0.582 . . . . 0.0 110.261 171.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.1 p -139.28 163.99 31.01 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 120.787 0.327 . . . . 0.0 110.613 178.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 77.5 mt -108.73 132.17 57.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -175.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.403 HG23 HD23 ' A' ' 36' ' ' LEU . 8.4 t -140.29 151.63 45.24 Favored 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 120.95 0.405 . . . . 0.0 110.976 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 26.7 p30 -108.72 30.35 6.58 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 122.096 -0.377 . . . . 0.0 110.603 167.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -122.83 -93.93 1.16 Allowed Glycine 0 N--CA 1.496 2.653 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 176.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 74.6 m-70 -149.59 172.11 15.56 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 122.052 -0.675 . . . . 0.0 109.463 176.075 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 75.0 m -92.41 139.06 30.97 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 166.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -130.81 150.7 51.86 Favored 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 120.401 -0.52 . . . . 0.0 110.539 -176.177 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -152.08 142.51 22.58 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 177.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.489 HD12 HD12 ' A' ' 99' ' ' ILE . 18.0 tt -143.67 149.17 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.354 -173.444 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.517 HD12 ' HG ' ' A' ' 73' ' ' LEU . 16.1 tt -137.63 145.23 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.193 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -148.12 146.65 28.88 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 -167.431 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.8 tm-20 -101.59 117.77 35.58 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 122.146 -0.346 . . . . 0.0 110.237 -175.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 51.4 p30 -87.28 175.36 8.06 Favored 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 120.909 -0.316 . . . . 0.0 110.628 -175.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -60.34 -18.07 47.46 Favored 'General case' 0 N--CA 1.508 2.453 0 O-C-N 121.988 -0.445 . . . . 0.0 111.915 -173.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 16.1 mm-40 -93.21 -9.48 39.08 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.713 -0.617 . . . . 0.0 111.89 178.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 88.69 21.0 45.17 Favored Glycine 0 N--CA 1.498 2.826 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 177.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -96.9 143.63 27.6 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 118.413 1.107 . . . . 0.0 109.793 169.563 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.3 p -94.88 125.93 39.87 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.281 177.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 17.9 p -98.04 113.0 24.74 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 122.154 -0.341 . . . . 0.0 110.272 177.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.541 ' N ' HD12 ' A' ' 73' ' ' LEU . 6.4 mp -97.8 128.54 44.51 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 122.181 -0.324 . . . . 0.0 110.407 -178.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -145.34 145.78 31.34 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 122.183 -0.323 . . . . 0.0 110.348 176.455 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 97.1 p -143.6 166.96 23.39 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 178.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 179.95 -164.0 31.53 Favored Glycine 0 N--CA 1.496 2.681 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 -178.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 1.8 m -96.71 132.52 42.31 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 122.248 -0.56 . . . . 0.0 110.356 -175.389 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 47.4 ttm -102.56 122.0 43.51 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 122.038 -0.414 . . . . 0.0 110.159 177.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 27.7 pttt -67.03 162.05 23.01 Favored 'General case' 0 N--CA 1.503 2.195 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.407 177.184 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -67.06 147.7 52.84 Favored 'General case' 0 N--CA 1.504 2.244 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.215 179.382 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -155.02 26.44 0.42 Allowed 'General case' 0 N--CA 1.499 2.009 0 O-C-N 122.133 -0.354 . . . . 0.0 111.389 178.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 98.23 -40.06 2.59 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 110.151 -1.18 . . . . 0.0 110.151 176.089 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 54.1 m -74.57 111.49 9.81 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 122.021 -0.693 . . . . 0.0 110.376 -175.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -80.21 -38.35 31.3 Favored 'General case' 0 N--CA 1.5 2.038 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.049 177.242 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -155.64 76.69 0.96 Allowed 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.145 0.498 . . . . 0.0 109.869 -178.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -155.33 118.08 4.29 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.99 -0.444 . . . . 0.0 109.891 -177.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 91.2 m -140.19 38.26 1.92 Allowed 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 120.966 0.412 . . . . 0.0 109.899 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 35.7 pttt -76.33 170.72 15.81 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.925 -0.484 . . . . 0.0 110.728 -176.351 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -148.27 127.52 12.98 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 122.148 -0.345 . . . . 0.0 110.43 177.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.4 m -73.09 162.81 72.71 Favored Pre-proline 0 N--CA 1.501 2.086 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 176.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -83.25 57.81 5.97 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 O-C-N 123.325 1.171 . . . . 0.0 111.621 -173.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 32.2 tptt -155.77 36.38 0.36 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.603 -0.686 . . . . 0.0 109.538 170.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -82.35 -169.84 2.63 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-O 121.09 0.471 . . . . 0.0 110.958 -170.199 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 2.2 tp60 -65.0 -168.84 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.223 0 O-C-N 122.126 -0.359 . . . . 0.0 110.034 174.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' A' ' 95' ' ' LEU . 9.2 tp -64.0 168.62 5.06 Favored 'General case' 0 N--CA 1.508 2.452 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 -173.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 43.0 mtp180 -68.03 134.21 50.29 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.647 -0.658 . . . . 0.0 110.23 -161.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 28.5 ptt180 -161.51 165.34 28.76 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 120.872 0.367 . . . . 0.0 110.584 -167.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.418 HG21 ' O ' ' A' ' 114' ' ' THR . 17.0 m -125.78 149.0 48.93 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 171.7 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.489 HD12 HD12 ' A' ' 62' ' ' ILE . 18.3 tt -143.15 154.24 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.156 -176.013 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -146.85 150.81 36.0 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 120.858 0.361 . . . . 0.0 110.407 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 26.9 p -142.95 149.99 39.11 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 122.06 -0.4 . . . . 0.0 110.091 176.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 19.2 p -157.58 133.43 9.3 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.971 -0.456 . . . . 0.0 110.821 -172.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 61.7 ttp85 -106.35 52.51 0.72 Allowed 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 121.353 0.597 . . . . 0.0 110.536 -176.426 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.1 p -144.08 151.07 39.12 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.788 -0.57 . . . . 0.0 109.947 175.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 18.2 p-10 -62.39 132.11 51.48 Favored 'General case' 0 N--CA 1.503 2.213 0 CA-C-O 121.418 0.627 . . . . 0.0 111.726 -163.298 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.47 HD21 ' CE ' ' A' ' 37' ' ' LYS . 79.4 mt 51.75 28.06 4.61 Favored 'General case' 0 N--CA 1.506 2.334 0 O-C-N 121.936 -0.477 . . . . 0.0 111.955 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 25.7 p -62.56 -24.16 67.38 Favored 'General case' 0 N--CA 1.507 2.404 0 O-C-N 121.904 -0.498 . . . . 0.0 111.506 174.289 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -73.0 -30.33 63.71 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.877 -0.514 . . . . 0.0 110.944 178.485 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -62.84 -39.29 93.9 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.616 -0.678 . . . . 0.0 110.752 -168.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -100.2 16.24 24.88 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 122.103 -0.373 . . . . 0.0 111.696 -179.028 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 16.9 tp -112.73 110.35 20.43 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.649 -0.657 . . . . 0.0 110.314 -175.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -96.68 120.83 61.22 Favored Pre-proline 0 N--CA 1.496 1.837 0 CA-C-O 118.922 -0.561 . . . . 0.0 110.096 174.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -72.13 138.16 30.2 Favored 'Trans proline' 0 N--CA 1.492 1.415 0 O-C-N 123.293 1.154 . . . . 0.0 110.307 173.317 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.418 ' O ' HG21 ' A' ' 98' ' ' THR . 35.5 p -139.18 150.0 45.07 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 122.096 -0.377 . . . . 0.0 110.203 178.022 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 12.9 mt -71.48 146.88 92.13 Favored Pre-proline 0 N--CA 1.501 2.088 0 CA-C-O 119.215 -0.421 . . . . 0.0 109.984 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -70.55 149.72 62.31 Favored 'Trans proline' 0 N--CA 1.491 1.338 0 O-C-N 123.477 1.251 . . . . 0.0 110.252 -178.233 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -68.86 142.54 52.35 Favored 'Trans proline' 0 N--CA 1.491 1.362 0 O-C-N 123.493 1.259 . . . . 0.0 110.276 177.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.424 HG12 ' N ' ' A' ' 119' ' ' VAL . 47.9 t -150.34 165.26 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.168 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.424 ' N ' HG12 ' A' ' 118' ' ' VAL . 14.6 p -88.63 135.14 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 122.026 -0.421 . . . . 0.0 110.378 -179.066 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.462 ' O ' HG23 ' A' ' 120' ' ' ILE . 7.1 tp -152.68 119.36 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 122.071 -0.393 . . . . 0.0 109.962 178.694 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 68.75 -156.2 53.4 Favored Glycine 0 N--CA 1.496 2.68 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -178.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_exo -58.62 139.97 92.92 Favored 'Trans proline' 0 N--CA 1.501 1.956 0 O-C-N 123.364 1.192 . . . . 0.0 111.232 176.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -84.34 144.42 28.85 Favored 'General case' 0 N--CA 1.499 2.009 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.371 -179.304 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -155.84 112.72 3.19 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 177.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -155.37 152.11 28.71 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 122.069 -0.394 . . . . 0.0 110.157 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -102.33 34.9 5.35 Favored Glycine 0 N--CA 1.496 2.695 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.169 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 70.5 m -155.39 155.61 33.91 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 122.09 -0.653 . . . . 0.0 110.123 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 75.4 mt -90.2 131.47 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 67.2 ttp85 . . . . . 0 N--CA 1.499 2.001 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.201 -179.978 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.242 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_exo -58.55 120.04 7.67 Favored 'Trans proline' 0 N--CA 1.501 1.929 0 O-C-N 123.367 1.193 . . . . 0.0 111.313 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -90.47 47.2 1.41 Allowed 'General case' 0 N--CA 1.501 2.093 0 CA-C-O 121.056 0.455 . . . . 0.0 110.898 179.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -79.65 61.42 3.63 Favored 'General case' 0 N--CA 1.504 2.259 0 CA-C-O 121.277 0.561 . . . . 0.0 110.503 -178.208 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.509 HG22 ' ND2' ' A' ' 56' ' ' ASN . 18.3 m -108.9 51.67 0.74 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.702 -0.624 . . . . 0.0 109.994 -178.458 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 27.2 mt -76.8 151.02 82.12 Favored Pre-proline 0 N--CA 1.5 2.04 0 O-C-N 121.831 -0.543 . . . . 0.0 110.101 -178.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -64.36 121.32 8.89 Favored 'Trans proline' 0 N--CA 1.498 1.791 0 O-C-N 123.368 1.194 . . . . 0.0 111.145 169.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -158.28 53.58 0.44 Allowed 'General case' 0 N--CA 1.5 2.034 0 CA-C-O 121.378 0.609 . . . . 0.0 110.235 164.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 22.7 tp -158.42 114.0 2.66 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.731 -0.606 . . . . 0.0 109.971 -179.073 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 53.1 tttt -99.74 132.27 45.19 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 122.164 -0.335 . . . . 0.0 110.205 -179.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 80.2 m -117.73 140.23 49.96 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 122.047 -0.408 . . . . 0.0 109.901 -177.42 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 62.9 t80 -84.35 142.83 29.89 Favored 'General case' 0 N--CA 1.501 2.077 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 175.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 28.1 p -114.84 138.36 50.87 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 122.05 -0.406 . . . . 0.0 110.714 -177.009 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 99.9 p -123.01 141.19 52.23 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 176.064 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.37 -68.36 1.46 Allowed Glycine 0 N--CA 1.495 2.629 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 83.6 t60 -113.17 124.78 53.34 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 122.08 -0.659 . . . . 0.0 110.663 -176.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -138.05 136.63 19.82 Favored Pre-proline 0 N--CA 1.497 1.92 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 175.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -60.28 152.17 68.56 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 O-C-N 123.107 1.056 . . . . 0.0 111.114 -171.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -60.15 -28.35 67.84 Favored 'General case' 0 N--CA 1.506 2.355 0 O-C-N 121.938 -0.476 . . . . 0.0 111.436 -172.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -92.02 14.23 16.45 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.857 -0.527 . . . . 0.0 111.754 -177.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.19 162.07 25.99 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.582 -0.699 . . . . 0.0 110.382 -172.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 75.2 mt -125.62 138.51 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 -178.086 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 38.7 43.29 0.69 Allowed 'General case' 0 N--CA 1.512 2.655 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -178.054 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 30.7 m120 55.05 42.27 31.07 Favored 'General case' 0 N--CA 1.509 2.488 0 O-C-N 121.759 -0.588 . . . . 0.0 111.453 -178.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 68.3 p -141.22 160.41 40.17 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.767 -0.583 . . . . 0.0 110.343 173.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.1 p -140.91 165.03 28.64 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 120.902 0.382 . . . . 0.0 110.641 179.497 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 78.0 mt -109.85 132.05 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 -175.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.7 t -138.93 150.87 46.4 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.978 -0.451 . . . . 0.0 110.999 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.509 ' ND2' HG22 ' A' ' 32' ' ' THR . 50.4 p30 -108.16 31.12 5.79 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 122.114 -0.366 . . . . 0.0 110.593 167.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -124.96 -93.39 0.97 Allowed Glycine 0 N--CA 1.497 2.707 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 176.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 45.0 m-70 -149.69 172.21 15.44 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 122.106 -0.644 . . . . 0.0 109.366 176.007 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 71.9 m -92.1 139.03 31.04 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 166.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 15.5 p90 -129.16 151.93 49.29 Favored 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 120.372 -0.531 . . . . 0.0 110.643 -176.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -151.18 142.68 23.51 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 176.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.478 HD11 ' NH2' ' A' ' 97' ' ' ARG . 18.3 tt -142.05 149.05 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 CA-C-O 120.864 0.364 . . . . 0.0 110.277 -172.67 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.53 HD12 ' HG ' ' A' ' 73' ' ' LEU . 15.3 tt -140.8 145.25 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 177.601 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -150.15 144.34 25.62 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 -170.084 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.5 tm-20 -101.62 117.88 35.8 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 110.11 -0.329 . . . . 0.0 110.11 -178.204 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 52.3 p30 -86.69 175.19 8.39 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 122.179 -0.326 . . . . 0.0 110.609 -175.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -60.19 -17.43 41.12 Favored 'General case' 0 N--CA 1.507 2.392 0 O-C-N 121.931 -0.48 . . . . 0.0 112.127 -173.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -92.79 -11.12 34.58 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.601 -0.687 . . . . 0.0 111.868 178.457 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.55 20.97 35.81 Favored Glycine 0 N--CA 1.498 2.781 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 177.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -96.94 139.91 32.27 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-N 118.324 1.062 . . . . 0.0 109.841 171.257 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.2 p -94.85 125.25 39.39 Favored 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 120.824 -0.351 . . . . 0.0 110.205 176.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 17.7 p -97.94 112.91 24.66 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 122.167 -0.333 . . . . 0.0 110.305 177.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.533 ' N ' HD12 ' A' ' 73' ' ' LEU . 6.4 mp -99.01 127.65 44.97 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 122.13 -0.356 . . . . 0.0 110.311 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -146.97 146.08 29.97 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 122.084 -0.385 . . . . 0.0 110.36 177.031 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 90.4 p -143.77 166.71 24.13 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 177.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 178.09 -163.69 32.02 Favored Glycine 0 N--CA 1.499 2.841 0 N-CA-C 110.256 -1.138 . . . . 0.0 110.256 -179.043 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 2.9 m -96.62 132.4 42.29 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 122.179 -0.601 . . . . 0.0 110.359 -175.384 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 44.4 ttm -99.46 121.94 41.85 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 122.034 -0.416 . . . . 0.0 110.042 178.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 26.0 pttt -66.08 166.12 12.25 Favored 'General case' 0 N--CA 1.503 2.193 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.562 -179.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 54.1 p90 -64.96 125.29 24.43 Favored 'General case' 0 N--CA 1.504 2.251 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.572 -179.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -110.9 -34.48 6.22 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 122.146 -0.346 . . . . 0.0 110.255 178.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 102.16 -39.8 2.64 Favored Glycine 0 N--CA 1.497 2.731 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 -179.036 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.2 m -75.29 117.22 16.86 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 122.154 -0.615 . . . . 0.0 110.209 178.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -78.9 -33.4 45.65 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 122.056 -0.402 . . . . 0.0 110.537 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -82.19 4.11 24.67 Favored 'General case' 0 N--CA 1.502 2.135 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -175.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -75.94 65.7 2.05 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.379 -0.826 . . . . 0.0 110.14 -178.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 38.4 t -155.19 62.85 0.63 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.705 -0.622 . . . . 0.0 109.881 179.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -155.43 161.99 40.86 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.728 -0.607 . . . . 0.0 110.222 -177.14 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -99.89 121.59 41.55 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 178.419 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.8 m -76.38 143.93 73.54 Favored Pre-proline 0 N--CA 1.498 1.95 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.069 -173.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -77.81 62.58 7.9 Favored 'Trans proline' 0 N--CA 1.494 1.531 0 O-C-N 123.34 1.179 . . . . 0.0 110.508 176.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 60.3 tttt -155.41 43.86 0.46 Allowed 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.325 0.583 . . . . 0.0 109.873 -178.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -155.65 147.55 23.29 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -107.72 67.16 0.68 Allowed 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 121.346 0.594 . . . . 0.0 110.103 -179.241 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 17.1 tp -155.0 149.86 26.71 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.839 -0.538 . . . . 0.0 110.171 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 93.6 mtt-85 -98.24 124.09 42.66 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 122.065 -0.397 . . . . 0.0 110.114 179.186 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.478 ' NH2' HD11 ' A' ' 62' ' ' ILE . 10.1 ptm180 -161.48 165.11 29.18 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 122.087 -0.383 . . . . 0.0 110.592 -178.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 17.0 m -134.0 149.35 51.2 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 177.092 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.4 tt -142.6 150.95 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 122.023 -0.423 . . . . 0.0 109.873 178.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 48.5 mm-40 -144.64 151.65 39.3 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 120.862 0.363 . . . . 0.0 110.655 -176.414 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 26.3 p -143.04 150.98 40.3 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 177.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 19.5 p -157.56 134.43 10.04 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 122.016 -0.427 . . . . 0.0 110.852 -175.1 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 29.4 ttp180 -106.98 47.38 0.88 Allowed 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 121.208 0.528 . . . . 0.0 110.608 -173.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.0 p -142.16 151.39 42.18 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.88 -0.513 . . . . 0.0 109.888 178.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 15.8 p30 -62.78 132.44 52.24 Favored 'General case' 0 N--CA 1.505 2.285 0 CA-C-O 121.466 0.651 . . . . 0.0 111.628 -163.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 78.9 mt 52.14 27.78 4.89 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 122.03 -0.419 . . . . 0.0 111.922 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 25.8 p -62.71 -24.84 67.87 Favored 'General case' 0 N--CA 1.508 2.444 0 O-C-N 121.9 -0.5 . . . . 0.0 111.489 174.09 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -72.57 -29.59 63.68 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 121.918 -0.489 . . . . 0.0 111.076 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -62.23 -39.71 93.74 Favored 'General case' 0 N--CA 1.505 2.324 0 O-C-N 121.674 -0.641 . . . . 0.0 110.821 -168.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -101.34 16.22 26.28 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 122.066 -0.396 . . . . 0.0 111.763 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 12.9 tp -115.26 108.89 17.16 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.673 -0.642 . . . . 0.0 110.338 -175.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -100.62 120.78 55.03 Favored Pre-proline 0 N--CA 1.496 1.84 0 CA-C-O 118.913 -0.565 . . . . 0.0 110.183 173.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -67.94 140.06 49.14 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 O-C-N 123.153 1.081 . . . . 0.0 110.256 173.108 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 49.3 p -139.19 149.65 44.65 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 122.118 -0.364 . . . . 0.0 110.087 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 18.9 mt -71.29 155.03 93.45 Favored Pre-proline 0 N--CA 1.501 2.098 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.056 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -68.07 146.56 71.1 Favored 'Trans proline' 0 N--CA 1.491 1.35 0 O-C-N 123.476 1.25 . . . . 0.0 110.3 -178.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -70.44 151.97 65.5 Favored 'Trans proline' 0 N--CA 1.491 1.361 0 O-C-N 123.477 1.251 . . . . 0.0 110.328 -178.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.406 HG12 ' N ' ' A' ' 119' ' ' VAL . 43.7 t -79.37 165.61 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 177.352 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.406 ' N ' HG12 ' A' ' 118' ' ' VAL . 59.5 t -87.85 129.07 39.75 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -178.527 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.438 ' O ' HG23 ' A' ' 120' ' ' ILE . 16.7 tt -153.71 122.16 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 177.622 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -67.63 -85.45 0.1 OUTLIER Glycine 0 N--CA 1.497 2.704 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 -178.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -59.46 151.33 69.53 Favored 'Trans proline' 0 N--CA 1.503 2.073 0 C-N-CA 121.012 1.142 . . . . 0.0 111.11 178.012 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -155.16 149.43 26.01 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 122.141 -0.349 . . . . 0.0 110.318 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -155.42 96.91 1.84 Allowed 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -178.053 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -155.38 -55.94 0.09 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 122.131 -0.356 . . . . 0.0 110.22 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -82.28 169.56 49.75 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -178.327 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 86.9 p -155.46 163.69 39.69 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 122.059 -0.671 . . . . 0.0 110.106 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 50.8 mm -90.27 132.01 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 54.6 ttt180 . . . . . 0 N--CA 1.498 1.925 0 CA-C-O 118.026 -0.988 . . . . 0.0 110.194 179.954 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.219 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_exo -58.59 123.73 14.22 Favored 'Trans proline' 0 N--CA 1.499 1.843 0 C-N-CA 121.109 1.206 . . . . 0.0 111.356 179.096 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -90.16 47.13 1.41 Allowed 'General case' 0 N--CA 1.503 2.178 0 CA-C-O 121.096 0.474 . . . . 0.0 110.781 179.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -77.38 83.04 3.83 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.729 -0.607 . . . . 0.0 109.89 -176.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 21.6 m -124.72 108.34 11.9 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.978 -0.452 . . . . 0.0 110.241 178.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 73.5 mt -142.48 118.65 6.88 Favored Pre-proline 0 N--CA 1.496 1.87 0 CA-C-O 118.777 -0.63 . . . . 0.0 109.325 178.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -59.52 143.46 99.68 Favored 'Trans proline' 0 N--CA 1.502 2.0 0 C-N-CA 120.835 1.023 . . . . 0.0 111.277 -177.101 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -150.17 47.52 0.91 Allowed 'General case' 0 N--CA 1.499 1.989 0 CA-C-O 121.14 0.495 . . . . 0.0 110.647 -178.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.458 HD23 HG23 ' A' ' 55' ' ' THR . 20.3 tp -160.69 114.38 2.08 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.796 -0.565 . . . . 0.0 110.378 -174.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.448 ' CE ' HD21 ' A' ' 106' ' ' LEU . 30.1 ttpt -99.85 129.91 45.99 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 175.696 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 75.4 m -112.4 140.36 47.2 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -82.63 141.43 32.52 Favored 'General case' 0 N--CA 1.5 2.031 0 C-N-CA 120.764 -0.374 . . . . 0.0 109.992 175.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 27.8 p -115.38 137.12 52.38 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 122.021 -0.424 . . . . 0.0 110.649 -175.149 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 48.3 m -123.02 140.49 52.98 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 122.109 -0.37 . . . . 0.0 110.03 177.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 75.52 -67.24 2.26 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.307 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 83.8 t60 -115.92 124.33 50.34 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 122.061 -0.67 . . . . 0.0 110.543 -176.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -138.08 135.72 18.87 Favored Pre-proline 0 N--CA 1.497 1.907 0 N-CA-C 109.19 -0.671 . . . . 0.0 109.19 174.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.77 153.23 64.02 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 O-C-N 123.145 1.076 . . . . 0.0 111.193 -169.429 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -60.34 -28.33 68.07 Favored 'General case' 0 N--CA 1.506 2.335 0 O-C-N 121.918 -0.489 . . . . 0.0 111.43 -173.032 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -92.3 14.25 16.92 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.934 -0.479 . . . . 0.0 111.714 -178.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.92 161.99 27.95 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.731 -0.606 . . . . 0.0 110.225 -172.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 69.5 mt -124.92 136.97 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -176.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 18.0 p30 37.78 42.91 0.44 Allowed 'General case' 0 N--CA 1.514 2.731 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -175.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 24.0 t30 56.17 42.26 28.4 Favored 'General case' 0 N--CA 1.508 2.469 0 O-C-N 121.795 -0.566 . . . . 0.0 111.439 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 60.7 p -140.4 164.45 30.08 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.73 -0.606 . . . . 0.0 110.36 172.329 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.1 p -139.07 163.31 32.74 Favored 'General case' 0 N--CA 1.499 2.024 0 CA-C-O 120.889 0.376 . . . . 0.0 110.638 178.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 77.5 mt -110.36 134.35 52.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -175.18 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.458 HG23 HD23 ' A' ' 36' ' ' LEU . 8.1 t -144.0 153.97 42.79 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.996 -0.44 . . . . 0.0 111.106 179.129 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 39.5 p-10 -107.72 29.73 6.96 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 122.128 -0.357 . . . . 0.0 110.652 167.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -122.17 -100.98 1.63 Allowed Glycine 0 N--CA 1.497 2.702 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 176.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 25.6 m-70 -141.13 171.26 14.31 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 122.091 -0.652 . . . . 0.0 109.562 176.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 70.4 m -91.67 139.09 31.02 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 164.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -129.18 148.27 51.1 Favored 'General case' 0 N--CA 1.498 1.939 0 C-N-CA 120.374 -0.531 . . . . 0.0 110.423 -179.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -151.55 140.33 20.88 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 176.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.52 HD12 HD12 ' A' ' 99' ' ' ILE . 18.2 tt -143.86 149.3 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 CA-C-O 120.969 0.414 . . . . 0.0 110.611 -170.055 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.65 HD12 HD21 ' A' ' 73' ' ' LEU . 14.7 tt -135.02 145.19 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 175.452 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -148.27 146.38 28.59 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -169.085 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.7 tm-20 -101.79 117.95 35.93 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 120.793 0.33 . . . . 0.0 110.202 -175.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 26.9 p-10 -87.98 175.36 7.81 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 122.118 -0.364 . . . . 0.0 110.468 -176.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -60.34 -17.21 41.61 Favored 'General case' 0 N--CA 1.507 2.414 0 O-C-N 121.937 -0.477 . . . . 0.0 112.122 -172.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -92.41 -11.49 34.71 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.608 -0.682 . . . . 0.0 111.842 178.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.13 21.2 36.32 Favored Glycine 0 N--CA 1.497 2.743 0 N-CA-C 111.099 -0.801 . . . . 0.0 111.099 176.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -97.79 144.59 27.23 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-N 118.309 1.055 . . . . 0.0 109.872 170.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.9 p -94.92 128.42 41.69 Favored 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.24 176.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 20.1 p -97.82 116.05 29.27 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 122.138 -0.351 . . . . 0.0 110.474 178.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.65 HD21 HD12 ' A' ' 63' ' ' ILE . 15.3 mt -97.41 126.62 42.77 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 122.101 -0.374 . . . . 0.0 110.456 -179.476 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -150.52 146.16 26.42 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 122.065 -0.397 . . . . 0.0 110.474 175.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 93.7 p -143.7 167.06 23.17 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 175.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -179.23 -167.23 36.36 Favored Glycine 0 N--CA 1.497 2.748 0 N-CA-C 110.244 -1.142 . . . . 0.0 110.244 -178.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 2.2 m -96.6 132.72 41.93 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 122.221 -0.576 . . . . 0.0 110.147 -175.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 43.2 ttm -97.47 121.83 39.82 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 122.026 -0.421 . . . . 0.0 109.982 177.199 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 26.7 pttt -67.5 165.96 15.71 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 122.028 -0.42 . . . . 0.0 110.609 -176.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 58.1 t80 -66.44 148.11 52.34 Favored 'General case' 0 N--CA 1.503 2.182 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.267 176.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -140.03 -47.89 0.45 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 122.158 -0.339 . . . . 0.0 110.492 -178.404 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 150.08 -33.99 1.02 Allowed Glycine 0 N--CA 1.494 2.535 0 N-CA-C 109.729 -1.349 . . . . 0.0 109.729 -177.435 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.1 m -71.9 123.54 22.92 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 122.026 -0.69 . . . . 0.0 109.892 178.451 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -75.76 -41.46 53.09 Favored 'General case' 0 N--CA 1.501 2.122 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.373 -178.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -155.78 31.19 0.36 Allowed 'General case' 0 N--CA 1.498 1.931 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.665 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -77.31 82.68 3.77 Favored 'General case' 0 N--CA 1.501 2.083 0 CA-C-O 121.231 0.539 . . . . 0.0 109.885 178.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 14.8 t -117.76 32.12 6.33 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.917 -0.489 . . . . 0.0 110.374 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -83.73 -170.98 3.34 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.996 -0.44 . . . . 0.0 110.453 -178.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -107.24 121.05 43.76 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 122.14 -0.35 . . . . 0.0 110.211 178.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.4 m -81.78 172.33 9.91 Favored Pre-proline 0 N--CA 1.498 1.957 0 O-C-N 122.07 -0.394 . . . . 0.0 110.124 -177.28 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -85.61 51.38 2.88 Favored 'Trans proline' 0 N--CA 1.494 1.516 0 O-C-N 123.398 1.21 . . . . 0.0 111.396 174.027 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 43.4 tptt -155.81 45.07 0.45 Allowed 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.86 -173.09 1.14 Allowed 'General case' 0 N--CA 1.5 2.071 0 CA-C-O 121.109 0.48 . . . . 0.0 110.798 -162.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 2.2 tp60 -133.86 -168.95 2.21 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -167.402 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 9.1 tp -64.3 166.77 7.6 Favored 'General case' 0 N--CA 1.508 2.445 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -178.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 -68.21 123.59 21.13 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 121.799 -0.563 . . . . 0.0 110.146 -165.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 43.8 ptt85 -161.46 165.37 28.83 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 120.877 0.37 . . . . 0.0 110.41 -170.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 18.4 m -125.81 148.14 49.21 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 172.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.52 HD12 HD12 ' A' ' 62' ' ' ILE . 18.5 tt -143.2 156.08 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 122.048 -0.408 . . . . 0.0 110.186 -177.118 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.467 ' HB3' HD21 ' A' ' 111' ' ' LEU . 45.3 mt-10 -141.85 147.88 37.91 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 120.879 0.371 . . . . 0.0 110.411 178.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 25.3 p -143.09 136.35 28.2 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 -177.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 22.5 p -157.44 128.82 6.82 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.888 -0.507 . . . . 0.0 111.016 -171.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 52.9 ttt180 -103.73 48.76 0.84 Allowed 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 121.319 0.581 . . . . 0.0 110.481 -178.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 23.9 p -135.66 150.5 49.62 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.919 -0.488 . . . . 0.0 109.739 175.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -62.91 132.13 51.06 Favored 'General case' 0 N--CA 1.504 2.248 0 CA-C-O 121.358 0.599 . . . . 0.0 111.643 -162.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.448 HD21 ' CE ' ' A' ' 37' ' ' LYS . 82.7 mt 51.72 28.0 4.53 Favored 'General case' 0 N--CA 1.507 2.409 0 O-C-N 122.032 -0.418 . . . . 0.0 111.936 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 26.2 p -62.66 -23.01 66.88 Favored 'General case' 0 N--CA 1.507 2.391 0 O-C-N 121.908 -0.495 . . . . 0.0 111.591 174.01 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -77.39 -29.18 53.06 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.824 -0.547 . . . . 0.0 111.126 177.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -62.04 -40.26 95.13 Favored 'General case' 0 N--CA 1.506 2.357 0 O-C-N 121.69 -0.631 . . . . 0.0 110.879 -168.439 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -100.04 16.26 24.57 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 122.088 -0.383 . . . . 0.0 111.631 178.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.467 HD21 ' HB3' ' A' ' 100' ' ' GLU . 11.9 tp -115.88 108.9 16.88 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.504 -0.748 . . . . 0.0 110.25 -175.616 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -98.27 120.79 58.81 Favored Pre-proline 0 N--CA 1.497 1.888 0 CA-C-O 118.96 -0.543 . . . . 0.0 110.102 174.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.7 134.06 19.61 Favored 'Trans proline' 0 N--CA 1.49 1.273 0 O-C-N 123.227 1.119 . . . . 0.0 110.24 172.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 35.1 p -139.31 149.39 44.17 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 122.097 -0.377 . . . . 0.0 110.217 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 15.9 mt -72.16 155.09 92.02 Favored Pre-proline 0 N--CA 1.501 2.12 0 O-C-N 121.987 -0.445 . . . . 0.0 109.985 177.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -63.48 147.51 93.18 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 O-C-N 123.504 1.265 . . . . 0.0 110.704 178.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -68.72 134.14 29.45 Favored 'Trans proline' 0 N--CA 1.49 1.302 0 O-C-N 123.633 1.333 . . . . 0.0 110.328 -177.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.417 HG12 ' N ' ' A' ' 119' ' ' VAL . 43.4 t -80.39 165.71 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 178.349 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.417 ' N ' HG12 ' A' ' 118' ' ' VAL . 35.8 m -88.13 145.14 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 O-C-N 122.037 -0.414 . . . . 0.0 110.341 -179.446 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 23.1 pt -91.44 51.67 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 CA-C-O 121.149 0.499 . . . . 0.0 110.314 179.4 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 68.95 164.26 3.46 Favored Glycine 0 N--CA 1.496 2.676 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 -178.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_exo -58.66 133.08 51.86 Favored 'Trans proline' 0 N--CA 1.503 2.038 0 C-N-CA 121.091 1.194 . . . . 0.0 111.317 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -84.29 137.62 33.36 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 122.109 -0.37 . . . . 0.0 110.343 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -155.86 150.26 25.82 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 178.218 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -81.11 156.32 25.83 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 139.48 51.21 0.05 OUTLIER Glycine 0 N--CA 1.495 2.574 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 87.6 p -80.3 161.08 25.27 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 122.201 -0.588 . . . . 0.0 110.243 179.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 50.7 mm -90.19 137.77 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 63.6 ttt180 . . . . . 0 N--CA 1.499 1.994 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.211 179.895 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.269 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_exo -58.42 123.38 13.48 Favored 'Trans proline' 0 N--CA 1.502 2.006 0 C-N-CA 121.059 1.173 . . . . 0.0 111.436 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 69.5 mt-10 -90.36 46.85 1.37 Allowed 'General case' 0 N--CA 1.501 2.124 0 CA-C-O 121.167 0.508 . . . . 0.0 110.813 178.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -77.95 69.78 4.22 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.738 -0.601 . . . . 0.0 110.3 -176.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 18.3 m -147.81 119.42 7.99 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.851 -0.531 . . . . 0.0 110.047 176.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 20.4 mt -81.02 149.68 67.12 Favored Pre-proline 0 N--CA 1.501 2.097 0 O-C-N 122.106 -0.372 . . . . 0.0 110.311 -175.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -65.51 127.75 18.75 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 O-C-N 123.266 1.14 . . . . 0.0 110.929 166.044 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -156.07 50.99 0.53 Allowed 'General case' 0 N--CA 1.501 2.096 0 CA-C-O 121.305 0.574 . . . . 0.0 110.326 164.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.445 HD23 HG23 ' A' ' 55' ' ' THR . 21.1 tp -158.56 114.57 2.69 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.792 -0.567 . . . . 0.0 110.287 -177.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 29.7 ttmt -99.88 131.72 45.67 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 122.16 -0.338 . . . . 0.0 110.16 177.422 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 79.7 m -114.74 140.17 49.1 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 -179.395 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.484 ' CD1' ' NE2' ' A' ' 109' ' ' GLN . 68.6 t80 -87.49 143.38 27.25 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 122.093 -0.379 . . . . 0.0 110.097 176.537 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 27.5 p -117.49 137.0 52.84 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 122.089 -0.382 . . . . 0.0 110.58 -175.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 29.3 t -123.01 119.68 31.07 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 122.124 -0.36 . . . . 0.0 110.158 178.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 83.69 -61.96 4.67 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -106.54 112.84 26.01 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 122.109 -0.642 . . . . 0.0 110.519 -177.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -138.04 136.52 19.73 Favored Pre-proline 0 N--CA 1.495 1.803 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 176.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.78 152.78 67.32 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 O-C-N 123.118 1.062 . . . . 0.0 111.186 -171.189 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -60.55 -28.65 68.6 Favored 'General case' 0 N--CA 1.507 2.419 0 O-C-N 121.932 -0.48 . . . . 0.0 111.34 -172.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -92.21 14.37 16.41 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 122.009 -0.432 . . . . 0.0 111.752 -178.345 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.4 160.66 30.01 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.671 -0.643 . . . . 0.0 110.361 -172.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 58.7 mt -126.02 140.46 48.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 -178.388 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 38.74 42.79 0.65 Allowed 'General case' 0 N--CA 1.512 2.655 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -176.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 18.7 t30 55.48 41.33 30.98 Favored 'General case' 0 N--CA 1.508 2.453 0 O-C-N 121.789 -0.569 . . . . 0.0 111.401 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 40.1 p -144.09 163.95 32.06 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.804 -0.56 . . . . 0.0 110.647 174.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.3 p -140.63 164.97 28.74 Favored 'General case' 0 N--CA 1.499 1.975 0 CA-C-O 120.882 0.372 . . . . 0.0 110.564 178.168 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 76.7 mt -112.82 133.62 58.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -175.304 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.445 HG23 HD23 ' A' ' 36' ' ' LEU . 9.0 t -141.22 153.0 45.04 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 122.054 -0.404 . . . . 0.0 111.083 -178.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -109.77 31.27 5.96 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 122.172 -0.33 . . . . 0.0 110.469 167.083 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -123.41 -94.11 1.12 Allowed Glycine 0 N--CA 1.497 2.725 0 N-CA-C 109.131 -1.588 . . . . 0.0 109.131 175.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 39.2 m80 -149.81 172.06 15.74 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 122.054 -0.674 . . . . 0.0 109.512 176.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 77.3 m -93.21 139.31 30.75 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 167.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 15.1 p90 -130.46 153.75 48.46 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.833 -0.542 . . . . 0.0 110.599 -176.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -151.52 142.23 22.78 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 177.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 17.8 tt -142.51 149.24 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 CA-C-O 120.888 0.375 . . . . 0.0 110.338 -173.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.529 HD12 ' HG ' ' A' ' 73' ' ' LEU . 16.1 tt -139.87 145.39 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 63.8 mt-10 -146.21 142.82 28.78 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.985 -0.447 . . . . 0.0 109.845 -168.07 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.403 ' O ' HD23 ' A' ' 95' ' ' LEU . 13.3 tm-20 -101.61 116.45 32.78 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 120.793 0.33 . . . . 0.0 110.179 -176.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -87.28 175.19 8.14 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 122.17 -0.331 . . . . 0.0 110.583 -175.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -60.65 -17.11 45.27 Favored 'General case' 0 N--CA 1.506 2.374 0 O-C-N 121.993 -0.442 . . . . 0.0 112.159 -172.364 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -92.48 -12.01 33.14 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.666 -0.646 . . . . 0.0 111.829 177.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.14 21.01 36.85 Favored Glycine 0 N--CA 1.498 2.785 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 176.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -97.59 142.41 29.44 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 118.395 1.098 . . . . 0.0 109.799 169.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.5 p -94.94 127.25 40.85 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 120.779 -0.369 . . . . 0.0 110.277 178.109 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.1 p -97.94 112.9 24.66 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 120.906 -0.318 . . . . 0.0 110.348 176.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.536 ' N ' HD12 ' A' ' 73' ' ' LEU . 6.4 mp -98.38 129.79 45.03 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 120.774 0.321 . . . . 0.0 110.452 -178.557 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -149.58 146.27 27.24 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 122.038 -0.413 . . . . 0.0 110.194 175.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 98.8 p -143.64 167.1 23.06 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 178.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -177.36 -163.99 30.23 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 -177.392 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 2.1 m -97.21 132.56 42.85 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 122.131 -0.629 . . . . 0.0 110.378 -175.374 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 55.1 ttm -100.3 124.41 45.73 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 122.068 -0.395 . . . . 0.0 110.231 179.293 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.3 ptpp? -66.94 172.14 4.73 Favored 'General case' 0 N--CA 1.504 2.227 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.348 176.442 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -64.82 136.39 56.83 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 122.038 -0.414 . . . . 0.0 110.559 -176.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -131.25 -47.02 1.0 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 122.107 -0.371 . . . . 0.0 110.394 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 138.43 -35.06 2.05 Favored Glycine 0 N--CA 1.496 2.637 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 74.6 m -72.31 115.59 11.74 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.983 -0.716 . . . . 0.0 110.219 -178.041 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -79.03 -36.06 41.68 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 122.115 -0.365 . . . . 0.0 110.381 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -155.5 75.21 0.92 Allowed 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.274 0.559 . . . . 0.0 110.182 176.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 63.4 mt-30 -155.3 103.63 2.36 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.928 -0.483 . . . . 0.0 109.731 -178.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 97.7 m -140.54 36.53 1.84 Allowed 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 120.914 0.388 . . . . 0.0 110.206 -176.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 55.7 mttm -79.82 173.83 12.2 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.965 -0.46 . . . . 0.0 110.213 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -135.79 136.73 40.94 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 122.156 -0.34 . . . . 0.0 110.557 -179.405 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.4 m -77.74 156.13 80.46 Favored Pre-proline 0 N--CA 1.5 2.036 0 O-C-N 122.155 -0.34 . . . . 0.0 110.208 178.246 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -83.85 53.08 3.95 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 O-C-N 123.53 1.279 . . . . 0.0 111.132 173.09 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 71.2 mttt -155.46 55.27 0.62 Allowed 'General case' 0 N--CA 1.498 1.925 0 CA-C-O 121.558 0.694 . . . . 0.0 109.141 -175.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -155.7 -169.48 3.12 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 120.954 0.407 . . . . 0.0 110.523 -166.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 2.3 tp60 -64.56 -169.16 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.326 0 CA-C-O 120.99 0.424 . . . . 0.0 110.231 -176.04 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.403 HD23 ' O ' ' A' ' 65' ' ' GLU . 8.7 tp -64.12 163.65 12.15 Favored 'General case' 0 N--CA 1.507 2.376 0 O-C-N 121.903 -0.498 . . . . 0.0 109.949 -166.79 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 79.3 mtp180 -68.29 146.35 53.39 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.775 -0.578 . . . . 0.0 110.485 -163.232 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 30.4 ptt180 -161.49 165.23 28.98 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-O 120.902 0.382 . . . . 0.0 110.381 -175.157 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.467 HG21 ' O ' ' A' ' 114' ' ' THR . 14.0 m -123.93 149.02 46.38 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 171.672 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.2 tt -143.1 153.34 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 122.089 -0.382 . . . . 0.0 110.189 -175.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -148.85 150.91 33.81 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-O 120.804 0.335 . . . . 0.0 110.543 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 26.3 p -143.14 155.31 44.54 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 175.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 19.7 p -157.47 136.71 11.86 Favored 'General case' 0 N--CA 1.503 2.205 0 CA-C-O 121.013 0.435 . . . . 0.0 110.738 -172.195 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 38.7 ttt180 -108.54 50.45 0.78 Allowed 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.413 0.625 . . . . 0.0 110.653 -171.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.0 p -147.4 151.76 37.02 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.69 -0.631 . . . . 0.0 109.888 178.065 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 17.6 p-10 -62.07 132.71 53.75 Favored 'General case' 0 N--CA 1.505 2.317 0 CA-C-O 121.44 0.638 . . . . 0.0 111.656 -164.468 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 74.7 mt 52.57 27.14 4.83 Favored 'General case' 0 N--CA 1.506 2.374 0 O-C-N 121.971 -0.455 . . . . 0.0 111.962 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 26.0 p -63.05 -23.39 67.43 Favored 'General case' 0 N--CA 1.508 2.435 0 C-N-CA 120.402 -0.519 . . . . 0.0 111.605 174.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -70.97 -26.51 63.19 Favored 'General case' 0 N--CA 1.505 2.293 0 O-C-N 121.799 -0.563 . . . . 0.0 111.025 177.183 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLN . . . . . 0.484 ' NE2' ' CD1' ' A' ' 39' ' ' TYR . 7.6 tp-100 -61.15 -43.32 99.07 Favored 'General case' 0 N--CA 1.508 2.442 0 O-C-N 121.647 -0.658 . . . . 0.0 110.617 -174.191 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -100.46 16.26 25.17 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 122.157 -0.339 . . . . 0.0 111.851 -176.332 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 16.4 tp -115.48 108.91 17.08 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.53 -0.731 . . . . 0.0 110.336 -176.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -98.6 120.7 58.49 Favored Pre-proline 0 N--CA 1.496 1.832 0 CA-C-O 118.936 -0.554 . . . . 0.0 110.16 174.481 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -70.54 134.42 26.29 Favored 'Trans proline' 0 N--CA 1.491 1.336 0 O-C-N 123.133 1.07 . . . . 0.0 110.262 175.073 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.467 ' O ' HG21 ' A' ' 98' ' ' THR . 34.9 p -139.24 150.03 45.02 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 122.137 -0.352 . . . . 0.0 110.2 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 14.9 mt -70.45 155.07 93.98 Favored Pre-proline 0 N--CA 1.502 2.141 0 CA-C-O 119.208 -0.425 . . . . 0.0 109.955 179.137 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -62.52 154.97 61.08 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 O-C-N 123.393 1.207 . . . . 0.0 110.844 -176.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -63.83 160.25 37.93 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 O-C-N 123.339 1.178 . . . . 0.0 110.802 179.031 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.417 HG12 ' N ' ' A' ' 119' ' ' VAL . 48.2 t -150.16 165.16 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.202 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.417 ' N ' HG12 ' A' ' 118' ' ' VAL . 58.9 t -89.54 130.14 39.34 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 -178.535 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 75.7 mt -90.66 116.57 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 177.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -104.19 167.55 16.0 Favored Glycine 0 N--CA 1.496 2.661 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -58.17 141.6 96.65 Favored 'Trans proline' 0 N--CA 1.502 2.004 0 C-N-CA 121.05 1.167 . . . . 0.0 111.426 179.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -84.25 140.04 31.94 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 122.085 -0.384 . . . . 0.0 110.257 -179.18 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -73.1 152.04 41.37 Favored 'General case' 0 N--CA 1.501 2.115 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.054 178.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -82.28 61.13 5.35 Favored 'General case' 0 N--CA 1.501 2.115 0 CA-C-O 121.332 0.587 . . . . 0.0 110.317 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -93.06 -170.75 39.93 Favored Glycine 0 N--CA 1.496 2.657 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 88.5 p -79.99 166.2 21.82 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 122.098 -0.648 . . . . 0.0 110.063 179.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 50.9 mm -89.55 138.1 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -179.383 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 22.4 ttm180 . . . . . 0 N--CA 1.498 1.96 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.151 -179.741 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.289 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_exo -58.34 120.61 8.61 Favored 'Trans proline' 0 N--CA 1.501 1.97 0 O-C-N 123.35 1.184 . . . . 0.0 111.39 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -155.4 79.03 1.03 Allowed 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.204 0.526 . . . . 0.0 109.612 -177.072 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -79.3 86.47 5.05 Favored 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 121.131 0.491 . . . . 0.0 109.939 178.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 18.9 m -152.1 125.88 9.01 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.997 -0.439 . . . . 0.0 110.13 178.337 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 67.6 mt -80.71 118.78 73.95 Favored Pre-proline 0 N--CA 1.5 2.051 0 CA-C-O 118.769 -0.634 . . . . 0.0 109.819 -178.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -61.78 141.0 88.82 Favored 'Trans proline' 0 N--CA 1.501 1.961 0 O-C-N 123.218 1.115 . . . . 0.0 111.189 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -157.0 48.57 0.44 Allowed 'General case' 0 N--CA 1.499 1.993 0 CA-C-O 121.046 0.451 . . . . 0.0 110.706 173.347 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 17.5 tp -161.32 114.44 1.92 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.783 -0.573 . . . . 0.0 110.42 -174.157 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 32.8 tttt -99.92 131.48 45.86 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 177.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 86.0 m -116.76 140.35 49.52 Favored 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -179.233 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -83.17 142.74 30.98 Favored 'General case' 0 N--CA 1.501 2.097 0 C-N-CA 120.73 -0.388 . . . . 0.0 109.992 175.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 28.1 p -114.66 136.92 52.52 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.849 -0.532 . . . . 0.0 110.561 -178.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.6 m -123.01 138.73 54.61 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 122.099 -0.376 . . . . 0.0 110.116 176.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 75.54 -67.07 2.28 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -113.54 124.54 52.61 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 122.11 -0.641 . . . . 0.0 110.465 -177.07 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -138.16 136.36 19.4 Favored Pre-proline 0 N--CA 1.496 1.844 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 174.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.36 152.42 67.24 Favored 'Trans proline' 0 N--CA 1.498 1.749 0 O-C-N 123.053 1.028 . . . . 0.0 111.185 -171.115 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -60.34 -28.11 67.9 Favored 'General case' 0 N--CA 1.507 2.378 0 O-C-N 121.944 -0.472 . . . . 0.0 111.391 -172.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -91.96 14.39 15.87 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.958 -0.464 . . . . 0.0 111.75 -178.085 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.92 162.07 25.18 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.652 -0.655 . . . . 0.0 110.246 -173.297 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 76.4 mt -125.53 140.11 49.33 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -177.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 38.72 42.47 0.61 Allowed 'General case' 0 N--CA 1.512 2.629 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -178.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 55.04 42.73 30.69 Favored 'General case' 0 N--CA 1.508 2.461 0 O-C-N 121.768 -0.582 . . . . 0.0 111.432 -178.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 39.9 p -142.75 161.59 37.69 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.785 -0.572 . . . . 0.0 110.622 173.174 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.5 p -139.53 165.12 28.09 Favored 'General case' 0 N--CA 1.498 1.973 0 CA-C-O 120.97 0.414 . . . . 0.0 110.486 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 75.9 mt -117.01 131.92 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 -173.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.9 t -143.65 155.66 44.31 Favored 'General case' 0 N--CA 1.502 2.143 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.168 -178.127 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -108.63 30.65 6.29 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 122.081 -0.387 . . . . 0.0 110.524 167.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -118.87 -103.44 2.1 Favored Glycine 0 N--CA 1.497 2.708 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 174.334 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 23.9 m-70 -139.55 171.93 13.54 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 122.169 -0.606 . . . . 0.0 109.655 176.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 83.2 m -93.92 139.21 31.18 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 165.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -129.59 150.04 51.09 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.591 -177.219 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.44 ' HB2' ' ND2' ' A' ' 108' ' ' ASN . . . -150.32 143.77 25.1 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 175.516 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.515 HD12 HD12 ' A' ' 99' ' ' ILE . 18.3 tt -144.18 149.17 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 122.091 -0.381 . . . . 0.0 110.099 -171.295 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.436 ' O ' HG23 ' A' ' 63' ' ' ILE . 15.6 tt -138.13 118.74 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 CA-C-O 120.877 0.37 . . . . 0.0 110.209 179.052 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 69.2 mt-10 -105.16 145.65 30.29 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 122.107 -0.371 . . . . 0.0 110.505 -178.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.711 ' O ' HD21 ' A' ' 95' ' ' LEU . 13.1 tm-20 -101.96 116.49 32.8 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 122.016 -0.427 . . . . 0.0 110.166 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -85.34 175.19 9.04 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 122.008 -0.433 . . . . 0.0 110.56 -175.065 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -60.75 -17.71 50.43 Favored 'General case' 0 N--CA 1.507 2.41 0 O-C-N 122.019 -0.426 . . . . 0.0 111.989 -173.061 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -92.87 -10.7 35.72 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.693 -0.629 . . . . 0.0 111.823 178.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 89.65 18.22 52.38 Favored Glycine 0 N--CA 1.498 2.809 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 177.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 69.5 mt-10 -93.98 149.72 20.98 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 118.521 1.161 . . . . 0.0 111.311 168.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.403 ' HB ' ' CG1' ' A' ' 63' ' ' ILE . 4.5 p -94.96 134.97 37.04 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 122.038 -0.414 . . . . 0.0 110.467 177.62 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.2 p -102.15 110.5 22.48 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 169.344 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.543 ' N ' HD12 ' A' ' 73' ' ' LEU . 6.4 mp -97.27 132.86 42.6 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 122.177 -0.327 . . . . 0.0 110.587 -175.286 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -148.07 145.32 28.39 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 122.154 -0.341 . . . . 0.0 110.399 175.385 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 99.2 p -143.74 166.97 23.4 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 176.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 178.58 -164.44 32.96 Favored Glycine 0 N--CA 1.497 2.742 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 2.6 m -96.41 132.74 41.64 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 122.15 -0.618 . . . . 0.0 110.298 -175.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 55.4 ttm -101.21 122.0 42.85 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 122.068 -0.395 . . . . 0.0 110.117 176.386 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 26.8 pttt -66.36 165.89 13.29 Favored 'General case' 0 N--CA 1.503 2.222 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.339 177.164 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -65.74 147.04 54.03 Favored 'General case' 0 N--CA 1.505 2.289 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.4 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -142.18 -48.83 0.36 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 122.112 -0.368 . . . . 0.0 110.347 -178.09 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 142.38 -33.91 1.86 Allowed Glycine 0 N--CA 1.497 2.704 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -176.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.9 m -71.42 124.3 24.29 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 122.126 -0.632 . . . . 0.0 109.975 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -77.37 -40.17 44.81 Favored 'General case' 0 N--CA 1.5 2.072 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.29 -178.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -155.55 33.59 0.36 Allowed 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.503 -176.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 91.9 mm-40 -75.48 65.31 1.71 Allowed 'General case' 0 N--CA 1.502 2.156 0 CA-C-O 121.391 0.615 . . . . 0.0 109.852 178.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 4.0 t -111.8 30.19 7.21 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.809 -0.557 . . . . 0.0 110.672 -177.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 6.3 mmmm -84.86 -178.81 6.94 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.986 -0.446 . . . . 0.0 110.411 -178.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -146.05 112.85 6.02 Favored 'General case' 0 N--CA 1.499 2.009 0 CA-C-O 120.946 0.403 . . . . 0.0 110.555 177.172 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.2 m -80.32 152.07 72.99 Favored Pre-proline 0 N--CA 1.502 2.146 0 O-C-N 122.006 -0.434 . . . . 0.0 110.26 179.291 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -83.33 55.5 5.07 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 O-C-N 123.427 1.225 . . . . 0.0 111.101 173.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 37.7 tttp -155.7 47.82 0.5 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.622 -0.674 . . . . 0.0 109.206 -178.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -155.68 -169.2 3.03 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.96 -0.463 . . . . 0.0 110.401 -162.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 2.8 tp60 -64.15 -168.93 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.25 0 CA-C-O 120.899 0.381 . . . . 0.0 110.243 -176.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.711 HD21 ' O ' ' A' ' 65' ' ' GLU . 9.7 tt -64.09 155.7 30.58 Favored 'General case' 0 N--CA 1.506 2.331 0 O-C-N 121.872 -0.517 . . . . 0.0 110.322 -162.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.47 ' N ' HD23 ' A' ' 95' ' ' LEU . 43.0 mtp180 -68.67 138.63 55.12 Favored 'General case' 0 N--CA 1.5 2.062 0 CA-C-O 120.893 0.377 . . . . 0.0 110.332 -166.738 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 48.6 ptt85 -161.54 165.16 28.94 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 -178.11 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.461 HG21 ' O ' ' A' ' 114' ' ' THR . 15.5 m -112.55 149.15 33.12 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 171.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.515 HD12 HD12 ' A' ' 62' ' ' ILE . 18.8 tt -143.25 154.89 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.017 -177.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 66.8 mt-10 -142.99 149.95 38.99 Favored 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.63 -178.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 92.5 m -141.97 138.8 32.18 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 -177.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 20.4 p -157.63 131.41 8.0 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.906 -0.496 . . . . 0.0 110.914 -175.371 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 51.1 ttt180 -104.61 48.05 0.85 Allowed 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.287 0.565 . . . . 0.0 110.65 -176.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 23.9 p -136.65 151.47 49.34 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.904 -0.497 . . . . 0.0 109.861 175.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 17.6 p-10 -61.88 132.07 51.84 Favored 'General case' 0 N--CA 1.505 2.3 0 CA-C-O 121.429 0.633 . . . . 0.0 111.735 -163.344 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.464 HD22 ' OE1' ' A' ' 109' ' ' GLN . 75.4 mt 51.98 26.83 3.95 Favored 'General case' 0 N--CA 1.508 2.474 0 O-C-N 122.098 -0.376 . . . . 0.0 111.923 179.3 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 26.3 p -63.16 -21.91 66.52 Favored 'General case' 0 N--CA 1.507 2.384 0 C-N-CA 120.439 -0.504 . . . . 0.0 111.6 176.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.44 ' ND2' ' HB2' ' A' ' 61' ' ' ALA . 4.6 m120 -90.91 -22.99 20.63 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.737 -0.602 . . . . 0.0 111.282 177.693 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLN . . . . . 0.464 ' OE1' HD22 ' A' ' 106' ' ' LEU . 27.2 tt0 -61.01 -38.23 85.33 Favored 'General case' 0 N--CA 1.508 2.46 0 O-C-N 121.604 -0.685 . . . . 0.0 110.791 -175.49 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -100.69 16.32 25.32 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 122.094 -0.379 . . . . 0.0 111.674 177.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 15.7 tp -112.93 112.31 23.69 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.544 -0.723 . . . . 0.0 110.294 -174.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -96.27 120.86 61.8 Favored Pre-proline 0 N--CA 1.498 1.944 0 CA-C-O 118.894 -0.574 . . . . 0.0 109.912 172.187 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -71.0 143.71 45.55 Favored 'Trans proline' 0 N--CA 1.491 1.338 0 O-C-N 123.129 1.068 . . . . 0.0 110.225 177.181 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.461 ' O ' HG21 ' A' ' 98' ' ' THR . 35.3 p -139.11 150.05 45.24 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 122.1 -0.375 . . . . 0.0 110.204 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 16.4 mt -71.94 150.14 92.67 Favored Pre-proline 0 N--CA 1.501 2.124 0 C-N-CA 120.689 -0.405 . . . . 0.0 110.114 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -69.11 152.61 72.64 Favored 'Trans proline' 0 N--CA 1.491 1.35 0 O-C-N 123.55 1.29 . . . . 0.0 110.198 178.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -68.13 136.94 39.2 Favored 'Trans proline' 0 N--CA 1.49 1.313 0 O-C-N 123.502 1.264 . . . . 0.0 110.353 179.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 60.9 t -77.46 -38.65 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.19 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 58.1 t -89.78 135.2 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 76.2 mt -89.94 113.63 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 127.53 -171.52 18.94 Favored Glycine 0 N--CA 1.497 2.734 0 N-CA-C 109.439 -1.465 . . . . 0.0 109.439 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_exo -58.14 152.3 53.22 Favored 'Trans proline' 0 N--CA 1.501 1.961 0 C-N-CA 121.113 1.209 . . . . 0.0 111.429 178.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -155.29 164.3 38.96 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 122.177 -0.327 . . . . 0.0 110.217 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -155.88 130.79 9.22 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 109.981 -0.378 . . . . 0.0 109.981 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -155.18 34.08 0.38 Allowed 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 120.946 -0.301 . . . . 0.0 110.274 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -68.1 -35.78 84.28 Favored Glycine 0 N--CA 1.496 2.673 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.026 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 28.7 t -81.12 134.53 35.66 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 122.136 -0.626 . . . . 0.0 110.194 -179.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 76.3 mt -90.78 134.62 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.329 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 39.4 ttm180 . . . . . 0 N--CA 1.5 2.052 0 CA-C-O 118.117 -0.944 . . . . 0.0 110.111 179.519 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.288 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_exo -58.37 123.18 13.04 Favored 'Trans proline' 0 N--CA 1.501 1.971 0 O-C-N 123.367 1.193 . . . . 0.0 111.343 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -90.12 47.62 1.47 Allowed 'General case' 0 N--CA 1.5 2.035 0 CA-C-O 121.125 0.488 . . . . 0.0 110.796 179.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -77.5 82.06 3.95 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.749 -0.594 . . . . 0.0 109.865 -177.489 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.419 HG22 ' HB2' ' A' ' 56' ' ' ASN . 21.3 m -147.22 123.77 11.08 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.88 -0.512 . . . . 0.0 110.074 179.012 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 17.5 mt -76.53 150.95 82.68 Favored Pre-proline 0 N--CA 1.5 2.04 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.079 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -63.79 122.98 11.23 Favored 'Trans proline' 0 N--CA 1.499 1.799 0 O-C-N 123.269 1.142 . . . . 0.0 111.16 170.331 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -156.67 53.07 0.52 Allowed 'General case' 0 N--CA 1.5 2.06 0 CA-C-O 121.325 0.583 . . . . 0.0 110.3 164.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 20.5 tp -157.61 114.38 2.94 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.804 -0.56 . . . . 0.0 109.967 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 13.0 tttp -99.86 129.08 45.91 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 84.9 m -116.42 140.2 49.61 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -178.004 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -81.34 146.19 30.47 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 122.033 -0.417 . . . . 0.0 109.891 177.172 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 27.9 p -115.8 157.77 23.88 Favored 'General case' 0 N--CA 1.502 2.129 0 CA-C-O 120.997 0.427 . . . . 0.0 110.985 -173.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 96.7 p -65.65 162.99 17.23 Favored 'General case' 0 N--CA 1.503 2.196 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 167.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -51.35 -18.14 3.26 Favored Glycine 0 N--CA 1.507 3.397 0 N-CA-C 111.946 -0.462 . . . . 0.0 111.946 -173.107 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -84.4 111.8 19.77 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.8 -0.824 . . . . 0.0 109.621 163.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -138.32 136.08 18.91 Favored Pre-proline 0 N--CA 1.497 1.901 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -175.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -56.65 153.52 35.6 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 O-C-N 122.978 0.988 . . . . 0.0 111.599 -165.352 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -60.67 -31.24 70.49 Favored 'General case' 0 N--CA 1.506 2.353 0 O-C-N 121.953 -0.467 . . . . 0.0 111.357 -167.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -91.4 14.17 15.44 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 122.023 -0.423 . . . . 0.0 111.877 -177.192 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -86.01 162.14 18.63 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.654 -0.654 . . . . 0.0 110.542 -174.195 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 76.2 mt -122.02 140.53 45.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 -176.071 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 39.31 42.75 0.84 Allowed 'General case' 0 N--CA 1.513 2.69 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 55.05 41.73 31.53 Favored 'General case' 0 N--CA 1.508 2.438 0 O-C-N 121.844 -0.535 . . . . 0.0 111.455 -179.132 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 66.8 p -138.84 150.1 45.64 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.776 -0.577 . . . . 0.0 110.279 173.413 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.8 p -120.65 160.28 23.59 Favored 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 120.963 0.411 . . . . 0.0 110.598 178.249 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 77.5 mt -108.95 133.23 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -176.405 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.6 t -140.79 153.9 46.03 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.98 -0.45 . . . . 0.0 111.271 -178.34 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.419 ' HB2' HG22 ' A' ' 32' ' ' THR . 26.7 p30 -108.06 30.11 6.68 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 122.178 -0.326 . . . . 0.0 110.528 166.256 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -122.58 -96.79 1.34 Allowed Glycine 0 N--CA 1.496 2.656 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 177.517 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 15.9 m80 -148.98 172.07 15.33 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 122.097 -0.649 . . . . 0.0 109.428 178.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 82.3 m -95.84 139.19 32.42 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 168.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 16.5 p90 -132.08 150.83 52.05 Favored 'General case' 0 N--CA 1.499 1.994 0 C-N-CA 120.352 -0.539 . . . . 0.0 110.705 -178.33 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -152.55 144.66 23.83 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 175.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.529 HD12 HD12 ' A' ' 99' ' ' ILE . 18.3 tt -143.36 149.2 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 C-N-CA 120.741 -0.383 . . . . 0.0 110.492 -171.498 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.673 HD12 HD21 ' A' ' 73' ' ' LEU . 13.4 tt -136.1 145.09 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 176.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -150.04 145.86 26.64 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -170.714 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.3 tm-20 -101.62 117.35 34.71 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 122.128 -0.357 . . . . 0.0 110.098 -178.059 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -87.21 175.31 8.11 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 122.111 -0.368 . . . . 0.0 110.607 -175.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -60.67 -17.61 48.67 Favored 'General case' 0 N--CA 1.507 2.393 0 O-C-N 121.973 -0.454 . . . . 0.0 112.016 -172.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -92.77 -10.81 35.63 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.547 -0.721 . . . . 0.0 111.863 178.263 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.27 19.71 44.84 Favored Glycine 0 N--CA 1.498 2.769 0 N-CA-C 111.159 -0.776 . . . . 0.0 111.159 176.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -97.22 145.28 26.21 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 118.472 1.136 . . . . 0.0 109.915 169.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.2 p -94.87 129.62 41.79 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 122.127 -0.358 . . . . 0.0 110.24 178.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 19.3 p -97.9 115.6 28.44 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 122.156 -0.34 . . . . 0.0 110.346 178.24 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.673 HD21 HD12 ' A' ' 63' ' ' ILE . 18.4 mt -97.23 124.97 41.47 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 122.136 -0.352 . . . . 0.0 110.291 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -143.32 143.74 31.81 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 120.842 0.353 . . . . 0.0 110.534 175.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 89.4 p -143.73 166.99 23.33 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 176.285 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 176.48 -164.32 33.99 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 179.256 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 2.0 m -98.87 132.49 44.17 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 122.251 -0.558 . . . . 0.0 110.424 -174.178 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 50.0 ttm -102.52 133.66 47.13 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 122.116 -0.365 . . . . 0.0 110.185 176.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 22.5 pttm -65.98 172.05 4.01 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 122.054 -0.404 . . . . 0.0 110.543 178.106 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -64.93 147.12 53.99 Favored 'General case' 0 N--CA 1.504 2.274 0 O-C-N 122.063 -0.398 . . . . 0.0 110.397 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 74.8 mt-10 -137.21 -48.69 0.6 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 122.032 -0.417 . . . . 0.0 110.586 -175.051 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 147.81 140.81 3.42 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -177.072 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 27.5 t -78.23 0.26 25.87 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 122.085 -0.656 . . . . 0.0 112.525 -178.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -77.59 -32.17 53.49 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.524 -0.735 . . . . 0.0 110.366 178.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -155.65 77.29 0.97 Allowed 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.329 0.585 . . . . 0.0 109.78 176.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -78.94 60.2 2.82 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.833 -0.542 . . . . 0.0 110.857 -176.209 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 1.3 t -155.55 119.9 4.64 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.569 -0.707 . . . . 0.0 109.966 178.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 25.5 mmtt -79.6 117.62 20.69 Favored 'General case' 0 N--CA 1.502 2.146 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.316 179.204 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.448 ' OD1' HG21 ' A' ' 99' ' ' ILE . 64.9 m-20 -149.67 110.82 4.39 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 122.143 -0.348 . . . . 0.0 110.108 176.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 21.3 m -81.48 114.7 51.64 Favored Pre-proline 0 N--CA 1.502 2.133 0 CA-C-O 118.978 -0.534 . . . . 0.0 110.034 -177.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -75.37 61.78 6.02 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 O-C-N 123.083 1.044 . . . . 0.0 110.809 173.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 47.8 tttm -155.76 43.11 0.42 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.692 -0.63 . . . . 0.0 109.449 -178.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -155.63 121.91 5.17 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 122.047 -0.408 . . . . 0.0 110.041 -170.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 44.9 tt0 -111.45 52.94 0.73 Allowed 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.309 0.576 . . . . 0.0 110.093 -179.089 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.473 HD23 ' N ' ' A' ' 96' ' ' ARG . 4.4 tt -120.19 143.33 48.3 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.905 -0.497 . . . . 0.0 109.983 -179.537 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.473 ' N ' HD23 ' A' ' 95' ' ' LEU . 55.2 ttt85 -68.95 114.8 7.57 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 122.031 -0.418 . . . . 0.0 109.878 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 46.3 ptt85 -161.43 165.14 29.24 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 122.078 -0.389 . . . . 0.0 110.735 -176.286 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 19.9 m -134.03 149.23 51.17 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 178.424 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.529 HD12 HD12 ' A' ' 62' ' ' ILE . 18.3 tt -143.07 156.06 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 122.061 -0.399 . . . . 0.0 110.047 -179.267 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -142.88 146.58 34.22 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 120.825 0.345 . . . . 0.0 110.54 -178.17 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 26.0 p -143.12 137.67 29.29 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -178.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 20.5 p -157.57 133.74 9.53 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.96 -0.463 . . . . 0.0 110.989 -171.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 62.1 ttt180 -106.65 52.66 0.71 Allowed 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 121.426 0.631 . . . . 0.0 110.451 -176.519 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.0 p -142.26 151.64 42.27 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.766 -0.583 . . . . 0.0 109.753 174.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -61.28 131.79 51.5 Favored 'General case' 0 N--CA 1.506 2.337 0 CA-C-O 121.427 0.632 . . . . 0.0 111.771 -163.391 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.473 HD22 ' OE1' ' A' ' 109' ' ' GLN . 74.1 mt 52.08 26.8 4.04 Favored 'General case' 0 N--CA 1.507 2.404 0 O-C-N 122.064 -0.398 . . . . 0.0 111.964 179.274 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 26.3 p -63.06 -22.06 66.6 Favored 'General case' 0 N--CA 1.506 2.358 0 O-C-N 121.888 -0.507 . . . . 0.0 111.58 176.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -90.07 -22.94 21.58 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.79 -0.569 . . . . 0.0 111.277 176.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLN . . . . . 0.473 ' OE1' HD22 ' A' ' 106' ' ' LEU . 28.5 tt0 -61.14 -38.84 87.82 Favored 'General case' 0 N--CA 1.508 2.438 0 O-C-N 121.595 -0.69 . . . . 0.0 110.768 -175.246 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -100.06 16.3 24.48 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 122.16 -0.337 . . . . 0.0 111.606 177.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 15.4 tp -112.65 111.81 22.88 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.595 -0.69 . . . . 0.0 110.31 -175.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -96.54 120.8 61.49 Favored Pre-proline 0 N--CA 1.498 1.974 0 CA-C-O 118.904 -0.57 . . . . 0.0 109.922 173.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -71.26 139.03 34.35 Favored 'Trans proline' 0 N--CA 1.49 1.311 0 O-C-N 123.182 1.096 . . . . 0.0 110.164 175.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 50.4 p -139.16 150.06 45.17 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 122.094 -0.379 . . . . 0.0 110.125 178.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.441 HD22 ' HG2' ' A' ' 96' ' ' ARG . 17.4 mt -73.21 111.64 12.5 Favored Pre-proline 0 N--CA 1.502 2.136 0 CA-C-O 118.975 -0.536 . . . . 0.0 110.012 178.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -68.06 150.57 77.6 Favored 'Trans proline' 0 N--CA 1.491 1.336 0 O-C-N 123.132 1.07 . . . . 0.0 110.265 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -63.61 146.39 92.51 Favored 'Trans proline' 0 N--CA 1.494 1.532 0 O-C-N 123.414 1.218 . . . . 0.0 110.787 176.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.411 HG12 ' N ' ' A' ' 119' ' ' VAL . 48.0 t -150.4 165.17 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.235 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.411 ' N ' HG12 ' A' ' 118' ' ' VAL . 60.4 t -90.64 131.86 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -178.596 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.473 ' O ' HG23 ' A' ' 120' ' ' ILE . 17.3 tt -153.18 118.59 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 122.109 -0.369 . . . . 0.0 110.078 178.492 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 68.36 170.11 5.68 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_exo -58.76 132.39 47.61 Favored 'Trans proline' 0 N--CA 1.501 1.966 0 C-N-CA 121.103 1.202 . . . . 0.0 111.307 178.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -85.89 127.5 34.61 Favored 'General case' 0 N--CA 1.5 2.04 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.284 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -70.04 131.23 44.03 Favored 'General case' 0 N--CA 1.501 2.113 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.188 178.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -82.42 165.5 20.2 Favored 'General case' 0 N--CA 1.501 2.089 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.526 -179.16 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 72.11 35.43 60.9 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 28.9 t -82.22 133.31 35.25 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.982 -0.717 . . . . 0.0 110.19 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 76.2 mt -90.86 130.65 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 23.1 ttm180 . . . . . 0 N--CA 1.496 1.853 0 CA-C-O 117.917 -1.04 . . . . 0.0 110.283 179.737 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.282 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -58.22 123.26 13.24 Favored 'Trans proline' 0 N--CA 1.501 1.939 0 C-N-CA 121.12 1.213 . . . . 0.0 111.383 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -90.08 47.33 1.44 Allowed 'General case' 0 N--CA 1.501 2.124 0 CA-C-O 121.13 0.49 . . . . 0.0 110.709 179.195 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -77.12 83.8 3.61 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.677 -0.639 . . . . 0.0 109.896 -176.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 22.1 m -124.35 107.72 11.44 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 122.025 -0.422 . . . . 0.0 110.126 178.136 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 76.6 mt -142.43 148.94 49.34 Favored Pre-proline 0 N--CA 1.497 1.881 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -61.24 142.15 95.43 Favored 'Trans proline' 0 N--CA 1.503 2.049 0 O-C-N 123.269 1.142 . . . . 0.0 111.187 175.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -158.55 49.66 0.37 Allowed 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 121.097 0.475 . . . . 0.0 110.898 172.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.426 HD23 HG23 ' A' ' 55' ' ' THR . 20.2 tp -161.53 114.09 1.84 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.696 -0.627 . . . . 0.0 110.276 -175.495 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.4 ' HE2' HG21 ' A' ' 52' ' ' THR . 58.0 tttt -99.76 130.39 45.96 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 122.167 -0.333 . . . . 0.0 110.151 177.406 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 77.4 m -113.86 140.31 48.45 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -179.174 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -84.75 140.76 31.02 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 175.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 28.2 p -114.16 138.09 50.89 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 122.024 -0.422 . . . . 0.0 110.676 -176.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.4 m -122.94 139.44 54.05 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 122.036 -0.415 . . . . 0.0 109.947 176.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.16 -68.27 1.4 Allowed Glycine 0 N--CA 1.496 2.659 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 63.9 m170 -110.8 123.06 49.35 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 122.163 -0.61 . . . . 0.0 110.602 -176.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -138.08 136.25 19.4 Favored Pre-proline 0 N--CA 1.497 1.881 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 174.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -60.32 152.47 66.68 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 O-C-N 123.062 1.033 . . . . 0.0 111.221 -170.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -60.34 -28.15 67.94 Favored 'General case' 0 N--CA 1.507 2.379 0 O-C-N 121.961 -0.462 . . . . 0.0 111.43 -172.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -92.07 14.25 16.48 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.955 -0.466 . . . . 0.0 111.782 -178.194 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.89 162.01 26.33 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.631 -0.668 . . . . 0.0 110.308 -172.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 76.7 mt -125.97 139.77 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -177.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 38.6 43.29 0.66 Allowed 'General case' 0 N--CA 1.512 2.64 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -177.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 16.2 t30 55.44 42.29 30.12 Favored 'General case' 0 N--CA 1.507 2.418 0 O-C-N 121.811 -0.555 . . . . 0.0 111.467 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.4 HG21 ' HE2' ' A' ' 37' ' ' LYS . 39.2 p -144.38 162.72 35.77 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.76 -0.588 . . . . 0.0 110.658 173.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.3 p -139.77 164.95 28.59 Favored 'General case' 0 N--CA 1.499 1.992 0 CA-C-O 120.787 0.327 . . . . 0.0 110.613 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 77.2 mt -113.74 133.05 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -174.34 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.426 HG23 HD23 ' A' ' 36' ' ' LEU . 9.1 t -142.5 154.09 44.2 Favored 'General case' 0 N--CA 1.502 2.143 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.059 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 40.1 p-10 -108.37 30.29 6.57 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 122.109 -0.369 . . . . 0.0 110.608 167.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -122.31 -97.78 1.43 Allowed Glycine 0 N--CA 1.497 2.717 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 176.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 31.1 m80 -143.8 170.66 15.46 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 122.136 -0.626 . . . . 0.0 109.473 177.195 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 71.4 m -91.85 139.14 30.95 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 164.222 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 15.9 p90 -130.0 148.17 51.83 Favored 'General case' 0 N--CA 1.497 1.9 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.518 -177.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -151.46 141.75 22.37 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 178.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.498 HD12 HD12 ' A' ' 99' ' ' ILE . 18.0 tt -144.17 149.2 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 122.065 -0.397 . . . . 0.0 110.559 -171.603 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.749 HD12 HD21 ' A' ' 73' ' ' LEU . 16.4 tt -134.26 145.21 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 176.679 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -147.94 146.18 28.89 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -167.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.4 tm-20 -101.49 116.83 33.66 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 120.864 0.364 . . . . 0.0 110.179 -176.206 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -87.36 175.24 8.09 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 122.03 -0.419 . . . . 0.0 110.594 -175.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -60.49 -17.51 45.74 Favored 'General case' 0 N--CA 1.506 2.359 0 O-C-N 121.904 -0.498 . . . . 0.0 112.12 -172.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -92.89 -11.35 33.7 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.613 -0.679 . . . . 0.0 111.811 178.242 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.56 20.13 42.09 Favored Glycine 0 N--CA 1.497 2.751 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 177.039 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -97.32 145.27 26.28 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 118.49 1.145 . . . . 0.0 109.786 169.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.8 p -94.89 128.8 41.93 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 122.117 -0.364 . . . . 0.0 110.183 178.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 21.4 p -97.98 118.99 35.82 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 122.165 -0.334 . . . . 0.0 110.276 178.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.749 HD21 HD12 ' A' ' 63' ' ' ILE . 23.0 mt -97.61 127.13 43.33 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 122.14 -0.35 . . . . 0.0 110.408 179.179 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -147.98 144.88 28.29 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 122.039 -0.413 . . . . 0.0 110.481 174.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 78.8 p -143.69 167.01 23.28 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 176.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -178.3 -166.5 34.71 Favored Glycine 0 N--CA 1.497 2.709 0 N-CA-C 110.15 -1.18 . . . . 0.0 110.15 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 2.2 m -96.99 132.85 42.38 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 122.172 -0.605 . . . . 0.0 110.415 -176.414 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 56.0 ttm -100.66 122.93 44.15 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 122.097 -0.377 . . . . 0.0 110.15 178.449 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.1 pttm -65.88 167.97 8.74 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 122.01 -0.431 . . . . 0.0 110.59 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -65.74 147.6 53.12 Favored 'General case' 0 N--CA 1.504 2.244 0 O-C-N 122.045 -0.409 . . . . 0.0 110.515 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 68.5 mt-10 -142.09 -48.37 0.36 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 122.126 -0.359 . . . . 0.0 110.455 -178.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 142.7 -34.18 1.81 Allowed Glycine 0 N--CA 1.496 2.691 0 N-CA-C 109.816 -1.313 . . . . 0.0 109.816 -178.062 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 11.5 p -71.75 125.2 26.53 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 122.125 -0.632 . . . . 0.0 110.076 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -75.83 -45.0 38.18 Favored 'General case' 0 N--CA 1.501 2.089 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.121 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -155.67 30.24 0.37 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 122.065 -0.397 . . . . 0.0 110.632 177.096 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -79.07 83.43 5.16 Favored 'General case' 0 N--CA 1.501 2.084 0 CA-C-O 121.125 0.488 . . . . 0.0 109.974 179.131 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 90.2 m -111.48 32.04 5.68 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.883 -0.51 . . . . 0.0 110.347 178.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -83.4 175.53 9.77 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 122.023 -0.423 . . . . 0.0 110.325 -179.176 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.476 ' OD2' ' HB2' ' A' ' 93' ' ' ALA . 9.9 t70 -155.01 142.79 19.92 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 122.119 -0.363 . . . . 0.0 110.399 176.238 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 7.4 m -77.5 163.04 66.39 Favored Pre-proline 0 N--CA 1.501 2.082 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 177.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -84.28 56.01 4.78 Favored 'Trans proline' 0 N--CA 1.495 1.568 0 O-C-N 123.391 1.206 . . . . 0.0 111.717 -174.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 71.8 tttt -155.81 36.72 0.36 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.64 -0.662 . . . . 0.0 109.503 171.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.476 ' HB2' ' OD2' ' A' ' 89' ' ' ASP . . . -83.46 -169.91 2.79 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-O 121.137 0.494 . . . . 0.0 111.212 -166.48 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -65.03 -168.83 0.04 OUTLIER 'General case' 0 N--CA 1.504 2.244 0 CA-C-O 120.902 0.382 . . . . 0.0 110.045 173.376 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' A' ' 95' ' ' LEU . 9.2 tp -63.99 164.69 10.05 Favored 'General case' 0 N--CA 1.509 2.475 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 -173.492 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 73.9 mtt85 -68.18 137.07 54.56 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.824 -0.547 . . . . 0.0 110.425 -161.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 28.2 ptt-85 -161.41 165.31 29.04 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 120.805 0.336 . . . . 0.0 110.388 -174.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 15.1 m -124.41 147.91 47.95 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 171.524 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.498 HD12 HD12 ' A' ' 62' ' ' ILE . 18.5 tt -143.18 155.99 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 122.0 -0.437 . . . . 0.0 110.284 -174.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.424 ' HB3' HD21 ' A' ' 111' ' ' LEU . 47.7 mt-10 -144.81 149.84 36.14 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 120.723 0.297 . . . . 0.0 110.388 178.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 26.7 p -143.06 142.06 31.45 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 21.8 p -157.55 129.29 6.97 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 122.011 -0.431 . . . . 0.0 110.802 -171.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 53.0 ttp180 -104.02 48.45 0.85 Allowed 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.329 0.585 . . . . 0.0 110.504 -177.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.1 p -135.5 150.72 49.86 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.905 -0.497 . . . . 0.0 109.798 175.122 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 17.6 p-10 -62.5 131.93 50.79 Favored 'General case' 0 N--CA 1.504 2.269 0 CA-C-O 121.388 0.613 . . . . 0.0 111.734 -162.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 79.6 mt 51.76 27.84 4.46 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 122.003 -0.436 . . . . 0.0 111.936 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 26.0 p -62.69 -23.26 67.05 Favored 'General case' 0 N--CA 1.506 2.337 0 O-C-N 121.874 -0.516 . . . . 0.0 111.564 174.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -75.5 -29.66 59.58 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.907 -0.495 . . . . 0.0 111.079 177.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -62.16 -39.39 92.49 Favored 'General case' 0 N--CA 1.507 2.399 0 O-C-N 121.764 -0.585 . . . . 0.0 110.826 -169.435 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -100.3 16.16 25.28 Favored 'General case' 0 N--CA 1.498 1.938 0 C-N-CA 120.936 -0.306 . . . . 0.0 111.688 179.064 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.424 HD21 ' HB3' ' A' ' 100' ' ' GLU . 12.2 tp -117.99 108.93 15.86 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.511 -0.743 . . . . 0.0 110.296 -176.18 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -98.7 120.87 57.94 Favored Pre-proline 0 N--CA 1.497 1.896 0 CA-C-O 118.86 -0.59 . . . . 0.0 110.078 174.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -71.15 133.89 23.96 Favored 'Trans proline' 0 N--CA 1.491 1.341 0 O-C-N 123.247 1.13 . . . . 0.0 110.15 172.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 35.0 p -139.16 147.14 41.46 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 122.102 -0.374 . . . . 0.0 110.371 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 27.0 mt -72.23 155.11 91.88 Favored Pre-proline 0 N--CA 1.502 2.162 0 CA-C-O 119.277 -0.392 . . . . 0.0 110.01 176.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -62.26 146.8 95.8 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 O-C-N 123.313 1.165 . . . . 0.0 110.778 -178.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -68.37 143.11 56.85 Favored 'Trans proline' 0 N--CA 1.49 1.313 0 O-C-N 123.432 1.227 . . . . 0.0 110.402 -175.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.423 HG12 ' N ' ' A' ' 119' ' ' VAL . 48.5 t -150.66 165.55 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.146 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.423 ' N ' HG12 ' A' ' 118' ' ' VAL . 12.3 p -90.04 144.09 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 O-C-N 122.002 -0.436 . . . . 0.0 110.127 -179.214 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 76.3 mt -91.26 117.26 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 68.19 178.39 14.84 Favored Glycine 0 N--CA 1.497 2.718 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 178.449 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -58.45 161.38 14.48 Favored 'Trans proline' 0 N--CA 1.501 1.92 0 C-N-CA 121.109 1.206 . . . . 0.0 111.377 178.187 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -155.24 162.1 40.99 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 122.195 -0.316 . . . . 0.0 110.188 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -155.75 168.85 25.87 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 -178.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -155.23 -46.07 0.08 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 122.095 -0.378 . . . . 0.0 110.18 -179.42 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 90.79 36.82 6.64 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.09 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 30.6 t -155.39 101.85 2.22 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 122.133 -0.628 . . . . 0.0 110.108 179.217 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 76.3 mt -90.93 139.11 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 58.5 ttm-85 . . . . . 0 N--CA 1.498 1.961 0 CA-C-O 117.973 -1.013 . . . . 0.0 110.186 179.39 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.31 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -58.56 120.57 8.54 Favored 'Trans proline' 0 N--CA 1.501 1.951 0 O-C-N 123.328 1.173 . . . . 0.0 111.309 179.367 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -90.3 47.1 1.4 Allowed 'General case' 0 N--CA 1.501 2.121 0 CA-C-O 121.164 0.507 . . . . 0.0 110.703 179.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -77.63 82.18 4.05 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.639 -0.663 . . . . 0.0 109.922 -176.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.511 HG22 ' ND2' ' A' ' 56' ' ' ASN . 17.1 m -106.4 50.37 0.78 Allowed 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.296 0.569 . . . . 0.0 109.991 178.175 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 23.9 mt -77.65 151.0 79.71 Favored Pre-proline 0 N--CA 1.501 2.117 0 O-C-N 121.838 -0.539 . . . . 0.0 110.052 -178.088 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -64.13 122.21 10.12 Favored 'Trans proline' 0 N--CA 1.498 1.785 0 O-C-N 123.369 1.194 . . . . 0.0 111.208 169.131 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -158.32 53.37 0.44 Allowed 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 121.332 0.586 . . . . 0.0 110.264 164.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.404 HD23 HG23 ' A' ' 55' ' ' THR . 19.1 tp -158.41 114.72 2.75 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.803 -0.561 . . . . 0.0 110.032 -179.251 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.44 ' HE3' HD21 ' A' ' 106' ' ' LEU . 35.4 ttpt -99.74 131.6 45.62 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 122.112 -0.367 . . . . 0.0 110.256 178.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 73.3 m -117.87 140.38 49.8 Favored 'General case' 0 N--CA 1.502 2.155 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 -178.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -82.4 146.2 29.46 Favored 'General case' 0 N--CA 1.501 2.079 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.125 178.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 27.9 p -116.05 136.99 52.52 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 122.021 -0.424 . . . . 0.0 110.54 -178.287 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 29.1 t -122.29 135.04 54.67 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 122.039 -0.413 . . . . 0.0 110.064 177.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.83 -66.52 2.77 Favored Glycine 0 N--CA 1.496 2.698 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -112.42 124.0 51.52 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 122.077 -0.66 . . . . 0.0 110.57 -177.15 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -138.03 136.98 20.21 Favored Pre-proline 0 N--CA 1.496 1.875 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 175.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -60.59 151.78 73.26 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 O-C-N 123.171 1.09 . . . . 0.0 111.105 -172.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -60.25 -28.1 67.77 Favored 'General case' 0 N--CA 1.508 2.431 0 O-C-N 121.995 -0.441 . . . . 0.0 111.383 -172.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -92.21 14.29 16.63 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.935 -0.478 . . . . 0.0 111.782 -177.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.4 161.98 26.76 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.708 -0.62 . . . . 0.0 110.232 -172.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 71.4 mt -124.76 137.02 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -177.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 19.9 p30 37.81 43.16 0.47 Allowed 'General case' 0 N--CA 1.514 2.773 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -176.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 30.8 m120 55.32 43.08 29.59 Favored 'General case' 0 N--CA 1.509 2.493 0 O-C-N 121.882 -0.511 . . . . 0.0 111.43 -178.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 71.5 p -139.13 160.87 38.77 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.814 -0.554 . . . . 0.0 110.283 171.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.1 p -137.57 161.27 36.88 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-O 120.973 0.416 . . . . 0.0 110.452 178.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 77.7 mt -107.52 131.63 57.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -175.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.404 HG23 HD23 ' A' ' 36' ' ' LEU . 8.4 t -140.07 151.65 45.55 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 122.04 -0.413 . . . . 0.0 110.972 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.511 ' ND2' HG22 ' A' ' 32' ' ' THR . 49.9 p30 -107.81 30.57 6.21 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 122.127 -0.358 . . . . 0.0 110.585 167.746 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -122.86 -95.77 1.25 Allowed Glycine 0 N--CA 1.497 2.733 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 176.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 38.1 m-70 -149.59 172.03 15.68 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 122.108 -0.643 . . . . 0.0 109.556 176.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 82.7 m -94.51 139.2 31.46 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 168.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 19.5 p90 -129.06 151.28 49.92 Favored 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.476 -178.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.416 ' HB2' ' ND2' ' A' ' 108' ' ' ASN . . . -151.21 143.39 24.05 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 175.24 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.572 HD12 HD12 ' A' ' 99' ' ' ILE . 18.2 tt -144.02 149.33 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 122.109 -0.369 . . . . 0.0 110.276 -172.274 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.522 HD12 ' HG ' ' A' ' 73' ' ' LEU . 16.5 tt -136.46 145.25 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 178.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -147.99 145.88 28.71 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 122.013 -0.429 . . . . 0.0 109.914 -168.01 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.5 tm-20 -101.61 117.18 34.38 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 120.751 0.31 . . . . 0.0 110.185 -176.423 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 26.6 p-10 -87.6 175.35 7.95 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 122.123 -0.36 . . . . 0.0 110.563 -176.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -60.47 -17.24 43.6 Favored 'General case' 0 N--CA 1.506 2.368 0 O-C-N 122.007 -0.433 . . . . 0.0 112.082 -172.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -91.89 -11.57 35.99 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.551 -0.718 . . . . 0.0 111.819 178.128 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.84 20.95 37.98 Favored Glycine 0 N--CA 1.498 2.774 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 176.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -97.58 143.87 27.84 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 118.324 1.062 . . . . 0.0 109.898 170.515 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.8 p -94.84 124.32 38.82 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.234 176.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.7 p -97.92 113.72 25.62 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 122.093 -0.38 . . . . 0.0 110.336 178.258 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.542 ' N ' HD12 ' A' ' 73' ' ' LEU . 6.4 mp -97.51 128.35 44.2 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 122.147 -0.346 . . . . 0.0 110.26 -178.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -144.37 147.84 33.93 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 122.099 -0.375 . . . . 0.0 110.349 176.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 87.3 p -143.69 166.18 25.58 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 178.089 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -179.22 -167.11 36.17 Favored Glycine 0 N--CA 1.496 2.69 0 N-CA-C 110.354 -1.098 . . . . 0.0 110.354 -178.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 2.9 m -96.55 132.25 42.34 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 122.187 -0.596 . . . . 0.0 110.25 -175.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 51.1 ttm -98.53 121.88 41.02 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.946 -0.471 . . . . 0.0 110.087 176.396 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 26.6 pttt -66.77 165.28 15.42 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 122.043 -0.411 . . . . 0.0 110.508 -178.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 54.3 p90 -65.02 126.21 27.31 Favored 'General case' 0 N--CA 1.504 2.263 0 O-C-N 122.056 -0.403 . . . . 0.0 110.498 177.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -122.41 -44.16 2.26 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 122.101 -0.374 . . . . 0.0 110.488 -179.085 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 137.43 -33.54 2.28 Favored Glycine 0 N--CA 1.495 2.626 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 -176.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 86.4 p -71.26 125.11 26.09 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 122.067 -0.667 . . . . 0.0 109.955 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -75.87 -41.42 52.33 Favored 'General case' 0 N--CA 1.501 2.116 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.421 -176.023 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -155.69 34.52 0.36 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 122.037 -0.415 . . . . 0.0 110.504 -176.103 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -75.96 83.14 2.85 Favored 'General case' 0 N--CA 1.502 2.136 0 CA-C-O 121.274 0.559 . . . . 0.0 109.985 177.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 4.4 t -123.86 29.57 6.46 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.88 -0.512 . . . . 0.0 110.556 176.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 77.5 mttt -85.57 -175.54 5.69 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.913 -0.492 . . . . 0.0 110.488 -178.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -150.4 115.44 5.34 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 122.174 -0.329 . . . . 0.0 110.325 178.101 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 5.4 m -76.52 160.35 77.5 Favored Pre-proline 0 N--CA 1.501 2.092 0 O-C-N 122.062 -0.399 . . . . 0.0 109.945 176.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -84.23 55.81 4.74 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 O-C-N 123.394 1.207 . . . . 0.0 111.866 -173.123 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 22.2 pttm -155.83 32.38 0.35 Allowed 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.558 -0.714 . . . . 0.0 110.055 170.275 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -84.73 -169.94 2.88 Favored 'General case' 0 N--CA 1.499 2.0 0 CA-C-O 121.078 0.466 . . . . 0.0 111.124 -168.423 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -64.83 -168.73 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.261 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 170.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 9.0 tp -63.96 165.71 8.49 Favored 'General case' 0 N--CA 1.507 2.397 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 -172.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -68.03 137.81 55.35 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.509 -0.744 . . . . 0.0 110.47 -157.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 30.7 ptt180 -161.45 165.32 28.92 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 120.903 0.382 . . . . 0.0 110.557 -170.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 16.6 m -128.69 149.12 50.81 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 172.434 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.572 HD12 HD12 ' A' ' 62' ' ' ILE . 18.6 tt -143.02 156.0 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 122.023 -0.423 . . . . 0.0 110.165 -176.506 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -143.8 151.63 40.19 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 120.947 0.403 . . . . 0.0 110.581 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 89.6 m -141.98 141.31 32.89 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 19.9 p -157.56 137.9 12.78 Favored 'General case' 0 N--CA 1.504 2.243 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.137 -174.164 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 27.8 ttt180 -109.38 45.82 1.04 Allowed 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 121.275 0.56 . . . . 0.0 110.637 -172.056 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.0 p -141.92 152.08 43.22 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.869 -0.519 . . . . 0.0 109.97 178.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 17.6 p-10 -61.78 132.68 53.92 Favored 'General case' 0 N--CA 1.505 2.281 0 CA-C-O 121.373 0.606 . . . . 0.0 111.793 -164.375 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.478 HD22 ' OE1' ' A' ' 109' ' ' GLN . 74.4 mt 52.24 26.76 4.18 Favored 'General case' 0 N--CA 1.507 2.416 0 O-C-N 122.048 -0.408 . . . . 0.0 111.966 179.337 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 25.9 p -63.15 -22.2 66.7 Favored 'General case' 0 N--CA 1.507 2.419 0 O-C-N 121.858 -0.526 . . . . 0.0 111.572 175.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.416 ' ND2' ' HB2' ' A' ' 61' ' ' ALA . 4.9 m120 -91.1 -22.95 20.46 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.723 -0.611 . . . . 0.0 111.304 177.498 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLN . . . . . 0.478 ' OE1' HD22 ' A' ' 106' ' ' LEU . 28.3 tt0 -60.97 -37.9 84.08 Favored 'General case' 0 N--CA 1.509 2.504 0 O-C-N 121.595 -0.691 . . . . 0.0 110.721 -176.47 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -100.16 16.22 24.9 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 122.126 -0.359 . . . . 0.0 111.59 177.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 17.4 tp -113.73 112.83 24.1 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.579 -0.701 . . . . 0.0 110.345 -175.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 37.8 tt0 -96.48 120.72 61.72 Favored Pre-proline 0 N--CA 1.496 1.872 0 CA-C-O 118.853 -0.594 . . . . 0.0 110.028 173.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -71.11 139.33 35.37 Favored 'Trans proline' 0 N--CA 1.49 1.303 0 O-C-N 123.197 1.104 . . . . 0.0 110.326 175.219 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 35.0 p -139.17 149.96 45.05 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 122.113 -0.367 . . . . 0.0 110.206 178.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 17.4 mt -72.68 111.16 10.12 Favored Pre-proline 0 N--CA 1.502 2.157 0 CA-C-O 118.896 -0.573 . . . . 0.0 110.037 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -68.44 150.64 75.8 Favored 'Trans proline' 0 N--CA 1.492 1.432 0 O-C-N 123.234 1.123 . . . . 0.0 110.284 -178.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -68.61 155.29 69.42 Favored 'Trans proline' 0 N--CA 1.492 1.389 0 O-C-N 123.517 1.272 . . . . 0.0 110.222 178.128 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.407 HG12 ' N ' ' A' ' 119' ' ' VAL . 42.5 t -79.08 165.16 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.407 ' N ' HG12 ' A' ' 118' ' ' VAL . 58.4 t -89.81 131.48 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 -178.189 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 76.2 mt -90.43 116.15 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 177.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 72.41 -163.25 54.68 Favored Glycine 0 N--CA 1.495 2.607 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.196 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_exo -58.25 148.99 75.86 Favored 'Trans proline' 0 N--CA 1.501 1.928 0 C-N-CA 121.119 1.213 . . . . 0.0 111.447 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -82.73 153.38 25.33 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 122.076 -0.39 . . . . 0.0 110.286 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -155.77 159.07 39.15 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 122.119 -0.363 . . . . 0.0 110.158 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -82.89 -42.56 17.58 Favored 'General case' 0 N--CA 1.5 2.028 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.159 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -150.03 175.61 29.05 Favored Glycine 0 N--CA 1.495 2.621 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 29.3 t -155.41 143.32 19.91 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 122.128 -0.631 . . . . 0.0 110.136 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 76.4 mt -90.21 139.44 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 30.3 ttp180 . . . . . 0 N--CA 1.499 1.98 0 CA-C-O 118.003 -0.999 . . . . 0.0 110.22 -179.616 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.209 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_exo -58.51 120.18 7.9 Favored 'Trans proline' 0 N--CA 1.5 1.908 0 C-N-CA 121.061 1.174 . . . . 0.0 111.403 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -90.42 46.97 1.38 Allowed 'General case' 0 N--CA 1.5 2.068 0 CA-C-O 121.131 0.491 . . . . 0.0 110.847 178.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -77.42 78.41 3.94 Favored 'General case' 0 N--CA 1.503 2.179 0 CA-C-O 121.313 0.578 . . . . 0.0 110.335 -177.382 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.477 HG22 ' HB2' ' A' ' 56' ' ' ASN . 14.0 m -109.35 98.57 7.96 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.799 -0.563 . . . . 0.0 110.024 178.771 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 25.3 mt -80.77 150.97 70.44 Favored Pre-proline 0 N--CA 1.502 2.136 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.369 -175.428 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -65.16 129.68 23.58 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 O-C-N 123.3 1.158 . . . . 0.0 110.978 165.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -157.84 50.94 0.43 Allowed 'General case' 0 N--CA 1.498 1.967 0 CA-C-O 121.423 0.63 . . . . 0.0 110.407 164.479 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 20.5 tp -158.72 114.88 2.68 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.733 -0.604 . . . . 0.0 110.29 -177.043 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.425 ' HE3' HD21 ' A' ' 106' ' ' LEU . 33.1 ttpt -99.77 132.14 45.3 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 120.95 -0.3 . . . . 0.0 110.233 176.767 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 76.4 m -117.52 140.33 49.75 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -179.46 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -81.86 142.13 32.79 Favored 'General case' 0 N--CA 1.502 2.143 0 C-N-CA 120.535 -0.466 . . . . 0.0 109.961 176.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 28.2 p -113.38 136.98 52.17 Favored 'General case' 0 N--CA 1.501 2.111 0 C-N-CA 120.779 -0.368 . . . . 0.0 110.589 -177.318 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.8 m -122.61 142.94 50.11 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 122.095 -0.378 . . . . 0.0 110.021 177.118 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.44 -68.13 1.5 Allowed Glycine 0 N--CA 1.494 2.547 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.535 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -115.27 126.47 54.54 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 122.003 -0.704 . . . . 0.0 110.613 -176.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -137.96 136.25 19.56 Favored Pre-proline 0 N--CA 1.496 1.852 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 174.532 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -60.7 152.65 67.76 Favored 'Trans proline' 0 N--CA 1.497 1.702 0 O-C-N 123.072 1.038 . . . . 0.0 111.194 -170.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -60.25 -28.03 67.7 Favored 'General case' 0 N--CA 1.508 2.44 0 O-C-N 122.021 -0.424 . . . . 0.0 111.34 -173.129 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -92.1 14.39 16.16 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.9 -0.5 . . . . 0.0 111.78 -178.105 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.92 162.04 26.29 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.581 -0.699 . . . . 0.0 110.259 -173.182 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 70.7 mt -124.11 136.45 60.33 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -176.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 19.8 p30 37.8 43.15 0.46 Allowed 'General case' 0 N--CA 1.512 2.658 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 -176.505 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 55.5 43.34 28.67 Favored 'General case' 0 N--CA 1.509 2.476 0 O-C-N 121.83 -0.544 . . . . 0.0 111.429 -178.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 56.1 p -139.53 161.98 36.17 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.801 -0.562 . . . . 0.0 110.273 171.076 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.4 p -137.29 160.43 39.07 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-O 120.737 0.304 . . . . 0.0 110.608 178.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 76.5 mt -110.09 132.97 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -174.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.0 t -143.5 155.19 44.27 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.952 -0.468 . . . . 0.0 111.022 -179.395 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.477 ' HB2' HG22 ' A' ' 32' ' ' THR . 48.9 p30 -108.09 29.31 7.43 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 122.036 -0.415 . . . . 0.0 110.705 167.181 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -119.59 -102.63 1.99 Allowed Glycine 0 N--CA 1.497 2.741 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 176.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 24.6 m-70 -140.89 169.75 17.03 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 122.007 -0.702 . . . . 0.0 109.709 177.19 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 78.0 m -93.13 139.24 30.79 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 166.16 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -129.38 149.58 51.1 Favored 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.486 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -152.12 138.4 18.42 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 176.198 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.579 HD12 HD12 ' A' ' 99' ' ' ILE . 18.2 tt -136.36 149.05 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 CA-C-O 120.961 0.41 . . . . 0.0 110.459 -168.552 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.791 HD12 HD21 ' A' ' 73' ' ' LEU . 16.3 tt -132.36 145.11 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 177.609 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -149.79 143.43 25.37 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 -169.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.6 tm-20 -101.64 117.68 35.38 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 122.169 -0.332 . . . . 0.0 110.119 -177.049 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 51.7 p30 -87.05 175.34 8.16 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 122.132 -0.355 . . . . 0.0 110.676 -175.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -60.44 -17.55 45.35 Favored 'General case' 0 N--CA 1.507 2.413 0 O-C-N 121.941 -0.474 . . . . 0.0 112.069 -173.481 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -93.18 -10.71 34.81 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.589 -0.695 . . . . 0.0 111.9 178.481 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 89.99 21.16 40.1 Favored Glycine 0 N--CA 1.498 2.785 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 178.055 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -96.98 143.79 27.51 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-N 118.312 1.056 . . . . 0.0 109.77 170.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 15.8 p -94.81 126.54 40.2 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 122.069 -0.395 . . . . 0.0 110.2 177.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 20.7 p -97.91 117.56 32.51 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 122.13 -0.357 . . . . 0.0 110.298 179.031 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.791 HD21 HD12 ' A' ' 63' ' ' ILE . 83.7 mt -97.7 128.18 44.19 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 122.136 -0.353 . . . . 0.0 110.295 -179.617 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -146.98 144.7 29.38 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 122.079 -0.388 . . . . 0.0 110.523 175.548 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 97.0 p -143.72 167.02 23.26 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 177.48 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -178.26 -169.14 38.69 Favored Glycine 0 N--CA 1.496 2.659 0 N-CA-C 110.224 -1.15 . . . . 0.0 110.224 -179.197 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 2.9 m -96.17 132.77 41.24 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 122.175 -0.603 . . . . 0.0 110.181 -176.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 54.9 ttm -98.92 122.01 41.62 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 122.052 -0.405 . . . . 0.0 110.071 175.233 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 17.5 pttm -66.74 163.84 18.34 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 122.024 -0.423 . . . . 0.0 110.48 -179.028 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -66.08 146.78 54.27 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 122.031 -0.418 . . . . 0.0 110.418 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -146.08 -48.32 0.21 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 122.173 -0.33 . . . . 0.0 110.242 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 136.82 58.64 0.05 OUTLIER Glycine 0 N--CA 1.495 2.586 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 -178.558 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.7 m -152.58 115.93 4.71 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 122.198 -0.589 . . . . 0.0 110.396 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -74.35 -39.27 62.9 Favored 'General case' 0 N--CA 1.503 2.188 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.244 177.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -155.63 30.78 0.37 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 122.153 -0.342 . . . . 0.0 110.569 176.398 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 60.0 mt-30 -78.57 83.98 4.72 Favored 'General case' 0 N--CA 1.502 2.16 0 CA-C-O 121.173 0.511 . . . . 0.0 110.066 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 87.9 m -113.38 36.32 3.62 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.937 -0.477 . . . . 0.0 109.892 177.733 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -79.3 -172.08 3.01 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.99 -0.444 . . . . 0.0 110.399 -175.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -122.15 139.81 53.31 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 122.043 -0.41 . . . . 0.0 111.863 -178.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.0 m -77.67 175.18 4.82 Favored Pre-proline 0 N--CA 1.499 1.987 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 177.366 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -88.39 52.44 1.95 Allowed 'Trans proline' 0 N--CA 1.494 1.53 0 N-CA-C 107.857 -1.632 . . . . 0.0 107.857 173.34 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 51.6 tttm -155.71 42.88 0.42 Allowed 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.137 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.59 163.52 27.6 Favored 'General case' 0 N--CA 1.5 2.026 0 CA-C-O 121.146 0.498 . . . . 0.0 110.952 -161.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -98.91 -169.05 1.72 Allowed 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 -177.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' A' ' 95' ' ' LEU . 8.9 tp -64.29 169.62 4.46 Favored 'General case' 0 N--CA 1.506 2.347 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 57.9 mtm180 -68.02 130.69 43.73 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.488 -0.758 . . . . 0.0 110.295 -163.413 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 46.4 ptt85 -161.46 165.25 29.03 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 120.824 0.345 . . . . 0.0 110.594 -168.619 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 18.1 m -128.75 148.78 50.87 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 172.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.579 HD12 HD12 ' A' ' 62' ' ' ILE . 18.4 tt -143.18 127.38 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.997 -0.439 . . . . 0.0 110.167 -176.263 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -105.81 149.23 26.68 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 122.234 -0.291 . . . . 0.0 110.455 177.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 26.7 p -143.02 134.63 26.46 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 177.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 20.4 p -157.57 131.38 8.04 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.926 -0.484 . . . . 0.0 110.81 -170.034 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 21.6 ttp-105 -104.86 48.48 0.84 Allowed 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 121.385 0.612 . . . . 0.0 110.604 -176.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.0 p -135.12 151.36 50.63 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.895 -0.503 . . . . 0.0 109.785 174.117 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 15.7 p30 -61.77 132.24 52.51 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 121.724 -0.61 . . . . 0.0 111.793 -163.257 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.425 HD21 ' HE3' ' A' ' 37' ' ' LYS . 75.3 mt 52.0 26.55 3.8 Favored 'General case' 0 N--CA 1.507 2.376 0 O-C-N 122.089 -0.382 . . . . 0.0 111.991 179.394 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 26.3 p -63.11 -21.99 66.56 Favored 'General case' 0 N--CA 1.506 2.363 0 O-C-N 121.849 -0.532 . . . . 0.0 111.583 176.503 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -93.04 -22.93 18.85 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.684 -0.635 . . . . 0.0 111.323 178.009 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -60.66 -38.6 85.42 Favored 'General case' 0 N--CA 1.508 2.436 0 O-C-N 121.577 -0.702 . . . . 0.0 110.768 -177.137 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -100.74 16.23 25.67 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 122.078 -0.389 . . . . 0.0 111.685 179.207 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 16.8 tp -111.87 117.34 32.52 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.586 -0.697 . . . . 0.0 110.394 -174.324 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 3.3 tp-100 -96.45 120.71 61.79 Favored Pre-proline 0 N--CA 1.496 1.868 0 CA-C-O 118.862 -0.589 . . . . 0.0 109.965 171.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -69.93 145.22 55.51 Favored 'Trans proline' 0 N--CA 1.491 1.347 0 O-C-N 123.235 1.124 . . . . 0.0 110.291 175.49 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 34.5 p -139.22 147.05 41.25 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 122.175 -0.328 . . . . 0.0 110.156 179.148 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 14.9 mt -72.1 154.97 92.2 Favored Pre-proline 0 N--CA 1.502 2.166 0 CA-C-O 119.305 -0.379 . . . . 0.0 110.152 178.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -67.94 148.85 77.08 Favored 'Trans proline' 0 N--CA 1.491 1.326 0 O-C-N 123.47 1.247 . . . . 0.0 110.292 179.31 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -68.25 140.42 48.84 Favored 'Trans proline' 0 N--CA 1.492 1.394 0 O-C-N 123.452 1.238 . . . . 0.0 110.425 -178.047 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.42 HG12 ' N ' ' A' ' 119' ' ' VAL . 43.5 t -80.14 165.86 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.182 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.627 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.42 ' N ' HG12 ' A' ' 118' ' ' VAL . 58.2 t -88.82 125.64 41.94 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -179.417 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 76.3 mt -91.53 117.88 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 178.419 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 101.99 79.94 1.44 Allowed Glycine 0 N--CA 1.495 2.587 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 177.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_exo -58.68 -177.47 0.11 Allowed 'Trans proline' 0 N--CA 1.502 1.978 0 O-C-N 123.352 1.185 . . . . 0.0 111.361 176.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -155.23 94.88 1.66 Allowed 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 120.836 0.35 . . . . 0.0 110.254 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -73.21 154.06 40.41 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 122.065 -0.397 . . . . 0.0 110.099 178.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -81.63 -34.15 31.01 Favored 'General case' 0 N--CA 1.5 2.044 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.174 179.122 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 87.13 166.13 42.17 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 109.594 -1.403 . . . . 0.0 109.594 178.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 60.2 m -80.85 157.82 25.56 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 122.125 -0.632 . . . . 0.0 110.228 179.346 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 76.2 mt -89.88 134.66 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 55.5 ttt85 . . . . . 0 N--CA 1.498 1.93 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.152 -179.924 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.351 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_exo -58.39 119.87 7.4 Favored 'Trans proline' 0 N--CA 1.501 1.958 0 O-C-N 123.357 1.188 . . . . 0.0 111.365 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -90.31 47.01 1.39 Allowed 'General case' 0 N--CA 1.501 2.107 0 CA-C-O 121.082 0.468 . . . . 0.0 110.722 179.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -78.12 81.17 4.51 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.708 -0.62 . . . . 0.0 109.866 -177.125 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 21.6 m -135.52 114.37 12.02 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.856 -0.527 . . . . 0.0 110.188 178.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 73.4 mt -142.48 118.7 6.89 Favored Pre-proline 0 N--CA 1.496 1.862 0 CA-C-O 118.817 -0.611 . . . . 0.0 109.414 178.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -60.45 145.29 98.99 Favored 'Trans proline' 0 N--CA 1.502 2.011 0 C-N-CA 120.823 1.015 . . . . 0.0 111.224 -178.553 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -151.73 47.99 0.8 Allowed 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 121.188 0.518 . . . . 0.0 110.743 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.433 HD23 HG23 ' A' ' 55' ' ' THR . 18.9 tp -161.0 115.01 2.05 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.771 -0.581 . . . . 0.0 110.449 -174.475 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 48.6 tttt -99.81 132.5 45.12 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 122.146 -0.347 . . . . 0.0 110.223 177.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 86.4 m -118.97 140.43 50.01 Favored 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 -178.614 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -83.07 144.49 29.86 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 122.027 -0.421 . . . . 0.0 110.015 176.273 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 28.1 p -115.67 137.07 52.44 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.952 -0.467 . . . . 0.0 110.588 -178.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 98.6 p -123.02 141.57 51.82 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 109.894 -0.409 . . . . 0.0 109.894 175.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.18 -68.16 1.41 Allowed Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -112.15 123.59 50.59 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.997 -0.708 . . . . 0.0 110.498 -176.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -138.07 136.99 20.14 Favored Pre-proline 0 N--CA 1.496 1.87 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 174.108 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -61.11 152.52 70.99 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 O-C-N 123.087 1.046 . . . . 0.0 111.077 -172.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -60.44 -28.21 68.11 Favored 'General case' 0 N--CA 1.508 2.462 0 O-C-N 121.88 -0.512 . . . . 0.0 111.415 -172.495 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -91.97 14.26 16.27 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.953 -0.467 . . . . 0.0 111.735 -177.662 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.86 161.97 27.22 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.533 -0.73 . . . . 0.0 110.243 -173.515 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 70.7 mt -124.36 136.38 60.69 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -177.154 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 19.8 p30 37.78 43.36 0.48 Allowed 'General case' 0 N--CA 1.515 2.776 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -176.547 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 30.8 m120 55.39 44.0 27.88 Favored 'General case' 0 N--CA 1.507 2.386 0 O-C-N 121.785 -0.572 . . . . 0.0 111.466 -178.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 58.2 p -140.76 161.75 37.05 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.725 -0.609 . . . . 0.0 110.306 171.174 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.4 p -139.66 165.07 28.26 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-O 120.752 0.311 . . . . 0.0 110.691 179.235 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 76.4 mt -111.91 132.53 60.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 -175.534 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.433 HG23 HD23 ' A' ' 36' ' ' LEU . 9.1 t -140.44 153.05 46.14 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 122.027 -0.421 . . . . 0.0 111.059 -179.522 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 48.5 p30 -108.61 29.96 6.92 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 122.037 -0.415 . . . . 0.0 110.672 167.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -122.89 -96.05 1.26 Allowed Glycine 0 N--CA 1.497 2.73 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 176.244 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 49.7 m-70 -144.5 171.03 14.93 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 122.136 -0.626 . . . . 0.0 109.761 176.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 73.7 m -92.96 139.09 30.89 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 164.354 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -129.52 150.34 50.9 Favored 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 120.291 -0.564 . . . . 0.0 110.613 -178.611 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -151.26 143.98 24.39 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 175.362 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.487 HD12 HD12 ' A' ' 99' ' ' ILE . 18.1 tt -143.29 149.26 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.397 -171.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.668 HD12 HD21 ' A' ' 73' ' ' LEU . 13.5 tt -134.28 145.32 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 177.68 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -148.58 145.15 27.69 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 -169.471 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.3 tm-20 -101.53 116.94 33.9 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 122.146 -0.346 . . . . 0.0 110.134 -176.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -87.4 175.33 8.04 Favored 'General case' 0 N--CA 1.501 2.101 0 CA-C-O 120.796 0.332 . . . . 0.0 110.584 -175.384 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -60.44 -17.86 47.35 Favored 'General case' 0 N--CA 1.506 2.372 0 O-C-N 121.895 -0.503 . . . . 0.0 112.0 -172.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -92.85 -10.37 36.96 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.599 -0.688 . . . . 0.0 111.861 178.299 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 89.47 20.21 45.73 Favored Glycine 0 N--CA 1.498 2.791 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 176.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -97.38 145.74 25.86 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-N 118.466 1.133 . . . . 0.0 109.793 169.386 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 13.6 p -94.92 129.16 42.06 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 122.106 -0.371 . . . . 0.0 110.26 178.49 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 20.9 p -97.86 118.16 33.81 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 122.057 -0.402 . . . . 0.0 110.353 178.476 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.668 HD21 HD12 ' A' ' 63' ' ' ILE . 23.2 mt -97.53 126.87 43.07 Favored 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 120.966 -0.294 . . . . 0.0 110.307 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -145.18 143.41 30.3 Favored 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.646 174.609 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 98.9 p -143.85 167.06 23.2 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 176.204 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 178.91 -165.66 34.8 Favored Glycine 0 N--CA 1.496 2.663 0 N-CA-C 110.379 -1.088 . . . . 0.0 110.379 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 2.6 m -96.27 132.4 41.78 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 122.178 -0.601 . . . . 0.0 110.227 -176.242 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 55.8 ttm -98.49 121.82 40.91 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 122.069 -0.394 . . . . 0.0 110.156 177.176 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 22.5 pttt -66.99 165.05 16.39 Favored 'General case' 0 N--CA 1.503 2.199 0 C-N-CA 120.699 -0.401 . . . . 0.0 110.537 -178.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -66.44 148.54 51.73 Favored 'General case' 0 N--CA 1.503 2.22 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.244 177.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -139.62 -48.58 0.47 Allowed 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.404 -178.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 147.31 -33.82 1.32 Allowed Glycine 0 N--CA 1.497 2.726 0 N-CA-C 109.846 -1.301 . . . . 0.0 109.846 -176.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.9 m -71.1 125.49 27.04 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 122.028 -0.689 . . . . 0.0 109.907 178.754 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -74.04 -41.27 62.05 Favored 'General case' 0 N--CA 1.502 2.133 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.294 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -155.6 28.55 0.38 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 122.138 -0.351 . . . . 0.0 110.826 178.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -79.67 85.39 5.39 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.837 -0.539 . . . . 0.0 110.153 -179.386 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 90.8 m -100.88 34.61 2.42 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.88 -0.512 . . . . 0.0 109.979 175.337 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 79.2 mttt -80.06 -171.69 3.06 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 122.089 -0.382 . . . . 0.0 110.366 -176.348 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -116.08 135.74 53.66 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 122.129 -0.357 . . . . 0.0 111.421 -177.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.0 m -78.59 174.88 5.33 Favored Pre-proline 0 N--CA 1.498 1.934 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 178.618 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -88.18 52.49 2.05 Favored 'Trans proline' 0 N--CA 1.495 1.616 0 N-CA-C 108.324 -1.452 . . . . 0.0 108.324 173.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 11.8 ptmt -155.74 43.06 0.42 Allowed 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 177.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.98 -171.41 0.71 Allowed 'General case' 0 N--CA 1.5 2.057 0 CA-C-O 121.069 0.461 . . . . 0.0 110.988 -162.508 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -136.49 -169.1 2.38 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -169.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.6 tp -64.47 166.52 8.27 Favored 'General case' 0 N--CA 1.51 2.525 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 -178.713 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 42.2 ttt180 -68.18 135.7 52.48 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.654 -0.654 . . . . 0.0 110.428 -164.325 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 33.4 ptt-85 -161.51 165.42 28.63 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 120.984 0.421 . . . . 0.0 110.575 -170.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 17.0 m -126.81 149.06 49.88 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 171.289 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.487 HD12 HD12 ' A' ' 62' ' ' ILE . 18.5 tt -143.14 155.92 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.963 -0.461 . . . . 0.0 110.308 -175.28 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 57.1 mm-40 -141.46 147.75 38.39 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 120.866 0.365 . . . . 0.0 110.412 179.299 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 26.8 p -143.1 136.84 28.69 Favored 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 179.597 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 18.9 p -157.5 132.53 8.8 Favored 'General case' 0 N--CA 1.504 2.244 0 O-C-N 121.97 -0.456 . . . . 0.0 110.973 -171.026 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 22.4 ttm180 -105.14 48.68 0.83 Allowed 'General case' 0 N--CA 1.498 1.974 0 CA-C-O 121.382 0.61 . . . . 0.0 110.559 -177.043 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 23.8 p -136.02 151.16 49.59 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.714 -0.616 . . . . 0.0 109.799 174.522 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -61.73 131.98 51.68 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.69 -0.631 . . . . 0.0 111.821 -163.296 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 72.9 mt 52.28 26.4 4.0 Favored 'General case' 0 N--CA 1.506 2.36 0 O-C-N 122.047 -0.408 . . . . 0.0 111.948 179.306 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 26.4 p -62.86 -22.06 66.42 Favored 'General case' 0 N--CA 1.507 2.422 0 O-C-N 121.859 -0.526 . . . . 0.0 111.615 176.35 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -92.21 -22.86 19.57 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.83 -0.544 . . . . 0.0 111.331 177.218 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -60.76 -38.1 84.09 Favored 'General case' 0 N--CA 1.507 2.395 0 O-C-N 121.635 -0.666 . . . . 0.0 110.775 -177.362 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -100.24 16.26 24.88 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 122.179 -0.325 . . . . 0.0 111.701 178.191 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 14.0 tp -116.9 111.53 19.78 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.492 -0.755 . . . . 0.0 110.289 -175.025 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 21.9 tp60 -96.49 120.7 61.74 Favored Pre-proline 0 N--CA 1.497 1.893 0 CA-C-O 118.756 -0.64 . . . . 0.0 109.982 172.274 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.69 133.89 21.12 Favored 'Trans proline' 0 N--CA 1.49 1.296 0 O-C-N 123.237 1.125 . . . . 0.0 110.395 176.53 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 34.9 p -139.22 147.84 42.3 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 122.004 -0.435 . . . . 0.0 110.048 177.264 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 13.5 mt -72.46 138.16 80.89 Favored Pre-proline 0 N--CA 1.502 2.128 0 CA-C-O 119.01 -0.519 . . . . 0.0 109.929 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -75.82 146.67 30.07 Favored 'Trans proline' 0 N--CA 1.489 1.255 0 O-C-N 123.285 1.15 . . . . 0.0 110.247 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -71.28 132.35 20.75 Favored 'Trans proline' 0 N--CA 1.49 1.32 0 O-C-N 123.379 1.2 . . . . 0.0 110.134 175.535 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.413 HG12 ' N ' ' A' ' 119' ' ' VAL . 42.5 t -80.75 165.19 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.587 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.486 HG13 ' O ' ' A' ' 119' ' ' VAL . 13.2 p -90.18 114.17 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 CA-C-O 120.984 0.421 . . . . 0.0 110.314 -179.565 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 10.0 tt -155.15 47.18 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 121.996 -0.44 . . . . 0.0 110.063 176.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 66.66 65.23 2.9 Favored Glycine 0 N--CA 1.497 2.725 0 N-CA-C 109.846 -1.301 . . . . 0.0 109.846 -178.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_exo -57.87 150.85 60.63 Favored 'Trans proline' 0 N--CA 1.502 2.017 0 C-N-CA 121.125 1.217 . . . . 0.0 111.504 -177.198 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -155.24 160.19 40.64 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 122.178 -0.327 . . . . 0.0 110.248 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -155.33 45.5 0.49 Allowed 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 121.281 0.562 . . . . 0.0 109.54 -176.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -85.2 113.79 21.82 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.937 -0.477 . . . . 0.0 110.174 -178.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 77.31 -159.19 48.49 Favored Glycine 0 N--CA 1.495 2.625 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.102 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 32.8 t -155.45 145.33 21.46 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 122.147 -0.619 . . . . 0.0 110.064 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 76.8 mt -90.19 134.08 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 32.7 ttp180 . . . . . 0 N--CA 1.495 1.82 0 CA-C-O 117.993 -1.004 . . . . 0.0 110.286 179.755 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.331 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_exo -58.22 120.38 8.23 Favored 'Trans proline' 0 N--CA 1.502 1.978 0 O-C-N 123.361 1.19 . . . . 0.0 111.395 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -90.27 47.15 1.41 Allowed 'General case' 0 N--CA 1.501 2.108 0 CA-C-O 121.117 0.485 . . . . 0.0 110.85 179.556 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -78.09 80.83 4.51 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.746 -0.596 . . . . 0.0 109.853 -177.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.445 HG22 ' HB2' ' A' ' 56' ' ' ASN . 22.5 m -140.64 118.71 11.92 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.968 -0.458 . . . . 0.0 110.152 179.29 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 28.2 mt -79.31 145.06 63.39 Favored Pre-proline 0 N--CA 1.501 2.09 0 CA-C-O 119.053 -0.498 . . . . 0.0 109.872 179.01 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -61.17 138.55 78.47 Favored 'Trans proline' 0 N--CA 1.502 1.996 0 O-C-N 123.176 1.093 . . . . 0.0 111.237 176.028 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -155.38 47.29 0.51 Allowed 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.931 -0.481 . . . . 0.0 110.752 172.804 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 25.1 tp -159.33 102.77 1.59 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.767 -0.583 . . . . 0.0 110.396 -173.026 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 41.0 tttp -99.91 119.07 37.64 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 110.288 -0.264 . . . . 0.0 110.288 177.49 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 69.2 m -121.73 140.63 52.09 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 122.078 -0.389 . . . . 0.0 110.945 -178.485 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -79.7 155.44 28.01 Favored 'General case' 0 N--CA 1.501 2.087 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.07 -178.358 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 27.2 p -119.3 141.14 49.25 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.996 -0.44 . . . . 0.0 110.529 -179.356 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 49.7 m -122.98 138.93 54.55 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 122.086 -0.383 . . . . 0.0 110.169 177.627 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.52 -68.38 1.51 Allowed Glycine 0 N--CA 1.496 2.661 0 N-CA-C 109.669 -1.373 . . . . 0.0 109.669 178.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 83.2 t60 -112.97 125.79 54.78 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 122.073 -0.663 . . . . 0.0 110.537 -176.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -138.03 137.68 21.73 Favored Pre-proline 0 N--CA 1.496 1.839 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 176.17 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -61.11 150.89 82.18 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 O-C-N 123.049 1.026 . . . . 0.0 111.072 -174.001 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -59.77 -27.18 66.32 Favored 'General case' 0 N--CA 1.507 2.41 0 O-C-N 121.938 -0.477 . . . . 0.0 111.463 -173.083 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -92.17 14.23 16.74 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.871 -0.518 . . . . 0.0 111.746 -177.665 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.63 162.03 25.53 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.655 -0.653 . . . . 0.0 110.333 -173.561 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 76.2 mt -125.75 140.52 48.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -178.204 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 38.8 42.08 0.59 Allowed 'General case' 0 N--CA 1.513 2.696 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -178.519 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 30.7 m120 54.96 41.8 31.59 Favored 'General case' 0 N--CA 1.509 2.511 0 O-C-N 121.955 -0.465 . . . . 0.0 111.437 -178.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 43.1 p -140.54 161.77 36.95 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.825 -0.547 . . . . 0.0 110.332 173.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.4 p -138.38 163.32 32.18 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 120.967 0.413 . . . . 0.0 110.542 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 79.1 mt -129.33 125.32 61.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -168.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.2 t -143.6 158.25 43.81 Favored 'General case' 0 N--CA 1.501 2.12 0 C-N-CA 120.578 -0.449 . . . . 0.0 111.337 -177.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.445 ' HB2' HG22 ' A' ' 32' ' ' THR . 10.6 p-10 -109.58 29.23 7.77 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 122.168 -0.333 . . . . 0.0 110.473 165.211 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -112.44 -103.66 2.67 Favored Glycine 0 N--CA 1.496 2.662 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 178.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 22.9 m80 -147.22 158.88 44.11 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 170.026 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 87.5 m -96.71 139.35 32.9 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 176.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -129.01 158.36 39.11 Favored 'General case' 0 N--CA 1.497 1.915 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.694 -171.093 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -150.98 143.86 24.55 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 176.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.476 HD12 HD12 ' A' ' 99' ' ' ILE . 18.2 tt -142.21 149.15 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.444 -170.417 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.858 HD12 HD21 ' A' ' 73' ' ' LEU . 15.4 tt -137.88 145.11 29.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 178.327 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -150.04 140.85 22.74 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 -170.117 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.1 tm-20 -101.67 116.54 32.98 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -86.78 175.23 8.33 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 122.068 -0.395 . . . . 0.0 110.582 -175.401 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -60.65 -17.49 47.74 Favored 'General case' 0 N--CA 1.507 2.423 0 O-C-N 122.076 -0.39 . . . . 0.0 112.002 -172.748 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -92.49 -10.82 36.42 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.628 -0.67 . . . . 0.0 111.855 178.035 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.14 20.91 40.5 Favored Glycine 0 N--CA 1.497 2.757 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 176.335 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -97.49 142.8 28.88 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 118.378 1.089 . . . . 0.0 109.784 169.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.3 p -94.91 128.83 41.99 Favored 'General case' 0 N--CA 1.498 1.961 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.273 177.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.1 p -98.05 114.33 26.46 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 120.851 0.358 . . . . 0.0 110.232 177.526 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.858 HD21 HD12 ' A' ' 63' ' ' ILE . 82.4 mt -96.66 123.98 40.51 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 122.169 -0.332 . . . . 0.0 110.235 179.646 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -145.23 147.88 32.9 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 122.087 -0.383 . . . . 0.0 110.465 178.368 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 92.5 p -143.57 164.99 28.83 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 176.129 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -173.98 -178.96 44.3 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 -177.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 6.6 m -100.08 133.46 44.43 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 122.203 -0.587 . . . . 0.0 110.309 -178.128 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 35.2 ttm -99.85 123.13 43.78 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 122.038 -0.414 . . . . 0.0 110.167 176.505 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 24.5 pttt -65.49 170.86 4.49 Favored 'General case' 0 N--CA 1.504 2.27 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.381 177.039 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -65.46 144.51 56.99 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.957 -0.464 . . . . 0.0 110.424 -179.301 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -148.15 -48.23 0.16 Allowed 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.293 -178.456 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 147.42 -35.42 1.23 Allowed Glycine 0 N--CA 1.495 2.626 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -178.531 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 64.4 m -72.98 123.62 23.84 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 122.028 -0.69 . . . . 0.0 110.006 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -78.24 -46.16 21.07 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 122.043 -0.41 . . . . 0.0 110.199 -179.355 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -155.67 33.62 0.36 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.999 -0.438 . . . . 0.0 110.41 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -76.09 65.38 2.09 Favored 'General case' 0 N--CA 1.501 2.105 0 CA-C-O 121.402 0.62 . . . . 0.0 110.013 179.135 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 95.6 m -111.81 33.77 4.59 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.748 -0.595 . . . . 0.0 110.232 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 63.3 mttm -80.83 170.23 16.55 Favored 'General case' 0 N--CA 1.501 2.11 0 C-N-CA 120.706 -0.397 . . . . 0.0 110.296 -178.664 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -109.52 132.89 53.72 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.417 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.6 t -78.33 142.69 63.34 Favored Pre-proline 0 N--CA 1.498 1.974 0 C-N-CA 120.604 -0.438 . . . . 0.0 110.123 -175.482 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -78.23 61.59 7.83 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 O-C-N 123.25 1.132 . . . . 0.0 110.479 173.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 25.8 ttmt -155.45 46.15 0.49 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.774 -0.579 . . . . 0.0 109.901 -177.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -155.69 144.07 20.16 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.155 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -109.99 60.48 0.6 Allowed 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.406 0.622 . . . . 0.0 110.178 -176.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 20.5 tp -154.96 153.85 31.68 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.723 -0.61 . . . . 0.0 110.03 178.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 3.8 mmp_? -87.06 126.99 35.11 Favored 'General case' 0 N--CA 1.5 2.038 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.01 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 62.1 ttp85 -161.39 145.76 13.25 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 122.056 -0.403 . . . . 0.0 110.147 -177.417 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 12.2 m -134.26 149.09 50.92 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 172.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.476 HD12 HD12 ' A' ' 62' ' ' ILE . 18.6 tt -143.06 155.99 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 177.138 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -145.95 156.64 43.65 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 120.873 0.368 . . . . 0.0 110.474 -178.274 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 97.0 m -141.81 154.12 44.98 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 178.628 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 25.4 p -157.6 133.34 9.22 Favored 'General case' 0 N--CA 1.502 2.146 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.842 -170.465 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 48.9 ttt85 -109.46 45.91 1.04 Allowed 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.299 0.571 . . . . 0.0 110.516 -179.172 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 44.2 p -138.1 151.97 48.31 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.805 -0.559 . . . . 0.0 110.055 176.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 21.3 p30 -64.12 140.46 58.87 Favored 'General case' 0 N--CA 1.505 2.292 0 CA-C-O 121.315 0.579 . . . . 0.0 111.198 -169.445 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 20.3 mt 53.07 25.85 4.44 Favored 'General case' 0 N--CA 1.507 2.39 0 O-C-N 121.814 -0.554 . . . . 0.0 112.289 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 27.9 p -67.84 -25.18 65.42 Favored 'General case' 0 N--CA 1.505 2.275 0 C-N-CA 119.968 -0.693 . . . . 0.0 111.164 172.567 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -81.09 -33.79 33.09 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.723 -0.611 . . . . 0.0 110.463 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLN . . . . . 0.475 ' NE2' ' CZ ' ' A' ' 110' ' ' TYR . 12.2 tt0 -63.06 -40.73 98.57 Favored 'General case' 0 N--CA 1.506 2.358 0 O-C-N 122.002 -0.436 . . . . 0.0 110.89 -177.332 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.475 ' CZ ' ' NE2' ' A' ' 109' ' ' GLN . 67.0 m-85 -102.4 16.26 26.79 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 122.067 -0.395 . . . . 0.0 111.978 -174.221 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 13.5 tp -125.84 109.05 12.06 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.535 -0.728 . . . . 0.0 110.37 -176.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -98.33 120.78 58.74 Favored Pre-proline 0 N--CA 1.497 1.889 0 CA-C-O 118.799 -0.619 . . . . 0.0 110.132 173.456 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -68.84 147.13 68.06 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 O-C-N 123.234 1.123 . . . . 0.0 110.205 175.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 35.3 p -139.17 149.98 45.07 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 122.133 -0.355 . . . . 0.0 110.169 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 64.1 mt -71.76 155.02 92.7 Favored Pre-proline 0 N--CA 1.502 2.145 0 CA-C-O 119.187 -0.435 . . . . 0.0 110.138 179.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -64.82 156.69 60.46 Favored 'Trans proline' 0 N--CA 1.492 1.424 0 O-C-N 123.36 1.189 . . . . 0.0 110.596 178.251 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -68.25 147.12 71.71 Favored 'Trans proline' 0 N--CA 1.492 1.439 0 O-C-N 123.555 1.292 . . . . 0.0 110.227 178.156 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 61.0 t -76.92 -37.63 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 60.4 t -89.72 138.33 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 179.565 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.516 ' O ' HG23 ' A' ' 120' ' ' ILE . 4.5 tp -153.26 68.71 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 CA-C-O 121.169 0.509 . . . . 0.0 110.156 -179.427 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -169.11 -100.89 0.14 Allowed Glycine 0 N--CA 1.496 2.64 0 N-CA-C 103.557 -3.817 . . . . 0.0 103.557 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -39.59 146.73 0.2 Allowed 'Trans proline' 0 N--CA 1.502 2.0 0 O-C-N 123.369 1.194 . . . . 0.0 114.885 177.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -84.45 136.39 33.86 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 122.13 -0.356 . . . . 0.0 110.457 179.07 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -155.79 164.31 38.71 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 122.096 -0.378 . . . . 0.0 110.073 178.15 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -155.19 155.96 34.83 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 122.154 -0.342 . . . . 0.0 110.109 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 85.93 170.25 46.81 Favored Glycine 0 N--CA 1.495 2.603 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 87.9 p -81.09 159.7 24.66 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 122.17 -0.606 . . . . 0.0 110.232 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 76.1 mt -90.26 132.26 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.417 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 63.6 ttt180 . . . . . 0 N--CA 1.498 1.939 0 CA-C-O 118.066 -0.969 . . . . 0.0 110.198 179.954 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.304 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_exo -58.35 120.5 8.43 Favored 'Trans proline' 0 N--CA 1.502 1.975 0 O-C-N 123.3 1.158 . . . . 0.0 111.409 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -155.48 78.78 1.02 Allowed 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 -176.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -79.15 86.55 4.95 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.822 -0.549 . . . . 0.0 110.006 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.404 HG22 ' HB2' ' A' ' 56' ' ' ASN . 18.8 m -146.04 120.04 9.4 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.932 -0.48 . . . . 0.0 109.949 177.288 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 22.0 mt -80.17 148.45 67.44 Favored Pre-proline 0 N--CA 1.5 2.071 0 O-C-N 122.098 -0.376 . . . . 0.0 110.217 -175.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_exo -65.48 127.88 19.04 Favored 'Trans proline' 0 N--CA 1.498 1.757 0 O-C-N 123.279 1.147 . . . . 0.0 110.942 166.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -156.12 51.33 0.53 Allowed 'General case' 0 N--CA 1.498 1.971 0 CA-C-O 121.364 0.602 . . . . 0.0 110.372 164.565 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.436 HD23 HG23 ' A' ' 55' ' ' THR . 20.8 tp -158.26 114.81 2.81 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.615 -0.678 . . . . 0.0 110.29 -178.547 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 55.5 tttt -99.79 130.09 45.96 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 178.245 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 80.1 m -114.62 140.21 49.0 Favored 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.231 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -84.5 142.79 29.79 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 176.547 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 28.1 p -113.88 137.67 51.35 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 122.052 -0.405 . . . . 0.0 110.595 -177.644 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 28.0 t -122.95 133.05 54.4 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 122.089 -0.382 . . . . 0.0 110.109 178.403 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.75 -66.26 2.77 Favored Glycine 0 N--CA 1.495 2.586 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 63.9 m170 -110.79 123.34 49.88 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 122.069 -0.665 . . . . 0.0 110.554 -177.366 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -138.1 136.01 19.14 Favored Pre-proline 0 N--CA 1.496 1.858 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 175.331 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -60.54 152.69 66.46 Favored 'Trans proline' 0 N--CA 1.496 1.662 0 O-C-N 123.024 1.013 . . . . 0.0 111.201 -170.108 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -60.36 -28.15 67.95 Favored 'General case' 0 N--CA 1.507 2.377 0 O-C-N 122.04 -0.412 . . . . 0.0 111.365 -172.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -92.32 14.35 16.68 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.985 -0.447 . . . . 0.0 111.763 -178.329 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.45 162.07 27.47 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.554 -0.716 . . . . 0.0 110.217 -172.024 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.419 HG22 HD22 ' A' ' 50' ' ' ASN . 68.7 mt -126.06 137.59 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -176.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.419 HD22 HG22 ' A' ' 49' ' ' ILE . 17.2 p30 37.82 43.31 0.48 Allowed 'General case' 0 N--CA 1.512 2.675 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -175.574 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 24.9 t30 56.1 42.66 28.08 Favored 'General case' 0 N--CA 1.508 2.457 0 O-C-N 121.805 -0.559 . . . . 0.0 111.451 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 44.3 p -142.02 165.24 27.99 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.765 -0.584 . . . . 0.0 110.555 171.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.6 p -137.8 163.7 30.74 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 122.166 -0.333 . . . . 0.0 110.567 176.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 77.0 mt -112.55 132.57 60.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -175.341 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.436 HG23 HD23 ' A' ' 36' ' ' LEU . 9.1 t -139.62 152.78 47.06 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.95 -0.469 . . . . 0.0 111.104 -178.002 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.404 ' HB2' HG22 ' A' ' 32' ' ' THR . 15.3 p-10 -108.92 31.25 5.82 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 122.116 -0.365 . . . . 0.0 110.432 167.098 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -124.79 -95.85 1.09 Allowed Glycine 0 N--CA 1.496 2.648 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 176.171 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 23.3 m80 -146.86 171.91 14.48 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 122.076 -0.661 . . . . 0.0 109.507 177.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 74.8 m -93.78 139.25 31.07 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 166.485 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -130.41 148.65 52.25 Favored 'General case' 0 N--CA 1.499 2.006 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.49 -178.384 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -151.9 143.5 23.55 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 177.646 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.549 HD12 HD12 ' A' ' 99' ' ' ILE . 18.3 tt -145.15 149.27 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 122.063 -0.398 . . . . 0.0 110.479 -171.628 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.658 HD12 HD21 ' A' ' 73' ' ' LEU . 15.4 tt -135.75 145.32 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 176.319 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -148.2 148.49 30.58 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 -169.683 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.4 tm-20 -101.6 117.51 35.06 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 -175.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -87.38 175.28 8.06 Favored 'General case' 0 N--CA 1.501 2.093 0 CA-C-O 120.796 0.331 . . . . 0.0 110.582 -175.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -60.84 -17.57 50.74 Favored 'General case' 0 N--CA 1.506 2.347 0 O-C-N 121.988 -0.445 . . . . 0.0 111.954 -172.552 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -92.63 -10.86 35.86 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.678 -0.639 . . . . 0.0 111.801 178.238 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.54 19.33 45.26 Favored Glycine 0 N--CA 1.497 2.766 0 O-C-N 121.469 -0.769 . . . . 0.0 111.194 177.003 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -97.2 145.37 26.12 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-N 118.483 1.141 . . . . 0.0 109.818 169.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.9 p -94.72 128.54 41.48 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 122.079 -0.388 . . . . 0.0 110.342 178.116 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 19.8 p -97.96 116.25 29.79 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 122.134 -0.354 . . . . 0.0 110.354 178.248 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.658 HD21 HD12 ' A' ' 63' ' ' ILE . 14.7 mt -97.42 126.58 42.76 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 122.152 -0.342 . . . . 0.0 110.423 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -145.75 144.82 30.56 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 120.811 -0.355 . . . . 0.0 110.434 175.294 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 80.1 p -143.72 165.55 27.35 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 176.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -178.02 -166.87 35.17 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 110.226 -1.15 . . . . 0.0 110.226 -178.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 2.7 m -97.32 132.68 42.82 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 122.212 -0.581 . . . . 0.0 110.309 -175.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 47.3 ttm -99.1 123.33 43.32 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 122.028 -0.42 . . . . 0.0 110.197 178.36 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 23.5 pttm -65.22 172.02 3.37 Favored 'General case' 0 N--CA 1.504 2.241 0 O-C-N 122.049 -0.407 . . . . 0.0 110.642 -178.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -65.49 148.35 51.88 Favored 'General case' 0 N--CA 1.505 2.321 0 O-C-N 122.006 -0.434 . . . . 0.0 110.542 -178.072 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 69.3 mt-10 -132.7 -45.97 0.88 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 122.143 -0.348 . . . . 0.0 110.268 178.336 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 108.52 34.31 2.7 Favored Glycine 0 N--CA 1.497 2.735 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 28.2 p -155.79 109.54 2.79 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 122.072 -0.664 . . . . 0.0 109.915 177.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -79.32 -43.58 23.29 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 122.12 -0.363 . . . . 0.0 110.376 -178.074 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -78.8 -12.16 60.02 Favored 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -174.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -75.32 85.12 2.48 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.729 -0.607 . . . . 0.0 110.278 -172.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 13.4 t -151.21 27.72 0.67 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 122.069 -0.395 . . . . 0.0 110.657 173.1 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 73.6 mttt -87.61 -169.83 2.76 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.948 -0.47 . . . . 0.0 110.549 -178.424 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -102.58 120.55 40.73 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 122.053 -0.404 . . . . 0.0 110.218 176.594 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.0 m -81.66 172.07 10.57 Favored Pre-proline 0 N--CA 1.497 1.89 0 O-C-N 122.057 -0.402 . . . . 0.0 110.3 -173.421 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -84.95 52.9 3.53 Favored 'Trans proline' 0 N--CA 1.494 1.518 0 O-C-N 123.412 1.217 . . . . 0.0 111.406 173.695 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 8.8 ptpt -155.74 44.23 0.44 Allowed 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 178.136 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.46 -171.04 0.57 Allowed 'General case' 0 N--CA 1.5 2.068 0 CA-C-O 121.133 0.492 . . . . 0.0 110.831 -161.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -147.23 -168.96 3.19 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -164.404 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.9 tp -64.2 164.5 10.85 Favored 'General case' 0 N--CA 1.507 2.393 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 -179.269 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 79.7 mtm180 -68.19 126.8 30.68 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.725 -0.609 . . . . 0.0 110.33 -162.604 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 16.9 ptt-85 -161.49 165.35 28.8 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 120.841 0.353 . . . . 0.0 110.332 -174.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 15.2 m -128.56 149.14 50.75 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 173.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.549 HD12 HD12 ' A' ' 62' ' ' ILE . 18.5 tt -143.09 155.77 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 122.064 -0.397 . . . . 0.0 109.976 -179.111 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.454 ' HB3' HD21 ' A' ' 111' ' ' LEU . 45.2 mt-10 -143.02 149.76 38.69 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 120.932 0.396 . . . . 0.0 110.506 -178.729 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 25.6 p -143.06 137.78 29.46 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -178.124 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 22.6 p -157.39 131.7 8.4 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.895 -0.503 . . . . 0.0 110.979 -172.545 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 30.4 ttp180 -105.83 44.81 1.01 Allowed 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 121.285 0.564 . . . . 0.0 110.532 -176.072 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.0 p -135.19 150.89 50.21 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.929 -0.482 . . . . 0.0 109.931 177.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 17.6 p-10 -62.82 131.81 50.08 Favored 'General case' 0 N--CA 1.504 2.228 0 CA-C-O 121.436 0.636 . . . . 0.0 111.635 -163.191 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 81.2 mt 51.76 28.13 4.69 Favored 'General case' 0 N--CA 1.506 2.355 0 O-C-N 121.927 -0.483 . . . . 0.0 111.934 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 25.8 p -62.46 -23.85 67.12 Favored 'General case' 0 N--CA 1.506 2.36 0 O-C-N 121.823 -0.548 . . . . 0.0 111.53 173.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -75.31 -30.0 60.22 Favored 'General case' 0 N--CA 1.504 2.241 0 O-C-N 121.811 -0.556 . . . . 0.0 111.046 177.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -62.3 -39.63 93.63 Favored 'General case' 0 N--CA 1.506 2.339 0 O-C-N 121.673 -0.642 . . . . 0.0 110.81 -168.686 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -100.17 16.11 25.27 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 122.176 -0.328 . . . . 0.0 111.693 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.454 HD21 ' HB3' ' A' ' 100' ' ' GLU . 12.5 tp -116.36 108.95 16.71 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.597 -0.69 . . . . 0.0 110.347 -175.256 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -99.45 120.72 57.1 Favored Pre-proline 0 N--CA 1.497 1.903 0 CA-C-O 118.955 -0.545 . . . . 0.0 110.125 173.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -68.79 137.41 38.31 Favored 'Trans proline' 0 N--CA 1.49 1.277 0 O-C-N 123.158 1.083 . . . . 0.0 110.157 172.385 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 34.7 p -139.29 146.8 40.8 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.119 178.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 21.0 mt -71.26 149.58 94.21 Favored Pre-proline 0 N--CA 1.503 2.205 0 C-N-CA 120.685 -0.406 . . . . 0.0 109.94 179.233 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -68.1 146.51 70.73 Favored 'Trans proline' 0 N--CA 1.491 1.326 0 O-C-N 123.435 1.229 . . . . 0.0 110.273 -178.398 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -69.11 145.34 60.56 Favored 'Trans proline' 0 N--CA 1.49 1.294 0 O-C-N 123.468 1.246 . . . . 0.0 110.301 -179.019 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.401 HG12 ' N ' ' A' ' 119' ' ' VAL . 43.7 t -79.68 165.31 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.214 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 178.197 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.401 ' N ' HG12 ' A' ' 118' ' ' VAL . 12.0 p -152.07 137.32 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.999 -0.438 . . . . 0.0 110.18 -178.513 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.507 ' O ' HG23 ' A' ' 120' ' ' ILE . 4.5 tp -154.81 68.35 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 CA-C-O 121.186 0.517 . . . . 0.0 110.014 178.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 80.98 -171.06 53.54 Favored Glycine 0 N--CA 1.496 2.666 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -178.485 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_exo -58.32 144.71 95.7 Favored 'Trans proline' 0 N--CA 1.502 1.985 0 C-N-CA 121.064 1.176 . . . . 0.0 111.37 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -84.92 145.99 27.49 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 122.071 -0.393 . . . . 0.0 110.231 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -155.74 49.88 0.53 Allowed 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.238 0.542 . . . . 0.0 109.913 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -155.25 33.67 0.38 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.806 -0.559 . . . . 0.0 110.275 -179.562 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 83.83 170.03 45.99 Favored Glycine 0 N--CA 1.496 2.663 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 31.0 t -82.06 140.82 33.67 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 122.171 -0.606 . . . . 0.0 110.197 179.488 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 50.9 mm -90.65 136.71 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 179.434 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 . . . . . 0 N--CA 1.497 1.886 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.229 179.839 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.366 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_exo -58.35 117.17 3.84 Favored 'Trans proline' 0 N--CA 1.502 1.989 0 O-C-N 123.355 1.187 . . . . 0.0 111.398 179.602 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -155.44 78.16 1.0 Allowed 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.204 0.526 . . . . 0.0 109.738 -176.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -78.11 73.87 4.67 Favored 'General case' 0 N--CA 1.502 2.144 0 CA-C-O 121.355 0.598 . . . . 0.0 110.353 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.492 HG22 ' HB2' ' A' ' 56' ' ' ASN . 19.8 m -147.68 121.93 9.59 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.818 -0.551 . . . . 0.0 110.102 179.033 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 22.8 mt -77.6 151.09 79.93 Favored Pre-proline 0 N--CA 1.502 2.141 0 O-C-N 122.118 -0.364 . . . . 0.0 110.24 -177.593 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo -63.64 122.99 11.29 Favored 'Trans proline' 0 N--CA 1.499 1.807 0 O-C-N 123.304 1.16 . . . . 0.0 111.19 167.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -161.76 54.21 0.25 Allowed 'General case' 0 N--CA 1.5 2.034 0 CA-C-O 121.359 0.6 . . . . 0.0 110.281 165.149 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 21.6 tp -157.63 115.47 3.08 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.748 -0.595 . . . . 0.0 109.919 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.3 tptt -99.67 131.1 45.88 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 122.18 -0.325 . . . . 0.0 110.162 -178.349 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 72.6 m -121.12 140.59 51.78 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -176.325 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -83.71 144.15 29.56 Favored 'General case' 0 N--CA 1.5 2.033 0 C-N-CA 120.601 -0.44 . . . . 0.0 109.9 176.136 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 27.1 p -118.57 136.96 53.56 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 122.056 -0.403 . . . . 0.0 110.568 -177.1 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.4 m -123.0 141.19 52.24 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 122.059 -0.4 . . . . 0.0 110.088 177.692 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 75.89 -67.14 2.39 Favored Glycine 0 N--CA 1.496 2.636 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.263 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -116.68 123.68 47.86 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 122.132 -0.628 . . . . 0.0 110.579 -176.739 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -138.08 136.75 19.91 Favored Pre-proline 0 N--CA 1.497 1.891 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 174.607 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -61.31 151.77 76.98 Favored 'Trans proline' 0 N--CA 1.496 1.633 0 O-C-N 123.114 1.06 . . . . 0.0 111.094 -172.008 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -59.21 -25.72 64.23 Favored 'General case' 0 N--CA 1.507 2.394 0 O-C-N 122.032 -0.418 . . . . 0.0 111.625 -173.141 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -91.57 14.27 15.47 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.944 -0.473 . . . . 0.0 111.899 -176.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -82.67 161.53 22.12 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.565 -0.71 . . . . 0.0 110.242 -175.695 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 76.4 mt -125.74 139.38 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -178.652 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 38.42 42.26 0.52 Allowed 'General case' 0 N--CA 1.513 2.708 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -177.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 55.16 42.37 30.71 Favored 'General case' 0 N--CA 1.509 2.494 0 O-C-N 121.921 -0.487 . . . . 0.0 111.487 -178.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 27.4 p -140.43 157.49 45.44 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.878 -0.514 . . . . 0.0 110.402 172.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.8 p -145.82 165.82 27.75 Favored 'General case' 0 N--CA 1.499 1.988 0 CA-C-O 121.0 0.429 . . . . 0.0 110.718 -172.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 78.0 mt -123.58 120.32 59.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -166.544 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.9 t -135.8 153.26 51.57 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-O 121.0 0.428 . . . . 0.0 110.965 -174.374 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.492 ' HB2' HG22 ' A' ' 32' ' ' THR . 44.3 p-10 -102.57 30.15 4.83 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 122.121 -0.362 . . . . 0.0 110.659 170.34 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -122.45 -108.33 1.97 Allowed Glycine 0 N--CA 1.496 2.658 0 N-CA-C 109.08 -1.608 . . . . 0.0 109.08 172.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -141.18 172.14 13.09 Favored 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -176.655 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 67.0 m -97.68 139.27 33.82 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 170.266 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -135.47 155.79 49.96 Favored 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 120.053 -0.659 . . . . 0.0 110.952 -176.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -151.06 150.66 30.98 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.392 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 18.4 tt -143.15 149.14 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 CA-C-O 120.904 0.383 . . . . 0.0 110.364 -172.179 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.823 HD12 HD11 ' A' ' 73' ' ' LEU . 16.0 tt -138.01 145.2 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 177.35 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -150.21 141.18 22.92 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 122.109 -0.369 . . . . 0.0 110.04 -170.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.0 tm-20 -101.69 116.52 32.93 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -86.67 175.25 8.37 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 122.212 -0.305 . . . . 0.0 110.59 -175.289 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -60.74 -17.5 48.97 Favored 'General case' 0 N--CA 1.506 2.35 0 O-C-N 122.032 -0.417 . . . . 0.0 111.998 -172.699 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -92.56 -10.8 36.3 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.668 -0.645 . . . . 0.0 111.819 178.047 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.1 20.95 40.49 Favored Glycine 0 N--CA 1.496 2.641 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 176.411 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -97.59 142.01 29.93 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-N 118.368 1.084 . . . . 0.0 109.893 169.621 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 10.9 p -94.84 129.62 41.74 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 122.168 -0.333 . . . . 0.0 110.36 178.153 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 17.9 p -97.85 112.94 24.66 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 122.147 -0.346 . . . . 0.0 110.324 177.153 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.823 HD11 HD12 ' A' ' 63' ' ' ILE . 4.6 mm? -97.36 122.31 40.25 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 122.124 -0.36 . . . . 0.0 110.254 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -144.99 155.66 43.51 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 122.004 -0.435 . . . . 0.0 110.541 178.456 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 91.0 p -143.51 162.89 34.66 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 176.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -158.81 -177.76 32.19 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 110.289 -1.124 . . . . 0.0 110.289 -173.127 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 1.7 m -113.09 115.71 28.74 Favored 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 -169.293 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 49.8 ttm -95.88 121.93 38.14 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.878 -0.514 . . . . 0.0 110.474 -170.302 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 22.1 pttt -66.08 171.49 4.55 Favored 'General case' 0 N--CA 1.503 2.209 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.412 175.695 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -65.7 145.74 55.64 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 122.025 -0.422 . . . . 0.0 110.427 178.136 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 67.2 mt-10 -143.21 -48.45 0.31 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 122.18 -0.325 . . . . 0.0 110.361 -177.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 143.07 -35.27 1.7 Allowed Glycine 0 N--CA 1.494 2.561 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -178.255 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 36.6 m -72.99 113.99 10.64 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 122.125 -0.633 . . . . 0.0 110.094 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -76.92 -34.64 57.68 Favored 'General case' 0 N--CA 1.501 2.121 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.114 178.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -155.39 76.03 0.95 Allowed 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.195 0.521 . . . . 0.0 109.868 179.453 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -155.38 94.37 1.59 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.941 -0.474 . . . . 0.0 109.971 -179.269 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 14.0 m -125.42 47.6 2.17 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.213 0.53 . . . . 0.0 109.809 177.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 74.6 mttt -78.59 -173.98 3.64 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.917 -0.49 . . . . 0.0 110.435 -174.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -119.21 141.86 48.52 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 176.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.3 m -74.91 145.68 81.62 Favored Pre-proline 0 N--CA 1.5 2.03 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.034 -177.253 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -77.92 63.16 8.09 Favored 'Trans proline' 0 N--CA 1.493 1.485 0 O-C-N 123.354 1.187 . . . . 0.0 110.578 177.652 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 37.0 tttp -155.41 42.54 0.44 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.73 -0.606 . . . . 0.0 109.798 179.442 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -155.73 145.33 21.11 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 109.929 -0.396 . . . . 0.0 109.929 178.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 44.5 tt0 -109.93 75.89 0.96 Allowed 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 121.334 0.587 . . . . 0.0 110.176 -179.201 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 17.9 tp -155.1 149.63 26.3 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.851 -0.531 . . . . 0.0 110.105 177.46 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 18.5 mmt180 -98.68 124.69 43.66 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 122.067 -0.395 . . . . 0.0 110.0 178.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 30.1 ptt180 -161.55 165.06 29.07 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 122.064 -0.398 . . . . 0.0 110.7 -178.431 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 24.3 m -133.95 149.39 51.25 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 177.511 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.6 tt -141.75 156.06 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 122.017 -0.427 . . . . 0.0 109.94 -178.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 51.6 mm-40 -143.86 151.43 39.87 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 122.146 -0.346 . . . . 0.0 110.615 -176.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 99.0 m -142.89 149.37 38.41 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 176.423 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 15.4 p -157.51 141.31 15.86 Favored 'General case' 0 N--CA 1.502 2.155 0 CA-C-O 121.07 0.462 . . . . 0.0 110.951 -173.593 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 68.8 mtp180 -110.55 49.51 0.85 Allowed 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.377 0.608 . . . . 0.0 110.693 -169.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.1 p -148.66 152.26 36.38 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.793 -0.567 . . . . 0.0 109.966 178.561 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -60.96 132.02 52.52 Favored 'General case' 0 N--CA 1.507 2.376 0 O-C-N 121.646 -0.659 . . . . 0.0 111.81 -163.664 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 69.1 mt 52.49 26.03 3.97 Favored 'General case' 0 N--CA 1.507 2.387 0 O-C-N 122.085 -0.385 . . . . 0.0 111.925 179.115 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 26.1 p -62.71 -21.97 66.18 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 121.853 -0.529 . . . . 0.0 111.762 177.489 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -90.09 -22.9 21.57 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.748 -0.595 . . . . 0.0 111.275 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -60.45 -38.9 85.62 Favored 'General case' 0 N--CA 1.509 2.488 0 O-C-N 121.58 -0.7 . . . . 0.0 110.775 -175.377 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -101.37 16.25 26.2 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 122.104 -0.373 . . . . 0.0 111.73 179.158 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 15.5 tp -110.53 113.54 26.25 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.567 -0.708 . . . . 0.0 110.38 -174.026 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 -96.83 120.76 61.1 Favored Pre-proline 0 N--CA 1.497 1.911 0 CA-C-O 118.803 -0.617 . . . . 0.0 109.989 172.021 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -68.34 133.89 29.58 Favored 'Trans proline' 0 N--CA 1.491 1.364 0 O-C-N 123.273 1.144 . . . . 0.0 110.408 176.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 32.7 p -98.84 125.32 44.19 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 122.098 -0.376 . . . . 0.0 110.428 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 15.7 mt -72.79 155.1 91.01 Favored Pre-proline 0 N--CA 1.501 2.102 0 CA-C-O 119.282 -0.39 . . . . 0.0 110.097 176.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -68.2 159.08 54.71 Favored 'Trans proline' 0 N--CA 1.491 1.365 0 O-C-N 123.455 1.239 . . . . 0.0 110.302 -178.507 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -64.01 147.68 91.7 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 O-C-N 123.384 1.202 . . . . 0.0 110.728 179.328 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.416 HG12 ' N ' ' A' ' 119' ' ' VAL . 43.4 t -79.53 165.29 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.162 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -179.537 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.416 ' N ' HG12 ' A' ' 118' ' ' VAL . 11.8 p -152.19 146.6 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 122.071 -0.393 . . . . 0.0 110.105 -178.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 7.1 tp -151.62 131.18 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 122.131 -0.355 . . . . 0.0 110.123 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 111.05 168.59 18.97 Favored Glycine 0 N--CA 1.496 2.687 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 178.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_exo -58.2 142.23 97.11 Favored 'Trans proline' 0 N--CA 1.501 1.97 0 C-N-CA 121.078 1.185 . . . . 0.0 111.431 -179.277 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -85.77 130.24 34.61 Favored 'General case' 0 N--CA 1.501 2.096 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.303 -179.397 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -155.74 47.73 0.5 Allowed 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 121.108 0.48 . . . . 0.0 109.787 178.417 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -155.28 173.14 17.05 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.981 -0.449 . . . . 0.0 110.314 -178.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 101.38 -35.57 4.81 Favored Glycine 0 N--CA 1.496 2.681 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 87.2 p -80.15 157.94 26.47 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 122.082 -0.658 . . . . 0.0 110.237 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 76.1 mt -90.37 136.77 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 63.9 ttt180 . . . . . 0 N--CA 1.499 2.016 0 CA-C-O 118.081 -0.961 . . . . 0.0 110.12 179.76 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.376 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_exo -58.5 120.16 7.86 Favored 'Trans proline' 0 N--CA 1.501 1.913 0 O-C-N 123.411 1.216 . . . . 0.0 111.379 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -90.13 47.25 1.43 Allowed 'General case' 0 N--CA 1.502 2.165 0 CA-C-O 121.163 0.506 . . . . 0.0 110.685 179.397 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -76.8 84.67 3.4 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.631 -0.668 . . . . 0.0 109.79 -176.614 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 22.0 m -128.88 110.51 12.18 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.982 -0.449 . . . . 0.0 110.08 177.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 74.1 mt -142.47 118.9 6.94 Favored Pre-proline 0 N--CA 1.498 1.93 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -179.655 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -59.82 144.98 99.36 Favored 'Trans proline' 0 N--CA 1.503 2.047 0 O-C-N 123.016 1.009 . . . . 0.0 111.268 -177.503 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -153.38 49.84 0.7 Allowed 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.882 -0.511 . . . . 0.0 110.677 178.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.448 HD23 HG23 ' A' ' 55' ' ' THR . 19.7 tp -159.94 114.97 2.34 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.821 -0.549 . . . . 0.0 110.112 -176.328 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 50.9 tttt -99.86 130.87 46.09 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 122.151 -0.343 . . . . 0.0 110.158 178.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 85.8 m -117.01 140.39 49.54 Favored 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 -178.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -83.83 145.91 28.4 Favored 'General case' 0 N--CA 1.501 2.082 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.16 178.243 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 27.8 p -118.26 137.03 53.32 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 122.086 -0.384 . . . . 0.0 110.457 178.703 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 29.3 t -123.03 120.22 32.68 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 122.025 -0.422 . . . . 0.0 110.145 177.671 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 82.35 -62.77 4.53 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -103.89 112.05 24.85 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 122.03 -0.688 . . . . 0.0 110.486 -177.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -138.09 137.51 21.23 Favored Pre-proline 0 N--CA 1.497 1.915 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 176.472 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -60.97 151.85 75.13 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 O-C-N 123.114 1.06 . . . . 0.0 111.101 -174.019 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -60.35 -28.1 67.91 Favored 'General case' 0 N--CA 1.507 2.414 0 O-C-N 121.896 -0.503 . . . . 0.0 111.439 -172.725 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -92.28 14.36 16.59 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.921 -0.487 . . . . 0.0 111.749 -177.7 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.16 161.99 26.95 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.706 -0.621 . . . . 0.0 110.293 -173.329 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 76.1 mt -125.92 139.85 50.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 -177.385 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 38.88 42.75 0.68 Allowed 'General case' 0 N--CA 1.513 2.686 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -178.313 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 30.7 m120 54.96 43.0 30.59 Favored 'General case' 0 N--CA 1.508 2.452 0 O-C-N 121.838 -0.538 . . . . 0.0 111.496 -178.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 40.3 p -144.01 161.99 37.34 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.881 -0.512 . . . . 0.0 110.535 173.557 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.5 p -139.75 165.0 28.45 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 120.837 0.351 . . . . 0.0 110.666 179.136 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 77.4 mt -112.07 131.86 62.33 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -175.21 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.448 HG23 HD23 ' A' ' 36' ' ' LEU . 9.0 t -140.37 152.86 46.11 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 122.041 -0.412 . . . . 0.0 111.065 -178.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 40.1 p-10 -109.28 29.38 7.59 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 122.109 -0.369 . . . . 0.0 110.711 167.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -122.03 -92.79 1.18 Allowed Glycine 0 N--CA 1.496 2.65 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 177.449 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -149.86 172.04 15.8 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 122.099 -0.647 . . . . 0.0 109.574 176.027 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 75.9 m -94.01 139.17 31.27 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 166.513 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -129.11 153.22 47.87 Favored 'General case' 0 N--CA 1.499 1.997 0 C-N-CA 120.338 -0.545 . . . . 0.0 110.635 -178.223 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -151.24 143.39 24.03 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 176.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.534 HD12 HD12 ' A' ' 99' ' ' ILE . 18.1 tt -143.12 149.26 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.277 -172.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.46 HD12 ' HG ' ' A' ' 73' ' ' LEU . 14.9 tt -138.35 145.32 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 -179.4 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -148.71 145.76 27.81 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 -169.52 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.6 tm-20 -101.62 118.22 36.5 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 122.142 -0.349 . . . . 0.0 110.089 -176.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 52.1 p30 -87.17 175.29 8.14 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 122.21 -0.306 . . . . 0.0 110.601 -175.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -60.39 -17.93 47.11 Favored 'General case' 0 N--CA 1.508 2.43 0 O-C-N 122.025 -0.422 . . . . 0.0 111.988 -173.466 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -92.74 -10.47 36.94 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.689 -0.632 . . . . 0.0 111.921 178.579 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.08 21.03 40.21 Favored Glycine 0 N--CA 1.498 2.776 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 177.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -97.29 142.8 28.74 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 118.41 1.105 . . . . 0.0 109.823 170.196 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.1 p -94.83 125.67 39.65 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.249 177.225 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.2 p -97.89 112.95 24.68 Favored 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 120.877 -0.329 . . . . 0.0 110.296 177.632 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.544 ' N ' HD12 ' A' ' 73' ' ' LEU . 6.4 mp -97.51 127.2 43.28 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 122.157 -0.339 . . . . 0.0 110.313 -178.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -142.79 145.36 33.17 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 122.021 -0.424 . . . . 0.0 110.329 177.139 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 88.1 p -143.53 166.53 24.55 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 177.658 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -179.72 -165.77 34.26 Favored Glycine 0 N--CA 1.497 2.736 0 N-CA-C 110.239 -1.145 . . . . 0.0 110.239 -178.486 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 3.7 m -96.66 132.11 42.64 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 122.226 -0.573 . . . . 0.0 110.343 -175.314 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 53.5 ttm -98.62 121.82 41.04 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.1 176.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.3 ptpp? -68.09 155.32 39.82 Favored 'General case' 0 N--CA 1.504 2.233 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.398 -178.614 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 55.9 t80 -66.51 146.53 54.42 Favored 'General case' 0 N--CA 1.504 2.231 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.275 178.349 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -151.44 -34.8 0.14 Allowed 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -179.432 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 137.73 50.44 0.06 OUTLIER Glycine 0 N--CA 1.495 2.568 0 N-CA-C 111.555 -0.618 . . . . 0.0 111.555 -178.455 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.4 m -155.5 113.21 3.35 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 122.219 -0.577 . . . . 0.0 109.842 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -74.44 -40.31 62.02 Favored 'General case' 0 N--CA 1.503 2.182 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.292 -179.363 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -155.68 31.49 0.36 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 122.168 -0.333 . . . . 0.0 110.373 177.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -77.48 83.99 3.89 Favored 'General case' 0 N--CA 1.501 2.112 0 CA-C-O 121.12 0.486 . . . . 0.0 110.059 -178.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 93.2 m -117.49 42.2 2.64 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.264 0.554 . . . . 0.0 109.753 176.402 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -78.71 -169.89 1.91 Allowed 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.92 -0.487 . . . . 0.0 110.426 -175.002 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -97.16 -170.02 1.96 Allowed 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 169.026 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.1 m -155.63 176.7 2.4 Favored Pre-proline 0 N--CA 1.493 1.697 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 -178.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -82.38 56.56 5.8 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 O-C-N 123.38 1.2 . . . . 0.0 111.149 167.416 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 46.9 pttt -155.76 49.39 0.52 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.666 -0.647 . . . . 0.0 109.397 177.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.65 177.41 1.6 Allowed 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.999 -0.438 . . . . 0.0 110.564 -168.3 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -154.99 -169.48 3.2 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 -167.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.2 tp -64.54 162.31 15.67 Favored 'General case' 0 N--CA 1.507 2.418 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 177.656 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 79.4 mtp180 -68.33 129.27 39.42 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.807 -0.558 . . . . 0.0 110.346 -166.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 46.5 ptt85 -161.48 165.3 28.88 Favored 'General case' 0 N--CA 1.496 1.825 0 CA-C-O 120.771 0.32 . . . . 0.0 110.509 -175.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.41 HG21 ' O ' ' A' ' 114' ' ' THR . 17.1 m -129.47 149.09 51.4 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 174.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.534 HD12 HD12 ' A' ' 62' ' ' ILE . 18.5 tt -143.09 155.91 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.993 -0.442 . . . . 0.0 110.135 -177.373 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -146.53 152.1 38.42 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 120.834 0.35 . . . . 0.0 110.632 -178.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 26.9 p -143.01 148.3 36.54 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 177.066 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 14.9 p -157.56 137.51 12.44 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.919 -0.488 . . . . 0.0 111.171 -173.182 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 44.9 ttt85 -107.91 53.01 0.7 Allowed 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 121.356 0.598 . . . . 0.0 110.604 -173.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.0 p -148.38 151.99 36.24 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.765 -0.584 . . . . 0.0 109.92 175.618 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 16.5 p30 -61.76 133.46 55.55 Favored 'General case' 0 N--CA 1.505 2.295 0 CA-C-O 121.444 0.64 . . . . 0.0 111.74 -164.314 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 72.8 mt 52.08 26.5 3.85 Favored 'General case' 0 N--CA 1.506 2.363 0 O-C-N 121.949 -0.469 . . . . 0.0 111.962 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 25.9 p -63.22 -21.92 66.54 Favored 'General case' 0 N--CA 1.506 2.338 0 O-C-N 121.889 -0.507 . . . . 0.0 111.7 176.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -92.29 -22.89 19.49 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.761 -0.587 . . . . 0.0 111.275 178.723 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -60.52 -37.17 80.29 Favored 'General case' 0 N--CA 1.506 2.338 0 O-C-N 121.433 -0.792 . . . . 0.0 110.762 -177.607 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -100.6 16.16 25.72 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 122.085 -0.384 . . . . 0.0 111.616 177.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 17.6 tp -112.19 113.48 25.76 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.675 -0.641 . . . . 0.0 110.346 -174.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -96.72 120.65 61.5 Favored Pre-proline 0 N--CA 1.496 1.863 0 CA-C-O 118.827 -0.606 . . . . 0.0 110.073 173.337 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -70.19 148.07 61.52 Favored 'Trans proline' 0 N--CA 1.49 1.293 0 O-C-N 123.122 1.064 . . . . 0.0 110.283 175.082 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.41 ' O ' HG21 ' A' ' 98' ' ' THR . 34.9 p -139.19 149.95 45.0 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 122.028 -0.42 . . . . 0.0 110.123 178.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 15.9 mt -71.9 149.89 92.68 Favored Pre-proline 0 N--CA 1.503 2.177 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.112 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -69.9 160.26 50.29 Favored 'Trans proline' 0 N--CA 1.489 1.214 0 O-C-N 123.472 1.248 . . . . 0.0 110.237 178.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -67.91 149.94 77.99 Favored 'Trans proline' 0 N--CA 1.491 1.355 0 O-C-N 123.512 1.27 . . . . 0.0 110.306 178.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.407 HG12 ' N ' ' A' ' 119' ' ' VAL . 42.6 t -79.27 165.1 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 -179.123 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.407 ' N ' HG12 ' A' ' 118' ' ' VAL . 12.0 p -89.96 145.54 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 122.024 -0.422 . . . . 0.0 110.232 -178.55 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.405 HG23 ' O ' ' A' ' 120' ' ' ILE . 17.7 tt -152.08 124.39 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 122.062 -0.399 . . . . 0.0 110.05 179.019 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 68.55 66.09 2.42 Favored Glycine 0 N--CA 1.496 2.64 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_exo -58.47 135.16 65.89 Favored 'Trans proline' 0 N--CA 1.502 2.009 0 O-C-N 123.433 1.228 . . . . 0.0 111.373 -179.219 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -86.02 131.49 34.26 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 122.022 -0.424 . . . . 0.0 110.146 178.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 31.8 p90 -71.86 140.85 49.51 Favored 'General case' 0 N--CA 1.501 2.104 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.152 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -155.3 98.11 1.96 Allowed 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -140.69 35.43 1.87 Allowed Glycine 0 N--CA 1.497 2.71 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 27.9 t -155.46 100.49 2.12 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 122.163 -0.61 . . . . 0.0 110.098 179.184 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 76.3 mt -90.9 129.41 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.087 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 10.0 tpp180 . . . . . 0 N--CA 1.499 2.023 0 CA-C-O 118.022 -0.989 . . . . 0.0 110.21 179.527 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.247 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_exo -58.62 123.2 13.03 Favored 'Trans proline' 0 N--CA 1.501 1.944 0 C-N-CA 121.082 1.188 . . . . 0.0 111.3 179.129 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -90.33 47.32 1.43 Allowed 'General case' 0 N--CA 1.5 2.07 0 CA-C-O 121.102 0.477 . . . . 0.0 110.884 179.736 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -78.19 80.18 4.62 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.703 -0.623 . . . . 0.0 109.807 -178.093 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.571 HG23 ' ND2' ' A' ' 56' ' ' ASN . 17.8 m -107.36 51.06 0.75 Allowed 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.281 0.562 . . . . 0.0 110.113 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 19.7 mt -79.13 119.87 78.67 Favored Pre-proline 0 N--CA 1.501 2.085 0 O-C-N 121.884 -0.51 . . . . 0.0 110.111 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_exo -65.59 131.27 27.26 Favored 'Trans proline' 0 N--CA 1.498 1.791 0 O-C-N 123.12 1.063 . . . . 0.0 111.012 168.714 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -158.29 52.34 0.43 Allowed 'General case' 0 N--CA 1.501 2.107 0 CA-C-O 121.32 0.581 . . . . 0.0 110.515 164.175 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.467 HD23 HG23 ' A' ' 55' ' ' THR . 21.4 tp -158.22 114.65 2.8 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.656 -0.652 . . . . 0.0 110.23 -179.275 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.413 ' HE3' HD21 ' A' ' 106' ' ' LEU . 32.8 ttpt -99.77 131.63 45.63 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 122.11 -0.369 . . . . 0.0 110.225 177.546 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 79.3 m -115.31 140.22 49.3 Favored 'General case' 0 N--CA 1.501 2.077 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 -178.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -84.59 141.34 30.75 Favored 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 176.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 28.1 p -115.01 137.01 52.5 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 122.008 -0.433 . . . . 0.0 110.608 -177.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 49.4 m -122.99 135.58 54.53 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 175.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 75.49 -67.05 2.27 Favored Glycine 0 N--CA 1.495 2.606 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 83.7 t60 -109.2 119.55 39.85 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.99 -0.712 . . . . 0.0 110.576 -176.662 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -137.99 136.71 19.99 Favored Pre-proline 0 N--CA 1.496 1.868 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 174.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -60.12 151.88 69.65 Favored 'Trans proline' 0 N--CA 1.497 1.714 0 O-C-N 123.04 1.021 . . . . 0.0 111.225 -171.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -60.32 -28.14 67.89 Favored 'General case' 0 N--CA 1.507 2.394 0 O-C-N 121.966 -0.459 . . . . 0.0 111.401 -172.638 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -92.21 14.34 16.5 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.923 -0.486 . . . . 0.0 111.786 -178.051 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.46 162.06 26.64 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.606 -0.684 . . . . 0.0 110.348 -172.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 77.4 mt -126.08 140.5 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -177.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 38.68 42.69 0.62 Allowed 'General case' 0 N--CA 1.514 2.743 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -178.148 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 55.03 42.55 30.87 Favored 'General case' 0 N--CA 1.506 2.372 0 O-C-N 121.841 -0.537 . . . . 0.0 111.47 -179.113 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 41.5 p -142.96 161.16 38.87 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.89 -0.507 . . . . 0.0 110.465 173.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.3 p -138.46 162.52 34.27 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 120.874 0.369 . . . . 0.0 110.622 177.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 77.5 mt -108.73 132.58 56.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -176.087 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.467 HG23 HD23 ' A' ' 36' ' ' LEU . 7.9 t -138.74 151.95 47.55 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.989 -0.445 . . . . 0.0 110.936 -179.579 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.571 ' ND2' HG23 ' A' ' 32' ' ' THR . 36.4 p-10 -108.8 29.76 7.15 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 122.143 -0.348 . . . . 0.0 110.64 167.857 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -125.19 -93.29 0.95 Allowed Glycine 0 N--CA 1.496 2.659 0 N-CA-C 109.286 -1.525 . . . . 0.0 109.286 177.596 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 41.7 m80 -148.4 172.06 15.04 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 122.074 -0.662 . . . . 0.0 109.521 177.106 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 71.9 m -93.32 139.21 30.91 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 165.698 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 15.6 p90 -129.98 151.38 50.6 Favored 'General case' 0 N--CA 1.499 2.024 0 C-N-CA 120.365 -0.534 . . . . 0.0 110.595 -177.198 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -151.02 143.68 24.39 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -179.505 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.459 HD12 HD12 ' A' ' 99' ' ' ILE . 18.1 tt -143.82 149.22 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 CA-C-O 120.905 0.383 . . . . 0.0 110.413 -173.081 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.806 HD12 HD21 ' A' ' 73' ' ' LEU . 16.6 tt -133.85 145.23 33.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.638 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -146.92 145.17 29.71 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -167.636 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.7 tm-20 -101.58 118.17 36.4 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -176.354 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 50.8 p30 -87.45 175.31 8.02 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 122.077 -0.39 . . . . 0.0 110.605 -175.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -60.42 -17.91 47.41 Favored 'General case' 0 N--CA 1.508 2.443 0 O-C-N 122.033 -0.417 . . . . 0.0 111.957 -173.45 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 84.1 mm-40 -93.27 -9.84 37.62 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.662 -0.649 . . . . 0.0 111.926 178.569 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 89.4 20.96 42.79 Favored Glycine 0 N--CA 1.499 2.877 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 177.637 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -97.16 144.39 27.04 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-N 118.427 1.113 . . . . 0.0 109.791 169.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.8 p -94.84 126.31 40.09 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.988 -0.445 . . . . 0.0 110.276 177.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 24.5 p -97.92 122.68 41.33 Favored 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 120.921 -0.312 . . . . 0.0 110.284 178.724 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.806 HD21 HD12 ' A' ' 63' ' ' ILE . 75.2 mt -97.09 127.84 43.45 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 122.119 -0.363 . . . . 0.0 110.289 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -143.0 144.24 32.22 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 122.025 -0.422 . . . . 0.0 110.369 175.288 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 40.5 p -143.78 167.01 23.31 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 178.409 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -177.84 -167.25 35.65 Favored Glycine 0 N--CA 1.496 2.691 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 2.0 m -97.4 132.84 42.74 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 122.211 -0.582 . . . . 0.0 110.271 -176.355 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 54.7 ttm -100.91 129.62 46.8 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 122.039 -0.413 . . . . 0.0 110.279 179.098 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.6 pttm -64.96 172.04 3.15 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 122.08 -0.388 . . . . 0.0 110.58 177.385 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -64.93 139.91 58.81 Favored 'General case' 0 N--CA 1.505 2.28 0 C-N-CA 120.781 -0.367 . . . . 0.0 110.597 -177.197 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 67.5 mt-10 -131.8 -46.26 0.95 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 122.125 -0.359 . . . . 0.0 110.281 179.332 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 99.75 37.01 4.07 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 85.6 p -155.71 110.83 2.96 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 122.142 -0.622 . . . . 0.0 109.961 177.108 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -80.17 -48.03 13.78 Favored 'General case' 0 N--CA 1.501 2.092 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.41 -177.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -79.67 -21.3 44.92 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 122.078 -0.388 . . . . 0.0 111.7 -174.7 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 90.9 mm-40 -73.63 84.76 1.58 Allowed 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 121.207 0.527 . . . . 0.0 110.249 -172.529 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 95.0 m -139.17 33.31 2.12 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.964 -0.46 . . . . 0.0 110.089 174.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 47.2 mttp -81.23 169.4 17.38 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 122.049 -0.407 . . . . 0.0 110.352 -176.155 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.466 ' OD1' HG22 ' A' ' 99' ' ' ILE . 9.2 m-20 -109.13 114.71 28.66 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 122.144 -0.347 . . . . 0.0 110.309 179.013 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.9 m -78.12 149.17 76.03 Favored Pre-proline 0 N--CA 1.5 2.047 0 O-C-N 122.121 -0.362 . . . . 0.0 110.078 179.477 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -82.23 56.49 5.81 Favored 'Trans proline' 0 N--CA 1.495 1.561 0 O-C-N 123.358 1.189 . . . . 0.0 110.855 174.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 30.8 pttt -155.69 49.0 0.52 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.661 -0.65 . . . . 0.0 109.782 -177.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -155.56 -169.51 3.14 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.93 -0.481 . . . . 0.0 110.492 -168.36 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -64.71 -169.26 0.04 OUTLIER 'General case' 0 N--CA 1.504 2.248 0 CA-C-O 120.959 0.409 . . . . 0.0 110.413 -174.452 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 9.4 tp -64.45 173.61 2.03 Favored 'General case' 0 N--CA 1.507 2.377 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 -170.245 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -68.23 148.94 50.13 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.504 -0.748 . . . . 0.0 110.318 -163.113 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 44.6 ptt85 -161.48 165.25 28.96 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 120.954 0.406 . . . . 0.0 110.711 -171.135 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.406 HG21 ' O ' ' A' ' 114' ' ' THR . 13.6 m -124.95 149.12 47.98 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 169.738 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.466 HG22 ' OD1' ' A' ' 89' ' ' ASP . 18.2 tt -143.09 154.57 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 C-N-CA 120.537 -0.465 . . . . 0.0 110.326 -172.603 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -147.26 154.68 41.28 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 120.811 0.339 . . . . 0.0 110.573 -178.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 26.6 p -143.05 151.9 41.3 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 177.166 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 20.3 p -157.6 134.49 10.03 Favored 'General case' 0 N--CA 1.502 2.152 0 CA-C-O 120.976 0.417 . . . . 0.0 110.77 -174.102 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 40.8 ttp85 -107.37 49.38 0.81 Allowed 'General case' 0 N--CA 1.497 1.907 0 CA-C-O 121.384 0.611 . . . . 0.0 110.661 -173.67 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.2 p -143.41 151.5 40.45 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.759 -0.588 . . . . 0.0 109.863 177.241 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 15.8 p30 -62.24 132.57 53.15 Favored 'General case' 0 N--CA 1.506 2.359 0 CA-C-O 121.406 0.622 . . . . 0.0 111.684 -164.039 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.413 HD21 ' HE3' ' A' ' 37' ' ' LYS . 76.5 mt 52.24 27.31 4.6 Favored 'General case' 0 N--CA 1.506 2.357 0 O-C-N 121.976 -0.453 . . . . 0.0 111.961 179.671 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 25.7 p -62.75 -23.32 67.14 Favored 'General case' 0 N--CA 1.507 2.42 0 O-C-N 121.852 -0.53 . . . . 0.0 111.624 174.548 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -73.73 -29.86 62.49 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.735 -0.603 . . . . 0.0 111.043 178.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -62.11 -39.55 92.91 Favored 'General case' 0 N--CA 1.505 2.318 0 O-C-N 121.653 -0.655 . . . . 0.0 110.855 -169.479 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -100.83 16.17 26.0 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 122.073 -0.392 . . . . 0.0 111.75 -178.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 15.9 tp -114.19 108.98 17.68 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.635 -0.665 . . . . 0.0 110.367 -175.651 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -98.15 120.82 58.94 Favored Pre-proline 0 N--CA 1.497 1.876 0 CA-C-O 118.943 -0.551 . . . . 0.0 110.102 174.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -70.99 143.37 44.73 Favored 'Trans proline' 0 N--CA 1.49 1.313 0 O-C-N 123.142 1.075 . . . . 0.0 110.343 174.597 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.406 ' O ' HG21 ' A' ' 98' ' ' THR . 35.1 p -139.16 150.01 45.12 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 122.154 -0.341 . . . . 0.0 110.095 178.493 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 15.0 mt -70.54 153.28 95.1 Favored Pre-proline 0 N--CA 1.502 2.172 0 O-C-N 122.02 -0.425 . . . . 0.0 110.066 -179.568 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -68.06 155.23 70.36 Favored 'Trans proline' 0 N--CA 1.492 1.405 0 O-C-N 123.599 1.315 . . . . 0.0 110.307 -178.408 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -64.21 169.77 10.25 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 O-C-N 123.373 1.196 . . . . 0.0 110.671 178.21 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 43.5 t -78.36 164.97 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.13 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 76.6 t -146.28 131.27 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -177.727 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.406 ' O ' HG23 ' A' ' 120' ' ' ILE . 7.8 tp -89.75 124.15 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 122.121 -0.362 . . . . 0.0 110.119 173.025 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -65.07 -56.41 16.22 Favored Glycine 0 N--CA 1.499 2.852 0 N-CA-C 109.974 -1.25 . . . . 0.0 109.974 179.42 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_exo -58.87 152.89 54.35 Favored 'Trans proline' 0 N--CA 1.501 1.944 0 C-N-CA 121.042 1.161 . . . . 0.0 111.204 173.051 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -155.16 160.29 40.8 Favored 'General case' 0 N--CA 1.498 1.932 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.533 -178.092 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -155.82 175.3 14.11 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 178.69 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -80.08 109.12 14.23 Favored 'General case' 0 N--CA 1.502 2.126 0 CA-C-O 121.056 0.455 . . . . 0.0 110.354 -179.439 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -150.1 60.85 0.42 Allowed Glycine 0 N--CA 1.495 2.567 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.395 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 52.3 m -79.96 137.48 36.86 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 122.098 -0.648 . . . . 0.0 110.311 -178.037 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 76.3 mt -91.06 135.89 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 38.5 tpt85 . . . . . 0 N--CA 1.496 1.862 0 CA-C-O 118.003 -0.999 . . . . 0.0 110.258 179.748 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.373 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -58.5 123.25 13.16 Favored 'Trans proline' 0 N--CA 1.501 1.918 0 C-N-CA 121.099 1.199 . . . . 0.0 111.362 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -90.16 47.53 1.46 Allowed 'General case' 0 N--CA 1.502 2.134 0 CA-C-O 121.134 0.492 . . . . 0.0 110.652 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -76.76 84.38 3.37 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.653 -0.654 . . . . 0.0 109.783 -177.262 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 22.2 m -133.74 114.89 13.93 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.998 -0.439 . . . . 0.0 110.13 179.085 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 75.1 mt -142.42 145.85 36.6 Favored Pre-proline 0 N--CA 1.497 1.879 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 178.212 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -59.23 142.5 99.26 Favored 'Trans proline' 0 N--CA 1.504 2.14 0 O-C-N 123.273 1.144 . . . . 0.0 111.369 -179.377 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -156.32 48.19 0.47 Allowed 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 121.067 0.46 . . . . 0.0 110.872 176.087 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 18.5 tp -161.35 116.06 2.04 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.805 -0.56 . . . . 0.0 110.388 -173.349 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -99.81 133.66 43.85 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 122.214 -0.304 . . . . 0.0 110.21 176.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 64.3 m -120.82 140.34 51.87 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 -179.476 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -82.37 148.21 28.39 Favored 'General case' 0 N--CA 1.501 2.085 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.061 177.691 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 27.9 p -117.06 137.02 52.54 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.982 -0.448 . . . . 0.0 110.565 -179.147 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.0 m -123.02 139.25 54.27 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 176.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 75.06 -67.27 2.11 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -114.34 127.51 55.89 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 122.086 -0.655 . . . . 0.0 110.565 -177.315 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -138.04 136.93 20.14 Favored Pre-proline 0 N--CA 1.497 1.897 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 174.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -60.74 151.91 73.34 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 O-C-N 123.044 1.023 . . . . 0.0 111.142 -172.506 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -60.26 -28.09 67.76 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 121.966 -0.459 . . . . 0.0 111.476 -172.401 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -92.13 14.29 16.47 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 122.019 -0.426 . . . . 0.0 111.817 -177.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.93 162.07 26.25 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.602 -0.686 . . . . 0.0 110.33 -172.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 75.0 mt -125.29 138.14 55.34 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -178.447 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 38.84 43.0 0.69 Allowed 'General case' 0 N--CA 1.512 2.65 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -178.124 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 55.09 41.85 31.34 Favored 'General case' 0 N--CA 1.507 2.418 0 O-C-N 121.817 -0.552 . . . . 0.0 111.484 -178.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 70.9 p -140.25 161.02 38.67 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.857 -0.527 . . . . 0.0 110.314 173.631 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.3 p -140.65 165.12 28.34 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 120.874 0.369 . . . . 0.0 110.606 -179.423 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 77.2 mt -114.36 132.45 63.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -174.053 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.1 t -145.27 155.81 43.45 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 122.024 -0.423 . . . . 0.0 111.112 -179.25 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 41.4 p-10 -111.53 28.42 8.76 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 122.072 -0.393 . . . . 0.0 110.944 167.377 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -113.32 -95.39 2.16 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 109.105 -1.598 . . . . 0.0 109.105 173.234 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 76.0 m-70 -149.45 172.05 15.59 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 122.106 -0.643 . . . . 0.0 109.546 175.705 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 79.4 m -93.09 139.12 30.89 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 167.651 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 19.4 p90 -128.72 151.19 49.82 Favored 'General case' 0 N--CA 1.499 2.019 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.745 -178.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -151.25 141.83 22.63 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 173.641 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.42 HD12 HD12 ' A' ' 99' ' ' ILE . 18.1 tt -141.84 149.11 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 CA-C-O 120.979 0.419 . . . . 0.0 110.488 -170.153 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.875 HD12 HD21 ' A' ' 73' ' ' LEU . 15.9 tt -136.07 145.07 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 177.397 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -150.15 139.23 21.11 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 122.118 -0.364 . . . . 0.0 110.084 -169.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.2 tm-20 -101.8 116.18 32.15 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 51.2 p30 -85.74 175.25 8.81 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 122.097 -0.377 . . . . 0.0 110.494 -175.568 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -60.13 -17.48 40.68 Favored 'General case' 0 N--CA 1.507 2.415 0 O-C-N 121.976 -0.452 . . . . 0.0 112.006 -174.379 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -92.13 -11.07 36.65 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.607 -0.683 . . . . 0.0 111.9 178.076 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.18 21.09 36.51 Favored Glycine 0 N--CA 1.497 2.731 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 177.475 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -96.28 139.06 32.96 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-N 118.373 1.086 . . . . 0.0 109.799 171.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.8 p -94.87 124.53 38.96 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 122.141 -0.349 . . . . 0.0 110.335 176.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.2 p -97.99 114.49 26.64 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 122.138 -0.351 . . . . 0.0 110.366 178.285 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.875 HD21 HD12 ' A' ' 63' ' ' ILE . 24.8 mt -97.4 126.6 42.74 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 122.173 -0.329 . . . . 0.0 110.275 178.011 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -146.7 144.77 29.68 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 122.021 -0.424 . . . . 0.0 110.627 176.325 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 86.4 p -143.81 167.03 23.26 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 175.599 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 174.2 -164.24 35.35 Favored Glycine 0 N--CA 1.497 2.734 0 N-CA-C 110.33 -1.108 . . . . 0.0 110.33 179.387 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 4.5 m -95.95 133.14 40.5 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 122.316 -0.52 . . . . 0.0 110.302 -175.624 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 49.1 ttm -99.51 121.66 41.48 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 174.329 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 33.4 pttt -69.85 163.36 26.05 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 122.032 -0.417 . . . . 0.0 110.518 -178.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -65.95 126.36 28.3 Favored 'General case' 0 N--CA 1.502 2.173 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.329 176.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -127.29 26.52 6.01 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 122.032 -0.418 . . . . 0.0 111.176 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 98.78 -37.42 3.5 Favored Glycine 0 N--CA 1.496 2.663 0 N-CA-C 110.086 -1.206 . . . . 0.0 110.086 178.602 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 15.7 m -73.14 126.31 29.73 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 122.1 -0.647 . . . . 0.0 110.245 -175.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -76.6 -42.95 40.64 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 174.68 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -155.78 30.85 0.36 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 122.116 -0.365 . . . . 0.0 110.435 175.309 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -78.33 84.11 4.53 Favored 'General case' 0 N--CA 1.5 2.072 0 CA-C-O 121.22 0.533 . . . . 0.0 110.059 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 31.7 t -109.13 45.41 1.05 Allowed 'General case' 0 N--CA 1.497 1.89 0 CA-C-O 121.169 0.509 . . . . 0.0 109.985 179.074 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -80.3 166.31 21.47 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.851 -0.53 . . . . 0.0 110.376 -178.219 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -120.91 142.94 49.24 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 175.511 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 8.4 p -75.48 141.36 73.02 Favored Pre-proline 0 N--CA 1.501 2.125 0 C-N-CA 120.577 -0.449 . . . . 0.0 109.94 -178.377 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -83.78 56.78 5.31 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 O-C-N 123.176 1.093 . . . . 0.0 111.452 -179.33 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 63.6 tttt -155.74 35.76 0.36 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.645 -0.66 . . . . 0.0 110.196 174.238 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -82.71 117.82 22.91 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 122.097 -0.377 . . . . 0.0 110.252 179.522 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 43.1 tt0 -110.45 49.84 0.83 Allowed 'General case' 0 N--CA 1.498 1.97 0 CA-C-O 121.284 0.564 . . . . 0.0 110.428 -178.377 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 21.4 tp -155.29 154.55 32.28 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.829 -0.544 . . . . 0.0 109.984 179.481 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 75.6 mtt85 -77.55 116.0 17.77 Favored 'General case' 0 N--CA 1.501 2.084 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 174.3 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 48.8 ttp180 -161.33 146.97 14.04 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 120.976 0.417 . . . . 0.0 110.386 -172.69 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 14.4 m -134.24 149.01 50.94 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 170.145 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.42 HD12 HD12 ' A' ' 62' ' ' ILE . 18.2 tt -143.24 156.14 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.982 -0.448 . . . . 0.0 110.022 -179.004 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -143.7 146.45 33.2 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 120.959 0.409 . . . . 0.0 110.39 -179.206 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 25.3 p -143.09 141.41 31.24 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 -179.126 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 17.9 p -157.59 135.54 10.82 Favored 'General case' 0 N--CA 1.502 2.152 0 C-N-CA 120.514 -0.475 . . . . 0.0 111.044 -171.147 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 58.5 ttt180 -107.4 51.42 0.74 Allowed 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.364 0.602 . . . . 0.0 110.569 -175.722 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 23.6 p -143.23 151.67 40.85 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.778 -0.576 . . . . 0.0 109.861 175.322 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 15.9 p30 -61.72 132.3 52.75 Favored 'General case' 0 N--CA 1.506 2.355 0 CA-C-O 121.42 0.628 . . . . 0.0 111.772 -163.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.44 HD22 ' OE1' ' A' ' 109' ' ' GLN . 73.9 mt 52.19 26.93 4.23 Favored 'General case' 0 N--CA 1.507 2.403 0 O-C-N 122.036 -0.415 . . . . 0.0 111.891 179.461 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 26.1 p -63.0 -23.35 67.41 Favored 'General case' 0 N--CA 1.508 2.442 0 O-C-N 121.935 -0.478 . . . . 0.0 111.567 175.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -92.27 -22.81 19.55 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.77 -0.581 . . . . 0.0 111.273 178.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLN . . . . . 0.44 ' OE1' HD22 ' A' ' 106' ' ' LEU . 29.2 tt0 -60.67 -37.85 82.94 Favored 'General case' 0 N--CA 1.508 2.447 0 O-C-N 121.615 -0.678 . . . . 0.0 110.745 -177.491 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -100.03 16.15 24.93 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 122.135 -0.353 . . . . 0.0 111.709 178.036 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 14.8 tp -116.22 111.41 20.14 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.661 -0.649 . . . . 0.0 110.362 -174.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 3.1 tp-100 -96.39 120.73 61.84 Favored Pre-proline 0 N--CA 1.496 1.863 0 CA-C-O 118.848 -0.596 . . . . 0.0 110.04 172.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -70.69 141.84 42.42 Favored 'Trans proline' 0 N--CA 1.491 1.372 0 O-C-N 123.213 1.112 . . . . 0.0 110.168 175.285 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 48.4 p -139.22 150.02 45.04 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 122.135 -0.353 . . . . 0.0 110.138 179.557 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 15.0 mt -71.22 155.15 93.4 Favored Pre-proline 0 N--CA 1.502 2.164 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.016 179.09 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -62.36 150.39 87.37 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 O-C-N 123.356 1.187 . . . . 0.0 110.809 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -67.41 135.34 36.22 Favored 'Trans proline' 0 N--CA 1.492 1.415 0 O-C-N 123.537 1.283 . . . . 0.0 110.506 -176.221 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.424 HG12 ' N ' ' A' ' 119' ' ' VAL . 48.9 t -150.66 165.77 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.823 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.424 ' N ' HG12 ' A' ' 118' ' ' VAL . 60.3 t -89.58 120.55 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -179.171 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 33.7 pt -149.37 47.82 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 CA-C-O 121.195 0.521 . . . . 0.0 109.883 179.03 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 89.72 87.14 1.3 Allowed Glycine 0 N--CA 1.497 2.7 0 N-CA-C 109.416 -1.473 . . . . 0.0 109.416 -177.467 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_exo -58.05 147.08 84.76 Favored 'Trans proline' 0 N--CA 1.501 1.939 0 C-N-CA 121.112 1.208 . . . . 0.0 111.414 -178.619 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -84.84 136.3 33.72 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 122.048 -0.408 . . . . 0.0 110.099 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -72.04 143.83 48.98 Favored 'General case' 0 N--CA 1.501 2.094 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.156 -179.555 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -155.29 96.87 1.85 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 122.118 -0.364 . . . . 0.0 110.12 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 84.81 -174.19 49.65 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 49.8 m -80.76 153.0 28.03 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 122.149 -0.618 . . . . 0.0 110.181 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 75.7 mt -90.29 134.76 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.523 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 54.0 ttt180 . . . . . 0 N--CA 1.496 1.829 0 CA-C-O 118.05 -0.976 . . . . 0.0 110.217 179.91 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.32 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_exo -58.39 120.01 7.63 Favored 'Trans proline' 0 N--CA 1.499 1.828 0 C-N-CA 121.094 1.196 . . . . 0.0 111.461 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -90.35 46.94 1.38 Allowed 'General case' 0 N--CA 1.501 2.083 0 CA-C-O 121.084 0.469 . . . . 0.0 110.94 179.328 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -80.12 61.24 3.9 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.734 -0.604 . . . . 0.0 110.511 -177.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 21.9 m -132.91 112.46 11.9 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.851 -0.53 . . . . 0.0 110.167 -179.216 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 72.8 mt -142.56 118.78 6.85 Favored Pre-proline 0 N--CA 1.497 1.916 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -60.44 143.28 99.46 Favored 'Trans proline' 0 N--CA 1.502 2.013 0 O-C-N 123.072 1.038 . . . . 0.0 111.137 -179.003 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -149.95 46.67 0.93 Allowed 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.159 0.504 . . . . 0.0 110.792 -179.175 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.403 HD23 HG23 ' A' ' 55' ' ' THR . 15.5 tp -161.15 112.14 1.76 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.882 -0.511 . . . . 0.0 110.272 -173.696 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 29.2 ttpt -99.74 134.95 41.88 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 122.171 -0.331 . . . . 0.0 110.257 178.545 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 80.2 m -120.97 140.35 52.0 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 -176.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -82.77 143.16 31.05 Favored 'General case' 0 N--CA 1.501 2.091 0 C-N-CA 120.631 -0.428 . . . . 0.0 109.97 178.028 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 28.1 p -115.68 136.99 52.52 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 122.0 -0.438 . . . . 0.0 110.576 -178.404 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.2 m -122.88 138.75 54.57 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 176.581 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 75.47 -67.35 2.23 Favored Glycine 0 N--CA 1.495 2.626 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 179.619 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -113.14 122.74 48.44 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 122.035 -0.685 . . . . 0.0 110.522 -176.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -138.08 136.53 19.68 Favored Pre-proline 0 N--CA 1.496 1.826 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 174.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -60.55 152.13 70.53 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 O-C-N 123.075 1.039 . . . . 0.0 111.151 -171.409 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -60.26 -27.83 67.56 Favored 'General case' 0 N--CA 1.507 2.415 0 O-C-N 121.996 -0.44 . . . . 0.0 111.356 -173.052 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -92.12 14.26 16.56 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.843 -0.536 . . . . 0.0 111.737 -178.093 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.8 162.05 26.37 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.62 -0.675 . . . . 0.0 110.334 -173.355 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 70.9 mt -124.41 136.71 59.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -176.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 19.7 p30 37.95 43.12 0.5 Allowed 'General case' 0 N--CA 1.513 2.704 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -176.593 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 30.8 m120 55.36 43.41 28.93 Favored 'General case' 0 N--CA 1.508 2.428 0 O-C-N 121.824 -0.547 . . . . 0.0 111.462 -178.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 60.7 p -139.63 161.22 38.05 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.796 -0.565 . . . . 0.0 110.305 171.259 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.5 p -137.49 162.91 32.43 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 120.766 0.317 . . . . 0.0 110.565 178.316 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 77.5 mt -111.63 131.79 62.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -175.1 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.403 HG23 HD23 ' A' ' 36' ' ' LEU . 8.7 t -141.34 153.7 45.27 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.955 -0.465 . . . . 0.0 110.99 -177.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 26.8 p30 -107.57 28.66 7.93 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 122.055 -0.403 . . . . 0.0 110.771 167.643 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -119.15 -96.58 1.7 Allowed Glycine 0 N--CA 1.497 2.717 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 175.07 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 74.7 m80 -150.75 170.79 18.37 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 122.125 -0.633 . . . . 0.0 110.14 178.483 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 72.8 m -94.42 139.36 31.21 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 170.023 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -131.78 153.41 50.14 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.492 -178.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -152.91 136.01 15.62 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 174.082 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.689 HD12 HD12 ' A' ' 99' ' ' ILE . 18.1 tt -133.57 149.05 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 122.06 -0.4 . . . . 0.0 110.42 -168.414 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 13.5 tt -136.62 145.04 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.076 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -150.25 142.78 24.45 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 -172.096 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.4 tm-20 -101.63 117.81 35.65 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 -178.67 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 51.7 p30 -86.84 175.28 8.28 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-O 120.753 0.311 . . . . 0.0 110.551 -175.604 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -60.31 -17.64 44.2 Favored 'General case' 0 N--CA 1.507 2.414 0 O-C-N 121.915 -0.491 . . . . 0.0 112.1 -173.5 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -92.87 -11.0 34.64 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.616 -0.677 . . . . 0.0 111.88 178.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.18 21.06 36.59 Favored Glycine 0 N--CA 1.498 2.827 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 177.723 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -96.82 140.54 31.24 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 118.411 1.106 . . . . 0.0 109.866 170.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 10.9 p -94.86 125.67 39.68 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.304 176.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 17.9 p -97.97 112.92 24.68 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 122.124 -0.36 . . . . 0.0 110.289 177.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.54 ' N ' HD12 ' A' ' 73' ' ' LEU . 6.4 mp -98.77 126.67 44.47 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 122.12 -0.363 . . . . 0.0 110.379 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -146.52 145.63 30.23 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 122.098 -0.376 . . . . 0.0 110.402 176.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 98.1 p -143.64 166.91 23.55 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 178.355 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 177.59 -164.7 33.96 Favored Glycine 0 N--CA 1.497 2.721 0 N-CA-C 110.301 -1.119 . . . . 0.0 110.301 -178.451 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 2.1 m -95.86 131.68 41.93 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 122.187 -0.596 . . . . 0.0 110.244 -174.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 53.8 ttm -98.75 122.7 42.32 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 122.011 -0.431 . . . . 0.0 110.162 175.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 22.2 pttt -65.61 170.34 5.21 Favored 'General case' 0 N--CA 1.503 2.202 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.552 175.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 54.1 p90 -64.89 126.16 27.12 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 122.055 -0.403 . . . . 0.0 110.576 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -120.7 -46.52 2.35 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 122.171 -0.331 . . . . 0.0 110.352 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 149.65 -35.48 1.02 Allowed Glycine 0 N--CA 1.495 2.619 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 -179.155 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 87.3 p -72.93 122.88 22.39 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 122.039 -0.683 . . . . 0.0 110.157 -178.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -78.34 -34.64 48.37 Favored 'General case' 0 N--CA 1.501 2.114 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.389 -178.457 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -155.69 50.85 0.55 Allowed 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.161 0.505 . . . . 0.0 110.058 -179.25 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 60.6 mt-30 -155.5 120.43 4.8 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.89 -0.506 . . . . 0.0 110.218 -176.485 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 4.6 m -110.75 94.02 4.79 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 173.306 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -79.96 164.93 23.11 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.938 -0.476 . . . . 0.0 110.589 -174.369 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -119.44 143.97 47.21 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 174.257 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.4 m -74.5 141.11 76.11 Favored Pre-proline 0 N--CA 1.5 2.058 0 C-N-CA 120.604 -0.439 . . . . 0.0 109.959 -176.732 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -77.63 63.5 7.98 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 O-C-N 123.317 1.167 . . . . 0.0 110.613 179.533 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 15.4 ttmm -155.5 41.1 0.41 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.703 -0.623 . . . . 0.0 109.884 178.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -155.84 140.29 16.79 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 179.156 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -121.44 91.11 3.45 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 122.031 -0.418 . . . . 0.0 110.126 178.416 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 20.6 tp -155.07 154.18 32.04 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.994 -0.441 . . . . 0.0 110.099 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 73.4 mtt85 -91.39 118.63 30.7 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 110.062 -0.348 . . . . 0.0 110.062 177.352 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 30.1 ptt180 -161.36 165.22 29.31 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 122.064 -0.398 . . . . 0.0 110.648 -176.003 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 18.9 m -133.79 149.13 51.41 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 177.669 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.689 HD12 HD12 ' A' ' 62' ' ' ILE . 17.9 tt -143.27 119.73 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 122.017 -0.427 . . . . 0.0 110.078 -178.848 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -105.91 149.87 26.17 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 120.824 0.345 . . . . 0.0 110.595 -179.106 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 90.9 m -143.15 163.16 33.65 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 175.32 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 12.1 p -157.21 150.99 24.4 Favored 'General case' 0 N--CA 1.501 2.106 0 C-N-CA 120.071 -0.652 . . . . 0.0 111.267 176.437 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 59.3 ttt180 -99.68 44.49 1.02 Allowed 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.259 0.552 . . . . 0.0 109.826 166.358 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 34.2 p -144.73 142.7 30.24 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 121.37 0.605 . . . . 0.0 110.6 -175.794 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 17.8 p-10 -70.98 138.87 50.33 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-O 121.449 0.642 . . . . 0.0 111.544 -162.239 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 29.5 mt 51.38 27.92 4.03 Favored 'General case' 0 N--CA 1.505 2.302 0 CA-C-N 116.361 -0.381 . . . . 0.0 112.006 174.269 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 18.3 p -60.11 -32.72 71.25 Favored 'General case' 0 N--CA 1.51 2.541 0 C-N-CA 119.969 -0.693 . . . . 0.0 111.162 174.382 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -81.77 -22.95 36.9 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 122.1 -0.375 . . . . 0.0 111.45 -168.472 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -61.52 -39.32 90.6 Favored 'General case' 0 N--CA 1.508 2.435 0 O-C-N 121.658 -0.651 . . . . 0.0 110.717 -174.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -99.75 16.29 24.08 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 122.072 -0.392 . . . . 0.0 111.628 176.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 18.5 tp -108.73 116.73 32.54 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.613 -0.679 . . . . 0.0 110.224 -174.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -95.84 120.63 62.84 Favored Pre-proline 0 N--CA 1.497 1.885 0 CA-C-O 118.766 -0.635 . . . . 0.0 109.955 172.397 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -70.68 142.26 43.43 Favored 'Trans proline' 0 N--CA 1.491 1.368 0 O-C-N 123.329 1.173 . . . . 0.0 110.289 174.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 49.0 p -139.22 150.09 45.12 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 178.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 44.0 mt -71.22 150.83 94.5 Favored Pre-proline 0 N--CA 1.501 2.111 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.079 179.458 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -67.94 149.9 77.82 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 O-C-N 123.487 1.256 . . . . 0.0 110.338 -178.259 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -68.39 152.33 75.44 Favored 'Trans proline' 0 N--CA 1.491 1.368 0 O-C-N 123.482 1.253 . . . . 0.0 110.267 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.414 HG12 ' N ' ' A' ' 119' ' ' VAL . 43.1 t -79.4 165.37 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.414 ' N ' HG12 ' A' ' 118' ' ' VAL . 14.6 p -87.12 138.43 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 122.031 -0.418 . . . . 0.0 110.429 -178.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 17.9 tt -152.08 128.13 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 122.143 -0.348 . . . . 0.0 110.154 179.086 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -97.1 157.47 21.05 Favored Glycine 0 N--CA 1.496 2.638 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.07 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_exo -58.7 99.69 0.11 Allowed 'Trans proline' 0 N--CA 1.5 1.908 0 C-N-CA 121.057 1.172 . . . . 0.0 111.444 178.793 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -155.12 153.49 30.9 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 122.146 -0.346 . . . . 0.0 110.118 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -155.9 125.14 6.19 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.483 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -82.69 -39.59 21.79 Favored 'General case' 0 N--CA 1.5 2.032 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.146 -178.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 74.8 37.72 44.13 Favored Glycine 0 N--CA 1.495 2.607 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 87.4 p -80.21 159.31 25.99 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 122.099 -0.648 . . . . 0.0 110.211 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 50.6 mm -90.37 136.8 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 39.2 ttm180 . . . . . 0 N--CA 1.496 1.853 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.234 -179.891 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.25 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_exo -58.32 117.6 4.34 Favored 'Trans proline' 0 N--CA 1.502 1.985 0 O-C-N 123.319 1.168 . . . . 0.0 111.403 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -155.41 79.12 1.03 Allowed 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 -177.2 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -78.65 87.93 4.57 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.925 -0.485 . . . . 0.0 110.007 179.048 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.585 HG22 ' HB2' ' A' ' 56' ' ' ASN . 17.8 m -137.87 117.06 12.62 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.974 -0.454 . . . . 0.0 110.048 177.38 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 20.4 mt -78.43 151.04 77.44 Favored Pre-proline 0 N--CA 1.502 2.142 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.097 -177.687 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -64.47 126.26 16.58 Favored 'Trans proline' 0 N--CA 1.497 1.732 0 O-C-N 123.342 1.18 . . . . 0.0 111.14 168.406 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -158.1 52.24 0.44 Allowed 'General case' 0 N--CA 1.501 2.092 0 CA-C-O 121.434 0.635 . . . . 0.0 110.283 164.021 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.403 HD23 HG23 ' A' ' 55' ' ' THR . 20.7 tp -158.56 115.22 2.77 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.65 -0.656 . . . . 0.0 110.185 -177.644 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 49.8 tttt -99.82 133.59 43.96 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 122.162 -0.336 . . . . 0.0 110.236 179.483 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 77.6 m -121.01 140.44 51.92 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 -178.127 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -82.23 142.95 31.71 Favored 'General case' 0 N--CA 1.502 2.125 0 C-N-CA 120.581 -0.448 . . . . 0.0 109.958 176.466 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 27.8 p -115.82 136.99 52.52 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 122.016 -0.428 . . . . 0.0 110.561 -177.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 28.2 t -123.07 134.73 54.24 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 178.201 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.35 -66.33 2.95 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.008 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -111.54 118.42 35.67 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 122.098 -0.648 . . . . 0.0 110.548 -176.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -138.01 135.95 19.2 Favored Pre-proline 0 N--CA 1.495 1.809 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 174.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -61.75 153.84 64.82 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 O-C-N 123.237 1.125 . . . . 0.0 111.105 -170.512 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -60.2 -27.67 67.36 Favored 'General case' 0 N--CA 1.508 2.465 0 O-C-N 122.01 -0.431 . . . . 0.0 111.44 -173.519 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -92.22 14.27 16.73 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.964 -0.46 . . . . 0.0 111.737 -177.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.03 162.07 27.0 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.687 -0.633 . . . . 0.0 110.182 -174.018 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 70.3 mt -124.1 136.14 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -175.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 19.4 p30 37.62 43.36 0.44 Allowed 'General case' 0 N--CA 1.515 2.788 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 -176.092 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 30.6 t30 56.29 43.07 27.04 Favored 'General case' 0 N--CA 1.507 2.379 0 O-C-N 121.706 -0.621 . . . . 0.0 111.413 -179.608 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 51.0 p -140.69 163.97 31.45 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.78 -0.575 . . . . 0.0 110.363 171.462 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.7 p -139.05 164.97 28.37 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 120.955 0.407 . . . . 0.0 110.549 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 77.5 mt -112.62 133.03 59.71 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -175.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.403 HG23 HD23 ' A' ' 36' ' ' LEU . 8.8 t -140.67 152.62 45.51 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 122.022 -0.424 . . . . 0.0 111.163 -178.786 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.585 ' HB2' HG22 ' A' ' 32' ' ' THR . 8.9 p-10 -108.78 30.04 6.88 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 122.022 -0.424 . . . . 0.0 110.659 167.522 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -122.35 -94.81 1.25 Allowed Glycine 0 N--CA 1.496 2.657 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 176.533 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 27.5 m80 -147.73 171.95 14.86 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 122.042 -0.681 . . . . 0.0 109.429 176.396 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 78.6 m -93.85 139.0 31.4 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 166.144 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -129.81 152.27 49.48 Favored 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 120.306 -0.558 . . . . 0.0 110.7 -177.606 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -150.89 145.4 25.62 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 176.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.487 HD12 HD12 ' A' ' 99' ' ' ILE . 18.1 tt -142.07 149.25 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 CA-C-O 120.998 0.428 . . . . 0.0 110.357 -172.502 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.813 HD12 HD21 ' A' ' 73' ' ' LEU . 16.7 tt -136.54 145.19 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 178.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -149.48 138.44 21.19 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 -170.467 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.3 tm-20 -101.69 116.52 32.91 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 -179.626 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 24.1 p-10 -86.95 175.34 8.2 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 122.12 -0.363 . . . . 0.0 110.608 -176.224 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -60.37 -17.27 42.4 Favored 'General case' 0 N--CA 1.508 2.433 0 O-C-N 121.946 -0.471 . . . . 0.0 112.008 -173.05 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -91.88 -11.41 36.45 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.647 -0.658 . . . . 0.0 111.787 178.148 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.02 21.03 37.13 Favored Glycine 0 N--CA 1.497 2.754 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 176.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -96.66 141.13 30.28 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 118.263 1.031 . . . . 0.0 109.838 171.13 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.5 p -94.86 126.63 40.32 Favored 'General case' 0 N--CA 1.499 2.009 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.196 176.718 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.5 p -98.01 114.51 26.68 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 122.134 -0.354 . . . . 0.0 110.267 177.648 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.813 HD21 HD12 ' A' ' 63' ' ' ILE . 70.7 mt -97.09 127.81 43.42 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 122.149 -0.345 . . . . 0.0 110.297 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -144.68 144.98 31.51 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 122.089 -0.382 . . . . 0.0 110.572 176.206 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 99.8 p -143.67 166.48 24.74 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 176.495 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 179.47 -166.27 35.51 Favored Glycine 0 N--CA 1.497 2.731 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 2.2 m -97.24 133.0 42.44 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 122.319 -0.518 . . . . 0.0 110.263 -175.644 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 47.1 ttm -105.05 121.68 44.3 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 122.135 -0.353 . . . . 0.0 110.146 173.557 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 12.1 pttt -68.58 156.4 38.14 Favored 'General case' 0 N--CA 1.501 2.085 0 C-N-CA 120.514 -0.474 . . . . 0.0 110.262 174.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 35.2 t80 -68.58 139.71 55.56 Favored 'General case' 0 N--CA 1.501 2.078 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.24 -178.214 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -154.1 -65.8 0.14 Allowed 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 177.615 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -145.24 101.79 0.25 Allowed Glycine 0 N--CA 1.496 2.681 0 N-CA-C 108.013 -2.035 . . . . 0.0 108.013 178.676 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 16.1 m -82.49 -7.2 59.64 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.965 -0.727 . . . . 0.0 110.312 -179.46 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -81.56 -30.69 32.96 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.561 -0.712 . . . . 0.0 110.95 -174.569 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -155.55 79.52 1.02 Allowed 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 121.337 0.589 . . . . 0.0 110.305 -179.492 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -155.28 48.75 0.54 Allowed 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.329 0.585 . . . . 0.0 109.707 178.375 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 34.0 t -155.09 50.7 0.59 Allowed 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 121.223 0.535 . . . . 0.0 110.097 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.9 mmtp -154.98 -170.41 3.49 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -174.237 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -129.67 143.29 50.75 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 122.127 -0.358 . . . . 0.0 110.235 178.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.7 t -78.49 144.07 65.0 Favored Pre-proline 0 N--CA 1.499 1.982 0 CA-C-O 119.208 -0.425 . . . . 0.0 110.006 179.451 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -78.69 61.12 7.91 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 O-C-N 123.24 1.126 . . . . 0.0 110.598 175.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 50.4 tttm -155.5 44.94 0.47 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.795 -0.566 . . . . 0.0 109.928 -178.158 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -155.56 139.35 16.17 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.971 -0.456 . . . . 0.0 110.019 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -99.51 61.79 1.19 Allowed 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.363 0.601 . . . . 0.0 110.081 -177.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 19.6 tp -144.87 149.21 34.96 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.703 -0.623 . . . . 0.0 110.261 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 -104.89 123.47 47.79 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 122.086 -0.384 . . . . 0.0 110.104 179.623 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 27.7 ptt180 -161.57 165.15 28.89 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 122.007 -0.433 . . . . 0.0 110.803 -179.121 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.421 ' O ' HG22 ' A' ' 63' ' ' ILE . 19.1 m -133.66 149.43 51.56 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.487 HD12 HD12 ' A' ' 62' ' ' ILE . 18.3 tt -143.03 155.96 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.964 -0.46 . . . . 0.0 110.21 -177.299 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 52.1 mm-40 -143.65 152.01 40.82 Favored 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 120.901 -0.32 . . . . 0.0 110.613 -176.422 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 26.7 p -143.12 144.47 32.24 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 178.465 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 20.1 p -157.7 133.85 9.48 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.991 -0.443 . . . . 0.0 110.792 -175.229 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 31.6 ttp180 -106.25 47.21 0.89 Allowed 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.26 0.552 . . . . 0.0 110.659 -173.371 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.1 p -139.36 152.14 46.92 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.95 -0.469 . . . . 0.0 109.829 176.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 17.5 p-10 -61.35 131.94 51.93 Favored 'General case' 0 N--CA 1.506 2.344 0 CA-C-O 121.373 0.606 . . . . 0.0 111.904 -163.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 72.4 mt 52.22 26.38 3.93 Favored 'General case' 0 N--CA 1.506 2.348 0 O-C-N 122.078 -0.389 . . . . 0.0 112.007 179.059 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 26.2 p -62.9 -22.22 66.58 Favored 'General case' 0 N--CA 1.507 2.384 0 O-C-N 121.843 -0.536 . . . . 0.0 111.806 176.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -91.71 -22.81 20.02 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.785 -0.572 . . . . 0.0 111.37 179.419 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -60.29 -37.43 80.47 Favored 'General case' 0 N--CA 1.509 2.491 0 O-C-N 121.682 -0.637 . . . . 0.0 110.717 -175.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -101.41 16.19 26.43 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 122.116 -0.365 . . . . 0.0 111.649 177.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 15.0 tp -111.67 110.24 20.53 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.532 -0.73 . . . . 0.0 110.384 -174.518 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -97.08 120.76 60.74 Favored Pre-proline 0 N--CA 1.495 1.823 0 CA-C-O 118.94 -0.553 . . . . 0.0 110.063 173.496 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.4 149.32 50.28 Favored 'Trans proline' 0 N--CA 1.489 1.239 0 O-C-N 123.092 1.048 . . . . 0.0 110.274 175.62 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 34.1 p -139.13 137.82 36.45 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 122.144 -0.348 . . . . 0.0 110.238 178.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 41.9 mt -72.53 149.7 91.07 Favored Pre-proline 0 N--CA 1.502 2.156 0 C-N-CA 120.669 -0.413 . . . . 0.0 110.151 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -70.34 156.93 60.76 Favored 'Trans proline' 0 N--CA 1.49 1.32 0 O-C-N 123.491 1.258 . . . . 0.0 110.245 179.037 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -64.17 155.09 67.09 Favored 'Trans proline' 0 N--CA 1.494 1.549 0 O-C-N 123.348 1.183 . . . . 0.0 110.675 177.571 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.423 HG12 ' N ' ' A' ' 119' ' ' VAL . 48.0 t -150.1 165.52 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 -179.672 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.423 ' N ' HG12 ' A' ' 118' ' ' VAL . 11.7 p -152.64 146.89 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 122.05 -0.406 . . . . 0.0 110.04 -179.261 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.574 ' O ' HG23 ' A' ' 120' ' ' ILE . 17.8 tt -154.27 73.19 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 -179.138 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 118.1 -72.06 0.3 Allowed Glycine 0 N--CA 1.496 2.657 0 CA-C-O 119.457 -0.635 . . . . 0.0 112.671 178.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -63.88 148.21 91.88 Favored 'Trans proline' 0 N--CA 1.501 1.939 0 C-N-CA 121.086 1.191 . . . . 0.0 110.06 -179.216 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -84.2 150.41 25.5 Favored 'General case' 0 N--CA 1.499 2.018 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.261 179.734 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -73.29 65.32 0.85 Allowed 'General case' 0 N--CA 1.502 2.159 0 CA-C-O 121.295 0.569 . . . . 0.0 110.058 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -85.04 -35.42 21.9 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.737 -0.602 . . . . 0.0 110.726 -177.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -130.79 64.01 0.62 Allowed Glycine 0 N--CA 1.497 2.748 0 C-N-CA 121.087 -0.578 . . . . 0.0 112.958 -173.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 57.8 m -152.47 153.93 34.51 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 122.002 -0.705 . . . . 0.0 110.462 179.169 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 70.6 mt -87.23 134.13 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 O-C-N 122.039 -0.413 . . . . 0.0 111.102 -178.564 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 71.1 ttt-85 . . . . . 0 N--CA 1.498 1.94 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.243 179.902 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.29 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo -58.47 120.62 8.61 Favored 'Trans proline' 0 N--CA 1.502 1.977 0 C-N-CA 121.063 1.175 . . . . 0.0 111.34 179.12 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -90.45 47.04 1.39 Allowed 'General case' 0 N--CA 1.501 2.109 0 CA-C-O 121.156 0.503 . . . . 0.0 110.906 179.278 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -78.25 72.38 4.78 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.696 -0.628 . . . . 0.0 110.298 -178.2 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.542 HG22 ' HB2' ' A' ' 56' ' ' ASN . 20.0 m -145.34 120.73 10.3 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.841 -0.537 . . . . 0.0 110.096 179.666 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 21.6 mt -77.45 150.93 80.24 Favored Pre-proline 0 N--CA 1.501 2.091 0 CA-C-O 119.366 -0.35 . . . . 0.0 110.148 -178.934 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -63.99 122.95 11.15 Favored 'Trans proline' 0 N--CA 1.497 1.699 0 O-C-N 123.298 1.157 . . . . 0.0 111.193 168.961 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -157.82 52.53 0.45 Allowed 'General case' 0 N--CA 1.501 2.098 0 CA-C-O 121.363 0.601 . . . . 0.0 110.26 165.082 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.435 HD23 HG23 ' A' ' 55' ' ' THR . 21.1 tp -158.35 114.89 2.79 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.77 -0.581 . . . . 0.0 110.111 -177.858 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 27.9 ttmt -99.74 131.77 45.51 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 122.11 -0.368 . . . . 0.0 110.314 178.989 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 70.0 m -118.25 140.33 49.96 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -178.852 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -82.62 145.83 29.47 Favored 'General case' 0 N--CA 1.501 2.092 0 C-N-CA 120.624 -0.43 . . . . 0.0 109.984 176.255 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 28.0 p -115.15 137.07 52.43 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 122.007 -0.433 . . . . 0.0 110.599 -177.864 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 99.2 p -123.01 144.0 49.56 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 176.598 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.36 -68.22 1.46 Allowed Glycine 0 N--CA 1.495 2.587 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 -179.789 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -116.84 129.59 56.18 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.939 -0.742 . . . . 0.0 110.518 -177.042 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -138.07 136.86 20.02 Favored Pre-proline 0 N--CA 1.496 1.838 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 174.689 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -60.21 151.53 72.7 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 O-C-N 123.078 1.041 . . . . 0.0 111.231 -172.191 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -60.1 -28.21 67.66 Favored 'General case' 0 N--CA 1.507 2.407 0 O-C-N 121.98 -0.45 . . . . 0.0 111.478 -172.595 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -92.11 14.28 16.47 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.981 -0.449 . . . . 0.0 111.794 -177.937 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.85 161.61 26.64 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.674 -0.641 . . . . 0.0 110.277 -173.117 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 75.7 mt -126.08 141.1 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -177.991 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 38.9 41.87 0.58 Allowed 'General case' 0 N--CA 1.512 2.663 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -177.206 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 30.7 m120 54.89 41.55 31.81 Favored 'General case' 0 N--CA 1.508 2.464 0 O-C-N 121.845 -0.535 . . . . 0.0 111.461 -178.955 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 43.7 p -141.65 162.6 35.08 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.82 -0.55 . . . . 0.0 110.376 174.323 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.3 p -139.31 163.49 32.34 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 120.967 0.413 . . . . 0.0 110.555 -179.384 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 77.9 mt -109.43 131.95 58.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -176.189 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.435 HG23 HD23 ' A' ' 36' ' ' LEU . 8.9 t -139.16 152.83 47.73 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.935 -0.478 . . . . 0.0 110.893 179.804 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.542 ' HB2' HG22 ' A' ' 32' ' ' THR . 26.8 p30 -110.04 31.56 5.78 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 122.046 -0.409 . . . . 0.0 110.575 166.91 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -123.29 -94.71 1.16 Allowed Glycine 0 N--CA 1.497 2.718 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 175.642 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 31.9 m-70 -146.35 172.05 14.07 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 122.056 -0.673 . . . . 0.0 109.513 176.668 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 81.0 m -94.36 139.22 31.38 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 165.161 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 21.3 p90 -127.92 146.44 50.64 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 120.35 -0.54 . . . . 0.0 110.431 -179.199 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -147.61 140.2 24.68 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 174.431 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.63 HD12 HD12 ' A' ' 99' ' ' ILE . 18.3 tt -143.09 149.28 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.31 -171.644 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.511 HD12 ' HG ' ' A' ' 73' ' ' LEU . 15.6 tt -137.96 145.26 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 178.09 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -150.2 146.91 27.13 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 122.041 -0.412 . . . . 0.0 110.023 -168.044 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.3 tm-20 -101.69 116.94 33.84 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 122.124 -0.36 . . . . 0.0 110.117 -177.059 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -87.2 175.3 8.12 Favored 'General case' 0 N--CA 1.502 2.148 0 CA-C-O 120.868 0.366 . . . . 0.0 110.536 -175.621 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -60.56 -17.35 45.59 Favored 'General case' 0 N--CA 1.506 2.365 0 O-C-N 121.914 -0.491 . . . . 0.0 112.17 -172.646 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -92.77 -11.6 33.4 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.643 -0.66 . . . . 0.0 111.803 178.172 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.9 20.12 40.87 Favored Glycine 0 N--CA 1.499 2.862 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 177.083 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -97.37 143.88 27.68 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 118.399 1.099 . . . . 0.0 109.806 169.821 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.8 p -94.87 124.99 39.23 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.255 178.014 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 17.8 p -97.94 112.96 24.7 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 120.923 -0.311 . . . . 0.0 110.289 178.223 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.542 ' N ' HD12 ' A' ' 73' ' ' LEU . 6.3 mp -98.24 128.53 44.74 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 122.144 -0.347 . . . . 0.0 110.273 -179.91 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -145.87 145.94 30.92 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.347 177.275 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 86.8 p -143.68 165.85 26.5 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 177.015 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 178.4 -164.53 33.22 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 -179.902 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 3.9 m -97.07 132.51 42.8 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 122.185 -0.597 . . . . 0.0 110.384 -175.53 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 49.1 ttm -99.56 121.88 41.82 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.993 -0.442 . . . . 0.0 110.231 176.662 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.3 ptpp? -67.9 152.4 45.62 Favored 'General case' 0 N--CA 1.503 2.219 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.214 178.135 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -67.48 140.62 57.07 Favored 'General case' 0 N--CA 1.502 2.127 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.454 -176.981 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -153.76 -60.12 0.13 Allowed 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 178.818 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -147.51 69.06 0.37 Allowed Glycine 0 N--CA 1.494 2.536 0 N-CA-C 114.529 0.572 . . . . 0.0 114.529 174.068 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 54.7 m -66.27 8.52 0.22 Allowed 'General case' 0 N--CA 1.504 2.232 0 N-CA-C 117.98 2.585 . . . . 0.0 117.98 -168.778 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -74.63 -47.81 29.94 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.489 -0.757 . . . . 0.0 110.129 -175.047 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -156.0 26.44 0.37 Allowed 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 120.654 -0.418 . . . . 0.0 111.524 -175.133 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 62.7 mm-40 -83.23 60.47 5.57 Favored 'General case' 0 N--CA 1.504 2.271 0 CA-C-O 121.353 0.597 . . . . 0.0 111.155 -175.969 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 5.2 t -155.34 24.49 0.41 Allowed 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.46 -0.775 . . . . 0.0 110.929 168.974 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 69.7 mttt -86.84 -171.21 3.41 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.743 -0.598 . . . . 0.0 110.545 -176.504 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -110.44 117.62 34.08 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 122.115 -0.366 . . . . 0.0 110.284 177.904 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 7.0 m -80.02 167.65 31.9 Favored Pre-proline 0 N--CA 1.498 1.964 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.946 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -84.85 52.66 3.5 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 O-C-N 123.296 1.156 . . . . 0.0 111.338 175.201 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 54.0 tttm -155.84 45.66 0.46 Allowed 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.625 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.47 160.27 33.02 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.835 -0.541 . . . . 0.0 111.111 -157.956 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -98.96 -168.91 1.69 Allowed 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -177.42 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.8 tp -64.17 168.59 5.3 Favored 'General case' 0 N--CA 1.508 2.444 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -179.955 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 85.2 mtt180 -68.13 128.52 36.83 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.53 -0.732 . . . . 0.0 110.303 -160.696 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 27.7 ptt180 -161.47 165.19 29.07 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 120.843 0.354 . . . . 0.0 110.401 -170.682 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 18.1 m -131.03 149.04 52.8 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 174.841 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.63 HD12 HD12 ' A' ' 62' ' ' ILE . 18.5 tt -143.13 154.97 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.991 -0.443 . . . . 0.0 110.051 -178.586 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -143.92 125.9 15.36 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 120.842 0.353 . . . . 0.0 110.699 -179.572 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 92.8 m -104.9 147.55 27.64 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 168.63 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 22.9 p -157.76 135.19 10.37 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.858 -0.526 . . . . 0.0 111.031 176.22 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 9.4 ttm180 -108.2 47.04 0.92 Allowed 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 121.29 0.567 . . . . 0.0 110.788 -173.315 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.3 p -141.87 151.93 43.16 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.771 -0.581 . . . . 0.0 110.033 177.713 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 17.5 p-10 -61.69 132.43 53.21 Favored 'General case' 0 N--CA 1.505 2.287 0 CA-C-O 121.339 0.59 . . . . 0.0 111.821 -164.243 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.475 HD22 ' OE1' ' A' ' 109' ' ' GLN . 75.7 mt 52.0 27.13 4.18 Favored 'General case' 0 N--CA 1.506 2.365 0 O-C-N 122.051 -0.406 . . . . 0.0 111.995 179.547 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 25.3 p -62.62 -22.8 66.68 Favored 'General case' 0 N--CA 1.507 2.42 0 O-C-N 121.847 -0.533 . . . . 0.0 111.585 175.419 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -92.82 -22.82 19.09 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.682 -0.636 . . . . 0.0 111.224 178.071 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 109' ' ' GLN . . . . . 0.475 ' OE1' HD22 ' A' ' 106' ' ' LEU . 27.7 tt0 -61.63 -38.62 88.35 Favored 'General case' 0 N--CA 1.507 2.381 0 O-C-N 121.57 -0.706 . . . . 0.0 110.671 -177.034 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -100.1 16.19 24.89 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 122.113 -0.367 . . . . 0.0 111.596 178.772 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 18.0 tp -112.68 114.31 26.84 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.625 -0.672 . . . . 0.0 110.361 -175.458 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -96.31 120.83 61.78 Favored Pre-proline 0 N--CA 1.496 1.87 0 CA-C-O 118.927 -0.558 . . . . 0.0 109.944 173.022 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -68.81 144.93 60.97 Favored 'Trans proline' 0 N--CA 1.491 1.353 0 O-C-N 123.17 1.089 . . . . 0.0 110.253 175.33 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 47.6 p -139.18 134.15 32.38 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 122.074 -0.391 . . . . 0.0 110.121 179.624 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 17.2 mt -72.48 155.01 91.58 Favored Pre-proline 0 N--CA 1.5 2.035 0 CA-C-O 119.287 -0.387 . . . . 0.0 110.173 179.664 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_exo -63.42 163.05 25.0 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 O-C-N 123.453 1.239 . . . . 0.0 110.725 175.905 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -62.53 121.95 10.12 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 O-C-N 123.372 1.196 . . . . 0.0 110.954 -176.852 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.444 HG12 ' N ' ' A' ' 119' ' ' VAL . 43.4 t -81.66 167.14 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.196 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -178.674 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.444 ' N ' HG12 ' A' ' 118' ' ' VAL . 11.7 p -87.55 165.28 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 177.566 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 17.7 tt -146.27 138.58 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 -179.139 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 166.64 -59.94 0.23 Allowed Glycine 0 N--CA 1.496 2.675 0 N-CA-C 118.255 2.062 . . . . 0.0 118.255 -179.803 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_exo -87.09 170.29 7.14 Favored 'Trans proline' 0 N--CA 1.502 1.974 0 N-CA-C 104.385 -2.967 . . . . 0.0 104.385 173.523 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -155.21 159.84 40.4 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 122.115 -0.366 . . . . 0.0 110.365 -179.557 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -155.43 154.17 31.49 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 -177.194 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -155.18 33.65 0.38 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 122.141 -0.35 . . . . 0.0 110.313 -178.846 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -139.75 46.27 0.96 Allowed Glycine 0 N--CA 1.496 2.69 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.267 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 50.6 m -80.59 136.15 36.19 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 122.166 -0.608 . . . . 0.0 110.194 179.809 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 50.9 mm -91.53 140.7 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.577 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 71.3 ttt-85 . . . . . 0 N--CA 1.499 1.98 0 CA-C-O 117.979 -1.01 . . . . 0.0 110.136 179.103 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo . . . . . 0 N--CA 1.503 2.075 0 N-CA-C 111.304 -0.306 . . . . 0.40000000000000002 111.304 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -152.89 49.32 0.73 Allowed 'General case' 0 N--CA 1.498 1.948 0 CA-C-O 121.174 0.511 . . . . 0.64000000000000001 110.699 -178.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.443 HD23 HG23 ' A' ' 55' ' ' THR . 23.2 tp -158.82 101.53 1.64 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.811 -0.555 . . . . 0.19 110.601 -176.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -99.97 118.18 35.83 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 110.167 -0.308 . . . . 1.51 110.167 176.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 68.0 m -121.71 140.53 52.2 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 122.025 -0.422 . . . . 0.47999999999999998 110.935 -178.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -78.52 150.54 32.87 Favored 'General case' 0 N--CA 1.501 2.094 0 C-N-CA 120.751 -0.38 . . . . 0.51000000000000001 110.032 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 27.0 p -119.01 140.68 49.62 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 122.044 -0.41 . . . . 0.29999999999999999 110.547 -177.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 30.9 t -123.0 143.14 50.13 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 122.072 -0.392 . . . . 1.6899999999999999 110.155 178.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.63 -69.9 1.43 Allowed Glycine 0 N--CA 1.495 2.606 0 N-CA-C 109.668 -1.373 . . . . 0.77000000000000002 109.668 177.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -115.51 123.83 49.52 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 122.074 -0.662 . . . . 2.8199999999999998 110.544 -176.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -138.11 147.7 57.12 Favored Pre-proline 0 N--CA 1.497 1.879 0 N-CA-C 109.386 -0.598 . . . . 0.47999999999999998 109.386 175.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -63.8 151.62 84.32 Favored 'Trans proline' 0 N--CA 1.492 1.432 0 O-C-N 123.203 1.107 . . . . 0.41999999999999998 110.864 -174.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -59.15 -21.86 60.02 Favored 'General case' 0 N--CA 1.507 2.379 0 O-C-N 121.985 -0.447 . . . . 2.0299999999999998 111.521 177.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -96.7 14.15 25.97 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.776 -0.577 . . . . 1.1399999999999999 111.864 -177.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -83.31 162.1 21.22 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.607 -0.683 . . . . 0.34999999999999998 110.466 -173.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 77.5 mt -125.51 142.39 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 N-CA-C 108.873 -0.788 . . . . 0.45000000000000001 108.873 -178.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 38.44 41.58 0.46 Allowed 'General case' 0 N--CA 1.514 2.735 0 N-CA-C 113.271 0.841 . . . . 1.1100000000000001 113.271 -177.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 54.97 41.01 32.24 Favored 'General case' 0 N--CA 1.508 2.459 0 O-C-N 121.802 -0.561 . . . . 1.6499999999999999 111.489 -179.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 41.6 p -137.68 160.31 39.57 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.877 -0.514 . . . . 0.22 110.373 173.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.3 p -135.75 162.15 33.57 Favored 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 120.957 0.408 . . . . 0.20999999999999999 110.465 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 78.9 mt -129.29 125.91 62.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 108.774 -0.825 . . . . 0.33000000000000002 108.774 -169.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.443 HG23 HD23 ' A' ' 36' ' ' LEU . 9.5 t -140.12 159.21 42.68 Favored 'General case' 0 N--CA 1.5 2.049 0 C-N-CA 120.537 -0.465 . . . . 0.23000000000000001 111.288 -177.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 38.1 p-10 -106.59 28.22 8.06 Favored 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 120.856 -0.338 . . . . 0.81999999999999995 110.505 164.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -117.35 -113.86 2.69 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 109.057 -1.617 . . . . 0.23000000000000001 109.057 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 7.8 m-70 -136.75 157.57 46.44 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 108.996 -0.742 . . . . 1.26 108.996 175.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 96.4 m -99.11 139.43 34.77 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 109.31 -0.626 . . . . 0.25 109.31 176.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -129.35 158.14 39.96 Favored 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 120.604 -0.438 . . . . 0.23000000000000001 110.726 -170.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -151.05 143.39 24.19 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.293 -0.632 . . . . 0.22 109.293 177.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.44 HD12 HD12 ' A' ' 99' ' ' ILE . 18.0 tt -142.44 149.18 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 C-N-CA 120.686 -0.405 . . . . 0.29999999999999999 110.477 -170.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.799 HD12 HD11 ' A' ' 73' ' ' LEU . 16.0 tt -138.76 145.2 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 109.502 -0.555 . . . . 0.34000000000000002 109.502 178.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -150.1 141.08 22.91 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 109.93 -0.396 . . . . 1.1599999999999999 109.93 -170.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.9 tm-20 -101.68 116.29 32.42 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 109.975 -0.379 . . . . 0.35999999999999999 109.975 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -86.73 175.21 8.36 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 122.067 -0.396 . . . . 0.77000000000000002 110.583 -175.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -60.49 -17.29 44.3 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 121.995 -0.441 . . . . 1.5900000000000001 112.184 -172.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -92.49 -11.64 34.1 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.601 -0.687 . . . . 2.0 111.83 177.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.82 21.0 37.88 Favored Glycine 0 N--CA 1.497 2.765 0 N-CA-C 111.109 -0.796 . . . . 0.40000000000000002 111.109 176.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -97.42 142.42 29.3 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 118.417 1.108 . . . . 1.28 109.8 169.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.1 p -94.88 129.58 41.84 Favored 'General case' 0 N--CA 1.497 1.908 0 C-N-CA 120.797 -0.361 . . . . 0.33000000000000002 110.356 177.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 17.7 p -97.91 113.04 24.76 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 122.128 -0.357 . . . . 0.34000000000000002 110.327 177.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.799 HD11 HD12 ' A' ' 63' ' ' ILE . 4.5 mm? -96.77 121.98 39.22 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 110.157 -0.312 . . . . 1.1799999999999999 110.157 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -143.77 148.52 35.73 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 122.098 -0.376 . . . . 0.25 110.486 178.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 96.8 p -143.59 164.15 31.2 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 109.735 -0.469 . . . . 0.17000000000000001 109.735 176.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -172.51 -179.05 43.07 Favored Glycine 0 N--CA 1.496 2.688 0 N-CA-C 110.215 -1.154 . . . . 0.23999999999999999 110.215 -177.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 6.2 m -100.21 133.83 44.03 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 122.203 -0.587 . . . . 0.57999999999999996 110.282 -178.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 27.5 ttm -99.5 126.96 45.54 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 122.003 -0.436 . . . . 0.39000000000000001 110.114 176.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 22.2 pttm . . . . . 0 N--CA 1.503 2.222 0 O-C-N 122.07 -0.394 . . . . 1.6799999999999999 110.485 177.734 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 26.7 ptt-85 . . . . . 0 N--CA 1.498 1.944 0 CA-C-O 120.815 0.341 . . . . 2.21 110.685 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.494 ' OG1' HD23 ' A' ' 115' ' ' LEU . 11.7 m -128.48 149.1 50.73 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 109.676 -0.49 . . . . 0.40000000000000002 109.676 172.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.44 HD12 HD12 ' A' ' 62' ' ' ILE . 18.6 tt -143.17 155.96 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 122.04 -0.412 . . . . 0.44 110.098 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -147.48 155.88 42.32 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 120.978 -0.289 . . . . 1.6299999999999999 110.342 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 26.6 p -142.47 157.42 44.78 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 110.113 -0.329 . . . . 1.3700000000000001 110.113 176.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 24.4 p -157.55 138.13 12.99 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 122.014 -0.429 . . . . 0.40999999999999998 110.825 -168.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 70.3 mtp180 -112.01 44.57 1.38 Allowed 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 121.213 0.53 . . . . 2.4100000000000001 110.554 -177.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.3 p -140.44 153.22 46.21 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.863 -0.523 . . . . 0.27000000000000002 110.276 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 34.7 p-10 -64.51 139.77 58.8 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.817 -0.552 . . . . 1.02 111.233 -170.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 17.0 mt 53.15 25.8 4.51 Favored 'General case' 0 N--CA 1.507 2.381 0 O-C-N 121.936 -0.477 . . . . 0.42999999999999999 112.282 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 28.1 p -67.95 -25.3 65.38 Favored 'General case' 0 N--CA 1.503 2.217 0 C-N-CA 119.869 -0.732 . . . . 0.34999999999999998 111.067 172.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -81.05 -33.28 33.6 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.888 -0.508 . . . . 1.3700000000000001 110.484 179.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 47.0 tt0 -63.35 -41.42 98.84 Favored 'General case' 0 N--CA 1.506 2.328 0 O-C-N 121.968 -0.458 . . . . 1.3300000000000001 110.797 -176.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -102.32 16.21 26.89 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 122.1 -0.375 . . . . 0.64000000000000001 111.9 -174.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 12.4 tp -126.16 108.94 11.8 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.601 -0.687 . . . . 0.31 110.397 -176.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -98.3 120.93 58.43 Favored Pre-proline 0 N--CA 1.496 1.864 0 CA-C-O 118.811 -0.614 . . . . 1.8300000000000001 110.032 173.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -67.91 136.39 38.17 Favored 'Trans proline' 0 N--CA 1.492 1.424 0 O-C-N 123.18 1.095 . . . . 0.5 110.333 176.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 35.0 p -139.25 150.11 45.11 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 122.078 -0.389 . . . . 0.76000000000000001 110.204 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.494 HD23 ' OG1' ' A' ' 98' ' ' THR . 34.8 mt . . . . . 0 N--CA 1.502 2.135 0 C-N-CA 120.692 -0.403 . . . . 0.62 109.961 178.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo . . . . . 0 N--CA 1.498 1.746 0 N-CA-C 111.058 -0.401 . . . . 0.0 111.058 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -157.55 52.86 0.47 Allowed 'General case' 0 N--CA 1.5 2.065 0 CA-C-O 121.358 0.599 . . . . 0.0 110.254 165.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.455 HD23 HG23 ' A' ' 55' ' ' THR . 19.5 tp -158.57 113.98 2.62 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.766 -0.584 . . . . 0.0 109.993 -178.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 51.3 tttt -99.82 131.04 46.05 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 110.116 -0.328 . . . . 0.0 110.116 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 74.8 m -115.58 140.27 49.32 Favored 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 -177.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -85.3 145.07 27.7 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 122.155 -0.341 . . . . 0.0 110.098 176.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 27.8 p -117.64 137.51 52.59 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.983 -0.448 . . . . 0.0 110.562 -178.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 28.8 t -123.04 117.58 25.78 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 122.109 -0.37 . . . . 0.0 110.156 178.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 83.88 -61.74 4.69 Favored Glycine 0 N--CA 1.496 2.655 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -104.47 111.99 24.87 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 122.092 -0.652 . . . . 0.0 110.408 -177.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -138.08 137.38 20.97 Favored Pre-proline 0 N--CA 1.497 1.886 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 177.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -61.36 152.05 75.29 Favored 'Trans proline' 0 N--CA 1.497 1.683 0 O-C-N 123.118 1.062 . . . . 0.0 111.058 -173.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -60.33 -28.17 67.94 Favored 'General case' 0 N--CA 1.507 2.399 0 O-C-N 121.951 -0.468 . . . . 0.0 111.374 -173.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -92.16 14.31 16.5 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.941 -0.474 . . . . 0.0 111.77 -178.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.56 160.82 29.72 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.658 -0.651 . . . . 0.0 110.239 -173.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 70.6 mt -124.24 135.89 62.23 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -178.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 19.5 p30 37.52 43.61 0.44 Allowed 'General case' 0 N--CA 1.513 2.722 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -175.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 55.56 43.82 27.72 Favored 'General case' 0 N--CA 1.508 2.465 0 O-C-N 121.772 -0.58 . . . . 0.0 111.427 -179.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 51.4 p -141.19 161.33 38.14 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.738 -0.602 . . . . 0.0 110.346 171.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.1 p -141.39 164.69 29.54 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-O 120.847 0.356 . . . . 0.0 110.574 178.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 78.2 mt -109.6 132.44 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 -175.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.455 HG23 HD23 ' A' ' 36' ' ' LEU . 8.5 t -139.77 151.43 45.78 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 122.011 -0.431 . . . . 0.0 111.03 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 41.4 p-10 -108.21 30.38 6.45 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 122.097 -0.377 . . . . 0.0 110.636 167.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -124.71 -94.2 1.02 Allowed Glycine 0 N--CA 1.497 2.703 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 176.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 32.1 m80 -146.05 171.72 14.47 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 122.125 -0.632 . . . . 0.0 109.453 177.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 72.8 m -92.41 139.14 30.89 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 163.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -130.5 148.96 52.37 Favored 'General case' 0 N--CA 1.499 2.002 0 C-N-CA 120.404 -0.519 . . . . 0.0 110.54 -176.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -151.68 141.97 22.4 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 177.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.419 HD12 HD12 ' A' ' 99' ' ' ILE . 17.9 tt -142.24 149.19 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 CA-C-O 120.908 0.385 . . . . 0.0 110.248 -173.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.506 HD12 ' HG ' ' A' ' 73' ' ' LEU . 16.5 tt -139.15 145.4 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 -146.26 141.06 26.98 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 -167.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.2 tm-20 -101.57 115.78 31.29 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 122.165 -0.334 . . . . 0.0 110.139 -176.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -86.95 175.18 8.28 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 122.194 -0.316 . . . . 0.0 110.599 -175.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -60.59 -17.13 44.6 Favored 'General case' 0 N--CA 1.506 2.354 0 O-C-N 121.975 -0.453 . . . . 0.0 112.14 -172.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -92.48 -11.91 33.41 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.602 -0.686 . . . . 0.0 111.728 177.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.35 21.09 36.01 Favored Glycine 0 N--CA 1.497 2.715 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 176.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -97.28 141.07 30.84 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 118.379 1.089 . . . . 0.0 109.811 170.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.9 p -94.91 126.75 40.45 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 122.155 -0.341 . . . . 0.0 110.322 177.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 17.9 p -98.02 112.96 24.71 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 122.128 -0.358 . . . . 0.0 110.298 176.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.538 ' N ' HD12 ' A' ' 73' ' ' LEU . 6.4 mp -99.61 131.09 45.84 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 122.195 -0.316 . . . . 0.0 110.489 -179.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -149.34 145.89 27.25 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 122.168 -0.332 . . . . 0.0 110.249 175.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 83.8 p -143.7 166.94 23.47 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 178.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -178.64 -163.63 30.22 Favored Glycine 0 N--CA 1.496 2.687 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 -178.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 2.0 m -96.72 132.4 42.45 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 122.144 -0.621 . . . . 0.0 110.321 -176.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 45.2 ttm -101.58 124.87 47.94 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 122.13 -0.356 . . . . 0.0 110.277 179.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 25.3 pttt . . . . . 0 N--CA 1.503 2.21 0 O-C-N 122.032 -0.417 . . . . 0.0 110.516 177.097 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 3.1 ptt180 . . . . . 0 N--CA 1.494 1.743 0 CA-C-O 120.901 0.381 . . . . 0.0 110.477 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.404 ' O ' HG22 ' A' ' 63' ' ' ILE . 17.5 m -126.69 146.43 50.21 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 169.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.419 HD12 HD12 ' A' ' 62' ' ' ILE . 18.3 tt -143.17 155.98 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.993 -0.442 . . . . 0.0 110.29 -174.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.429 ' HB3' HD21 ' A' ' 111' ' ' LEU . 43.6 mt-10 -146.82 146.88 30.38 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 120.756 0.312 . . . . 0.0 110.239 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 26.4 p -143.11 146.38 33.71 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 177.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 18.2 p -157.55 131.97 8.42 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 122.002 -0.436 . . . . 0.0 110.805 -170.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 20.7 ttm-85 -104.97 48.67 0.83 Allowed 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 121.371 0.605 . . . . 0.0 110.645 -176.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.0 p -137.95 150.94 47.47 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.819 -0.551 . . . . 0.0 109.884 175.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 17.6 p-10 -62.55 132.35 52.15 Favored 'General case' 0 N--CA 1.505 2.286 0 CA-C-O 121.355 0.598 . . . . 0.0 111.674 -163.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 79.1 mt 51.86 27.6 4.39 Favored 'General case' 0 N--CA 1.507 2.409 0 O-C-N 122.061 -0.4 . . . . 0.0 111.937 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 26.1 p -62.7 -23.15 66.99 Favored 'General case' 0 N--CA 1.507 2.403 0 O-C-N 121.847 -0.533 . . . . 0.0 111.6 174.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -75.4 -29.9 59.95 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.855 -0.528 . . . . 0.0 111.01 178.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -62.36 -39.84 94.46 Favored 'General case' 0 N--CA 1.507 2.377 0 O-C-N 121.738 -0.602 . . . . 0.0 110.753 -169.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -100.22 16.2 25.04 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 122.105 -0.372 . . . . 0.0 111.678 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.429 HD21 ' HB3' ' A' ' 100' ' ' GLU . 16.3 tp -111.82 108.98 18.57 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.557 -0.715 . . . . 0.0 110.327 -175.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -97.9 120.87 59.2 Favored Pre-proline 0 N--CA 1.496 1.869 0 CA-C-O 118.858 -0.591 . . . . 0.0 110.14 174.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.413 ' HB2' HG21 ' A' ' 63' ' ' ILE . 37.2 Cg_endo -69.46 141.05 45.36 Favored 'Trans proline' 0 N--CA 1.491 1.342 0 O-C-N 123.202 1.107 . . . . 0.0 110.182 174.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 34.0 p -139.22 135.81 34.34 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 122.118 -0.364 . . . . 0.0 110.218 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 17.3 mt . . . . . 0 N--CA 1.501 2.107 0 CA-C-O 119.306 -0.378 . . . . 0.0 110.068 178.645 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_exo . . . . . 0 N--CA 1.497 1.711 0 N-CA-C 110.998 -0.424 . . . . 0.0 110.998 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -158.17 53.37 0.45 Allowed 'General case' 0 N--CA 1.5 2.028 0 CA-C-O 121.358 0.599 . . . . 0.0 110.159 165.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.403 HD23 HG23 ' A' ' 55' ' ' THR . 21.9 tp -158.05 114.36 2.81 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.696 -0.627 . . . . 0.0 110.032 -179.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.47 ' CE ' HD21 ' A' ' 106' ' ' LEU . 23.4 ttpt -99.71 130.5 45.93 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 122.137 -0.352 . . . . 0.0 110.194 179.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 78.2 m -115.28 140.32 49.21 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -177.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -84.29 142.91 29.89 Favored 'General case' 0 N--CA 1.502 2.141 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 177.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 28.1 p -115.31 137.29 52.2 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 122.127 -0.358 . . . . 0.0 110.642 -176.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 49.5 m -122.95 139.03 54.49 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 122.069 -0.394 . . . . 0.0 110.051 176.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 75.52 -67.17 2.27 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.721 -1.351 . . . . 0.0 109.721 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -114.08 124.12 51.34 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 122.11 -0.641 . . . . 0.0 110.486 -176.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -137.99 136.87 20.16 Favored Pre-proline 0 N--CA 1.497 1.901 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 175.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.44 151.93 71.29 Favored 'Trans proline' 0 N--CA 1.498 1.745 0 O-C-N 123.083 1.044 . . . . 0.0 111.111 -172.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -60.35 -28.55 68.26 Favored 'General case' 0 N--CA 1.507 2.391 0 O-C-N 121.935 -0.478 . . . . 0.0 111.356 -172.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -91.89 14.37 15.82 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.969 -0.457 . . . . 0.0 111.824 -177.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.65 162.04 27.33 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.622 -0.674 . . . . 0.0 110.27 -173.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 71.7 mt -124.59 136.69 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 -178.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 19.8 p30 37.76 43.07 0.45 Allowed 'General case' 0 N--CA 1.514 2.739 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -176.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 55.39 43.6 28.56 Favored 'General case' 0 N--CA 1.508 2.468 0 O-C-N 121.815 -0.553 . . . . 0.0 111.407 -178.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 59.5 p -139.55 160.56 39.58 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.768 -0.582 . . . . 0.0 110.261 171.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.1 p -139.28 163.99 31.01 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 120.787 0.327 . . . . 0.0 110.613 178.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 77.5 mt -108.73 132.17 57.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -175.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.403 HG23 HD23 ' A' ' 36' ' ' LEU . 8.4 t -140.29 151.63 45.24 Favored 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 120.95 0.405 . . . . 0.0 110.976 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 26.7 p30 -108.72 30.35 6.58 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 122.096 -0.377 . . . . 0.0 110.603 167.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -122.83 -93.93 1.16 Allowed Glycine 0 N--CA 1.496 2.653 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 176.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 74.6 m-70 -149.59 172.11 15.56 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 122.052 -0.675 . . . . 0.0 109.463 176.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 75.0 m -92.41 139.06 30.97 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 166.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -130.81 150.7 51.86 Favored 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 120.401 -0.52 . . . . 0.0 110.539 -176.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -152.08 142.51 22.58 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 177.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.489 HD12 HD12 ' A' ' 99' ' ' ILE . 18.0 tt -143.67 149.17 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.354 -173.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.517 HD12 ' HG ' ' A' ' 73' ' ' LEU . 16.1 tt -137.63 145.23 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -148.12 146.65 28.88 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 -167.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.8 tm-20 -101.59 117.77 35.58 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 122.146 -0.346 . . . . 0.0 110.237 -175.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 51.4 p30 -87.28 175.36 8.06 Favored 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 120.909 -0.316 . . . . 0.0 110.628 -175.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -60.34 -18.07 47.46 Favored 'General case' 0 N--CA 1.508 2.453 0 O-C-N 121.988 -0.445 . . . . 0.0 111.915 -173.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 16.1 mm-40 -93.21 -9.48 39.08 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.713 -0.617 . . . . 0.0 111.89 178.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 88.69 21.0 45.17 Favored Glycine 0 N--CA 1.498 2.826 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 177.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -96.9 143.63 27.6 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 118.413 1.107 . . . . 0.0 109.793 169.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.3 p -94.88 125.93 39.87 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.281 177.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 17.9 p -98.04 113.0 24.74 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 122.154 -0.341 . . . . 0.0 110.272 177.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.541 ' N ' HD12 ' A' ' 73' ' ' LEU . 6.4 mp -97.8 128.54 44.51 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 122.181 -0.324 . . . . 0.0 110.407 -178.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -145.34 145.78 31.34 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 122.183 -0.323 . . . . 0.0 110.348 176.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 97.1 p -143.6 166.96 23.39 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 178.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 179.95 -164.0 31.53 Favored Glycine 0 N--CA 1.496 2.681 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 -178.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 1.8 m -96.71 132.52 42.31 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 122.248 -0.56 . . . . 0.0 110.356 -175.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 47.4 ttm -102.56 122.0 43.51 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 122.038 -0.414 . . . . 0.0 110.159 177.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 27.7 pttt . . . . . 0 N--CA 1.503 2.195 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.407 177.184 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 28.5 ptt180 . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 120.872 0.367 . . . . 0.0 110.584 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.418 HG21 ' O ' ' A' ' 114' ' ' THR . 17.0 m -125.78 149.0 48.93 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 171.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.489 HD12 HD12 ' A' ' 62' ' ' ILE . 18.3 tt -143.15 154.24 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.156 -176.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -146.85 150.81 36.0 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 120.858 0.361 . . . . 0.0 110.407 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 26.9 p -142.95 149.99 39.11 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 122.06 -0.4 . . . . 0.0 110.091 176.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 19.2 p -157.58 133.43 9.3 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.971 -0.456 . . . . 0.0 110.821 -172.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 61.7 ttp85 -106.35 52.51 0.72 Allowed 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 121.353 0.597 . . . . 0.0 110.536 -176.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.1 p -144.08 151.07 39.12 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.788 -0.57 . . . . 0.0 109.947 175.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 18.2 p-10 -62.39 132.11 51.48 Favored 'General case' 0 N--CA 1.503 2.213 0 CA-C-O 121.418 0.627 . . . . 0.0 111.726 -163.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.47 HD21 ' CE ' ' A' ' 37' ' ' LYS . 79.4 mt 51.75 28.06 4.61 Favored 'General case' 0 N--CA 1.506 2.334 0 O-C-N 121.936 -0.477 . . . . 0.0 111.955 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 25.7 p -62.56 -24.16 67.38 Favored 'General case' 0 N--CA 1.507 2.404 0 O-C-N 121.904 -0.498 . . . . 0.0 111.506 174.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -73.0 -30.33 63.71 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.877 -0.514 . . . . 0.0 110.944 178.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -62.84 -39.29 93.9 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.616 -0.678 . . . . 0.0 110.752 -168.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -100.2 16.24 24.88 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 122.103 -0.373 . . . . 0.0 111.696 -179.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 16.9 tp -112.73 110.35 20.43 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.649 -0.657 . . . . 0.0 110.314 -175.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -96.68 120.83 61.22 Favored Pre-proline 0 N--CA 1.496 1.837 0 CA-C-O 118.922 -0.561 . . . . 0.0 110.096 174.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -72.13 138.16 30.2 Favored 'Trans proline' 0 N--CA 1.492 1.415 0 O-C-N 123.293 1.154 . . . . 0.0 110.307 173.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.418 ' O ' HG21 ' A' ' 98' ' ' THR . 35.5 p -139.18 150.0 45.07 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 122.096 -0.377 . . . . 0.0 110.203 178.022 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 12.9 mt . . . . . 0 N--CA 1.501 2.088 0 CA-C-O 119.215 -0.421 . . . . 0.0 109.984 179.741 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo . . . . . 0 N--CA 1.498 1.791 0 N-CA-C 111.145 -0.367 . . . . 0.0 111.145 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -158.28 53.58 0.44 Allowed 'General case' 0 N--CA 1.5 2.034 0 CA-C-O 121.378 0.609 . . . . 0.0 110.235 164.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 22.7 tp -158.42 114.0 2.66 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.731 -0.606 . . . . 0.0 109.971 -179.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 53.1 tttt -99.74 132.27 45.19 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 122.164 -0.335 . . . . 0.0 110.205 -179.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 80.2 m -117.73 140.23 49.96 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 122.047 -0.408 . . . . 0.0 109.901 -177.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 62.9 t80 -84.35 142.83 29.89 Favored 'General case' 0 N--CA 1.501 2.077 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 175.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 28.1 p -114.84 138.36 50.87 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 122.05 -0.406 . . . . 0.0 110.714 -177.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 99.9 p -123.01 141.19 52.23 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 176.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.37 -68.36 1.46 Allowed Glycine 0 N--CA 1.495 2.629 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 83.6 t60 -113.17 124.78 53.34 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 122.08 -0.659 . . . . 0.0 110.663 -176.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -138.05 136.63 19.82 Favored Pre-proline 0 N--CA 1.497 1.92 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 175.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -60.28 152.17 68.56 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 O-C-N 123.107 1.056 . . . . 0.0 111.114 -171.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -60.15 -28.35 67.84 Favored 'General case' 0 N--CA 1.506 2.355 0 O-C-N 121.938 -0.476 . . . . 0.0 111.436 -172.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -92.02 14.23 16.45 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.857 -0.527 . . . . 0.0 111.754 -177.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.19 162.07 25.99 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.582 -0.699 . . . . 0.0 110.382 -172.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 75.2 mt -125.62 138.51 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 -178.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 38.7 43.29 0.69 Allowed 'General case' 0 N--CA 1.512 2.655 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -178.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 30.7 m120 55.05 42.27 31.07 Favored 'General case' 0 N--CA 1.509 2.488 0 O-C-N 121.759 -0.588 . . . . 0.0 111.453 -178.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 68.3 p -141.22 160.41 40.17 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.767 -0.583 . . . . 0.0 110.343 173.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.1 p -140.91 165.03 28.64 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 120.902 0.382 . . . . 0.0 110.641 179.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 78.0 mt -109.85 132.05 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 -175.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.7 t -138.93 150.87 46.4 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.978 -0.451 . . . . 0.0 110.999 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 50.4 p30 -108.16 31.12 5.79 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 122.114 -0.366 . . . . 0.0 110.593 167.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -124.96 -93.39 0.97 Allowed Glycine 0 N--CA 1.497 2.707 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 176.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 45.0 m-70 -149.69 172.21 15.44 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 122.106 -0.644 . . . . 0.0 109.366 176.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 71.9 m -92.1 139.03 31.04 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 166.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 15.5 p90 -129.16 151.93 49.29 Favored 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 120.372 -0.531 . . . . 0.0 110.643 -176.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -151.18 142.68 23.51 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 176.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.478 HD11 ' NH2' ' A' ' 97' ' ' ARG . 18.3 tt -142.05 149.05 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 CA-C-O 120.864 0.364 . . . . 0.0 110.277 -172.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.53 HD12 ' HG ' ' A' ' 73' ' ' LEU . 15.3 tt -140.8 145.25 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 177.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -150.15 144.34 25.62 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 -170.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.5 tm-20 -101.62 117.88 35.8 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 110.11 -0.329 . . . . 0.0 110.11 -178.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 52.3 p30 -86.69 175.19 8.39 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 122.179 -0.326 . . . . 0.0 110.609 -175.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -60.19 -17.43 41.12 Favored 'General case' 0 N--CA 1.507 2.392 0 O-C-N 121.931 -0.48 . . . . 0.0 112.127 -173.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -92.79 -11.12 34.58 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.601 -0.687 . . . . 0.0 111.868 178.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.55 20.97 35.81 Favored Glycine 0 N--CA 1.498 2.781 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 177.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -96.94 139.91 32.27 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-N 118.324 1.062 . . . . 0.0 109.841 171.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.2 p -94.85 125.25 39.39 Favored 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 120.824 -0.351 . . . . 0.0 110.205 176.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 17.7 p -97.94 112.91 24.66 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 122.167 -0.333 . . . . 0.0 110.305 177.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.533 ' N ' HD12 ' A' ' 73' ' ' LEU . 6.4 mp -99.01 127.65 44.97 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 122.13 -0.356 . . . . 0.0 110.311 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -146.97 146.08 29.97 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 122.084 -0.385 . . . . 0.0 110.36 177.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 90.4 p -143.77 166.71 24.13 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 177.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 178.09 -163.69 32.02 Favored Glycine 0 N--CA 1.499 2.841 0 N-CA-C 110.256 -1.138 . . . . 0.0 110.256 -179.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 2.9 m -96.62 132.4 42.29 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 122.179 -0.601 . . . . 0.0 110.359 -175.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 44.4 ttm -99.46 121.94 41.85 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 122.034 -0.416 . . . . 0.0 110.042 178.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 26.0 pttt . . . . . 0 N--CA 1.503 2.193 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.562 -179.45 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.478 ' NH2' HD11 ' A' ' 62' ' ' ILE . 10.1 ptm180 . . . . . 0 N--CA 1.498 1.961 0 CA-C-O 120.871 0.367 . . . . 0.0 110.592 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 17.0 m -134.0 149.35 51.2 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 177.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.4 tt -142.6 150.95 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 122.023 -0.423 . . . . 0.0 109.873 178.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 48.5 mm-40 -144.64 151.65 39.3 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 120.862 0.363 . . . . 0.0 110.655 -176.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 26.3 p -143.04 150.98 40.3 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 177.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 19.5 p -157.56 134.43 10.04 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 122.016 -0.427 . . . . 0.0 110.852 -175.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 29.4 ttp180 -106.98 47.38 0.88 Allowed 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 121.208 0.528 . . . . 0.0 110.608 -173.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.0 p -142.16 151.39 42.18 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.88 -0.513 . . . . 0.0 109.888 178.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 15.8 p30 -62.78 132.44 52.24 Favored 'General case' 0 N--CA 1.505 2.285 0 CA-C-O 121.466 0.651 . . . . 0.0 111.628 -163.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 78.9 mt 52.14 27.78 4.89 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 122.03 -0.419 . . . . 0.0 111.922 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 25.8 p -62.71 -24.84 67.87 Favored 'General case' 0 N--CA 1.508 2.444 0 O-C-N 121.9 -0.5 . . . . 0.0 111.489 174.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -72.57 -29.59 63.68 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 121.918 -0.489 . . . . 0.0 111.076 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -62.23 -39.71 93.74 Favored 'General case' 0 N--CA 1.505 2.324 0 O-C-N 121.674 -0.641 . . . . 0.0 110.821 -168.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -101.34 16.22 26.28 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 122.066 -0.396 . . . . 0.0 111.763 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 12.9 tp -115.26 108.89 17.16 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.673 -0.642 . . . . 0.0 110.338 -175.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -100.62 120.78 55.03 Favored Pre-proline 0 N--CA 1.496 1.84 0 CA-C-O 118.913 -0.565 . . . . 0.0 110.183 173.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -67.94 140.06 49.14 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 O-C-N 123.153 1.081 . . . . 0.0 110.256 173.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 49.3 p -139.19 149.65 44.65 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 122.118 -0.364 . . . . 0.0 110.087 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 18.9 mt . . . . . 0 N--CA 1.501 2.098 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.056 179.634 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo . . . . . 0 N--CA 1.502 2.0 0 N-CA-C 111.277 -0.317 . . . . 0.0 111.277 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -150.17 47.52 0.91 Allowed 'General case' 0 N--CA 1.499 1.989 0 CA-C-O 121.14 0.495 . . . . 0.0 110.647 -178.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.458 HD23 HG23 ' A' ' 55' ' ' THR . 20.3 tp -160.69 114.38 2.08 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.796 -0.565 . . . . 0.0 110.378 -174.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.448 ' CE ' HD21 ' A' ' 106' ' ' LEU . 30.1 ttpt -99.85 129.91 45.99 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 175.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 75.4 m -112.4 140.36 47.2 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -82.63 141.43 32.52 Favored 'General case' 0 N--CA 1.5 2.031 0 C-N-CA 120.764 -0.374 . . . . 0.0 109.992 175.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 27.8 p -115.38 137.12 52.38 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 122.021 -0.424 . . . . 0.0 110.649 -175.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 48.3 m -123.02 140.49 52.98 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 122.109 -0.37 . . . . 0.0 110.03 177.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 75.52 -67.24 2.26 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 83.8 t60 -115.92 124.33 50.34 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 122.061 -0.67 . . . . 0.0 110.543 -176.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -138.08 135.72 18.87 Favored Pre-proline 0 N--CA 1.497 1.907 0 N-CA-C 109.19 -0.671 . . . . 0.0 109.19 174.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.77 153.23 64.02 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 O-C-N 123.145 1.076 . . . . 0.0 111.193 -169.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -60.34 -28.33 68.07 Favored 'General case' 0 N--CA 1.506 2.335 0 O-C-N 121.918 -0.489 . . . . 0.0 111.43 -173.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -92.3 14.25 16.92 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.934 -0.479 . . . . 0.0 111.714 -178.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.92 161.99 27.95 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.731 -0.606 . . . . 0.0 110.225 -172.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 69.5 mt -124.92 136.97 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -176.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 18.0 p30 37.78 42.91 0.44 Allowed 'General case' 0 N--CA 1.514 2.731 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -175.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 24.0 t30 56.17 42.26 28.4 Favored 'General case' 0 N--CA 1.508 2.469 0 O-C-N 121.795 -0.566 . . . . 0.0 111.439 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 60.7 p -140.4 164.45 30.08 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.73 -0.606 . . . . 0.0 110.36 172.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.1 p -139.07 163.31 32.74 Favored 'General case' 0 N--CA 1.499 2.024 0 CA-C-O 120.889 0.376 . . . . 0.0 110.638 178.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 77.5 mt -110.36 134.35 52.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -175.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.458 HG23 HD23 ' A' ' 36' ' ' LEU . 8.1 t -144.0 153.97 42.79 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.996 -0.44 . . . . 0.0 111.106 179.129 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 39.5 p-10 -107.72 29.73 6.96 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 122.128 -0.357 . . . . 0.0 110.652 167.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -122.17 -100.98 1.63 Allowed Glycine 0 N--CA 1.497 2.702 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 176.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 25.6 m-70 -141.13 171.26 14.31 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 122.091 -0.652 . . . . 0.0 109.562 176.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 70.4 m -91.67 139.09 31.02 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 164.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -129.18 148.27 51.1 Favored 'General case' 0 N--CA 1.498 1.939 0 C-N-CA 120.374 -0.531 . . . . 0.0 110.423 -179.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -151.55 140.33 20.88 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 176.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.52 HD12 HD12 ' A' ' 99' ' ' ILE . 18.2 tt -143.86 149.3 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 CA-C-O 120.969 0.414 . . . . 0.0 110.611 -170.055 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.65 HD12 HD21 ' A' ' 73' ' ' LEU . 14.7 tt -135.02 145.19 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 175.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -148.27 146.38 28.59 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -169.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.7 tm-20 -101.79 117.95 35.93 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 120.793 0.33 . . . . 0.0 110.202 -175.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 26.9 p-10 -87.98 175.36 7.81 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 122.118 -0.364 . . . . 0.0 110.468 -176.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -60.34 -17.21 41.61 Favored 'General case' 0 N--CA 1.507 2.414 0 O-C-N 121.937 -0.477 . . . . 0.0 112.122 -172.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -92.41 -11.49 34.71 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.608 -0.682 . . . . 0.0 111.842 178.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.13 21.2 36.32 Favored Glycine 0 N--CA 1.497 2.743 0 N-CA-C 111.099 -0.801 . . . . 0.0 111.099 176.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -97.79 144.59 27.23 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-N 118.309 1.055 . . . . 0.0 109.872 170.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.9 p -94.92 128.42 41.69 Favored 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.24 176.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 20.1 p -97.82 116.05 29.27 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 122.138 -0.351 . . . . 0.0 110.474 178.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.65 HD21 HD12 ' A' ' 63' ' ' ILE . 15.3 mt -97.41 126.62 42.77 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 122.101 -0.374 . . . . 0.0 110.456 -179.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -150.52 146.16 26.42 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 122.065 -0.397 . . . . 0.0 110.474 175.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 93.7 p -143.7 167.06 23.17 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 175.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -179.23 -167.23 36.36 Favored Glycine 0 N--CA 1.497 2.748 0 N-CA-C 110.244 -1.142 . . . . 0.0 110.244 -178.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 2.2 m -96.6 132.72 41.93 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 122.221 -0.576 . . . . 0.0 110.147 -175.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 43.2 ttm -97.47 121.83 39.82 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 122.026 -0.421 . . . . 0.0 109.982 177.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 26.7 pttt . . . . . 0 N--CA 1.502 2.14 0 O-C-N 122.028 -0.42 . . . . 0.0 110.609 -176.915 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 43.8 ptt85 . . . . . 0 N--CA 1.495 1.786 0 CA-C-O 120.877 0.37 . . . . 0.0 110.41 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 18.4 m -125.81 148.14 49.21 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 172.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.52 HD12 HD12 ' A' ' 62' ' ' ILE . 18.5 tt -143.2 156.08 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 122.048 -0.408 . . . . 0.0 110.186 -177.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.467 ' HB3' HD21 ' A' ' 111' ' ' LEU . 45.3 mt-10 -141.85 147.88 37.91 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 120.879 0.371 . . . . 0.0 110.411 178.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 25.3 p -143.09 136.35 28.2 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 -177.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 22.5 p -157.44 128.82 6.82 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.888 -0.507 . . . . 0.0 111.016 -171.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 52.9 ttt180 -103.73 48.76 0.84 Allowed 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 121.319 0.581 . . . . 0.0 110.481 -178.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 23.9 p -135.66 150.5 49.62 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.919 -0.488 . . . . 0.0 109.739 175.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -62.91 132.13 51.06 Favored 'General case' 0 N--CA 1.504 2.248 0 CA-C-O 121.358 0.599 . . . . 0.0 111.643 -162.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.448 HD21 ' CE ' ' A' ' 37' ' ' LYS . 82.7 mt 51.72 28.0 4.53 Favored 'General case' 0 N--CA 1.507 2.409 0 O-C-N 122.032 -0.418 . . . . 0.0 111.936 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 26.2 p -62.66 -23.01 66.88 Favored 'General case' 0 N--CA 1.507 2.391 0 O-C-N 121.908 -0.495 . . . . 0.0 111.591 174.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -77.39 -29.18 53.06 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.824 -0.547 . . . . 0.0 111.126 177.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -62.04 -40.26 95.13 Favored 'General case' 0 N--CA 1.506 2.357 0 O-C-N 121.69 -0.631 . . . . 0.0 110.879 -168.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -100.04 16.26 24.57 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 122.088 -0.383 . . . . 0.0 111.631 178.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.467 HD21 ' HB3' ' A' ' 100' ' ' GLU . 11.9 tp -115.88 108.9 16.88 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.504 -0.748 . . . . 0.0 110.25 -175.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -98.27 120.79 58.81 Favored Pre-proline 0 N--CA 1.497 1.888 0 CA-C-O 118.96 -0.543 . . . . 0.0 110.102 174.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.7 134.06 19.61 Favored 'Trans proline' 0 N--CA 1.49 1.273 0 O-C-N 123.227 1.119 . . . . 0.0 110.24 172.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 35.1 p -139.31 149.39 44.17 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 122.097 -0.377 . . . . 0.0 110.217 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 15.9 mt . . . . . 0 N--CA 1.501 2.12 0 O-C-N 121.987 -0.445 . . . . 0.0 109.985 177.85 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo . . . . . 0 N--CA 1.497 1.681 0 N-CA-C 110.929 -0.45 . . . . 0.0 110.929 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -156.07 50.99 0.53 Allowed 'General case' 0 N--CA 1.501 2.096 0 CA-C-O 121.305 0.574 . . . . 0.0 110.326 164.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.445 HD23 HG23 ' A' ' 55' ' ' THR . 21.1 tp -158.56 114.57 2.69 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.792 -0.567 . . . . 0.0 110.287 -177.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 29.7 ttmt -99.88 131.72 45.67 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 122.16 -0.338 . . . . 0.0 110.16 177.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 79.7 m -114.74 140.17 49.1 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 -179.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 68.6 t80 -87.49 143.38 27.25 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 122.093 -0.379 . . . . 0.0 110.097 176.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 27.5 p -117.49 137.0 52.84 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 122.089 -0.382 . . . . 0.0 110.58 -175.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 29.3 t -123.01 119.68 31.07 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 122.124 -0.36 . . . . 0.0 110.158 178.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 83.69 -61.96 4.67 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -106.54 112.84 26.01 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 122.109 -0.642 . . . . 0.0 110.519 -177.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -138.04 136.52 19.73 Favored Pre-proline 0 N--CA 1.495 1.803 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 176.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.78 152.78 67.32 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 O-C-N 123.118 1.062 . . . . 0.0 111.186 -171.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -60.55 -28.65 68.6 Favored 'General case' 0 N--CA 1.507 2.419 0 O-C-N 121.932 -0.48 . . . . 0.0 111.34 -172.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -92.21 14.37 16.41 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 122.009 -0.432 . . . . 0.0 111.752 -178.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.4 160.66 30.01 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.671 -0.643 . . . . 0.0 110.361 -172.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 58.7 mt -126.02 140.46 48.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 -178.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 38.74 42.79 0.65 Allowed 'General case' 0 N--CA 1.512 2.655 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -176.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 55.48 41.33 30.98 Favored 'General case' 0 N--CA 1.508 2.453 0 O-C-N 121.789 -0.569 . . . . 0.0 111.401 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 40.1 p -144.09 163.95 32.06 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.804 -0.56 . . . . 0.0 110.647 174.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.3 p -140.63 164.97 28.74 Favored 'General case' 0 N--CA 1.499 1.975 0 CA-C-O 120.882 0.372 . . . . 0.0 110.564 178.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 76.7 mt -112.82 133.62 58.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -175.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.445 HG23 HD23 ' A' ' 36' ' ' LEU . 9.0 t -141.22 153.0 45.04 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 122.054 -0.404 . . . . 0.0 111.083 -178.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -109.77 31.27 5.96 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 122.172 -0.33 . . . . 0.0 110.469 167.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -123.41 -94.11 1.12 Allowed Glycine 0 N--CA 1.497 2.725 0 N-CA-C 109.131 -1.588 . . . . 0.0 109.131 175.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 39.2 m80 -149.81 172.06 15.74 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 122.054 -0.674 . . . . 0.0 109.512 176.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 77.3 m -93.21 139.31 30.75 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 167.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 15.1 p90 -130.46 153.75 48.46 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.833 -0.542 . . . . 0.0 110.599 -176.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -151.52 142.23 22.78 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 177.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 17.8 tt -142.51 149.24 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 CA-C-O 120.888 0.375 . . . . 0.0 110.338 -173.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.529 HD12 ' HG ' ' A' ' 73' ' ' LEU . 16.1 tt -139.87 145.39 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 63.8 mt-10 -146.21 142.82 28.78 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.985 -0.447 . . . . 0.0 109.845 -168.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.3 tm-20 -101.61 116.45 32.78 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 120.793 0.33 . . . . 0.0 110.179 -176.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -87.28 175.19 8.14 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 122.17 -0.331 . . . . 0.0 110.583 -175.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -60.65 -17.11 45.27 Favored 'General case' 0 N--CA 1.506 2.374 0 O-C-N 121.993 -0.442 . . . . 0.0 112.159 -172.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -92.48 -12.01 33.14 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.666 -0.646 . . . . 0.0 111.829 177.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.14 21.01 36.85 Favored Glycine 0 N--CA 1.498 2.785 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 176.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -97.59 142.41 29.44 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 118.395 1.098 . . . . 0.0 109.799 169.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.5 p -94.94 127.25 40.85 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 120.779 -0.369 . . . . 0.0 110.277 178.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.1 p -97.94 112.9 24.66 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 120.906 -0.318 . . . . 0.0 110.348 176.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.536 ' N ' HD12 ' A' ' 73' ' ' LEU . 6.4 mp -98.38 129.79 45.03 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 120.774 0.321 . . . . 0.0 110.452 -178.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -149.58 146.27 27.24 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 122.038 -0.413 . . . . 0.0 110.194 175.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 98.8 p -143.64 167.1 23.06 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 178.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -177.36 -163.99 30.23 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 -177.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 2.1 m -97.21 132.56 42.85 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 122.131 -0.629 . . . . 0.0 110.378 -175.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 55.1 ttm -100.3 124.41 45.73 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 122.068 -0.395 . . . . 0.0 110.231 179.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.3 ptpp? . . . . . 0 N--CA 1.504 2.227 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.348 176.442 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 30.4 ptt180 . . . . . 0 N--CA 1.495 1.777 0 CA-C-O 120.902 0.382 . . . . 0.0 110.381 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.467 HG21 ' O ' ' A' ' 114' ' ' THR . 14.0 m -123.93 149.02 46.38 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 171.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.2 tt -143.1 153.34 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 122.089 -0.382 . . . . 0.0 110.189 -175.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -148.85 150.91 33.81 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-O 120.804 0.335 . . . . 0.0 110.543 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 26.3 p -143.14 155.31 44.54 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 175.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 19.7 p -157.47 136.71 11.86 Favored 'General case' 0 N--CA 1.503 2.205 0 CA-C-O 121.013 0.435 . . . . 0.0 110.738 -172.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 38.7 ttt180 -108.54 50.45 0.78 Allowed 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.413 0.625 . . . . 0.0 110.653 -171.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.0 p -147.4 151.76 37.02 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.69 -0.631 . . . . 0.0 109.888 178.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 17.6 p-10 -62.07 132.71 53.75 Favored 'General case' 0 N--CA 1.505 2.317 0 CA-C-O 121.44 0.638 . . . . 0.0 111.656 -164.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 74.7 mt 52.57 27.14 4.83 Favored 'General case' 0 N--CA 1.506 2.374 0 O-C-N 121.971 -0.455 . . . . 0.0 111.962 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 26.0 p -63.05 -23.39 67.43 Favored 'General case' 0 N--CA 1.508 2.435 0 C-N-CA 120.402 -0.519 . . . . 0.0 111.605 174.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -70.97 -26.51 63.19 Favored 'General case' 0 N--CA 1.505 2.293 0 O-C-N 121.799 -0.563 . . . . 0.0 111.025 177.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 49.0 tp60 -61.15 -43.32 99.07 Favored 'General case' 0 N--CA 1.508 2.442 0 O-C-N 121.647 -0.658 . . . . 0.0 110.617 -174.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -100.46 16.26 25.17 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 122.157 -0.339 . . . . 0.0 111.851 -176.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 16.4 tp -115.48 108.91 17.08 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.53 -0.731 . . . . 0.0 110.336 -176.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -98.6 120.7 58.49 Favored Pre-proline 0 N--CA 1.496 1.832 0 CA-C-O 118.936 -0.554 . . . . 0.0 110.16 174.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -70.54 134.42 26.29 Favored 'Trans proline' 0 N--CA 1.491 1.336 0 O-C-N 123.133 1.07 . . . . 0.0 110.262 175.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.467 ' O ' HG21 ' A' ' 98' ' ' THR . 34.9 p -139.24 150.03 45.02 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 122.137 -0.352 . . . . 0.0 110.2 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 14.9 mt . . . . . 0 N--CA 1.502 2.141 0 CA-C-O 119.208 -0.425 . . . . 0.0 109.955 179.137 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo . . . . . 0 N--CA 1.501 1.961 0 N-CA-C 111.189 -0.35 . . . . 0.0 111.189 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -157.0 48.57 0.44 Allowed 'General case' 0 N--CA 1.499 1.993 0 CA-C-O 121.046 0.451 . . . . 0.0 110.706 173.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 17.5 tp -161.32 114.44 1.92 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.783 -0.573 . . . . 0.0 110.42 -174.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 32.8 tttt -99.92 131.48 45.86 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 177.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 86.0 m -116.76 140.35 49.52 Favored 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -179.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -83.17 142.74 30.98 Favored 'General case' 0 N--CA 1.501 2.097 0 C-N-CA 120.73 -0.388 . . . . 0.0 109.992 175.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 28.1 p -114.66 136.92 52.52 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.849 -0.532 . . . . 0.0 110.561 -178.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.6 m -123.01 138.73 54.61 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 122.099 -0.376 . . . . 0.0 110.116 176.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 75.54 -67.07 2.28 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -113.54 124.54 52.61 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 122.11 -0.641 . . . . 0.0 110.465 -177.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -138.16 136.36 19.4 Favored Pre-proline 0 N--CA 1.496 1.844 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 174.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.36 152.42 67.24 Favored 'Trans proline' 0 N--CA 1.498 1.749 0 O-C-N 123.053 1.028 . . . . 0.0 111.185 -171.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -60.34 -28.11 67.9 Favored 'General case' 0 N--CA 1.507 2.378 0 O-C-N 121.944 -0.472 . . . . 0.0 111.391 -172.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -91.96 14.39 15.87 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.958 -0.464 . . . . 0.0 111.75 -178.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.92 162.07 25.18 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.652 -0.655 . . . . 0.0 110.246 -173.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 76.4 mt -125.53 140.11 49.33 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -177.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 38.72 42.47 0.61 Allowed 'General case' 0 N--CA 1.512 2.629 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -178.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 55.04 42.73 30.69 Favored 'General case' 0 N--CA 1.508 2.461 0 O-C-N 121.768 -0.582 . . . . 0.0 111.432 -178.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 39.9 p -142.75 161.59 37.69 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.785 -0.572 . . . . 0.0 110.622 173.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.5 p -139.53 165.12 28.09 Favored 'General case' 0 N--CA 1.498 1.973 0 CA-C-O 120.97 0.414 . . . . 0.0 110.486 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 75.9 mt -117.01 131.92 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 -173.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.9 t -143.65 155.66 44.31 Favored 'General case' 0 N--CA 1.502 2.143 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.168 -178.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -108.63 30.65 6.29 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 122.081 -0.387 . . . . 0.0 110.524 167.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -118.87 -103.44 2.1 Favored Glycine 0 N--CA 1.497 2.708 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 174.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 23.9 m-70 -139.55 171.93 13.54 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 122.169 -0.606 . . . . 0.0 109.655 176.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 83.2 m -93.92 139.21 31.18 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 165.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -129.59 150.04 51.09 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.591 -177.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.44 ' HB2' ' ND2' ' A' ' 108' ' ' ASN . . . -150.32 143.77 25.1 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 175.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.515 HD12 HD12 ' A' ' 99' ' ' ILE . 18.3 tt -144.18 149.17 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 122.091 -0.381 . . . . 0.0 110.099 -171.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.436 ' O ' HG23 ' A' ' 63' ' ' ILE . 15.6 tt -138.13 118.74 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 CA-C-O 120.877 0.37 . . . . 0.0 110.209 179.052 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 69.2 mt-10 -105.16 145.65 30.29 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 122.107 -0.371 . . . . 0.0 110.505 -178.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.1 tm-20 -101.96 116.49 32.8 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 122.016 -0.427 . . . . 0.0 110.166 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -85.34 175.19 9.04 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 122.008 -0.433 . . . . 0.0 110.56 -175.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -60.75 -17.71 50.43 Favored 'General case' 0 N--CA 1.507 2.41 0 O-C-N 122.019 -0.426 . . . . 0.0 111.989 -173.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -92.87 -10.7 35.72 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.693 -0.629 . . . . 0.0 111.823 178.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 89.65 18.22 52.38 Favored Glycine 0 N--CA 1.498 2.809 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 177.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 69.5 mt-10 -93.98 149.72 20.98 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 118.521 1.161 . . . . 0.0 111.311 168.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.403 ' HB ' ' CG1' ' A' ' 63' ' ' ILE . 4.5 p -94.96 134.97 37.04 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 122.038 -0.414 . . . . 0.0 110.467 177.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.2 p -102.15 110.5 22.48 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 169.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.543 ' N ' HD12 ' A' ' 73' ' ' LEU . 6.4 mp -97.27 132.86 42.6 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 122.177 -0.327 . . . . 0.0 110.587 -175.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -148.07 145.32 28.39 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 122.154 -0.341 . . . . 0.0 110.399 175.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 99.2 p -143.74 166.97 23.4 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 176.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 178.58 -164.44 32.96 Favored Glycine 0 N--CA 1.497 2.742 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 2.6 m -96.41 132.74 41.64 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 122.15 -0.618 . . . . 0.0 110.298 -175.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 55.4 ttm -101.21 122.0 42.85 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 122.068 -0.395 . . . . 0.0 110.117 176.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 26.8 pttt . . . . . 0 N--CA 1.503 2.222 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.339 177.164 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 48.6 ptt85 . . . . . 0 N--CA 1.493 1.721 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.461 HG21 ' O ' ' A' ' 114' ' ' THR . 15.5 m -112.55 149.15 33.12 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 171.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.515 HD12 HD12 ' A' ' 62' ' ' ILE . 18.8 tt -143.25 154.89 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.017 -177.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 66.8 mt-10 -142.99 149.95 38.99 Favored 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.63 -178.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 92.5 m -141.97 138.8 32.18 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 -177.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 20.4 p -157.63 131.41 8.0 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.906 -0.496 . . . . 0.0 110.914 -175.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 51.1 ttt180 -104.61 48.05 0.85 Allowed 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.287 0.565 . . . . 0.0 110.65 -176.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 23.9 p -136.65 151.47 49.34 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.904 -0.497 . . . . 0.0 109.861 175.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 17.6 p-10 -61.88 132.07 51.84 Favored 'General case' 0 N--CA 1.505 2.3 0 CA-C-O 121.429 0.633 . . . . 0.0 111.735 -163.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.464 HD22 ' OE1' ' A' ' 109' ' ' GLN . 75.4 mt 51.98 26.83 3.95 Favored 'General case' 0 N--CA 1.508 2.474 0 O-C-N 122.098 -0.376 . . . . 0.0 111.923 179.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 26.3 p -63.16 -21.91 66.52 Favored 'General case' 0 N--CA 1.507 2.384 0 C-N-CA 120.439 -0.504 . . . . 0.0 111.6 176.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.44 ' ND2' ' HB2' ' A' ' 61' ' ' ALA . 4.6 m120 -90.91 -22.99 20.63 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.737 -0.602 . . . . 0.0 111.282 177.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . 0.464 ' OE1' HD22 ' A' ' 106' ' ' LEU . 27.2 tt0 -61.01 -38.23 85.33 Favored 'General case' 0 N--CA 1.508 2.46 0 O-C-N 121.604 -0.685 . . . . 0.0 110.791 -175.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -100.69 16.32 25.32 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 122.094 -0.379 . . . . 0.0 111.674 177.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 15.7 tp -112.93 112.31 23.69 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.544 -0.723 . . . . 0.0 110.294 -174.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -96.27 120.86 61.8 Favored Pre-proline 0 N--CA 1.498 1.944 0 CA-C-O 118.894 -0.574 . . . . 0.0 109.912 172.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -71.0 143.71 45.55 Favored 'Trans proline' 0 N--CA 1.491 1.338 0 O-C-N 123.129 1.068 . . . . 0.0 110.225 177.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.461 ' O ' HG21 ' A' ' 98' ' ' THR . 35.3 p -139.11 150.05 45.24 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 122.1 -0.375 . . . . 0.0 110.204 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 16.4 mt . . . . . 0 N--CA 1.501 2.124 0 C-N-CA 120.689 -0.405 . . . . 0.0 110.114 -179.754 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo . . . . . 0 N--CA 1.499 1.799 0 N-CA-C 111.16 -0.362 . . . . 0.0 111.16 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -156.67 53.07 0.52 Allowed 'General case' 0 N--CA 1.5 2.06 0 CA-C-O 121.325 0.583 . . . . 0.0 110.3 164.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 20.5 tp -157.61 114.38 2.94 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.804 -0.56 . . . . 0.0 109.967 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 13.0 tttp -99.86 129.08 45.91 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 84.9 m -116.42 140.2 49.61 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -178.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -81.34 146.19 30.47 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 122.033 -0.417 . . . . 0.0 109.891 177.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 27.9 p -115.8 157.77 23.88 Favored 'General case' 0 N--CA 1.502 2.129 0 CA-C-O 120.997 0.427 . . . . 0.0 110.985 -173.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 96.7 p -65.65 162.99 17.23 Favored 'General case' 0 N--CA 1.503 2.196 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 167.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -51.35 -18.14 3.26 Favored Glycine 0 N--CA 1.507 3.397 0 N-CA-C 111.946 -0.462 . . . . 0.0 111.946 -173.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -84.4 111.8 19.77 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.8 -0.824 . . . . 0.0 109.621 163.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -138.32 136.08 18.91 Favored Pre-proline 0 N--CA 1.497 1.901 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -175.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -56.65 153.52 35.6 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 O-C-N 122.978 0.988 . . . . 0.0 111.599 -165.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -60.67 -31.24 70.49 Favored 'General case' 0 N--CA 1.506 2.353 0 O-C-N 121.953 -0.467 . . . . 0.0 111.357 -167.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -91.4 14.17 15.44 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 122.023 -0.423 . . . . 0.0 111.877 -177.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -86.01 162.14 18.63 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.654 -0.654 . . . . 0.0 110.542 -174.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 76.2 mt -122.02 140.53 45.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 -176.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 39.31 42.75 0.84 Allowed 'General case' 0 N--CA 1.513 2.69 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 55.05 41.73 31.53 Favored 'General case' 0 N--CA 1.508 2.438 0 O-C-N 121.844 -0.535 . . . . 0.0 111.455 -179.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 66.8 p -138.84 150.1 45.64 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.776 -0.577 . . . . 0.0 110.279 173.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.8 p -120.65 160.28 23.59 Favored 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 120.963 0.411 . . . . 0.0 110.598 178.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 77.5 mt -108.95 133.23 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -176.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.6 t -140.79 153.9 46.03 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.98 -0.45 . . . . 0.0 111.271 -178.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 26.7 p30 -108.06 30.11 6.68 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 122.178 -0.326 . . . . 0.0 110.528 166.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -122.58 -96.79 1.34 Allowed Glycine 0 N--CA 1.496 2.656 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 177.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 15.9 m80 -148.98 172.07 15.33 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 122.097 -0.649 . . . . 0.0 109.428 178.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 82.3 m -95.84 139.19 32.42 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 168.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 16.5 p90 -132.08 150.83 52.05 Favored 'General case' 0 N--CA 1.499 1.994 0 C-N-CA 120.352 -0.539 . . . . 0.0 110.705 -178.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -152.55 144.66 23.83 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 175.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.529 HD12 HD12 ' A' ' 99' ' ' ILE . 18.3 tt -143.36 149.2 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 C-N-CA 120.741 -0.383 . . . . 0.0 110.492 -171.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.673 HD12 HD21 ' A' ' 73' ' ' LEU . 13.4 tt -136.1 145.09 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 176.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -150.04 145.86 26.64 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -170.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.3 tm-20 -101.62 117.35 34.71 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 122.128 -0.357 . . . . 0.0 110.098 -178.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -87.21 175.31 8.11 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 122.111 -0.368 . . . . 0.0 110.607 -175.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -60.67 -17.61 48.67 Favored 'General case' 0 N--CA 1.507 2.393 0 O-C-N 121.973 -0.454 . . . . 0.0 112.016 -172.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -92.77 -10.81 35.63 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.547 -0.721 . . . . 0.0 111.863 178.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.27 19.71 44.84 Favored Glycine 0 N--CA 1.498 2.769 0 N-CA-C 111.159 -0.776 . . . . 0.0 111.159 176.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -97.22 145.28 26.21 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 118.472 1.136 . . . . 0.0 109.915 169.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.2 p -94.87 129.62 41.79 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 122.127 -0.358 . . . . 0.0 110.24 178.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 19.3 p -97.9 115.6 28.44 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 122.156 -0.34 . . . . 0.0 110.346 178.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.673 HD21 HD12 ' A' ' 63' ' ' ILE . 18.4 mt -97.23 124.97 41.47 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 122.136 -0.352 . . . . 0.0 110.291 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -143.32 143.74 31.81 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 120.842 0.353 . . . . 0.0 110.534 175.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 89.4 p -143.73 166.99 23.33 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 176.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 176.48 -164.32 33.99 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 179.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 2.0 m -98.87 132.49 44.17 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 122.251 -0.558 . . . . 0.0 110.424 -174.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 50.0 ttm -102.52 133.66 47.13 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 122.116 -0.365 . . . . 0.0 110.185 176.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 22.5 pttm . . . . . 0 N--CA 1.503 2.213 0 O-C-N 122.054 -0.404 . . . . 0.0 110.543 178.106 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 46.3 ptt85 . . . . . 0 N--CA 1.496 1.847 0 CA-C-O 120.845 0.355 . . . . 0.0 110.735 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 19.9 m -134.03 149.23 51.17 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 178.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.529 HD12 HD12 ' A' ' 62' ' ' ILE . 18.3 tt -143.07 156.06 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 122.061 -0.399 . . . . 0.0 110.047 -179.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -142.88 146.58 34.22 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 120.825 0.345 . . . . 0.0 110.54 -178.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 26.0 p -143.12 137.67 29.29 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -178.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 20.5 p -157.57 133.74 9.53 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.96 -0.463 . . . . 0.0 110.989 -171.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 62.1 ttt180 -106.65 52.66 0.71 Allowed 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 121.426 0.631 . . . . 0.0 110.451 -176.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.0 p -142.26 151.64 42.27 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.766 -0.583 . . . . 0.0 109.753 174.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -61.28 131.79 51.5 Favored 'General case' 0 N--CA 1.506 2.337 0 CA-C-O 121.427 0.632 . . . . 0.0 111.771 -163.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.473 HD22 ' OE1' ' A' ' 109' ' ' GLN . 74.1 mt 52.08 26.8 4.04 Favored 'General case' 0 N--CA 1.507 2.404 0 O-C-N 122.064 -0.398 . . . . 0.0 111.964 179.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 26.3 p -63.06 -22.06 66.6 Favored 'General case' 0 N--CA 1.506 2.358 0 O-C-N 121.888 -0.507 . . . . 0.0 111.58 176.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -90.07 -22.94 21.58 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.79 -0.569 . . . . 0.0 111.277 176.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . 0.473 ' OE1' HD22 ' A' ' 106' ' ' LEU . 28.5 tt0 -61.14 -38.84 87.82 Favored 'General case' 0 N--CA 1.508 2.438 0 O-C-N 121.595 -0.69 . . . . 0.0 110.768 -175.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -100.06 16.3 24.48 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 122.16 -0.337 . . . . 0.0 111.606 177.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 15.4 tp -112.65 111.81 22.88 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.595 -0.69 . . . . 0.0 110.31 -175.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -96.54 120.8 61.49 Favored Pre-proline 0 N--CA 1.498 1.974 0 CA-C-O 118.904 -0.57 . . . . 0.0 109.922 173.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -71.26 139.03 34.35 Favored 'Trans proline' 0 N--CA 1.49 1.311 0 O-C-N 123.182 1.096 . . . . 0.0 110.164 175.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 50.4 p -139.16 150.06 45.17 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 122.094 -0.379 . . . . 0.0 110.125 178.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 17.4 mt . . . . . 0 N--CA 1.502 2.136 0 CA-C-O 118.975 -0.536 . . . . 0.0 110.012 178.934 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo . . . . . 0 N--CA 1.503 2.049 0 N-CA-C 111.187 -0.351 . . . . 0.0 111.187 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -158.55 49.66 0.37 Allowed 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 121.097 0.475 . . . . 0.0 110.898 172.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.426 HD23 HG23 ' A' ' 55' ' ' THR . 20.2 tp -161.53 114.09 1.84 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.696 -0.627 . . . . 0.0 110.276 -175.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.4 ' HE2' HG21 ' A' ' 52' ' ' THR . 58.0 tttt -99.76 130.39 45.96 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 122.167 -0.333 . . . . 0.0 110.151 177.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 77.4 m -113.86 140.31 48.45 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -179.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -84.75 140.76 31.02 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 175.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 28.2 p -114.16 138.09 50.89 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 122.024 -0.422 . . . . 0.0 110.676 -176.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.4 m -122.94 139.44 54.05 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 122.036 -0.415 . . . . 0.0 109.947 176.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.16 -68.27 1.4 Allowed Glycine 0 N--CA 1.496 2.659 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 63.9 m170 -110.8 123.06 49.35 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 122.163 -0.61 . . . . 0.0 110.602 -176.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -138.08 136.25 19.4 Favored Pre-proline 0 N--CA 1.497 1.881 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 174.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -60.32 152.47 66.68 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 O-C-N 123.062 1.033 . . . . 0.0 111.221 -170.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -60.34 -28.15 67.94 Favored 'General case' 0 N--CA 1.507 2.379 0 O-C-N 121.961 -0.462 . . . . 0.0 111.43 -172.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -92.07 14.25 16.48 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.955 -0.466 . . . . 0.0 111.782 -178.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.89 162.01 26.33 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.631 -0.668 . . . . 0.0 110.308 -172.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 76.7 mt -125.97 139.77 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -177.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 38.6 43.29 0.66 Allowed 'General case' 0 N--CA 1.512 2.64 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -177.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 55.44 42.29 30.12 Favored 'General case' 0 N--CA 1.507 2.418 0 O-C-N 121.811 -0.555 . . . . 0.0 111.467 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.4 HG21 ' HE2' ' A' ' 37' ' ' LYS . 39.2 p -144.38 162.72 35.77 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.76 -0.588 . . . . 0.0 110.658 173.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.3 p -139.77 164.95 28.59 Favored 'General case' 0 N--CA 1.499 1.992 0 CA-C-O 120.787 0.327 . . . . 0.0 110.613 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 77.2 mt -113.74 133.05 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -174.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.426 HG23 HD23 ' A' ' 36' ' ' LEU . 9.1 t -142.5 154.09 44.2 Favored 'General case' 0 N--CA 1.502 2.143 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.059 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 40.1 p-10 -108.37 30.29 6.57 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 122.109 -0.369 . . . . 0.0 110.608 167.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -122.31 -97.78 1.43 Allowed Glycine 0 N--CA 1.497 2.717 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 176.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 31.1 m80 -143.8 170.66 15.46 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 122.136 -0.626 . . . . 0.0 109.473 177.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 71.4 m -91.85 139.14 30.95 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 164.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 15.9 p90 -130.0 148.17 51.83 Favored 'General case' 0 N--CA 1.497 1.9 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.518 -177.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -151.46 141.75 22.37 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 178.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.498 HD12 HD12 ' A' ' 99' ' ' ILE . 18.0 tt -144.17 149.2 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 122.065 -0.397 . . . . 0.0 110.559 -171.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.749 HD12 HD21 ' A' ' 73' ' ' LEU . 16.4 tt -134.26 145.21 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 176.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -147.94 146.18 28.89 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -167.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.4 tm-20 -101.49 116.83 33.66 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 120.864 0.364 . . . . 0.0 110.179 -176.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -87.36 175.24 8.09 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 122.03 -0.419 . . . . 0.0 110.594 -175.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -60.49 -17.51 45.74 Favored 'General case' 0 N--CA 1.506 2.359 0 O-C-N 121.904 -0.498 . . . . 0.0 112.12 -172.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -92.89 -11.35 33.7 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.613 -0.679 . . . . 0.0 111.811 178.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.56 20.13 42.09 Favored Glycine 0 N--CA 1.497 2.751 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 177.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -97.32 145.27 26.28 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 118.49 1.145 . . . . 0.0 109.786 169.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.8 p -94.89 128.8 41.93 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 122.117 -0.364 . . . . 0.0 110.183 178.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 21.4 p -97.98 118.99 35.82 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 122.165 -0.334 . . . . 0.0 110.276 178.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.749 HD21 HD12 ' A' ' 63' ' ' ILE . 23.0 mt -97.61 127.13 43.33 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 122.14 -0.35 . . . . 0.0 110.408 179.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -147.98 144.88 28.29 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 122.039 -0.413 . . . . 0.0 110.481 174.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 78.8 p -143.69 167.01 23.28 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 176.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -178.3 -166.5 34.71 Favored Glycine 0 N--CA 1.497 2.709 0 N-CA-C 110.15 -1.18 . . . . 0.0 110.15 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 2.2 m -96.99 132.85 42.38 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 122.172 -0.605 . . . . 0.0 110.415 -176.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 56.0 ttm -100.66 122.93 44.15 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 122.097 -0.377 . . . . 0.0 110.15 178.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.1 pttm . . . . . 0 N--CA 1.504 2.264 0 O-C-N 122.01 -0.431 . . . . 0.0 110.59 -179.736 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 28.2 ptt-85 . . . . . 0 N--CA 1.494 1.768 0 CA-C-O 120.805 0.336 . . . . 0.0 110.388 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 15.1 m -124.41 147.91 47.95 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 171.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.498 HD12 HD12 ' A' ' 62' ' ' ILE . 18.5 tt -143.18 155.99 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 122.0 -0.437 . . . . 0.0 110.284 -174.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.424 ' HB3' HD21 ' A' ' 111' ' ' LEU . 47.7 mt-10 -144.81 149.84 36.14 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 120.723 0.297 . . . . 0.0 110.388 178.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 26.7 p -143.06 142.06 31.45 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 21.8 p -157.55 129.29 6.97 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 122.011 -0.431 . . . . 0.0 110.802 -171.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 53.0 ttp180 -104.02 48.45 0.85 Allowed 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.329 0.585 . . . . 0.0 110.504 -177.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.1 p -135.5 150.72 49.86 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.905 -0.497 . . . . 0.0 109.798 175.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 17.6 p-10 -62.5 131.93 50.79 Favored 'General case' 0 N--CA 1.504 2.269 0 CA-C-O 121.388 0.613 . . . . 0.0 111.734 -162.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 79.6 mt 51.76 27.84 4.46 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 122.003 -0.436 . . . . 0.0 111.936 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 26.0 p -62.69 -23.26 67.05 Favored 'General case' 0 N--CA 1.506 2.337 0 O-C-N 121.874 -0.516 . . . . 0.0 111.564 174.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -75.5 -29.66 59.58 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.907 -0.495 . . . . 0.0 111.079 177.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -62.16 -39.39 92.49 Favored 'General case' 0 N--CA 1.507 2.399 0 O-C-N 121.764 -0.585 . . . . 0.0 110.826 -169.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -100.3 16.16 25.28 Favored 'General case' 0 N--CA 1.498 1.938 0 C-N-CA 120.936 -0.306 . . . . 0.0 111.688 179.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.424 HD21 ' HB3' ' A' ' 100' ' ' GLU . 12.2 tp -117.99 108.93 15.86 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.511 -0.743 . . . . 0.0 110.296 -176.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -98.7 120.87 57.94 Favored Pre-proline 0 N--CA 1.497 1.896 0 CA-C-O 118.86 -0.59 . . . . 0.0 110.078 174.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -71.15 133.89 23.96 Favored 'Trans proline' 0 N--CA 1.491 1.341 0 O-C-N 123.247 1.13 . . . . 0.0 110.15 172.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 35.0 p -139.16 147.14 41.46 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 122.102 -0.374 . . . . 0.0 110.371 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 27.0 mt . . . . . 0 N--CA 1.502 2.162 0 CA-C-O 119.277 -0.392 . . . . 0.0 110.01 176.607 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo . . . . . 0 N--CA 1.498 1.785 0 N-CA-C 111.208 -0.343 . . . . 0.0 111.208 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -158.32 53.37 0.44 Allowed 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 121.332 0.586 . . . . 0.0 110.264 164.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.404 HD23 HG23 ' A' ' 55' ' ' THR . 19.1 tp -158.41 114.72 2.75 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.803 -0.561 . . . . 0.0 110.032 -179.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.44 ' HE3' HD21 ' A' ' 106' ' ' LEU . 35.4 ttpt -99.74 131.6 45.62 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 122.112 -0.367 . . . . 0.0 110.256 178.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 73.3 m -117.87 140.38 49.8 Favored 'General case' 0 N--CA 1.502 2.155 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 -178.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -82.4 146.2 29.46 Favored 'General case' 0 N--CA 1.501 2.079 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.125 178.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 27.9 p -116.05 136.99 52.52 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 122.021 -0.424 . . . . 0.0 110.54 -178.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 29.1 t -122.29 135.04 54.67 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 122.039 -0.413 . . . . 0.0 110.064 177.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.83 -66.52 2.77 Favored Glycine 0 N--CA 1.496 2.698 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -112.42 124.0 51.52 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 122.077 -0.66 . . . . 0.0 110.57 -177.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -138.03 136.98 20.21 Favored Pre-proline 0 N--CA 1.496 1.875 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 175.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -60.59 151.78 73.26 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 O-C-N 123.171 1.09 . . . . 0.0 111.105 -172.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -60.25 -28.1 67.77 Favored 'General case' 0 N--CA 1.508 2.431 0 O-C-N 121.995 -0.441 . . . . 0.0 111.383 -172.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -92.21 14.29 16.63 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.935 -0.478 . . . . 0.0 111.782 -177.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.4 161.98 26.76 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.708 -0.62 . . . . 0.0 110.232 -172.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 71.4 mt -124.76 137.02 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -177.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 19.9 p30 37.81 43.16 0.47 Allowed 'General case' 0 N--CA 1.514 2.773 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -176.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 30.8 m120 55.32 43.08 29.59 Favored 'General case' 0 N--CA 1.509 2.493 0 O-C-N 121.882 -0.511 . . . . 0.0 111.43 -178.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 71.5 p -139.13 160.87 38.77 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.814 -0.554 . . . . 0.0 110.283 171.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.1 p -137.57 161.27 36.88 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-O 120.973 0.416 . . . . 0.0 110.452 178.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 77.7 mt -107.52 131.63 57.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -175.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.404 HG23 HD23 ' A' ' 36' ' ' LEU . 8.4 t -140.07 151.65 45.55 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 122.04 -0.413 . . . . 0.0 110.972 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 49.9 p30 -107.81 30.57 6.21 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 122.127 -0.358 . . . . 0.0 110.585 167.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -122.86 -95.77 1.25 Allowed Glycine 0 N--CA 1.497 2.733 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 176.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 38.1 m-70 -149.59 172.03 15.68 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 122.108 -0.643 . . . . 0.0 109.556 176.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 82.7 m -94.51 139.2 31.46 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 168.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 19.5 p90 -129.06 151.28 49.92 Favored 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.476 -178.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.416 ' HB2' ' ND2' ' A' ' 108' ' ' ASN . . . -151.21 143.39 24.05 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 175.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.572 HD12 HD12 ' A' ' 99' ' ' ILE . 18.2 tt -144.02 149.33 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 122.109 -0.369 . . . . 0.0 110.276 -172.274 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.522 HD12 ' HG ' ' A' ' 73' ' ' LEU . 16.5 tt -136.46 145.25 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 178.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -147.99 145.88 28.71 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 122.013 -0.429 . . . . 0.0 109.914 -168.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.5 tm-20 -101.61 117.18 34.38 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 120.751 0.31 . . . . 0.0 110.185 -176.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 26.6 p-10 -87.6 175.35 7.95 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 122.123 -0.36 . . . . 0.0 110.563 -176.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -60.47 -17.24 43.6 Favored 'General case' 0 N--CA 1.506 2.368 0 O-C-N 122.007 -0.433 . . . . 0.0 112.082 -172.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -91.89 -11.57 35.99 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.551 -0.718 . . . . 0.0 111.819 178.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.84 20.95 37.98 Favored Glycine 0 N--CA 1.498 2.774 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 176.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -97.58 143.87 27.84 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 118.324 1.062 . . . . 0.0 109.898 170.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.8 p -94.84 124.32 38.82 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.234 176.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.7 p -97.92 113.72 25.62 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 122.093 -0.38 . . . . 0.0 110.336 178.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.542 ' N ' HD12 ' A' ' 73' ' ' LEU . 6.4 mp -97.51 128.35 44.2 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 122.147 -0.346 . . . . 0.0 110.26 -178.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -144.37 147.84 33.93 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 122.099 -0.375 . . . . 0.0 110.349 176.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 87.3 p -143.69 166.18 25.58 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 178.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -179.22 -167.11 36.17 Favored Glycine 0 N--CA 1.496 2.69 0 N-CA-C 110.354 -1.098 . . . . 0.0 110.354 -178.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 2.9 m -96.55 132.25 42.34 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 122.187 -0.596 . . . . 0.0 110.25 -175.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 51.1 ttm -98.53 121.88 41.02 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.946 -0.471 . . . . 0.0 110.087 176.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 26.6 pttt . . . . . 0 N--CA 1.503 2.19 0 O-C-N 122.043 -0.411 . . . . 0.0 110.508 -178.271 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 30.7 ptt180 . . . . . 0 N--CA 1.494 1.736 0 CA-C-O 120.903 0.382 . . . . 0.0 110.557 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 16.6 m -128.69 149.12 50.81 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 172.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.572 HD12 HD12 ' A' ' 62' ' ' ILE . 18.6 tt -143.02 156.0 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 122.023 -0.423 . . . . 0.0 110.165 -176.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -143.8 151.63 40.19 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 120.947 0.403 . . . . 0.0 110.581 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 89.6 m -141.98 141.31 32.89 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 19.9 p -157.56 137.9 12.78 Favored 'General case' 0 N--CA 1.504 2.243 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.137 -174.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 27.8 ttt180 -109.38 45.82 1.04 Allowed 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 121.275 0.56 . . . . 0.0 110.637 -172.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.0 p -141.92 152.08 43.22 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.869 -0.519 . . . . 0.0 109.97 178.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 17.6 p-10 -61.78 132.68 53.92 Favored 'General case' 0 N--CA 1.505 2.281 0 CA-C-O 121.373 0.606 . . . . 0.0 111.793 -164.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.478 HD22 ' OE1' ' A' ' 109' ' ' GLN . 74.4 mt 52.24 26.76 4.18 Favored 'General case' 0 N--CA 1.507 2.416 0 O-C-N 122.048 -0.408 . . . . 0.0 111.966 179.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 25.9 p -63.15 -22.2 66.7 Favored 'General case' 0 N--CA 1.507 2.419 0 O-C-N 121.858 -0.526 . . . . 0.0 111.572 175.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.416 ' ND2' ' HB2' ' A' ' 61' ' ' ALA . 4.9 m120 -91.1 -22.95 20.46 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.723 -0.611 . . . . 0.0 111.304 177.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . 0.478 ' OE1' HD22 ' A' ' 106' ' ' LEU . 28.3 tt0 -60.97 -37.9 84.08 Favored 'General case' 0 N--CA 1.509 2.504 0 O-C-N 121.595 -0.691 . . . . 0.0 110.721 -176.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -100.16 16.22 24.9 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 122.126 -0.359 . . . . 0.0 111.59 177.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 17.4 tp -113.73 112.83 24.1 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.579 -0.701 . . . . 0.0 110.345 -175.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 37.8 tt0 -96.48 120.72 61.72 Favored Pre-proline 0 N--CA 1.496 1.872 0 CA-C-O 118.853 -0.594 . . . . 0.0 110.028 173.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -71.11 139.33 35.37 Favored 'Trans proline' 0 N--CA 1.49 1.303 0 O-C-N 123.197 1.104 . . . . 0.0 110.326 175.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 35.0 p -139.17 149.96 45.05 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 122.113 -0.367 . . . . 0.0 110.206 178.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 17.4 mt . . . . . 0 N--CA 1.502 2.157 0 CA-C-O 118.896 -0.573 . . . . 0.0 110.037 179.318 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo . . . . . 0 N--CA 1.497 1.68 0 N-CA-C 110.978 -0.431 . . . . 0.0 110.978 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -157.84 50.94 0.43 Allowed 'General case' 0 N--CA 1.498 1.967 0 CA-C-O 121.423 0.63 . . . . 0.0 110.407 164.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 20.5 tp -158.72 114.88 2.68 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.733 -0.604 . . . . 0.0 110.29 -177.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.425 ' HE3' HD21 ' A' ' 106' ' ' LEU . 33.1 ttpt -99.77 132.14 45.3 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 120.95 -0.3 . . . . 0.0 110.233 176.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 76.4 m -117.52 140.33 49.75 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -179.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -81.86 142.13 32.79 Favored 'General case' 0 N--CA 1.502 2.143 0 C-N-CA 120.535 -0.466 . . . . 0.0 109.961 176.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 28.2 p -113.38 136.98 52.17 Favored 'General case' 0 N--CA 1.501 2.111 0 C-N-CA 120.779 -0.368 . . . . 0.0 110.589 -177.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.8 m -122.61 142.94 50.11 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 122.095 -0.378 . . . . 0.0 110.021 177.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.44 -68.13 1.5 Allowed Glycine 0 N--CA 1.494 2.547 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -115.27 126.47 54.54 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 122.003 -0.704 . . . . 0.0 110.613 -176.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -137.96 136.25 19.56 Favored Pre-proline 0 N--CA 1.496 1.852 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 174.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -60.7 152.65 67.76 Favored 'Trans proline' 0 N--CA 1.497 1.702 0 O-C-N 123.072 1.038 . . . . 0.0 111.194 -170.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -60.25 -28.03 67.7 Favored 'General case' 0 N--CA 1.508 2.44 0 O-C-N 122.021 -0.424 . . . . 0.0 111.34 -173.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -92.1 14.39 16.16 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.9 -0.5 . . . . 0.0 111.78 -178.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.92 162.04 26.29 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.581 -0.699 . . . . 0.0 110.259 -173.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 70.7 mt -124.11 136.45 60.33 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -176.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 19.8 p30 37.8 43.15 0.46 Allowed 'General case' 0 N--CA 1.512 2.658 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 -176.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 55.5 43.34 28.67 Favored 'General case' 0 N--CA 1.509 2.476 0 O-C-N 121.83 -0.544 . . . . 0.0 111.429 -178.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 56.1 p -139.53 161.98 36.17 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.801 -0.562 . . . . 0.0 110.273 171.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.4 p -137.29 160.43 39.07 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-O 120.737 0.304 . . . . 0.0 110.608 178.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 76.5 mt -110.09 132.97 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -174.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.0 t -143.5 155.19 44.27 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.952 -0.468 . . . . 0.0 111.022 -179.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 48.9 p30 -108.09 29.31 7.43 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 122.036 -0.415 . . . . 0.0 110.705 167.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -119.59 -102.63 1.99 Allowed Glycine 0 N--CA 1.497 2.741 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 176.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 24.6 m-70 -140.89 169.75 17.03 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 122.007 -0.702 . . . . 0.0 109.709 177.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 78.0 m -93.13 139.24 30.79 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 166.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -129.38 149.58 51.1 Favored 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.486 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -152.12 138.4 18.42 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 176.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.579 HD12 HD12 ' A' ' 99' ' ' ILE . 18.2 tt -136.36 149.05 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 CA-C-O 120.961 0.41 . . . . 0.0 110.459 -168.552 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.791 HD12 HD21 ' A' ' 73' ' ' LEU . 16.3 tt -132.36 145.11 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 177.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -149.79 143.43 25.37 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 -169.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.6 tm-20 -101.64 117.68 35.38 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 122.169 -0.332 . . . . 0.0 110.119 -177.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 51.7 p30 -87.05 175.34 8.16 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 122.132 -0.355 . . . . 0.0 110.676 -175.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -60.44 -17.55 45.35 Favored 'General case' 0 N--CA 1.507 2.413 0 O-C-N 121.941 -0.474 . . . . 0.0 112.069 -173.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -93.18 -10.71 34.81 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.589 -0.695 . . . . 0.0 111.9 178.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 89.99 21.16 40.1 Favored Glycine 0 N--CA 1.498 2.785 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 178.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -96.98 143.79 27.51 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-N 118.312 1.056 . . . . 0.0 109.77 170.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 15.8 p -94.81 126.54 40.2 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 122.069 -0.395 . . . . 0.0 110.2 177.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 20.7 p -97.91 117.56 32.51 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 122.13 -0.357 . . . . 0.0 110.298 179.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.791 HD21 HD12 ' A' ' 63' ' ' ILE . 83.7 mt -97.7 128.18 44.19 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 122.136 -0.353 . . . . 0.0 110.295 -179.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -146.98 144.7 29.38 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 122.079 -0.388 . . . . 0.0 110.523 175.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 97.0 p -143.72 167.02 23.26 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 177.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -178.26 -169.14 38.69 Favored Glycine 0 N--CA 1.496 2.659 0 N-CA-C 110.224 -1.15 . . . . 0.0 110.224 -179.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 2.9 m -96.17 132.77 41.24 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 122.175 -0.603 . . . . 0.0 110.181 -176.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 54.9 ttm -98.92 122.01 41.62 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 122.052 -0.405 . . . . 0.0 110.071 175.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 17.5 pttm . . . . . 0 N--CA 1.503 2.191 0 O-C-N 122.024 -0.423 . . . . 0.0 110.48 -179.028 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 46.4 ptt85 . . . . . 0 N--CA 1.495 1.81 0 CA-C-O 120.824 0.345 . . . . 0.0 110.594 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 18.1 m -128.75 148.78 50.87 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 172.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.579 HD12 HD12 ' A' ' 62' ' ' ILE . 18.4 tt -143.18 127.38 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.997 -0.439 . . . . 0.0 110.167 -176.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -105.81 149.23 26.68 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 122.234 -0.291 . . . . 0.0 110.455 177.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 26.7 p -143.02 134.63 26.46 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 177.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 20.4 p -157.57 131.38 8.04 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.926 -0.484 . . . . 0.0 110.81 -170.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 21.6 ttp-105 -104.86 48.48 0.84 Allowed 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 121.385 0.612 . . . . 0.0 110.604 -176.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.0 p -135.12 151.36 50.63 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.895 -0.503 . . . . 0.0 109.785 174.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 15.7 p30 -61.77 132.24 52.51 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 121.724 -0.61 . . . . 0.0 111.793 -163.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.425 HD21 ' HE3' ' A' ' 37' ' ' LYS . 75.3 mt 52.0 26.55 3.8 Favored 'General case' 0 N--CA 1.507 2.376 0 O-C-N 122.089 -0.382 . . . . 0.0 111.991 179.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 26.3 p -63.11 -21.99 66.56 Favored 'General case' 0 N--CA 1.506 2.363 0 O-C-N 121.849 -0.532 . . . . 0.0 111.583 176.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -93.04 -22.93 18.85 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.684 -0.635 . . . . 0.0 111.323 178.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -60.66 -38.6 85.42 Favored 'General case' 0 N--CA 1.508 2.436 0 O-C-N 121.577 -0.702 . . . . 0.0 110.768 -177.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -100.74 16.23 25.67 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 122.078 -0.389 . . . . 0.0 111.685 179.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 16.8 tp -111.87 117.34 32.52 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.586 -0.697 . . . . 0.0 110.394 -174.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 3.3 tp-100 -96.45 120.71 61.79 Favored Pre-proline 0 N--CA 1.496 1.868 0 CA-C-O 118.862 -0.589 . . . . 0.0 109.965 171.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -69.93 145.22 55.51 Favored 'Trans proline' 0 N--CA 1.491 1.347 0 O-C-N 123.235 1.124 . . . . 0.0 110.291 175.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 34.5 p -139.22 147.05 41.25 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 122.175 -0.328 . . . . 0.0 110.156 179.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 14.9 mt . . . . . 0 N--CA 1.502 2.166 0 CA-C-O 119.305 -0.379 . . . . 0.0 110.152 178.987 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo . . . . . 0 N--CA 1.502 2.011 0 N-CA-C 111.224 -0.337 . . . . 0.0 111.224 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -151.73 47.99 0.8 Allowed 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 121.188 0.518 . . . . 0.0 110.743 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.433 HD23 HG23 ' A' ' 55' ' ' THR . 18.9 tp -161.0 115.01 2.05 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.771 -0.581 . . . . 0.0 110.449 -174.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 48.6 tttt -99.81 132.5 45.12 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 122.146 -0.347 . . . . 0.0 110.223 177.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 86.4 m -118.97 140.43 50.01 Favored 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 -178.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -83.07 144.49 29.86 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 122.027 -0.421 . . . . 0.0 110.015 176.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 28.1 p -115.67 137.07 52.44 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.952 -0.467 . . . . 0.0 110.588 -178.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 98.6 p -123.02 141.57 51.82 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 109.894 -0.409 . . . . 0.0 109.894 175.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.18 -68.16 1.41 Allowed Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -112.15 123.59 50.59 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.997 -0.708 . . . . 0.0 110.498 -176.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -138.07 136.99 20.14 Favored Pre-proline 0 N--CA 1.496 1.87 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 174.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -61.11 152.52 70.99 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 O-C-N 123.087 1.046 . . . . 0.0 111.077 -172.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -60.44 -28.21 68.11 Favored 'General case' 0 N--CA 1.508 2.462 0 O-C-N 121.88 -0.512 . . . . 0.0 111.415 -172.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -91.97 14.26 16.27 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.953 -0.467 . . . . 0.0 111.735 -177.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.86 161.97 27.22 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.533 -0.73 . . . . 0.0 110.243 -173.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 70.7 mt -124.36 136.38 60.69 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -177.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 19.8 p30 37.78 43.36 0.48 Allowed 'General case' 0 N--CA 1.515 2.776 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -176.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 30.8 m120 55.39 44.0 27.88 Favored 'General case' 0 N--CA 1.507 2.386 0 O-C-N 121.785 -0.572 . . . . 0.0 111.466 -178.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 58.2 p -140.76 161.75 37.05 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.725 -0.609 . . . . 0.0 110.306 171.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.4 p -139.66 165.07 28.26 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-O 120.752 0.311 . . . . 0.0 110.691 179.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 76.4 mt -111.91 132.53 60.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 -175.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.433 HG23 HD23 ' A' ' 36' ' ' LEU . 9.1 t -140.44 153.05 46.14 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 122.027 -0.421 . . . . 0.0 111.059 -179.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 48.5 p30 -108.61 29.96 6.92 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 122.037 -0.415 . . . . 0.0 110.672 167.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -122.89 -96.05 1.26 Allowed Glycine 0 N--CA 1.497 2.73 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 176.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 49.7 m-70 -144.5 171.03 14.93 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 122.136 -0.626 . . . . 0.0 109.761 176.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 73.7 m -92.96 139.09 30.89 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 164.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -129.52 150.34 50.9 Favored 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 120.291 -0.564 . . . . 0.0 110.613 -178.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -151.26 143.98 24.39 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 175.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.487 HD12 HD12 ' A' ' 99' ' ' ILE . 18.1 tt -143.29 149.26 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.397 -171.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.668 HD12 HD21 ' A' ' 73' ' ' LEU . 13.5 tt -134.28 145.32 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 177.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -148.58 145.15 27.69 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 -169.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.3 tm-20 -101.53 116.94 33.9 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 122.146 -0.346 . . . . 0.0 110.134 -176.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -87.4 175.33 8.04 Favored 'General case' 0 N--CA 1.501 2.101 0 CA-C-O 120.796 0.332 . . . . 0.0 110.584 -175.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -60.44 -17.86 47.35 Favored 'General case' 0 N--CA 1.506 2.372 0 O-C-N 121.895 -0.503 . . . . 0.0 112.0 -172.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -92.85 -10.37 36.96 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.599 -0.688 . . . . 0.0 111.861 178.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 89.47 20.21 45.73 Favored Glycine 0 N--CA 1.498 2.791 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 176.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -97.38 145.74 25.86 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-N 118.466 1.133 . . . . 0.0 109.793 169.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 13.6 p -94.92 129.16 42.06 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 122.106 -0.371 . . . . 0.0 110.26 178.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 20.9 p -97.86 118.16 33.81 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 122.057 -0.402 . . . . 0.0 110.353 178.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.668 HD21 HD12 ' A' ' 63' ' ' ILE . 23.2 mt -97.53 126.87 43.07 Favored 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 120.966 -0.294 . . . . 0.0 110.307 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -145.18 143.41 30.3 Favored 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.646 174.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 98.9 p -143.85 167.06 23.2 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 176.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 178.91 -165.66 34.8 Favored Glycine 0 N--CA 1.496 2.663 0 N-CA-C 110.379 -1.088 . . . . 0.0 110.379 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 2.6 m -96.27 132.4 41.78 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 122.178 -0.601 . . . . 0.0 110.227 -176.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 55.8 ttm -98.49 121.82 40.91 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 122.069 -0.394 . . . . 0.0 110.156 177.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 22.5 pttt . . . . . 0 N--CA 1.503 2.199 0 C-N-CA 120.699 -0.401 . . . . 0.0 110.537 -178.9 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 33.4 ptt-85 . . . . . 0 N--CA 1.496 1.833 0 CA-C-O 120.984 0.421 . . . . 0.0 110.575 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 17.0 m -126.81 149.06 49.88 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 171.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.487 HD12 HD12 ' A' ' 62' ' ' ILE . 18.5 tt -143.14 155.92 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.963 -0.461 . . . . 0.0 110.308 -175.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 57.1 mm-40 -141.46 147.75 38.39 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 120.866 0.365 . . . . 0.0 110.412 179.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 26.8 p -143.1 136.84 28.69 Favored 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 179.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 18.9 p -157.5 132.53 8.8 Favored 'General case' 0 N--CA 1.504 2.244 0 O-C-N 121.97 -0.456 . . . . 0.0 110.973 -171.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 22.4 ttm180 -105.14 48.68 0.83 Allowed 'General case' 0 N--CA 1.498 1.974 0 CA-C-O 121.382 0.61 . . . . 0.0 110.559 -177.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 23.8 p -136.02 151.16 49.59 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.714 -0.616 . . . . 0.0 109.799 174.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -61.73 131.98 51.68 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.69 -0.631 . . . . 0.0 111.821 -163.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 72.9 mt 52.28 26.4 4.0 Favored 'General case' 0 N--CA 1.506 2.36 0 O-C-N 122.047 -0.408 . . . . 0.0 111.948 179.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 26.4 p -62.86 -22.06 66.42 Favored 'General case' 0 N--CA 1.507 2.422 0 O-C-N 121.859 -0.526 . . . . 0.0 111.615 176.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -92.21 -22.86 19.57 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.83 -0.544 . . . . 0.0 111.331 177.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -60.76 -38.1 84.09 Favored 'General case' 0 N--CA 1.507 2.395 0 O-C-N 121.635 -0.666 . . . . 0.0 110.775 -177.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -100.24 16.26 24.88 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 122.179 -0.325 . . . . 0.0 111.701 178.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 14.0 tp -116.9 111.53 19.78 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.492 -0.755 . . . . 0.0 110.289 -175.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 21.9 tp60 -96.49 120.7 61.74 Favored Pre-proline 0 N--CA 1.497 1.893 0 CA-C-O 118.756 -0.64 . . . . 0.0 109.982 172.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.69 133.89 21.12 Favored 'Trans proline' 0 N--CA 1.49 1.296 0 O-C-N 123.237 1.125 . . . . 0.0 110.395 176.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 34.9 p -139.22 147.84 42.3 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 122.004 -0.435 . . . . 0.0 110.048 177.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 13.5 mt . . . . . 0 N--CA 1.502 2.128 0 CA-C-O 119.01 -0.519 . . . . 0.0 109.929 179.56 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo . . . . . 0 N--CA 1.502 1.996 0 N-CA-C 111.237 -0.332 . . . . 0.0 111.237 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -155.38 47.29 0.51 Allowed 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.931 -0.481 . . . . 0.0 110.752 172.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 25.1 tp -159.33 102.77 1.59 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.767 -0.583 . . . . 0.0 110.396 -173.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 41.0 tttp -99.91 119.07 37.64 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 110.288 -0.264 . . . . 0.0 110.288 177.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 69.2 m -121.73 140.63 52.09 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 122.078 -0.389 . . . . 0.0 110.945 -178.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -79.7 155.44 28.01 Favored 'General case' 0 N--CA 1.501 2.087 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.07 -178.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 27.2 p -119.3 141.14 49.25 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.996 -0.44 . . . . 0.0 110.529 -179.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 49.7 m -122.98 138.93 54.55 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 122.086 -0.383 . . . . 0.0 110.169 177.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.52 -68.38 1.51 Allowed Glycine 0 N--CA 1.496 2.661 0 N-CA-C 109.669 -1.373 . . . . 0.0 109.669 178.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 83.2 t60 -112.97 125.79 54.78 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 122.073 -0.663 . . . . 0.0 110.537 -176.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -138.03 137.68 21.73 Favored Pre-proline 0 N--CA 1.496 1.839 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 176.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -61.11 150.89 82.18 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 O-C-N 123.049 1.026 . . . . 0.0 111.072 -174.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -59.77 -27.18 66.32 Favored 'General case' 0 N--CA 1.507 2.41 0 O-C-N 121.938 -0.477 . . . . 0.0 111.463 -173.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -92.17 14.23 16.74 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.871 -0.518 . . . . 0.0 111.746 -177.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.63 162.03 25.53 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.655 -0.653 . . . . 0.0 110.333 -173.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 76.2 mt -125.75 140.52 48.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -178.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 38.8 42.08 0.59 Allowed 'General case' 0 N--CA 1.513 2.696 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -178.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 30.7 m120 54.96 41.8 31.59 Favored 'General case' 0 N--CA 1.509 2.511 0 O-C-N 121.955 -0.465 . . . . 0.0 111.437 -178.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 43.1 p -140.54 161.77 36.95 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.825 -0.547 . . . . 0.0 110.332 173.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.4 p -138.38 163.32 32.18 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 120.967 0.413 . . . . 0.0 110.542 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 79.1 mt -129.33 125.32 61.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -168.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.2 t -143.6 158.25 43.81 Favored 'General case' 0 N--CA 1.501 2.12 0 C-N-CA 120.578 -0.449 . . . . 0.0 111.337 -177.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 10.6 p-10 -109.58 29.23 7.77 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 122.168 -0.333 . . . . 0.0 110.473 165.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -112.44 -103.66 2.67 Favored Glycine 0 N--CA 1.496 2.662 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 178.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 22.9 m80 -147.22 158.88 44.11 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 170.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 87.5 m -96.71 139.35 32.9 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 176.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -129.01 158.36 39.11 Favored 'General case' 0 N--CA 1.497 1.915 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.694 -171.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -150.98 143.86 24.55 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 176.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.476 HD12 HD12 ' A' ' 99' ' ' ILE . 18.2 tt -142.21 149.15 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.444 -170.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.858 HD12 HD21 ' A' ' 73' ' ' LEU . 15.4 tt -137.88 145.11 29.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 178.327 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -150.04 140.85 22.74 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 -170.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.1 tm-20 -101.67 116.54 32.98 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -86.78 175.23 8.33 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 122.068 -0.395 . . . . 0.0 110.582 -175.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -60.65 -17.49 47.74 Favored 'General case' 0 N--CA 1.507 2.423 0 O-C-N 122.076 -0.39 . . . . 0.0 112.002 -172.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -92.49 -10.82 36.42 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.628 -0.67 . . . . 0.0 111.855 178.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.14 20.91 40.5 Favored Glycine 0 N--CA 1.497 2.757 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 176.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -97.49 142.8 28.88 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 118.378 1.089 . . . . 0.0 109.784 169.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.3 p -94.91 128.83 41.99 Favored 'General case' 0 N--CA 1.498 1.961 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.273 177.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.1 p -98.05 114.33 26.46 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 120.851 0.358 . . . . 0.0 110.232 177.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.858 HD21 HD12 ' A' ' 63' ' ' ILE . 82.4 mt -96.66 123.98 40.51 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 122.169 -0.332 . . . . 0.0 110.235 179.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -145.23 147.88 32.9 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 122.087 -0.383 . . . . 0.0 110.465 178.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 92.5 p -143.57 164.99 28.83 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 176.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -173.98 -178.96 44.3 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 -177.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 6.6 m -100.08 133.46 44.43 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 122.203 -0.587 . . . . 0.0 110.309 -178.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 35.2 ttm -99.85 123.13 43.78 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 122.038 -0.414 . . . . 0.0 110.167 176.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 24.5 pttt . . . . . 0 N--CA 1.504 2.27 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.381 177.039 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 62.1 ttp85 . . . . . 0 N--CA 1.495 1.818 0 CA-C-O 120.901 0.382 . . . . 0.0 110.147 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 12.2 m -134.26 149.09 50.92 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 172.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.476 HD12 HD12 ' A' ' 62' ' ' ILE . 18.6 tt -143.06 155.99 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 177.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -145.95 156.64 43.65 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 120.873 0.368 . . . . 0.0 110.474 -178.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 97.0 m -141.81 154.12 44.98 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 178.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 25.4 p -157.6 133.34 9.22 Favored 'General case' 0 N--CA 1.502 2.146 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.842 -170.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 48.9 ttt85 -109.46 45.91 1.04 Allowed 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.299 0.571 . . . . 0.0 110.516 -179.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 44.2 p -138.1 151.97 48.31 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.805 -0.559 . . . . 0.0 110.055 176.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 21.3 p30 -64.12 140.46 58.87 Favored 'General case' 0 N--CA 1.505 2.292 0 CA-C-O 121.315 0.579 . . . . 0.0 111.198 -169.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 20.3 mt 53.07 25.85 4.44 Favored 'General case' 0 N--CA 1.507 2.39 0 O-C-N 121.814 -0.554 . . . . 0.0 112.289 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 27.9 p -67.84 -25.18 65.42 Favored 'General case' 0 N--CA 1.505 2.275 0 C-N-CA 119.968 -0.693 . . . . 0.0 111.164 172.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -81.09 -33.79 33.09 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.723 -0.611 . . . . 0.0 110.463 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -63.06 -40.73 98.57 Favored 'General case' 0 N--CA 1.506 2.358 0 O-C-N 122.002 -0.436 . . . . 0.0 110.89 -177.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -102.4 16.26 26.79 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 122.067 -0.395 . . . . 0.0 111.978 -174.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 13.5 tp -125.84 109.05 12.06 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.535 -0.728 . . . . 0.0 110.37 -176.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -98.33 120.78 58.74 Favored Pre-proline 0 N--CA 1.497 1.889 0 CA-C-O 118.799 -0.619 . . . . 0.0 110.132 173.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -68.84 147.13 68.06 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 O-C-N 123.234 1.123 . . . . 0.0 110.205 175.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 35.3 p -139.17 149.98 45.07 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 122.133 -0.355 . . . . 0.0 110.169 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 64.1 mt . . . . . 0 N--CA 1.502 2.145 0 CA-C-O 119.187 -0.435 . . . . 0.0 110.138 179.723 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_exo . . . . . 0 N--CA 1.498 1.757 0 N-CA-C 110.942 -0.445 . . . . 0.0 110.942 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -156.12 51.33 0.53 Allowed 'General case' 0 N--CA 1.498 1.971 0 CA-C-O 121.364 0.602 . . . . 0.0 110.372 164.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.436 HD23 HG23 ' A' ' 55' ' ' THR . 20.8 tp -158.26 114.81 2.81 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.615 -0.678 . . . . 0.0 110.29 -178.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 55.5 tttt -99.79 130.09 45.96 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 178.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 80.1 m -114.62 140.21 49.0 Favored 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -84.5 142.79 29.79 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 176.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 28.1 p -113.88 137.67 51.35 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 122.052 -0.405 . . . . 0.0 110.595 -177.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 28.0 t -122.95 133.05 54.4 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 122.089 -0.382 . . . . 0.0 110.109 178.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.75 -66.26 2.77 Favored Glycine 0 N--CA 1.495 2.586 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 63.9 m170 -110.79 123.34 49.88 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 122.069 -0.665 . . . . 0.0 110.554 -177.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -138.1 136.01 19.14 Favored Pre-proline 0 N--CA 1.496 1.858 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 175.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -60.54 152.69 66.46 Favored 'Trans proline' 0 N--CA 1.496 1.662 0 O-C-N 123.024 1.013 . . . . 0.0 111.201 -170.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -60.36 -28.15 67.95 Favored 'General case' 0 N--CA 1.507 2.377 0 O-C-N 122.04 -0.412 . . . . 0.0 111.365 -172.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -92.32 14.35 16.68 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.985 -0.447 . . . . 0.0 111.763 -178.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.45 162.07 27.47 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.554 -0.716 . . . . 0.0 110.217 -172.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.419 HG22 HD22 ' A' ' 50' ' ' ASN . 68.7 mt -126.06 137.59 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -176.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.419 HD22 HG22 ' A' ' 49' ' ' ILE . 17.2 p30 37.82 43.31 0.48 Allowed 'General case' 0 N--CA 1.512 2.675 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -175.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 24.9 t30 56.1 42.66 28.08 Favored 'General case' 0 N--CA 1.508 2.457 0 O-C-N 121.805 -0.559 . . . . 0.0 111.451 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 44.3 p -142.02 165.24 27.99 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.765 -0.584 . . . . 0.0 110.555 171.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.6 p -137.8 163.7 30.74 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 122.166 -0.333 . . . . 0.0 110.567 176.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 77.0 mt -112.55 132.57 60.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -175.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.436 HG23 HD23 ' A' ' 36' ' ' LEU . 9.1 t -139.62 152.78 47.06 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.95 -0.469 . . . . 0.0 111.104 -178.002 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -108.92 31.25 5.82 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 122.116 -0.365 . . . . 0.0 110.432 167.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -124.79 -95.85 1.09 Allowed Glycine 0 N--CA 1.496 2.648 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 176.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 23.3 m80 -146.86 171.91 14.48 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 122.076 -0.661 . . . . 0.0 109.507 177.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 74.8 m -93.78 139.25 31.07 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 166.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -130.41 148.65 52.25 Favored 'General case' 0 N--CA 1.499 2.006 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.49 -178.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -151.9 143.5 23.55 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 177.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.549 HD12 HD12 ' A' ' 99' ' ' ILE . 18.3 tt -145.15 149.27 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 122.063 -0.398 . . . . 0.0 110.479 -171.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.658 HD12 HD21 ' A' ' 73' ' ' LEU . 15.4 tt -135.75 145.32 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 176.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -148.2 148.49 30.58 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 -169.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.4 tm-20 -101.6 117.51 35.06 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 -175.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -87.38 175.28 8.06 Favored 'General case' 0 N--CA 1.501 2.093 0 CA-C-O 120.796 0.331 . . . . 0.0 110.582 -175.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -60.84 -17.57 50.74 Favored 'General case' 0 N--CA 1.506 2.347 0 O-C-N 121.988 -0.445 . . . . 0.0 111.954 -172.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -92.63 -10.86 35.86 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.678 -0.639 . . . . 0.0 111.801 178.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.54 19.33 45.26 Favored Glycine 0 N--CA 1.497 2.766 0 O-C-N 121.469 -0.769 . . . . 0.0 111.194 177.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -97.2 145.37 26.12 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-N 118.483 1.141 . . . . 0.0 109.818 169.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.9 p -94.72 128.54 41.48 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 122.079 -0.388 . . . . 0.0 110.342 178.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 19.8 p -97.96 116.25 29.79 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 122.134 -0.354 . . . . 0.0 110.354 178.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.658 HD21 HD12 ' A' ' 63' ' ' ILE . 14.7 mt -97.42 126.58 42.76 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 122.152 -0.342 . . . . 0.0 110.423 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -145.75 144.82 30.56 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 120.811 -0.355 . . . . 0.0 110.434 175.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 80.1 p -143.72 165.55 27.35 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 176.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -178.02 -166.87 35.17 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 110.226 -1.15 . . . . 0.0 110.226 -178.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 2.7 m -97.32 132.68 42.82 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 122.212 -0.581 . . . . 0.0 110.309 -175.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 47.3 ttm -99.1 123.33 43.32 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 122.028 -0.42 . . . . 0.0 110.197 178.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 23.5 pttm . . . . . 0 N--CA 1.504 2.241 0 O-C-N 122.049 -0.407 . . . . 0.0 110.642 -178.881 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 16.9 ptt-85 . . . . . 0 N--CA 1.495 1.776 0 CA-C-O 120.841 0.353 . . . . 0.0 110.332 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 15.2 m -128.56 149.14 50.75 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 173.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.549 HD12 HD12 ' A' ' 62' ' ' ILE . 18.5 tt -143.09 155.77 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 122.064 -0.397 . . . . 0.0 109.976 -179.111 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.454 ' HB3' HD21 ' A' ' 111' ' ' LEU . 45.2 mt-10 -143.02 149.76 38.69 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 120.932 0.396 . . . . 0.0 110.506 -178.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 25.6 p -143.06 137.78 29.46 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -178.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 22.6 p -157.39 131.7 8.4 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.895 -0.503 . . . . 0.0 110.979 -172.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 30.4 ttp180 -105.83 44.81 1.01 Allowed 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 121.285 0.564 . . . . 0.0 110.532 -176.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.0 p -135.19 150.89 50.21 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.929 -0.482 . . . . 0.0 109.931 177.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 17.6 p-10 -62.82 131.81 50.08 Favored 'General case' 0 N--CA 1.504 2.228 0 CA-C-O 121.436 0.636 . . . . 0.0 111.635 -163.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 81.2 mt 51.76 28.13 4.69 Favored 'General case' 0 N--CA 1.506 2.355 0 O-C-N 121.927 -0.483 . . . . 0.0 111.934 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 25.8 p -62.46 -23.85 67.12 Favored 'General case' 0 N--CA 1.506 2.36 0 O-C-N 121.823 -0.548 . . . . 0.0 111.53 173.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -75.31 -30.0 60.22 Favored 'General case' 0 N--CA 1.504 2.241 0 O-C-N 121.811 -0.556 . . . . 0.0 111.046 177.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -62.3 -39.63 93.63 Favored 'General case' 0 N--CA 1.506 2.339 0 O-C-N 121.673 -0.642 . . . . 0.0 110.81 -168.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -100.17 16.11 25.27 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 122.176 -0.328 . . . . 0.0 111.693 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.454 HD21 ' HB3' ' A' ' 100' ' ' GLU . 12.5 tp -116.36 108.95 16.71 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.597 -0.69 . . . . 0.0 110.347 -175.256 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -99.45 120.72 57.1 Favored Pre-proline 0 N--CA 1.497 1.903 0 CA-C-O 118.955 -0.545 . . . . 0.0 110.125 173.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -68.79 137.41 38.31 Favored 'Trans proline' 0 N--CA 1.49 1.277 0 O-C-N 123.158 1.083 . . . . 0.0 110.157 172.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 34.7 p -139.29 146.8 40.8 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.119 178.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 21.0 mt . . . . . 0 N--CA 1.503 2.205 0 C-N-CA 120.685 -0.406 . . . . 0.0 109.94 179.233 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo . . . . . 0 N--CA 1.499 1.807 0 N-CA-C 111.19 -0.35 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -161.76 54.21 0.25 Allowed 'General case' 0 N--CA 1.5 2.034 0 CA-C-O 121.359 0.6 . . . . 0.0 110.281 165.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 21.6 tp -157.63 115.47 3.08 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.748 -0.595 . . . . 0.0 109.919 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.3 tptt -99.67 131.1 45.88 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 122.18 -0.325 . . . . 0.0 110.162 -178.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 72.6 m -121.12 140.59 51.78 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -176.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -83.71 144.15 29.56 Favored 'General case' 0 N--CA 1.5 2.033 0 C-N-CA 120.601 -0.44 . . . . 0.0 109.9 176.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 27.1 p -118.57 136.96 53.56 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 122.056 -0.403 . . . . 0.0 110.568 -177.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.4 m -123.0 141.19 52.24 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 122.059 -0.4 . . . . 0.0 110.088 177.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 75.89 -67.14 2.39 Favored Glycine 0 N--CA 1.496 2.636 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -116.68 123.68 47.86 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 122.132 -0.628 . . . . 0.0 110.579 -176.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -138.08 136.75 19.91 Favored Pre-proline 0 N--CA 1.497 1.891 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 174.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -61.31 151.77 76.98 Favored 'Trans proline' 0 N--CA 1.496 1.633 0 O-C-N 123.114 1.06 . . . . 0.0 111.094 -172.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -59.21 -25.72 64.23 Favored 'General case' 0 N--CA 1.507 2.394 0 O-C-N 122.032 -0.418 . . . . 0.0 111.625 -173.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -91.57 14.27 15.47 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.944 -0.473 . . . . 0.0 111.899 -176.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -82.67 161.53 22.12 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.565 -0.71 . . . . 0.0 110.242 -175.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 76.4 mt -125.74 139.38 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -178.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 38.42 42.26 0.52 Allowed 'General case' 0 N--CA 1.513 2.708 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -177.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 55.16 42.37 30.71 Favored 'General case' 0 N--CA 1.509 2.494 0 O-C-N 121.921 -0.487 . . . . 0.0 111.487 -178.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 27.4 p -140.43 157.49 45.44 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.878 -0.514 . . . . 0.0 110.402 172.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.8 p -145.82 165.82 27.75 Favored 'General case' 0 N--CA 1.499 1.988 0 CA-C-O 121.0 0.429 . . . . 0.0 110.718 -172.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 78.0 mt -123.58 120.32 59.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -166.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.9 t -135.8 153.26 51.57 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-O 121.0 0.428 . . . . 0.0 110.965 -174.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 44.3 p-10 -102.57 30.15 4.83 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 122.121 -0.362 . . . . 0.0 110.659 170.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -122.45 -108.33 1.97 Allowed Glycine 0 N--CA 1.496 2.658 0 N-CA-C 109.08 -1.608 . . . . 0.0 109.08 172.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -141.18 172.14 13.09 Favored 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -176.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 67.0 m -97.68 139.27 33.82 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 170.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -135.47 155.79 49.96 Favored 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 120.053 -0.659 . . . . 0.0 110.952 -176.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -151.06 150.66 30.98 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 18.4 tt -143.15 149.14 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 CA-C-O 120.904 0.383 . . . . 0.0 110.364 -172.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.823 HD12 HD11 ' A' ' 73' ' ' LEU . 16.0 tt -138.01 145.2 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 177.35 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -150.21 141.18 22.92 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 122.109 -0.369 . . . . 0.0 110.04 -170.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.0 tm-20 -101.69 116.52 32.93 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -86.67 175.25 8.37 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 122.212 -0.305 . . . . 0.0 110.59 -175.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -60.74 -17.5 48.97 Favored 'General case' 0 N--CA 1.506 2.35 0 O-C-N 122.032 -0.417 . . . . 0.0 111.998 -172.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -92.56 -10.8 36.3 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.668 -0.645 . . . . 0.0 111.819 178.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.1 20.95 40.49 Favored Glycine 0 N--CA 1.496 2.641 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 176.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -97.59 142.01 29.93 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-N 118.368 1.084 . . . . 0.0 109.893 169.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 10.9 p -94.84 129.62 41.74 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 122.168 -0.333 . . . . 0.0 110.36 178.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 17.9 p -97.85 112.94 24.66 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 122.147 -0.346 . . . . 0.0 110.324 177.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.823 HD11 HD12 ' A' ' 63' ' ' ILE . 4.6 mm? -97.36 122.31 40.25 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 122.124 -0.36 . . . . 0.0 110.254 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -144.99 155.66 43.51 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 122.004 -0.435 . . . . 0.0 110.541 178.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 91.0 p -143.51 162.89 34.66 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 176.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -158.81 -177.76 32.19 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 110.289 -1.124 . . . . 0.0 110.289 -173.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 1.7 m -113.09 115.71 28.74 Favored 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 -169.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 49.8 ttm -95.88 121.93 38.14 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.878 -0.514 . . . . 0.0 110.474 -170.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 22.1 pttt . . . . . 0 N--CA 1.503 2.209 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.412 175.695 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 30.1 ptt180 . . . . . 0 N--CA 1.496 1.862 0 CA-C-O 120.808 0.337 . . . . 0.0 110.7 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 24.3 m -133.95 149.39 51.25 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 177.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.6 tt -141.75 156.06 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 122.017 -0.427 . . . . 0.0 109.94 -178.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 51.6 mm-40 -143.86 151.43 39.87 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 122.146 -0.346 . . . . 0.0 110.615 -176.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 99.0 m -142.89 149.37 38.41 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 176.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 15.4 p -157.51 141.31 15.86 Favored 'General case' 0 N--CA 1.502 2.155 0 CA-C-O 121.07 0.462 . . . . 0.0 110.951 -173.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 68.8 mtp180 -110.55 49.51 0.85 Allowed 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.377 0.608 . . . . 0.0 110.693 -169.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.1 p -148.66 152.26 36.38 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.793 -0.567 . . . . 0.0 109.966 178.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -60.96 132.02 52.52 Favored 'General case' 0 N--CA 1.507 2.376 0 O-C-N 121.646 -0.659 . . . . 0.0 111.81 -163.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 69.1 mt 52.49 26.03 3.97 Favored 'General case' 0 N--CA 1.507 2.387 0 O-C-N 122.085 -0.385 . . . . 0.0 111.925 179.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 26.1 p -62.71 -21.97 66.18 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 121.853 -0.529 . . . . 0.0 111.762 177.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -90.09 -22.9 21.57 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.748 -0.595 . . . . 0.0 111.275 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -60.45 -38.9 85.62 Favored 'General case' 0 N--CA 1.509 2.488 0 O-C-N 121.58 -0.7 . . . . 0.0 110.775 -175.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -101.37 16.25 26.2 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 122.104 -0.373 . . . . 0.0 111.73 179.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 15.5 tp -110.53 113.54 26.25 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.567 -0.708 . . . . 0.0 110.38 -174.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 -96.83 120.76 61.1 Favored Pre-proline 0 N--CA 1.497 1.911 0 CA-C-O 118.803 -0.617 . . . . 0.0 109.989 172.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -68.34 133.89 29.58 Favored 'Trans proline' 0 N--CA 1.491 1.364 0 O-C-N 123.273 1.144 . . . . 0.0 110.408 176.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 32.7 p -98.84 125.32 44.19 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 122.098 -0.376 . . . . 0.0 110.428 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 15.7 mt . . . . . 0 N--CA 1.501 2.102 0 CA-C-O 119.282 -0.39 . . . . 0.0 110.097 176.663 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo . . . . . 0 N--CA 1.503 2.047 0 N-CA-C 111.268 -0.32 . . . . 0.0 111.268 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -153.38 49.84 0.7 Allowed 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.882 -0.511 . . . . 0.0 110.677 178.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.448 HD23 HG23 ' A' ' 55' ' ' THR . 19.7 tp -159.94 114.97 2.34 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.821 -0.549 . . . . 0.0 110.112 -176.328 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 50.9 tttt -99.86 130.87 46.09 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 122.151 -0.343 . . . . 0.0 110.158 178.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 85.8 m -117.01 140.39 49.54 Favored 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 -178.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -83.83 145.91 28.4 Favored 'General case' 0 N--CA 1.501 2.082 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.16 178.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 27.8 p -118.26 137.03 53.32 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 122.086 -0.384 . . . . 0.0 110.457 178.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 29.3 t -123.03 120.22 32.68 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 122.025 -0.422 . . . . 0.0 110.145 177.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 82.35 -62.77 4.53 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -103.89 112.05 24.85 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 122.03 -0.688 . . . . 0.0 110.486 -177.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -138.09 137.51 21.23 Favored Pre-proline 0 N--CA 1.497 1.915 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 176.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -60.97 151.85 75.13 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 O-C-N 123.114 1.06 . . . . 0.0 111.101 -174.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -60.35 -28.1 67.91 Favored 'General case' 0 N--CA 1.507 2.414 0 O-C-N 121.896 -0.503 . . . . 0.0 111.439 -172.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -92.28 14.36 16.59 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.921 -0.487 . . . . 0.0 111.749 -177.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.16 161.99 26.95 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.706 -0.621 . . . . 0.0 110.293 -173.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 76.1 mt -125.92 139.85 50.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 -177.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 38.88 42.75 0.68 Allowed 'General case' 0 N--CA 1.513 2.686 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -178.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 30.7 m120 54.96 43.0 30.59 Favored 'General case' 0 N--CA 1.508 2.452 0 O-C-N 121.838 -0.538 . . . . 0.0 111.496 -178.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 40.3 p -144.01 161.99 37.34 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.881 -0.512 . . . . 0.0 110.535 173.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.5 p -139.75 165.0 28.45 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 120.837 0.351 . . . . 0.0 110.666 179.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 77.4 mt -112.07 131.86 62.33 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -175.21 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.448 HG23 HD23 ' A' ' 36' ' ' LEU . 9.0 t -140.37 152.86 46.11 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 122.041 -0.412 . . . . 0.0 111.065 -178.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 40.1 p-10 -109.28 29.38 7.59 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 122.109 -0.369 . . . . 0.0 110.711 167.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -122.03 -92.79 1.18 Allowed Glycine 0 N--CA 1.496 2.65 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 177.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -149.86 172.04 15.8 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 122.099 -0.647 . . . . 0.0 109.574 176.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 75.9 m -94.01 139.17 31.27 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 166.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -129.11 153.22 47.87 Favored 'General case' 0 N--CA 1.499 1.997 0 C-N-CA 120.338 -0.545 . . . . 0.0 110.635 -178.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -151.24 143.39 24.03 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 176.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.534 HD12 HD12 ' A' ' 99' ' ' ILE . 18.1 tt -143.12 149.26 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.277 -172.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.46 HD12 ' HG ' ' A' ' 73' ' ' LEU . 14.9 tt -138.35 145.32 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 -179.4 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -148.71 145.76 27.81 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 -169.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.6 tm-20 -101.62 118.22 36.5 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 122.142 -0.349 . . . . 0.0 110.089 -176.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 52.1 p30 -87.17 175.29 8.14 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 122.21 -0.306 . . . . 0.0 110.601 -175.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -60.39 -17.93 47.11 Favored 'General case' 0 N--CA 1.508 2.43 0 O-C-N 122.025 -0.422 . . . . 0.0 111.988 -173.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -92.74 -10.47 36.94 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.689 -0.632 . . . . 0.0 111.921 178.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.08 21.03 40.21 Favored Glycine 0 N--CA 1.498 2.776 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 177.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -97.29 142.8 28.74 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 118.41 1.105 . . . . 0.0 109.823 170.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.1 p -94.83 125.67 39.65 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.249 177.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.2 p -97.89 112.95 24.68 Favored 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 120.877 -0.329 . . . . 0.0 110.296 177.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.544 ' N ' HD12 ' A' ' 73' ' ' LEU . 6.4 mp -97.51 127.2 43.28 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 122.157 -0.339 . . . . 0.0 110.313 -178.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -142.79 145.36 33.17 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 122.021 -0.424 . . . . 0.0 110.329 177.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 88.1 p -143.53 166.53 24.55 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 177.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -179.72 -165.77 34.26 Favored Glycine 0 N--CA 1.497 2.736 0 N-CA-C 110.239 -1.145 . . . . 0.0 110.239 -178.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 3.7 m -96.66 132.11 42.64 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 122.226 -0.573 . . . . 0.0 110.343 -175.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 53.5 ttm -98.62 121.82 41.04 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.1 176.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.3 ptpp? . . . . . 0 N--CA 1.504 2.233 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.398 -178.614 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 46.5 ptt85 . . . . . 0 N--CA 1.496 1.825 0 CA-C-O 120.771 0.32 . . . . 0.0 110.509 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.41 HG21 ' O ' ' A' ' 114' ' ' THR . 17.1 m -129.47 149.09 51.4 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 174.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.534 HD12 HD12 ' A' ' 62' ' ' ILE . 18.5 tt -143.09 155.91 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.993 -0.442 . . . . 0.0 110.135 -177.373 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -146.53 152.1 38.42 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 120.834 0.35 . . . . 0.0 110.632 -178.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 26.9 p -143.01 148.3 36.54 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 177.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 14.9 p -157.56 137.51 12.44 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.919 -0.488 . . . . 0.0 111.171 -173.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 44.9 ttt85 -107.91 53.01 0.7 Allowed 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 121.356 0.598 . . . . 0.0 110.604 -173.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.0 p -148.38 151.99 36.24 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.765 -0.584 . . . . 0.0 109.92 175.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 16.5 p30 -61.76 133.46 55.55 Favored 'General case' 0 N--CA 1.505 2.295 0 CA-C-O 121.444 0.64 . . . . 0.0 111.74 -164.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 72.8 mt 52.08 26.5 3.85 Favored 'General case' 0 N--CA 1.506 2.363 0 O-C-N 121.949 -0.469 . . . . 0.0 111.962 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 25.9 p -63.22 -21.92 66.54 Favored 'General case' 0 N--CA 1.506 2.338 0 O-C-N 121.889 -0.507 . . . . 0.0 111.7 176.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -92.29 -22.89 19.49 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.761 -0.587 . . . . 0.0 111.275 178.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -60.52 -37.17 80.29 Favored 'General case' 0 N--CA 1.506 2.338 0 O-C-N 121.433 -0.792 . . . . 0.0 110.762 -177.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -100.6 16.16 25.72 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 122.085 -0.384 . . . . 0.0 111.616 177.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 17.6 tp -112.19 113.48 25.76 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.675 -0.641 . . . . 0.0 110.346 -174.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -96.72 120.65 61.5 Favored Pre-proline 0 N--CA 1.496 1.863 0 CA-C-O 118.827 -0.606 . . . . 0.0 110.073 173.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -70.19 148.07 61.52 Favored 'Trans proline' 0 N--CA 1.49 1.293 0 O-C-N 123.122 1.064 . . . . 0.0 110.283 175.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.41 ' O ' HG21 ' A' ' 98' ' ' THR . 34.9 p -139.19 149.95 45.0 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 122.028 -0.42 . . . . 0.0 110.123 178.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 15.9 mt . . . . . 0 N--CA 1.503 2.177 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.112 -179.961 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_exo . . . . . 0 N--CA 1.498 1.791 0 N-CA-C 111.012 -0.418 . . . . 0.0 111.012 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -158.29 52.34 0.43 Allowed 'General case' 0 N--CA 1.501 2.107 0 CA-C-O 121.32 0.581 . . . . 0.0 110.515 164.175 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.467 HD23 HG23 ' A' ' 55' ' ' THR . 21.4 tp -158.22 114.65 2.8 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.656 -0.652 . . . . 0.0 110.23 -179.275 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.413 ' HE3' HD21 ' A' ' 106' ' ' LEU . 32.8 ttpt -99.77 131.63 45.63 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 122.11 -0.369 . . . . 0.0 110.225 177.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 79.3 m -115.31 140.22 49.3 Favored 'General case' 0 N--CA 1.501 2.077 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 -178.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -84.59 141.34 30.75 Favored 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 176.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 28.1 p -115.01 137.01 52.5 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 122.008 -0.433 . . . . 0.0 110.608 -177.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 49.4 m -122.99 135.58 54.53 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 175.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 75.49 -67.05 2.27 Favored Glycine 0 N--CA 1.495 2.606 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 83.7 t60 -109.2 119.55 39.85 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.99 -0.712 . . . . 0.0 110.576 -176.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -137.99 136.71 19.99 Favored Pre-proline 0 N--CA 1.496 1.868 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 174.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -60.12 151.88 69.65 Favored 'Trans proline' 0 N--CA 1.497 1.714 0 O-C-N 123.04 1.021 . . . . 0.0 111.225 -171.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -60.32 -28.14 67.89 Favored 'General case' 0 N--CA 1.507 2.394 0 O-C-N 121.966 -0.459 . . . . 0.0 111.401 -172.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -92.21 14.34 16.5 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.923 -0.486 . . . . 0.0 111.786 -178.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.46 162.06 26.64 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.606 -0.684 . . . . 0.0 110.348 -172.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 77.4 mt -126.08 140.5 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -177.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 38.68 42.69 0.62 Allowed 'General case' 0 N--CA 1.514 2.743 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -178.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 55.03 42.55 30.87 Favored 'General case' 0 N--CA 1.506 2.372 0 O-C-N 121.841 -0.537 . . . . 0.0 111.47 -179.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 41.5 p -142.96 161.16 38.87 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.89 -0.507 . . . . 0.0 110.465 173.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.3 p -138.46 162.52 34.27 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 120.874 0.369 . . . . 0.0 110.622 177.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 77.5 mt -108.73 132.58 56.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -176.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.467 HG23 HD23 ' A' ' 36' ' ' LEU . 7.9 t -138.74 151.95 47.55 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.989 -0.445 . . . . 0.0 110.936 -179.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.4 p-10 -108.8 29.76 7.15 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 122.143 -0.348 . . . . 0.0 110.64 167.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -125.19 -93.29 0.95 Allowed Glycine 0 N--CA 1.496 2.659 0 N-CA-C 109.286 -1.525 . . . . 0.0 109.286 177.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 42.8 m-70 -148.4 172.06 15.04 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 122.074 -0.662 . . . . 0.0 109.521 177.106 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 71.9 m -93.32 139.21 30.91 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 165.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 15.6 p90 -129.98 151.38 50.6 Favored 'General case' 0 N--CA 1.499 2.024 0 C-N-CA 120.365 -0.534 . . . . 0.0 110.595 -177.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -151.02 143.68 24.39 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -179.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.459 HD12 HD12 ' A' ' 99' ' ' ILE . 18.1 tt -143.82 149.22 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 CA-C-O 120.905 0.383 . . . . 0.0 110.413 -173.081 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.806 HD12 HD21 ' A' ' 73' ' ' LEU . 16.6 tt -133.85 145.23 33.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.638 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -146.92 145.17 29.71 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -167.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.7 tm-20 -101.58 118.17 36.4 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -176.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 50.8 p30 -87.45 175.31 8.02 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 122.077 -0.39 . . . . 0.0 110.605 -175.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -60.42 -17.91 47.41 Favored 'General case' 0 N--CA 1.508 2.443 0 O-C-N 122.033 -0.417 . . . . 0.0 111.957 -173.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 84.1 mm-40 -93.27 -9.84 37.62 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.662 -0.649 . . . . 0.0 111.926 178.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 89.4 20.96 42.79 Favored Glycine 0 N--CA 1.499 2.877 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 177.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -97.16 144.39 27.04 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-N 118.427 1.113 . . . . 0.0 109.791 169.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.8 p -94.84 126.31 40.09 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.988 -0.445 . . . . 0.0 110.276 177.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 24.5 p -97.92 122.68 41.33 Favored 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 120.921 -0.312 . . . . 0.0 110.284 178.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.806 HD21 HD12 ' A' ' 63' ' ' ILE . 75.2 mt -97.09 127.84 43.45 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 122.119 -0.363 . . . . 0.0 110.289 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -143.0 144.24 32.22 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 122.025 -0.422 . . . . 0.0 110.369 175.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 40.5 p -143.78 167.01 23.31 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 178.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -177.84 -167.25 35.65 Favored Glycine 0 N--CA 1.496 2.691 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 2.0 m -97.4 132.84 42.74 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 122.211 -0.582 . . . . 0.0 110.271 -176.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 54.7 ttm -100.91 129.62 46.8 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 122.039 -0.413 . . . . 0.0 110.279 179.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.6 pttm . . . . . 0 N--CA 1.503 2.223 0 O-C-N 122.08 -0.388 . . . . 0.0 110.58 177.385 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 44.6 ptt85 . . . . . 0 N--CA 1.494 1.766 0 CA-C-O 120.954 0.406 . . . . 0.0 110.711 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.406 HG21 ' O ' ' A' ' 114' ' ' THR . 13.6 m -124.95 149.12 47.98 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 169.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.459 HD12 HD12 ' A' ' 62' ' ' ILE . 18.2 tt -143.09 154.57 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 C-N-CA 120.537 -0.465 . . . . 0.0 110.326 -172.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -147.26 154.68 41.28 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 120.811 0.339 . . . . 0.0 110.573 -178.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 26.6 p -143.05 151.9 41.3 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 177.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 20.3 p -157.6 134.49 10.03 Favored 'General case' 0 N--CA 1.502 2.152 0 CA-C-O 120.976 0.417 . . . . 0.0 110.77 -174.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 40.8 ttp85 -107.37 49.38 0.81 Allowed 'General case' 0 N--CA 1.497 1.907 0 CA-C-O 121.384 0.611 . . . . 0.0 110.661 -173.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.2 p -143.41 151.5 40.45 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.759 -0.588 . . . . 0.0 109.863 177.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 15.8 p30 -62.24 132.57 53.15 Favored 'General case' 0 N--CA 1.506 2.359 0 CA-C-O 121.406 0.622 . . . . 0.0 111.684 -164.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.413 HD21 ' HE3' ' A' ' 37' ' ' LYS . 76.5 mt 52.24 27.31 4.6 Favored 'General case' 0 N--CA 1.506 2.357 0 O-C-N 121.976 -0.453 . . . . 0.0 111.961 179.671 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 25.7 p -62.75 -23.32 67.14 Favored 'General case' 0 N--CA 1.507 2.42 0 O-C-N 121.852 -0.53 . . . . 0.0 111.624 174.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -73.73 -29.86 62.49 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.735 -0.603 . . . . 0.0 111.043 178.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -62.11 -39.55 92.91 Favored 'General case' 0 N--CA 1.505 2.318 0 O-C-N 121.653 -0.655 . . . . 0.0 110.855 -169.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -100.83 16.17 26.0 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 122.073 -0.392 . . . . 0.0 111.75 -178.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 15.9 tp -114.19 108.98 17.68 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.635 -0.665 . . . . 0.0 110.367 -175.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -98.15 120.82 58.94 Favored Pre-proline 0 N--CA 1.497 1.876 0 CA-C-O 118.943 -0.551 . . . . 0.0 110.102 174.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -70.99 143.37 44.73 Favored 'Trans proline' 0 N--CA 1.49 1.313 0 O-C-N 123.142 1.075 . . . . 0.0 110.343 174.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.406 ' O ' HG21 ' A' ' 98' ' ' THR . 35.1 p -139.16 150.01 45.12 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 122.154 -0.341 . . . . 0.0 110.095 178.493 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 15.0 mt . . . . . 0 N--CA 1.502 2.172 0 O-C-N 122.02 -0.425 . . . . 0.0 110.066 -179.568 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo . . . . . 0 N--CA 1.504 2.14 0 N-CA-C 111.369 -0.281 . . . . 0.0 111.369 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -156.32 48.19 0.47 Allowed 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 121.067 0.46 . . . . 0.0 110.872 176.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 18.5 tp -161.35 116.06 2.04 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.805 -0.56 . . . . 0.0 110.388 -173.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -99.81 133.66 43.85 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 122.214 -0.304 . . . . 0.0 110.21 176.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 64.3 m -120.82 140.34 51.87 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 -179.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -82.37 148.21 28.39 Favored 'General case' 0 N--CA 1.501 2.085 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.061 177.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 27.9 p -117.06 137.02 52.54 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.982 -0.448 . . . . 0.0 110.565 -179.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.0 m -123.02 139.25 54.27 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 176.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 75.06 -67.27 2.11 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -114.34 127.51 55.89 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 122.086 -0.655 . . . . 0.0 110.565 -177.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -138.04 136.93 20.14 Favored Pre-proline 0 N--CA 1.497 1.897 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 174.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -60.74 151.91 73.34 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 O-C-N 123.044 1.023 . . . . 0.0 111.142 -172.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -60.26 -28.09 67.76 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 121.966 -0.459 . . . . 0.0 111.476 -172.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -92.13 14.29 16.47 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 122.019 -0.426 . . . . 0.0 111.817 -177.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.93 162.07 26.25 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.602 -0.686 . . . . 0.0 110.33 -172.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 75.0 mt -125.29 138.14 55.34 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -178.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 38.84 43.0 0.69 Allowed 'General case' 0 N--CA 1.512 2.65 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -178.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 55.09 41.85 31.34 Favored 'General case' 0 N--CA 1.507 2.418 0 O-C-N 121.817 -0.552 . . . . 0.0 111.484 -178.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 70.9 p -140.25 161.02 38.67 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.857 -0.527 . . . . 0.0 110.314 173.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.3 p -140.65 165.12 28.34 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 120.874 0.369 . . . . 0.0 110.606 -179.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 77.2 mt -114.36 132.45 63.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -174.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.1 t -145.27 155.81 43.45 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 122.024 -0.423 . . . . 0.0 111.112 -179.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 41.4 p-10 -111.53 28.42 8.76 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 122.072 -0.393 . . . . 0.0 110.944 167.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -113.32 -95.39 2.16 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 109.105 -1.598 . . . . 0.0 109.105 173.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 76.0 m-70 -149.45 172.05 15.59 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 122.106 -0.643 . . . . 0.0 109.546 175.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 79.4 m -93.09 139.12 30.89 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 167.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 19.4 p90 -128.72 151.19 49.82 Favored 'General case' 0 N--CA 1.499 2.019 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.745 -178.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -151.25 141.83 22.63 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 173.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.42 HD12 HD12 ' A' ' 99' ' ' ILE . 18.1 tt -141.84 149.11 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 CA-C-O 120.979 0.419 . . . . 0.0 110.488 -170.153 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.875 HD12 HD21 ' A' ' 73' ' ' LEU . 15.9 tt -136.07 145.07 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 177.397 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -150.15 139.23 21.11 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 122.118 -0.364 . . . . 0.0 110.084 -169.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.2 tm-20 -101.8 116.18 32.15 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 51.2 p30 -85.74 175.25 8.81 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 122.097 -0.377 . . . . 0.0 110.494 -175.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -60.13 -17.48 40.68 Favored 'General case' 0 N--CA 1.507 2.415 0 O-C-N 121.976 -0.452 . . . . 0.0 112.006 -174.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -92.13 -11.07 36.65 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.607 -0.683 . . . . 0.0 111.9 178.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.18 21.09 36.51 Favored Glycine 0 N--CA 1.497 2.731 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 177.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -96.28 139.06 32.96 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-N 118.373 1.086 . . . . 0.0 109.799 171.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.8 p -94.87 124.53 38.96 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 122.141 -0.349 . . . . 0.0 110.335 176.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.2 p -97.99 114.49 26.64 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 122.138 -0.351 . . . . 0.0 110.366 178.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.875 HD21 HD12 ' A' ' 63' ' ' ILE . 24.8 mt -97.4 126.6 42.74 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 122.173 -0.329 . . . . 0.0 110.275 178.011 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -146.7 144.77 29.68 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 122.021 -0.424 . . . . 0.0 110.627 176.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 86.4 p -143.81 167.03 23.26 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 175.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 174.2 -164.24 35.35 Favored Glycine 0 N--CA 1.497 2.734 0 N-CA-C 110.33 -1.108 . . . . 0.0 110.33 179.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 4.5 m -95.95 133.14 40.5 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 122.316 -0.52 . . . . 0.0 110.302 -175.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 49.1 ttm -99.51 121.66 41.48 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 174.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 33.4 pttt . . . . . 0 N--CA 1.503 2.202 0 O-C-N 122.032 -0.417 . . . . 0.0 110.518 -178.805 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 48.8 ttp180 . . . . . 0 N--CA 1.497 1.886 0 CA-C-O 120.976 0.417 . . . . 0.0 110.386 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 14.4 m -134.24 149.01 50.94 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 170.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.42 HD12 HD12 ' A' ' 62' ' ' ILE . 18.2 tt -143.24 156.14 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.982 -0.448 . . . . 0.0 110.022 -179.004 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -143.7 146.45 33.2 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 120.959 0.409 . . . . 0.0 110.39 -179.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 25.3 p -143.09 141.41 31.24 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 -179.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 17.9 p -157.59 135.54 10.82 Favored 'General case' 0 N--CA 1.502 2.152 0 C-N-CA 120.514 -0.475 . . . . 0.0 111.044 -171.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 58.5 ttt180 -107.4 51.42 0.74 Allowed 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.364 0.602 . . . . 0.0 110.569 -175.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 23.6 p -143.23 151.67 40.85 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.778 -0.576 . . . . 0.0 109.861 175.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 15.9 p30 -61.72 132.3 52.75 Favored 'General case' 0 N--CA 1.506 2.355 0 CA-C-O 121.42 0.628 . . . . 0.0 111.772 -163.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.44 HD22 ' OE1' ' A' ' 109' ' ' GLN . 73.9 mt 52.19 26.93 4.23 Favored 'General case' 0 N--CA 1.507 2.403 0 O-C-N 122.036 -0.415 . . . . 0.0 111.891 179.461 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 26.1 p -63.0 -23.35 67.41 Favored 'General case' 0 N--CA 1.508 2.442 0 O-C-N 121.935 -0.478 . . . . 0.0 111.567 175.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -92.27 -22.81 19.55 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.77 -0.581 . . . . 0.0 111.273 178.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . 0.44 ' OE1' HD22 ' A' ' 106' ' ' LEU . 29.2 tt0 -60.67 -37.85 82.94 Favored 'General case' 0 N--CA 1.508 2.447 0 O-C-N 121.615 -0.678 . . . . 0.0 110.745 -177.491 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -100.03 16.15 24.93 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 122.135 -0.353 . . . . 0.0 111.709 178.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 14.8 tp -116.22 111.41 20.14 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.661 -0.649 . . . . 0.0 110.362 -174.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 3.1 tp-100 -96.39 120.73 61.84 Favored Pre-proline 0 N--CA 1.496 1.863 0 CA-C-O 118.848 -0.596 . . . . 0.0 110.04 172.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -70.69 141.84 42.42 Favored 'Trans proline' 0 N--CA 1.491 1.372 0 O-C-N 123.213 1.112 . . . . 0.0 110.168 175.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 48.4 p -139.22 150.02 45.04 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 122.135 -0.353 . . . . 0.0 110.138 179.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 15.0 mt . . . . . 0 N--CA 1.502 2.164 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.016 179.09 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo . . . . . 0 N--CA 1.502 2.013 0 N-CA-C 111.137 -0.37 . . . . 0.0 111.137 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -149.95 46.67 0.93 Allowed 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.159 0.504 . . . . 0.0 110.792 -179.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.403 HD23 HG23 ' A' ' 55' ' ' THR . 15.5 tp -161.15 112.14 1.76 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.882 -0.511 . . . . 0.0 110.272 -173.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 29.2 ttpt -99.74 134.95 41.88 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 122.171 -0.331 . . . . 0.0 110.257 178.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 80.2 m -120.97 140.35 52.0 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 -176.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -82.77 143.16 31.05 Favored 'General case' 0 N--CA 1.501 2.091 0 C-N-CA 120.631 -0.428 . . . . 0.0 109.97 178.028 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 28.1 p -115.68 136.99 52.52 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 122.0 -0.438 . . . . 0.0 110.576 -178.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.2 m -122.88 138.75 54.57 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 176.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 75.47 -67.35 2.23 Favored Glycine 0 N--CA 1.495 2.626 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 179.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -113.14 122.74 48.44 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 122.035 -0.685 . . . . 0.0 110.522 -176.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -138.08 136.53 19.68 Favored Pre-proline 0 N--CA 1.496 1.826 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 174.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -60.55 152.13 70.53 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 O-C-N 123.075 1.039 . . . . 0.0 111.151 -171.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -60.26 -27.83 67.56 Favored 'General case' 0 N--CA 1.507 2.415 0 O-C-N 121.996 -0.44 . . . . 0.0 111.356 -173.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -92.12 14.26 16.56 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.843 -0.536 . . . . 0.0 111.737 -178.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.8 162.05 26.37 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.62 -0.675 . . . . 0.0 110.334 -173.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 70.9 mt -124.41 136.71 59.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -176.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 19.7 p30 37.95 43.12 0.5 Allowed 'General case' 0 N--CA 1.513 2.704 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -176.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 30.8 m120 55.36 43.41 28.93 Favored 'General case' 0 N--CA 1.508 2.428 0 O-C-N 121.824 -0.547 . . . . 0.0 111.462 -178.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 60.7 p -139.63 161.22 38.05 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.796 -0.565 . . . . 0.0 110.305 171.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.5 p -137.49 162.91 32.43 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 120.766 0.317 . . . . 0.0 110.565 178.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 77.5 mt -111.63 131.79 62.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -175.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.403 HG23 HD23 ' A' ' 36' ' ' LEU . 8.7 t -141.34 153.7 45.27 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.955 -0.465 . . . . 0.0 110.99 -177.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 26.8 p30 -107.57 28.66 7.93 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 122.055 -0.403 . . . . 0.0 110.771 167.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -119.15 -96.58 1.7 Allowed Glycine 0 N--CA 1.497 2.717 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 175.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 74.7 m80 -150.75 170.79 18.37 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 122.125 -0.633 . . . . 0.0 110.14 178.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 72.8 m -94.42 139.36 31.21 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 170.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -131.78 153.41 50.14 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.492 -178.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -152.91 136.01 15.62 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 174.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.689 HD12 HD12 ' A' ' 99' ' ' ILE . 18.1 tt -133.57 149.05 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 122.06 -0.4 . . . . 0.0 110.42 -168.414 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 13.5 tt -136.62 145.04 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -150.25 142.78 24.45 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 -172.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.4 tm-20 -101.63 117.81 35.65 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 -178.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 51.7 p30 -86.84 175.28 8.28 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-O 120.753 0.311 . . . . 0.0 110.551 -175.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -60.31 -17.64 44.2 Favored 'General case' 0 N--CA 1.507 2.414 0 O-C-N 121.915 -0.491 . . . . 0.0 112.1 -173.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -92.87 -11.0 34.64 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.616 -0.677 . . . . 0.0 111.88 178.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.18 21.06 36.59 Favored Glycine 0 N--CA 1.498 2.827 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 177.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -96.82 140.54 31.24 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 118.411 1.106 . . . . 0.0 109.866 170.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 10.9 p -94.86 125.67 39.68 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.304 176.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 17.9 p -97.97 112.92 24.68 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 122.124 -0.36 . . . . 0.0 110.289 177.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.54 ' N ' HD12 ' A' ' 73' ' ' LEU . 6.4 mp -98.77 126.67 44.47 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 122.12 -0.363 . . . . 0.0 110.379 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -146.52 145.63 30.23 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 122.098 -0.376 . . . . 0.0 110.402 176.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 98.1 p -143.64 166.91 23.55 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 178.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 177.59 -164.7 33.96 Favored Glycine 0 N--CA 1.497 2.721 0 N-CA-C 110.301 -1.119 . . . . 0.0 110.301 -178.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 2.1 m -95.86 131.68 41.93 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 122.187 -0.596 . . . . 0.0 110.244 -174.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 53.8 ttm -98.75 122.7 42.32 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 122.011 -0.431 . . . . 0.0 110.162 175.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 22.2 pttt . . . . . 0 N--CA 1.503 2.202 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.552 175.858 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 30.1 ptt180 . . . . . 0 N--CA 1.498 1.956 0 CA-C-O 120.856 0.36 . . . . 0.0 110.648 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 18.9 m -133.79 149.13 51.41 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 177.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.689 HD12 HD12 ' A' ' 62' ' ' ILE . 17.9 tt -143.27 119.73 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 122.017 -0.427 . . . . 0.0 110.078 -178.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -105.91 149.87 26.17 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 120.824 0.345 . . . . 0.0 110.595 -179.106 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 90.9 m -143.15 163.16 33.65 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 175.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 12.1 p -157.21 150.99 24.4 Favored 'General case' 0 N--CA 1.501 2.106 0 C-N-CA 120.071 -0.652 . . . . 0.0 111.267 176.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 59.3 ttt180 -99.68 44.49 1.02 Allowed 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.259 0.552 . . . . 0.0 109.826 166.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 34.2 p -144.73 142.7 30.24 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 121.37 0.605 . . . . 0.0 110.6 -175.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 17.8 p-10 -70.98 138.87 50.33 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-O 121.449 0.642 . . . . 0.0 111.544 -162.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 29.5 mt 51.38 27.92 4.03 Favored 'General case' 0 N--CA 1.505 2.302 0 CA-C-N 116.361 -0.381 . . . . 0.0 112.006 174.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 18.3 p -60.11 -32.72 71.25 Favored 'General case' 0 N--CA 1.51 2.541 0 C-N-CA 119.969 -0.693 . . . . 0.0 111.162 174.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -81.77 -22.95 36.9 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 122.1 -0.375 . . . . 0.0 111.45 -168.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -61.52 -39.32 90.6 Favored 'General case' 0 N--CA 1.508 2.435 0 O-C-N 121.658 -0.651 . . . . 0.0 110.717 -174.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -99.75 16.29 24.08 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 122.072 -0.392 . . . . 0.0 111.628 176.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 18.5 tp -108.73 116.73 32.54 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.613 -0.679 . . . . 0.0 110.224 -174.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -95.84 120.63 62.84 Favored Pre-proline 0 N--CA 1.497 1.885 0 CA-C-O 118.766 -0.635 . . . . 0.0 109.955 172.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -70.68 142.26 43.43 Favored 'Trans proline' 0 N--CA 1.491 1.368 0 O-C-N 123.329 1.173 . . . . 0.0 110.289 174.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 49.0 p -139.22 150.09 45.12 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 178.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 44.0 mt . . . . . 0 N--CA 1.501 2.111 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.079 179.458 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo . . . . . 0 N--CA 1.497 1.732 0 N-CA-C 111.14 -0.369 . . . . 0.0 111.14 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -158.1 52.24 0.44 Allowed 'General case' 0 N--CA 1.501 2.092 0 CA-C-O 121.434 0.635 . . . . 0.0 110.283 164.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.403 HD23 HG23 ' A' ' 55' ' ' THR . 20.7 tp -158.56 115.22 2.77 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.65 -0.656 . . . . 0.0 110.185 -177.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 49.8 tttt -99.82 133.59 43.96 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 122.162 -0.336 . . . . 0.0 110.236 179.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 77.6 m -121.01 140.44 51.92 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 -178.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -82.23 142.95 31.71 Favored 'General case' 0 N--CA 1.502 2.125 0 C-N-CA 120.581 -0.448 . . . . 0.0 109.958 176.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 27.8 p -115.82 136.99 52.52 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 122.016 -0.428 . . . . 0.0 110.561 -177.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 28.2 t -123.07 134.73 54.24 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 178.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.35 -66.33 2.95 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -111.54 118.42 35.67 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 122.098 -0.648 . . . . 0.0 110.548 -176.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -138.01 135.95 19.2 Favored Pre-proline 0 N--CA 1.495 1.809 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 174.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -61.75 153.84 64.82 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 O-C-N 123.237 1.125 . . . . 0.0 111.105 -170.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -60.2 -27.67 67.36 Favored 'General case' 0 N--CA 1.508 2.465 0 O-C-N 122.01 -0.431 . . . . 0.0 111.44 -173.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -92.22 14.27 16.73 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.964 -0.46 . . . . 0.0 111.737 -177.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.03 162.07 27.0 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.687 -0.633 . . . . 0.0 110.182 -174.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 70.3 mt -124.1 136.14 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -175.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 19.4 p30 37.62 43.36 0.44 Allowed 'General case' 0 N--CA 1.515 2.788 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 -176.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 30.6 t30 56.29 43.07 27.04 Favored 'General case' 0 N--CA 1.507 2.379 0 O-C-N 121.706 -0.621 . . . . 0.0 111.413 -179.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 51.0 p -140.69 163.97 31.45 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.78 -0.575 . . . . 0.0 110.363 171.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.7 p -139.05 164.97 28.37 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 120.955 0.407 . . . . 0.0 110.549 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 77.5 mt -112.62 133.03 59.71 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -175.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.403 HG23 HD23 ' A' ' 36' ' ' LEU . 8.8 t -140.67 152.62 45.51 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 122.022 -0.424 . . . . 0.0 111.163 -178.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -108.78 30.04 6.88 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 122.022 -0.424 . . . . 0.0 110.659 167.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -122.35 -94.81 1.25 Allowed Glycine 0 N--CA 1.496 2.657 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 176.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 27.5 m80 -147.73 171.95 14.86 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 122.042 -0.681 . . . . 0.0 109.429 176.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 78.6 m -93.85 139.0 31.4 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 166.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -129.81 152.27 49.48 Favored 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 120.306 -0.558 . . . . 0.0 110.7 -177.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -150.89 145.4 25.62 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 176.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.487 HD12 HD12 ' A' ' 99' ' ' ILE . 18.1 tt -142.07 149.25 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 CA-C-O 120.998 0.428 . . . . 0.0 110.357 -172.502 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.813 HD12 HD21 ' A' ' 73' ' ' LEU . 16.7 tt -136.54 145.19 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 178.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -149.48 138.44 21.19 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 -170.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.3 tm-20 -101.69 116.52 32.91 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 -179.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 24.1 p-10 -86.95 175.34 8.2 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 122.12 -0.363 . . . . 0.0 110.608 -176.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -60.37 -17.27 42.4 Favored 'General case' 0 N--CA 1.508 2.433 0 O-C-N 121.946 -0.471 . . . . 0.0 112.008 -173.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -91.88 -11.41 36.45 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.647 -0.658 . . . . 0.0 111.787 178.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.02 21.03 37.13 Favored Glycine 0 N--CA 1.497 2.754 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 176.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -96.66 141.13 30.28 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 118.263 1.031 . . . . 0.0 109.838 171.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.5 p -94.86 126.63 40.32 Favored 'General case' 0 N--CA 1.499 2.009 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.196 176.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.5 p -98.01 114.51 26.68 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 122.134 -0.354 . . . . 0.0 110.267 177.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.813 HD21 HD12 ' A' ' 63' ' ' ILE . 70.7 mt -97.09 127.81 43.42 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 122.149 -0.345 . . . . 0.0 110.297 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -144.68 144.98 31.51 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 122.089 -0.382 . . . . 0.0 110.572 176.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 99.8 p -143.67 166.48 24.74 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 176.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 179.47 -166.27 35.51 Favored Glycine 0 N--CA 1.497 2.731 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 2.2 m -97.24 133.0 42.44 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 122.319 -0.518 . . . . 0.0 110.263 -175.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 47.1 ttm -105.05 121.68 44.3 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 122.135 -0.353 . . . . 0.0 110.146 173.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 12.1 pttt . . . . . 0 N--CA 1.501 2.085 0 C-N-CA 120.514 -0.474 . . . . 0.0 110.262 174.865 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 27.7 ptt180 . . . . . 0 N--CA 1.497 1.892 0 CA-C-O 120.891 0.377 . . . . 0.0 110.803 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.421 ' O ' HG22 ' A' ' 63' ' ' ILE . 19.1 m -133.66 149.43 51.56 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.487 HD12 HD12 ' A' ' 62' ' ' ILE . 18.3 tt -143.03 155.96 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.964 -0.46 . . . . 0.0 110.21 -177.299 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 52.1 mm-40 -143.65 152.01 40.82 Favored 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 120.901 -0.32 . . . . 0.0 110.613 -176.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 26.7 p -143.12 144.47 32.24 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 178.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 20.1 p -157.7 133.85 9.48 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.991 -0.443 . . . . 0.0 110.792 -175.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 31.6 ttp180 -106.25 47.21 0.89 Allowed 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.26 0.552 . . . . 0.0 110.659 -173.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.1 p -139.36 152.14 46.92 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.95 -0.469 . . . . 0.0 109.829 176.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 17.5 p-10 -61.35 131.94 51.93 Favored 'General case' 0 N--CA 1.506 2.344 0 CA-C-O 121.373 0.606 . . . . 0.0 111.904 -163.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 72.4 mt 52.22 26.38 3.93 Favored 'General case' 0 N--CA 1.506 2.348 0 O-C-N 122.078 -0.389 . . . . 0.0 112.007 179.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 26.2 p -62.9 -22.22 66.58 Favored 'General case' 0 N--CA 1.507 2.384 0 O-C-N 121.843 -0.536 . . . . 0.0 111.806 176.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -91.71 -22.81 20.02 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.785 -0.572 . . . . 0.0 111.37 179.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -60.29 -37.43 80.47 Favored 'General case' 0 N--CA 1.509 2.491 0 O-C-N 121.682 -0.637 . . . . 0.0 110.717 -175.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -101.41 16.19 26.43 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 122.116 -0.365 . . . . 0.0 111.649 177.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 15.0 tp -111.67 110.24 20.53 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.532 -0.73 . . . . 0.0 110.384 -174.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -97.08 120.76 60.74 Favored Pre-proline 0 N--CA 1.495 1.823 0 CA-C-O 118.94 -0.553 . . . . 0.0 110.063 173.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.4 149.32 50.28 Favored 'Trans proline' 0 N--CA 1.489 1.239 0 O-C-N 123.092 1.048 . . . . 0.0 110.274 175.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 34.1 p -139.13 137.82 36.45 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 122.144 -0.348 . . . . 0.0 110.238 178.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 41.9 mt . . . . . 0 N--CA 1.502 2.156 0 C-N-CA 120.669 -0.413 . . . . 0.0 110.151 179.788 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo . . . . . 0 N--CA 1.497 1.699 0 N-CA-C 111.193 -0.349 . . . . 0.0 111.193 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -157.82 52.53 0.45 Allowed 'General case' 0 N--CA 1.501 2.098 0 CA-C-O 121.363 0.601 . . . . 0.0 110.26 165.082 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.435 HD23 HG23 ' A' ' 55' ' ' THR . 21.1 tp -158.35 114.89 2.79 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.77 -0.581 . . . . 0.0 110.111 -177.858 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 27.9 ttmt -99.74 131.77 45.51 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 122.11 -0.368 . . . . 0.0 110.314 178.989 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 70.0 m -118.25 140.33 49.96 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -178.852 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -82.62 145.83 29.47 Favored 'General case' 0 N--CA 1.501 2.092 0 C-N-CA 120.624 -0.43 . . . . 0.0 109.984 176.255 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 28.0 p -115.15 137.07 52.43 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 122.007 -0.433 . . . . 0.0 110.599 -177.864 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 99.2 p -123.01 144.0 49.56 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 176.598 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.36 -68.22 1.46 Allowed Glycine 0 N--CA 1.495 2.587 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 -179.789 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -116.84 129.59 56.18 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.939 -0.742 . . . . 0.0 110.518 -177.042 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -138.07 136.86 20.02 Favored Pre-proline 0 N--CA 1.496 1.838 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 174.689 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -60.21 151.53 72.7 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 O-C-N 123.078 1.041 . . . . 0.0 111.231 -172.191 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -60.1 -28.21 67.66 Favored 'General case' 0 N--CA 1.507 2.407 0 O-C-N 121.98 -0.45 . . . . 0.0 111.478 -172.595 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -92.11 14.28 16.47 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.981 -0.449 . . . . 0.0 111.794 -177.937 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.85 161.61 26.64 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.674 -0.641 . . . . 0.0 110.277 -173.117 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 75.7 mt -126.08 141.1 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -177.991 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 38.9 41.87 0.58 Allowed 'General case' 0 N--CA 1.512 2.663 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -177.206 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 30.7 m120 54.89 41.55 31.81 Favored 'General case' 0 N--CA 1.508 2.464 0 O-C-N 121.845 -0.535 . . . . 0.0 111.461 -178.955 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 43.7 p -141.65 162.6 35.08 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.82 -0.55 . . . . 0.0 110.376 174.323 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.3 p -139.31 163.49 32.34 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 120.967 0.413 . . . . 0.0 110.555 -179.384 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 77.9 mt -109.43 131.95 58.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -176.189 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.435 HG23 HD23 ' A' ' 36' ' ' LEU . 8.9 t -139.16 152.83 47.73 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.935 -0.478 . . . . 0.0 110.893 179.804 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 26.8 p30 -110.04 31.56 5.78 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 122.046 -0.409 . . . . 0.0 110.575 166.91 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -123.29 -94.71 1.16 Allowed Glycine 0 N--CA 1.497 2.718 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 175.642 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 31.9 m-70 -146.35 172.05 14.07 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 122.056 -0.673 . . . . 0.0 109.513 176.668 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 81.0 m -94.36 139.22 31.38 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 165.161 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 21.3 p90 -127.92 146.44 50.64 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 120.35 -0.54 . . . . 0.0 110.431 -179.199 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -147.61 140.2 24.68 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 174.431 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.63 HD12 HD12 ' A' ' 99' ' ' ILE . 18.3 tt -143.09 149.28 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.31 -171.644 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.511 HD12 ' HG ' ' A' ' 73' ' ' LEU . 15.6 tt -137.96 145.26 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 178.09 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -150.2 146.91 27.13 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 122.041 -0.412 . . . . 0.0 110.023 -168.044 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.3 tm-20 -101.69 116.94 33.84 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 122.124 -0.36 . . . . 0.0 110.117 -177.059 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -87.2 175.3 8.12 Favored 'General case' 0 N--CA 1.502 2.148 0 CA-C-O 120.868 0.366 . . . . 0.0 110.536 -175.621 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -60.56 -17.35 45.59 Favored 'General case' 0 N--CA 1.506 2.365 0 O-C-N 121.914 -0.491 . . . . 0.0 112.17 -172.646 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -92.77 -11.6 33.4 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.643 -0.66 . . . . 0.0 111.803 178.172 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.9 20.12 40.87 Favored Glycine 0 N--CA 1.499 2.862 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 177.083 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -97.37 143.88 27.68 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 118.399 1.099 . . . . 0.0 109.806 169.821 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.8 p -94.87 124.99 39.23 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.255 178.014 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 17.8 p -97.94 112.96 24.7 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 120.923 -0.311 . . . . 0.0 110.289 178.223 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.542 ' N ' HD12 ' A' ' 73' ' ' LEU . 6.3 mp -98.24 128.53 44.74 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 122.144 -0.347 . . . . 0.0 110.273 -179.91 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -145.87 145.94 30.92 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.347 177.275 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 86.8 p -143.68 165.85 26.5 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 177.015 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 178.4 -164.53 33.22 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 -179.902 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 3.9 m -97.07 132.51 42.8 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 122.185 -0.597 . . . . 0.0 110.384 -175.53 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 49.1 ttm -99.56 121.88 41.82 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.993 -0.442 . . . . 0.0 110.231 176.662 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.3 ptpp? . . . . . 0 N--CA 1.503 2.219 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.214 178.135 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 27.7 ptt180 . . . . . 0 N--CA 1.494 1.772 0 CA-C-O 120.843 0.354 . . . . 0.0 110.401 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 18.1 m -131.03 149.04 52.8 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 174.841 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.63 HD12 HD12 ' A' ' 62' ' ' ILE . 18.5 tt -143.13 154.97 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.991 -0.443 . . . . 0.0 110.051 -178.586 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -143.92 125.9 15.36 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 120.842 0.353 . . . . 0.0 110.699 -179.572 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 92.8 m -104.9 147.55 27.64 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 168.63 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 22.9 p -157.76 135.19 10.37 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.858 -0.526 . . . . 0.0 111.031 176.22 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 9.4 ttm180 -108.2 47.04 0.92 Allowed 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 121.29 0.567 . . . . 0.0 110.788 -173.315 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.3 p -141.87 151.93 43.16 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.771 -0.581 . . . . 0.0 110.033 177.713 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 17.5 p-10 -61.69 132.43 53.21 Favored 'General case' 0 N--CA 1.505 2.287 0 CA-C-O 121.339 0.59 . . . . 0.0 111.821 -164.243 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.475 HD22 ' OE1' ' A' ' 109' ' ' GLN . 75.7 mt 52.0 27.13 4.18 Favored 'General case' 0 N--CA 1.506 2.365 0 O-C-N 122.051 -0.406 . . . . 0.0 111.995 179.547 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 25.3 p -62.62 -22.8 66.68 Favored 'General case' 0 N--CA 1.507 2.42 0 O-C-N 121.847 -0.533 . . . . 0.0 111.585 175.419 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -92.82 -22.82 19.09 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.682 -0.636 . . . . 0.0 111.224 178.071 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . 0.475 ' OE1' HD22 ' A' ' 106' ' ' LEU . 27.7 tt0 -61.63 -38.62 88.35 Favored 'General case' 0 N--CA 1.507 2.381 0 O-C-N 121.57 -0.706 . . . . 0.0 110.671 -177.034 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -100.1 16.19 24.89 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 122.113 -0.367 . . . . 0.0 111.596 178.772 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 18.0 tp -112.68 114.31 26.84 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.625 -0.672 . . . . 0.0 110.361 -175.458 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -96.31 120.83 61.78 Favored Pre-proline 0 N--CA 1.496 1.87 0 CA-C-O 118.927 -0.558 . . . . 0.0 109.944 173.022 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -68.81 144.93 60.97 Favored 'Trans proline' 0 N--CA 1.491 1.353 0 O-C-N 123.17 1.089 . . . . 0.0 110.253 175.33 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 47.6 p -139.18 134.15 32.38 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 122.074 -0.391 . . . . 0.0 110.121 179.624 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 17.2 mt . . . . . 0 N--CA 1.5 2.035 0 CA-C-O 119.287 -0.387 . . . . 0.0 110.173 179.664 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.314 0 N-CA-C 109.554 -1.419 . . . . 7.0800000000000001 109.554 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -58.4 117.7 4.46 Favored 'Trans proline' 0 N--CA 1.501 1.945 0 O-C-N 123.339 1.178 . . . . 6.3700000000000001 111.372 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -155.34 79.8 1.04 Allowed 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 109.551 -0.537 . . . . 5.7400000000000002 109.551 -176.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -78.66 88.09 4.57 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.888 -0.507 . . . . 3.1499999999999999 109.881 177.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 21.7 m -101.92 97.51 7.86 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 122.017 -0.427 . . . . 2.2000000000000002 110.191 179.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 72.6 mt -142.41 118.85 6.97 Favored Pre-proline 0 N--CA 1.497 1.9 0 N-CA-C 109.445 -0.576 . . . . 1.1499999999999999 109.445 178.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -58.89 146.61 92.81 Favored 'Trans proline' 0 N--CA 1.503 2.075 0 C-N-CA 120.893 1.062 . . . . 0.40000000000000002 111.304 -178.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -152.89 49.32 0.73 Allowed 'General case' 0 N--CA 1.498 1.948 0 CA-C-O 121.174 0.511 . . . . 0.64000000000000001 110.699 -178.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.443 HD23 HG23 ' A' ' 55' ' ' THR . 23.2 tp -158.82 101.53 1.64 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.811 -0.555 . . . . 0.19 110.601 -176.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -99.97 118.18 35.83 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 110.167 -0.308 . . . . 1.51 110.167 176.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 68.0 m -121.71 140.53 52.2 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 122.025 -0.422 . . . . 0.47999999999999998 110.935 -178.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -78.52 150.54 32.87 Favored 'General case' 0 N--CA 1.501 2.094 0 C-N-CA 120.751 -0.38 . . . . 0.51000000000000001 110.032 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 27.0 p -119.01 140.68 49.62 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 122.044 -0.41 . . . . 0.29999999999999999 110.547 -177.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 30.9 t -123.0 143.14 50.13 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 122.072 -0.392 . . . . 1.6899999999999999 110.155 178.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.63 -69.9 1.43 Allowed Glycine 0 N--CA 1.495 2.606 0 N-CA-C 109.668 -1.373 . . . . 0.77000000000000002 109.668 177.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -115.51 123.83 49.52 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 122.074 -0.662 . . . . 2.8199999999999998 110.544 -176.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -138.11 147.7 57.12 Favored Pre-proline 0 N--CA 1.497 1.879 0 N-CA-C 109.386 -0.598 . . . . 0.47999999999999998 109.386 175.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -63.8 151.62 84.32 Favored 'Trans proline' 0 N--CA 1.492 1.432 0 O-C-N 123.203 1.107 . . . . 0.41999999999999998 110.864 -174.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -59.15 -21.86 60.02 Favored 'General case' 0 N--CA 1.507 2.379 0 O-C-N 121.985 -0.447 . . . . 2.0299999999999998 111.521 177.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -96.7 14.15 25.97 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.776 -0.577 . . . . 1.1399999999999999 111.864 -177.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -83.31 162.1 21.22 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.607 -0.683 . . . . 0.34999999999999998 110.466 -173.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 77.5 mt -125.51 142.39 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 N-CA-C 108.873 -0.788 . . . . 0.45000000000000001 108.873 -178.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 38.44 41.58 0.46 Allowed 'General case' 0 N--CA 1.514 2.735 0 N-CA-C 113.271 0.841 . . . . 1.1100000000000001 113.271 -177.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 54.97 41.01 32.24 Favored 'General case' 0 N--CA 1.508 2.459 0 O-C-N 121.802 -0.561 . . . . 1.6499999999999999 111.489 -179.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 41.6 p -137.68 160.31 39.57 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.877 -0.514 . . . . 0.22 110.373 173.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.3 p -135.75 162.15 33.57 Favored 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 120.957 0.408 . . . . 0.20999999999999999 110.465 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 78.9 mt -129.29 125.91 62.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 108.774 -0.825 . . . . 0.33000000000000002 108.774 -169.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.443 HG23 HD23 ' A' ' 36' ' ' LEU . 9.5 t -140.12 159.21 42.68 Favored 'General case' 0 N--CA 1.5 2.049 0 C-N-CA 120.537 -0.465 . . . . 0.23000000000000001 111.288 -177.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 38.1 p-10 -106.59 28.22 8.06 Favored 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 120.856 -0.338 . . . . 0.81999999999999995 110.505 164.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -117.35 -113.86 2.69 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 109.057 -1.617 . . . . 0.23000000000000001 109.057 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 7.8 m-70 -136.75 157.57 46.44 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 108.996 -0.742 . . . . 1.26 108.996 175.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 96.4 m -99.11 139.43 34.77 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 109.31 -0.626 . . . . 0.25 109.31 176.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -129.35 158.14 39.96 Favored 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 120.604 -0.438 . . . . 0.23000000000000001 110.726 -170.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -151.05 143.39 24.19 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.293 -0.632 . . . . 0.22 109.293 177.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.44 HD12 HD12 ' A' ' 99' ' ' ILE . 18.0 tt -142.44 149.18 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 C-N-CA 120.686 -0.405 . . . . 0.29999999999999999 110.477 -170.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.799 HD12 HD11 ' A' ' 73' ' ' LEU . 16.0 tt -138.76 145.2 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 109.502 -0.555 . . . . 0.34000000000000002 109.502 178.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -150.1 141.08 22.91 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 109.93 -0.396 . . . . 1.1599999999999999 109.93 -170.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.9 tm-20 -101.68 116.29 32.42 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 109.975 -0.379 . . . . 0.35999999999999999 109.975 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -86.73 175.21 8.36 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 122.067 -0.396 . . . . 0.77000000000000002 110.583 -175.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -60.49 -17.29 44.3 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 121.995 -0.441 . . . . 1.5900000000000001 112.184 -172.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -92.49 -11.64 34.1 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.601 -0.687 . . . . 2.0 111.83 177.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.82 21.0 37.88 Favored Glycine 0 N--CA 1.497 2.765 0 N-CA-C 111.109 -0.796 . . . . 0.40000000000000002 111.109 176.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -97.42 142.42 29.3 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 118.417 1.108 . . . . 1.28 109.8 169.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.1 p -94.88 129.58 41.84 Favored 'General case' 0 N--CA 1.497 1.908 0 C-N-CA 120.797 -0.361 . . . . 0.33000000000000002 110.356 177.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 17.7 p -97.91 113.04 24.76 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 122.128 -0.357 . . . . 0.34000000000000002 110.327 177.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.799 HD11 HD12 ' A' ' 63' ' ' ILE . 4.5 mm? -96.77 121.98 39.22 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 110.157 -0.312 . . . . 1.1799999999999999 110.157 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -143.77 148.52 35.73 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 122.098 -0.376 . . . . 0.25 110.486 178.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 96.8 p -143.59 164.15 31.2 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 109.735 -0.469 . . . . 0.17000000000000001 109.735 176.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -172.51 -179.05 43.07 Favored Glycine 0 N--CA 1.496 2.688 0 N-CA-C 110.215 -1.154 . . . . 0.23999999999999999 110.215 -177.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 6.2 m -100.21 133.83 44.03 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 122.203 -0.587 . . . . 0.57999999999999996 110.282 -178.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 27.5 ttm -99.5 126.96 45.54 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 122.003 -0.436 . . . . 0.39000000000000001 110.114 176.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 22.2 pttm -65.69 172.0 3.79 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 122.07 -0.394 . . . . 1.6799999999999999 110.485 177.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 56.7 t80 -65.02 146.61 54.79 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 122.095 -0.378 . . . . 4.4800000000000004 110.472 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -133.17 -47.22 0.84 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 122.137 -0.352 . . . . 2.0 110.326 -177.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 146.85 -35.41 1.29 Allowed Glycine 0 N--CA 1.496 2.64 0 N-CA-C 109.714 -1.354 . . . . 1.6799999999999999 109.714 -178.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 46.4 m -72.76 123.34 23.13 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 122.084 -0.656 . . . . 2.9500000000000002 110.113 -179.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -76.36 -37.53 57.11 Favored 'General case' 0 N--CA 1.501 2.118 0 C-N-CA 120.752 -0.379 . . . . 2.9900000000000002 110.398 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -155.62 68.1 0.65 Allowed 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 121.265 0.555 . . . . 6.2000000000000002 109.968 -179.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -155.37 106.87 2.6 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.868 -0.52 . . . . 4.0 109.837 -177.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 87.3 m -105.28 88.95 2.98 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.045 0.45 . . . . 1.6499999999999999 109.869 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -82.75 175.09 10.39 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.994 -0.441 . . . . 4.4800000000000004 110.767 -173.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -132.72 150.31 52.17 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 109.983 -0.377 . . . . 2.73 109.983 171.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.1 m -75.23 139.38 72.16 Favored Pre-proline 0 N--CA 1.502 2.137 0 CA-C-O 119.246 -0.407 . . . . 3.1600000000000001 109.92 -178.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -81.11 60.52 7.86 Favored 'Trans proline' 0 N--CA 1.494 1.539 0 O-C-N 123.277 1.146 . . . . 3.9100000000000001 111.393 -172.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 16.9 pttp -155.67 33.9 0.36 Allowed 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.554 -0.716 . . . . 5.0599999999999996 110.338 172.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.454 ' HB1' ' NH1' ' A' ' 97' ' ' ARG . . . -83.74 122.82 29.16 Favored 'General case' 0 N--CA 1.499 2.012 0 C-N-CA 120.933 -0.307 . . . . 2.23 110.498 -176.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -119.81 53.64 1.05 Allowed 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.265 0.555 . . . . 6.1500000000000004 110.281 176.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 20.4 tp -155.18 154.12 31.79 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.738 -0.601 . . . . 1.8600000000000001 110.29 -178.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 71.6 mtp85 -93.32 122.55 35.84 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 109.985 -0.376 . . . . 2.98 109.985 175.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.454 ' NH1' ' HB1' ' A' ' 93' ' ' ALA . 26.7 ptt-85 -161.51 165.38 28.7 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 122.063 -0.398 . . . . 2.21 110.685 -173.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.494 ' OG1' HD23 ' A' ' 115' ' ' LEU . 11.7 m -128.48 149.1 50.73 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 109.676 -0.49 . . . . 0.40000000000000002 109.676 172.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.44 HD12 HD12 ' A' ' 62' ' ' ILE . 18.6 tt -143.17 155.96 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 122.04 -0.412 . . . . 0.44 110.098 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -147.48 155.88 42.32 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 120.978 -0.289 . . . . 1.6299999999999999 110.342 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 26.6 p -142.47 157.42 44.78 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 110.113 -0.329 . . . . 1.3700000000000001 110.113 176.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 24.4 p -157.55 138.13 12.99 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 122.014 -0.429 . . . . 0.40999999999999998 110.825 -168.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 70.3 mtp180 -112.01 44.57 1.38 Allowed 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 121.213 0.53 . . . . 2.4100000000000001 110.554 -177.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.3 p -140.44 153.22 46.21 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.863 -0.523 . . . . 0.27000000000000002 110.276 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 34.7 p-10 -64.51 139.77 58.8 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.817 -0.552 . . . . 1.02 111.233 -170.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 17.0 mt 53.15 25.8 4.51 Favored 'General case' 0 N--CA 1.507 2.381 0 O-C-N 121.936 -0.477 . . . . 0.42999999999999999 112.282 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 28.1 p -67.95 -25.3 65.38 Favored 'General case' 0 N--CA 1.503 2.217 0 C-N-CA 119.869 -0.732 . . . . 0.34999999999999998 111.067 172.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -81.05 -33.28 33.6 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.888 -0.508 . . . . 1.3700000000000001 110.484 179.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 47.0 tt0 -63.35 -41.42 98.84 Favored 'General case' 0 N--CA 1.506 2.328 0 O-C-N 121.968 -0.458 . . . . 1.3300000000000001 110.797 -176.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -102.32 16.21 26.89 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 122.1 -0.375 . . . . 0.64000000000000001 111.9 -174.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 12.4 tp -126.16 108.94 11.8 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.601 -0.687 . . . . 0.31 110.397 -176.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -98.3 120.93 58.43 Favored Pre-proline 0 N--CA 1.496 1.864 0 CA-C-O 118.811 -0.614 . . . . 1.8300000000000001 110.032 173.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -67.91 136.39 38.17 Favored 'Trans proline' 0 N--CA 1.492 1.424 0 O-C-N 123.18 1.095 . . . . 0.5 110.333 176.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 35.0 p -139.25 150.11 45.11 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 122.078 -0.389 . . . . 0.76000000000000001 110.204 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.494 HD23 ' OG1' ' A' ' 98' ' ' THR . 34.8 mt -70.3 152.83 95.51 Favored Pre-proline 0 N--CA 1.502 2.135 0 C-N-CA 120.692 -0.403 . . . . 0.62 109.961 178.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -67.87 148.88 77.52 Favored 'Trans proline' 0 N--CA 1.491 1.336 0 O-C-N 123.49 1.258 . . . . 1.26 110.347 -176.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -69.43 165.56 30.16 Favored 'Trans proline' 0 N--CA 1.491 1.339 0 O-C-N 123.482 1.253 . . . . 1.8700000000000001 110.282 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.405 HG12 ' N ' ' A' ' 119' ' ' VAL . 43.3 t -79.09 164.85 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 N-CA-C 109.052 -0.721 . . . . 3.0499999999999998 109.052 179.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.405 ' N ' HG12 ' A' ' 118' ' ' VAL . 79.2 t -147.06 151.7 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 N-CA-C 109.259 -0.645 . . . . 4.6900000000000004 109.259 -178.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 37.3 pt -146.87 137.77 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 CA-C-O 120.997 0.427 . . . . 7.2599999999999998 109.976 173.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -73.98 -56.25 5.41 Favored Glycine 0 N--CA 1.496 2.654 0 N-CA-C 109.596 -1.402 . . . . 7.75 109.596 177.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_exo -58.1 152.28 53.09 Favored 'Trans proline' 0 N--CA 1.501 1.947 0 C-N-CA 121.119 1.212 . . . . 9.0899999999999999 111.503 -178.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -155.18 162.37 40.97 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 122.115 -0.366 . . . . 11.949999999999999 110.267 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -155.81 161.31 40.66 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 122.076 -0.39 . . . . 12.01 110.082 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -84.24 119.59 25.22 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 122.111 -0.368 . . . . 14.42 110.146 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -113.6 -39.97 1.05 Allowed Glycine 0 N--CA 1.497 2.717 0 N-CA-C 109.601 -1.4 . . . . 15.73 109.601 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 62.2 m -155.45 172.76 17.69 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 122.085 -0.656 . . . . 16.629999999999999 110.114 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 75.5 mt -89.15 132.94 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 N-CA-C 109.193 -0.669 . . . . 18.789999999999999 109.193 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 53.8 ttt180 . . . . . 0 N--CA 1.509 2.487 0 CA-C-O 118.319 -0.848 . . . . 20.73 111.478 -178.466 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.275 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_exo -58.5 120.59 8.57 Favored 'Trans proline' 0 N--CA 1.501 1.97 0 O-C-N 123.336 1.177 . . . . 0.0 111.351 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -155.49 78.84 1.02 Allowed 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 121.209 0.528 . . . . 0.0 109.581 -176.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -79.04 86.73 4.86 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.929 -0.482 . . . . 0.0 109.982 179.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.533 HG22 ' HB2' ' A' ' 56' ' ' ASN . 20.2 m -152.47 122.77 7.19 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 122.014 -0.429 . . . . 0.0 110.084 177.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 43.0 mt -78.29 150.36 76.99 Favored Pre-proline 0 N--CA 1.501 2.075 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.102 -178.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -64.63 121.5 9.08 Favored 'Trans proline' 0 N--CA 1.498 1.746 0 O-C-N 123.288 1.152 . . . . 0.0 111.058 168.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -157.55 52.86 0.47 Allowed 'General case' 0 N--CA 1.5 2.065 0 CA-C-O 121.358 0.599 . . . . 0.0 110.254 165.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.455 HD23 HG23 ' A' ' 55' ' ' THR . 19.5 tp -158.57 113.98 2.62 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.766 -0.584 . . . . 0.0 109.993 -178.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 51.3 tttt -99.82 131.04 46.05 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 110.116 -0.328 . . . . 0.0 110.116 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 74.8 m -115.58 140.27 49.32 Favored 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 -177.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -85.3 145.07 27.7 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 122.155 -0.341 . . . . 0.0 110.098 176.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 27.8 p -117.64 137.51 52.59 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.983 -0.448 . . . . 0.0 110.562 -178.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 28.8 t -123.04 117.58 25.78 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 122.109 -0.37 . . . . 0.0 110.156 178.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 83.88 -61.74 4.69 Favored Glycine 0 N--CA 1.496 2.655 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -104.47 111.99 24.87 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 122.092 -0.652 . . . . 0.0 110.408 -177.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -138.08 137.38 20.97 Favored Pre-proline 0 N--CA 1.497 1.886 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 177.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -61.36 152.05 75.29 Favored 'Trans proline' 0 N--CA 1.497 1.683 0 O-C-N 123.118 1.062 . . . . 0.0 111.058 -173.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -60.33 -28.17 67.94 Favored 'General case' 0 N--CA 1.507 2.399 0 O-C-N 121.951 -0.468 . . . . 0.0 111.374 -173.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -92.16 14.31 16.5 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.941 -0.474 . . . . 0.0 111.77 -178.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.56 160.82 29.72 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.658 -0.651 . . . . 0.0 110.239 -173.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 70.6 mt -124.24 135.89 62.23 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -178.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 19.5 p30 37.52 43.61 0.44 Allowed 'General case' 0 N--CA 1.513 2.722 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -175.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 55.56 43.82 27.72 Favored 'General case' 0 N--CA 1.508 2.465 0 O-C-N 121.772 -0.58 . . . . 0.0 111.427 -179.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 51.4 p -141.19 161.33 38.14 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.738 -0.602 . . . . 0.0 110.346 171.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.1 p -141.39 164.69 29.54 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-O 120.847 0.356 . . . . 0.0 110.574 178.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 78.2 mt -109.6 132.44 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 -175.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.455 HG23 HD23 ' A' ' 36' ' ' LEU . 8.5 t -139.77 151.43 45.78 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 122.011 -0.431 . . . . 0.0 111.03 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.533 ' HB2' HG22 ' A' ' 32' ' ' THR . 41.4 p-10 -108.21 30.38 6.45 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 122.097 -0.377 . . . . 0.0 110.636 167.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -124.71 -94.2 1.02 Allowed Glycine 0 N--CA 1.497 2.703 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 176.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 32.1 m80 -146.05 171.72 14.47 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 122.125 -0.632 . . . . 0.0 109.453 177.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 72.8 m -92.41 139.14 30.89 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 163.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -130.5 148.96 52.37 Favored 'General case' 0 N--CA 1.499 2.002 0 C-N-CA 120.404 -0.519 . . . . 0.0 110.54 -176.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -151.68 141.97 22.4 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 177.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.419 HD12 HD12 ' A' ' 99' ' ' ILE . 17.9 tt -142.24 149.19 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 CA-C-O 120.908 0.385 . . . . 0.0 110.248 -173.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.506 HD12 ' HG ' ' A' ' 73' ' ' LEU . 16.5 tt -139.15 145.4 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 -146.26 141.06 26.98 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 -167.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.52 ' O ' HD23 ' A' ' 95' ' ' LEU . 13.2 tm-20 -101.57 115.78 31.29 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 122.165 -0.334 . . . . 0.0 110.139 -176.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -86.95 175.18 8.28 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 122.194 -0.316 . . . . 0.0 110.599 -175.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -60.59 -17.13 44.6 Favored 'General case' 0 N--CA 1.506 2.354 0 O-C-N 121.975 -0.453 . . . . 0.0 112.14 -172.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -92.48 -11.91 33.41 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.602 -0.686 . . . . 0.0 111.728 177.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.35 21.09 36.01 Favored Glycine 0 N--CA 1.497 2.715 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 176.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -97.28 141.07 30.84 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 118.379 1.089 . . . . 0.0 109.811 170.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.9 p -94.91 126.75 40.45 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 122.155 -0.341 . . . . 0.0 110.322 177.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 17.9 p -98.02 112.96 24.71 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 122.128 -0.358 . . . . 0.0 110.298 176.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.538 ' N ' HD12 ' A' ' 73' ' ' LEU . 6.4 mp -99.61 131.09 45.84 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 122.195 -0.316 . . . . 0.0 110.489 -179.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -149.34 145.89 27.25 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 122.168 -0.332 . . . . 0.0 110.249 175.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 83.8 p -143.7 166.94 23.47 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 178.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -178.64 -163.63 30.22 Favored Glycine 0 N--CA 1.496 2.687 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 -178.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 2.0 m -96.72 132.4 42.45 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 122.144 -0.621 . . . . 0.0 110.321 -176.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 45.2 ttm -101.58 124.87 47.94 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 122.13 -0.356 . . . . 0.0 110.277 179.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 25.3 pttt -65.69 168.66 7.36 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 122.032 -0.417 . . . . 0.0 110.516 177.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 56.7 t80 -65.36 146.82 54.41 Favored 'General case' 0 N--CA 1.504 2.267 0 O-C-N 122.062 -0.399 . . . . 0.0 110.483 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -140.97 -48.4 0.41 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 122.115 -0.365 . . . . 0.0 110.397 -178.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 136.8 -34.97 2.15 Favored Glycine 0 N--CA 1.497 2.709 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 -178.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.1 m -72.23 123.97 24.06 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 122.042 -0.681 . . . . 0.0 110.029 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -75.59 -41.35 54.82 Favored 'General case' 0 N--CA 1.502 2.131 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.446 -179.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -155.72 30.0 0.37 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 122.061 -0.399 . . . . 0.0 110.81 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 65.7 mt-30 -78.4 82.12 4.71 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.84 -0.537 . . . . 0.0 109.852 177.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 90.6 m -123.45 33.04 5.46 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.828 -0.545 . . . . 0.0 110.385 -177.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -82.36 160.72 22.76 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.96 -0.462 . . . . 0.0 110.356 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -116.98 120.77 39.44 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 122.13 -0.356 . . . . 0.0 110.357 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 7.0 m -78.69 150.31 75.7 Favored Pre-proline 0 N--CA 1.5 2.069 0 O-C-N 122.086 -0.384 . . . . 0.0 110.17 179.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -82.82 56.25 5.57 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 O-C-N 123.424 1.223 . . . . 0.0 111.006 174.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 16.5 pttp -155.67 50.08 0.54 Allowed 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.63 -0.669 . . . . 0.0 109.693 -178.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.463 ' HB1' HH22 ' A' ' 97' ' ' ARG . . . -155.66 -169.39 3.1 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.949 -0.469 . . . . 0.0 110.49 -166.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -64.56 -169.23 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.274 0 CA-C-O 120.968 0.413 . . . . 0.0 110.148 -175.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.52 HD23 ' O ' ' A' ' 65' ' ' GLU . 8.8 tp -64.21 163.77 12.15 Favored 'General case' 0 N--CA 1.506 2.342 0 O-C-N 122.014 -0.429 . . . . 0.0 109.971 -168.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 72.2 mtp85 -66.44 155.76 36.6 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.788 -0.57 . . . . 0.0 110.172 -163.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.463 HH22 ' HB1' ' A' ' 93' ' ' ALA . 3.1 ptt180 -161.39 165.41 28.95 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 120.901 0.381 . . . . 0.0 110.477 -175.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.404 ' O ' HG22 ' A' ' 63' ' ' ILE . 17.5 m -126.69 146.43 50.21 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 169.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.419 HD12 HD12 ' A' ' 62' ' ' ILE . 18.3 tt -143.17 155.98 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.993 -0.442 . . . . 0.0 110.29 -174.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.429 ' HB3' HD21 ' A' ' 111' ' ' LEU . 43.6 mt-10 -146.82 146.88 30.38 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 120.756 0.312 . . . . 0.0 110.239 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 26.4 p -143.11 146.38 33.71 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 177.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 18.2 p -157.55 131.97 8.42 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 122.002 -0.436 . . . . 0.0 110.805 -170.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 20.7 ttm-85 -104.97 48.67 0.83 Allowed 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 121.371 0.605 . . . . 0.0 110.645 -176.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.0 p -137.95 150.94 47.47 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.819 -0.551 . . . . 0.0 109.884 175.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 17.6 p-10 -62.55 132.35 52.15 Favored 'General case' 0 N--CA 1.505 2.286 0 CA-C-O 121.355 0.598 . . . . 0.0 111.674 -163.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 79.1 mt 51.86 27.6 4.39 Favored 'General case' 0 N--CA 1.507 2.409 0 O-C-N 122.061 -0.4 . . . . 0.0 111.937 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 26.1 p -62.7 -23.15 66.99 Favored 'General case' 0 N--CA 1.507 2.403 0 O-C-N 121.847 -0.533 . . . . 0.0 111.6 174.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -75.4 -29.9 59.95 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.855 -0.528 . . . . 0.0 111.01 178.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -62.36 -39.84 94.46 Favored 'General case' 0 N--CA 1.507 2.377 0 O-C-N 121.738 -0.602 . . . . 0.0 110.753 -169.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -100.22 16.2 25.04 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 122.105 -0.372 . . . . 0.0 111.678 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.429 HD21 ' HB3' ' A' ' 100' ' ' GLU . 16.3 tp -111.82 108.98 18.57 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.557 -0.715 . . . . 0.0 110.327 -175.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -97.9 120.87 59.2 Favored Pre-proline 0 N--CA 1.496 1.869 0 CA-C-O 118.858 -0.591 . . . . 0.0 110.14 174.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.413 ' HB2' HG21 ' A' ' 63' ' ' ILE . 37.2 Cg_endo -69.46 141.05 45.36 Favored 'Trans proline' 0 N--CA 1.491 1.342 0 O-C-N 123.202 1.107 . . . . 0.0 110.182 174.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 34.0 p -139.22 135.81 34.34 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 122.118 -0.364 . . . . 0.0 110.218 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 17.3 mt -71.77 155.07 92.65 Favored Pre-proline 0 N--CA 1.501 2.107 0 CA-C-O 119.306 -0.378 . . . . 0.0 110.068 178.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -62.77 152.61 77.54 Favored 'Trans proline' 0 N--CA 1.495 1.573 0 O-C-N 123.351 1.185 . . . . 0.0 110.792 179.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -67.62 133.09 28.74 Favored 'Trans proline' 0 N--CA 1.491 1.35 0 O-C-N 123.542 1.286 . . . . 0.0 110.478 -176.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.425 HG12 ' N ' ' A' ' 119' ' ' VAL . 43.7 t -80.42 166.25 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.425 ' N ' HG12 ' A' ' 118' ' ' VAL . 11.9 p -88.1 145.25 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 122.091 -0.38 . . . . 0.0 110.052 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.43 HD13 ' CZ ' ' A' ' 124' ' ' PHE . 75.8 mt -89.49 127.84 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -178.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -112.1 -63.66 0.47 Allowed Glycine 0 N--CA 1.496 2.67 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_exo -58.05 167.12 4.73 Favored 'Trans proline' 0 N--CA 1.501 1.965 0 O-C-N 123.36 1.189 . . . . 0.0 111.446 179.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -83.3 153.45 24.62 Favored 'General case' 0 N--CA 1.5 2.036 0 C-N-CA 120.824 -0.35 . . . . 0.0 110.201 -179.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.43 ' CZ ' HD13 ' A' ' 120' ' ' ILE . 97.0 m-85 -71.51 152.22 43.2 Favored 'General case' 0 N--CA 1.502 2.131 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.155 -179.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -81.76 -33.6 30.88 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 122.102 -0.374 . . . . 0.0 110.285 -179.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 80.75 59.29 2.51 Favored Glycine 0 N--CA 1.495 2.62 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 87.7 p -79.66 163.64 24.4 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 122.148 -0.619 . . . . 0.0 110.167 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 76.2 mt -89.77 139.96 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 -179.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 54.6 ttt180 . . . . . 0 N--CA 1.495 1.812 0 CA-C-O 117.98 -1.009 . . . . 0.0 110.196 179.899 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.333 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo -58.45 120.53 8.48 Favored 'Trans proline' 0 N--CA 1.5 1.876 0 C-N-CA 121.106 1.204 . . . . 0.0 111.357 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -155.4 78.81 1.02 Allowed 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -177.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -79.15 87.04 4.91 Favored 'General case' 0 N--CA 1.501 2.098 0 CA-C-O 121.13 0.491 . . . . 0.0 109.948 178.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 22.3 m -135.81 65.09 1.55 Allowed 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.365 0.602 . . . . 0.0 110.071 177.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 21.7 mt -78.68 150.84 76.45 Favored Pre-proline 0 N--CA 1.5 2.061 0 O-C-N 121.736 -0.603 . . . . 0.0 110.091 -179.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_exo -64.68 120.68 8.01 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 O-C-N 123.322 1.17 . . . . 0.0 110.998 167.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -158.17 53.37 0.45 Allowed 'General case' 0 N--CA 1.5 2.028 0 CA-C-O 121.358 0.599 . . . . 0.0 110.159 165.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.403 HD23 HG23 ' A' ' 55' ' ' THR . 21.9 tp -158.05 114.36 2.81 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.696 -0.627 . . . . 0.0 110.032 -179.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.47 ' CE ' HD21 ' A' ' 106' ' ' LEU . 23.4 ttpt -99.71 130.5 45.93 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 122.137 -0.352 . . . . 0.0 110.194 179.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 78.2 m -115.28 140.32 49.21 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -177.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -84.29 142.91 29.89 Favored 'General case' 0 N--CA 1.502 2.141 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 177.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 28.1 p -115.31 137.29 52.2 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 122.127 -0.358 . . . . 0.0 110.642 -176.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 49.5 m -122.95 139.03 54.49 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 122.069 -0.394 . . . . 0.0 110.051 176.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 75.52 -67.17 2.27 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.721 -1.351 . . . . 0.0 109.721 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -114.08 124.12 51.34 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 122.11 -0.641 . . . . 0.0 110.486 -176.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -137.99 136.87 20.16 Favored Pre-proline 0 N--CA 1.497 1.901 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 175.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.44 151.93 71.29 Favored 'Trans proline' 0 N--CA 1.498 1.745 0 O-C-N 123.083 1.044 . . . . 0.0 111.111 -172.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -60.35 -28.55 68.26 Favored 'General case' 0 N--CA 1.507 2.391 0 O-C-N 121.935 -0.478 . . . . 0.0 111.356 -172.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -91.89 14.37 15.82 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.969 -0.457 . . . . 0.0 111.824 -177.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.65 162.04 27.33 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.622 -0.674 . . . . 0.0 110.27 -173.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 71.7 mt -124.59 136.69 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 -178.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 19.8 p30 37.76 43.07 0.45 Allowed 'General case' 0 N--CA 1.514 2.739 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -176.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 55.39 43.6 28.56 Favored 'General case' 0 N--CA 1.508 2.468 0 O-C-N 121.815 -0.553 . . . . 0.0 111.407 -178.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 59.5 p -139.55 160.56 39.58 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.768 -0.582 . . . . 0.0 110.261 171.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.1 p -139.28 163.99 31.01 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 120.787 0.327 . . . . 0.0 110.613 178.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 77.5 mt -108.73 132.17 57.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -175.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.403 HG23 HD23 ' A' ' 36' ' ' LEU . 8.4 t -140.29 151.63 45.24 Favored 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 120.95 0.405 . . . . 0.0 110.976 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 26.7 p30 -108.72 30.35 6.58 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 122.096 -0.377 . . . . 0.0 110.603 167.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -122.83 -93.93 1.16 Allowed Glycine 0 N--CA 1.496 2.653 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 176.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 74.6 m-70 -149.59 172.11 15.56 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 122.052 -0.675 . . . . 0.0 109.463 176.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 75.0 m -92.41 139.06 30.97 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 166.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -130.81 150.7 51.86 Favored 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 120.401 -0.52 . . . . 0.0 110.539 -176.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -152.08 142.51 22.58 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 177.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.489 HD12 HD12 ' A' ' 99' ' ' ILE . 18.0 tt -143.67 149.17 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.354 -173.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.517 HD12 ' HG ' ' A' ' 73' ' ' LEU . 16.1 tt -137.63 145.23 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -148.12 146.65 28.88 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 -167.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.8 tm-20 -101.59 117.77 35.58 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 122.146 -0.346 . . . . 0.0 110.237 -175.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 51.4 p30 -87.28 175.36 8.06 Favored 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 120.909 -0.316 . . . . 0.0 110.628 -175.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -60.34 -18.07 47.46 Favored 'General case' 0 N--CA 1.508 2.453 0 O-C-N 121.988 -0.445 . . . . 0.0 111.915 -173.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 16.1 mm-40 -93.21 -9.48 39.08 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.713 -0.617 . . . . 0.0 111.89 178.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 88.69 21.0 45.17 Favored Glycine 0 N--CA 1.498 2.826 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 177.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -96.9 143.63 27.6 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 118.413 1.107 . . . . 0.0 109.793 169.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.3 p -94.88 125.93 39.87 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.281 177.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 17.9 p -98.04 113.0 24.74 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 122.154 -0.341 . . . . 0.0 110.272 177.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.541 ' N ' HD12 ' A' ' 73' ' ' LEU . 6.4 mp -97.8 128.54 44.51 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 122.181 -0.324 . . . . 0.0 110.407 -178.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -145.34 145.78 31.34 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 122.183 -0.323 . . . . 0.0 110.348 176.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 97.1 p -143.6 166.96 23.39 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 178.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 179.95 -164.0 31.53 Favored Glycine 0 N--CA 1.496 2.681 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 -178.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 1.8 m -96.71 132.52 42.31 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 122.248 -0.56 . . . . 0.0 110.356 -175.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 47.4 ttm -102.56 122.0 43.51 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 122.038 -0.414 . . . . 0.0 110.159 177.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 27.7 pttt -67.03 162.05 23.01 Favored 'General case' 0 N--CA 1.503 2.195 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.407 177.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -67.06 147.7 52.84 Favored 'General case' 0 N--CA 1.504 2.244 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.215 179.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -155.02 26.44 0.42 Allowed 'General case' 0 N--CA 1.499 2.009 0 O-C-N 122.133 -0.354 . . . . 0.0 111.389 178.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 98.23 -40.06 2.59 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 110.151 -1.18 . . . . 0.0 110.151 176.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 54.1 m -74.57 111.49 9.81 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 122.021 -0.693 . . . . 0.0 110.376 -175.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -80.21 -38.35 31.3 Favored 'General case' 0 N--CA 1.5 2.038 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.049 177.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -155.64 76.69 0.96 Allowed 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.145 0.498 . . . . 0.0 109.869 -178.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -155.33 118.08 4.29 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.99 -0.444 . . . . 0.0 109.891 -177.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 91.2 m -140.19 38.26 1.92 Allowed 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 120.966 0.412 . . . . 0.0 109.899 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 35.7 pttt -76.33 170.72 15.81 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.925 -0.484 . . . . 0.0 110.728 -176.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -148.27 127.52 12.98 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 122.148 -0.345 . . . . 0.0 110.43 177.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.4 m -73.09 162.81 72.71 Favored Pre-proline 0 N--CA 1.501 2.086 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 176.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -83.25 57.81 5.97 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 O-C-N 123.325 1.171 . . . . 0.0 111.621 -173.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 32.2 tptt -155.77 36.38 0.36 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.603 -0.686 . . . . 0.0 109.538 170.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -82.35 -169.84 2.63 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-O 121.09 0.471 . . . . 0.0 110.958 -170.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 2.2 tp60 -65.0 -168.84 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.223 0 O-C-N 122.126 -0.359 . . . . 0.0 110.034 174.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' A' ' 95' ' ' LEU . 9.2 tp -64.0 168.62 5.06 Favored 'General case' 0 N--CA 1.508 2.452 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 -173.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 43.0 mtp180 -68.03 134.21 50.29 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.647 -0.658 . . . . 0.0 110.23 -161.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 28.5 ptt180 -161.51 165.34 28.76 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 120.872 0.367 . . . . 0.0 110.584 -167.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.418 HG21 ' O ' ' A' ' 114' ' ' THR . 17.0 m -125.78 149.0 48.93 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 171.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.489 HD12 HD12 ' A' ' 62' ' ' ILE . 18.3 tt -143.15 154.24 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.156 -176.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -146.85 150.81 36.0 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 120.858 0.361 . . . . 0.0 110.407 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 26.9 p -142.95 149.99 39.11 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 122.06 -0.4 . . . . 0.0 110.091 176.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 19.2 p -157.58 133.43 9.3 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.971 -0.456 . . . . 0.0 110.821 -172.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 61.7 ttp85 -106.35 52.51 0.72 Allowed 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 121.353 0.597 . . . . 0.0 110.536 -176.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.1 p -144.08 151.07 39.12 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.788 -0.57 . . . . 0.0 109.947 175.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 18.2 p-10 -62.39 132.11 51.48 Favored 'General case' 0 N--CA 1.503 2.213 0 CA-C-O 121.418 0.627 . . . . 0.0 111.726 -163.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.47 HD21 ' CE ' ' A' ' 37' ' ' LYS . 79.4 mt 51.75 28.06 4.61 Favored 'General case' 0 N--CA 1.506 2.334 0 O-C-N 121.936 -0.477 . . . . 0.0 111.955 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 25.7 p -62.56 -24.16 67.38 Favored 'General case' 0 N--CA 1.507 2.404 0 O-C-N 121.904 -0.498 . . . . 0.0 111.506 174.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -73.0 -30.33 63.71 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.877 -0.514 . . . . 0.0 110.944 178.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -62.84 -39.29 93.9 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.616 -0.678 . . . . 0.0 110.752 -168.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -100.2 16.24 24.88 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 122.103 -0.373 . . . . 0.0 111.696 -179.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 16.9 tp -112.73 110.35 20.43 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.649 -0.657 . . . . 0.0 110.314 -175.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -96.68 120.83 61.22 Favored Pre-proline 0 N--CA 1.496 1.837 0 CA-C-O 118.922 -0.561 . . . . 0.0 110.096 174.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -72.13 138.16 30.2 Favored 'Trans proline' 0 N--CA 1.492 1.415 0 O-C-N 123.293 1.154 . . . . 0.0 110.307 173.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.418 ' O ' HG21 ' A' ' 98' ' ' THR . 35.5 p -139.18 150.0 45.07 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 122.096 -0.377 . . . . 0.0 110.203 178.022 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 12.9 mt -71.48 146.88 92.13 Favored Pre-proline 0 N--CA 1.501 2.088 0 CA-C-O 119.215 -0.421 . . . . 0.0 109.984 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -70.55 149.72 62.31 Favored 'Trans proline' 0 N--CA 1.491 1.338 0 O-C-N 123.477 1.251 . . . . 0.0 110.252 -178.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -68.86 142.54 52.35 Favored 'Trans proline' 0 N--CA 1.491 1.362 0 O-C-N 123.493 1.259 . . . . 0.0 110.276 177.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.424 HG12 ' N ' ' A' ' 119' ' ' VAL . 47.9 t -150.34 165.26 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.168 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.424 ' N ' HG12 ' A' ' 118' ' ' VAL . 14.6 p -88.63 135.14 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 122.026 -0.421 . . . . 0.0 110.378 -179.066 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.462 ' O ' HG23 ' A' ' 120' ' ' ILE . 7.1 tp -152.68 119.36 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 122.071 -0.393 . . . . 0.0 109.962 178.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 68.75 -156.2 53.4 Favored Glycine 0 N--CA 1.496 2.68 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -178.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_exo -58.62 139.97 92.92 Favored 'Trans proline' 0 N--CA 1.501 1.956 0 O-C-N 123.364 1.192 . . . . 0.0 111.232 176.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -84.34 144.42 28.85 Favored 'General case' 0 N--CA 1.499 2.009 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.371 -179.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -155.84 112.72 3.19 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 177.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -155.37 152.11 28.71 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 122.069 -0.394 . . . . 0.0 110.157 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -102.33 34.9 5.35 Favored Glycine 0 N--CA 1.496 2.695 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 70.5 m -155.39 155.61 33.91 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 122.09 -0.653 . . . . 0.0 110.123 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 75.4 mt -90.2 131.47 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 67.2 ttp85 . . . . . 0 N--CA 1.499 2.001 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.201 -179.978 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.242 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_exo -58.55 120.04 7.67 Favored 'Trans proline' 0 N--CA 1.501 1.929 0 O-C-N 123.367 1.193 . . . . 0.0 111.313 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -90.47 47.2 1.41 Allowed 'General case' 0 N--CA 1.501 2.093 0 CA-C-O 121.056 0.455 . . . . 0.0 110.898 179.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -79.65 61.42 3.63 Favored 'General case' 0 N--CA 1.504 2.259 0 CA-C-O 121.277 0.561 . . . . 0.0 110.503 -178.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.509 HG22 ' ND2' ' A' ' 56' ' ' ASN . 18.3 m -108.9 51.67 0.74 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.702 -0.624 . . . . 0.0 109.994 -178.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 27.2 mt -76.8 151.02 82.12 Favored Pre-proline 0 N--CA 1.5 2.04 0 O-C-N 121.831 -0.543 . . . . 0.0 110.101 -178.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -64.36 121.32 8.89 Favored 'Trans proline' 0 N--CA 1.498 1.791 0 O-C-N 123.368 1.194 . . . . 0.0 111.145 169.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -158.28 53.58 0.44 Allowed 'General case' 0 N--CA 1.5 2.034 0 CA-C-O 121.378 0.609 . . . . 0.0 110.235 164.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 22.7 tp -158.42 114.0 2.66 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.731 -0.606 . . . . 0.0 109.971 -179.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 53.1 tttt -99.74 132.27 45.19 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 122.164 -0.335 . . . . 0.0 110.205 -179.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 80.2 m -117.73 140.23 49.96 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 122.047 -0.408 . . . . 0.0 109.901 -177.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 62.9 t80 -84.35 142.83 29.89 Favored 'General case' 0 N--CA 1.501 2.077 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 175.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 28.1 p -114.84 138.36 50.87 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 122.05 -0.406 . . . . 0.0 110.714 -177.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 99.9 p -123.01 141.19 52.23 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 176.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.37 -68.36 1.46 Allowed Glycine 0 N--CA 1.495 2.629 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 83.6 t60 -113.17 124.78 53.34 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 122.08 -0.659 . . . . 0.0 110.663 -176.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -138.05 136.63 19.82 Favored Pre-proline 0 N--CA 1.497 1.92 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 175.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -60.28 152.17 68.56 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 O-C-N 123.107 1.056 . . . . 0.0 111.114 -171.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -60.15 -28.35 67.84 Favored 'General case' 0 N--CA 1.506 2.355 0 O-C-N 121.938 -0.476 . . . . 0.0 111.436 -172.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -92.02 14.23 16.45 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.857 -0.527 . . . . 0.0 111.754 -177.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.19 162.07 25.99 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.582 -0.699 . . . . 0.0 110.382 -172.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 75.2 mt -125.62 138.51 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 -178.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 38.7 43.29 0.69 Allowed 'General case' 0 N--CA 1.512 2.655 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -178.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 30.7 m120 55.05 42.27 31.07 Favored 'General case' 0 N--CA 1.509 2.488 0 O-C-N 121.759 -0.588 . . . . 0.0 111.453 -178.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 68.3 p -141.22 160.41 40.17 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.767 -0.583 . . . . 0.0 110.343 173.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.1 p -140.91 165.03 28.64 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 120.902 0.382 . . . . 0.0 110.641 179.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 78.0 mt -109.85 132.05 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 -175.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.7 t -138.93 150.87 46.4 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.978 -0.451 . . . . 0.0 110.999 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.509 ' ND2' HG22 ' A' ' 32' ' ' THR . 50.4 p30 -108.16 31.12 5.79 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 122.114 -0.366 . . . . 0.0 110.593 167.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -124.96 -93.39 0.97 Allowed Glycine 0 N--CA 1.497 2.707 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 176.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 45.0 m-70 -149.69 172.21 15.44 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 122.106 -0.644 . . . . 0.0 109.366 176.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 71.9 m -92.1 139.03 31.04 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 166.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 15.5 p90 -129.16 151.93 49.29 Favored 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 120.372 -0.531 . . . . 0.0 110.643 -176.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -151.18 142.68 23.51 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 176.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.478 HD11 ' NH2' ' A' ' 97' ' ' ARG . 18.3 tt -142.05 149.05 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 CA-C-O 120.864 0.364 . . . . 0.0 110.277 -172.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.53 HD12 ' HG ' ' A' ' 73' ' ' LEU . 15.3 tt -140.8 145.25 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 177.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -150.15 144.34 25.62 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 -170.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.5 tm-20 -101.62 117.88 35.8 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 110.11 -0.329 . . . . 0.0 110.11 -178.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 52.3 p30 -86.69 175.19 8.39 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 122.179 -0.326 . . . . 0.0 110.609 -175.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -60.19 -17.43 41.12 Favored 'General case' 0 N--CA 1.507 2.392 0 O-C-N 121.931 -0.48 . . . . 0.0 112.127 -173.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -92.79 -11.12 34.58 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.601 -0.687 . . . . 0.0 111.868 178.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.55 20.97 35.81 Favored Glycine 0 N--CA 1.498 2.781 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 177.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -96.94 139.91 32.27 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-N 118.324 1.062 . . . . 0.0 109.841 171.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.2 p -94.85 125.25 39.39 Favored 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 120.824 -0.351 . . . . 0.0 110.205 176.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 17.7 p -97.94 112.91 24.66 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 122.167 -0.333 . . . . 0.0 110.305 177.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.533 ' N ' HD12 ' A' ' 73' ' ' LEU . 6.4 mp -99.01 127.65 44.97 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 122.13 -0.356 . . . . 0.0 110.311 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -146.97 146.08 29.97 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 122.084 -0.385 . . . . 0.0 110.36 177.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 90.4 p -143.77 166.71 24.13 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 177.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 178.09 -163.69 32.02 Favored Glycine 0 N--CA 1.499 2.841 0 N-CA-C 110.256 -1.138 . . . . 0.0 110.256 -179.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 2.9 m -96.62 132.4 42.29 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 122.179 -0.601 . . . . 0.0 110.359 -175.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 44.4 ttm -99.46 121.94 41.85 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 122.034 -0.416 . . . . 0.0 110.042 178.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 26.0 pttt -66.08 166.12 12.25 Favored 'General case' 0 N--CA 1.503 2.193 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.562 -179.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 54.1 p90 -64.96 125.29 24.43 Favored 'General case' 0 N--CA 1.504 2.251 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.572 -179.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -110.9 -34.48 6.22 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 122.146 -0.346 . . . . 0.0 110.255 178.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 102.16 -39.8 2.64 Favored Glycine 0 N--CA 1.497 2.731 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 -179.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.2 m -75.29 117.22 16.86 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 122.154 -0.615 . . . . 0.0 110.209 178.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -78.9 -33.4 45.65 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 122.056 -0.402 . . . . 0.0 110.537 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -82.19 4.11 24.67 Favored 'General case' 0 N--CA 1.502 2.135 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -175.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -75.94 65.7 2.05 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.379 -0.826 . . . . 0.0 110.14 -178.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 38.4 t -155.19 62.85 0.63 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.705 -0.622 . . . . 0.0 109.881 179.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -155.43 161.99 40.86 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.728 -0.607 . . . . 0.0 110.222 -177.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -99.89 121.59 41.55 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 178.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.8 m -76.38 143.93 73.54 Favored Pre-proline 0 N--CA 1.498 1.95 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.069 -173.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -77.81 62.58 7.9 Favored 'Trans proline' 0 N--CA 1.494 1.531 0 O-C-N 123.34 1.179 . . . . 0.0 110.508 176.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 60.3 tttt -155.41 43.86 0.46 Allowed 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.325 0.583 . . . . 0.0 109.873 -178.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -155.65 147.55 23.29 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -107.72 67.16 0.68 Allowed 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 121.346 0.594 . . . . 0.0 110.103 -179.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 17.1 tp -155.0 149.86 26.71 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.839 -0.538 . . . . 0.0 110.171 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 93.6 mtt-85 -98.24 124.09 42.66 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 122.065 -0.397 . . . . 0.0 110.114 179.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.478 ' NH2' HD11 ' A' ' 62' ' ' ILE . 10.1 ptm180 -161.48 165.11 29.18 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 122.087 -0.383 . . . . 0.0 110.592 -178.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 17.0 m -134.0 149.35 51.2 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 177.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.4 tt -142.6 150.95 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 122.023 -0.423 . . . . 0.0 109.873 178.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 48.5 mm-40 -144.64 151.65 39.3 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 120.862 0.363 . . . . 0.0 110.655 -176.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 26.3 p -143.04 150.98 40.3 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 177.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 19.5 p -157.56 134.43 10.04 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 122.016 -0.427 . . . . 0.0 110.852 -175.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 29.4 ttp180 -106.98 47.38 0.88 Allowed 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 121.208 0.528 . . . . 0.0 110.608 -173.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.0 p -142.16 151.39 42.18 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.88 -0.513 . . . . 0.0 109.888 178.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 15.8 p30 -62.78 132.44 52.24 Favored 'General case' 0 N--CA 1.505 2.285 0 CA-C-O 121.466 0.651 . . . . 0.0 111.628 -163.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 78.9 mt 52.14 27.78 4.89 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 122.03 -0.419 . . . . 0.0 111.922 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 25.8 p -62.71 -24.84 67.87 Favored 'General case' 0 N--CA 1.508 2.444 0 O-C-N 121.9 -0.5 . . . . 0.0 111.489 174.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -72.57 -29.59 63.68 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 121.918 -0.489 . . . . 0.0 111.076 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -62.23 -39.71 93.74 Favored 'General case' 0 N--CA 1.505 2.324 0 O-C-N 121.674 -0.641 . . . . 0.0 110.821 -168.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -101.34 16.22 26.28 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 122.066 -0.396 . . . . 0.0 111.763 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 12.9 tp -115.26 108.89 17.16 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.673 -0.642 . . . . 0.0 110.338 -175.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -100.62 120.78 55.03 Favored Pre-proline 0 N--CA 1.496 1.84 0 CA-C-O 118.913 -0.565 . . . . 0.0 110.183 173.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -67.94 140.06 49.14 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 O-C-N 123.153 1.081 . . . . 0.0 110.256 173.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 49.3 p -139.19 149.65 44.65 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 122.118 -0.364 . . . . 0.0 110.087 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 18.9 mt -71.29 155.03 93.45 Favored Pre-proline 0 N--CA 1.501 2.098 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.056 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -68.07 146.56 71.1 Favored 'Trans proline' 0 N--CA 1.491 1.35 0 O-C-N 123.476 1.25 . . . . 0.0 110.3 -178.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -70.44 151.97 65.5 Favored 'Trans proline' 0 N--CA 1.491 1.361 0 O-C-N 123.477 1.251 . . . . 0.0 110.328 -178.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.406 HG12 ' N ' ' A' ' 119' ' ' VAL . 43.7 t -79.37 165.61 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 177.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.406 ' N ' HG12 ' A' ' 118' ' ' VAL . 59.5 t -87.85 129.07 39.75 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -178.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.438 ' O ' HG23 ' A' ' 120' ' ' ILE . 16.7 tt -153.71 122.16 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 177.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -67.63 -85.45 0.1 OUTLIER Glycine 0 N--CA 1.497 2.704 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 -178.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -59.46 151.33 69.53 Favored 'Trans proline' 0 N--CA 1.503 2.073 0 C-N-CA 121.012 1.142 . . . . 0.0 111.11 178.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -155.16 149.43 26.01 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 122.141 -0.349 . . . . 0.0 110.318 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -155.42 96.91 1.84 Allowed 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -178.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -155.38 -55.94 0.09 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 122.131 -0.356 . . . . 0.0 110.22 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -82.28 169.56 49.75 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -178.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 86.9 p -155.46 163.69 39.69 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 122.059 -0.671 . . . . 0.0 110.106 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 50.8 mm -90.27 132.01 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 54.6 ttt180 . . . . . 0 N--CA 1.498 1.925 0 CA-C-O 118.026 -0.988 . . . . 0.0 110.194 179.954 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.219 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_exo -58.59 123.73 14.22 Favored 'Trans proline' 0 N--CA 1.499 1.843 0 C-N-CA 121.109 1.206 . . . . 0.0 111.356 179.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -90.16 47.13 1.41 Allowed 'General case' 0 N--CA 1.503 2.178 0 CA-C-O 121.096 0.474 . . . . 0.0 110.781 179.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -77.38 83.04 3.83 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.729 -0.607 . . . . 0.0 109.89 -176.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 21.6 m -124.72 108.34 11.9 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.978 -0.452 . . . . 0.0 110.241 178.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 73.5 mt -142.48 118.65 6.88 Favored Pre-proline 0 N--CA 1.496 1.87 0 CA-C-O 118.777 -0.63 . . . . 0.0 109.325 178.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -59.52 143.46 99.68 Favored 'Trans proline' 0 N--CA 1.502 2.0 0 C-N-CA 120.835 1.023 . . . . 0.0 111.277 -177.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -150.17 47.52 0.91 Allowed 'General case' 0 N--CA 1.499 1.989 0 CA-C-O 121.14 0.495 . . . . 0.0 110.647 -178.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.458 HD23 HG23 ' A' ' 55' ' ' THR . 20.3 tp -160.69 114.38 2.08 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.796 -0.565 . . . . 0.0 110.378 -174.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.448 ' CE ' HD21 ' A' ' 106' ' ' LEU . 30.1 ttpt -99.85 129.91 45.99 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 175.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 75.4 m -112.4 140.36 47.2 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -82.63 141.43 32.52 Favored 'General case' 0 N--CA 1.5 2.031 0 C-N-CA 120.764 -0.374 . . . . 0.0 109.992 175.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 27.8 p -115.38 137.12 52.38 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 122.021 -0.424 . . . . 0.0 110.649 -175.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 48.3 m -123.02 140.49 52.98 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 122.109 -0.37 . . . . 0.0 110.03 177.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 75.52 -67.24 2.26 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 83.8 t60 -115.92 124.33 50.34 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 122.061 -0.67 . . . . 0.0 110.543 -176.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -138.08 135.72 18.87 Favored Pre-proline 0 N--CA 1.497 1.907 0 N-CA-C 109.19 -0.671 . . . . 0.0 109.19 174.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.77 153.23 64.02 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 O-C-N 123.145 1.076 . . . . 0.0 111.193 -169.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -60.34 -28.33 68.07 Favored 'General case' 0 N--CA 1.506 2.335 0 O-C-N 121.918 -0.489 . . . . 0.0 111.43 -173.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -92.3 14.25 16.92 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.934 -0.479 . . . . 0.0 111.714 -178.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.92 161.99 27.95 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.731 -0.606 . . . . 0.0 110.225 -172.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 69.5 mt -124.92 136.97 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -176.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 18.0 p30 37.78 42.91 0.44 Allowed 'General case' 0 N--CA 1.514 2.731 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -175.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 24.0 t30 56.17 42.26 28.4 Favored 'General case' 0 N--CA 1.508 2.469 0 O-C-N 121.795 -0.566 . . . . 0.0 111.439 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 60.7 p -140.4 164.45 30.08 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.73 -0.606 . . . . 0.0 110.36 172.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.1 p -139.07 163.31 32.74 Favored 'General case' 0 N--CA 1.499 2.024 0 CA-C-O 120.889 0.376 . . . . 0.0 110.638 178.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 77.5 mt -110.36 134.35 52.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -175.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.458 HG23 HD23 ' A' ' 36' ' ' LEU . 8.1 t -144.0 153.97 42.79 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.996 -0.44 . . . . 0.0 111.106 179.129 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 39.5 p-10 -107.72 29.73 6.96 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 122.128 -0.357 . . . . 0.0 110.652 167.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -122.17 -100.98 1.63 Allowed Glycine 0 N--CA 1.497 2.702 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 176.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 25.6 m-70 -141.13 171.26 14.31 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 122.091 -0.652 . . . . 0.0 109.562 176.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 70.4 m -91.67 139.09 31.02 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 164.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -129.18 148.27 51.1 Favored 'General case' 0 N--CA 1.498 1.939 0 C-N-CA 120.374 -0.531 . . . . 0.0 110.423 -179.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -151.55 140.33 20.88 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 176.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.52 HD12 HD12 ' A' ' 99' ' ' ILE . 18.2 tt -143.86 149.3 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 CA-C-O 120.969 0.414 . . . . 0.0 110.611 -170.055 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.65 HD12 HD21 ' A' ' 73' ' ' LEU . 14.7 tt -135.02 145.19 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 175.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -148.27 146.38 28.59 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -169.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.7 tm-20 -101.79 117.95 35.93 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 120.793 0.33 . . . . 0.0 110.202 -175.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 26.9 p-10 -87.98 175.36 7.81 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 122.118 -0.364 . . . . 0.0 110.468 -176.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -60.34 -17.21 41.61 Favored 'General case' 0 N--CA 1.507 2.414 0 O-C-N 121.937 -0.477 . . . . 0.0 112.122 -172.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -92.41 -11.49 34.71 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.608 -0.682 . . . . 0.0 111.842 178.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.13 21.2 36.32 Favored Glycine 0 N--CA 1.497 2.743 0 N-CA-C 111.099 -0.801 . . . . 0.0 111.099 176.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -97.79 144.59 27.23 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-N 118.309 1.055 . . . . 0.0 109.872 170.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.9 p -94.92 128.42 41.69 Favored 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.24 176.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 20.1 p -97.82 116.05 29.27 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 122.138 -0.351 . . . . 0.0 110.474 178.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.65 HD21 HD12 ' A' ' 63' ' ' ILE . 15.3 mt -97.41 126.62 42.77 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 122.101 -0.374 . . . . 0.0 110.456 -179.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -150.52 146.16 26.42 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 122.065 -0.397 . . . . 0.0 110.474 175.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 93.7 p -143.7 167.06 23.17 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 175.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -179.23 -167.23 36.36 Favored Glycine 0 N--CA 1.497 2.748 0 N-CA-C 110.244 -1.142 . . . . 0.0 110.244 -178.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 2.2 m -96.6 132.72 41.93 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 122.221 -0.576 . . . . 0.0 110.147 -175.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 43.2 ttm -97.47 121.83 39.82 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 122.026 -0.421 . . . . 0.0 109.982 177.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 26.7 pttt -67.5 165.96 15.71 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 122.028 -0.42 . . . . 0.0 110.609 -176.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 58.1 t80 -66.44 148.11 52.34 Favored 'General case' 0 N--CA 1.503 2.182 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.267 176.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -140.03 -47.89 0.45 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 122.158 -0.339 . . . . 0.0 110.492 -178.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 150.08 -33.99 1.02 Allowed Glycine 0 N--CA 1.494 2.535 0 N-CA-C 109.729 -1.349 . . . . 0.0 109.729 -177.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.1 m -71.9 123.54 22.92 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 122.026 -0.69 . . . . 0.0 109.892 178.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -75.76 -41.46 53.09 Favored 'General case' 0 N--CA 1.501 2.122 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.373 -178.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -155.78 31.19 0.36 Allowed 'General case' 0 N--CA 1.498 1.931 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.665 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -77.31 82.68 3.77 Favored 'General case' 0 N--CA 1.501 2.083 0 CA-C-O 121.231 0.539 . . . . 0.0 109.885 178.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 14.8 t -117.76 32.12 6.33 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.917 -0.489 . . . . 0.0 110.374 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -83.73 -170.98 3.34 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.996 -0.44 . . . . 0.0 110.453 -178.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -107.24 121.05 43.76 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 122.14 -0.35 . . . . 0.0 110.211 178.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.4 m -81.78 172.33 9.91 Favored Pre-proline 0 N--CA 1.498 1.957 0 O-C-N 122.07 -0.394 . . . . 0.0 110.124 -177.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -85.61 51.38 2.88 Favored 'Trans proline' 0 N--CA 1.494 1.516 0 O-C-N 123.398 1.21 . . . . 0.0 111.396 174.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 43.4 tptt -155.81 45.07 0.45 Allowed 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.86 -173.09 1.14 Allowed 'General case' 0 N--CA 1.5 2.071 0 CA-C-O 121.109 0.48 . . . . 0.0 110.798 -162.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 2.2 tp60 -133.86 -168.95 2.21 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -167.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 9.1 tp -64.3 166.77 7.6 Favored 'General case' 0 N--CA 1.508 2.445 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -178.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 -68.21 123.59 21.13 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 121.799 -0.563 . . . . 0.0 110.146 -165.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 43.8 ptt85 -161.46 165.37 28.83 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 120.877 0.37 . . . . 0.0 110.41 -170.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 18.4 m -125.81 148.14 49.21 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 172.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.52 HD12 HD12 ' A' ' 62' ' ' ILE . 18.5 tt -143.2 156.08 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 122.048 -0.408 . . . . 0.0 110.186 -177.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.467 ' HB3' HD21 ' A' ' 111' ' ' LEU . 45.3 mt-10 -141.85 147.88 37.91 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 120.879 0.371 . . . . 0.0 110.411 178.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 25.3 p -143.09 136.35 28.2 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 -177.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 22.5 p -157.44 128.82 6.82 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.888 -0.507 . . . . 0.0 111.016 -171.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 52.9 ttt180 -103.73 48.76 0.84 Allowed 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 121.319 0.581 . . . . 0.0 110.481 -178.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 23.9 p -135.66 150.5 49.62 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.919 -0.488 . . . . 0.0 109.739 175.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -62.91 132.13 51.06 Favored 'General case' 0 N--CA 1.504 2.248 0 CA-C-O 121.358 0.599 . . . . 0.0 111.643 -162.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.448 HD21 ' CE ' ' A' ' 37' ' ' LYS . 82.7 mt 51.72 28.0 4.53 Favored 'General case' 0 N--CA 1.507 2.409 0 O-C-N 122.032 -0.418 . . . . 0.0 111.936 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 26.2 p -62.66 -23.01 66.88 Favored 'General case' 0 N--CA 1.507 2.391 0 O-C-N 121.908 -0.495 . . . . 0.0 111.591 174.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -77.39 -29.18 53.06 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.824 -0.547 . . . . 0.0 111.126 177.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -62.04 -40.26 95.13 Favored 'General case' 0 N--CA 1.506 2.357 0 O-C-N 121.69 -0.631 . . . . 0.0 110.879 -168.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -100.04 16.26 24.57 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 122.088 -0.383 . . . . 0.0 111.631 178.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.467 HD21 ' HB3' ' A' ' 100' ' ' GLU . 11.9 tp -115.88 108.9 16.88 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.504 -0.748 . . . . 0.0 110.25 -175.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -98.27 120.79 58.81 Favored Pre-proline 0 N--CA 1.497 1.888 0 CA-C-O 118.96 -0.543 . . . . 0.0 110.102 174.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.7 134.06 19.61 Favored 'Trans proline' 0 N--CA 1.49 1.273 0 O-C-N 123.227 1.119 . . . . 0.0 110.24 172.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 35.1 p -139.31 149.39 44.17 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 122.097 -0.377 . . . . 0.0 110.217 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 15.9 mt -72.16 155.09 92.02 Favored Pre-proline 0 N--CA 1.501 2.12 0 O-C-N 121.987 -0.445 . . . . 0.0 109.985 177.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -63.48 147.51 93.18 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 O-C-N 123.504 1.265 . . . . 0.0 110.704 178.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -68.72 134.14 29.45 Favored 'Trans proline' 0 N--CA 1.49 1.302 0 O-C-N 123.633 1.333 . . . . 0.0 110.328 -177.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.417 HG12 ' N ' ' A' ' 119' ' ' VAL . 43.4 t -80.39 165.71 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 178.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.417 ' N ' HG12 ' A' ' 118' ' ' VAL . 35.8 m -88.13 145.14 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 O-C-N 122.037 -0.414 . . . . 0.0 110.341 -179.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 23.1 pt -91.44 51.67 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 CA-C-O 121.149 0.499 . . . . 0.0 110.314 179.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 68.95 164.26 3.46 Favored Glycine 0 N--CA 1.496 2.676 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 -178.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_exo -58.66 133.08 51.86 Favored 'Trans proline' 0 N--CA 1.503 2.038 0 C-N-CA 121.091 1.194 . . . . 0.0 111.317 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -84.29 137.62 33.36 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 122.109 -0.37 . . . . 0.0 110.343 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -155.86 150.26 25.82 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 178.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -81.11 156.32 25.83 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 139.48 51.21 0.05 OUTLIER Glycine 0 N--CA 1.495 2.574 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 87.6 p -80.3 161.08 25.27 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 122.201 -0.588 . . . . 0.0 110.243 179.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 50.7 mm -90.19 137.77 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 63.6 ttt180 . . . . . 0 N--CA 1.499 1.994 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.211 179.895 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.269 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_exo -58.42 123.38 13.48 Favored 'Trans proline' 0 N--CA 1.502 2.006 0 C-N-CA 121.059 1.173 . . . . 0.0 111.436 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 69.5 mt-10 -90.36 46.85 1.37 Allowed 'General case' 0 N--CA 1.501 2.124 0 CA-C-O 121.167 0.508 . . . . 0.0 110.813 178.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -77.95 69.78 4.22 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.738 -0.601 . . . . 0.0 110.3 -176.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 18.3 m -147.81 119.42 7.99 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.851 -0.531 . . . . 0.0 110.047 176.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 20.4 mt -81.02 149.68 67.12 Favored Pre-proline 0 N--CA 1.501 2.097 0 O-C-N 122.106 -0.372 . . . . 0.0 110.311 -175.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -65.51 127.75 18.75 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 O-C-N 123.266 1.14 . . . . 0.0 110.929 166.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -156.07 50.99 0.53 Allowed 'General case' 0 N--CA 1.501 2.096 0 CA-C-O 121.305 0.574 . . . . 0.0 110.326 164.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.445 HD23 HG23 ' A' ' 55' ' ' THR . 21.1 tp -158.56 114.57 2.69 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.792 -0.567 . . . . 0.0 110.287 -177.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 29.7 ttmt -99.88 131.72 45.67 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 122.16 -0.338 . . . . 0.0 110.16 177.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 79.7 m -114.74 140.17 49.1 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 -179.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 68.6 t80 -87.49 143.38 27.25 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 122.093 -0.379 . . . . 0.0 110.097 176.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 27.5 p -117.49 137.0 52.84 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 122.089 -0.382 . . . . 0.0 110.58 -175.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 29.3 t -123.01 119.68 31.07 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 122.124 -0.36 . . . . 0.0 110.158 178.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 83.69 -61.96 4.67 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -106.54 112.84 26.01 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 122.109 -0.642 . . . . 0.0 110.519 -177.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -138.04 136.52 19.73 Favored Pre-proline 0 N--CA 1.495 1.803 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 176.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.78 152.78 67.32 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 O-C-N 123.118 1.062 . . . . 0.0 111.186 -171.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -60.55 -28.65 68.6 Favored 'General case' 0 N--CA 1.507 2.419 0 O-C-N 121.932 -0.48 . . . . 0.0 111.34 -172.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -92.21 14.37 16.41 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 122.009 -0.432 . . . . 0.0 111.752 -178.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.4 160.66 30.01 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.671 -0.643 . . . . 0.0 110.361 -172.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 58.7 mt -126.02 140.46 48.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 -178.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 38.74 42.79 0.65 Allowed 'General case' 0 N--CA 1.512 2.655 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -176.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 55.48 41.33 30.98 Favored 'General case' 0 N--CA 1.508 2.453 0 O-C-N 121.789 -0.569 . . . . 0.0 111.401 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 40.1 p -144.09 163.95 32.06 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.804 -0.56 . . . . 0.0 110.647 174.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.3 p -140.63 164.97 28.74 Favored 'General case' 0 N--CA 1.499 1.975 0 CA-C-O 120.882 0.372 . . . . 0.0 110.564 178.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 76.7 mt -112.82 133.62 58.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -175.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.445 HG23 HD23 ' A' ' 36' ' ' LEU . 9.0 t -141.22 153.0 45.04 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 122.054 -0.404 . . . . 0.0 111.083 -178.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -109.77 31.27 5.96 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 122.172 -0.33 . . . . 0.0 110.469 167.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -123.41 -94.11 1.12 Allowed Glycine 0 N--CA 1.497 2.725 0 N-CA-C 109.131 -1.588 . . . . 0.0 109.131 175.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 39.2 m80 -149.81 172.06 15.74 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 122.054 -0.674 . . . . 0.0 109.512 176.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 77.3 m -93.21 139.31 30.75 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 167.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 15.1 p90 -130.46 153.75 48.46 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.833 -0.542 . . . . 0.0 110.599 -176.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -151.52 142.23 22.78 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 177.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 17.8 tt -142.51 149.24 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 CA-C-O 120.888 0.375 . . . . 0.0 110.338 -173.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.529 HD12 ' HG ' ' A' ' 73' ' ' LEU . 16.1 tt -139.87 145.39 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 63.8 mt-10 -146.21 142.82 28.78 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.985 -0.447 . . . . 0.0 109.845 -168.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.403 ' O ' HD23 ' A' ' 95' ' ' LEU . 13.3 tm-20 -101.61 116.45 32.78 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 120.793 0.33 . . . . 0.0 110.179 -176.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -87.28 175.19 8.14 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 122.17 -0.331 . . . . 0.0 110.583 -175.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -60.65 -17.11 45.27 Favored 'General case' 0 N--CA 1.506 2.374 0 O-C-N 121.993 -0.442 . . . . 0.0 112.159 -172.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -92.48 -12.01 33.14 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.666 -0.646 . . . . 0.0 111.829 177.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.14 21.01 36.85 Favored Glycine 0 N--CA 1.498 2.785 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 176.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -97.59 142.41 29.44 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 118.395 1.098 . . . . 0.0 109.799 169.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.5 p -94.94 127.25 40.85 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 120.779 -0.369 . . . . 0.0 110.277 178.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.1 p -97.94 112.9 24.66 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 120.906 -0.318 . . . . 0.0 110.348 176.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.536 ' N ' HD12 ' A' ' 73' ' ' LEU . 6.4 mp -98.38 129.79 45.03 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 120.774 0.321 . . . . 0.0 110.452 -178.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -149.58 146.27 27.24 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 122.038 -0.413 . . . . 0.0 110.194 175.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 98.8 p -143.64 167.1 23.06 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 178.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -177.36 -163.99 30.23 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 -177.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 2.1 m -97.21 132.56 42.85 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 122.131 -0.629 . . . . 0.0 110.378 -175.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 55.1 ttm -100.3 124.41 45.73 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 122.068 -0.395 . . . . 0.0 110.231 179.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.3 ptpp? -66.94 172.14 4.73 Favored 'General case' 0 N--CA 1.504 2.227 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.348 176.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -64.82 136.39 56.83 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 122.038 -0.414 . . . . 0.0 110.559 -176.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -131.25 -47.02 1.0 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 122.107 -0.371 . . . . 0.0 110.394 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 138.43 -35.06 2.05 Favored Glycine 0 N--CA 1.496 2.637 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 74.6 m -72.31 115.59 11.74 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.983 -0.716 . . . . 0.0 110.219 -178.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -79.03 -36.06 41.68 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 122.115 -0.365 . . . . 0.0 110.381 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -155.5 75.21 0.92 Allowed 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.274 0.559 . . . . 0.0 110.182 176.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 63.4 mt-30 -155.3 103.63 2.36 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.928 -0.483 . . . . 0.0 109.731 -178.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 97.7 m -140.54 36.53 1.84 Allowed 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 120.914 0.388 . . . . 0.0 110.206 -176.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 55.7 mttm -79.82 173.83 12.2 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.965 -0.46 . . . . 0.0 110.213 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -135.79 136.73 40.94 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 122.156 -0.34 . . . . 0.0 110.557 -179.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.4 m -77.74 156.13 80.46 Favored Pre-proline 0 N--CA 1.5 2.036 0 O-C-N 122.155 -0.34 . . . . 0.0 110.208 178.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -83.85 53.08 3.95 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 O-C-N 123.53 1.279 . . . . 0.0 111.132 173.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 71.2 mttt -155.46 55.27 0.62 Allowed 'General case' 0 N--CA 1.498 1.925 0 CA-C-O 121.558 0.694 . . . . 0.0 109.141 -175.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -155.7 -169.48 3.12 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 120.954 0.407 . . . . 0.0 110.523 -166.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 2.3 tp60 -64.56 -169.16 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.326 0 CA-C-O 120.99 0.424 . . . . 0.0 110.231 -176.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.403 HD23 ' O ' ' A' ' 65' ' ' GLU . 8.7 tp -64.12 163.65 12.15 Favored 'General case' 0 N--CA 1.507 2.376 0 O-C-N 121.903 -0.498 . . . . 0.0 109.949 -166.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 79.3 mtp180 -68.29 146.35 53.39 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.775 -0.578 . . . . 0.0 110.485 -163.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 30.4 ptt180 -161.49 165.23 28.98 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-O 120.902 0.382 . . . . 0.0 110.381 -175.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.467 HG21 ' O ' ' A' ' 114' ' ' THR . 14.0 m -123.93 149.02 46.38 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 171.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.2 tt -143.1 153.34 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 122.089 -0.382 . . . . 0.0 110.189 -175.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -148.85 150.91 33.81 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-O 120.804 0.335 . . . . 0.0 110.543 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 26.3 p -143.14 155.31 44.54 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 175.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 19.7 p -157.47 136.71 11.86 Favored 'General case' 0 N--CA 1.503 2.205 0 CA-C-O 121.013 0.435 . . . . 0.0 110.738 -172.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 38.7 ttt180 -108.54 50.45 0.78 Allowed 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.413 0.625 . . . . 0.0 110.653 -171.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.0 p -147.4 151.76 37.02 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.69 -0.631 . . . . 0.0 109.888 178.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 17.6 p-10 -62.07 132.71 53.75 Favored 'General case' 0 N--CA 1.505 2.317 0 CA-C-O 121.44 0.638 . . . . 0.0 111.656 -164.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 74.7 mt 52.57 27.14 4.83 Favored 'General case' 0 N--CA 1.506 2.374 0 O-C-N 121.971 -0.455 . . . . 0.0 111.962 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 26.0 p -63.05 -23.39 67.43 Favored 'General case' 0 N--CA 1.508 2.435 0 C-N-CA 120.402 -0.519 . . . . 0.0 111.605 174.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -70.97 -26.51 63.19 Favored 'General case' 0 N--CA 1.505 2.293 0 O-C-N 121.799 -0.563 . . . . 0.0 111.025 177.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 49.0 tp60 -61.15 -43.32 99.07 Favored 'General case' 0 N--CA 1.508 2.442 0 O-C-N 121.647 -0.658 . . . . 0.0 110.617 -174.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -100.46 16.26 25.17 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 122.157 -0.339 . . . . 0.0 111.851 -176.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 16.4 tp -115.48 108.91 17.08 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.53 -0.731 . . . . 0.0 110.336 -176.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -98.6 120.7 58.49 Favored Pre-proline 0 N--CA 1.496 1.832 0 CA-C-O 118.936 -0.554 . . . . 0.0 110.16 174.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -70.54 134.42 26.29 Favored 'Trans proline' 0 N--CA 1.491 1.336 0 O-C-N 123.133 1.07 . . . . 0.0 110.262 175.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.467 ' O ' HG21 ' A' ' 98' ' ' THR . 34.9 p -139.24 150.03 45.02 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 122.137 -0.352 . . . . 0.0 110.2 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 14.9 mt -70.45 155.07 93.98 Favored Pre-proline 0 N--CA 1.502 2.141 0 CA-C-O 119.208 -0.425 . . . . 0.0 109.955 179.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -62.52 154.97 61.08 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 O-C-N 123.393 1.207 . . . . 0.0 110.844 -176.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -63.83 160.25 37.93 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 O-C-N 123.339 1.178 . . . . 0.0 110.802 179.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.417 HG12 ' N ' ' A' ' 119' ' ' VAL . 48.2 t -150.16 165.16 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.417 ' N ' HG12 ' A' ' 118' ' ' VAL . 58.9 t -89.54 130.14 39.34 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 -178.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 75.7 mt -90.66 116.57 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 177.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -104.19 167.55 16.0 Favored Glycine 0 N--CA 1.496 2.661 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -58.17 141.6 96.65 Favored 'Trans proline' 0 N--CA 1.502 2.004 0 C-N-CA 121.05 1.167 . . . . 0.0 111.426 179.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -84.25 140.04 31.94 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 122.085 -0.384 . . . . 0.0 110.257 -179.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -73.1 152.04 41.37 Favored 'General case' 0 N--CA 1.501 2.115 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.054 178.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -82.28 61.13 5.35 Favored 'General case' 0 N--CA 1.501 2.115 0 CA-C-O 121.332 0.587 . . . . 0.0 110.317 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -93.06 -170.75 39.93 Favored Glycine 0 N--CA 1.496 2.657 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 88.5 p -79.99 166.2 21.82 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 122.098 -0.648 . . . . 0.0 110.063 179.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 50.9 mm -89.55 138.1 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -179.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 22.4 ttm180 . . . . . 0 N--CA 1.498 1.96 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.151 -179.741 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.289 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_exo -58.34 120.61 8.61 Favored 'Trans proline' 0 N--CA 1.501 1.97 0 O-C-N 123.35 1.184 . . . . 0.0 111.39 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -155.4 79.03 1.03 Allowed 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.204 0.526 . . . . 0.0 109.612 -177.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -79.3 86.47 5.05 Favored 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 121.131 0.491 . . . . 0.0 109.939 178.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 18.9 m -152.1 125.88 9.01 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.997 -0.439 . . . . 0.0 110.13 178.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 67.6 mt -80.71 118.78 73.95 Favored Pre-proline 0 N--CA 1.5 2.051 0 CA-C-O 118.769 -0.634 . . . . 0.0 109.819 -178.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -61.78 141.0 88.82 Favored 'Trans proline' 0 N--CA 1.501 1.961 0 O-C-N 123.218 1.115 . . . . 0.0 111.189 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -157.0 48.57 0.44 Allowed 'General case' 0 N--CA 1.499 1.993 0 CA-C-O 121.046 0.451 . . . . 0.0 110.706 173.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 17.5 tp -161.32 114.44 1.92 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.783 -0.573 . . . . 0.0 110.42 -174.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 32.8 tttt -99.92 131.48 45.86 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 177.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 86.0 m -116.76 140.35 49.52 Favored 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -179.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -83.17 142.74 30.98 Favored 'General case' 0 N--CA 1.501 2.097 0 C-N-CA 120.73 -0.388 . . . . 0.0 109.992 175.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 28.1 p -114.66 136.92 52.52 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.849 -0.532 . . . . 0.0 110.561 -178.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.6 m -123.01 138.73 54.61 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 122.099 -0.376 . . . . 0.0 110.116 176.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 75.54 -67.07 2.28 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -113.54 124.54 52.61 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 122.11 -0.641 . . . . 0.0 110.465 -177.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -138.16 136.36 19.4 Favored Pre-proline 0 N--CA 1.496 1.844 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 174.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.36 152.42 67.24 Favored 'Trans proline' 0 N--CA 1.498 1.749 0 O-C-N 123.053 1.028 . . . . 0.0 111.185 -171.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -60.34 -28.11 67.9 Favored 'General case' 0 N--CA 1.507 2.378 0 O-C-N 121.944 -0.472 . . . . 0.0 111.391 -172.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -91.96 14.39 15.87 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.958 -0.464 . . . . 0.0 111.75 -178.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.92 162.07 25.18 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.652 -0.655 . . . . 0.0 110.246 -173.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 76.4 mt -125.53 140.11 49.33 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -177.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 38.72 42.47 0.61 Allowed 'General case' 0 N--CA 1.512 2.629 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -178.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 55.04 42.73 30.69 Favored 'General case' 0 N--CA 1.508 2.461 0 O-C-N 121.768 -0.582 . . . . 0.0 111.432 -178.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 39.9 p -142.75 161.59 37.69 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.785 -0.572 . . . . 0.0 110.622 173.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.5 p -139.53 165.12 28.09 Favored 'General case' 0 N--CA 1.498 1.973 0 CA-C-O 120.97 0.414 . . . . 0.0 110.486 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 75.9 mt -117.01 131.92 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 -173.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.9 t -143.65 155.66 44.31 Favored 'General case' 0 N--CA 1.502 2.143 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.168 -178.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -108.63 30.65 6.29 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 122.081 -0.387 . . . . 0.0 110.524 167.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -118.87 -103.44 2.1 Favored Glycine 0 N--CA 1.497 2.708 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 174.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 23.9 m-70 -139.55 171.93 13.54 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 122.169 -0.606 . . . . 0.0 109.655 176.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 83.2 m -93.92 139.21 31.18 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 165.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -129.59 150.04 51.09 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.591 -177.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.44 ' HB2' ' ND2' ' A' ' 108' ' ' ASN . . . -150.32 143.77 25.1 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 175.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.515 HD12 HD12 ' A' ' 99' ' ' ILE . 18.3 tt -144.18 149.17 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 122.091 -0.381 . . . . 0.0 110.099 -171.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.436 ' O ' HG23 ' A' ' 63' ' ' ILE . 15.6 tt -138.13 118.74 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 CA-C-O 120.877 0.37 . . . . 0.0 110.209 179.052 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 69.2 mt-10 -105.16 145.65 30.29 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 122.107 -0.371 . . . . 0.0 110.505 -178.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.711 ' O ' HD21 ' A' ' 95' ' ' LEU . 13.1 tm-20 -101.96 116.49 32.8 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 122.016 -0.427 . . . . 0.0 110.166 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -85.34 175.19 9.04 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 122.008 -0.433 . . . . 0.0 110.56 -175.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -60.75 -17.71 50.43 Favored 'General case' 0 N--CA 1.507 2.41 0 O-C-N 122.019 -0.426 . . . . 0.0 111.989 -173.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -92.87 -10.7 35.72 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.693 -0.629 . . . . 0.0 111.823 178.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 89.65 18.22 52.38 Favored Glycine 0 N--CA 1.498 2.809 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 177.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 69.5 mt-10 -93.98 149.72 20.98 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 118.521 1.161 . . . . 0.0 111.311 168.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.403 ' HB ' ' CG1' ' A' ' 63' ' ' ILE . 4.5 p -94.96 134.97 37.04 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 122.038 -0.414 . . . . 0.0 110.467 177.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.2 p -102.15 110.5 22.48 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 169.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.543 ' N ' HD12 ' A' ' 73' ' ' LEU . 6.4 mp -97.27 132.86 42.6 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 122.177 -0.327 . . . . 0.0 110.587 -175.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -148.07 145.32 28.39 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 122.154 -0.341 . . . . 0.0 110.399 175.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 99.2 p -143.74 166.97 23.4 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 176.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 178.58 -164.44 32.96 Favored Glycine 0 N--CA 1.497 2.742 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 2.6 m -96.41 132.74 41.64 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 122.15 -0.618 . . . . 0.0 110.298 -175.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 55.4 ttm -101.21 122.0 42.85 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 122.068 -0.395 . . . . 0.0 110.117 176.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 26.8 pttt -66.36 165.89 13.29 Favored 'General case' 0 N--CA 1.503 2.222 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.339 177.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -65.74 147.04 54.03 Favored 'General case' 0 N--CA 1.505 2.289 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.4 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -142.18 -48.83 0.36 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 122.112 -0.368 . . . . 0.0 110.347 -178.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 142.38 -33.91 1.86 Allowed Glycine 0 N--CA 1.497 2.704 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -176.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.9 m -71.42 124.3 24.29 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 122.126 -0.632 . . . . 0.0 109.975 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -77.37 -40.17 44.81 Favored 'General case' 0 N--CA 1.5 2.072 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.29 -178.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -155.55 33.59 0.36 Allowed 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.503 -176.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 91.9 mm-40 -75.48 65.31 1.71 Allowed 'General case' 0 N--CA 1.502 2.156 0 CA-C-O 121.391 0.615 . . . . 0.0 109.852 178.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 4.0 t -111.8 30.19 7.21 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.809 -0.557 . . . . 0.0 110.672 -177.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 6.3 mmmm -84.86 -178.81 6.94 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.986 -0.446 . . . . 0.0 110.411 -178.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -146.05 112.85 6.02 Favored 'General case' 0 N--CA 1.499 2.009 0 CA-C-O 120.946 0.403 . . . . 0.0 110.555 177.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.2 m -80.32 152.07 72.99 Favored Pre-proline 0 N--CA 1.502 2.146 0 O-C-N 122.006 -0.434 . . . . 0.0 110.26 179.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -83.33 55.5 5.07 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 O-C-N 123.427 1.225 . . . . 0.0 111.101 173.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 37.7 tttp -155.7 47.82 0.5 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.622 -0.674 . . . . 0.0 109.206 -178.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -155.68 -169.2 3.03 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.96 -0.463 . . . . 0.0 110.401 -162.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 2.8 tp60 -64.15 -168.93 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.25 0 CA-C-O 120.899 0.381 . . . . 0.0 110.243 -176.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.711 HD21 ' O ' ' A' ' 65' ' ' GLU . 9.7 tt -64.09 155.7 30.58 Favored 'General case' 0 N--CA 1.506 2.331 0 O-C-N 121.872 -0.517 . . . . 0.0 110.322 -162.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.47 ' N ' HD23 ' A' ' 95' ' ' LEU . 43.0 mtp180 -68.67 138.63 55.12 Favored 'General case' 0 N--CA 1.5 2.062 0 CA-C-O 120.893 0.377 . . . . 0.0 110.332 -166.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 48.6 ptt85 -161.54 165.16 28.94 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 -178.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.461 HG21 ' O ' ' A' ' 114' ' ' THR . 15.5 m -112.55 149.15 33.12 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 171.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.515 HD12 HD12 ' A' ' 62' ' ' ILE . 18.8 tt -143.25 154.89 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.017 -177.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 66.8 mt-10 -142.99 149.95 38.99 Favored 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.63 -178.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 92.5 m -141.97 138.8 32.18 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 -177.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 20.4 p -157.63 131.41 8.0 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.906 -0.496 . . . . 0.0 110.914 -175.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 51.1 ttt180 -104.61 48.05 0.85 Allowed 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.287 0.565 . . . . 0.0 110.65 -176.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 23.9 p -136.65 151.47 49.34 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.904 -0.497 . . . . 0.0 109.861 175.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 17.6 p-10 -61.88 132.07 51.84 Favored 'General case' 0 N--CA 1.505 2.3 0 CA-C-O 121.429 0.633 . . . . 0.0 111.735 -163.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.464 HD22 ' OE1' ' A' ' 109' ' ' GLN . 75.4 mt 51.98 26.83 3.95 Favored 'General case' 0 N--CA 1.508 2.474 0 O-C-N 122.098 -0.376 . . . . 0.0 111.923 179.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 26.3 p -63.16 -21.91 66.52 Favored 'General case' 0 N--CA 1.507 2.384 0 C-N-CA 120.439 -0.504 . . . . 0.0 111.6 176.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.44 ' ND2' ' HB2' ' A' ' 61' ' ' ALA . 4.6 m120 -90.91 -22.99 20.63 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.737 -0.602 . . . . 0.0 111.282 177.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.464 ' OE1' HD22 ' A' ' 106' ' ' LEU . 27.2 tt0 -61.01 -38.23 85.33 Favored 'General case' 0 N--CA 1.508 2.46 0 O-C-N 121.604 -0.685 . . . . 0.0 110.791 -175.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -100.69 16.32 25.32 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 122.094 -0.379 . . . . 0.0 111.674 177.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 15.7 tp -112.93 112.31 23.69 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.544 -0.723 . . . . 0.0 110.294 -174.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -96.27 120.86 61.8 Favored Pre-proline 0 N--CA 1.498 1.944 0 CA-C-O 118.894 -0.574 . . . . 0.0 109.912 172.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -71.0 143.71 45.55 Favored 'Trans proline' 0 N--CA 1.491 1.338 0 O-C-N 123.129 1.068 . . . . 0.0 110.225 177.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.461 ' O ' HG21 ' A' ' 98' ' ' THR . 35.3 p -139.11 150.05 45.24 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 122.1 -0.375 . . . . 0.0 110.204 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 16.4 mt -71.94 150.14 92.67 Favored Pre-proline 0 N--CA 1.501 2.124 0 C-N-CA 120.689 -0.405 . . . . 0.0 110.114 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -69.11 152.61 72.64 Favored 'Trans proline' 0 N--CA 1.491 1.35 0 O-C-N 123.55 1.29 . . . . 0.0 110.198 178.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -68.13 136.94 39.2 Favored 'Trans proline' 0 N--CA 1.49 1.313 0 O-C-N 123.502 1.264 . . . . 0.0 110.353 179.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 60.9 t -77.46 -38.65 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.19 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 58.1 t -89.78 135.2 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 76.2 mt -89.94 113.63 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 127.53 -171.52 18.94 Favored Glycine 0 N--CA 1.497 2.734 0 N-CA-C 109.439 -1.465 . . . . 0.0 109.439 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_exo -58.14 152.3 53.22 Favored 'Trans proline' 0 N--CA 1.501 1.961 0 C-N-CA 121.113 1.209 . . . . 0.0 111.429 178.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -155.29 164.3 38.96 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 122.177 -0.327 . . . . 0.0 110.217 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -155.88 130.79 9.22 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 109.981 -0.378 . . . . 0.0 109.981 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -155.18 34.08 0.38 Allowed 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 120.946 -0.301 . . . . 0.0 110.274 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -68.1 -35.78 84.28 Favored Glycine 0 N--CA 1.496 2.673 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 28.7 t -81.12 134.53 35.66 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 122.136 -0.626 . . . . 0.0 110.194 -179.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 76.3 mt -90.78 134.62 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 39.4 ttm180 . . . . . 0 N--CA 1.5 2.052 0 CA-C-O 118.117 -0.944 . . . . 0.0 110.111 179.519 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.288 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_exo -58.37 123.18 13.04 Favored 'Trans proline' 0 N--CA 1.501 1.971 0 O-C-N 123.367 1.193 . . . . 0.0 111.343 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -90.12 47.62 1.47 Allowed 'General case' 0 N--CA 1.5 2.035 0 CA-C-O 121.125 0.488 . . . . 0.0 110.796 179.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -77.5 82.06 3.95 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.749 -0.594 . . . . 0.0 109.865 -177.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.419 HG22 ' HB2' ' A' ' 56' ' ' ASN . 21.3 m -147.22 123.77 11.08 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.88 -0.512 . . . . 0.0 110.074 179.012 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 17.5 mt -76.53 150.95 82.68 Favored Pre-proline 0 N--CA 1.5 2.04 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.079 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -63.79 122.98 11.23 Favored 'Trans proline' 0 N--CA 1.499 1.799 0 O-C-N 123.269 1.142 . . . . 0.0 111.16 170.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -156.67 53.07 0.52 Allowed 'General case' 0 N--CA 1.5 2.06 0 CA-C-O 121.325 0.583 . . . . 0.0 110.3 164.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 20.5 tp -157.61 114.38 2.94 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.804 -0.56 . . . . 0.0 109.967 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 13.0 tttp -99.86 129.08 45.91 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 84.9 m -116.42 140.2 49.61 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -178.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -81.34 146.19 30.47 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 122.033 -0.417 . . . . 0.0 109.891 177.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 27.9 p -115.8 157.77 23.88 Favored 'General case' 0 N--CA 1.502 2.129 0 CA-C-O 120.997 0.427 . . . . 0.0 110.985 -173.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 96.7 p -65.65 162.99 17.23 Favored 'General case' 0 N--CA 1.503 2.196 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 167.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -51.35 -18.14 3.26 Favored Glycine 0 N--CA 1.507 3.397 0 N-CA-C 111.946 -0.462 . . . . 0.0 111.946 -173.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -84.4 111.8 19.77 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.8 -0.824 . . . . 0.0 109.621 163.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -138.32 136.08 18.91 Favored Pre-proline 0 N--CA 1.497 1.901 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -175.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -56.65 153.52 35.6 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 O-C-N 122.978 0.988 . . . . 0.0 111.599 -165.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -60.67 -31.24 70.49 Favored 'General case' 0 N--CA 1.506 2.353 0 O-C-N 121.953 -0.467 . . . . 0.0 111.357 -167.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -91.4 14.17 15.44 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 122.023 -0.423 . . . . 0.0 111.877 -177.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -86.01 162.14 18.63 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.654 -0.654 . . . . 0.0 110.542 -174.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 76.2 mt -122.02 140.53 45.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 -176.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 39.31 42.75 0.84 Allowed 'General case' 0 N--CA 1.513 2.69 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 55.05 41.73 31.53 Favored 'General case' 0 N--CA 1.508 2.438 0 O-C-N 121.844 -0.535 . . . . 0.0 111.455 -179.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 66.8 p -138.84 150.1 45.64 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.776 -0.577 . . . . 0.0 110.279 173.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.8 p -120.65 160.28 23.59 Favored 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 120.963 0.411 . . . . 0.0 110.598 178.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 77.5 mt -108.95 133.23 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -176.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.6 t -140.79 153.9 46.03 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.98 -0.45 . . . . 0.0 111.271 -178.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.419 ' HB2' HG22 ' A' ' 32' ' ' THR . 26.7 p30 -108.06 30.11 6.68 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 122.178 -0.326 . . . . 0.0 110.528 166.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -122.58 -96.79 1.34 Allowed Glycine 0 N--CA 1.496 2.656 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 177.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 15.9 m80 -148.98 172.07 15.33 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 122.097 -0.649 . . . . 0.0 109.428 178.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 82.3 m -95.84 139.19 32.42 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 168.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 16.5 p90 -132.08 150.83 52.05 Favored 'General case' 0 N--CA 1.499 1.994 0 C-N-CA 120.352 -0.539 . . . . 0.0 110.705 -178.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -152.55 144.66 23.83 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 175.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.529 HD12 HD12 ' A' ' 99' ' ' ILE . 18.3 tt -143.36 149.2 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 C-N-CA 120.741 -0.383 . . . . 0.0 110.492 -171.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.673 HD12 HD21 ' A' ' 73' ' ' LEU . 13.4 tt -136.1 145.09 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 176.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -150.04 145.86 26.64 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -170.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.3 tm-20 -101.62 117.35 34.71 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 122.128 -0.357 . . . . 0.0 110.098 -178.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -87.21 175.31 8.11 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 122.111 -0.368 . . . . 0.0 110.607 -175.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -60.67 -17.61 48.67 Favored 'General case' 0 N--CA 1.507 2.393 0 O-C-N 121.973 -0.454 . . . . 0.0 112.016 -172.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -92.77 -10.81 35.63 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.547 -0.721 . . . . 0.0 111.863 178.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.27 19.71 44.84 Favored Glycine 0 N--CA 1.498 2.769 0 N-CA-C 111.159 -0.776 . . . . 0.0 111.159 176.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -97.22 145.28 26.21 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 118.472 1.136 . . . . 0.0 109.915 169.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.2 p -94.87 129.62 41.79 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 122.127 -0.358 . . . . 0.0 110.24 178.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 19.3 p -97.9 115.6 28.44 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 122.156 -0.34 . . . . 0.0 110.346 178.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.673 HD21 HD12 ' A' ' 63' ' ' ILE . 18.4 mt -97.23 124.97 41.47 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 122.136 -0.352 . . . . 0.0 110.291 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -143.32 143.74 31.81 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 120.842 0.353 . . . . 0.0 110.534 175.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 89.4 p -143.73 166.99 23.33 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 176.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 176.48 -164.32 33.99 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 179.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 2.0 m -98.87 132.49 44.17 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 122.251 -0.558 . . . . 0.0 110.424 -174.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 50.0 ttm -102.52 133.66 47.13 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 122.116 -0.365 . . . . 0.0 110.185 176.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 22.5 pttm -65.98 172.05 4.01 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 122.054 -0.404 . . . . 0.0 110.543 178.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -64.93 147.12 53.99 Favored 'General case' 0 N--CA 1.504 2.274 0 O-C-N 122.063 -0.398 . . . . 0.0 110.397 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 74.8 mt-10 -137.21 -48.69 0.6 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 122.032 -0.417 . . . . 0.0 110.586 -175.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 147.81 140.81 3.42 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -177.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 27.5 t -78.23 0.26 25.87 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 122.085 -0.656 . . . . 0.0 112.525 -178.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -77.59 -32.17 53.49 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.524 -0.735 . . . . 0.0 110.366 178.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -155.65 77.29 0.97 Allowed 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.329 0.585 . . . . 0.0 109.78 176.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -78.94 60.2 2.82 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.833 -0.542 . . . . 0.0 110.857 -176.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 1.3 t -155.55 119.9 4.64 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.569 -0.707 . . . . 0.0 109.966 178.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 25.5 mmtt -79.6 117.62 20.69 Favored 'General case' 0 N--CA 1.502 2.146 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.316 179.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.448 ' OD1' HG21 ' A' ' 99' ' ' ILE . 64.9 m-20 -149.67 110.82 4.39 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 122.143 -0.348 . . . . 0.0 110.108 176.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 21.3 m -81.48 114.7 51.64 Favored Pre-proline 0 N--CA 1.502 2.133 0 CA-C-O 118.978 -0.534 . . . . 0.0 110.034 -177.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -75.37 61.78 6.02 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 O-C-N 123.083 1.044 . . . . 0.0 110.809 173.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 47.8 tttm -155.76 43.11 0.42 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.692 -0.63 . . . . 0.0 109.449 -178.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -155.63 121.91 5.17 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 122.047 -0.408 . . . . 0.0 110.041 -170.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 44.9 tt0 -111.45 52.94 0.73 Allowed 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.309 0.576 . . . . 0.0 110.093 -179.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.473 HD23 ' N ' ' A' ' 96' ' ' ARG . 4.4 tt -120.19 143.33 48.3 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.905 -0.497 . . . . 0.0 109.983 -179.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.473 ' N ' HD23 ' A' ' 95' ' ' LEU . 55.2 ttt85 -68.95 114.8 7.57 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 122.031 -0.418 . . . . 0.0 109.878 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 46.3 ptt85 -161.43 165.14 29.24 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 122.078 -0.389 . . . . 0.0 110.735 -176.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 19.9 m -134.03 149.23 51.17 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 178.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.529 HD12 HD12 ' A' ' 62' ' ' ILE . 18.3 tt -143.07 156.06 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 122.061 -0.399 . . . . 0.0 110.047 -179.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -142.88 146.58 34.22 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 120.825 0.345 . . . . 0.0 110.54 -178.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 26.0 p -143.12 137.67 29.29 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -178.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 20.5 p -157.57 133.74 9.53 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.96 -0.463 . . . . 0.0 110.989 -171.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 62.1 ttt180 -106.65 52.66 0.71 Allowed 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 121.426 0.631 . . . . 0.0 110.451 -176.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.0 p -142.26 151.64 42.27 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.766 -0.583 . . . . 0.0 109.753 174.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -61.28 131.79 51.5 Favored 'General case' 0 N--CA 1.506 2.337 0 CA-C-O 121.427 0.632 . . . . 0.0 111.771 -163.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.473 HD22 ' OE1' ' A' ' 109' ' ' GLN . 74.1 mt 52.08 26.8 4.04 Favored 'General case' 0 N--CA 1.507 2.404 0 O-C-N 122.064 -0.398 . . . . 0.0 111.964 179.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 26.3 p -63.06 -22.06 66.6 Favored 'General case' 0 N--CA 1.506 2.358 0 O-C-N 121.888 -0.507 . . . . 0.0 111.58 176.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -90.07 -22.94 21.58 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.79 -0.569 . . . . 0.0 111.277 176.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.473 ' OE1' HD22 ' A' ' 106' ' ' LEU . 28.5 tt0 -61.14 -38.84 87.82 Favored 'General case' 0 N--CA 1.508 2.438 0 O-C-N 121.595 -0.69 . . . . 0.0 110.768 -175.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -100.06 16.3 24.48 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 122.16 -0.337 . . . . 0.0 111.606 177.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 15.4 tp -112.65 111.81 22.88 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.595 -0.69 . . . . 0.0 110.31 -175.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -96.54 120.8 61.49 Favored Pre-proline 0 N--CA 1.498 1.974 0 CA-C-O 118.904 -0.57 . . . . 0.0 109.922 173.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -71.26 139.03 34.35 Favored 'Trans proline' 0 N--CA 1.49 1.311 0 O-C-N 123.182 1.096 . . . . 0.0 110.164 175.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 50.4 p -139.16 150.06 45.17 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 122.094 -0.379 . . . . 0.0 110.125 178.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.441 HD22 ' HG2' ' A' ' 96' ' ' ARG . 17.4 mt -73.21 111.64 12.5 Favored Pre-proline 0 N--CA 1.502 2.136 0 CA-C-O 118.975 -0.536 . . . . 0.0 110.012 178.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -68.06 150.57 77.6 Favored 'Trans proline' 0 N--CA 1.491 1.336 0 O-C-N 123.132 1.07 . . . . 0.0 110.265 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -63.61 146.39 92.51 Favored 'Trans proline' 0 N--CA 1.494 1.532 0 O-C-N 123.414 1.218 . . . . 0.0 110.787 176.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.411 HG12 ' N ' ' A' ' 119' ' ' VAL . 48.0 t -150.4 165.17 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.235 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.411 ' N ' HG12 ' A' ' 118' ' ' VAL . 60.4 t -90.64 131.86 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -178.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.473 ' O ' HG23 ' A' ' 120' ' ' ILE . 17.3 tt -153.18 118.59 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 122.109 -0.369 . . . . 0.0 110.078 178.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 68.36 170.11 5.68 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_exo -58.76 132.39 47.61 Favored 'Trans proline' 0 N--CA 1.501 1.966 0 C-N-CA 121.103 1.202 . . . . 0.0 111.307 178.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -85.89 127.5 34.61 Favored 'General case' 0 N--CA 1.5 2.04 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.284 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -70.04 131.23 44.03 Favored 'General case' 0 N--CA 1.501 2.113 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.188 178.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -82.42 165.5 20.2 Favored 'General case' 0 N--CA 1.501 2.089 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.526 -179.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 72.11 35.43 60.9 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 28.9 t -82.22 133.31 35.25 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.982 -0.717 . . . . 0.0 110.19 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 76.2 mt -90.86 130.65 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 23.1 ttm180 . . . . . 0 N--CA 1.496 1.853 0 CA-C-O 117.917 -1.04 . . . . 0.0 110.283 179.737 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.282 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -58.22 123.26 13.24 Favored 'Trans proline' 0 N--CA 1.501 1.939 0 C-N-CA 121.12 1.213 . . . . 0.0 111.383 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -90.08 47.33 1.44 Allowed 'General case' 0 N--CA 1.501 2.124 0 CA-C-O 121.13 0.49 . . . . 0.0 110.709 179.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -77.12 83.8 3.61 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.677 -0.639 . . . . 0.0 109.896 -176.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 22.1 m -124.35 107.72 11.44 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 122.025 -0.422 . . . . 0.0 110.126 178.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 76.6 mt -142.43 148.94 49.34 Favored Pre-proline 0 N--CA 1.497 1.881 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -61.24 142.15 95.43 Favored 'Trans proline' 0 N--CA 1.503 2.049 0 O-C-N 123.269 1.142 . . . . 0.0 111.187 175.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -158.55 49.66 0.37 Allowed 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 121.097 0.475 . . . . 0.0 110.898 172.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.426 HD23 HG23 ' A' ' 55' ' ' THR . 20.2 tp -161.53 114.09 1.84 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.696 -0.627 . . . . 0.0 110.276 -175.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.4 ' HE2' HG21 ' A' ' 52' ' ' THR . 58.0 tttt -99.76 130.39 45.96 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 122.167 -0.333 . . . . 0.0 110.151 177.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 77.4 m -113.86 140.31 48.45 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -179.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -84.75 140.76 31.02 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 175.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 28.2 p -114.16 138.09 50.89 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 122.024 -0.422 . . . . 0.0 110.676 -176.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.4 m -122.94 139.44 54.05 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 122.036 -0.415 . . . . 0.0 109.947 176.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.16 -68.27 1.4 Allowed Glycine 0 N--CA 1.496 2.659 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 63.9 m170 -110.8 123.06 49.35 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 122.163 -0.61 . . . . 0.0 110.602 -176.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -138.08 136.25 19.4 Favored Pre-proline 0 N--CA 1.497 1.881 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 174.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -60.32 152.47 66.68 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 O-C-N 123.062 1.033 . . . . 0.0 111.221 -170.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -60.34 -28.15 67.94 Favored 'General case' 0 N--CA 1.507 2.379 0 O-C-N 121.961 -0.462 . . . . 0.0 111.43 -172.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -92.07 14.25 16.48 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.955 -0.466 . . . . 0.0 111.782 -178.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.89 162.01 26.33 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.631 -0.668 . . . . 0.0 110.308 -172.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 76.7 mt -125.97 139.77 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -177.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 38.6 43.29 0.66 Allowed 'General case' 0 N--CA 1.512 2.64 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -177.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 55.44 42.29 30.12 Favored 'General case' 0 N--CA 1.507 2.418 0 O-C-N 121.811 -0.555 . . . . 0.0 111.467 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.4 HG21 ' HE2' ' A' ' 37' ' ' LYS . 39.2 p -144.38 162.72 35.77 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.76 -0.588 . . . . 0.0 110.658 173.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.3 p -139.77 164.95 28.59 Favored 'General case' 0 N--CA 1.499 1.992 0 CA-C-O 120.787 0.327 . . . . 0.0 110.613 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 77.2 mt -113.74 133.05 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -174.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.426 HG23 HD23 ' A' ' 36' ' ' LEU . 9.1 t -142.5 154.09 44.2 Favored 'General case' 0 N--CA 1.502 2.143 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.059 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 40.1 p-10 -108.37 30.29 6.57 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 122.109 -0.369 . . . . 0.0 110.608 167.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -122.31 -97.78 1.43 Allowed Glycine 0 N--CA 1.497 2.717 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 176.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 31.1 m80 -143.8 170.66 15.46 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 122.136 -0.626 . . . . 0.0 109.473 177.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 71.4 m -91.85 139.14 30.95 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 164.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 15.9 p90 -130.0 148.17 51.83 Favored 'General case' 0 N--CA 1.497 1.9 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.518 -177.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -151.46 141.75 22.37 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 178.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.498 HD12 HD12 ' A' ' 99' ' ' ILE . 18.0 tt -144.17 149.2 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 122.065 -0.397 . . . . 0.0 110.559 -171.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.749 HD12 HD21 ' A' ' 73' ' ' LEU . 16.4 tt -134.26 145.21 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 176.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -147.94 146.18 28.89 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -167.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.4 tm-20 -101.49 116.83 33.66 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 120.864 0.364 . . . . 0.0 110.179 -176.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -87.36 175.24 8.09 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 122.03 -0.419 . . . . 0.0 110.594 -175.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -60.49 -17.51 45.74 Favored 'General case' 0 N--CA 1.506 2.359 0 O-C-N 121.904 -0.498 . . . . 0.0 112.12 -172.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -92.89 -11.35 33.7 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.613 -0.679 . . . . 0.0 111.811 178.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.56 20.13 42.09 Favored Glycine 0 N--CA 1.497 2.751 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 177.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -97.32 145.27 26.28 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 118.49 1.145 . . . . 0.0 109.786 169.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.8 p -94.89 128.8 41.93 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 122.117 -0.364 . . . . 0.0 110.183 178.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 21.4 p -97.98 118.99 35.82 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 122.165 -0.334 . . . . 0.0 110.276 178.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.749 HD21 HD12 ' A' ' 63' ' ' ILE . 23.0 mt -97.61 127.13 43.33 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 122.14 -0.35 . . . . 0.0 110.408 179.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -147.98 144.88 28.29 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 122.039 -0.413 . . . . 0.0 110.481 174.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 78.8 p -143.69 167.01 23.28 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 176.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -178.3 -166.5 34.71 Favored Glycine 0 N--CA 1.497 2.709 0 N-CA-C 110.15 -1.18 . . . . 0.0 110.15 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 2.2 m -96.99 132.85 42.38 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 122.172 -0.605 . . . . 0.0 110.415 -176.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 56.0 ttm -100.66 122.93 44.15 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 122.097 -0.377 . . . . 0.0 110.15 178.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.1 pttm -65.88 167.97 8.74 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 122.01 -0.431 . . . . 0.0 110.59 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -65.74 147.6 53.12 Favored 'General case' 0 N--CA 1.504 2.244 0 O-C-N 122.045 -0.409 . . . . 0.0 110.515 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 68.5 mt-10 -142.09 -48.37 0.36 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 122.126 -0.359 . . . . 0.0 110.455 -178.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 142.7 -34.18 1.81 Allowed Glycine 0 N--CA 1.496 2.691 0 N-CA-C 109.816 -1.313 . . . . 0.0 109.816 -178.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 11.5 p -71.75 125.2 26.53 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 122.125 -0.632 . . . . 0.0 110.076 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -75.83 -45.0 38.18 Favored 'General case' 0 N--CA 1.501 2.089 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.121 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -155.67 30.24 0.37 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 122.065 -0.397 . . . . 0.0 110.632 177.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -79.07 83.43 5.16 Favored 'General case' 0 N--CA 1.501 2.084 0 CA-C-O 121.125 0.488 . . . . 0.0 109.974 179.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 90.2 m -111.48 32.04 5.68 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.883 -0.51 . . . . 0.0 110.347 178.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -83.4 175.53 9.77 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 122.023 -0.423 . . . . 0.0 110.325 -179.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.476 ' OD2' ' HB2' ' A' ' 93' ' ' ALA . 9.9 t70 -155.01 142.79 19.92 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 122.119 -0.363 . . . . 0.0 110.399 176.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 7.4 m -77.5 163.04 66.39 Favored Pre-proline 0 N--CA 1.501 2.082 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 177.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -84.28 56.01 4.78 Favored 'Trans proline' 0 N--CA 1.495 1.568 0 O-C-N 123.391 1.206 . . . . 0.0 111.717 -174.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 71.8 tttt -155.81 36.72 0.36 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.64 -0.662 . . . . 0.0 109.503 171.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.476 ' HB2' ' OD2' ' A' ' 89' ' ' ASP . . . -83.46 -169.91 2.79 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-O 121.137 0.494 . . . . 0.0 111.212 -166.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -65.03 -168.83 0.04 OUTLIER 'General case' 0 N--CA 1.504 2.244 0 CA-C-O 120.902 0.382 . . . . 0.0 110.045 173.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' A' ' 95' ' ' LEU . 9.2 tp -63.99 164.69 10.05 Favored 'General case' 0 N--CA 1.509 2.475 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 -173.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 73.9 mtt85 -68.18 137.07 54.56 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.824 -0.547 . . . . 0.0 110.425 -161.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 28.2 ptt-85 -161.41 165.31 29.04 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 120.805 0.336 . . . . 0.0 110.388 -174.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 15.1 m -124.41 147.91 47.95 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 171.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.498 HD12 HD12 ' A' ' 62' ' ' ILE . 18.5 tt -143.18 155.99 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 122.0 -0.437 . . . . 0.0 110.284 -174.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.424 ' HB3' HD21 ' A' ' 111' ' ' LEU . 47.7 mt-10 -144.81 149.84 36.14 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 120.723 0.297 . . . . 0.0 110.388 178.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 26.7 p -143.06 142.06 31.45 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 21.8 p -157.55 129.29 6.97 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 122.011 -0.431 . . . . 0.0 110.802 -171.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 53.0 ttp180 -104.02 48.45 0.85 Allowed 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.329 0.585 . . . . 0.0 110.504 -177.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.1 p -135.5 150.72 49.86 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.905 -0.497 . . . . 0.0 109.798 175.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 17.6 p-10 -62.5 131.93 50.79 Favored 'General case' 0 N--CA 1.504 2.269 0 CA-C-O 121.388 0.613 . . . . 0.0 111.734 -162.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 79.6 mt 51.76 27.84 4.46 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 122.003 -0.436 . . . . 0.0 111.936 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 26.0 p -62.69 -23.26 67.05 Favored 'General case' 0 N--CA 1.506 2.337 0 O-C-N 121.874 -0.516 . . . . 0.0 111.564 174.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -75.5 -29.66 59.58 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.907 -0.495 . . . . 0.0 111.079 177.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -62.16 -39.39 92.49 Favored 'General case' 0 N--CA 1.507 2.399 0 O-C-N 121.764 -0.585 . . . . 0.0 110.826 -169.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -100.3 16.16 25.28 Favored 'General case' 0 N--CA 1.498 1.938 0 C-N-CA 120.936 -0.306 . . . . 0.0 111.688 179.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.424 HD21 ' HB3' ' A' ' 100' ' ' GLU . 12.2 tp -117.99 108.93 15.86 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.511 -0.743 . . . . 0.0 110.296 -176.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -98.7 120.87 57.94 Favored Pre-proline 0 N--CA 1.497 1.896 0 CA-C-O 118.86 -0.59 . . . . 0.0 110.078 174.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -71.15 133.89 23.96 Favored 'Trans proline' 0 N--CA 1.491 1.341 0 O-C-N 123.247 1.13 . . . . 0.0 110.15 172.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 35.0 p -139.16 147.14 41.46 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 122.102 -0.374 . . . . 0.0 110.371 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 27.0 mt -72.23 155.11 91.88 Favored Pre-proline 0 N--CA 1.502 2.162 0 CA-C-O 119.277 -0.392 . . . . 0.0 110.01 176.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -62.26 146.8 95.8 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 O-C-N 123.313 1.165 . . . . 0.0 110.778 -178.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -68.37 143.11 56.85 Favored 'Trans proline' 0 N--CA 1.49 1.313 0 O-C-N 123.432 1.227 . . . . 0.0 110.402 -175.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.423 HG12 ' N ' ' A' ' 119' ' ' VAL . 48.5 t -150.66 165.55 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.146 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.423 ' N ' HG12 ' A' ' 118' ' ' VAL . 12.3 p -90.04 144.09 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 O-C-N 122.002 -0.436 . . . . 0.0 110.127 -179.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 76.3 mt -91.26 117.26 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 68.19 178.39 14.84 Favored Glycine 0 N--CA 1.497 2.718 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 178.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -58.45 161.38 14.48 Favored 'Trans proline' 0 N--CA 1.501 1.92 0 C-N-CA 121.109 1.206 . . . . 0.0 111.377 178.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -155.24 162.1 40.99 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 122.195 -0.316 . . . . 0.0 110.188 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -155.75 168.85 25.87 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 -178.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -155.23 -46.07 0.08 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 122.095 -0.378 . . . . 0.0 110.18 -179.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 90.79 36.82 6.64 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 30.6 t -155.39 101.85 2.22 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 122.133 -0.628 . . . . 0.0 110.108 179.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 76.3 mt -90.93 139.11 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 58.5 ttm-85 . . . . . 0 N--CA 1.498 1.961 0 CA-C-O 117.973 -1.013 . . . . 0.0 110.186 179.39 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.31 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -58.56 120.57 8.54 Favored 'Trans proline' 0 N--CA 1.501 1.951 0 O-C-N 123.328 1.173 . . . . 0.0 111.309 179.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -90.3 47.1 1.4 Allowed 'General case' 0 N--CA 1.501 2.121 0 CA-C-O 121.164 0.507 . . . . 0.0 110.703 179.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -77.63 82.18 4.05 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.639 -0.663 . . . . 0.0 109.922 -176.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.511 HG22 ' ND2' ' A' ' 56' ' ' ASN . 17.1 m -106.4 50.37 0.78 Allowed 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.296 0.569 . . . . 0.0 109.991 178.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 23.9 mt -77.65 151.0 79.71 Favored Pre-proline 0 N--CA 1.501 2.117 0 O-C-N 121.838 -0.539 . . . . 0.0 110.052 -178.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -64.13 122.21 10.12 Favored 'Trans proline' 0 N--CA 1.498 1.785 0 O-C-N 123.369 1.194 . . . . 0.0 111.208 169.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -158.32 53.37 0.44 Allowed 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 121.332 0.586 . . . . 0.0 110.264 164.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.404 HD23 HG23 ' A' ' 55' ' ' THR . 19.1 tp -158.41 114.72 2.75 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.803 -0.561 . . . . 0.0 110.032 -179.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.44 ' HE3' HD21 ' A' ' 106' ' ' LEU . 35.4 ttpt -99.74 131.6 45.62 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 122.112 -0.367 . . . . 0.0 110.256 178.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 73.3 m -117.87 140.38 49.8 Favored 'General case' 0 N--CA 1.502 2.155 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 -178.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -82.4 146.2 29.46 Favored 'General case' 0 N--CA 1.501 2.079 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.125 178.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 27.9 p -116.05 136.99 52.52 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 122.021 -0.424 . . . . 0.0 110.54 -178.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 29.1 t -122.29 135.04 54.67 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 122.039 -0.413 . . . . 0.0 110.064 177.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.83 -66.52 2.77 Favored Glycine 0 N--CA 1.496 2.698 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -112.42 124.0 51.52 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 122.077 -0.66 . . . . 0.0 110.57 -177.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -138.03 136.98 20.21 Favored Pre-proline 0 N--CA 1.496 1.875 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 175.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -60.59 151.78 73.26 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 O-C-N 123.171 1.09 . . . . 0.0 111.105 -172.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -60.25 -28.1 67.77 Favored 'General case' 0 N--CA 1.508 2.431 0 O-C-N 121.995 -0.441 . . . . 0.0 111.383 -172.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -92.21 14.29 16.63 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.935 -0.478 . . . . 0.0 111.782 -177.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.4 161.98 26.76 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.708 -0.62 . . . . 0.0 110.232 -172.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 71.4 mt -124.76 137.02 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -177.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 19.9 p30 37.81 43.16 0.47 Allowed 'General case' 0 N--CA 1.514 2.773 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -176.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 30.8 m120 55.32 43.08 29.59 Favored 'General case' 0 N--CA 1.509 2.493 0 O-C-N 121.882 -0.511 . . . . 0.0 111.43 -178.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 71.5 p -139.13 160.87 38.77 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.814 -0.554 . . . . 0.0 110.283 171.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.1 p -137.57 161.27 36.88 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-O 120.973 0.416 . . . . 0.0 110.452 178.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 77.7 mt -107.52 131.63 57.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -175.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.404 HG23 HD23 ' A' ' 36' ' ' LEU . 8.4 t -140.07 151.65 45.55 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 122.04 -0.413 . . . . 0.0 110.972 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.511 ' ND2' HG22 ' A' ' 32' ' ' THR . 49.9 p30 -107.81 30.57 6.21 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 122.127 -0.358 . . . . 0.0 110.585 167.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -122.86 -95.77 1.25 Allowed Glycine 0 N--CA 1.497 2.733 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 176.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 38.1 m-70 -149.59 172.03 15.68 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 122.108 -0.643 . . . . 0.0 109.556 176.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 82.7 m -94.51 139.2 31.46 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 168.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 19.5 p90 -129.06 151.28 49.92 Favored 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.476 -178.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.416 ' HB2' ' ND2' ' A' ' 108' ' ' ASN . . . -151.21 143.39 24.05 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 175.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.572 HD12 HD12 ' A' ' 99' ' ' ILE . 18.2 tt -144.02 149.33 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 122.109 -0.369 . . . . 0.0 110.276 -172.274 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.522 HD12 ' HG ' ' A' ' 73' ' ' LEU . 16.5 tt -136.46 145.25 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 178.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -147.99 145.88 28.71 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 122.013 -0.429 . . . . 0.0 109.914 -168.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.5 tm-20 -101.61 117.18 34.38 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 120.751 0.31 . . . . 0.0 110.185 -176.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 26.6 p-10 -87.6 175.35 7.95 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 122.123 -0.36 . . . . 0.0 110.563 -176.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -60.47 -17.24 43.6 Favored 'General case' 0 N--CA 1.506 2.368 0 O-C-N 122.007 -0.433 . . . . 0.0 112.082 -172.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -91.89 -11.57 35.99 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.551 -0.718 . . . . 0.0 111.819 178.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.84 20.95 37.98 Favored Glycine 0 N--CA 1.498 2.774 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 176.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -97.58 143.87 27.84 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 118.324 1.062 . . . . 0.0 109.898 170.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.8 p -94.84 124.32 38.82 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.234 176.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.7 p -97.92 113.72 25.62 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 122.093 -0.38 . . . . 0.0 110.336 178.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.542 ' N ' HD12 ' A' ' 73' ' ' LEU . 6.4 mp -97.51 128.35 44.2 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 122.147 -0.346 . . . . 0.0 110.26 -178.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -144.37 147.84 33.93 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 122.099 -0.375 . . . . 0.0 110.349 176.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 87.3 p -143.69 166.18 25.58 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 178.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -179.22 -167.11 36.17 Favored Glycine 0 N--CA 1.496 2.69 0 N-CA-C 110.354 -1.098 . . . . 0.0 110.354 -178.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 2.9 m -96.55 132.25 42.34 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 122.187 -0.596 . . . . 0.0 110.25 -175.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 51.1 ttm -98.53 121.88 41.02 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.946 -0.471 . . . . 0.0 110.087 176.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 26.6 pttt -66.77 165.28 15.42 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 122.043 -0.411 . . . . 0.0 110.508 -178.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 54.3 p90 -65.02 126.21 27.31 Favored 'General case' 0 N--CA 1.504 2.263 0 O-C-N 122.056 -0.403 . . . . 0.0 110.498 177.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -122.41 -44.16 2.26 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 122.101 -0.374 . . . . 0.0 110.488 -179.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 137.43 -33.54 2.28 Favored Glycine 0 N--CA 1.495 2.626 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 -176.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 86.4 p -71.26 125.11 26.09 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 122.067 -0.667 . . . . 0.0 109.955 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -75.87 -41.42 52.33 Favored 'General case' 0 N--CA 1.501 2.116 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.421 -176.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -155.69 34.52 0.36 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 122.037 -0.415 . . . . 0.0 110.504 -176.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -75.96 83.14 2.85 Favored 'General case' 0 N--CA 1.502 2.136 0 CA-C-O 121.274 0.559 . . . . 0.0 109.985 177.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 4.4 t -123.86 29.57 6.46 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.88 -0.512 . . . . 0.0 110.556 176.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 77.5 mttt -85.57 -175.54 5.69 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.913 -0.492 . . . . 0.0 110.488 -178.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -150.4 115.44 5.34 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 122.174 -0.329 . . . . 0.0 110.325 178.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 5.4 m -76.52 160.35 77.5 Favored Pre-proline 0 N--CA 1.501 2.092 0 O-C-N 122.062 -0.399 . . . . 0.0 109.945 176.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -84.23 55.81 4.74 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 O-C-N 123.394 1.207 . . . . 0.0 111.866 -173.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 22.2 pttm -155.83 32.38 0.35 Allowed 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.558 -0.714 . . . . 0.0 110.055 170.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -84.73 -169.94 2.88 Favored 'General case' 0 N--CA 1.499 2.0 0 CA-C-O 121.078 0.466 . . . . 0.0 111.124 -168.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -64.83 -168.73 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.261 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 170.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 9.0 tp -63.96 165.71 8.49 Favored 'General case' 0 N--CA 1.507 2.397 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 -172.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -68.03 137.81 55.35 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.509 -0.744 . . . . 0.0 110.47 -157.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 30.7 ptt180 -161.45 165.32 28.92 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 120.903 0.382 . . . . 0.0 110.557 -170.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 16.6 m -128.69 149.12 50.81 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 172.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.572 HD12 HD12 ' A' ' 62' ' ' ILE . 18.6 tt -143.02 156.0 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 122.023 -0.423 . . . . 0.0 110.165 -176.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -143.8 151.63 40.19 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 120.947 0.403 . . . . 0.0 110.581 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 89.6 m -141.98 141.31 32.89 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 19.9 p -157.56 137.9 12.78 Favored 'General case' 0 N--CA 1.504 2.243 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.137 -174.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 27.8 ttt180 -109.38 45.82 1.04 Allowed 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 121.275 0.56 . . . . 0.0 110.637 -172.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.0 p -141.92 152.08 43.22 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.869 -0.519 . . . . 0.0 109.97 178.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 17.6 p-10 -61.78 132.68 53.92 Favored 'General case' 0 N--CA 1.505 2.281 0 CA-C-O 121.373 0.606 . . . . 0.0 111.793 -164.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.478 HD22 ' OE1' ' A' ' 109' ' ' GLN . 74.4 mt 52.24 26.76 4.18 Favored 'General case' 0 N--CA 1.507 2.416 0 O-C-N 122.048 -0.408 . . . . 0.0 111.966 179.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 25.9 p -63.15 -22.2 66.7 Favored 'General case' 0 N--CA 1.507 2.419 0 O-C-N 121.858 -0.526 . . . . 0.0 111.572 175.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.416 ' ND2' ' HB2' ' A' ' 61' ' ' ALA . 4.9 m120 -91.1 -22.95 20.46 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.723 -0.611 . . . . 0.0 111.304 177.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.478 ' OE1' HD22 ' A' ' 106' ' ' LEU . 28.3 tt0 -60.97 -37.9 84.08 Favored 'General case' 0 N--CA 1.509 2.504 0 O-C-N 121.595 -0.691 . . . . 0.0 110.721 -176.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -100.16 16.22 24.9 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 122.126 -0.359 . . . . 0.0 111.59 177.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 17.4 tp -113.73 112.83 24.1 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.579 -0.701 . . . . 0.0 110.345 -175.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 37.8 tt0 -96.48 120.72 61.72 Favored Pre-proline 0 N--CA 1.496 1.872 0 CA-C-O 118.853 -0.594 . . . . 0.0 110.028 173.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -71.11 139.33 35.37 Favored 'Trans proline' 0 N--CA 1.49 1.303 0 O-C-N 123.197 1.104 . . . . 0.0 110.326 175.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 35.0 p -139.17 149.96 45.05 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 122.113 -0.367 . . . . 0.0 110.206 178.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 17.4 mt -72.68 111.16 10.12 Favored Pre-proline 0 N--CA 1.502 2.157 0 CA-C-O 118.896 -0.573 . . . . 0.0 110.037 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -68.44 150.64 75.8 Favored 'Trans proline' 0 N--CA 1.492 1.432 0 O-C-N 123.234 1.123 . . . . 0.0 110.284 -178.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -68.61 155.29 69.42 Favored 'Trans proline' 0 N--CA 1.492 1.389 0 O-C-N 123.517 1.272 . . . . 0.0 110.222 178.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.407 HG12 ' N ' ' A' ' 119' ' ' VAL . 42.5 t -79.08 165.16 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.407 ' N ' HG12 ' A' ' 118' ' ' VAL . 58.4 t -89.81 131.48 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 -178.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 76.2 mt -90.43 116.15 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 177.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 72.41 -163.25 54.68 Favored Glycine 0 N--CA 1.495 2.607 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_exo -58.25 148.99 75.86 Favored 'Trans proline' 0 N--CA 1.501 1.928 0 C-N-CA 121.119 1.213 . . . . 0.0 111.447 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -82.73 153.38 25.33 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 122.076 -0.39 . . . . 0.0 110.286 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -155.77 159.07 39.15 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 122.119 -0.363 . . . . 0.0 110.158 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -82.89 -42.56 17.58 Favored 'General case' 0 N--CA 1.5 2.028 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.159 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -150.03 175.61 29.05 Favored Glycine 0 N--CA 1.495 2.621 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 29.3 t -155.41 143.32 19.91 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 122.128 -0.631 . . . . 0.0 110.136 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 76.4 mt -90.21 139.44 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 30.3 ttp180 . . . . . 0 N--CA 1.499 1.98 0 CA-C-O 118.003 -0.999 . . . . 0.0 110.22 -179.616 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.209 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_exo -58.51 120.18 7.9 Favored 'Trans proline' 0 N--CA 1.5 1.908 0 C-N-CA 121.061 1.174 . . . . 0.0 111.403 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -90.42 46.97 1.38 Allowed 'General case' 0 N--CA 1.5 2.068 0 CA-C-O 121.131 0.491 . . . . 0.0 110.847 178.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -77.42 78.41 3.94 Favored 'General case' 0 N--CA 1.503 2.179 0 CA-C-O 121.313 0.578 . . . . 0.0 110.335 -177.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.477 HG22 ' HB2' ' A' ' 56' ' ' ASN . 14.0 m -109.35 98.57 7.96 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.799 -0.563 . . . . 0.0 110.024 178.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 25.3 mt -80.77 150.97 70.44 Favored Pre-proline 0 N--CA 1.502 2.136 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.369 -175.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -65.16 129.68 23.58 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 O-C-N 123.3 1.158 . . . . 0.0 110.978 165.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -157.84 50.94 0.43 Allowed 'General case' 0 N--CA 1.498 1.967 0 CA-C-O 121.423 0.63 . . . . 0.0 110.407 164.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 20.5 tp -158.72 114.88 2.68 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.733 -0.604 . . . . 0.0 110.29 -177.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.425 ' HE3' HD21 ' A' ' 106' ' ' LEU . 33.1 ttpt -99.77 132.14 45.3 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 120.95 -0.3 . . . . 0.0 110.233 176.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 76.4 m -117.52 140.33 49.75 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -179.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -81.86 142.13 32.79 Favored 'General case' 0 N--CA 1.502 2.143 0 C-N-CA 120.535 -0.466 . . . . 0.0 109.961 176.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 28.2 p -113.38 136.98 52.17 Favored 'General case' 0 N--CA 1.501 2.111 0 C-N-CA 120.779 -0.368 . . . . 0.0 110.589 -177.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.8 m -122.61 142.94 50.11 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 122.095 -0.378 . . . . 0.0 110.021 177.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.44 -68.13 1.5 Allowed Glycine 0 N--CA 1.494 2.547 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -115.27 126.47 54.54 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 122.003 -0.704 . . . . 0.0 110.613 -176.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -137.96 136.25 19.56 Favored Pre-proline 0 N--CA 1.496 1.852 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 174.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -60.7 152.65 67.76 Favored 'Trans proline' 0 N--CA 1.497 1.702 0 O-C-N 123.072 1.038 . . . . 0.0 111.194 -170.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -60.25 -28.03 67.7 Favored 'General case' 0 N--CA 1.508 2.44 0 O-C-N 122.021 -0.424 . . . . 0.0 111.34 -173.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -92.1 14.39 16.16 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.9 -0.5 . . . . 0.0 111.78 -178.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.92 162.04 26.29 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.581 -0.699 . . . . 0.0 110.259 -173.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 70.7 mt -124.11 136.45 60.33 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -176.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 19.8 p30 37.8 43.15 0.46 Allowed 'General case' 0 N--CA 1.512 2.658 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 -176.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 55.5 43.34 28.67 Favored 'General case' 0 N--CA 1.509 2.476 0 O-C-N 121.83 -0.544 . . . . 0.0 111.429 -178.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 56.1 p -139.53 161.98 36.17 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.801 -0.562 . . . . 0.0 110.273 171.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.4 p -137.29 160.43 39.07 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-O 120.737 0.304 . . . . 0.0 110.608 178.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 76.5 mt -110.09 132.97 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -174.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.0 t -143.5 155.19 44.27 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.952 -0.468 . . . . 0.0 111.022 -179.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.477 ' HB2' HG22 ' A' ' 32' ' ' THR . 48.9 p30 -108.09 29.31 7.43 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 122.036 -0.415 . . . . 0.0 110.705 167.181 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -119.59 -102.63 1.99 Allowed Glycine 0 N--CA 1.497 2.741 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 176.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 24.6 m-70 -140.89 169.75 17.03 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 122.007 -0.702 . . . . 0.0 109.709 177.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 78.0 m -93.13 139.24 30.79 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 166.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -129.38 149.58 51.1 Favored 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.486 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -152.12 138.4 18.42 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 176.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.579 HD12 HD12 ' A' ' 99' ' ' ILE . 18.2 tt -136.36 149.05 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 CA-C-O 120.961 0.41 . . . . 0.0 110.459 -168.552 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.791 HD12 HD21 ' A' ' 73' ' ' LEU . 16.3 tt -132.36 145.11 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 177.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -149.79 143.43 25.37 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 -169.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.6 tm-20 -101.64 117.68 35.38 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 122.169 -0.332 . . . . 0.0 110.119 -177.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 51.7 p30 -87.05 175.34 8.16 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 122.132 -0.355 . . . . 0.0 110.676 -175.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -60.44 -17.55 45.35 Favored 'General case' 0 N--CA 1.507 2.413 0 O-C-N 121.941 -0.474 . . . . 0.0 112.069 -173.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -93.18 -10.71 34.81 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.589 -0.695 . . . . 0.0 111.9 178.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 89.99 21.16 40.1 Favored Glycine 0 N--CA 1.498 2.785 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 178.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -96.98 143.79 27.51 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-N 118.312 1.056 . . . . 0.0 109.77 170.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 15.8 p -94.81 126.54 40.2 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 122.069 -0.395 . . . . 0.0 110.2 177.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 20.7 p -97.91 117.56 32.51 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 122.13 -0.357 . . . . 0.0 110.298 179.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.791 HD21 HD12 ' A' ' 63' ' ' ILE . 83.7 mt -97.7 128.18 44.19 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 122.136 -0.353 . . . . 0.0 110.295 -179.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -146.98 144.7 29.38 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 122.079 -0.388 . . . . 0.0 110.523 175.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 97.0 p -143.72 167.02 23.26 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 177.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -178.26 -169.14 38.69 Favored Glycine 0 N--CA 1.496 2.659 0 N-CA-C 110.224 -1.15 . . . . 0.0 110.224 -179.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 2.9 m -96.17 132.77 41.24 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 122.175 -0.603 . . . . 0.0 110.181 -176.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 54.9 ttm -98.92 122.01 41.62 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 122.052 -0.405 . . . . 0.0 110.071 175.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 17.5 pttm -66.74 163.84 18.34 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 122.024 -0.423 . . . . 0.0 110.48 -179.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -66.08 146.78 54.27 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 122.031 -0.418 . . . . 0.0 110.418 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -146.08 -48.32 0.21 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 122.173 -0.33 . . . . 0.0 110.242 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 136.82 58.64 0.05 OUTLIER Glycine 0 N--CA 1.495 2.586 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 -178.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.7 m -152.58 115.93 4.71 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 122.198 -0.589 . . . . 0.0 110.396 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -74.35 -39.27 62.9 Favored 'General case' 0 N--CA 1.503 2.188 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.244 177.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -155.63 30.78 0.37 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 122.153 -0.342 . . . . 0.0 110.569 176.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 60.0 mt-30 -78.57 83.98 4.72 Favored 'General case' 0 N--CA 1.502 2.16 0 CA-C-O 121.173 0.511 . . . . 0.0 110.066 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 87.9 m -113.38 36.32 3.62 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.937 -0.477 . . . . 0.0 109.892 177.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -79.3 -172.08 3.01 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.99 -0.444 . . . . 0.0 110.399 -175.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -122.15 139.81 53.31 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 122.043 -0.41 . . . . 0.0 111.863 -178.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.0 m -77.67 175.18 4.82 Favored Pre-proline 0 N--CA 1.499 1.987 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 177.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -88.39 52.44 1.95 Allowed 'Trans proline' 0 N--CA 1.494 1.53 0 N-CA-C 107.857 -1.632 . . . . 0.0 107.857 173.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 51.6 tttm -155.71 42.88 0.42 Allowed 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.59 163.52 27.6 Favored 'General case' 0 N--CA 1.5 2.026 0 CA-C-O 121.146 0.498 . . . . 0.0 110.952 -161.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -98.91 -169.05 1.72 Allowed 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 -177.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' A' ' 95' ' ' LEU . 8.9 tp -64.29 169.62 4.46 Favored 'General case' 0 N--CA 1.506 2.347 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 57.9 mtm180 -68.02 130.69 43.73 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.488 -0.758 . . . . 0.0 110.295 -163.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 46.4 ptt85 -161.46 165.25 29.03 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 120.824 0.345 . . . . 0.0 110.594 -168.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 18.1 m -128.75 148.78 50.87 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 172.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.579 HD12 HD12 ' A' ' 62' ' ' ILE . 18.4 tt -143.18 127.38 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.997 -0.439 . . . . 0.0 110.167 -176.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -105.81 149.23 26.68 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 122.234 -0.291 . . . . 0.0 110.455 177.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 26.7 p -143.02 134.63 26.46 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 177.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 20.4 p -157.57 131.38 8.04 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.926 -0.484 . . . . 0.0 110.81 -170.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 21.6 ttp-105 -104.86 48.48 0.84 Allowed 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 121.385 0.612 . . . . 0.0 110.604 -176.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.0 p -135.12 151.36 50.63 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.895 -0.503 . . . . 0.0 109.785 174.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 15.7 p30 -61.77 132.24 52.51 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 121.724 -0.61 . . . . 0.0 111.793 -163.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.425 HD21 ' HE3' ' A' ' 37' ' ' LYS . 75.3 mt 52.0 26.55 3.8 Favored 'General case' 0 N--CA 1.507 2.376 0 O-C-N 122.089 -0.382 . . . . 0.0 111.991 179.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 26.3 p -63.11 -21.99 66.56 Favored 'General case' 0 N--CA 1.506 2.363 0 O-C-N 121.849 -0.532 . . . . 0.0 111.583 176.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -93.04 -22.93 18.85 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.684 -0.635 . . . . 0.0 111.323 178.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -60.66 -38.6 85.42 Favored 'General case' 0 N--CA 1.508 2.436 0 O-C-N 121.577 -0.702 . . . . 0.0 110.768 -177.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -100.74 16.23 25.67 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 122.078 -0.389 . . . . 0.0 111.685 179.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 16.8 tp -111.87 117.34 32.52 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.586 -0.697 . . . . 0.0 110.394 -174.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 3.3 tp-100 -96.45 120.71 61.79 Favored Pre-proline 0 N--CA 1.496 1.868 0 CA-C-O 118.862 -0.589 . . . . 0.0 109.965 171.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -69.93 145.22 55.51 Favored 'Trans proline' 0 N--CA 1.491 1.347 0 O-C-N 123.235 1.124 . . . . 0.0 110.291 175.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 34.5 p -139.22 147.05 41.25 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 122.175 -0.328 . . . . 0.0 110.156 179.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 14.9 mt -72.1 154.97 92.2 Favored Pre-proline 0 N--CA 1.502 2.166 0 CA-C-O 119.305 -0.379 . . . . 0.0 110.152 178.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -67.94 148.85 77.08 Favored 'Trans proline' 0 N--CA 1.491 1.326 0 O-C-N 123.47 1.247 . . . . 0.0 110.292 179.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -68.25 140.42 48.84 Favored 'Trans proline' 0 N--CA 1.492 1.394 0 O-C-N 123.452 1.238 . . . . 0.0 110.425 -178.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.42 HG12 ' N ' ' A' ' 119' ' ' VAL . 43.5 t -80.14 165.86 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.182 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.42 ' N ' HG12 ' A' ' 118' ' ' VAL . 58.2 t -88.82 125.64 41.94 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -179.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 76.3 mt -91.53 117.88 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 178.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 101.99 79.94 1.44 Allowed Glycine 0 N--CA 1.495 2.587 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 177.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_exo -58.68 -177.47 0.11 Allowed 'Trans proline' 0 N--CA 1.502 1.978 0 O-C-N 123.352 1.185 . . . . 0.0 111.361 176.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -155.23 94.88 1.66 Allowed 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 120.836 0.35 . . . . 0.0 110.254 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -73.21 154.06 40.41 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 122.065 -0.397 . . . . 0.0 110.099 178.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -81.63 -34.15 31.01 Favored 'General case' 0 N--CA 1.5 2.044 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.174 179.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 87.13 166.13 42.17 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 109.594 -1.403 . . . . 0.0 109.594 178.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 60.2 m -80.85 157.82 25.56 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 122.125 -0.632 . . . . 0.0 110.228 179.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 76.2 mt -89.88 134.66 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 55.5 ttt85 . . . . . 0 N--CA 1.498 1.93 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.152 -179.924 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.351 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_exo -58.39 119.87 7.4 Favored 'Trans proline' 0 N--CA 1.501 1.958 0 O-C-N 123.357 1.188 . . . . 0.0 111.365 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -90.31 47.01 1.39 Allowed 'General case' 0 N--CA 1.501 2.107 0 CA-C-O 121.082 0.468 . . . . 0.0 110.722 179.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -78.12 81.17 4.51 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.708 -0.62 . . . . 0.0 109.866 -177.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 21.6 m -135.52 114.37 12.02 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.856 -0.527 . . . . 0.0 110.188 178.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 73.4 mt -142.48 118.7 6.89 Favored Pre-proline 0 N--CA 1.496 1.862 0 CA-C-O 118.817 -0.611 . . . . 0.0 109.414 178.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -60.45 145.29 98.99 Favored 'Trans proline' 0 N--CA 1.502 2.011 0 C-N-CA 120.823 1.015 . . . . 0.0 111.224 -178.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -151.73 47.99 0.8 Allowed 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 121.188 0.518 . . . . 0.0 110.743 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.433 HD23 HG23 ' A' ' 55' ' ' THR . 18.9 tp -161.0 115.01 2.05 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.771 -0.581 . . . . 0.0 110.449 -174.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 48.6 tttt -99.81 132.5 45.12 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 122.146 -0.347 . . . . 0.0 110.223 177.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 86.4 m -118.97 140.43 50.01 Favored 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 -178.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -83.07 144.49 29.86 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 122.027 -0.421 . . . . 0.0 110.015 176.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 28.1 p -115.67 137.07 52.44 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.952 -0.467 . . . . 0.0 110.588 -178.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 98.6 p -123.02 141.57 51.82 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 109.894 -0.409 . . . . 0.0 109.894 175.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.18 -68.16 1.41 Allowed Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -112.15 123.59 50.59 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.997 -0.708 . . . . 0.0 110.498 -176.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -138.07 136.99 20.14 Favored Pre-proline 0 N--CA 1.496 1.87 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 174.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -61.11 152.52 70.99 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 O-C-N 123.087 1.046 . . . . 0.0 111.077 -172.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -60.44 -28.21 68.11 Favored 'General case' 0 N--CA 1.508 2.462 0 O-C-N 121.88 -0.512 . . . . 0.0 111.415 -172.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -91.97 14.26 16.27 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.953 -0.467 . . . . 0.0 111.735 -177.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.86 161.97 27.22 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.533 -0.73 . . . . 0.0 110.243 -173.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 70.7 mt -124.36 136.38 60.69 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -177.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 19.8 p30 37.78 43.36 0.48 Allowed 'General case' 0 N--CA 1.515 2.776 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -176.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 30.8 m120 55.39 44.0 27.88 Favored 'General case' 0 N--CA 1.507 2.386 0 O-C-N 121.785 -0.572 . . . . 0.0 111.466 -178.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 58.2 p -140.76 161.75 37.05 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.725 -0.609 . . . . 0.0 110.306 171.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.4 p -139.66 165.07 28.26 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-O 120.752 0.311 . . . . 0.0 110.691 179.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 76.4 mt -111.91 132.53 60.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 -175.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.433 HG23 HD23 ' A' ' 36' ' ' LEU . 9.1 t -140.44 153.05 46.14 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 122.027 -0.421 . . . . 0.0 111.059 -179.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 48.5 p30 -108.61 29.96 6.92 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 122.037 -0.415 . . . . 0.0 110.672 167.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -122.89 -96.05 1.26 Allowed Glycine 0 N--CA 1.497 2.73 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 176.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 49.7 m-70 -144.5 171.03 14.93 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 122.136 -0.626 . . . . 0.0 109.761 176.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 73.7 m -92.96 139.09 30.89 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 164.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -129.52 150.34 50.9 Favored 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 120.291 -0.564 . . . . 0.0 110.613 -178.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -151.26 143.98 24.39 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 175.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.487 HD12 HD12 ' A' ' 99' ' ' ILE . 18.1 tt -143.29 149.26 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.397 -171.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.668 HD12 HD21 ' A' ' 73' ' ' LEU . 13.5 tt -134.28 145.32 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 177.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -148.58 145.15 27.69 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 -169.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.3 tm-20 -101.53 116.94 33.9 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 122.146 -0.346 . . . . 0.0 110.134 -176.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -87.4 175.33 8.04 Favored 'General case' 0 N--CA 1.501 2.101 0 CA-C-O 120.796 0.332 . . . . 0.0 110.584 -175.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -60.44 -17.86 47.35 Favored 'General case' 0 N--CA 1.506 2.372 0 O-C-N 121.895 -0.503 . . . . 0.0 112.0 -172.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -92.85 -10.37 36.96 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.599 -0.688 . . . . 0.0 111.861 178.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 89.47 20.21 45.73 Favored Glycine 0 N--CA 1.498 2.791 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 176.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -97.38 145.74 25.86 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-N 118.466 1.133 . . . . 0.0 109.793 169.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 13.6 p -94.92 129.16 42.06 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 122.106 -0.371 . . . . 0.0 110.26 178.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 20.9 p -97.86 118.16 33.81 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 122.057 -0.402 . . . . 0.0 110.353 178.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.668 HD21 HD12 ' A' ' 63' ' ' ILE . 23.2 mt -97.53 126.87 43.07 Favored 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 120.966 -0.294 . . . . 0.0 110.307 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -145.18 143.41 30.3 Favored 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.646 174.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 98.9 p -143.85 167.06 23.2 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 176.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 178.91 -165.66 34.8 Favored Glycine 0 N--CA 1.496 2.663 0 N-CA-C 110.379 -1.088 . . . . 0.0 110.379 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 2.6 m -96.27 132.4 41.78 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 122.178 -0.601 . . . . 0.0 110.227 -176.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 55.8 ttm -98.49 121.82 40.91 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 122.069 -0.394 . . . . 0.0 110.156 177.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 22.5 pttt -66.99 165.05 16.39 Favored 'General case' 0 N--CA 1.503 2.199 0 C-N-CA 120.699 -0.401 . . . . 0.0 110.537 -178.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -66.44 148.54 51.73 Favored 'General case' 0 N--CA 1.503 2.22 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.244 177.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -139.62 -48.58 0.47 Allowed 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.404 -178.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 147.31 -33.82 1.32 Allowed Glycine 0 N--CA 1.497 2.726 0 N-CA-C 109.846 -1.301 . . . . 0.0 109.846 -176.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.9 m -71.1 125.49 27.04 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 122.028 -0.689 . . . . 0.0 109.907 178.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -74.04 -41.27 62.05 Favored 'General case' 0 N--CA 1.502 2.133 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.294 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -155.6 28.55 0.38 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 122.138 -0.351 . . . . 0.0 110.826 178.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -79.67 85.39 5.39 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.837 -0.539 . . . . 0.0 110.153 -179.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 90.8 m -100.88 34.61 2.42 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.88 -0.512 . . . . 0.0 109.979 175.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 79.2 mttt -80.06 -171.69 3.06 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 122.089 -0.382 . . . . 0.0 110.366 -176.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -116.08 135.74 53.66 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 122.129 -0.357 . . . . 0.0 111.421 -177.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.0 m -78.59 174.88 5.33 Favored Pre-proline 0 N--CA 1.498 1.934 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 178.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -88.18 52.49 2.05 Favored 'Trans proline' 0 N--CA 1.495 1.616 0 N-CA-C 108.324 -1.452 . . . . 0.0 108.324 173.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 11.8 ptmt -155.74 43.06 0.42 Allowed 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 177.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.98 -171.41 0.71 Allowed 'General case' 0 N--CA 1.5 2.057 0 CA-C-O 121.069 0.461 . . . . 0.0 110.988 -162.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -136.49 -169.1 2.38 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -169.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.6 tp -64.47 166.52 8.27 Favored 'General case' 0 N--CA 1.51 2.525 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 -178.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 42.2 ttt180 -68.18 135.7 52.48 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.654 -0.654 . . . . 0.0 110.428 -164.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 33.4 ptt-85 -161.51 165.42 28.63 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 120.984 0.421 . . . . 0.0 110.575 -170.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 17.0 m -126.81 149.06 49.88 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 171.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.487 HD12 HD12 ' A' ' 62' ' ' ILE . 18.5 tt -143.14 155.92 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.963 -0.461 . . . . 0.0 110.308 -175.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 57.1 mm-40 -141.46 147.75 38.39 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 120.866 0.365 . . . . 0.0 110.412 179.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 26.8 p -143.1 136.84 28.69 Favored 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 179.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 18.9 p -157.5 132.53 8.8 Favored 'General case' 0 N--CA 1.504 2.244 0 O-C-N 121.97 -0.456 . . . . 0.0 110.973 -171.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 22.4 ttm180 -105.14 48.68 0.83 Allowed 'General case' 0 N--CA 1.498 1.974 0 CA-C-O 121.382 0.61 . . . . 0.0 110.559 -177.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 23.8 p -136.02 151.16 49.59 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.714 -0.616 . . . . 0.0 109.799 174.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -61.73 131.98 51.68 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.69 -0.631 . . . . 0.0 111.821 -163.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 72.9 mt 52.28 26.4 4.0 Favored 'General case' 0 N--CA 1.506 2.36 0 O-C-N 122.047 -0.408 . . . . 0.0 111.948 179.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 26.4 p -62.86 -22.06 66.42 Favored 'General case' 0 N--CA 1.507 2.422 0 O-C-N 121.859 -0.526 . . . . 0.0 111.615 176.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -92.21 -22.86 19.57 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.83 -0.544 . . . . 0.0 111.331 177.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -60.76 -38.1 84.09 Favored 'General case' 0 N--CA 1.507 2.395 0 O-C-N 121.635 -0.666 . . . . 0.0 110.775 -177.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -100.24 16.26 24.88 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 122.179 -0.325 . . . . 0.0 111.701 178.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 14.0 tp -116.9 111.53 19.78 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.492 -0.755 . . . . 0.0 110.289 -175.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 21.9 tp60 -96.49 120.7 61.74 Favored Pre-proline 0 N--CA 1.497 1.893 0 CA-C-O 118.756 -0.64 . . . . 0.0 109.982 172.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.69 133.89 21.12 Favored 'Trans proline' 0 N--CA 1.49 1.296 0 O-C-N 123.237 1.125 . . . . 0.0 110.395 176.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 34.9 p -139.22 147.84 42.3 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 122.004 -0.435 . . . . 0.0 110.048 177.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 13.5 mt -72.46 138.16 80.89 Favored Pre-proline 0 N--CA 1.502 2.128 0 CA-C-O 119.01 -0.519 . . . . 0.0 109.929 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -75.82 146.67 30.07 Favored 'Trans proline' 0 N--CA 1.489 1.255 0 O-C-N 123.285 1.15 . . . . 0.0 110.247 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -71.28 132.35 20.75 Favored 'Trans proline' 0 N--CA 1.49 1.32 0 O-C-N 123.379 1.2 . . . . 0.0 110.134 175.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.413 HG12 ' N ' ' A' ' 119' ' ' VAL . 42.5 t -80.75 165.19 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.486 HG13 ' O ' ' A' ' 119' ' ' VAL . 13.2 p -90.18 114.17 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 CA-C-O 120.984 0.421 . . . . 0.0 110.314 -179.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 10.0 tt -155.15 47.18 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 121.996 -0.44 . . . . 0.0 110.063 176.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 66.66 65.23 2.9 Favored Glycine 0 N--CA 1.497 2.725 0 N-CA-C 109.846 -1.301 . . . . 0.0 109.846 -178.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_exo -57.87 150.85 60.63 Favored 'Trans proline' 0 N--CA 1.502 2.017 0 C-N-CA 121.125 1.217 . . . . 0.0 111.504 -177.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -155.24 160.19 40.64 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 122.178 -0.327 . . . . 0.0 110.248 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -155.33 45.5 0.49 Allowed 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 121.281 0.562 . . . . 0.0 109.54 -176.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -85.2 113.79 21.82 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.937 -0.477 . . . . 0.0 110.174 -178.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 77.31 -159.19 48.49 Favored Glycine 0 N--CA 1.495 2.625 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 32.8 t -155.45 145.33 21.46 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 122.147 -0.619 . . . . 0.0 110.064 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 76.8 mt -90.19 134.08 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 32.7 ttp180 . . . . . 0 N--CA 1.495 1.82 0 CA-C-O 117.993 -1.004 . . . . 0.0 110.286 179.755 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.331 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_exo -58.22 120.38 8.23 Favored 'Trans proline' 0 N--CA 1.502 1.978 0 O-C-N 123.361 1.19 . . . . 0.0 111.395 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -90.27 47.15 1.41 Allowed 'General case' 0 N--CA 1.501 2.108 0 CA-C-O 121.117 0.485 . . . . 0.0 110.85 179.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -78.09 80.83 4.51 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.746 -0.596 . . . . 0.0 109.853 -177.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.445 HG22 ' HB2' ' A' ' 56' ' ' ASN . 22.5 m -140.64 118.71 11.92 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.968 -0.458 . . . . 0.0 110.152 179.29 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 28.2 mt -79.31 145.06 63.39 Favored Pre-proline 0 N--CA 1.501 2.09 0 CA-C-O 119.053 -0.498 . . . . 0.0 109.872 179.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -61.17 138.55 78.47 Favored 'Trans proline' 0 N--CA 1.502 1.996 0 O-C-N 123.176 1.093 . . . . 0.0 111.237 176.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -155.38 47.29 0.51 Allowed 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.931 -0.481 . . . . 0.0 110.752 172.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 25.1 tp -159.33 102.77 1.59 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.767 -0.583 . . . . 0.0 110.396 -173.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 41.0 tttp -99.91 119.07 37.64 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 110.288 -0.264 . . . . 0.0 110.288 177.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 69.2 m -121.73 140.63 52.09 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 122.078 -0.389 . . . . 0.0 110.945 -178.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -79.7 155.44 28.01 Favored 'General case' 0 N--CA 1.501 2.087 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.07 -178.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 27.2 p -119.3 141.14 49.25 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.996 -0.44 . . . . 0.0 110.529 -179.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 49.7 m -122.98 138.93 54.55 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 122.086 -0.383 . . . . 0.0 110.169 177.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.52 -68.38 1.51 Allowed Glycine 0 N--CA 1.496 2.661 0 N-CA-C 109.669 -1.373 . . . . 0.0 109.669 178.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 83.2 t60 -112.97 125.79 54.78 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 122.073 -0.663 . . . . 0.0 110.537 -176.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -138.03 137.68 21.73 Favored Pre-proline 0 N--CA 1.496 1.839 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 176.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -61.11 150.89 82.18 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 O-C-N 123.049 1.026 . . . . 0.0 111.072 -174.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -59.77 -27.18 66.32 Favored 'General case' 0 N--CA 1.507 2.41 0 O-C-N 121.938 -0.477 . . . . 0.0 111.463 -173.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -92.17 14.23 16.74 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.871 -0.518 . . . . 0.0 111.746 -177.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.63 162.03 25.53 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.655 -0.653 . . . . 0.0 110.333 -173.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 76.2 mt -125.75 140.52 48.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -178.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 38.8 42.08 0.59 Allowed 'General case' 0 N--CA 1.513 2.696 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -178.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 30.7 m120 54.96 41.8 31.59 Favored 'General case' 0 N--CA 1.509 2.511 0 O-C-N 121.955 -0.465 . . . . 0.0 111.437 -178.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 43.1 p -140.54 161.77 36.95 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.825 -0.547 . . . . 0.0 110.332 173.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.4 p -138.38 163.32 32.18 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 120.967 0.413 . . . . 0.0 110.542 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 79.1 mt -129.33 125.32 61.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -168.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.2 t -143.6 158.25 43.81 Favored 'General case' 0 N--CA 1.501 2.12 0 C-N-CA 120.578 -0.449 . . . . 0.0 111.337 -177.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.445 ' HB2' HG22 ' A' ' 32' ' ' THR . 10.6 p-10 -109.58 29.23 7.77 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 122.168 -0.333 . . . . 0.0 110.473 165.211 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -112.44 -103.66 2.67 Favored Glycine 0 N--CA 1.496 2.662 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 178.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 22.9 m80 -147.22 158.88 44.11 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 170.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 87.5 m -96.71 139.35 32.9 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 176.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -129.01 158.36 39.11 Favored 'General case' 0 N--CA 1.497 1.915 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.694 -171.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -150.98 143.86 24.55 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 176.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.476 HD12 HD12 ' A' ' 99' ' ' ILE . 18.2 tt -142.21 149.15 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.444 -170.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.858 HD12 HD21 ' A' ' 73' ' ' LEU . 15.4 tt -137.88 145.11 29.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 178.327 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -150.04 140.85 22.74 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 -170.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.1 tm-20 -101.67 116.54 32.98 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -86.78 175.23 8.33 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 122.068 -0.395 . . . . 0.0 110.582 -175.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -60.65 -17.49 47.74 Favored 'General case' 0 N--CA 1.507 2.423 0 O-C-N 122.076 -0.39 . . . . 0.0 112.002 -172.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -92.49 -10.82 36.42 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.628 -0.67 . . . . 0.0 111.855 178.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.14 20.91 40.5 Favored Glycine 0 N--CA 1.497 2.757 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 176.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -97.49 142.8 28.88 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 118.378 1.089 . . . . 0.0 109.784 169.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.3 p -94.91 128.83 41.99 Favored 'General case' 0 N--CA 1.498 1.961 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.273 177.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.1 p -98.05 114.33 26.46 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 120.851 0.358 . . . . 0.0 110.232 177.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.858 HD21 HD12 ' A' ' 63' ' ' ILE . 82.4 mt -96.66 123.98 40.51 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 122.169 -0.332 . . . . 0.0 110.235 179.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -145.23 147.88 32.9 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 122.087 -0.383 . . . . 0.0 110.465 178.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 92.5 p -143.57 164.99 28.83 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 176.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -173.98 -178.96 44.3 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 -177.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 6.6 m -100.08 133.46 44.43 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 122.203 -0.587 . . . . 0.0 110.309 -178.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 35.2 ttm -99.85 123.13 43.78 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 122.038 -0.414 . . . . 0.0 110.167 176.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 24.5 pttt -65.49 170.86 4.49 Favored 'General case' 0 N--CA 1.504 2.27 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.381 177.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -65.46 144.51 56.99 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.957 -0.464 . . . . 0.0 110.424 -179.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -148.15 -48.23 0.16 Allowed 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.293 -178.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 147.42 -35.42 1.23 Allowed Glycine 0 N--CA 1.495 2.626 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -178.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 64.4 m -72.98 123.62 23.84 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 122.028 -0.69 . . . . 0.0 110.006 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -78.24 -46.16 21.07 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 122.043 -0.41 . . . . 0.0 110.199 -179.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -155.67 33.62 0.36 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.999 -0.438 . . . . 0.0 110.41 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -76.09 65.38 2.09 Favored 'General case' 0 N--CA 1.501 2.105 0 CA-C-O 121.402 0.62 . . . . 0.0 110.013 179.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 95.6 m -111.81 33.77 4.59 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.748 -0.595 . . . . 0.0 110.232 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 63.3 mttm -80.83 170.23 16.55 Favored 'General case' 0 N--CA 1.501 2.11 0 C-N-CA 120.706 -0.397 . . . . 0.0 110.296 -178.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -109.52 132.89 53.72 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.6 t -78.33 142.69 63.34 Favored Pre-proline 0 N--CA 1.498 1.974 0 C-N-CA 120.604 -0.438 . . . . 0.0 110.123 -175.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -78.23 61.59 7.83 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 O-C-N 123.25 1.132 . . . . 0.0 110.479 173.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 25.8 ttmt -155.45 46.15 0.49 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.774 -0.579 . . . . 0.0 109.901 -177.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -155.69 144.07 20.16 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -109.99 60.48 0.6 Allowed 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.406 0.622 . . . . 0.0 110.178 -176.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 20.5 tp -154.96 153.85 31.68 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.723 -0.61 . . . . 0.0 110.03 178.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 3.8 mmp_? -87.06 126.99 35.11 Favored 'General case' 0 N--CA 1.5 2.038 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.01 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 62.1 ttp85 -161.39 145.76 13.25 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 122.056 -0.403 . . . . 0.0 110.147 -177.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 12.2 m -134.26 149.09 50.92 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 172.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.476 HD12 HD12 ' A' ' 62' ' ' ILE . 18.6 tt -143.06 155.99 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 177.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -145.95 156.64 43.65 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 120.873 0.368 . . . . 0.0 110.474 -178.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 97.0 m -141.81 154.12 44.98 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 178.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 25.4 p -157.6 133.34 9.22 Favored 'General case' 0 N--CA 1.502 2.146 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.842 -170.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 48.9 ttt85 -109.46 45.91 1.04 Allowed 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.299 0.571 . . . . 0.0 110.516 -179.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 44.2 p -138.1 151.97 48.31 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.805 -0.559 . . . . 0.0 110.055 176.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 21.3 p30 -64.12 140.46 58.87 Favored 'General case' 0 N--CA 1.505 2.292 0 CA-C-O 121.315 0.579 . . . . 0.0 111.198 -169.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 20.3 mt 53.07 25.85 4.44 Favored 'General case' 0 N--CA 1.507 2.39 0 O-C-N 121.814 -0.554 . . . . 0.0 112.289 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 27.9 p -67.84 -25.18 65.42 Favored 'General case' 0 N--CA 1.505 2.275 0 C-N-CA 119.968 -0.693 . . . . 0.0 111.164 172.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -81.09 -33.79 33.09 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.723 -0.611 . . . . 0.0 110.463 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -63.06 -40.73 98.57 Favored 'General case' 0 N--CA 1.506 2.358 0 O-C-N 122.002 -0.436 . . . . 0.0 110.89 -177.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -102.4 16.26 26.79 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 122.067 -0.395 . . . . 0.0 111.978 -174.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 13.5 tp -125.84 109.05 12.06 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.535 -0.728 . . . . 0.0 110.37 -176.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -98.33 120.78 58.74 Favored Pre-proline 0 N--CA 1.497 1.889 0 CA-C-O 118.799 -0.619 . . . . 0.0 110.132 173.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -68.84 147.13 68.06 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 O-C-N 123.234 1.123 . . . . 0.0 110.205 175.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 35.3 p -139.17 149.98 45.07 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 122.133 -0.355 . . . . 0.0 110.169 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 64.1 mt -71.76 155.02 92.7 Favored Pre-proline 0 N--CA 1.502 2.145 0 CA-C-O 119.187 -0.435 . . . . 0.0 110.138 179.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -64.82 156.69 60.46 Favored 'Trans proline' 0 N--CA 1.492 1.424 0 O-C-N 123.36 1.189 . . . . 0.0 110.596 178.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -68.25 147.12 71.71 Favored 'Trans proline' 0 N--CA 1.492 1.439 0 O-C-N 123.555 1.292 . . . . 0.0 110.227 178.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 61.0 t -76.92 -37.63 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 60.4 t -89.72 138.33 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 179.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.516 ' O ' HG23 ' A' ' 120' ' ' ILE . 4.5 tp -153.26 68.71 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 CA-C-O 121.169 0.509 . . . . 0.0 110.156 -179.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -169.11 -100.89 0.14 Allowed Glycine 0 N--CA 1.496 2.64 0 N-CA-C 103.557 -3.817 . . . . 0.0 103.557 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -39.59 146.73 0.2 Allowed 'Trans proline' 0 N--CA 1.502 2.0 0 O-C-N 123.369 1.194 . . . . 0.0 114.885 177.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -84.45 136.39 33.86 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 122.13 -0.356 . . . . 0.0 110.457 179.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -155.79 164.31 38.71 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 122.096 -0.378 . . . . 0.0 110.073 178.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -155.19 155.96 34.83 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 122.154 -0.342 . . . . 0.0 110.109 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 85.93 170.25 46.81 Favored Glycine 0 N--CA 1.495 2.603 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 87.9 p -81.09 159.7 24.66 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 122.17 -0.606 . . . . 0.0 110.232 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 76.1 mt -90.26 132.26 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 63.6 ttt180 . . . . . 0 N--CA 1.498 1.939 0 CA-C-O 118.066 -0.969 . . . . 0.0 110.198 179.954 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.304 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_exo -58.35 120.5 8.43 Favored 'Trans proline' 0 N--CA 1.502 1.975 0 O-C-N 123.3 1.158 . . . . 0.0 111.409 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -155.48 78.78 1.02 Allowed 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 -176.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -79.15 86.55 4.95 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.822 -0.549 . . . . 0.0 110.006 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.404 HG22 ' HB2' ' A' ' 56' ' ' ASN . 18.8 m -146.04 120.04 9.4 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.932 -0.48 . . . . 0.0 109.949 177.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 22.0 mt -80.17 148.45 67.44 Favored Pre-proline 0 N--CA 1.5 2.071 0 O-C-N 122.098 -0.376 . . . . 0.0 110.217 -175.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_exo -65.48 127.88 19.04 Favored 'Trans proline' 0 N--CA 1.498 1.757 0 O-C-N 123.279 1.147 . . . . 0.0 110.942 166.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -156.12 51.33 0.53 Allowed 'General case' 0 N--CA 1.498 1.971 0 CA-C-O 121.364 0.602 . . . . 0.0 110.372 164.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.436 HD23 HG23 ' A' ' 55' ' ' THR . 20.8 tp -158.26 114.81 2.81 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.615 -0.678 . . . . 0.0 110.29 -178.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 55.5 tttt -99.79 130.09 45.96 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 178.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 80.1 m -114.62 140.21 49.0 Favored 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -84.5 142.79 29.79 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 176.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 28.1 p -113.88 137.67 51.35 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 122.052 -0.405 . . . . 0.0 110.595 -177.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 28.0 t -122.95 133.05 54.4 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 122.089 -0.382 . . . . 0.0 110.109 178.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.75 -66.26 2.77 Favored Glycine 0 N--CA 1.495 2.586 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 63.9 m170 -110.79 123.34 49.88 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 122.069 -0.665 . . . . 0.0 110.554 -177.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -138.1 136.01 19.14 Favored Pre-proline 0 N--CA 1.496 1.858 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 175.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -60.54 152.69 66.46 Favored 'Trans proline' 0 N--CA 1.496 1.662 0 O-C-N 123.024 1.013 . . . . 0.0 111.201 -170.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -60.36 -28.15 67.95 Favored 'General case' 0 N--CA 1.507 2.377 0 O-C-N 122.04 -0.412 . . . . 0.0 111.365 -172.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -92.32 14.35 16.68 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.985 -0.447 . . . . 0.0 111.763 -178.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.45 162.07 27.47 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.554 -0.716 . . . . 0.0 110.217 -172.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.419 HG22 HD22 ' A' ' 50' ' ' ASN . 68.7 mt -126.06 137.59 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -176.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.419 HD22 HG22 ' A' ' 49' ' ' ILE . 17.2 p30 37.82 43.31 0.48 Allowed 'General case' 0 N--CA 1.512 2.675 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -175.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 24.9 t30 56.1 42.66 28.08 Favored 'General case' 0 N--CA 1.508 2.457 0 O-C-N 121.805 -0.559 . . . . 0.0 111.451 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 44.3 p -142.02 165.24 27.99 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.765 -0.584 . . . . 0.0 110.555 171.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.6 p -137.8 163.7 30.74 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 122.166 -0.333 . . . . 0.0 110.567 176.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 77.0 mt -112.55 132.57 60.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -175.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.436 HG23 HD23 ' A' ' 36' ' ' LEU . 9.1 t -139.62 152.78 47.06 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.95 -0.469 . . . . 0.0 111.104 -178.002 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.404 ' HB2' HG22 ' A' ' 32' ' ' THR . 15.3 p-10 -108.92 31.25 5.82 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 122.116 -0.365 . . . . 0.0 110.432 167.098 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -124.79 -95.85 1.09 Allowed Glycine 0 N--CA 1.496 2.648 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 176.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 23.3 m80 -146.86 171.91 14.48 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 122.076 -0.661 . . . . 0.0 109.507 177.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 74.8 m -93.78 139.25 31.07 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 166.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -130.41 148.65 52.25 Favored 'General case' 0 N--CA 1.499 2.006 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.49 -178.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -151.9 143.5 23.55 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 177.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.549 HD12 HD12 ' A' ' 99' ' ' ILE . 18.3 tt -145.15 149.27 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 122.063 -0.398 . . . . 0.0 110.479 -171.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.658 HD12 HD21 ' A' ' 73' ' ' LEU . 15.4 tt -135.75 145.32 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 176.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -148.2 148.49 30.58 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 -169.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.4 tm-20 -101.6 117.51 35.06 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 -175.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -87.38 175.28 8.06 Favored 'General case' 0 N--CA 1.501 2.093 0 CA-C-O 120.796 0.331 . . . . 0.0 110.582 -175.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -60.84 -17.57 50.74 Favored 'General case' 0 N--CA 1.506 2.347 0 O-C-N 121.988 -0.445 . . . . 0.0 111.954 -172.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -92.63 -10.86 35.86 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.678 -0.639 . . . . 0.0 111.801 178.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.54 19.33 45.26 Favored Glycine 0 N--CA 1.497 2.766 0 O-C-N 121.469 -0.769 . . . . 0.0 111.194 177.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -97.2 145.37 26.12 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-N 118.483 1.141 . . . . 0.0 109.818 169.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.9 p -94.72 128.54 41.48 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 122.079 -0.388 . . . . 0.0 110.342 178.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 19.8 p -97.96 116.25 29.79 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 122.134 -0.354 . . . . 0.0 110.354 178.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.658 HD21 HD12 ' A' ' 63' ' ' ILE . 14.7 mt -97.42 126.58 42.76 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 122.152 -0.342 . . . . 0.0 110.423 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -145.75 144.82 30.56 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 120.811 -0.355 . . . . 0.0 110.434 175.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 80.1 p -143.72 165.55 27.35 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 176.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -178.02 -166.87 35.17 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 110.226 -1.15 . . . . 0.0 110.226 -178.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 2.7 m -97.32 132.68 42.82 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 122.212 -0.581 . . . . 0.0 110.309 -175.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 47.3 ttm -99.1 123.33 43.32 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 122.028 -0.42 . . . . 0.0 110.197 178.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 23.5 pttm -65.22 172.02 3.37 Favored 'General case' 0 N--CA 1.504 2.241 0 O-C-N 122.049 -0.407 . . . . 0.0 110.642 -178.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -65.49 148.35 51.88 Favored 'General case' 0 N--CA 1.505 2.321 0 O-C-N 122.006 -0.434 . . . . 0.0 110.542 -178.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 69.3 mt-10 -132.7 -45.97 0.88 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 122.143 -0.348 . . . . 0.0 110.268 178.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 108.52 34.31 2.7 Favored Glycine 0 N--CA 1.497 2.735 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 28.2 p -155.79 109.54 2.79 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 122.072 -0.664 . . . . 0.0 109.915 177.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -79.32 -43.58 23.29 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 122.12 -0.363 . . . . 0.0 110.376 -178.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -78.8 -12.16 60.02 Favored 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -174.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -75.32 85.12 2.48 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.729 -0.607 . . . . 0.0 110.278 -172.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 13.4 t -151.21 27.72 0.67 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 122.069 -0.395 . . . . 0.0 110.657 173.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 73.6 mttt -87.61 -169.83 2.76 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.948 -0.47 . . . . 0.0 110.549 -178.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -102.58 120.55 40.73 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 122.053 -0.404 . . . . 0.0 110.218 176.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.0 m -81.66 172.07 10.57 Favored Pre-proline 0 N--CA 1.497 1.89 0 O-C-N 122.057 -0.402 . . . . 0.0 110.3 -173.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -84.95 52.9 3.53 Favored 'Trans proline' 0 N--CA 1.494 1.518 0 O-C-N 123.412 1.217 . . . . 0.0 111.406 173.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 8.8 ptpt -155.74 44.23 0.44 Allowed 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 178.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.46 -171.04 0.57 Allowed 'General case' 0 N--CA 1.5 2.068 0 CA-C-O 121.133 0.492 . . . . 0.0 110.831 -161.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -147.23 -168.96 3.19 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -164.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.9 tp -64.2 164.5 10.85 Favored 'General case' 0 N--CA 1.507 2.393 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 -179.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 79.7 mtm180 -68.19 126.8 30.68 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.725 -0.609 . . . . 0.0 110.33 -162.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 16.9 ptt-85 -161.49 165.35 28.8 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 120.841 0.353 . . . . 0.0 110.332 -174.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 15.2 m -128.56 149.14 50.75 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 173.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.549 HD12 HD12 ' A' ' 62' ' ' ILE . 18.5 tt -143.09 155.77 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 122.064 -0.397 . . . . 0.0 109.976 -179.111 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.454 ' HB3' HD21 ' A' ' 111' ' ' LEU . 45.2 mt-10 -143.02 149.76 38.69 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 120.932 0.396 . . . . 0.0 110.506 -178.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 25.6 p -143.06 137.78 29.46 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -178.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 22.6 p -157.39 131.7 8.4 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.895 -0.503 . . . . 0.0 110.979 -172.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 30.4 ttp180 -105.83 44.81 1.01 Allowed 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 121.285 0.564 . . . . 0.0 110.532 -176.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.0 p -135.19 150.89 50.21 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.929 -0.482 . . . . 0.0 109.931 177.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 17.6 p-10 -62.82 131.81 50.08 Favored 'General case' 0 N--CA 1.504 2.228 0 CA-C-O 121.436 0.636 . . . . 0.0 111.635 -163.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 81.2 mt 51.76 28.13 4.69 Favored 'General case' 0 N--CA 1.506 2.355 0 O-C-N 121.927 -0.483 . . . . 0.0 111.934 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 25.8 p -62.46 -23.85 67.12 Favored 'General case' 0 N--CA 1.506 2.36 0 O-C-N 121.823 -0.548 . . . . 0.0 111.53 173.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -75.31 -30.0 60.22 Favored 'General case' 0 N--CA 1.504 2.241 0 O-C-N 121.811 -0.556 . . . . 0.0 111.046 177.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -62.3 -39.63 93.63 Favored 'General case' 0 N--CA 1.506 2.339 0 O-C-N 121.673 -0.642 . . . . 0.0 110.81 -168.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -100.17 16.11 25.27 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 122.176 -0.328 . . . . 0.0 111.693 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.454 HD21 ' HB3' ' A' ' 100' ' ' GLU . 12.5 tp -116.36 108.95 16.71 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.597 -0.69 . . . . 0.0 110.347 -175.256 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -99.45 120.72 57.1 Favored Pre-proline 0 N--CA 1.497 1.903 0 CA-C-O 118.955 -0.545 . . . . 0.0 110.125 173.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -68.79 137.41 38.31 Favored 'Trans proline' 0 N--CA 1.49 1.277 0 O-C-N 123.158 1.083 . . . . 0.0 110.157 172.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 34.7 p -139.29 146.8 40.8 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.119 178.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 21.0 mt -71.26 149.58 94.21 Favored Pre-proline 0 N--CA 1.503 2.205 0 C-N-CA 120.685 -0.406 . . . . 0.0 109.94 179.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -68.1 146.51 70.73 Favored 'Trans proline' 0 N--CA 1.491 1.326 0 O-C-N 123.435 1.229 . . . . 0.0 110.273 -178.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -69.11 145.34 60.56 Favored 'Trans proline' 0 N--CA 1.49 1.294 0 O-C-N 123.468 1.246 . . . . 0.0 110.301 -179.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.401 HG12 ' N ' ' A' ' 119' ' ' VAL . 43.7 t -79.68 165.31 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.214 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 178.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.401 ' N ' HG12 ' A' ' 118' ' ' VAL . 12.0 p -152.07 137.32 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.999 -0.438 . . . . 0.0 110.18 -178.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.507 ' O ' HG23 ' A' ' 120' ' ' ILE . 4.5 tp -154.81 68.35 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 CA-C-O 121.186 0.517 . . . . 0.0 110.014 178.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 80.98 -171.06 53.54 Favored Glycine 0 N--CA 1.496 2.666 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -178.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_exo -58.32 144.71 95.7 Favored 'Trans proline' 0 N--CA 1.502 1.985 0 C-N-CA 121.064 1.176 . . . . 0.0 111.37 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -84.92 145.99 27.49 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 122.071 -0.393 . . . . 0.0 110.231 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -155.74 49.88 0.53 Allowed 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.238 0.542 . . . . 0.0 109.913 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -155.25 33.67 0.38 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.806 -0.559 . . . . 0.0 110.275 -179.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 83.83 170.03 45.99 Favored Glycine 0 N--CA 1.496 2.663 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 31.0 t -82.06 140.82 33.67 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 122.171 -0.606 . . . . 0.0 110.197 179.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 50.9 mm -90.65 136.71 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 179.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 . . . . . 0 N--CA 1.497 1.886 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.229 179.839 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.366 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_exo -58.35 117.17 3.84 Favored 'Trans proline' 0 N--CA 1.502 1.989 0 O-C-N 123.355 1.187 . . . . 0.0 111.398 179.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -155.44 78.16 1.0 Allowed 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.204 0.526 . . . . 0.0 109.738 -176.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -78.11 73.87 4.67 Favored 'General case' 0 N--CA 1.502 2.144 0 CA-C-O 121.355 0.598 . . . . 0.0 110.353 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.492 HG22 ' HB2' ' A' ' 56' ' ' ASN . 19.8 m -147.68 121.93 9.59 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.818 -0.551 . . . . 0.0 110.102 179.033 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 22.8 mt -77.6 151.09 79.93 Favored Pre-proline 0 N--CA 1.502 2.141 0 O-C-N 122.118 -0.364 . . . . 0.0 110.24 -177.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo -63.64 122.99 11.29 Favored 'Trans proline' 0 N--CA 1.499 1.807 0 O-C-N 123.304 1.16 . . . . 0.0 111.19 167.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -161.76 54.21 0.25 Allowed 'General case' 0 N--CA 1.5 2.034 0 CA-C-O 121.359 0.6 . . . . 0.0 110.281 165.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 21.6 tp -157.63 115.47 3.08 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.748 -0.595 . . . . 0.0 109.919 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.3 tptt -99.67 131.1 45.88 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 122.18 -0.325 . . . . 0.0 110.162 -178.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 72.6 m -121.12 140.59 51.78 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -176.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -83.71 144.15 29.56 Favored 'General case' 0 N--CA 1.5 2.033 0 C-N-CA 120.601 -0.44 . . . . 0.0 109.9 176.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 27.1 p -118.57 136.96 53.56 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 122.056 -0.403 . . . . 0.0 110.568 -177.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.4 m -123.0 141.19 52.24 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 122.059 -0.4 . . . . 0.0 110.088 177.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 75.89 -67.14 2.39 Favored Glycine 0 N--CA 1.496 2.636 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -116.68 123.68 47.86 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 122.132 -0.628 . . . . 0.0 110.579 -176.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -138.08 136.75 19.91 Favored Pre-proline 0 N--CA 1.497 1.891 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 174.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -61.31 151.77 76.98 Favored 'Trans proline' 0 N--CA 1.496 1.633 0 O-C-N 123.114 1.06 . . . . 0.0 111.094 -172.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -59.21 -25.72 64.23 Favored 'General case' 0 N--CA 1.507 2.394 0 O-C-N 122.032 -0.418 . . . . 0.0 111.625 -173.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -91.57 14.27 15.47 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.944 -0.473 . . . . 0.0 111.899 -176.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -82.67 161.53 22.12 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.565 -0.71 . . . . 0.0 110.242 -175.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 76.4 mt -125.74 139.38 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -178.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 38.42 42.26 0.52 Allowed 'General case' 0 N--CA 1.513 2.708 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -177.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 55.16 42.37 30.71 Favored 'General case' 0 N--CA 1.509 2.494 0 O-C-N 121.921 -0.487 . . . . 0.0 111.487 -178.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 27.4 p -140.43 157.49 45.44 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.878 -0.514 . . . . 0.0 110.402 172.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.8 p -145.82 165.82 27.75 Favored 'General case' 0 N--CA 1.499 1.988 0 CA-C-O 121.0 0.429 . . . . 0.0 110.718 -172.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 78.0 mt -123.58 120.32 59.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -166.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.9 t -135.8 153.26 51.57 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-O 121.0 0.428 . . . . 0.0 110.965 -174.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.492 ' HB2' HG22 ' A' ' 32' ' ' THR . 44.3 p-10 -102.57 30.15 4.83 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 122.121 -0.362 . . . . 0.0 110.659 170.34 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -122.45 -108.33 1.97 Allowed Glycine 0 N--CA 1.496 2.658 0 N-CA-C 109.08 -1.608 . . . . 0.0 109.08 172.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -141.18 172.14 13.09 Favored 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -176.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 67.0 m -97.68 139.27 33.82 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 170.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -135.47 155.79 49.96 Favored 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 120.053 -0.659 . . . . 0.0 110.952 -176.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -151.06 150.66 30.98 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 18.4 tt -143.15 149.14 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 CA-C-O 120.904 0.383 . . . . 0.0 110.364 -172.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.823 HD12 HD11 ' A' ' 73' ' ' LEU . 16.0 tt -138.01 145.2 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 177.35 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -150.21 141.18 22.92 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 122.109 -0.369 . . . . 0.0 110.04 -170.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.0 tm-20 -101.69 116.52 32.93 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -86.67 175.25 8.37 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 122.212 -0.305 . . . . 0.0 110.59 -175.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -60.74 -17.5 48.97 Favored 'General case' 0 N--CA 1.506 2.35 0 O-C-N 122.032 -0.417 . . . . 0.0 111.998 -172.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -92.56 -10.8 36.3 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.668 -0.645 . . . . 0.0 111.819 178.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.1 20.95 40.49 Favored Glycine 0 N--CA 1.496 2.641 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 176.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -97.59 142.01 29.93 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-N 118.368 1.084 . . . . 0.0 109.893 169.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 10.9 p -94.84 129.62 41.74 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 122.168 -0.333 . . . . 0.0 110.36 178.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 17.9 p -97.85 112.94 24.66 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 122.147 -0.346 . . . . 0.0 110.324 177.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.823 HD11 HD12 ' A' ' 63' ' ' ILE . 4.6 mm? -97.36 122.31 40.25 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 122.124 -0.36 . . . . 0.0 110.254 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -144.99 155.66 43.51 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 122.004 -0.435 . . . . 0.0 110.541 178.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 91.0 p -143.51 162.89 34.66 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 176.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -158.81 -177.76 32.19 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 110.289 -1.124 . . . . 0.0 110.289 -173.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 1.7 m -113.09 115.71 28.74 Favored 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 -169.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 49.8 ttm -95.88 121.93 38.14 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.878 -0.514 . . . . 0.0 110.474 -170.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 22.1 pttt -66.08 171.49 4.55 Favored 'General case' 0 N--CA 1.503 2.209 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.412 175.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -65.7 145.74 55.64 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 122.025 -0.422 . . . . 0.0 110.427 178.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 67.2 mt-10 -143.21 -48.45 0.31 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 122.18 -0.325 . . . . 0.0 110.361 -177.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 143.07 -35.27 1.7 Allowed Glycine 0 N--CA 1.494 2.561 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -178.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 36.6 m -72.99 113.99 10.64 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 122.125 -0.633 . . . . 0.0 110.094 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -76.92 -34.64 57.68 Favored 'General case' 0 N--CA 1.501 2.121 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.114 178.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -155.39 76.03 0.95 Allowed 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.195 0.521 . . . . 0.0 109.868 179.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -155.38 94.37 1.59 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.941 -0.474 . . . . 0.0 109.971 -179.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 14.0 m -125.42 47.6 2.17 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.213 0.53 . . . . 0.0 109.809 177.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 74.6 mttt -78.59 -173.98 3.64 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.917 -0.49 . . . . 0.0 110.435 -174.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -119.21 141.86 48.52 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 176.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.3 m -74.91 145.68 81.62 Favored Pre-proline 0 N--CA 1.5 2.03 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.034 -177.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -77.92 63.16 8.09 Favored 'Trans proline' 0 N--CA 1.493 1.485 0 O-C-N 123.354 1.187 . . . . 0.0 110.578 177.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 37.0 tttp -155.41 42.54 0.44 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.73 -0.606 . . . . 0.0 109.798 179.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -155.73 145.33 21.11 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 109.929 -0.396 . . . . 0.0 109.929 178.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 44.5 tt0 -109.93 75.89 0.96 Allowed 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 121.334 0.587 . . . . 0.0 110.176 -179.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 17.9 tp -155.1 149.63 26.3 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.851 -0.531 . . . . 0.0 110.105 177.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 18.5 mmt180 -98.68 124.69 43.66 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 122.067 -0.395 . . . . 0.0 110.0 178.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 30.1 ptt180 -161.55 165.06 29.07 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 122.064 -0.398 . . . . 0.0 110.7 -178.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 24.3 m -133.95 149.39 51.25 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 177.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.6 tt -141.75 156.06 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 122.017 -0.427 . . . . 0.0 109.94 -178.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 51.6 mm-40 -143.86 151.43 39.87 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 122.146 -0.346 . . . . 0.0 110.615 -176.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 99.0 m -142.89 149.37 38.41 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 176.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 15.4 p -157.51 141.31 15.86 Favored 'General case' 0 N--CA 1.502 2.155 0 CA-C-O 121.07 0.462 . . . . 0.0 110.951 -173.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 68.8 mtp180 -110.55 49.51 0.85 Allowed 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.377 0.608 . . . . 0.0 110.693 -169.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.1 p -148.66 152.26 36.38 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.793 -0.567 . . . . 0.0 109.966 178.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -60.96 132.02 52.52 Favored 'General case' 0 N--CA 1.507 2.376 0 O-C-N 121.646 -0.659 . . . . 0.0 111.81 -163.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 69.1 mt 52.49 26.03 3.97 Favored 'General case' 0 N--CA 1.507 2.387 0 O-C-N 122.085 -0.385 . . . . 0.0 111.925 179.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 26.1 p -62.71 -21.97 66.18 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 121.853 -0.529 . . . . 0.0 111.762 177.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -90.09 -22.9 21.57 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.748 -0.595 . . . . 0.0 111.275 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -60.45 -38.9 85.62 Favored 'General case' 0 N--CA 1.509 2.488 0 O-C-N 121.58 -0.7 . . . . 0.0 110.775 -175.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -101.37 16.25 26.2 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 122.104 -0.373 . . . . 0.0 111.73 179.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 15.5 tp -110.53 113.54 26.25 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.567 -0.708 . . . . 0.0 110.38 -174.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 -96.83 120.76 61.1 Favored Pre-proline 0 N--CA 1.497 1.911 0 CA-C-O 118.803 -0.617 . . . . 0.0 109.989 172.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -68.34 133.89 29.58 Favored 'Trans proline' 0 N--CA 1.491 1.364 0 O-C-N 123.273 1.144 . . . . 0.0 110.408 176.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 32.7 p -98.84 125.32 44.19 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 122.098 -0.376 . . . . 0.0 110.428 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 15.7 mt -72.79 155.1 91.01 Favored Pre-proline 0 N--CA 1.501 2.102 0 CA-C-O 119.282 -0.39 . . . . 0.0 110.097 176.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -68.2 159.08 54.71 Favored 'Trans proline' 0 N--CA 1.491 1.365 0 O-C-N 123.455 1.239 . . . . 0.0 110.302 -178.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -64.01 147.68 91.7 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 O-C-N 123.384 1.202 . . . . 0.0 110.728 179.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.416 HG12 ' N ' ' A' ' 119' ' ' VAL . 43.4 t -79.53 165.29 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.162 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -179.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.416 ' N ' HG12 ' A' ' 118' ' ' VAL . 11.8 p -152.19 146.6 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 122.071 -0.393 . . . . 0.0 110.105 -178.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 7.1 tp -151.62 131.18 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 122.131 -0.355 . . . . 0.0 110.123 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 111.05 168.59 18.97 Favored Glycine 0 N--CA 1.496 2.687 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 178.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_exo -58.2 142.23 97.11 Favored 'Trans proline' 0 N--CA 1.501 1.97 0 C-N-CA 121.078 1.185 . . . . 0.0 111.431 -179.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -85.77 130.24 34.61 Favored 'General case' 0 N--CA 1.501 2.096 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.303 -179.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -155.74 47.73 0.5 Allowed 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 121.108 0.48 . . . . 0.0 109.787 178.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -155.28 173.14 17.05 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.981 -0.449 . . . . 0.0 110.314 -178.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 101.38 -35.57 4.81 Favored Glycine 0 N--CA 1.496 2.681 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 87.2 p -80.15 157.94 26.47 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 122.082 -0.658 . . . . 0.0 110.237 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 76.1 mt -90.37 136.77 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 63.9 ttt180 . . . . . 0 N--CA 1.499 2.016 0 CA-C-O 118.081 -0.961 . . . . 0.0 110.12 179.76 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.376 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_exo -58.5 120.16 7.86 Favored 'Trans proline' 0 N--CA 1.501 1.913 0 O-C-N 123.411 1.216 . . . . 0.0 111.379 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -90.13 47.25 1.43 Allowed 'General case' 0 N--CA 1.502 2.165 0 CA-C-O 121.163 0.506 . . . . 0.0 110.685 179.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -76.8 84.67 3.4 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.631 -0.668 . . . . 0.0 109.79 -176.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 22.0 m -128.88 110.51 12.18 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.982 -0.449 . . . . 0.0 110.08 177.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 74.1 mt -142.47 118.9 6.94 Favored Pre-proline 0 N--CA 1.498 1.93 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -179.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -59.82 144.98 99.36 Favored 'Trans proline' 0 N--CA 1.503 2.047 0 O-C-N 123.016 1.009 . . . . 0.0 111.268 -177.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -153.38 49.84 0.7 Allowed 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.882 -0.511 . . . . 0.0 110.677 178.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.448 HD23 HG23 ' A' ' 55' ' ' THR . 19.7 tp -159.94 114.97 2.34 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.821 -0.549 . . . . 0.0 110.112 -176.328 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 50.9 tttt -99.86 130.87 46.09 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 122.151 -0.343 . . . . 0.0 110.158 178.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 85.8 m -117.01 140.39 49.54 Favored 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 -178.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -83.83 145.91 28.4 Favored 'General case' 0 N--CA 1.501 2.082 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.16 178.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 27.8 p -118.26 137.03 53.32 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 122.086 -0.384 . . . . 0.0 110.457 178.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 29.3 t -123.03 120.22 32.68 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 122.025 -0.422 . . . . 0.0 110.145 177.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 82.35 -62.77 4.53 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -103.89 112.05 24.85 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 122.03 -0.688 . . . . 0.0 110.486 -177.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -138.09 137.51 21.23 Favored Pre-proline 0 N--CA 1.497 1.915 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 176.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -60.97 151.85 75.13 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 O-C-N 123.114 1.06 . . . . 0.0 111.101 -174.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -60.35 -28.1 67.91 Favored 'General case' 0 N--CA 1.507 2.414 0 O-C-N 121.896 -0.503 . . . . 0.0 111.439 -172.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -92.28 14.36 16.59 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.921 -0.487 . . . . 0.0 111.749 -177.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.16 161.99 26.95 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.706 -0.621 . . . . 0.0 110.293 -173.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 76.1 mt -125.92 139.85 50.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 -177.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 38.88 42.75 0.68 Allowed 'General case' 0 N--CA 1.513 2.686 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -178.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 30.7 m120 54.96 43.0 30.59 Favored 'General case' 0 N--CA 1.508 2.452 0 O-C-N 121.838 -0.538 . . . . 0.0 111.496 -178.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 40.3 p -144.01 161.99 37.34 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.881 -0.512 . . . . 0.0 110.535 173.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.5 p -139.75 165.0 28.45 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 120.837 0.351 . . . . 0.0 110.666 179.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 77.4 mt -112.07 131.86 62.33 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -175.21 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.448 HG23 HD23 ' A' ' 36' ' ' LEU . 9.0 t -140.37 152.86 46.11 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 122.041 -0.412 . . . . 0.0 111.065 -178.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 40.1 p-10 -109.28 29.38 7.59 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 122.109 -0.369 . . . . 0.0 110.711 167.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -122.03 -92.79 1.18 Allowed Glycine 0 N--CA 1.496 2.65 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 177.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -149.86 172.04 15.8 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 122.099 -0.647 . . . . 0.0 109.574 176.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 75.9 m -94.01 139.17 31.27 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 166.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -129.11 153.22 47.87 Favored 'General case' 0 N--CA 1.499 1.997 0 C-N-CA 120.338 -0.545 . . . . 0.0 110.635 -178.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -151.24 143.39 24.03 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 176.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.534 HD12 HD12 ' A' ' 99' ' ' ILE . 18.1 tt -143.12 149.26 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.277 -172.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.46 HD12 ' HG ' ' A' ' 73' ' ' LEU . 14.9 tt -138.35 145.32 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 -179.4 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -148.71 145.76 27.81 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 -169.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.6 tm-20 -101.62 118.22 36.5 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 122.142 -0.349 . . . . 0.0 110.089 -176.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 52.1 p30 -87.17 175.29 8.14 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 122.21 -0.306 . . . . 0.0 110.601 -175.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -60.39 -17.93 47.11 Favored 'General case' 0 N--CA 1.508 2.43 0 O-C-N 122.025 -0.422 . . . . 0.0 111.988 -173.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -92.74 -10.47 36.94 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.689 -0.632 . . . . 0.0 111.921 178.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.08 21.03 40.21 Favored Glycine 0 N--CA 1.498 2.776 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 177.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -97.29 142.8 28.74 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 118.41 1.105 . . . . 0.0 109.823 170.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.1 p -94.83 125.67 39.65 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.249 177.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.2 p -97.89 112.95 24.68 Favored 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 120.877 -0.329 . . . . 0.0 110.296 177.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.544 ' N ' HD12 ' A' ' 73' ' ' LEU . 6.4 mp -97.51 127.2 43.28 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 122.157 -0.339 . . . . 0.0 110.313 -178.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -142.79 145.36 33.17 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 122.021 -0.424 . . . . 0.0 110.329 177.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 88.1 p -143.53 166.53 24.55 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 177.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -179.72 -165.77 34.26 Favored Glycine 0 N--CA 1.497 2.736 0 N-CA-C 110.239 -1.145 . . . . 0.0 110.239 -178.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 3.7 m -96.66 132.11 42.64 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 122.226 -0.573 . . . . 0.0 110.343 -175.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 53.5 ttm -98.62 121.82 41.04 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.1 176.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.3 ptpp? -68.09 155.32 39.82 Favored 'General case' 0 N--CA 1.504 2.233 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.398 -178.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 55.9 t80 -66.51 146.53 54.42 Favored 'General case' 0 N--CA 1.504 2.231 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.275 178.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -151.44 -34.8 0.14 Allowed 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -179.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 137.73 50.44 0.06 OUTLIER Glycine 0 N--CA 1.495 2.568 0 N-CA-C 111.555 -0.618 . . . . 0.0 111.555 -178.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.4 m -155.5 113.21 3.35 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 122.219 -0.577 . . . . 0.0 109.842 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -74.44 -40.31 62.02 Favored 'General case' 0 N--CA 1.503 2.182 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.292 -179.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -155.68 31.49 0.36 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 122.168 -0.333 . . . . 0.0 110.373 177.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -77.48 83.99 3.89 Favored 'General case' 0 N--CA 1.501 2.112 0 CA-C-O 121.12 0.486 . . . . 0.0 110.059 -178.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 93.2 m -117.49 42.2 2.64 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.264 0.554 . . . . 0.0 109.753 176.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -78.71 -169.89 1.91 Allowed 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.92 -0.487 . . . . 0.0 110.426 -175.002 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -97.16 -170.02 1.96 Allowed 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 169.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.1 m -155.63 176.7 2.4 Favored Pre-proline 0 N--CA 1.493 1.697 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 -178.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -82.38 56.56 5.8 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 O-C-N 123.38 1.2 . . . . 0.0 111.149 167.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 46.9 pttt -155.76 49.39 0.52 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.666 -0.647 . . . . 0.0 109.397 177.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.65 177.41 1.6 Allowed 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.999 -0.438 . . . . 0.0 110.564 -168.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -154.99 -169.48 3.2 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 -167.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.2 tp -64.54 162.31 15.67 Favored 'General case' 0 N--CA 1.507 2.418 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 177.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 79.4 mtp180 -68.33 129.27 39.42 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.807 -0.558 . . . . 0.0 110.346 -166.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 46.5 ptt85 -161.48 165.3 28.88 Favored 'General case' 0 N--CA 1.496 1.825 0 CA-C-O 120.771 0.32 . . . . 0.0 110.509 -175.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.41 HG21 ' O ' ' A' ' 114' ' ' THR . 17.1 m -129.47 149.09 51.4 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 174.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.534 HD12 HD12 ' A' ' 62' ' ' ILE . 18.5 tt -143.09 155.91 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.993 -0.442 . . . . 0.0 110.135 -177.373 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -146.53 152.1 38.42 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 120.834 0.35 . . . . 0.0 110.632 -178.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 26.9 p -143.01 148.3 36.54 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 177.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 14.9 p -157.56 137.51 12.44 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.919 -0.488 . . . . 0.0 111.171 -173.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 44.9 ttt85 -107.91 53.01 0.7 Allowed 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 121.356 0.598 . . . . 0.0 110.604 -173.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.0 p -148.38 151.99 36.24 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.765 -0.584 . . . . 0.0 109.92 175.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 16.5 p30 -61.76 133.46 55.55 Favored 'General case' 0 N--CA 1.505 2.295 0 CA-C-O 121.444 0.64 . . . . 0.0 111.74 -164.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 72.8 mt 52.08 26.5 3.85 Favored 'General case' 0 N--CA 1.506 2.363 0 O-C-N 121.949 -0.469 . . . . 0.0 111.962 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 25.9 p -63.22 -21.92 66.54 Favored 'General case' 0 N--CA 1.506 2.338 0 O-C-N 121.889 -0.507 . . . . 0.0 111.7 176.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -92.29 -22.89 19.49 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.761 -0.587 . . . . 0.0 111.275 178.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -60.52 -37.17 80.29 Favored 'General case' 0 N--CA 1.506 2.338 0 O-C-N 121.433 -0.792 . . . . 0.0 110.762 -177.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -100.6 16.16 25.72 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 122.085 -0.384 . . . . 0.0 111.616 177.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 17.6 tp -112.19 113.48 25.76 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.675 -0.641 . . . . 0.0 110.346 -174.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -96.72 120.65 61.5 Favored Pre-proline 0 N--CA 1.496 1.863 0 CA-C-O 118.827 -0.606 . . . . 0.0 110.073 173.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -70.19 148.07 61.52 Favored 'Trans proline' 0 N--CA 1.49 1.293 0 O-C-N 123.122 1.064 . . . . 0.0 110.283 175.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.41 ' O ' HG21 ' A' ' 98' ' ' THR . 34.9 p -139.19 149.95 45.0 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 122.028 -0.42 . . . . 0.0 110.123 178.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 15.9 mt -71.9 149.89 92.68 Favored Pre-proline 0 N--CA 1.503 2.177 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.112 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -69.9 160.26 50.29 Favored 'Trans proline' 0 N--CA 1.489 1.214 0 O-C-N 123.472 1.248 . . . . 0.0 110.237 178.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -67.91 149.94 77.99 Favored 'Trans proline' 0 N--CA 1.491 1.355 0 O-C-N 123.512 1.27 . . . . 0.0 110.306 178.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.407 HG12 ' N ' ' A' ' 119' ' ' VAL . 42.6 t -79.27 165.1 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 -179.123 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.407 ' N ' HG12 ' A' ' 118' ' ' VAL . 12.0 p -89.96 145.54 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 122.024 -0.422 . . . . 0.0 110.232 -178.55 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.405 HG23 ' O ' ' A' ' 120' ' ' ILE . 17.7 tt -152.08 124.39 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 122.062 -0.399 . . . . 0.0 110.05 179.019 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 68.55 66.09 2.42 Favored Glycine 0 N--CA 1.496 2.64 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_exo -58.47 135.16 65.89 Favored 'Trans proline' 0 N--CA 1.502 2.009 0 O-C-N 123.433 1.228 . . . . 0.0 111.373 -179.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -86.02 131.49 34.26 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 122.022 -0.424 . . . . 0.0 110.146 178.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 31.8 p90 -71.86 140.85 49.51 Favored 'General case' 0 N--CA 1.501 2.104 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.152 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -155.3 98.11 1.96 Allowed 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -140.69 35.43 1.87 Allowed Glycine 0 N--CA 1.497 2.71 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 27.9 t -155.46 100.49 2.12 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 122.163 -0.61 . . . . 0.0 110.098 179.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 76.3 mt -90.9 129.41 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 10.0 tpp180 . . . . . 0 N--CA 1.499 2.023 0 CA-C-O 118.022 -0.989 . . . . 0.0 110.21 179.527 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.247 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_exo -58.62 123.2 13.03 Favored 'Trans proline' 0 N--CA 1.501 1.944 0 C-N-CA 121.082 1.188 . . . . 0.0 111.3 179.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -90.33 47.32 1.43 Allowed 'General case' 0 N--CA 1.5 2.07 0 CA-C-O 121.102 0.477 . . . . 0.0 110.884 179.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -78.19 80.18 4.62 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.703 -0.623 . . . . 0.0 109.807 -178.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.571 HG23 ' ND2' ' A' ' 56' ' ' ASN . 17.8 m -107.36 51.06 0.75 Allowed 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.281 0.562 . . . . 0.0 110.113 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 19.7 mt -79.13 119.87 78.67 Favored Pre-proline 0 N--CA 1.501 2.085 0 O-C-N 121.884 -0.51 . . . . 0.0 110.111 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_exo -65.59 131.27 27.26 Favored 'Trans proline' 0 N--CA 1.498 1.791 0 O-C-N 123.12 1.063 . . . . 0.0 111.012 168.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -158.29 52.34 0.43 Allowed 'General case' 0 N--CA 1.501 2.107 0 CA-C-O 121.32 0.581 . . . . 0.0 110.515 164.175 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.467 HD23 HG23 ' A' ' 55' ' ' THR . 21.4 tp -158.22 114.65 2.8 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.656 -0.652 . . . . 0.0 110.23 -179.275 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.413 ' HE3' HD21 ' A' ' 106' ' ' LEU . 32.8 ttpt -99.77 131.63 45.63 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 122.11 -0.369 . . . . 0.0 110.225 177.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 79.3 m -115.31 140.22 49.3 Favored 'General case' 0 N--CA 1.501 2.077 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 -178.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -84.59 141.34 30.75 Favored 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 176.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 28.1 p -115.01 137.01 52.5 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 122.008 -0.433 . . . . 0.0 110.608 -177.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 49.4 m -122.99 135.58 54.53 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 175.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 75.49 -67.05 2.27 Favored Glycine 0 N--CA 1.495 2.606 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 83.7 t60 -109.2 119.55 39.85 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.99 -0.712 . . . . 0.0 110.576 -176.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -137.99 136.71 19.99 Favored Pre-proline 0 N--CA 1.496 1.868 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 174.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -60.12 151.88 69.65 Favored 'Trans proline' 0 N--CA 1.497 1.714 0 O-C-N 123.04 1.021 . . . . 0.0 111.225 -171.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -60.32 -28.14 67.89 Favored 'General case' 0 N--CA 1.507 2.394 0 O-C-N 121.966 -0.459 . . . . 0.0 111.401 -172.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -92.21 14.34 16.5 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.923 -0.486 . . . . 0.0 111.786 -178.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.46 162.06 26.64 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.606 -0.684 . . . . 0.0 110.348 -172.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 77.4 mt -126.08 140.5 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -177.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 38.68 42.69 0.62 Allowed 'General case' 0 N--CA 1.514 2.743 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -178.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 55.03 42.55 30.87 Favored 'General case' 0 N--CA 1.506 2.372 0 O-C-N 121.841 -0.537 . . . . 0.0 111.47 -179.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 41.5 p -142.96 161.16 38.87 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.89 -0.507 . . . . 0.0 110.465 173.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.3 p -138.46 162.52 34.27 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 120.874 0.369 . . . . 0.0 110.622 177.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 77.5 mt -108.73 132.58 56.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -176.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.467 HG23 HD23 ' A' ' 36' ' ' LEU . 7.9 t -138.74 151.95 47.55 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.989 -0.445 . . . . 0.0 110.936 -179.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.571 ' ND2' HG23 ' A' ' 32' ' ' THR . 36.4 p-10 -108.8 29.76 7.15 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 122.143 -0.348 . . . . 0.0 110.64 167.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -125.19 -93.29 0.95 Allowed Glycine 0 N--CA 1.496 2.659 0 N-CA-C 109.286 -1.525 . . . . 0.0 109.286 177.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 42.8 m-70 -148.4 172.06 15.04 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 122.074 -0.662 . . . . 0.0 109.521 177.106 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 71.9 m -93.32 139.21 30.91 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 165.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 15.6 p90 -129.98 151.38 50.6 Favored 'General case' 0 N--CA 1.499 2.024 0 C-N-CA 120.365 -0.534 . . . . 0.0 110.595 -177.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -151.02 143.68 24.39 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -179.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.459 HD12 HD12 ' A' ' 99' ' ' ILE . 18.1 tt -143.82 149.22 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 CA-C-O 120.905 0.383 . . . . 0.0 110.413 -173.081 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.806 HD12 HD21 ' A' ' 73' ' ' LEU . 16.6 tt -133.85 145.23 33.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.638 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -146.92 145.17 29.71 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -167.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.7 tm-20 -101.58 118.17 36.4 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -176.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 50.8 p30 -87.45 175.31 8.02 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 122.077 -0.39 . . . . 0.0 110.605 -175.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -60.42 -17.91 47.41 Favored 'General case' 0 N--CA 1.508 2.443 0 O-C-N 122.033 -0.417 . . . . 0.0 111.957 -173.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 84.1 mm-40 -93.27 -9.84 37.62 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.662 -0.649 . . . . 0.0 111.926 178.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 89.4 20.96 42.79 Favored Glycine 0 N--CA 1.499 2.877 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 177.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -97.16 144.39 27.04 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-N 118.427 1.113 . . . . 0.0 109.791 169.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.8 p -94.84 126.31 40.09 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.988 -0.445 . . . . 0.0 110.276 177.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 24.5 p -97.92 122.68 41.33 Favored 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 120.921 -0.312 . . . . 0.0 110.284 178.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.806 HD21 HD12 ' A' ' 63' ' ' ILE . 75.2 mt -97.09 127.84 43.45 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 122.119 -0.363 . . . . 0.0 110.289 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -143.0 144.24 32.22 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 122.025 -0.422 . . . . 0.0 110.369 175.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 40.5 p -143.78 167.01 23.31 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 178.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -177.84 -167.25 35.65 Favored Glycine 0 N--CA 1.496 2.691 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 2.0 m -97.4 132.84 42.74 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 122.211 -0.582 . . . . 0.0 110.271 -176.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 54.7 ttm -100.91 129.62 46.8 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 122.039 -0.413 . . . . 0.0 110.279 179.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.6 pttm -64.96 172.04 3.15 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 122.08 -0.388 . . . . 0.0 110.58 177.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -64.93 139.91 58.81 Favored 'General case' 0 N--CA 1.505 2.28 0 C-N-CA 120.781 -0.367 . . . . 0.0 110.597 -177.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 67.5 mt-10 -131.8 -46.26 0.95 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 122.125 -0.359 . . . . 0.0 110.281 179.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 99.75 37.01 4.07 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 85.6 p -155.71 110.83 2.96 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 122.142 -0.622 . . . . 0.0 109.961 177.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -80.17 -48.03 13.78 Favored 'General case' 0 N--CA 1.501 2.092 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.41 -177.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -79.67 -21.3 44.92 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 122.078 -0.388 . . . . 0.0 111.7 -174.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 90.9 mm-40 -73.63 84.76 1.58 Allowed 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 121.207 0.527 . . . . 0.0 110.249 -172.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 95.0 m -139.17 33.31 2.12 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.964 -0.46 . . . . 0.0 110.089 174.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 47.2 mttp -81.23 169.4 17.38 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 122.049 -0.407 . . . . 0.0 110.352 -176.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.466 ' OD1' HG22 ' A' ' 99' ' ' ILE . 9.2 m-20 -109.13 114.71 28.66 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 122.144 -0.347 . . . . 0.0 110.309 179.013 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.9 m -78.12 149.17 76.03 Favored Pre-proline 0 N--CA 1.5 2.047 0 O-C-N 122.121 -0.362 . . . . 0.0 110.078 179.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -82.23 56.49 5.81 Favored 'Trans proline' 0 N--CA 1.495 1.561 0 O-C-N 123.358 1.189 . . . . 0.0 110.855 174.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 30.8 pttt -155.69 49.0 0.52 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.661 -0.65 . . . . 0.0 109.782 -177.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -155.56 -169.51 3.14 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.93 -0.481 . . . . 0.0 110.492 -168.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -64.71 -169.26 0.04 OUTLIER 'General case' 0 N--CA 1.504 2.248 0 CA-C-O 120.959 0.409 . . . . 0.0 110.413 -174.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 9.4 tp -64.45 173.61 2.03 Favored 'General case' 0 N--CA 1.507 2.377 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 -170.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -68.23 148.94 50.13 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.504 -0.748 . . . . 0.0 110.318 -163.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 44.6 ptt85 -161.48 165.25 28.96 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 120.954 0.406 . . . . 0.0 110.711 -171.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.406 HG21 ' O ' ' A' ' 114' ' ' THR . 13.6 m -124.95 149.12 47.98 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 169.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.466 HG22 ' OD1' ' A' ' 89' ' ' ASP . 18.2 tt -143.09 154.57 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 C-N-CA 120.537 -0.465 . . . . 0.0 110.326 -172.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -147.26 154.68 41.28 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 120.811 0.339 . . . . 0.0 110.573 -178.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 26.6 p -143.05 151.9 41.3 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 177.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 20.3 p -157.6 134.49 10.03 Favored 'General case' 0 N--CA 1.502 2.152 0 CA-C-O 120.976 0.417 . . . . 0.0 110.77 -174.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 40.8 ttp85 -107.37 49.38 0.81 Allowed 'General case' 0 N--CA 1.497 1.907 0 CA-C-O 121.384 0.611 . . . . 0.0 110.661 -173.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.2 p -143.41 151.5 40.45 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.759 -0.588 . . . . 0.0 109.863 177.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 15.8 p30 -62.24 132.57 53.15 Favored 'General case' 0 N--CA 1.506 2.359 0 CA-C-O 121.406 0.622 . . . . 0.0 111.684 -164.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.413 HD21 ' HE3' ' A' ' 37' ' ' LYS . 76.5 mt 52.24 27.31 4.6 Favored 'General case' 0 N--CA 1.506 2.357 0 O-C-N 121.976 -0.453 . . . . 0.0 111.961 179.671 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 25.7 p -62.75 -23.32 67.14 Favored 'General case' 0 N--CA 1.507 2.42 0 O-C-N 121.852 -0.53 . . . . 0.0 111.624 174.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -73.73 -29.86 62.49 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.735 -0.603 . . . . 0.0 111.043 178.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -62.11 -39.55 92.91 Favored 'General case' 0 N--CA 1.505 2.318 0 O-C-N 121.653 -0.655 . . . . 0.0 110.855 -169.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -100.83 16.17 26.0 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 122.073 -0.392 . . . . 0.0 111.75 -178.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 15.9 tp -114.19 108.98 17.68 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.635 -0.665 . . . . 0.0 110.367 -175.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -98.15 120.82 58.94 Favored Pre-proline 0 N--CA 1.497 1.876 0 CA-C-O 118.943 -0.551 . . . . 0.0 110.102 174.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -70.99 143.37 44.73 Favored 'Trans proline' 0 N--CA 1.49 1.313 0 O-C-N 123.142 1.075 . . . . 0.0 110.343 174.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.406 ' O ' HG21 ' A' ' 98' ' ' THR . 35.1 p -139.16 150.01 45.12 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 122.154 -0.341 . . . . 0.0 110.095 178.493 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 15.0 mt -70.54 153.28 95.1 Favored Pre-proline 0 N--CA 1.502 2.172 0 O-C-N 122.02 -0.425 . . . . 0.0 110.066 -179.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -68.06 155.23 70.36 Favored 'Trans proline' 0 N--CA 1.492 1.405 0 O-C-N 123.599 1.315 . . . . 0.0 110.307 -178.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -64.21 169.77 10.25 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 O-C-N 123.373 1.196 . . . . 0.0 110.671 178.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 43.5 t -78.36 164.97 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 76.6 t -146.28 131.27 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -177.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.406 ' O ' HG23 ' A' ' 120' ' ' ILE . 7.8 tp -89.75 124.15 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 122.121 -0.362 . . . . 0.0 110.119 173.025 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -65.07 -56.41 16.22 Favored Glycine 0 N--CA 1.499 2.852 0 N-CA-C 109.974 -1.25 . . . . 0.0 109.974 179.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_exo -58.87 152.89 54.35 Favored 'Trans proline' 0 N--CA 1.501 1.944 0 C-N-CA 121.042 1.161 . . . . 0.0 111.204 173.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -155.16 160.29 40.8 Favored 'General case' 0 N--CA 1.498 1.932 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.533 -178.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -155.82 175.3 14.11 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 178.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -80.08 109.12 14.23 Favored 'General case' 0 N--CA 1.502 2.126 0 CA-C-O 121.056 0.455 . . . . 0.0 110.354 -179.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -150.1 60.85 0.42 Allowed Glycine 0 N--CA 1.495 2.567 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 52.3 m -79.96 137.48 36.86 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 122.098 -0.648 . . . . 0.0 110.311 -178.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 76.3 mt -91.06 135.89 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 38.5 tpt85 . . . . . 0 N--CA 1.496 1.862 0 CA-C-O 118.003 -0.999 . . . . 0.0 110.258 179.748 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.373 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -58.5 123.25 13.16 Favored 'Trans proline' 0 N--CA 1.501 1.918 0 C-N-CA 121.099 1.199 . . . . 0.0 111.362 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -90.16 47.53 1.46 Allowed 'General case' 0 N--CA 1.502 2.134 0 CA-C-O 121.134 0.492 . . . . 0.0 110.652 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -76.76 84.38 3.37 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.653 -0.654 . . . . 0.0 109.783 -177.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 22.2 m -133.74 114.89 13.93 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.998 -0.439 . . . . 0.0 110.13 179.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 75.1 mt -142.42 145.85 36.6 Favored Pre-proline 0 N--CA 1.497 1.879 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 178.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -59.23 142.5 99.26 Favored 'Trans proline' 0 N--CA 1.504 2.14 0 O-C-N 123.273 1.144 . . . . 0.0 111.369 -179.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -156.32 48.19 0.47 Allowed 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 121.067 0.46 . . . . 0.0 110.872 176.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 18.5 tp -161.35 116.06 2.04 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.805 -0.56 . . . . 0.0 110.388 -173.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -99.81 133.66 43.85 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 122.214 -0.304 . . . . 0.0 110.21 176.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 64.3 m -120.82 140.34 51.87 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 -179.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -82.37 148.21 28.39 Favored 'General case' 0 N--CA 1.501 2.085 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.061 177.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 27.9 p -117.06 137.02 52.54 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.982 -0.448 . . . . 0.0 110.565 -179.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.0 m -123.02 139.25 54.27 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 176.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 75.06 -67.27 2.11 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -114.34 127.51 55.89 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 122.086 -0.655 . . . . 0.0 110.565 -177.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -138.04 136.93 20.14 Favored Pre-proline 0 N--CA 1.497 1.897 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 174.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -60.74 151.91 73.34 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 O-C-N 123.044 1.023 . . . . 0.0 111.142 -172.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -60.26 -28.09 67.76 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 121.966 -0.459 . . . . 0.0 111.476 -172.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -92.13 14.29 16.47 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 122.019 -0.426 . . . . 0.0 111.817 -177.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.93 162.07 26.25 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.602 -0.686 . . . . 0.0 110.33 -172.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 75.0 mt -125.29 138.14 55.34 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -178.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 38.84 43.0 0.69 Allowed 'General case' 0 N--CA 1.512 2.65 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -178.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 55.09 41.85 31.34 Favored 'General case' 0 N--CA 1.507 2.418 0 O-C-N 121.817 -0.552 . . . . 0.0 111.484 -178.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 70.9 p -140.25 161.02 38.67 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.857 -0.527 . . . . 0.0 110.314 173.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.3 p -140.65 165.12 28.34 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 120.874 0.369 . . . . 0.0 110.606 -179.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 77.2 mt -114.36 132.45 63.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -174.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.1 t -145.27 155.81 43.45 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 122.024 -0.423 . . . . 0.0 111.112 -179.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 41.4 p-10 -111.53 28.42 8.76 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 122.072 -0.393 . . . . 0.0 110.944 167.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -113.32 -95.39 2.16 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 109.105 -1.598 . . . . 0.0 109.105 173.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 76.0 m-70 -149.45 172.05 15.59 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 122.106 -0.643 . . . . 0.0 109.546 175.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 79.4 m -93.09 139.12 30.89 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 167.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 19.4 p90 -128.72 151.19 49.82 Favored 'General case' 0 N--CA 1.499 2.019 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.745 -178.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -151.25 141.83 22.63 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 173.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.42 HD12 HD12 ' A' ' 99' ' ' ILE . 18.1 tt -141.84 149.11 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 CA-C-O 120.979 0.419 . . . . 0.0 110.488 -170.153 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.875 HD12 HD21 ' A' ' 73' ' ' LEU . 15.9 tt -136.07 145.07 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 177.397 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -150.15 139.23 21.11 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 122.118 -0.364 . . . . 0.0 110.084 -169.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.2 tm-20 -101.8 116.18 32.15 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 51.2 p30 -85.74 175.25 8.81 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 122.097 -0.377 . . . . 0.0 110.494 -175.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -60.13 -17.48 40.68 Favored 'General case' 0 N--CA 1.507 2.415 0 O-C-N 121.976 -0.452 . . . . 0.0 112.006 -174.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -92.13 -11.07 36.65 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.607 -0.683 . . . . 0.0 111.9 178.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.18 21.09 36.51 Favored Glycine 0 N--CA 1.497 2.731 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 177.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -96.28 139.06 32.96 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-N 118.373 1.086 . . . . 0.0 109.799 171.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.8 p -94.87 124.53 38.96 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 122.141 -0.349 . . . . 0.0 110.335 176.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.2 p -97.99 114.49 26.64 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 122.138 -0.351 . . . . 0.0 110.366 178.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.875 HD21 HD12 ' A' ' 63' ' ' ILE . 24.8 mt -97.4 126.6 42.74 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 122.173 -0.329 . . . . 0.0 110.275 178.011 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -146.7 144.77 29.68 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 122.021 -0.424 . . . . 0.0 110.627 176.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 86.4 p -143.81 167.03 23.26 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 175.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 174.2 -164.24 35.35 Favored Glycine 0 N--CA 1.497 2.734 0 N-CA-C 110.33 -1.108 . . . . 0.0 110.33 179.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 4.5 m -95.95 133.14 40.5 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 122.316 -0.52 . . . . 0.0 110.302 -175.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 49.1 ttm -99.51 121.66 41.48 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 174.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 33.4 pttt -69.85 163.36 26.05 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 122.032 -0.417 . . . . 0.0 110.518 -178.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -65.95 126.36 28.3 Favored 'General case' 0 N--CA 1.502 2.173 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.329 176.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -127.29 26.52 6.01 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 122.032 -0.418 . . . . 0.0 111.176 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 98.78 -37.42 3.5 Favored Glycine 0 N--CA 1.496 2.663 0 N-CA-C 110.086 -1.206 . . . . 0.0 110.086 178.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 15.7 m -73.14 126.31 29.73 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 122.1 -0.647 . . . . 0.0 110.245 -175.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -76.6 -42.95 40.64 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 174.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -155.78 30.85 0.36 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 122.116 -0.365 . . . . 0.0 110.435 175.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -78.33 84.11 4.53 Favored 'General case' 0 N--CA 1.5 2.072 0 CA-C-O 121.22 0.533 . . . . 0.0 110.059 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 31.7 t -109.13 45.41 1.05 Allowed 'General case' 0 N--CA 1.497 1.89 0 CA-C-O 121.169 0.509 . . . . 0.0 109.985 179.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -80.3 166.31 21.47 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.851 -0.53 . . . . 0.0 110.376 -178.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -120.91 142.94 49.24 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 175.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 8.4 p -75.48 141.36 73.02 Favored Pre-proline 0 N--CA 1.501 2.125 0 C-N-CA 120.577 -0.449 . . . . 0.0 109.94 -178.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -83.78 56.78 5.31 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 O-C-N 123.176 1.093 . . . . 0.0 111.452 -179.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 63.6 tttt -155.74 35.76 0.36 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.645 -0.66 . . . . 0.0 110.196 174.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -82.71 117.82 22.91 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 122.097 -0.377 . . . . 0.0 110.252 179.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 43.1 tt0 -110.45 49.84 0.83 Allowed 'General case' 0 N--CA 1.498 1.97 0 CA-C-O 121.284 0.564 . . . . 0.0 110.428 -178.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 21.4 tp -155.29 154.55 32.28 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.829 -0.544 . . . . 0.0 109.984 179.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 75.6 mtt85 -77.55 116.0 17.77 Favored 'General case' 0 N--CA 1.501 2.084 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 174.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 48.8 ttp180 -161.33 146.97 14.04 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 120.976 0.417 . . . . 0.0 110.386 -172.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 14.4 m -134.24 149.01 50.94 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 170.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.42 HD12 HD12 ' A' ' 62' ' ' ILE . 18.2 tt -143.24 156.14 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.982 -0.448 . . . . 0.0 110.022 -179.004 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -143.7 146.45 33.2 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 120.959 0.409 . . . . 0.0 110.39 -179.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 25.3 p -143.09 141.41 31.24 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 -179.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 17.9 p -157.59 135.54 10.82 Favored 'General case' 0 N--CA 1.502 2.152 0 C-N-CA 120.514 -0.475 . . . . 0.0 111.044 -171.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 58.5 ttt180 -107.4 51.42 0.74 Allowed 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.364 0.602 . . . . 0.0 110.569 -175.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 23.6 p -143.23 151.67 40.85 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.778 -0.576 . . . . 0.0 109.861 175.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 15.9 p30 -61.72 132.3 52.75 Favored 'General case' 0 N--CA 1.506 2.355 0 CA-C-O 121.42 0.628 . . . . 0.0 111.772 -163.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.44 HD22 ' OE1' ' A' ' 109' ' ' GLN . 73.9 mt 52.19 26.93 4.23 Favored 'General case' 0 N--CA 1.507 2.403 0 O-C-N 122.036 -0.415 . . . . 0.0 111.891 179.461 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 26.1 p -63.0 -23.35 67.41 Favored 'General case' 0 N--CA 1.508 2.442 0 O-C-N 121.935 -0.478 . . . . 0.0 111.567 175.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -92.27 -22.81 19.55 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.77 -0.581 . . . . 0.0 111.273 178.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.44 ' OE1' HD22 ' A' ' 106' ' ' LEU . 29.2 tt0 -60.67 -37.85 82.94 Favored 'General case' 0 N--CA 1.508 2.447 0 O-C-N 121.615 -0.678 . . . . 0.0 110.745 -177.491 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -100.03 16.15 24.93 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 122.135 -0.353 . . . . 0.0 111.709 178.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 14.8 tp -116.22 111.41 20.14 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.661 -0.649 . . . . 0.0 110.362 -174.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 3.1 tp-100 -96.39 120.73 61.84 Favored Pre-proline 0 N--CA 1.496 1.863 0 CA-C-O 118.848 -0.596 . . . . 0.0 110.04 172.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -70.69 141.84 42.42 Favored 'Trans proline' 0 N--CA 1.491 1.372 0 O-C-N 123.213 1.112 . . . . 0.0 110.168 175.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 48.4 p -139.22 150.02 45.04 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 122.135 -0.353 . . . . 0.0 110.138 179.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 15.0 mt -71.22 155.15 93.4 Favored Pre-proline 0 N--CA 1.502 2.164 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.016 179.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -62.36 150.39 87.37 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 O-C-N 123.356 1.187 . . . . 0.0 110.809 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -67.41 135.34 36.22 Favored 'Trans proline' 0 N--CA 1.492 1.415 0 O-C-N 123.537 1.283 . . . . 0.0 110.506 -176.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.424 HG12 ' N ' ' A' ' 119' ' ' VAL . 48.9 t -150.66 165.77 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.424 ' N ' HG12 ' A' ' 118' ' ' VAL . 60.3 t -89.58 120.55 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -179.171 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 33.7 pt -149.37 47.82 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 CA-C-O 121.195 0.521 . . . . 0.0 109.883 179.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 89.72 87.14 1.3 Allowed Glycine 0 N--CA 1.497 2.7 0 N-CA-C 109.416 -1.473 . . . . 0.0 109.416 -177.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_exo -58.05 147.08 84.76 Favored 'Trans proline' 0 N--CA 1.501 1.939 0 C-N-CA 121.112 1.208 . . . . 0.0 111.414 -178.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -84.84 136.3 33.72 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 122.048 -0.408 . . . . 0.0 110.099 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -72.04 143.83 48.98 Favored 'General case' 0 N--CA 1.501 2.094 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.156 -179.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -155.29 96.87 1.85 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 122.118 -0.364 . . . . 0.0 110.12 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 84.81 -174.19 49.65 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 49.8 m -80.76 153.0 28.03 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 122.149 -0.618 . . . . 0.0 110.181 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 75.7 mt -90.29 134.76 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 54.0 ttt180 . . . . . 0 N--CA 1.496 1.829 0 CA-C-O 118.05 -0.976 . . . . 0.0 110.217 179.91 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.32 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_exo -58.39 120.01 7.63 Favored 'Trans proline' 0 N--CA 1.499 1.828 0 C-N-CA 121.094 1.196 . . . . 0.0 111.461 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -90.35 46.94 1.38 Allowed 'General case' 0 N--CA 1.501 2.083 0 CA-C-O 121.084 0.469 . . . . 0.0 110.94 179.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -80.12 61.24 3.9 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.734 -0.604 . . . . 0.0 110.511 -177.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 21.9 m -132.91 112.46 11.9 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.851 -0.53 . . . . 0.0 110.167 -179.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 72.8 mt -142.56 118.78 6.85 Favored Pre-proline 0 N--CA 1.497 1.916 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -60.44 143.28 99.46 Favored 'Trans proline' 0 N--CA 1.502 2.013 0 O-C-N 123.072 1.038 . . . . 0.0 111.137 -179.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -149.95 46.67 0.93 Allowed 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.159 0.504 . . . . 0.0 110.792 -179.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.403 HD23 HG23 ' A' ' 55' ' ' THR . 15.5 tp -161.15 112.14 1.76 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.882 -0.511 . . . . 0.0 110.272 -173.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 29.2 ttpt -99.74 134.95 41.88 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 122.171 -0.331 . . . . 0.0 110.257 178.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 80.2 m -120.97 140.35 52.0 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 -176.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -82.77 143.16 31.05 Favored 'General case' 0 N--CA 1.501 2.091 0 C-N-CA 120.631 -0.428 . . . . 0.0 109.97 178.028 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 28.1 p -115.68 136.99 52.52 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 122.0 -0.438 . . . . 0.0 110.576 -178.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.2 m -122.88 138.75 54.57 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 176.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 75.47 -67.35 2.23 Favored Glycine 0 N--CA 1.495 2.626 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 179.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -113.14 122.74 48.44 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 122.035 -0.685 . . . . 0.0 110.522 -176.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -138.08 136.53 19.68 Favored Pre-proline 0 N--CA 1.496 1.826 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 174.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -60.55 152.13 70.53 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 O-C-N 123.075 1.039 . . . . 0.0 111.151 -171.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -60.26 -27.83 67.56 Favored 'General case' 0 N--CA 1.507 2.415 0 O-C-N 121.996 -0.44 . . . . 0.0 111.356 -173.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -92.12 14.26 16.56 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.843 -0.536 . . . . 0.0 111.737 -178.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.8 162.05 26.37 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.62 -0.675 . . . . 0.0 110.334 -173.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 70.9 mt -124.41 136.71 59.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -176.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 19.7 p30 37.95 43.12 0.5 Allowed 'General case' 0 N--CA 1.513 2.704 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -176.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 30.8 m120 55.36 43.41 28.93 Favored 'General case' 0 N--CA 1.508 2.428 0 O-C-N 121.824 -0.547 . . . . 0.0 111.462 -178.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 60.7 p -139.63 161.22 38.05 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.796 -0.565 . . . . 0.0 110.305 171.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.5 p -137.49 162.91 32.43 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 120.766 0.317 . . . . 0.0 110.565 178.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 77.5 mt -111.63 131.79 62.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -175.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.403 HG23 HD23 ' A' ' 36' ' ' LEU . 8.7 t -141.34 153.7 45.27 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.955 -0.465 . . . . 0.0 110.99 -177.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 26.8 p30 -107.57 28.66 7.93 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 122.055 -0.403 . . . . 0.0 110.771 167.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -119.15 -96.58 1.7 Allowed Glycine 0 N--CA 1.497 2.717 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 175.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 74.7 m80 -150.75 170.79 18.37 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 122.125 -0.633 . . . . 0.0 110.14 178.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 72.8 m -94.42 139.36 31.21 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 170.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -131.78 153.41 50.14 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.492 -178.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -152.91 136.01 15.62 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 174.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.689 HD12 HD12 ' A' ' 99' ' ' ILE . 18.1 tt -133.57 149.05 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 122.06 -0.4 . . . . 0.0 110.42 -168.414 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 13.5 tt -136.62 145.04 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -150.25 142.78 24.45 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 -172.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.4 tm-20 -101.63 117.81 35.65 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 -178.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 51.7 p30 -86.84 175.28 8.28 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-O 120.753 0.311 . . . . 0.0 110.551 -175.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -60.31 -17.64 44.2 Favored 'General case' 0 N--CA 1.507 2.414 0 O-C-N 121.915 -0.491 . . . . 0.0 112.1 -173.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -92.87 -11.0 34.64 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.616 -0.677 . . . . 0.0 111.88 178.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.18 21.06 36.59 Favored Glycine 0 N--CA 1.498 2.827 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 177.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -96.82 140.54 31.24 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 118.411 1.106 . . . . 0.0 109.866 170.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 10.9 p -94.86 125.67 39.68 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.304 176.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 17.9 p -97.97 112.92 24.68 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 122.124 -0.36 . . . . 0.0 110.289 177.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.54 ' N ' HD12 ' A' ' 73' ' ' LEU . 6.4 mp -98.77 126.67 44.47 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 122.12 -0.363 . . . . 0.0 110.379 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -146.52 145.63 30.23 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 122.098 -0.376 . . . . 0.0 110.402 176.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 98.1 p -143.64 166.91 23.55 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 178.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 177.59 -164.7 33.96 Favored Glycine 0 N--CA 1.497 2.721 0 N-CA-C 110.301 -1.119 . . . . 0.0 110.301 -178.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 2.1 m -95.86 131.68 41.93 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 122.187 -0.596 . . . . 0.0 110.244 -174.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 53.8 ttm -98.75 122.7 42.32 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 122.011 -0.431 . . . . 0.0 110.162 175.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 22.2 pttt -65.61 170.34 5.21 Favored 'General case' 0 N--CA 1.503 2.202 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.552 175.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 54.1 p90 -64.89 126.16 27.12 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 122.055 -0.403 . . . . 0.0 110.576 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -120.7 -46.52 2.35 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 122.171 -0.331 . . . . 0.0 110.352 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 149.65 -35.48 1.02 Allowed Glycine 0 N--CA 1.495 2.619 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 -179.155 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 87.3 p -72.93 122.88 22.39 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 122.039 -0.683 . . . . 0.0 110.157 -178.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -78.34 -34.64 48.37 Favored 'General case' 0 N--CA 1.501 2.114 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.389 -178.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -155.69 50.85 0.55 Allowed 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.161 0.505 . . . . 0.0 110.058 -179.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 60.6 mt-30 -155.5 120.43 4.8 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.89 -0.506 . . . . 0.0 110.218 -176.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 4.6 m -110.75 94.02 4.79 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 173.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -79.96 164.93 23.11 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.938 -0.476 . . . . 0.0 110.589 -174.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -119.44 143.97 47.21 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 174.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.4 m -74.5 141.11 76.11 Favored Pre-proline 0 N--CA 1.5 2.058 0 C-N-CA 120.604 -0.439 . . . . 0.0 109.959 -176.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -77.63 63.5 7.98 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 O-C-N 123.317 1.167 . . . . 0.0 110.613 179.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 15.4 ttmm -155.5 41.1 0.41 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.703 -0.623 . . . . 0.0 109.884 178.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -155.84 140.29 16.79 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 179.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -121.44 91.11 3.45 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 122.031 -0.418 . . . . 0.0 110.126 178.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 20.6 tp -155.07 154.18 32.04 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.994 -0.441 . . . . 0.0 110.099 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 73.4 mtt85 -91.39 118.63 30.7 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 110.062 -0.348 . . . . 0.0 110.062 177.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 30.1 ptt180 -161.36 165.22 29.31 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 122.064 -0.398 . . . . 0.0 110.648 -176.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 18.9 m -133.79 149.13 51.41 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 177.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.689 HD12 HD12 ' A' ' 62' ' ' ILE . 17.9 tt -143.27 119.73 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 122.017 -0.427 . . . . 0.0 110.078 -178.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -105.91 149.87 26.17 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 120.824 0.345 . . . . 0.0 110.595 -179.106 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 90.9 m -143.15 163.16 33.65 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 175.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 12.1 p -157.21 150.99 24.4 Favored 'General case' 0 N--CA 1.501 2.106 0 C-N-CA 120.071 -0.652 . . . . 0.0 111.267 176.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 59.3 ttt180 -99.68 44.49 1.02 Allowed 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.259 0.552 . . . . 0.0 109.826 166.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 34.2 p -144.73 142.7 30.24 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 121.37 0.605 . . . . 0.0 110.6 -175.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 17.8 p-10 -70.98 138.87 50.33 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-O 121.449 0.642 . . . . 0.0 111.544 -162.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 29.5 mt 51.38 27.92 4.03 Favored 'General case' 0 N--CA 1.505 2.302 0 CA-C-N 116.361 -0.381 . . . . 0.0 112.006 174.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 18.3 p -60.11 -32.72 71.25 Favored 'General case' 0 N--CA 1.51 2.541 0 C-N-CA 119.969 -0.693 . . . . 0.0 111.162 174.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -81.77 -22.95 36.9 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 122.1 -0.375 . . . . 0.0 111.45 -168.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -61.52 -39.32 90.6 Favored 'General case' 0 N--CA 1.508 2.435 0 O-C-N 121.658 -0.651 . . . . 0.0 110.717 -174.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -99.75 16.29 24.08 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 122.072 -0.392 . . . . 0.0 111.628 176.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 18.5 tp -108.73 116.73 32.54 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.613 -0.679 . . . . 0.0 110.224 -174.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -95.84 120.63 62.84 Favored Pre-proline 0 N--CA 1.497 1.885 0 CA-C-O 118.766 -0.635 . . . . 0.0 109.955 172.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -70.68 142.26 43.43 Favored 'Trans proline' 0 N--CA 1.491 1.368 0 O-C-N 123.329 1.173 . . . . 0.0 110.289 174.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 49.0 p -139.22 150.09 45.12 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 178.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 44.0 mt -71.22 150.83 94.5 Favored Pre-proline 0 N--CA 1.501 2.111 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.079 179.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -67.94 149.9 77.82 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 O-C-N 123.487 1.256 . . . . 0.0 110.338 -178.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -68.39 152.33 75.44 Favored 'Trans proline' 0 N--CA 1.491 1.368 0 O-C-N 123.482 1.253 . . . . 0.0 110.267 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.414 HG12 ' N ' ' A' ' 119' ' ' VAL . 43.1 t -79.4 165.37 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.414 ' N ' HG12 ' A' ' 118' ' ' VAL . 14.6 p -87.12 138.43 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 122.031 -0.418 . . . . 0.0 110.429 -178.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 17.9 tt -152.08 128.13 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 122.143 -0.348 . . . . 0.0 110.154 179.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -97.1 157.47 21.05 Favored Glycine 0 N--CA 1.496 2.638 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_exo -58.7 99.69 0.11 Allowed 'Trans proline' 0 N--CA 1.5 1.908 0 C-N-CA 121.057 1.172 . . . . 0.0 111.444 178.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -155.12 153.49 30.9 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 122.146 -0.346 . . . . 0.0 110.118 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -155.9 125.14 6.19 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -82.69 -39.59 21.79 Favored 'General case' 0 N--CA 1.5 2.032 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.146 -178.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 74.8 37.72 44.13 Favored Glycine 0 N--CA 1.495 2.607 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 87.4 p -80.21 159.31 25.99 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 122.099 -0.648 . . . . 0.0 110.211 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 50.6 mm -90.37 136.8 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 39.2 ttm180 . . . . . 0 N--CA 1.496 1.853 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.234 -179.891 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.25 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_exo -58.32 117.6 4.34 Favored 'Trans proline' 0 N--CA 1.502 1.985 0 O-C-N 123.319 1.168 . . . . 0.0 111.403 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -155.41 79.12 1.03 Allowed 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 -177.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -78.65 87.93 4.57 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.925 -0.485 . . . . 0.0 110.007 179.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.585 HG22 ' HB2' ' A' ' 56' ' ' ASN . 17.8 m -137.87 117.06 12.62 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.974 -0.454 . . . . 0.0 110.048 177.38 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 20.4 mt -78.43 151.04 77.44 Favored Pre-proline 0 N--CA 1.502 2.142 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.097 -177.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -64.47 126.26 16.58 Favored 'Trans proline' 0 N--CA 1.497 1.732 0 O-C-N 123.342 1.18 . . . . 0.0 111.14 168.406 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -158.1 52.24 0.44 Allowed 'General case' 0 N--CA 1.501 2.092 0 CA-C-O 121.434 0.635 . . . . 0.0 110.283 164.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.403 HD23 HG23 ' A' ' 55' ' ' THR . 20.7 tp -158.56 115.22 2.77 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.65 -0.656 . . . . 0.0 110.185 -177.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 49.8 tttt -99.82 133.59 43.96 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 122.162 -0.336 . . . . 0.0 110.236 179.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 77.6 m -121.01 140.44 51.92 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 -178.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -82.23 142.95 31.71 Favored 'General case' 0 N--CA 1.502 2.125 0 C-N-CA 120.581 -0.448 . . . . 0.0 109.958 176.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 27.8 p -115.82 136.99 52.52 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 122.016 -0.428 . . . . 0.0 110.561 -177.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 28.2 t -123.07 134.73 54.24 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 178.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.35 -66.33 2.95 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -111.54 118.42 35.67 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 122.098 -0.648 . . . . 0.0 110.548 -176.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -138.01 135.95 19.2 Favored Pre-proline 0 N--CA 1.495 1.809 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 174.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -61.75 153.84 64.82 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 O-C-N 123.237 1.125 . . . . 0.0 111.105 -170.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -60.2 -27.67 67.36 Favored 'General case' 0 N--CA 1.508 2.465 0 O-C-N 122.01 -0.431 . . . . 0.0 111.44 -173.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -92.22 14.27 16.73 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.964 -0.46 . . . . 0.0 111.737 -177.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.03 162.07 27.0 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.687 -0.633 . . . . 0.0 110.182 -174.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 70.3 mt -124.1 136.14 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -175.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 19.4 p30 37.62 43.36 0.44 Allowed 'General case' 0 N--CA 1.515 2.788 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 -176.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 30.6 t30 56.29 43.07 27.04 Favored 'General case' 0 N--CA 1.507 2.379 0 O-C-N 121.706 -0.621 . . . . 0.0 111.413 -179.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 51.0 p -140.69 163.97 31.45 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.78 -0.575 . . . . 0.0 110.363 171.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.7 p -139.05 164.97 28.37 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 120.955 0.407 . . . . 0.0 110.549 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 77.5 mt -112.62 133.03 59.71 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -175.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.403 HG23 HD23 ' A' ' 36' ' ' LEU . 8.8 t -140.67 152.62 45.51 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 122.022 -0.424 . . . . 0.0 111.163 -178.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.585 ' HB2' HG22 ' A' ' 32' ' ' THR . 8.9 p-10 -108.78 30.04 6.88 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 122.022 -0.424 . . . . 0.0 110.659 167.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -122.35 -94.81 1.25 Allowed Glycine 0 N--CA 1.496 2.657 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 176.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 27.5 m80 -147.73 171.95 14.86 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 122.042 -0.681 . . . . 0.0 109.429 176.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 78.6 m -93.85 139.0 31.4 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 166.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -129.81 152.27 49.48 Favored 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 120.306 -0.558 . . . . 0.0 110.7 -177.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -150.89 145.4 25.62 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 176.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.487 HD12 HD12 ' A' ' 99' ' ' ILE . 18.1 tt -142.07 149.25 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 CA-C-O 120.998 0.428 . . . . 0.0 110.357 -172.502 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.813 HD12 HD21 ' A' ' 73' ' ' LEU . 16.7 tt -136.54 145.19 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 178.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -149.48 138.44 21.19 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 -170.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.3 tm-20 -101.69 116.52 32.91 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 -179.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 24.1 p-10 -86.95 175.34 8.2 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 122.12 -0.363 . . . . 0.0 110.608 -176.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -60.37 -17.27 42.4 Favored 'General case' 0 N--CA 1.508 2.433 0 O-C-N 121.946 -0.471 . . . . 0.0 112.008 -173.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -91.88 -11.41 36.45 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.647 -0.658 . . . . 0.0 111.787 178.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.02 21.03 37.13 Favored Glycine 0 N--CA 1.497 2.754 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 176.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -96.66 141.13 30.28 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 118.263 1.031 . . . . 0.0 109.838 171.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.5 p -94.86 126.63 40.32 Favored 'General case' 0 N--CA 1.499 2.009 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.196 176.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.5 p -98.01 114.51 26.68 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 122.134 -0.354 . . . . 0.0 110.267 177.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.813 HD21 HD12 ' A' ' 63' ' ' ILE . 70.7 mt -97.09 127.81 43.42 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 122.149 -0.345 . . . . 0.0 110.297 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -144.68 144.98 31.51 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 122.089 -0.382 . . . . 0.0 110.572 176.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 99.8 p -143.67 166.48 24.74 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 176.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 179.47 -166.27 35.51 Favored Glycine 0 N--CA 1.497 2.731 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 2.2 m -97.24 133.0 42.44 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 122.319 -0.518 . . . . 0.0 110.263 -175.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 47.1 ttm -105.05 121.68 44.3 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 122.135 -0.353 . . . . 0.0 110.146 173.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 12.1 pttt -68.58 156.4 38.14 Favored 'General case' 0 N--CA 1.501 2.085 0 C-N-CA 120.514 -0.474 . . . . 0.0 110.262 174.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 35.2 t80 -68.58 139.71 55.56 Favored 'General case' 0 N--CA 1.501 2.078 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.24 -178.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -154.1 -65.8 0.14 Allowed 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 177.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -145.24 101.79 0.25 Allowed Glycine 0 N--CA 1.496 2.681 0 N-CA-C 108.013 -2.035 . . . . 0.0 108.013 178.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 16.1 m -82.49 -7.2 59.64 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.965 -0.727 . . . . 0.0 110.312 -179.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -81.56 -30.69 32.96 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.561 -0.712 . . . . 0.0 110.95 -174.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -155.55 79.52 1.02 Allowed 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 121.337 0.589 . . . . 0.0 110.305 -179.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -155.28 48.75 0.54 Allowed 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.329 0.585 . . . . 0.0 109.707 178.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 34.0 t -155.09 50.7 0.59 Allowed 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 121.223 0.535 . . . . 0.0 110.097 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.9 mmtp -154.98 -170.41 3.49 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -174.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -129.67 143.29 50.75 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 122.127 -0.358 . . . . 0.0 110.235 178.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.7 t -78.49 144.07 65.0 Favored Pre-proline 0 N--CA 1.499 1.982 0 CA-C-O 119.208 -0.425 . . . . 0.0 110.006 179.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -78.69 61.12 7.91 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 O-C-N 123.24 1.126 . . . . 0.0 110.598 175.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 50.4 tttm -155.5 44.94 0.47 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.795 -0.566 . . . . 0.0 109.928 -178.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -155.56 139.35 16.17 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.971 -0.456 . . . . 0.0 110.019 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -99.51 61.79 1.19 Allowed 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.363 0.601 . . . . 0.0 110.081 -177.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 19.6 tp -144.87 149.21 34.96 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.703 -0.623 . . . . 0.0 110.261 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 -104.89 123.47 47.79 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 122.086 -0.384 . . . . 0.0 110.104 179.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 27.7 ptt180 -161.57 165.15 28.89 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 122.007 -0.433 . . . . 0.0 110.803 -179.121 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.421 ' O ' HG22 ' A' ' 63' ' ' ILE . 19.1 m -133.66 149.43 51.56 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.487 HD12 HD12 ' A' ' 62' ' ' ILE . 18.3 tt -143.03 155.96 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.964 -0.46 . . . . 0.0 110.21 -177.299 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 52.1 mm-40 -143.65 152.01 40.82 Favored 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 120.901 -0.32 . . . . 0.0 110.613 -176.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 26.7 p -143.12 144.47 32.24 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 178.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 20.1 p -157.7 133.85 9.48 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.991 -0.443 . . . . 0.0 110.792 -175.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 31.6 ttp180 -106.25 47.21 0.89 Allowed 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.26 0.552 . . . . 0.0 110.659 -173.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.1 p -139.36 152.14 46.92 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.95 -0.469 . . . . 0.0 109.829 176.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 17.5 p-10 -61.35 131.94 51.93 Favored 'General case' 0 N--CA 1.506 2.344 0 CA-C-O 121.373 0.606 . . . . 0.0 111.904 -163.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 72.4 mt 52.22 26.38 3.93 Favored 'General case' 0 N--CA 1.506 2.348 0 O-C-N 122.078 -0.389 . . . . 0.0 112.007 179.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 26.2 p -62.9 -22.22 66.58 Favored 'General case' 0 N--CA 1.507 2.384 0 O-C-N 121.843 -0.536 . . . . 0.0 111.806 176.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -91.71 -22.81 20.02 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.785 -0.572 . . . . 0.0 111.37 179.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -60.29 -37.43 80.47 Favored 'General case' 0 N--CA 1.509 2.491 0 O-C-N 121.682 -0.637 . . . . 0.0 110.717 -175.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -101.41 16.19 26.43 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 122.116 -0.365 . . . . 0.0 111.649 177.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 15.0 tp -111.67 110.24 20.53 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.532 -0.73 . . . . 0.0 110.384 -174.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -97.08 120.76 60.74 Favored Pre-proline 0 N--CA 1.495 1.823 0 CA-C-O 118.94 -0.553 . . . . 0.0 110.063 173.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.4 149.32 50.28 Favored 'Trans proline' 0 N--CA 1.489 1.239 0 O-C-N 123.092 1.048 . . . . 0.0 110.274 175.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 34.1 p -139.13 137.82 36.45 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 122.144 -0.348 . . . . 0.0 110.238 178.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 41.9 mt -72.53 149.7 91.07 Favored Pre-proline 0 N--CA 1.502 2.156 0 C-N-CA 120.669 -0.413 . . . . 0.0 110.151 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -70.34 156.93 60.76 Favored 'Trans proline' 0 N--CA 1.49 1.32 0 O-C-N 123.491 1.258 . . . . 0.0 110.245 179.037 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -64.17 155.09 67.09 Favored 'Trans proline' 0 N--CA 1.494 1.549 0 O-C-N 123.348 1.183 . . . . 0.0 110.675 177.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.423 HG12 ' N ' ' A' ' 119' ' ' VAL . 48.0 t -150.1 165.52 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 -179.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.423 ' N ' HG12 ' A' ' 118' ' ' VAL . 11.7 p -152.64 146.89 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 122.05 -0.406 . . . . 0.0 110.04 -179.261 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.574 ' O ' HG23 ' A' ' 120' ' ' ILE . 17.8 tt -154.27 73.19 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 -179.138 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 118.1 -72.06 0.3 Allowed Glycine 0 N--CA 1.496 2.657 0 CA-C-O 119.457 -0.635 . . . . 0.0 112.671 178.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -63.88 148.21 91.88 Favored 'Trans proline' 0 N--CA 1.501 1.939 0 C-N-CA 121.086 1.191 . . . . 0.0 110.06 -179.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -84.2 150.41 25.5 Favored 'General case' 0 N--CA 1.499 2.018 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.261 179.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -73.29 65.32 0.85 Allowed 'General case' 0 N--CA 1.502 2.159 0 CA-C-O 121.295 0.569 . . . . 0.0 110.058 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -85.04 -35.42 21.9 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.737 -0.602 . . . . 0.0 110.726 -177.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -130.79 64.01 0.62 Allowed Glycine 0 N--CA 1.497 2.748 0 C-N-CA 121.087 -0.578 . . . . 0.0 112.958 -173.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 57.8 m -152.47 153.93 34.51 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 122.002 -0.705 . . . . 0.0 110.462 179.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 70.6 mt -87.23 134.13 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 O-C-N 122.039 -0.413 . . . . 0.0 111.102 -178.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 71.1 ttt-85 . . . . . 0 N--CA 1.498 1.94 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.243 179.902 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.29 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo -58.47 120.62 8.61 Favored 'Trans proline' 0 N--CA 1.502 1.977 0 C-N-CA 121.063 1.175 . . . . 0.0 111.34 179.12 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -90.45 47.04 1.39 Allowed 'General case' 0 N--CA 1.501 2.109 0 CA-C-O 121.156 0.503 . . . . 0.0 110.906 179.278 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -78.25 72.38 4.78 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.696 -0.628 . . . . 0.0 110.298 -178.2 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.542 HG22 ' HB2' ' A' ' 56' ' ' ASN . 20.0 m -145.34 120.73 10.3 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.841 -0.537 . . . . 0.0 110.096 179.666 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 21.6 mt -77.45 150.93 80.24 Favored Pre-proline 0 N--CA 1.501 2.091 0 CA-C-O 119.366 -0.35 . . . . 0.0 110.148 -178.934 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -63.99 122.95 11.15 Favored 'Trans proline' 0 N--CA 1.497 1.699 0 O-C-N 123.298 1.157 . . . . 0.0 111.193 168.961 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -157.82 52.53 0.45 Allowed 'General case' 0 N--CA 1.501 2.098 0 CA-C-O 121.363 0.601 . . . . 0.0 110.26 165.082 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.435 HD23 HG23 ' A' ' 55' ' ' THR . 21.1 tp -158.35 114.89 2.79 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.77 -0.581 . . . . 0.0 110.111 -177.858 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 27.9 ttmt -99.74 131.77 45.51 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 122.11 -0.368 . . . . 0.0 110.314 178.989 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 70.0 m -118.25 140.33 49.96 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -178.852 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -82.62 145.83 29.47 Favored 'General case' 0 N--CA 1.501 2.092 0 C-N-CA 120.624 -0.43 . . . . 0.0 109.984 176.255 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 28.0 p -115.15 137.07 52.43 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 122.007 -0.433 . . . . 0.0 110.599 -177.864 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 99.2 p -123.01 144.0 49.56 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 176.598 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.36 -68.22 1.46 Allowed Glycine 0 N--CA 1.495 2.587 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 -179.789 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -116.84 129.59 56.18 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.939 -0.742 . . . . 0.0 110.518 -177.042 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -138.07 136.86 20.02 Favored Pre-proline 0 N--CA 1.496 1.838 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 174.689 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -60.21 151.53 72.7 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 O-C-N 123.078 1.041 . . . . 0.0 111.231 -172.191 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -60.1 -28.21 67.66 Favored 'General case' 0 N--CA 1.507 2.407 0 O-C-N 121.98 -0.45 . . . . 0.0 111.478 -172.595 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -92.11 14.28 16.47 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.981 -0.449 . . . . 0.0 111.794 -177.937 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.85 161.61 26.64 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.674 -0.641 . . . . 0.0 110.277 -173.117 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 75.7 mt -126.08 141.1 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -177.991 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 38.9 41.87 0.58 Allowed 'General case' 0 N--CA 1.512 2.663 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -177.206 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 30.7 m120 54.89 41.55 31.81 Favored 'General case' 0 N--CA 1.508 2.464 0 O-C-N 121.845 -0.535 . . . . 0.0 111.461 -178.955 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 43.7 p -141.65 162.6 35.08 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.82 -0.55 . . . . 0.0 110.376 174.323 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.3 p -139.31 163.49 32.34 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 120.967 0.413 . . . . 0.0 110.555 -179.384 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 77.9 mt -109.43 131.95 58.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -176.189 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.435 HG23 HD23 ' A' ' 36' ' ' LEU . 8.9 t -139.16 152.83 47.73 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.935 -0.478 . . . . 0.0 110.893 179.804 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.542 ' HB2' HG22 ' A' ' 32' ' ' THR . 26.8 p30 -110.04 31.56 5.78 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 122.046 -0.409 . . . . 0.0 110.575 166.91 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -123.29 -94.71 1.16 Allowed Glycine 0 N--CA 1.497 2.718 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 175.642 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 31.9 m-70 -146.35 172.05 14.07 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 122.056 -0.673 . . . . 0.0 109.513 176.668 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 81.0 m -94.36 139.22 31.38 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 165.161 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 21.3 p90 -127.92 146.44 50.64 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 120.35 -0.54 . . . . 0.0 110.431 -179.199 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -147.61 140.2 24.68 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 174.431 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.63 HD12 HD12 ' A' ' 99' ' ' ILE . 18.3 tt -143.09 149.28 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.31 -171.644 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.511 HD12 ' HG ' ' A' ' 73' ' ' LEU . 15.6 tt -137.96 145.26 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 178.09 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -150.2 146.91 27.13 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 122.041 -0.412 . . . . 0.0 110.023 -168.044 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.3 tm-20 -101.69 116.94 33.84 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 122.124 -0.36 . . . . 0.0 110.117 -177.059 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -87.2 175.3 8.12 Favored 'General case' 0 N--CA 1.502 2.148 0 CA-C-O 120.868 0.366 . . . . 0.0 110.536 -175.621 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -60.56 -17.35 45.59 Favored 'General case' 0 N--CA 1.506 2.365 0 O-C-N 121.914 -0.491 . . . . 0.0 112.17 -172.646 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -92.77 -11.6 33.4 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.643 -0.66 . . . . 0.0 111.803 178.172 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.9 20.12 40.87 Favored Glycine 0 N--CA 1.499 2.862 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 177.083 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -97.37 143.88 27.68 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 118.399 1.099 . . . . 0.0 109.806 169.821 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.8 p -94.87 124.99 39.23 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.255 178.014 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 17.8 p -97.94 112.96 24.7 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 120.923 -0.311 . . . . 0.0 110.289 178.223 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.542 ' N ' HD12 ' A' ' 73' ' ' LEU . 6.3 mp -98.24 128.53 44.74 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 122.144 -0.347 . . . . 0.0 110.273 -179.91 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -145.87 145.94 30.92 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.347 177.275 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 86.8 p -143.68 165.85 26.5 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 177.015 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 178.4 -164.53 33.22 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 -179.902 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 3.9 m -97.07 132.51 42.8 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 122.185 -0.597 . . . . 0.0 110.384 -175.53 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 49.1 ttm -99.56 121.88 41.82 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.993 -0.442 . . . . 0.0 110.231 176.662 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.3 ptpp? -67.9 152.4 45.62 Favored 'General case' 0 N--CA 1.503 2.219 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.214 178.135 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -67.48 140.62 57.07 Favored 'General case' 0 N--CA 1.502 2.127 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.454 -176.981 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -153.76 -60.12 0.13 Allowed 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 178.818 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -147.51 69.06 0.37 Allowed Glycine 0 N--CA 1.494 2.536 0 N-CA-C 114.529 0.572 . . . . 0.0 114.529 174.068 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 54.7 m -66.27 8.52 0.22 Allowed 'General case' 0 N--CA 1.504 2.232 0 N-CA-C 117.98 2.585 . . . . 0.0 117.98 -168.778 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -74.63 -47.81 29.94 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.489 -0.757 . . . . 0.0 110.129 -175.047 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -156.0 26.44 0.37 Allowed 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 120.654 -0.418 . . . . 0.0 111.524 -175.133 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 62.7 mm-40 -83.23 60.47 5.57 Favored 'General case' 0 N--CA 1.504 2.271 0 CA-C-O 121.353 0.597 . . . . 0.0 111.155 -175.969 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 5.2 t -155.34 24.49 0.41 Allowed 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.46 -0.775 . . . . 0.0 110.929 168.974 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 69.7 mttt -86.84 -171.21 3.41 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.743 -0.598 . . . . 0.0 110.545 -176.504 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -110.44 117.62 34.08 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 122.115 -0.366 . . . . 0.0 110.284 177.904 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 7.0 m -80.02 167.65 31.9 Favored Pre-proline 0 N--CA 1.498 1.964 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.946 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -84.85 52.66 3.5 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 O-C-N 123.296 1.156 . . . . 0.0 111.338 175.201 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 54.0 tttm -155.84 45.66 0.46 Allowed 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.625 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.47 160.27 33.02 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.835 -0.541 . . . . 0.0 111.111 -157.956 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -98.96 -168.91 1.69 Allowed 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -177.42 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.8 tp -64.17 168.59 5.3 Favored 'General case' 0 N--CA 1.508 2.444 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -179.955 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 85.2 mtt180 -68.13 128.52 36.83 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.53 -0.732 . . . . 0.0 110.303 -160.696 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 27.7 ptt180 -161.47 165.19 29.07 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 120.843 0.354 . . . . 0.0 110.401 -170.682 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 18.1 m -131.03 149.04 52.8 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 174.841 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.63 HD12 HD12 ' A' ' 62' ' ' ILE . 18.5 tt -143.13 154.97 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.991 -0.443 . . . . 0.0 110.051 -178.586 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -143.92 125.9 15.36 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 120.842 0.353 . . . . 0.0 110.699 -179.572 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 92.8 m -104.9 147.55 27.64 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 168.63 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 22.9 p -157.76 135.19 10.37 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.858 -0.526 . . . . 0.0 111.031 176.22 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 9.4 ttm180 -108.2 47.04 0.92 Allowed 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 121.29 0.567 . . . . 0.0 110.788 -173.315 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.3 p -141.87 151.93 43.16 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.771 -0.581 . . . . 0.0 110.033 177.713 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 17.5 p-10 -61.69 132.43 53.21 Favored 'General case' 0 N--CA 1.505 2.287 0 CA-C-O 121.339 0.59 . . . . 0.0 111.821 -164.243 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.475 HD22 ' OE1' ' A' ' 109' ' ' GLN . 75.7 mt 52.0 27.13 4.18 Favored 'General case' 0 N--CA 1.506 2.365 0 O-C-N 122.051 -0.406 . . . . 0.0 111.995 179.547 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 25.3 p -62.62 -22.8 66.68 Favored 'General case' 0 N--CA 1.507 2.42 0 O-C-N 121.847 -0.533 . . . . 0.0 111.585 175.419 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -92.82 -22.82 19.09 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.682 -0.636 . . . . 0.0 111.224 178.071 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.475 ' OE1' HD22 ' A' ' 106' ' ' LEU . 27.7 tt0 -61.63 -38.62 88.35 Favored 'General case' 0 N--CA 1.507 2.381 0 O-C-N 121.57 -0.706 . . . . 0.0 110.671 -177.034 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -100.1 16.19 24.89 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 122.113 -0.367 . . . . 0.0 111.596 178.772 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 18.0 tp -112.68 114.31 26.84 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.625 -0.672 . . . . 0.0 110.361 -175.458 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -96.31 120.83 61.78 Favored Pre-proline 0 N--CA 1.496 1.87 0 CA-C-O 118.927 -0.558 . . . . 0.0 109.944 173.022 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -68.81 144.93 60.97 Favored 'Trans proline' 0 N--CA 1.491 1.353 0 O-C-N 123.17 1.089 . . . . 0.0 110.253 175.33 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 47.6 p -139.18 134.15 32.38 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 122.074 -0.391 . . . . 0.0 110.121 179.624 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 17.2 mt -72.48 155.01 91.58 Favored Pre-proline 0 N--CA 1.5 2.035 0 CA-C-O 119.287 -0.387 . . . . 0.0 110.173 179.664 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_exo -63.42 163.05 25.0 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 O-C-N 123.453 1.239 . . . . 0.0 110.725 175.905 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -62.53 121.95 10.12 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 O-C-N 123.372 1.196 . . . . 0.0 110.954 -176.852 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.444 HG12 ' N ' ' A' ' 119' ' ' VAL . 43.4 t -81.66 167.14 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.196 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -178.674 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.444 ' N ' HG12 ' A' ' 118' ' ' VAL . 11.7 p -87.55 165.28 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 177.566 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 17.7 tt -146.27 138.58 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 -179.139 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 166.64 -59.94 0.23 Allowed Glycine 0 N--CA 1.496 2.675 0 N-CA-C 118.255 2.062 . . . . 0.0 118.255 -179.803 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_exo -87.09 170.29 7.14 Favored 'Trans proline' 0 N--CA 1.502 1.974 0 N-CA-C 104.385 -2.967 . . . . 0.0 104.385 173.523 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -155.21 159.84 40.4 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 122.115 -0.366 . . . . 0.0 110.365 -179.557 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -155.43 154.17 31.49 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 -177.194 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -155.18 33.65 0.38 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 122.141 -0.35 . . . . 0.0 110.313 -178.846 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -139.75 46.27 0.96 Allowed Glycine 0 N--CA 1.496 2.69 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.267 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 50.6 m -80.59 136.15 36.19 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 122.166 -0.608 . . . . 0.0 110.194 179.809 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 50.9 mm -91.53 140.7 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.577 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 71.3 ttt-85 . . . . . 0 N--CA 1.499 1.98 0 CA-C-O 117.979 -1.01 . . . . 0.0 110.136 179.103 . . . . . . . . 0 0 . 1 stop_ save_